10.07.2015 Views

Chemical Analysis of Value Added Dairy Products and Their Quality ...

Chemical Analysis of Value Added Dairy Products and Their Quality ...

Chemical Analysis of Value Added Dairy Products and Their Quality ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Dr. Rajan SharmaSenior Scientist & Director, Winter SchoolDr. (Mrs.) Bimlesh MannPrincipal Scientist & Co-Director, Winter SchoolCourse AdvisorsDr. (Mrs.) B.K. WadhwaDr. Darshan LalDr. Raman SethALL RIGHTS RESERVEDNo part <strong>of</strong> the lecture compendium may be reproduced or transmitted in any form or byany means, electronic or mechanical, including photocopy, recording, or any information,storage <strong>and</strong> retrieval system without the written permission <strong>of</strong> Director, NDRI, Karnal.


Committees for Organisation <strong>of</strong> Winter SchoolOrganizing CommitteeDr. (Mrs.) B.K. Wadhwa, Head & Principal ScientistDr. Darshan Lal, Principal ScientistDr. Raman Seth, Principal ScientistDr. (Mrs) Bimlesh Mann, Principal ScientistDr. Sumit Arora, Senior ScientistDr. Vivek Sharma, Senior ScientistDr. Rajesh Kumar, Senior ScientistDr. Rajan Sharma, Senior Scientist (Convener)Registration CommitteeDr. Raman Seth (Chairman)Dr. Rajesh Kumar (Convener)Dr. Sumit AroraSh. P.C. SinghSh. Ajit SinghTechnical ComiitteeDr. Darshan Lal (Chairman)Dr. (Mrs) Bimlesh Mann (Convener)Dr. Raman SethDr. Rajesh KumarDr. Rajan SharmaHospitality CommitteeDr. (Mrs.) B.K. Wadhwa (Chairman)Dr. Vivek Sharma (Convener)Dr. (Mrs.) Bimlesh MannSh. Rajeev SharmaPurchase CommitteeDr. (Mrs) Bimlesh Mann (Chairman)Dr. Rajan Sharma (Convener)Dr. Rajesh KumarDr. Vivek Sharma


THEORYContents1. Novel <strong>and</strong> Emerging Food Technologies for Defence Food Supplies 1A. S. Bawa2. An Overview <strong>of</strong> Designer Functional <strong>and</strong> Health Foods5A. K. Srivastava3. Prospects <strong>of</strong> <strong>Value</strong> Addition Through Functional Ingredients 10G. R. Patil4. Technological <strong>and</strong> Nutritional Aspects <strong>of</strong> Milk Phospholipids 17B. K. Wadhwa <strong>and</strong> Rajesh Kumar5.Methods <strong>of</strong> Cholesterol Removal to Develop Low –Cholesterol <strong>Dairy</strong> <strong>Products</strong> 22Darshan Lal <strong>and</strong> Vivek Sharma6. Fortification <strong>of</strong> Milk <strong>and</strong> Milk <strong>Products</strong> for <strong>Value</strong> Addition 29Sumit Arora7. Packaging <strong>of</strong> <strong>Value</strong> <strong>Added</strong> Foods <strong>and</strong> <strong>Their</strong> Storage Stability 36P. P. Gothwal8.Novel Technologies for Processing <strong>and</strong> Packaging <strong>of</strong>Health Foods <strong>and</strong> Beverages 40H. N. Mishra9. Glycomacropeptide – Biological Properties <strong>and</strong> its Application 49Rajan Sharma <strong>and</strong> Neelima Sharma10.11.New Approaches to Detect the Adulteration <strong>of</strong> Gheewith Animal Body Fats <strong>and</strong> Vegetable Oils/ Fats 54Vivek Sharma, Darshan Lal, Arun Kumar <strong>and</strong> Amit KumarColostrum Powder <strong>and</strong> its HealthBenefits 59Raman Seth <strong>and</strong> Anamika Das12. Cow Ghee Protects from Mammary Carcinogenesis: Mechanism 68Vinod K. Kansal, Rita Rani <strong>and</strong> Ekta Bhatia13.Lateral Flow Assay- Principle <strong>and</strong> its Application inAnalytical Food Science 72Rajan Sharma <strong>and</strong> Priyanka Singh Rao14. Separation Strategies for Bioactive Milk Proteins 77Rajesh Kumar15. SDS-PAGE – Principle <strong>and</strong> Applications 81Y. S. Rajput <strong>and</strong> Rajan SharmaWestern Blot: Theoretical Aspects 816. 5Y. S. Rajput <strong>and</strong> Rajan Sharma


17. Enzyme Linked Immunosorbent Assay - Theory 88Rajeev Kapila <strong>and</strong> Suman Kapila18.19.Experimental Determination <strong>of</strong> Thermal Stability <strong>of</strong>Proteins: A Theoretical Background 93Jai K. KaushikSpecies-Specific Identification <strong>of</strong> Milk <strong>and</strong> Milk<strong>Products</strong>: A Molecular Approach 97Archana Verma20. Proteomic Techniques for Application in Food Science 100Ashok K. Mohanty21.Evaluation <strong>of</strong> Probiotic Attributes <strong>of</strong> <strong>Dairy</strong> StarterCultures Using Various Test Methods 106Rameshwar Singh22. Identification <strong>of</strong> Lactobacillus spp by PCR based MolecularMethodology 110Sachin<strong>and</strong>an De <strong>and</strong> Rupinder Kaur23.24.25.Antimicrobial Substances produced by LacticAcid Bacteria (LAB) 114Shilpa Vij, Subrota Hati <strong>and</strong> Minakshi DahiyaMicrobiological Risk Assessment: A NewConcept to Ensure Food Safety 117Naresh Kumar <strong>and</strong> Raghu H. V.Biopreservation <strong>of</strong> <strong>Dairy</strong> <strong>Products</strong>: Role <strong>of</strong> Bacteriocins<strong>of</strong> Lactic Acid Bacteria 126R. K. Malik <strong>and</strong> Gurpreet Kaur26. Regulatory Aspects <strong>of</strong> Functional Foods 135Bimlesh mann , Rajesh Kumar <strong>and</strong> Prerna Saini27.28.29.30.31.Nanomaterials - <strong>Their</strong> Applications <strong>and</strong> SafetyAspects in Foods 142Bimlesh Mann , Rajesh Kumar <strong>and</strong> Prabhakar PadghamStrategies for Animals Studies to Assess theSafety Aspects <strong>and</strong> Bioavailability <strong>of</strong> Netraceuticals 145Ayyasamy Manimaran <strong>and</strong> Bimlesh MannRecent Advances in Synbiotic <strong>Dairy</strong> Foods <strong>and</strong><strong>Their</strong> Safety Evaluation 151Ch<strong>and</strong> Ram, Manju <strong>and</strong> Santosh An<strong>and</strong>Physical Characterization <strong>of</strong> <strong>Dairy</strong> Foods withReference to Viscosity, Colour <strong>and</strong> Water Activity 160R. R. B. Singh <strong>and</strong> Prateek SharmaMalt Based Milk Foods as “<strong>Value</strong> <strong>Added</strong>Functional <strong>Dairy</strong> <strong>Products</strong>” 165Laxmana Naik, Rajan Sharma, Manju G. <strong>and</strong> Amit K. Barui


32.PRACTICALPreparation <strong>and</strong> Characterization <strong>of</strong> Gold Nanoparticles,<strong>Their</strong> Conjugation with Antibodies <strong>and</strong> Construction<strong>of</strong> Lateral Flow Devices 170Priyanka Singh Rao, Swapnil Sonar, Y.S. Rajput <strong>and</strong> Rajan Sharma33. Use <strong>of</strong> Lateral Flow Technique for Detecting Melamine in Milk 173Raman Seth <strong>and</strong> Anamika Dass34.35.Rancimat (Accelerated <strong>and</strong> Automated) Method forEvaluation <strong>of</strong> Oxidative Stability <strong>of</strong> Fats <strong>and</strong> Oils 177Sumit AroraEstimation <strong>of</strong> Cholesterol Content in Ghee Using aCholesterol Estimation Kit 182Vivek Sharma <strong>and</strong> Darshan Lal36. Rapid Methods for Detection <strong>of</strong> Adulterants in Milk 184Rajan Sharma, Raman Seth <strong>and</strong> Amit K. Bauri37.38.39.Detection <strong>of</strong> Foreign Fats/Oils in Milk <strong>and</strong> GheeUsing Newer Approaches 189Darshan Lal, Vivek Sharma, Arun Kumar <strong>and</strong> Amit KumarDetermination <strong>of</strong> Total Polyphenolic Content in FruitEnriched <strong>Dairy</strong> Product 195Rajesh Kumar <strong>and</strong> Richa SinghSeparation <strong>and</strong> Identification <strong>of</strong> Low MolecularWeight Proteins Using Tricine SDS-PAGE 197Neelima Sharma, Rajan Sharma <strong>and</strong> Y. S. Rajput40. Identification <strong>of</strong> Proteins Through Western Blotting – Practical 200Neelima Sharma, Amit K.Barui <strong>and</strong> Y.S. Rajput41. Typing <strong>of</strong> Milk for A1 <strong>and</strong> A2 beta Casein 204Sachin<strong>and</strong>an De, C. M. Hari Kishore, Ayan Mukherjee <strong>and</strong> Rupinder Kaur42. Enzyme-Linked Immunosorbent Assay-Practical 206Suman Kapila <strong>and</strong> Rajeev Kapila43. Evaluation <strong>of</strong> Biological Activity <strong>of</strong> Milk Protein Ingredients 208Bimlesh Mann, Prerna Saini, Prabhakar Padghan, Anuradha Kumari44. Purification <strong>of</strong> Bioactive Proteins from Milk 212Neha Mishra, Rajesh Kumar <strong>and</strong> Jai K Kaushik45. Immunological Method to Detect Buffalo Milk in Cow Milk 214Archana Verma46. Conjugated Linoleic Acid <strong>and</strong> Its Estimation 217A. K. Tyagi, A. Hossain, A. Tyagi47.Importance <strong>and</strong> Estimation <strong>of</strong> Vitamins A & Ein <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> 221Harjit Kaur


48.49.50.Use <strong>of</strong> Atomic Absorption Spectrophotometer for theEstimation <strong>of</strong> Minerals in Milk <strong>and</strong> Milk <strong>Products</strong> 225Veena ManiPesticides: <strong>Their</strong> <strong>Analysis</strong> in Milk Using HighPerformance Liquid Chromatography 230Ch<strong>and</strong>er Datt <strong>and</strong> Monica PuniyaEstimation <strong>of</strong> Microbial GOS by High PerformanceLiquid Chromatography 233Vikas Sangwan <strong>and</strong> Sudhir Kumar Tomar51. Estimation <strong>of</strong> Trehalose Production by Propionibacteria 236Poonam <strong>and</strong> Sudhir Kumar Tomar52.53.Spore Based Biosensor as A <strong>Quality</strong> Control Tool in<strong>Dairy</strong> Industry 239Naresh Kumar, Raghu H. V. <strong>and</strong> AvinashDetection <strong>and</strong> Evaluation <strong>of</strong> Antimicrobial Activities <strong>of</strong>Bacteriocins <strong>and</strong> Bioactive Peptides Produced by LAB 248Shilpa Vij, Subrota Hati <strong>and</strong> Meenakshi Dahiy


Programme Schedule for Winter SchoolProgramme Schedule for Winter School<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceJanuary 11-31, 201111 th January 2011(Tuesday)9.00 AM – 9.30 AM Registration <strong>of</strong> Participants9.30 AM -12.30 PMInauguration <strong>of</strong> Winter SchoolNovel <strong>and</strong> Emerging Food Technologies for Defence Food Supplies – Inagural Lectureby Dr. A.S.Bawa, Director, Defence Food Research Laboratory, Mysore12.30 PM -1.00 PM Visit to ATIC/Institute FilmLunch2.15 PM – 3.15 PM Achievements <strong>of</strong> <strong>Dairy</strong> Chemistry Division Dr. (Mrs.) B.K. Wadhwa3.15 PM – 4.30 PM Prospects <strong>of</strong> <strong>Value</strong> Addition Through functional Ingredients Dr. G.R. Patil12 th January 2011 (Wednesday)9.45 AM -10.45 AM11.00 AM – 12.00 PM12.00 PM – 1.00 PMLunch2.15 PM -5.00 PMMethod <strong>of</strong> Cholesterol Removal to Develop Low Cholesterol<strong>Dairy</strong> <strong>Products</strong> – TheoryFortifi cation <strong>of</strong> Milk <strong>and</strong> Milk <strong>Products</strong> for <strong>Value</strong> Addition –TheoryCow Ghee Protects from Mammary Carcinogenesis:Mechanism – TheoryEstimation <strong>of</strong> Cholesterol Content in Ghee Using aCholesterol Estimation Kit– PracticalDr. Darshan LalDr. Sumit AroraDr.V.K. KansalDr. Vivek Sharma13 th January 2011 (Thursday)9.45 AM -10.45 AMEvaluation <strong>of</strong> Probiotic Attributes <strong>of</strong> <strong>Dairy</strong> Starter Culturesusing Various Test Methods – TheoryDr. Rameshwar Singh11.00 AM – 12.00 PM Separation Strategies for Bioactive Milk Proteins – Theory Dr. Rajesh Kumar12.00 PM – 1.00 PMLunch2.15 PM – 3.15 PM3.15 PM – 5.00 PMNew Approaches to Detect the Adulteration <strong>of</strong> Milk Gheewith Animal Body Fats <strong>and</strong> Vegetable Oils/ Fats – Theory<strong>Quality</strong> <strong>and</strong> Food Safety in Yoghurt Industry – Guest LectureDetection <strong>of</strong> Foreign Fats/Oils in Milk <strong>and</strong> Ghee Using NewerApproaches - PracticalDr. Vivek SharmaMr. Anuj Mehta(Danone India Ltd.)Dr. Darshan Lal14 th January 2011 (Friday)9.45 AM -10.45 AMTechnological <strong>and</strong> Nutritional Aspects <strong>of</strong> Milk Phospholipids -TheoryDr.(Mrs.) B.K. Wadhwa11.00 AM – 12.00 PM Colostrum Powder <strong>and</strong> its Health benefi t - Theory Dr. Raman Seth12.00 PM – 1.00 PMNovel Technologies for Processing <strong>and</strong> Packaging <strong>of</strong> HealthFoods <strong>and</strong> Beverages – Guest LectureDr. H.N. MisraIIT, Kharagpur


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceLunch2.15 PM – 5.00 PM Purifi cation <strong>of</strong> Bioactive Proteins from Milk – Practical Dr. Jai K. Kaushik15 th January 2011 (Saturday)9.45 AM -10.45 AM11.00 AM – 12.00 PM12.00 PM – 1.00 PMLunch2.15 PM – 3.15 PM3.15 PM – 5.15 PMNanomaterials - <strong>Their</strong> Applications <strong>and</strong> Safety Aspects inFood – TheoryRecent Advances in Synbiotic <strong>Dairy</strong> Foods <strong>and</strong> their SafetyEvaluation – TheoryDetermination <strong>of</strong> Total Polyphenolic Content in Fruit Enriched<strong>Dairy</strong> Product– Theory & Practicalcontd…. Determination <strong>of</strong> Total Polyphenolic Content in FruitEnriched <strong>Dairy</strong> Product – PracticalRancimat (Accelerated <strong>and</strong> Automated) Method forEvaluation <strong>of</strong> Oxidative Stability <strong>of</strong> Fats <strong>and</strong> Oils – Theory &PracticalDr. (Mrs.) Bimlesh MannDr. Ch<strong>and</strong> RamDr. Rajesh KumarDr. Rajesh KumarDr. Sumit Arora16 th January 2011(Sunday)17 th January 2011 (Monday)9.45 AM -10.45 AM SDS-PAGE – Principle <strong>and</strong> Applications -Theory Dr. Y.S. Rajput11.00 AM – 1.00 PMLunchSeparation <strong>and</strong> Identifi cation <strong>of</strong> Low Molecular WeightProteins using SDS-PAGE – PracticalDr. Y.S. Rajput2.15 PM – 3.15 PM Western Blot: Theoretical Aspects – Theory Dr. Y.S. Rajput3.15 PM- 5.00 PM Identifi cation <strong>of</strong> Proteins through Western Blotting – Practical Dr. Y.S. Rajput18 th January 2011 (Tuesday)9.45 AM -10.45 AM11.00 AM – 1.00 PMLunch2.15 PM – 3.15 PM3.15 PM - 4.00 PMLateral Flow Assay- Principle <strong>and</strong> its Application in AnalyticalFood Science – TheoryPreparation <strong>and</strong> Characterization <strong>of</strong> Gold Nanoparticles, theirConjugation with Antibodies <strong>and</strong> Construction <strong>of</strong> Lateral FlowDevices – Practicalcontd…. Preparation <strong>and</strong> Characterization <strong>of</strong> GoldNanoparticles, their Conjugation with Antibodies <strong>and</strong>Construction <strong>of</strong> Lateral Flow Devices - PracticalUse <strong>of</strong> Lateral Flow Technique for Detecting Melamine inMilk – PracticalDr. Rajan SharmaDr. Rajan SharmaDr. Rajan SharmaDr. Raman Seth4.00 PM – 5.00 PM Regulatory Aspects <strong>of</strong> Functional Foods Dr. Bimlesh Mann19 th January 2011 (Wednesday)9.45 AM -10.45 AM11.00 AM – 1.00 PMLunchImportance <strong>and</strong> Estimation <strong>of</strong> Vitamin A & E in <strong>Value</strong> <strong>Added</strong><strong>Dairy</strong> <strong>Products</strong> – Theorycontd…. Importance <strong>and</strong> estimation <strong>of</strong> vitamin A & E in <strong>Value</strong><strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> – PracticalDr. (Mrs.) Harjeet KaurDr. (Mrs.) Harjeet Kaur


Programme Schedule for Winter School2.15 PM – 3.30 PM3.30 PM – 5.00 PMEstimation <strong>of</strong> Microbial GOS by HPLC - Theory <strong>and</strong> PracticalEstimation <strong>of</strong> Trehalose Production by Propionibacteria –Theory <strong>and</strong> PracticalDr. S.K. TomarDr. S.K. Tomar20 th January 2011 (Thursday)9.45 AM -10.45 AM11.00 AM – 1.00 PMLunchMicrobiological Risk Assessment: A New Concept to EnsureFood Safety – TheorySpore Based Biosensor as A <strong>Quality</strong> Control Tool in <strong>Dairy</strong>Industry – PracticalDr. Naresh KumarDr. Naresh Kumar2.15 PM – 3.15 PM Enzyme Linked Immunossorbent Assay –Theory Dr. Rajeev Kapila3.15 PM – 5.00 PM Enzyme Linked Immunossorbent Assay – Practical Dr. Suman Kapila21 st January 2011 (Friday)9.45 AM -10.45 AM11.00 AM- 12.00 PMExperimental Determination <strong>of</strong> Thermal Stability <strong>of</strong> Proteins: ATheoretical BackgroundBiopreservation <strong>of</strong> <strong>Dairy</strong> <strong>Products</strong>: Role <strong>of</strong> Bacteriocins <strong>of</strong>Lactic Acid Bacteria – TheoryDr. Jai K KaushikDr. R.K. Malik11.00 AM- 1.00 PM Glycomacropeptide – Biological Properties <strong>and</strong> its Application Dr. Rajan SharmaLunch2.15 PM – 3.15 PM3.15 PM – 5.00 PMPesticides: <strong>Their</strong> <strong>Analysis</strong> in Milk Using High PerformanceLiquid Chromatography– TheoryContd…. Pesticides: <strong>Their</strong> <strong>Analysis</strong> in Milk Using HighPerformance Liquid Chromatography – PracticalDr. Ch<strong>and</strong>er DattDr. Ch<strong>and</strong>er Datt22 nd January 2011(Saturday)Exposure <strong>of</strong> Participants <strong>of</strong> Winter School to “Brain Storming Session on Promotion <strong>of</strong> Indigenous <strong>Dairy</strong> <strong>Products</strong> inInternational Market” being organized by Alumni Association, NDRI, Karnal23 rd January 2011 (Sunday)24 th January 2011(Monday)2.15 PM – 3.30 PMIdentifi cation <strong>of</strong> Lactobacillus spp by PCR based MolecularMethodology – Theory & PracticalDr. Sachin<strong>and</strong>an De3.30 PM – 5.00 PM Typing <strong>of</strong> Milk for A1 <strong>and</strong> A2 beta casein - Theory & Practical Dr. Sachin<strong>and</strong>an DeLunch2.15 PM – 3.15 PM3.15 PM- 5.00 PM9.45 AM -12.00 PM12.00 AM – 1.00 PMLunchUse <strong>of</strong> Atomic Absorption Spectrophotometer for theEstimation <strong>of</strong> Minerals in Milk <strong>and</strong> Milk <strong>Products</strong> – TheoryContd…. Use <strong>of</strong> Atomic Absorption Spectrophotometer for theEstimation <strong>of</strong> Minerals in Milk <strong>and</strong> Milk <strong>Products</strong> – Practical25th January 2011(Tuesday)Physical Characterization <strong>of</strong> <strong>Dairy</strong> Foods with Reference toViscosity, Colour <strong>and</strong> Water Activity – Theory & PracticalAllergen Mangement in Foods - Emerging TrendsDr. (Mrs.) Veena ManiDr. (Mrs.) Veena ManiDr. R.R. B. SinghRajesh Kumar Sharma(Cadbury India Ltd.)


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assurance2.15 PM – 3.15 PM3.15 PM- 5.00 PMCommon Statistical Techniques for Analytical <strong>Dairy</strong> <strong>and</strong> FoodScience – Theorycontd…. Common Statistical Techniques for Analytical <strong>Dairy</strong><strong>and</strong> Food Science – PracticalDr. A.P. RuhilDr. A.P. Ruhil26 th January 2011(Wednesday) – Republic Day27 th January 2011 (Thursday)9.45 AM -10.45 AMStrategies for Animals Studies to Assess the Safety Aspects<strong>and</strong> Bioavailability <strong>of</strong> Netraceuticals – TheoryDr. AyyasamyManimaran11.00 AM – 12.00 PM Rapid Methods for Detection <strong>of</strong> Adulterants in Milk – Practical Dr. Rajan Sharma12.00 PM – 1.00 PM Visit to Model <strong>Dairy</strong> Mr. G. MutrejaLunch2.15 PM – 3.15 PM3.15 PM- 5.00 PMImmunological Method to Detect Buffalo Milk in Cow Milk –PracticalSpecies-Specifi c Identifi cation <strong>of</strong> Milk <strong>and</strong> Milk <strong>Products</strong>: AMolecular Approach - TheoryDr. (Mrs.) ArchanaVermaDr. (Mrs.) Archna Verma28 th January 2011 (Friday)9.45 AM -10.45 AM11.00 AM – 12.00 PMPackaging <strong>of</strong> <strong>Value</strong> <strong>Added</strong> Foods <strong>and</strong> <strong>Their</strong> Storage Stability– Guest LectureFood Additives <strong>and</strong> <strong>Quality</strong> Issues – Guest LectureP.P. Gothwal (CFTRI,Regional Center,Lucknow)Ravinder Kumar(Danisco India Ltd.)12.00 PM – 1.00 PM Proteomic Techniques for Application in Food Science Dr. Ashok K. MohantyLunch2.15 PM – 3.15 PMEvaluation <strong>of</strong> Biological Activity <strong>of</strong> Milk Protein Ingredients –TheoryDr. (Mrs.) Bimlesh Mann3.15 PM – 5.00 PMcontd…. Evaluation <strong>of</strong> Biological Activity <strong>of</strong> Milk ProteinIngredients – PracticalDr. (Mrs.) Bimlesh Mann29 th January 2011 (Saturday)9.45 AM -10.45 AMAntimicrobial Substances Produced by Lactic Acid Bacteria(LAB) - TheoryDr. (Mrs.) Shilpa Vij11.00 AM – 1.00 PMDetection <strong>and</strong> Evaluation <strong>of</strong> Antimicrobial Activities <strong>of</strong>Bacteriocins <strong>and</strong> Bioactive Peptides Produced by LAB – Dr. (Mrs.) Shilpa VijTheory & PracticalLunch2.15 PM – 3.15 PM Conjugated Linoleic Acid <strong>and</strong> Its Estimation – Theory Dr. Amrish TyagiContd…. Conjugated Linoleic Acid <strong>and</strong> Its Estimation –3.15 PM- 5.00 PMPractical30 th January 2011 (Sunday)31 st January 2011(Monday)9.45 AM -10.45 AMCourse EvaluationDr. Amrish TyagiDr. (Mrs.) Bimlesh Mann<strong>and</strong> Dr. Rajan Sharma10.45 AM – 1.00 PMLunchInteraction with FacultyChaired by Head, DCDivision


Novel <strong>and</strong> Emerging Food Technologies for Defence Food SuppliesNovel <strong>and</strong> Emerging Food Technologiesfor Defence Food SuppliesDr. A. S. BawaDirectorDefence Food Research Laboratory, MysoreThe Defence Food Research Laboratory (DFRL) was established in December, 1961 under theaegis <strong>of</strong> Defence Research & Development Organisation (DRDO), Ministry <strong>of</strong> Defence to cater to thestrategic operational requirements <strong>of</strong> our Services <strong>and</strong> to provide logistical support to the Armedforces in the area <strong>of</strong> food supplies. Our troops <strong>of</strong>ten operate in far flung in hospitable treacherousterrains under inclement <strong>and</strong> hostile weather conditions. In such operational situations, not only arethey deprived <strong>of</strong> the fresh produce needed to sustain life processes even normal regime <strong>of</strong> cookingbecomes extremely cumbersome <strong>and</strong> difficult. The R & D efforts at DFRL are aimed at designing <strong>and</strong>engineering light weight convenient, pack rations for Army,Navy,Air force <strong>and</strong> other paramilitaryforces which do not require any elaborate cooking or preparation at the consumer’s end <strong>and</strong> remainshelf-stable under varying climate condition for periods ranging from 6 months to 1 year. Throughenormous <strong>and</strong> substantive contribution, DFRL has developed a wide verity <strong>of</strong> food products <strong>of</strong> Indi<strong>and</strong>ietary matching the mainframe palate tastes <strong>of</strong> the country. Many <strong>of</strong> the DFRL foods, born out <strong>of</strong>innovative state <strong>of</strong> the art technology, lend themselves eminently suitable to industrial scale commercialexploitation by enterprising entrepreneurs <strong>of</strong> different genre. DFRL also has products which are exportworthy <strong>and</strong> amenable to working women. Owing to its singular dedicated contributions in processedfoods, DFRL can be reckoned as the leader in convenience food <strong>and</strong> packed ration developments inthis country. Indigenous ingenuity is the hallmark <strong>of</strong> most <strong>of</strong> the technologies developed at DFRL.Over the decades, the technological advancements have resulted in several innovative technologiesfor various applications. Among the dehydration techniques freeze-drying maintains the quality <strong>of</strong>products which is quite close to that <strong>of</strong> fresh one. During freeze drying the thermal evaporation <strong>of</strong>moisture is through sublimation at low temperatures <strong>and</strong> under high vacuum. Hurdle technology helpsto preserve foods for a period <strong>of</strong> 2-4 months <strong>and</strong> is applicable to fruits, vegetables <strong>and</strong> their productsas well as meat <strong>and</strong> fish products <strong>and</strong> is sparingly used for cereal products preservation. Hurdletechnology is an intelligent combination <strong>of</strong> hurdles such as pH, temperature, water activity, redoxpotential, preservative etc. to ensure the microbial safety as well as sensory <strong>and</strong> nutritional acceptance.Membrane technology is used in the manufacture <strong>of</strong> clarified juices, for initial concentration throughultra filtration, nano-filtration <strong>and</strong> reverse osmosis processes.Thermal treatment is the most widely used technology for preservation <strong>of</strong> foods. Thus retortprocessing <strong>of</strong> foods has been the most promising technique for preservation <strong>of</strong> both vegetarian <strong>and</strong>non-vegetarian foods in the ready-to-eat form. The temperatures in the range <strong>of</strong> 110 – 125ºC are usedfor low acid foods with the main objective <strong>of</strong> inactivating the undesirable micro-organisms to achievecommercial sterilization. High pressure technology is a novel non-thermal processing method <strong>of</strong> foodpreservation where the food is subjected to high hydrostatic pressures in the range <strong>of</strong> 100-600 Mpa atroom temperature. The Armed Forces are the biggest consumer <strong>of</strong> processed foods <strong>and</strong> approximately13 thous<strong>and</strong> tonnes <strong>of</strong> processed food is used annually. They have to subsist mainly on pack rationsduring operational situations. With the advancements in technological methods, Defence FoodResearch Laboratory (DFRL), Mysore, has contributed significantly to develop suitable technologiesfor preserving traditional Indian foods in light weight flexible packages so that pack rations couldbe designed based on such items to meet the nutritional requirements <strong>of</strong> the Defence personnel foroperational situations <strong>and</strong> this has also paved the way for providing variety <strong>of</strong> foods suiting to theirtaste. These efforts led to the development <strong>of</strong> convenience foods based on cereals, pulses, fruits <strong>and</strong>vegetables with a long shelf-life in flexible packs.1


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceFruit <strong>and</strong> vegetable technologiesThe Indian Army operates on hazardous terrain inclusive <strong>of</strong> Siachen Glacier <strong>and</strong> the s<strong>and</strong>y deserts<strong>of</strong> Rajasthan. Similarly, the Indian Navy is a blue water navy <strong>and</strong> the operations go deeper in theoceans to protect the maritime zones used for international shipping. The concept <strong>of</strong> fruit <strong>and</strong> vegetablestorage as such has undergone a change <strong>and</strong> the troops favors precut fruits <strong>and</strong> vegetables in packagedform on operational rations due to the logistic utility <strong>and</strong> convenience. Therefore, minimal processing<strong>of</strong> precut fruits <strong>and</strong> vegetables needs to be emphasized <strong>and</strong> the unit packages can be formulated as perthe ration scales <strong>and</strong> logistic requirements.The futuristic technologies encompass non-thermal processing i.e. high pressure processing <strong>and</strong>pulsed electric field applications. Eco-friendly <strong>and</strong> energy saving technologies are envisaged to occupytheir rightful place in the area <strong>of</strong> fruit <strong>and</strong> vegetable products. Use <strong>of</strong> biodegradable packaging forfresh <strong>and</strong> processed fruits <strong>and</strong> vegetables is a certainty <strong>and</strong> an absolute necessity. It is a common siteto notice heavy accumulation <strong>of</strong> wastage <strong>and</strong> spent packaging material even in partially inhabitatedareas including the high altitude locations. Use <strong>of</strong> biodegradable plastics <strong>and</strong> other materials <strong>of</strong> organicor inorganic origin need to be stressed upon to minimize the pollution hazards in the army locationsas well as the high seas <strong>of</strong> naval operations.Minimal processing <strong>of</strong> fruits <strong>and</strong> vegetablesSupply <strong>of</strong> fruits <strong>and</strong> vegetables in precut <strong>and</strong> packaged form is a challenging task as the precuttingoperations impose severe physiological stress on the commodity. Minimal processing <strong>of</strong> fruits <strong>and</strong>vegetables had been contemplated as a ‘bridge technology’, touching technologies concerned withpost harvest h<strong>and</strong>ling <strong>of</strong> fresh produce on one side <strong>and</strong> conventional process technologies on theother side. It is well accepted notion that minimally processed products can be defined as ‘lightlyprocessed’ products. This does not describe either the living or non living nature <strong>of</strong> the plant tissue. Inother words, it enlarges the horizons <strong>of</strong> minimally processed products giving scope for use <strong>of</strong> minutethermal treatments <strong>and</strong> also application <strong>of</strong> anti-metabolic substances. As such the emphasis is on‘fresh like’ sensory attributes <strong>of</strong> the products <strong>and</strong> any minimal process strategy shall keep the same asthe main objective.Microbiological aspectsMinimally processed fruits <strong>and</strong> vegetables encounter incidence <strong>of</strong> enhanced microbial attacks dueto the elimination <strong>of</strong> natural barriers <strong>of</strong> the plant tissue <strong>and</strong> enhanced accessibility to moisture <strong>and</strong>nutrition on the surface <strong>of</strong> the plant tissue. A number <strong>of</strong> contaminating microorganism includingspoilage organisms <strong>and</strong> pathogens were isolated from precut fruits <strong>and</strong> vegetables. The minimallyprocessed products were successfully subjected to field trials in different Naval comm<strong>and</strong>s <strong>and</strong> thefield trials on zero energy cooling devices were successfully completed in the forward locations <strong>of</strong>desert areas in Rajasthan. Freezing <strong>of</strong> fruits <strong>and</strong> vegetables in whole or precut form is a major problemduring peak winters in high altitude locations such as Ladakh sector. Antifreeze containers with therated capacities <strong>of</strong> 30 <strong>and</strong> 80 kg were field evaluated in Ladakh sector <strong>and</strong> the feed back was highlyencouraging for the induction <strong>of</strong> the same in Armed Forces. As such, the time is ripe for consideration<strong>of</strong> supply <strong>of</strong> precut fruits <strong>and</strong> vegetables to Armed Forces in packaged form <strong>and</strong> the strategies <strong>of</strong> thetransport <strong>and</strong> storage are encompassed to make the supply chain flexible enough to be accommodatedin the existing infrastructure prevailing in the areas <strong>of</strong> army deployment.Ultra high pressure processingThe search for newer methods <strong>of</strong> food processing aims at processing <strong>of</strong> food without resortingto thermal processing. The concept <strong>of</strong> high pressure processing had emerged from the depth <strong>of</strong> theoceans as the sea beds are devoid <strong>of</strong> the usual microorganisms that one can find at sea level. Only afew microorganisms can survive under high pressure conditions <strong>and</strong> the lethality grows manifoldfrom 500 MPa onwards. Ultra high pressure processing is an innovative technological conceptunder the category <strong>of</strong> non thermal processing with minimal or no heat treatment. It is a process2


Novel <strong>and</strong> Emerging Food Technologies for Defence Food Suppliesaimed at controlling growth <strong>of</strong> microbial populations <strong>and</strong> also inactivation <strong>of</strong> quality deterioratingenzymes. High pressure processing involves instantaneous <strong>and</strong> uniform transmission <strong>of</strong> the pressurethroughout the product independent on the product volume. Upon reaching the desired pressurelevel, the pressure can be maintained without further inputs <strong>of</strong> energy. Liquid foods such as fruitjuices can be subjected to high pressure processing holding the required pressure for specific duration<strong>and</strong> decompressing for further aseptic filling as per the st<strong>and</strong>ard procedures <strong>of</strong> aseptic packaging.Apart from these aspects, high pressure processing can also be used for pressure shift freezing, highpressure thawing, texture modifications <strong>and</strong> enhancement <strong>of</strong> nutritive value <strong>of</strong> foods. High pressuresresult in the physical confirmation <strong>of</strong> biological entities such as proteins, resulting in positive changesin the bio-accessibility <strong>of</strong> nutrients.Infrared processing <strong>of</strong> cereals <strong>and</strong> pulsesThe infrared processing is also known as ‘micronising processes <strong>and</strong> is widely used for cookingcereals, oil seeds, pulses <strong>and</strong> also for the processing <strong>of</strong> cocoa. Micronisation is used for the development<strong>of</strong> different types <strong>of</strong> consumer foods, animal feeds inclusive <strong>of</strong> pet foods <strong>and</strong> several brewed products.It is one <strong>of</strong> the most flexible <strong>and</strong> efficient means <strong>of</strong> processing for the development <strong>of</strong> value addedproducts.Infrared radiation has wavelengths between 0.7 <strong>and</strong> 500 µm. Radiation with wavelengthsjust below 0.7 µm consists visible light, whereas radiation with wavelengths just above 500 µm ismicrowave radiation. Infrared radiation with shorter wavelengths transmits more thermal energy t<strong>of</strong>oods in shallow-bed radiators designed for in-depth processing. Such radiators are equipped withglass-encapsulated heaters operating at about 3,000 kW. Microniser consists <strong>of</strong> a long flat moving belt<strong>of</strong> approximately 5 meters in length onto which cereals (wheat, ragi, barley, soy, etc.) are fed at oneend. Above the belt <strong>and</strong> along its length are suspended gas burners which emit infrared energy onthe grains which is carried through the machine by the belt. Infrared energy is absorbed by the moistgrains, causing expansion <strong>of</strong> starch gelatinization. Extent <strong>of</strong> gelatinization depends upon magnitude<strong>of</strong> infrared heat <strong>and</strong> the time the material takes to travel from one end to the other. The exp<strong>and</strong>edgrain upon processing is subjected to flaking, cooling <strong>and</strong> subsequent packaging. Infrared processingimproves starch accessibility for easy digestion <strong>and</strong> the same could be attributed to opening up <strong>of</strong>crystalline starch structurally. Conventional cooking methods also improve the accessibility <strong>of</strong> starchfor digestion but the process may result in nutrient losses besides being a long duration process.Micronization is highly reliable <strong>and</strong> consistent “Short Time High Temperature Process” usinghumidity, temperature <strong>and</strong> mechanical pressure to achieve high levels <strong>of</strong> starch gelatinization <strong>and</strong>elimination <strong>of</strong> anti nutritional factors, without any significant loss in nutrient value. Infrared energymakes the starch s<strong>of</strong>t <strong>and</strong> turgid, causing it to swell, fracture <strong>and</strong> gelatinize. Immediate rolling /flaking or secondary processing enhance the digestibility <strong>and</strong> nutritional value. The nutritive value orprotein quality <strong>of</strong> a food / feed protein depends not only on its content <strong>of</strong> amino-acids but also theirbio-availability. The products as such could be made ready-to-eat or instantized to suit the logisticrequirement <strong>of</strong> defence forces.Retort processing technologyRetort processing <strong>of</strong> foods in rigid, semi rigid <strong>and</strong> flexible packaging systems is the most acceptableform <strong>of</strong> food preservation. It represents a unique combination <strong>of</strong> product, process <strong>and</strong> packagetechnologies with potential, functional, quality <strong>and</strong> economical benefits. The increasing consumerawareness <strong>and</strong> inhibition/dislike to accept other methods <strong>of</strong> food preservation such as use <strong>of</strong> chemicalpreservatives, irradiation etc. has <strong>of</strong>fered a vast scope for retort processed foods.Although retort pouch processing <strong>of</strong> foods is similar to conventional canning, it has certain majoradvantages like (i) Consumes less energy for processing (ii) enhances the quality attributes <strong>and</strong> (iii)reduces the cost <strong>of</strong> transportation <strong>and</strong> storage.Retort processing is generally carried out for low acid foods with a pH more than 4.5 at a temperature<strong>of</strong> 121.1ºC using moist heat. During heat treatment, undesirable spoilage as well as pathogenic3


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assurancemicroorganisms is inactivated / killed <strong>and</strong> thereby the food products become commercially sterile.Thermal destruction <strong>of</strong> microorganisms is measured <strong>and</strong> monitored by time-temperature history,lethality <strong>and</strong> Fo-value.Despite distinct advantages, retort pouch processing <strong>of</strong> foods till recent years did not becomepopular in India as compared to countries like Japan mainly because <strong>of</strong> the high cost <strong>of</strong> processingequipment <strong>and</strong> non-availability <strong>of</strong> indigenous multi layer flexible packaging materials.DFRL, Mysore has been a pioneer in developing the retort processing technology indigenouslyin the country. Over the past two decades, research <strong>and</strong> development work has been carried outin developing multilayer flexible packaging materials as well as designing a simple low cost retort(semi-automatic <strong>and</strong> automatic) amenable to Indian food industry. Due to continuous efforts, DFRLhas so far successfully transferred the retort pouch processing technology to 40 firms for commercialexploitation.Functional foodsFunctional food is a three way concept wherein the (i) agricultural or animal origin serves asraw material, (ii) specific ingredients components <strong>of</strong> the products exerting functionality <strong>and</strong> (iii)physiological effects with respect to human system. Hence the balanced view <strong>of</strong> the three factors,with specific ingredient action, imparts the needful strategic effect. Thus functional food is a recentstrategic application in the food field <strong>and</strong> a driving force for the product development in this century.The functional foods viz. antioxidant rich herbal tea, squash, baked foods, anti-ulcerative fruit spread,low calorie squash for diabetics, fibre rich ash gourd juice, etc. are some <strong>of</strong> the recent developmentsmade in the field.Appetisers are another class <strong>of</strong> functional foods which improve the appetite. The physiologicalmechanism in brief is stimulation <strong>of</strong> trignomial nerves to increase the secretion <strong>of</strong> digestive juices.On the other h<strong>and</strong>, the hormone leptin formed at hypothalmous in the brain for the appetite controlincreases at high altitude stay; thereby satiety setting is signaled <strong>and</strong> results in lack <strong>of</strong> appetite. DFRLhas developed several appetisers for high altitudes which have proved its efficacy for the cause.In conclusion, the food technologies from the ancient to the advanced technologies adopted in thepresent, along with the emerging, promising technologies as well as the present day requirement <strong>of</strong>functional foods have been reviewed in brief. Based on the raw materials i.e., fruits, vegetables, cereals,nuts, medicinal but natural herbs as well as the food requirements <strong>of</strong> the Defence Forces along withthe logistic convenience <strong>of</strong> longer shelf life, ease <strong>of</strong> transportation, DFRL has developed more than100 processed foods with varied technologies adopted. Packed rations with ready-to-eat products,emergency rations with calorie dense products, logistic based foods with functionality, energy densefood bars, functional food bars for low intensity conflicts, convenient processing machine such asautomatic chapathi making machine, automatic coconut processing system, on-line continuousblancher for vegetables, soy paneer making plant, etc. are the important contributions <strong>of</strong> DFRL forDefence Forces, besides the need based techniques <strong>and</strong> quick test kits for meat <strong>and</strong> processed foodswhich are adopted by them.4


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceFunctional foods for infant <strong>and</strong> weaning purposeIndia is among the nations with higher incidence <strong>of</strong> child malnutrition <strong>and</strong> deficiency diseases.According to an estimate more than 50% <strong>of</strong> children are born with low birth weight resulting instunted growth. Lack <strong>of</strong> key nutrients <strong>and</strong> bio-protective components in infancy led to prevalence <strong>of</strong>anaemia <strong>and</strong> infectious disease among children. Mother’s milk is considered as perfect food <strong>of</strong> naturebut in many incidences maternal nursing is not possible <strong>and</strong> new born has to feed with infant formula.Infant formula is the best example <strong>of</strong> designer foods. Normal infant formulas are manufacturedfrom cow’s milk, but this requires substantial alteration to parallel the composition <strong>of</strong> breast milk.These modifications include reduction in protein <strong>and</strong> minerals, an increase in carbohydrates <strong>and</strong> theaddition <strong>of</strong> vitamins <strong>and</strong> trace elements. In recent years, studies have indicated that infants may havean impaired ability <strong>of</strong> synthesizing taurine <strong>and</strong> carnitine, <strong>and</strong> a dietary source is therefore required.Carnitine is necessary for the transportation <strong>of</strong> long chain fatty acids into cell for the β-oxidation <strong>and</strong>energy production. Fatty acid pr<strong>of</strong>ile <strong>of</strong> different fat sources do not meet the complexity <strong>of</strong> maturebreast milk, therefore mixture <strong>of</strong> different fat sources is preferred. Most manufacturers use a mixture<strong>of</strong> vegetable oils (Simmer, 2000). The fat source must also provide the essential fatty acids linoleic(C18:2, ω-6) <strong>and</strong> α-linolenic acid (C18:3, ω-3). A ratio <strong>of</strong> 5:1 <strong>of</strong> ω-6:ω-3, as occurs in breast milk, isbeing suggested. Short chain as well as medium chain fatty acids should also be present in sufficientquantities as they are easy to absorb <strong>and</strong> assimilate. However there is a need for more short-<strong>and</strong>long-term studies before the optimum ratio <strong>and</strong> its effects on growth are evaluated. Linoleic acid <strong>and</strong>α-linolenic acid are the precursors <strong>of</strong> the very-long-chain (C20 - C22), polyunsaturated fatty acids(LCPUFA): Arachidonic <strong>and</strong> docosahexaenoic acid (DHA). LCPUFA are involved in the neural <strong>and</strong>vascular development <strong>of</strong> the fetus <strong>and</strong> neonates <strong>and</strong> are present in human milk.Nucleotides, a component <strong>of</strong> non-protein nitrogen in human milk, may be important for normalimmune function. Supplementation <strong>of</strong> infant formula with nucleotides seems to be beneficial inclinical trials, although further research is needed before routine nucleotide supplementation <strong>of</strong> infantformula can be considered. The success <strong>of</strong> commercially prepared infant formulas has stimulated thedevelopment <strong>of</strong> numerous formulations <strong>and</strong> several hundred varieties <strong>of</strong> proprietary infant formulasare now available throughout the world. In addition, special formulas for use in clinical situations orfor premature infants or for infants with special inborn errors <strong>of</strong> metabolism are available as specialdietary foods.The GI tract <strong>of</strong> infant is dominated by Bifidobacteria which provides health promoting <strong>and</strong>protective properties such as activation <strong>of</strong> immune system, inhibition <strong>of</strong> pathogens by the secretion <strong>of</strong>substances which are directly inhibitory towards several bacteria, lowering <strong>of</strong> pH by the production <strong>of</strong>acids such as acetate <strong>and</strong> lactic acid, leading to an antibacterial environment, production <strong>of</strong> digestiveenzymes such as casein phosphatase <strong>and</strong> lysozyme <strong>and</strong> production <strong>of</strong> vitamins. For these reasons itseems desirable to also increase the numbers <strong>of</strong> Bifidobacteria in the intestinal flora <strong>of</strong> formula-fedinfants. Administration <strong>of</strong> prebiotic oligosaccharides <strong>and</strong> probiotic supplements appear to be the mosteffective way to increase the number <strong>of</strong> the Bifidobacteria in the intestine. Human milk oligosaccharidesare mainly responsible for Bifidogenic effects <strong>of</strong> breast milk. Several commercial formulations havebeen developed with the view <strong>of</strong> providing a predominance <strong>of</strong> Bifidobacteria in the intestinal floraformula-fed infants. However the inclusion <strong>of</strong> such unconventional ingredients in formulation <strong>of</strong>infant formula needs long-term investigations before being approved.Inadequate nutrition during first 2-3 years <strong>of</strong>ten leads to problems associated with malnutrition inseveral developing nations in the world. Complementary nutrition is must for the normal <strong>and</strong> healthygrowth <strong>of</strong> a child after the age <strong>of</strong> 6 months, owing to increased requirement <strong>of</strong> nutrition in additionto those provided by breast milk. Moreover the food preparations consumed as weaning foods donot contain adequate nutrients desired for children. Traditional infant-feeding practiced, in countrieslike India, is usually cereal based. For the preparation <strong>of</strong> such foods grains are <strong>of</strong>ten germinated,6


An Overview <strong>of</strong> Designer Functional <strong>and</strong> Health Foodsfermented, processed <strong>and</strong> cooked in various ways to improve digestibility, <strong>and</strong> mixed with oilseeds oranimal products to enhance their nutritional pr<strong>of</strong>ile, however most <strong>of</strong> these complementary foods arereported to be less energy dense <strong>and</strong> less safer for children because <strong>of</strong> the higher proportion <strong>of</strong> antinutrients.Cereals in combination with milk solids are generally used for the preparation <strong>of</strong> weaningfoods. Milk-Cereal-millet based complementary foods appear to be unique in the sense that they c<strong>and</strong>eliver multitude <strong>of</strong> nutrients to children <strong>and</strong> complement each other as well. The correct form <strong>of</strong>incorporation, effective concentration <strong>and</strong> required technological inputs determine the effectiveness<strong>of</strong> the resulted complementary food. Such products could be an attractive option for mass childrenfeeding programmes.Specialized foods with plant bioactiveNutritional significance <strong>of</strong> plant molecules is well documented <strong>and</strong> increasing cases <strong>of</strong> cancers,coronary heart diseases, diabetes <strong>and</strong> many other chronic diseases, have been attributed to underconsumption <strong>of</strong> fruits <strong>and</strong> vegetables in our diet. But beyond these known nutrients i.e. vitamins,fibers, plants have clearly more to <strong>of</strong>fer <strong>and</strong> scientists are scurrying to discover exactly which plantcomponents might fend <strong>of</strong>f specific diseases. An ever-exp<strong>and</strong>ing array <strong>of</strong> previously unknown plantmolecules with hard to pronounce names are being uncovered. But there exact metabolic role <strong>and</strong> howthese can be utilized in designer food, need to be clarified.The number <strong>of</strong> identified physiologically has increased dramatically in the last decades <strong>and</strong>overwhelming evidence from epidemiological, in vivo, in vitro <strong>and</strong> clinical trial indicate that plant richdiet can reduce the risk <strong>of</strong> certain chronic diseases (Hasler, 2000) Health pr<strong>of</strong>essionals are graduallyrecognizing the role <strong>of</strong> phytochemicals in health improvement. The major mechanism associated withtherapeutic aspects <strong>of</strong> plant bioactive is their ability to act as antioxidants.There are certain other compounds present in plant foods, with significant health promoting effectinclude plant fatty acids, tocotrienols, phenolic derivatives <strong>and</strong> dietary fibers etc. Docosahexaenoicacid (DHA), which is one <strong>of</strong> the most important structural component <strong>of</strong> brain <strong>and</strong> retina, <strong>and</strong> de-novosynthesis <strong>of</strong> this compound, is very rare. The decline in DHA intake could have serious implications forpublic health, since low plasma, DHA concentrations have been correlated with increased incidence <strong>of</strong>number <strong>of</strong> important chronic diseases such as depression, attention deficit disorders <strong>and</strong> Alzheimer’sdementia. Crypthecodinium cohmii strain <strong>of</strong> marine algae is used for the commercial production <strong>of</strong> DHArich oil. Spirulina, termed as wonder alga is one <strong>of</strong> riches source <strong>of</strong> omeg-3-fatty acids, quality protein<strong>and</strong> many other therapeutic molecules.Plant polyphenols are secondary metabolites widely distributed in higher plants. Polyphenolshistorically have been considered as anti-nutrients by nutritionists, because some, eg. tannins havesuch adverse effects as decreasing the activities <strong>of</strong> digestive enzymes, energy, protein <strong>and</strong> amino acidavailabilities, mineral uptake <strong>and</strong> having other toxic effects. Recognition <strong>of</strong> the antioxidant activities<strong>of</strong> many polyphenols has realigned thinking toward the health benefits provided by many <strong>of</strong> thesecompounds. Phytoestrogens are a broad group <strong>of</strong> plant-derived compounds that are structuralmimics <strong>of</strong> endogenous 17 beta-estradiol. Two major phytoestrogens, which are <strong>of</strong> great importancefrom nutritional <strong>and</strong> health perspectives, include lignans (Flaxseed) <strong>and</strong> is<strong>of</strong>lavones (soy bean).These compounds either compete with or antagonize estrdiol action. Exact biochemical mechanisminvolving CYP3A monoxygenase activity in presence <strong>of</strong> phase I enzyme inducers such as dixamethane.Phytosterols are another important terpene subclass. Two sterol molecules that are synthesized byplants are β - sitosterol <strong>and</strong> its glycoside. In animals, these two molecules exhibit anti-inflammatory,anti-neoplastic, anti-pyretic <strong>and</strong> immune-modulating activity. In the body, phytosterols can competewith cholesterol in the intestine for uptake, <strong>and</strong> aid in the elimination <strong>of</strong> cholesterol from the body.Saturated phytosterols appear to be more effective than unsaturated ones in decreasing cholesterolconcentrations in the body. Certain designer foods like phytosterol containing yoghurt, β-glucan richdairy drink, DHA containing infant foods etc. have already reach to the stage <strong>of</strong> commercialization.7


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceMilk proteins <strong>and</strong> peptides based nutraceuticalsDietary proteins possess nutritional, functional <strong>and</strong> biological properties, <strong>and</strong> the technologicalprocesses used in food manufacture <strong>and</strong> processing <strong>of</strong>ten affect these properties. The role <strong>of</strong> proteinsas physiologically active components in the diet has been increasingly acknowledged in recent years.Such proteins or their precursors may occur naturally in raw food materials, exerting their physiologicalaction directly or upon enzymatic hydrolysis in vitro or in vivo. Several dietary proteins, can act as asource <strong>of</strong> biologically active peptides. These peptides inactive within remain the parent protein, <strong>and</strong>released during gastrointestinal digestion or food processing. Once liberated, the bioactive peptidesmay provide different functions in vitro or in vivo.Bioactive peptides have to be released from the parent protein by enzymatic hydrolysis. Thiscan be achieved by the use <strong>of</strong> isolated enzymes, as well by microbial fermentation. Biologicallyactive peptides are <strong>of</strong> particular interest for pharma industry because they have been shown to playdifferent physiological roles, including opioid like activity, antimicrobial, immunomodulatory <strong>and</strong>antihypertensive. Such peptides can be released during hydrolysis by digestive or microbial enzymes.Microbial enzymes from lactic acid bacteria have demonstrated to be able to liberate theses peptidesfrom milk proteins, in various fermented milk products.Upon oral administration bioactive peptides may affect the major body systems- namely thecardiovascular, digestive, immune <strong>and</strong> nervous systems. For this reason, the potential <strong>of</strong> certainpeptides sequences to reduce the risk <strong>of</strong> chronic diseases or boost natural immune protection hasaroused a lot <strong>of</strong> scientific interest over the past few years. These beneficial health effects may beattributed to known peptide sequences exhibiting, e.g., antimicrobial, antioxidative, antithrombotic,antihypertensive <strong>and</strong> immunomodulatory activities. Milk proteins are considered the most importantsource <strong>of</strong> bioactive peptides <strong>and</strong> an increasing number <strong>of</strong> bioactive peptides have been identified inmilk protein hydrolysates <strong>and</strong> fermented dairy products.Over the last few years a number <strong>of</strong> investigations have been carried out across the world toelucidate the bioactivity <strong>of</strong> milk proteins <strong>and</strong> derivatives. These components may be either serve asfunctional ingredients in development <strong>of</strong> functional foods or can be utilized by pharma industry asnutraceuticals. Most <strong>of</strong> the claimed physiological properties <strong>of</strong> milk proteins <strong>and</strong> derivatives havebeen carried out in in-vitro or animal models, these hypothesized properties remains to be proven inhumans. Whey proteins are becoming an important constituent in the recipe <strong>of</strong> wide range <strong>of</strong> functional<strong>and</strong> health foods because <strong>of</strong> the unique amino acid composition <strong>and</strong> bioactivity. Whey proteins basedcommercially available food products include sports supplements, low fat dairy desserts, medicalfoods, infant formulations <strong>and</strong> geriatric foods. Antihypertensive bioactive peptides may be utilized indevelopment <strong>of</strong> mood drinks <strong>and</strong> also foods for cardiac patients.Other prospective designer foodsBeverages are another range <strong>of</strong> products that <strong>of</strong>fer tremendous market potential for Indian foodindustry because <strong>of</strong> being nutritionally-rich. Similarly, minor cereals <strong>and</strong> millets based milk beveragesseem to be lucrative products for school feeding programmes. Liquid milk fortification with vitamins A<strong>and</strong>/D is m<strong>and</strong>atory in several countries. However, the milk fortification usually impaired its sensory<strong>and</strong> processing quality characteristics. Moreover, bio-availability <strong>of</strong> fortified nutrients is another majorconcern. Investigations carried out at NDRI suggest possibilities <strong>of</strong> fortification <strong>of</strong> liquid milk withcalcium <strong>and</strong> iron. Beverages <strong>and</strong> soups based on whey continue to receive a considerable amount<strong>of</strong> attention nowadays. These indicate the growing awareness among consumers <strong>and</strong> manufacturersalike for the enormous potential these <strong>of</strong>fered for diversifying product pr<strong>of</strong>ile. Other designer foodsinclude low calories/low fat variants, low sodium foods <strong>and</strong> fun foods etc.ConclusionConsumer interest in the relationship between diet <strong>and</strong> health has increased the dem<strong>and</strong> forinformation on functional foods. Rapid advances in science <strong>and</strong> technology, increasing healthcare8


An Overview <strong>of</strong> Designer Functional <strong>and</strong> Health Foodscosts, changes in food laws affecting label <strong>and</strong> product claims, an aging population, <strong>and</strong> rising interestin attaining wellness through diet are among the factors fueling interest in functional foods. Crediblescientific research indicates many potential health benefits from milk components.ReferencesFinley, J.W. 2005. Proposed criteria for assessing the efficacy <strong>of</strong> cancer reduction by plant foods enriched in carotenoids,glucosinolates, polyphenols <strong>and</strong> selenocompounds. Annals <strong>of</strong> Botany, 95:1075-1096 pp.Hasler, C.M. 1998. Functional Foods: <strong>Their</strong> role in disease prevention <strong>and</strong> health promotion. Food Technology 52(11),63-70 ppHasler, C.M. 2000. The changing face <strong>of</strong> functional foods. Journal <strong>of</strong> American College <strong>of</strong> Nutrition 19 (5), 499S-506S pp.Hirayama, M. 2002. Novel physiological functions <strong>of</strong> oligosaccharides. Pure Appl. Chem. 74 (7) 1271-1279 ppShah, N. P. 2000. Probiotic Bacteria: Slective Enumeration <strong>and</strong> survival in dairy foods. J. <strong>Dairy</strong> Science, 88:894-907Simmer, K. 2000 a. Long-chain polyunsaturated fatty acid supplementation in preterm infants. Cochrane Database Syst.Rev., -HD-(2): CD 000375 2000.Wollowski, I. 2001. Protective role <strong>of</strong> probiotics <strong>and</strong> prebiotics in colon cancer. Am. J. Clin. Nutrition: 73 (Suppl):451S-5S9


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceIntroduction:Prospects <strong>of</strong> <strong>Value</strong> Addition ThroughFunctional IngredientsG. R. Patil<strong>Dairy</strong> Technology Division, NDRI, KarnalIn recent years, there has been a vast <strong>and</strong> rapidly growing body <strong>of</strong> scientific data showing thatdiet plays an important part in diseases. Diet is thought to contribute to six <strong>of</strong> the 10 leading causes <strong>of</strong>death. Nutrients <strong>and</strong> nonnutritive food components have been associated with the prevention <strong>and</strong>/or treatment <strong>of</strong> chronic diseases such as cancer, coronary heart disease, diabetes, hypertension, <strong>and</strong>osteoporosis. Up to 70% <strong>of</strong> certain cancers may be attributed to diet. As the data supporting the role<strong>of</strong> diet in health promotion <strong>and</strong> disease prevention continue to mount, it is likely that the quantity <strong>of</strong>enhanced foods will exp<strong>and</strong> substantially. There is an increasing dem<strong>and</strong> by consumers for quality<strong>of</strong> life, which is fueling the functional foods revolution. Functional foods are viewed as one optionavailable for seeking cost-effective health care <strong>and</strong> improved health status. Moreover, the large babyboomersegment <strong>of</strong> the population is aging <strong>and</strong> considerable health care budget in most country isfocused on treatment rather than prevention. Thus, the use <strong>of</strong> nutraceuticals in daily diets can be seenas means to reduce escalating health care costs that will contribute not only to a longer lifespan, butalso more importantly, to a longer health span. Development <strong>of</strong> functional food products will continueto grow throughout the 21 st century as consumer dem<strong>and</strong> for healthful products grows.The exploding area <strong>of</strong> functional foods <strong>and</strong> probiotics shows considerable promise to exp<strong>and</strong>the industry into new arenas. Both convenience <strong>and</strong> better for you attitudes are selling. Consumersclearly believe in the concept <strong>of</strong> functional nutrition, or specific association between foods/nutrients<strong>and</strong> health functions. They are interested in foods that boost the immure system, reduce the risk <strong>of</strong>disease <strong>and</strong> enhance health, which consumers self-prescribe for themselves <strong>and</strong> their families. Hence,there are clear opportunities to <strong>of</strong>fer consumers dietary alternatives to medical solutions. Theseopportunities, however, will be highly consumer driven <strong>and</strong> success will ultimately be dependentupon defining your segment <strong>and</strong> knowing your target group.The markets <strong>of</strong> traditional dairy products are increasingly getting overcrowded <strong>and</strong> our futuresuccess will depend on our ability to provide innovative products, which consumers want <strong>and</strong> need.Whatever the innovation - products, processing method or packaging - it should meet the real consumerneed. We know today’s families want “grab-<strong>and</strong>-go” convenience. They are also concerned aboutnutrition <strong>and</strong> health. Different ages <strong>and</strong> demographics want different things. Therefore, investment atthis level is essential if we are to respond rapidly to customers who are increasingly dem<strong>and</strong>ing new <strong>and</strong>different taste experiences from products that are also competitively priced. Thanks to advancementsin technology, researchers have shown that specific components <strong>of</strong> milk, as well as ingredients canbe readily added to dairy products, which contribute to health <strong>and</strong> wellness, <strong>and</strong> assist consumerswith feeling balanced <strong>and</strong> satisfied. There is a golden opportunity for dairy marketers to formulateinnovative products to meet consumers’ needs <strong>and</strong> to effectively market the product’s value. Newvariants <strong>of</strong> sweets can be developed. <strong>Dairy</strong> products containing health-promoting ingredients may bedeveloped <strong>and</strong> promoted. Host <strong>of</strong> ingredients with health benefits are available for value addition <strong>of</strong>dairy products. Some <strong>of</strong> these issues are discussed hereunder.Functional ingredients for value additionFunctional nutrition is a broad topic, <strong>and</strong> covers many ingredient categories. The functionalcomponents used in formulation <strong>of</strong> these formulated foods are given in Table 1.10


Prospects <strong>of</strong> <strong>Value</strong> Addition Through Functional IngredientsTable 1: Examples <strong>of</strong> Functional Ingredients*Class/ Ingredients Source* Potential BenefitCarotenoidsBeta-carotene carrots, various fruits neutralizes free radicals which maydamage cells; bolsters cellularantioxidant defensesLutein, Zeaxanthinkale, collards, spinach, corn, eggs,citrusmay contribute to maintenance <strong>of</strong>healthy visionLycopenetomatoes <strong>and</strong> processed tomatoproductsmay contribute to maintenance <strong>of</strong>prostate healthDietary (functional <strong>and</strong> total) FiberInsoluble fi ber wheat bran may contribute to maintenance <strong>of</strong> ahealthy digestive tractBeta glucan oat bran, rolled oats, oat fl our may reduce risk <strong>of</strong> coronary heartdisease (CHD)Soluble fi ber psyllium seed husk may reduce risk <strong>of</strong> CHDWhole grains cereal grains may reduce risk <strong>of</strong> CHD <strong>and</strong> cancer;may contribute to maintenance <strong>of</strong>healthy blood glucose levelsFatty AcidsMonounsaturated fatty acids(MUFAs)tree nutsmay reduce risk <strong>of</strong> CHDPolyunsaturated fatty acids (PUFAs)- Omega-3 fatty acids—ALAPUFAs - Omega-3 fatty acids—DHA/EPAPUFAs - Conjugated linoleic acid(CLA)walnuts, fl axsalmon, tuna, marine <strong>and</strong> other fi shoilsbeef <strong>and</strong> lamb; some cheesemay contribute to maintenance <strong>of</strong>mental <strong>and</strong> visual functionmay reduce risk <strong>of</strong> CHD; maycontribute to maintenance <strong>of</strong> mental<strong>and</strong> visual functionmay contribute to maintenance <strong>of</strong>desirable body composition <strong>and</strong>healthy immune functionFlavonoidsAnthocyanidins berries, cherries, red grapes bolster cellular antioxidant defenses;may contribute to maintenance <strong>of</strong>brain functionFlavanols—Catechins, Epicatechins,Procyanidinstea, cocoa, chocolate, apples,grapesmay contribute to maintenance <strong>of</strong>heart healthFlavanones citrus foods neutralize free radicals which maydamage cells; bolster cellularantioxidant defensesFlavonols onions, apples, tea, broccoli neutralize free radicals which maydamage cells; bolster cellularantioxidant defensesProanthocyanidinsIsothiocyanatesSulforaphanePhenolsCaffeic acid, Ferulic acidcranberries, cocoa, apples,strawberries, grapes, wine, peanuts,cinnamoncaulifl ower, broccoli, broccoli sprouts,cabbage, kale, horseradishapples, pears, citrus fruits, somevegetablesmay contribute to maintenance <strong>of</strong>urinary tract health <strong>and</strong> heart healthmay enhance detoxifi cation <strong>of</strong>undesirable compounds <strong>and</strong> bolstercellular antioxidant defensesmay bolster cellular antioxidantdefenses; may contribute tomaintenance <strong>of</strong> healthy vision <strong>and</strong>heart health11


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceClass/ Ingredients Source* Potential BenefitPlant Stanols/SterolsFree Stanols/Sterolscorn, soy, wheat, wood oils, fortifi ed may reduce risk <strong>of</strong> CHDfoods <strong>and</strong> beveragesStanol/Sterol estersfortifi ed table spreads, stanol ester may reduce risk <strong>of</strong> CHDdietary supplementsPolyolsSugar alcohols—xylitol, sorbitol,mannitol, lactitolInulin, Fructo-oligosaccharides(FOS), PolydextroseLactobacilli, Bifi dobacteria12some chewing gums <strong>and</strong> other foodapplicationsPrebiotic/Probioticswhole grains, onions, some fruits,garlic, honey, leeks, fortifi ed foods<strong>and</strong> beveragesyogurt, other dairy <strong>and</strong> non-dairyapplicationsmay reduce risk <strong>of</strong> dental cariesmay improve gastrointestinal health;may improve calcium absorptionmay improve gastrointestinal health<strong>and</strong> systemic immunityPhytoestrogensIs<strong>of</strong>l avones—Daidzein, Genistein soybeans <strong>and</strong> soy-based foods may contribute to maintenance<strong>of</strong> bone health, healthy brain <strong>and</strong>immune function; for women,maintenance <strong>of</strong> menopausal healthLignans fl ax, rye, some vegetables may contribute to maintenance <strong>of</strong>heart health <strong>and</strong> healthy immunefunctionSoy ProteinSoy Protein soybeans <strong>and</strong> soy-based foods may reduce risk <strong>of</strong> CHDSulfi des/ThiolsDiallyl sulfi de, Allyl methyl trisulfi de garlic, onions, leeks, scallions may enhance detoxifi cation <strong>of</strong>undesirable compounds; maycontribute to maintenance <strong>of</strong> hearthealth <strong>and</strong> healthy immune functionDithiolthiones cruciferous vegetables contribute to maintenance <strong>of</strong> healthyimmune functionSource: IIFC (2004)Examples are not an all-inclusive list.Several functional dairy products can be developed using either single or combination <strong>of</strong>ingredients given in the table targeting specific health benefits. Besides these functional ingredients,which are mostly obtained from plant source, there are other ingredients such as fat replacers, artificialsweeteners, micronutrients like vitamins <strong>and</strong> minerals, which can be used for value addition.3.0 What are the possibilities?Innovative milk beverages:Recently, a whole new generation <strong>of</strong> beverages containing milk <strong>and</strong> dairy ingredient are emerging.Thanks to new technologies, including processes <strong>and</strong> ingredients, such dairy based beverages not only<strong>of</strong>fer a wider range <strong>of</strong> flavour, texture <strong>and</strong> other sensory properties than are current present but alsoprovides new marketing opportunities for these products in the healthy/ neutraceutical/ bioactivefoods category foods today’s consumer’s want. Some <strong>of</strong> the ingredients highlighted above, along withother ingredients that are currently used or can be used for development <strong>of</strong> such beverages. <strong>Dairy</strong>manufacturers can develop a signature formula to appeal to specific market segments.Select European countries use whey as a base for nutritional, fruity dairy-based beverages. A refreshingbeverage made from fermented milk <strong>and</strong> whey <strong>and</strong> containing fruit juice, or a probiotic beverage fromwhey <strong>and</strong> fruit juice that is fortified with vitamins <strong>and</strong> calcium are being marketed in these countries.NDRI has also recently developed formulations from whey such as whey-jaljeera beverage, whey-baelbeverage, <strong>and</strong> whey –mango beverage, which are available for commercial exploitation.


Prospects <strong>of</strong> <strong>Value</strong> Addition Through Functional IngredientsProbiotic dairy products:“Probiotic, food products in generals <strong>and</strong> “probiotic “ organism in particular are in the center <strong>of</strong>current R & D activities all over the world. “Functional foods” segment that is registering a steady<strong>and</strong> consistent growth at present, among processed food products, gathered the momentum primarilyfrom the scientific investigations based on “probiotic” food products. A probiotic is a mono-or mixedculture <strong>of</strong> live microorganisms which benefits man or animals by improving the properties <strong>of</strong> theindigenous micr<strong>of</strong>lora. Viable counts delivered to the gastrointestinal tract are key to the functionality<strong>of</strong> probiotics. The consumption <strong>of</strong> probiotic culture positively affect the composition <strong>of</strong> this micr<strong>of</strong>loraor extends a range <strong>of</strong> host benefits including.1. Pathogen interference, exclusion <strong>and</strong> antagonism.2. Immunostimulation <strong>and</strong> immunomodulation.3. Anticarcinogenic or antimutagenic activities.4. Alleviation <strong>of</strong> symptoms <strong>of</strong> lactose intolerance.5. Reductiion in serum cholesterols.6. Reduction in blood pressures.7. Decreased incidence & duration <strong>of</strong> diarrhoea.8. Prevention <strong>of</strong> vaginitis.9. Maintenance <strong>of</strong> mucosal integrity.Industrial interest in developing probiotics <strong>and</strong> probiotic functional foods is thriving, drivenlargely by the market potential for foods that target general health or well being. NDRI has madesome progress in this area by developing probiotic dahi, lassi <strong>and</strong> probiotic cheese. There is possibility<strong>of</strong> developing other milk based fermented traditional dairy products such as probiotic shrik<strong>and</strong> <strong>and</strong>Rabadi – a milk-cereal based fermented product.Fat-replacement in dairy products:High fat consumption has been linked to several chronic diseases including cardiovascular diseases,obesity <strong>and</strong> certain forms <strong>of</strong> cancer. Nutrition experts recommend a total fat intake <strong>of</strong> less than 30 percent <strong>of</strong> total daily calories. These dietary recommendations are one reason for the increasing dem<strong>and</strong>for lower fat food products <strong>of</strong> the world market has been flooded with the food products carrying thelabels “low fat”, ‘no fat’ or ‘reduced fat’. Fat mimics or fat substitutes are normally used to producelow-fat foods, fat mimics are substances that help replace the mouthfeel <strong>of</strong> fat but can not substitutefor fat on a gram for gram basis <strong>and</strong> can not be used for applications involving frying. Substanceswhose physical or thermal properties resemble fat are termed as fat substitutes <strong>and</strong> can replace fat ona gram-for gram basis <strong>and</strong> can also be used for frying applications.Categories <strong>of</strong> fat replacersFat mimicsFat replacersProtein based Carbohydrate based -Emulsifiers-Medium chain triacylglycerols.- whey protein conc. - Starches -Structural lipids.- Microparticulated protein - Maltodextrins -Acaloric synthetic compounds.- Polydextrose * fatty alcohol esters <strong>of</strong> alkylmalonic or malonic acid.* esterified propoxylated glycerols* trialkoxy tricarballylate* poly carboxylic acid.* Sucrose polyestersLow-fat cheese, processed cheese, cultured products, frozen desserts, butters <strong>and</strong> spreads havebeen successfully developed using commercially available fat mimics/replacers. Using similartechnique several low fat varieties <strong>of</strong> traditional dairy products can be developed. An attempt hasbeen made to develop low fat burfi at this institute.13


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assurance<strong>Dairy</strong> products for providing satiety:There are a few dairy products currently in the marketplace, which claim to provide satiety. Thisis an opportunity dairy product manufacturers need to tap into, too. Satiety is the state <strong>of</strong> being fullor gratified to the point <strong>of</strong> satisfaction. Scientific studies indicate that satiety is dependant on not onlyhow much food you eat, but what type <strong>of</strong> food you eat as well. Satiety is being addressed on food labelswith synonymous terms such as “hearty” <strong>and</strong> “controls or reduces hunger.” Unabsorbed nutrients inthe ileum, which is the final section <strong>of</strong> the small intestine, inhibit gastric emptying, providing a sense<strong>of</strong> satiety. Fat, in particular, penetrates the ileum when a person has eaten too much for the body toprocess. When this happens the ileum triggers a “full” message to the brain. That full message is theresult <strong>of</strong> the secretion <strong>of</strong> cholecystokinin (CCK), a peptide hormone <strong>of</strong> the gastrointestinal systemresponsible for stimulating the digestion <strong>of</strong> fat <strong>and</strong> protein. It is secreted by the duodenum, the firstsegment <strong>of</strong> the small intestine, <strong>and</strong> causes the release <strong>of</strong> digestive enzymes <strong>and</strong> bile from the pancreas<strong>and</strong> gall bladder, respectively.A satiety ingredient concept is available to dairy foods manufacturers. A patented combination <strong>of</strong>oat <strong>and</strong> palm oils has been formulated into a novel emulsion with the oat oil extract containing a largequantity <strong>of</strong> polar lipids that coat the palm oil droplets. This coating prevents digestion <strong>of</strong> the palm oilin the stomach until it reaches the ileum.Fiber ingredient suppliers, too, are touting some <strong>of</strong> their products for satiety value. For example,research shows consumers on diets supplemented with inulin <strong>and</strong> olig<strong>of</strong>ructose report higher levels<strong>of</strong> satiety, longer feelings <strong>of</strong> fullness <strong>and</strong> lower calorie intake, which can all assist with weight loss.Research also shows that foods high in fiber <strong>and</strong> protein slow digestion <strong>and</strong> extend the release <strong>of</strong> CCK.With knowledge <strong>of</strong> this relationship between fiber, protein <strong>and</strong> satiety, several convenient, nutritious<strong>and</strong> delicious products can be created for obese people, which can help them feel full <strong>and</strong> thus preventunhealthful snacking between meals.A heart-healthy opportunityWith the functional food market abuzz about the heart-health benefits <strong>of</strong> plant sterols, dairy foodsformulators have excellent opportunity to develop variety <strong>of</strong> dairy products with heart healthy benefit.Plant sterols can help lower serum low-density lipoprotein (LDL)—or bad—cholesterol levels, whichare well recognized as impacting heart disease risk. Eating foods low in saturated fat <strong>and</strong> cholesterol<strong>and</strong> high in sterols can reduce LDL cholesterol by 20%. Plant sterols provide an effective, dietarymethod for countering elevated cholesterol, a crisis facing millions <strong>of</strong> Indians.Plant sterols are relatively easy to formulate into existing dairy applications, <strong>and</strong> sterols areavailable in different forms to aid in the ease <strong>of</strong> processing.Likewise, plant sterols can be used in virtually any dairy application. If included in the amountsspecified for health claim, plant sterols also enhance a finished dairy product’s nutritional pr<strong>of</strong>ilewithout altering its flavor or texture. The qualified claim states that foods containing at least 0.4g perserving <strong>of</strong> plant sterols, eaten twice a day with meals for a daily total intake <strong>of</strong> at least 0.8g, as part <strong>of</strong>a diet low in saturated fat <strong>and</strong> cholesterol, may reduce the risk <strong>of</strong> heart disease.Arjuna Ghee: Arjuna ghee, with functionalities like resistance against heart diseases <strong>and</strong> bloodpressure regulating properties was developed at this institute. The developed ghee was foundsensorily similar to the market ghee. It had overall acceptability score <strong>of</strong> 85.1 compared to the control(90.84). The Arjuna ghee was found to be 4 times more stable to oxidative deterioration as compared tocontrol ghee. This is due to the fact that Arjuna extract contains several antioxidants like polyphenols,terpenoids in addition to phytosterol, which are beneficial in case <strong>of</strong> Cardio-vascular Diseases (CVD),high blood pressure <strong>and</strong> to boost up our immune system.Dietetic dairy productsThe dairy industry has responded to the growing needs <strong>of</strong> health conscious consumers for lowcaloriefoods. Consequently, a large number <strong>of</strong> dairy products made with low-calorie <strong>and</strong> nonnutritive14


Prospects <strong>of</strong> <strong>Value</strong> Addition Through Functional Ingredientssweeteners have been witnessed in the market. Low calorie sweeteners have become sugar alternativesto replace sucrose in a wide variety <strong>of</strong> dairy products. Kumar (2000) developed a low calorie lassi byusing aspartame <strong>and</strong> reported that aspartame at a level <strong>of</strong> 0.08% was required to replace 15% <strong>of</strong> canesugar in lassi.The technology for the production <strong>of</strong> rasogolla, the most popular channa based Indian sweetmeat,was developed by Jayaprakash (2003) using sorbitol (40%) <strong>and</strong> aspartame (0.08%). Chetana, et al.(2004) developed gulabjamun, a popular khoa based sweet, using sorbitol. Burfi, another khoa basedsweet delicacy was developed by completely replacing sugar using acesulfame-K (Yarrakula, 2006),aspartame (Muralidhar, 2006), saccharin (Narendra, 2006), sucralose (Singh, 2006), <strong>and</strong> sucralose<strong>and</strong> bulking agents (Prabha, 2006). Kalak<strong>and</strong> <strong>and</strong> flavored milk were developed using acesulfame-K(Yarrakula, 2006), aspartame (Muralidhar, 2006), saccharin (Narendra, 2006), <strong>and</strong> sucralose (Singh,2006). The Indian counterpart for ice cream, kulfi was developed by P<strong>and</strong>it (2004) using sorbitol(5.5%), maltodextrin (4.26%) <strong>and</strong> aspartame (742 ppm).<strong>Dairy</strong> products fortified with dietary fiberMilk <strong>and</strong> most dairy products are devoid <strong>of</strong> dietary fiber. With the growing interest in dietary fiber<strong>and</strong> its health benefits, dairy industry has geared up for fortifying the dairy products with fiber.Yogurt is one <strong>of</strong> the dairy products whose sales continues to increase due to diversification inthe range <strong>of</strong> yogurt-like products including reduced fat content yogurts, yogurt shakes, drinkableyogurts, yogurt mousse, yogurt ice cream, etc. (Fiszman <strong>and</strong> Salvador, 1999).In India, there are few traditional dairy products that contain significant quantities <strong>of</strong> fiber e.g.,Gajar-pak (carrot halwa), Giya-ka-halwa (bottle gourd halwa), Doda-burfi, <strong>and</strong> Kaju-burfi. Traditionallymade cereals-based milk desserts like kheer <strong>and</strong> dalia-dessert are other dairy food sources <strong>of</strong> dietaryfiber in Indian diets (Patel <strong>and</strong> Arora, 2005). Recently, dahi (Ch<strong>and</strong>rakant, 2002), lassi <strong>and</strong> other dairyproducts have been fortified with fruits <strong>and</strong> commercial dietary fibers to give the benefits <strong>of</strong> dietaryfiber. Kantha (2005) developed a low fat paneer using soy fiber <strong>and</strong> inulin <strong>and</strong> reported that milk with2.5% fat <strong>and</strong> 0.56% soy fiber or 1.8% fat <strong>and</strong> 4.5% inulin yielded a paneer similar to that prepared fromfull cream milk (6% fat) in respect to sensory quality. Amul has launched a new variety <strong>of</strong> isabgolenrichedice cream. Isabgol is the seed derived from Plantago ovata. Being a ‘true dietary fibre’, theisabgol husk is considered to be a natural laxative that aids easy bowel movement. Besides it is alsoknown to possess serum cholesterol reducing properties (Mann <strong>and</strong> Singh, 2005)Targeting a successful product launchIn order to launch the product successfully in the market it is necessary to look in to followingpoints:• Identifying where the gaps are in a specific market--what the new/unmet consumer needs are.• Developing product concepts <strong>and</strong> consumer value propositions to fill the gaps.• Prper ingredient selection, formulating prototypes <strong>and</strong> evaluating product concepts at an inhousepilot plant.Fundamentally the product needs to pass the taste test. If it does not taste good, it is not possibleto get that repeat buy from consumer. Any product that has been developed by hitting a bull’s eye ineach one <strong>of</strong> these areas (health <strong>and</strong> wellness, simplicity <strong>and</strong> taste) will certainly have a stronger chancefor a successful product launch.What are the prospects for functional foods in india?Population growth, rising incomes, increasing awareness on health, urbanization, lifestyle changes(“on-the-go” eating) <strong>and</strong> growing organized retailing are contributing to the potential for functionalfoods. Just as for processed foods in general, India will be the largest potential markets for functionalfoods with their GDP growth, demographics <strong>and</strong> burgeoning consumption.15


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceThanks to the growing acceptance <strong>of</strong> functional foods, India could hope to leverage the country’skey resources in this area to gain a foothold in the global market. Functional foods are among theNew Age drugs that are being developed to provide better health. Functional foods are gaining publicacceptance in many developed countries in recent times. Looking at the changing trends, the market<strong>of</strong> functional foods has huge potential. These days, industries are showing interest in the functionalfoods area. Within few years this potential can turn into a healthy growing market.The ingredients used in health/functional foods are mainly plant-based products <strong>and</strong> most <strong>of</strong> thembeing predominantly herbal. Hence clues to these functional ingredients could be got from our ancient<strong>and</strong> traditional systems <strong>of</strong> medicine like Ayurveda, Siddha <strong>and</strong> Unani. The ‘Rasayan’ <strong>and</strong> ‘Vajikarna’therapeutics <strong>of</strong> Ayurveda are essentially nutraceuticals <strong>and</strong> therefore there is ample scope for India todevelop a range <strong>of</strong> health food products. And to succeed, these products have to be st<strong>and</strong>ardized <strong>and</strong>with scientific validation to ensure safety <strong>and</strong> efficacy so as to instill confidence in the customers touse them not as an alternative medicine but as a well defined system <strong>of</strong> medicine. For this to happen,there has to be research carried out on these products. Thus India’s own traditional knowledge basegathered from Unani, Ayurveda <strong>and</strong> Siddha can help out in research work on nutraceuticals. And wecan take a lead on this from the western world.What are the key challenges for functional foods in india?In India, we have traditional products touted as functional but have little scientific validation.Regulations will thus have to evolve to weigh R&D, ensure validation <strong>and</strong> prevent exploitation <strong>of</strong>consumers. Companies will also have to be sincere <strong>and</strong> honest in their claims while marketing <strong>and</strong>communicating with consumers till appropriate regulations for scientific validation are evolved.Processors will need to provide an optimal merger between taste, convenience <strong>and</strong> health attributes.References:Ch<strong>and</strong>rakant, P.N. (2002) Development <strong>of</strong> Technology for Fruit Dahi. M. Tech Thesis submitted to National <strong>Dairy</strong>Research Institute, Deemed University, Karnal.Chetana, R., Manohar, B. <strong>and</strong> Reddy S.R. (2004) Process optimization <strong>of</strong> Gulab Jamun, an Indian traditional sweet,using sugar substitutes. Eur. Food Res. Technol. 209:386 – 392Fiszman, S.M. <strong>and</strong> Salvador, A. (1999) Effect <strong>of</strong> gelatine on the texture <strong>of</strong> yoghurt <strong>and</strong> <strong>of</strong> acid-heat-induced milk gels.Z. Lebensm. Unters. Forsch. 208: 100 – 05.IIFC (2004) Background on functional foods. http://www.ific.org/nutrition/ functional/ upload/FuncFdsBackgrounder.pdfJayaprakash, K.T. (2003) Technological Studies on the Manufacture <strong>of</strong> Rasogulla Using Artificial Sweeteners. M. TechThesis submitted to National <strong>Dairy</strong> Research Institute, Deemed University, Karnal.Kantha, K.L. (2005) Enhancement <strong>of</strong> Sensory <strong>and</strong> Functional Properties <strong>of</strong> Low-fat Paneer Using Dietary Fibre. M. Tech.Thesis submitted to National <strong>Dairy</strong> Research Institute, Deemed University, Karnal.Kumar, M. (2000) Physico-chemical Characteristics <strong>of</strong> Low-Calorie Lassi <strong>and</strong> Flavoured <strong>Dairy</strong> Drink Using Fat Replacer<strong>and</strong> Artificial Sweetener. M. Tech Thesis submitted to National <strong>Dairy</strong> Research Institute, Deemed University,Karnal.Mann, R.S. <strong>and</strong> Singh, P.K. (2005) Specialty frozen products. In: lecture compendium <strong>of</strong> “Recent Developments inHealth Foods <strong>and</strong> Nutraceuticals” 18th Short Course organized by Centre <strong>of</strong> Advanced stuies in <strong>Dairy</strong> Technology,NDRI, Karnal, pp 127 – 132.Muralidhar, G.H. (2006) Determination <strong>of</strong> Aspartame <strong>and</strong> its Stability in Indigenous <strong>Dairy</strong> <strong>Products</strong>. M.Sc. Thesissubmitted to National <strong>Dairy</strong> Research Institute, Deemed University, Karnal.Narendra, K. (2006) Estimation <strong>and</strong> Stability <strong>of</strong> Saccharin in Indigenous <strong>Dairy</strong> <strong>Products</strong>. M.Sc. Thesis submitted toNational <strong>Dairy</strong> Research Institute, Deemed University, Karnal.P<strong>and</strong>it, P. (2004) Technological Studies on manufacture <strong>of</strong> Kulfi using Artificial Sweeteners. M. Tech. Thesis submittedto National <strong>Dairy</strong> Research Institute, Deemed University, Karnal.Patel, A. A. <strong>and</strong> Arora, S.K. (2005) Fibre fortification <strong>of</strong> dairy products.Proceedings <strong>of</strong> the Seminar on <strong>Value</strong> <strong>Added</strong><strong>Dairy</strong> <strong>Products</strong> held at NDRI, Karnal from Dec. 21 – 22, 2005.Prabha, S. (2006) Development <strong>of</strong> Technology for the Manufacture <strong>of</strong> Dietetic Burfi. Ph. D. Thesis submitted to National<strong>Dairy</strong> Research Institute, Deemed University, Karnal.Singh, V.P. (2006) <strong>Analysis</strong> <strong>of</strong> Sucralose <strong>and</strong> its Stability in Indigenous <strong>Dairy</strong> <strong>Products</strong>. M.Sc. Thesis submitted toNational <strong>Dairy</strong> Research Institute, Deemed University, Karnal.Yarrakula, S. (2006) <strong>Analysis</strong> <strong>of</strong> Acesulfame-K <strong>and</strong> its Stability in Indigenous <strong>Dairy</strong> <strong>Products</strong>. M.Sc. Thesis submitted toNational <strong>Dairy</strong> Research Institute, Deemed University, Karnal.16


IntroductionTechnological <strong>and</strong> Nutritional Aspects <strong>of</strong> Milk PhospholipidsTechnological <strong>and</strong> NutritionalAspects <strong>of</strong> Milk PhospholipidsB. K. Wadhwa <strong>and</strong> Rajesh Kumar<strong>Dairy</strong> Chemistry Division, NDRI, KarnalMilk fat in the lactating cow is secreted as myriads <strong>of</strong> lipid droplets <strong>of</strong> size 0.1 to 15 µm. Thesemicro lipid droplets are encircled by a special membrane composed <strong>of</strong> lipid bilayer <strong>and</strong> proteins.This membrane has been designated the milk fat/ lipid globule membrane (MFGM). Milk fat globulemembrane is composed <strong>of</strong> proteins <strong>and</strong> lipids in a 1:1 weight ratio. Bovine MFGM is a potentialnutraceutical. The health beneficial factors are contributed by both protein <strong>and</strong> non protein components<strong>of</strong> bovine MFGM. Among the health-beneficial components <strong>of</strong> the MFGM are cholesterolemia-loweringfactor, inhibitors <strong>of</strong> cancer cell growth, vitamin binders, inhibitor <strong>of</strong> Helicobacter pylori, inhibitor <strong>of</strong> betaglucuronidase<strong>of</strong> the intestinal Escherichia coli, xanthine oxidase as a bactericidal agent, butyrophilinas a possible suppressor <strong>of</strong> multiple sclerosis, <strong>and</strong> phospholipids as agents against colon cancer,gastrointestinal pathogens, Alzheimer’s disease, depression, <strong>and</strong> stress (Spitsberg, 2005).Sources <strong>of</strong> phospholipidsUntil recently commercially available phospholipids were predominantly made from vegetablelecithin, the by-products <strong>of</strong> vegetable oil refining. Phospholipids <strong>of</strong> animal origin were extracted fromegg yolk or from fish roe, but played less important role compared to the plant derived products,which mainly found applications as food additives.Bovine milk is a very new source for a commercialTable 1: Phospholipid pr<strong>of</strong>ile (%)<strong>of</strong> different raw materialsSoya Egg Milk MarinePC 23 73 27 82PE 22 18 22 04PI 14 2 08 03PA 7 - - -PS Traces - 12 01SPM - 3 27 02Glycolipids 12 - 07 -Table 2: Fatty acid pr<strong>of</strong>ile (%) <strong>of</strong> phospholipidsfrom different raw materialsSoya Egg Milk MarineSaturated 22 41 50 17Mono-unsaturated 12 35 35 21Poly-unsaturated 66 24 15 62production <strong>of</strong> phospholipids as milk fat globule membranephospholipids are very unique in terms <strong>of</strong> phospholipidcomposition <strong>and</strong> application pr<strong>of</strong>ile (Schneider, 2007).Vegetable lecithin is a complex mixture <strong>of</strong> phospho- <strong>and</strong>glycolipids, some carbohydrates <strong>and</strong> optionally triglycerides.Most animal lecithin does not contain glycolipids, norcarbohydrates. Vegetable oilseeds are solvent extracted toobtain the oil. Traces <strong>of</strong> phospholipids are co-extracted <strong>and</strong>need to be removed during the refining process in order toimprove the oil for clarity <strong>and</strong> stability reasons. This is doneby the addition <strong>of</strong> small amounts <strong>of</strong> water; the phospholipidsstart swelling which makes them insoluble in oil. Mechanicalseparation <strong>and</strong> drying <strong>of</strong> the so-called wetgums finally gives vegetable lecithin. Toproduce egg <strong>and</strong>/or milk phospholipidsthe process is much more sophisticated.Especially in the case <strong>of</strong> milk, it is a multistep approach to separate them from themilk fat globule membrane - predominantlymilk processing technology, followed bysome solvent based steps. Concentrated orisolated phospholipids are made by solvent-based extraction or fractionation processes from lecithin,<strong>of</strong>ten followed by chromatographic purification steps. The qualitative <strong>and</strong> quantitative pr<strong>of</strong>ile<strong>of</strong> phospholipids varies with the type <strong>of</strong> raw materials used (Table 1). Milk phospholipids containsphingomyelin whereas soya phospholipids do not contain sphingomyelin (Schneider, 2007). Also, thefatty acid pr<strong>of</strong>ile <strong>of</strong> phospholipids from different raw materials is variable (Table 2). Milk phospholipidsare richer in saturated <strong>and</strong> MUFA but poorer in PUFA in comparison to soya phospholipids.17


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceProperties <strong>of</strong> phospholipidsThe molecular structure <strong>of</strong> phospholipids is bipolar <strong>and</strong> amphiphilic, means it combines a lipophilicpart (the fatty acid tails linked to the glycerol backbone) <strong>and</strong> a hydrophilic part (the polar head group, aphosphoric acid ester mostly <strong>of</strong> an amino alcohol like choline, ethanolamine, etc.).Technological applications<strong>Their</strong> bipolar structure makes phospholipids excellent natural emulsifiers, widely used in foods,cosmetics <strong>and</strong> also pharmaceutical applications. The application properties <strong>of</strong> the food additive lecithinrelates to a great extent to their phospholipid content <strong>and</strong> pr<strong>of</strong>ile. The most prominent applicationsare for margarine, chocolate, baked products, instant powders, etc. The cosmetic industry appreciatestheir emulsifying, skin friendly <strong>and</strong> moisturising properties; pharmaceuticals use them as emulsifiersfor intravenous fat emulsions, but also for complex drug delivery systems (Iiposome).Liposomes are versatile delivery systems, originally for pharmaceutical uses, but also widely usedin cosmetics. Liposomes are tiny, artificial cell-like structures, surrounded by either one (unilamellar)or many phospholipid double layers. Inside the vesicular structure, or between the differentphos¬pholipid membranes, water compartments are entrapped, carrying <strong>and</strong> protecting water-solubleactives. But also lipophilic payloads can be entrapped <strong>and</strong> protected from the environment inside thelipophilic domains <strong>of</strong> the phospholipid double layers.Nutritiona1 pr<strong>of</strong>ile <strong>of</strong> phospholipidsBesides their widely used technological properties, phospholipids have a very Interestingnutritiona1 pr<strong>of</strong>ile. Lots <strong>of</strong> clinical studies have shown• Cholesterol reducing properties ( soya phosphatidylcholine - PC)• Improvement <strong>of</strong> cognitive performance - stress symptom (soya phosphatidylserlne - PS)• Liver tissue detoxification <strong>and</strong> regeneration ( soya PC).• Egg phospholipids are used to supplement infant formulae because <strong>of</strong> their content <strong>of</strong> longchain polyunsaturated fatty acids (docosahexaenoic <strong>and</strong> arachidonic acid DHA <strong>and</strong> ARA).Milk polar lipidsAnother biologically interesting lipid group in milk fat is the polar lipids, which are mainlylocated in the milk fat globule membrane (MFGM). It is a highly complex biological structure thatsurrounds the fat globulestabilizing it in the continuous aqueous phase <strong>of</strong> milk <strong>and</strong> preventing it fromenzymatic degradation by lipases (Spitsberg, 2005 ). The membrane consists <strong>of</strong> about 60% proteins <strong>and</strong>40% lipids that are mainly composed <strong>of</strong> triglycerides, cholesterol, phospholipids, <strong>and</strong> sphingolipids.The polar lipid content <strong>of</strong> raw milk is reported to range between 9.4 <strong>and</strong> 35.5 mg per 100 g <strong>of</strong> milk.The major phospholipid fractions are phosphatidylethanolamine <strong>and</strong> phosphatidylcholine followedby smaller amounts <strong>of</strong> phosphatidylserine <strong>and</strong> phosphatidylinositol. The major sphingolipidfraction is sphingomyelin with smaller portions <strong>of</strong> ceramides <strong>and</strong> gangliosides. In processing milkinto different dairy products, the polar lipids are preferentially enriched in the aqueous phases likeskimmed milk, buttermilk <strong>and</strong> butter serum.The polar lipids in milk are gaining increasing interest due to their nutritional <strong>and</strong> technologicalproperties. These compounds are secondary messengers involved in transmembrane signaltransduction <strong>and</strong> regulation, growth, proliferation, differentiation, <strong>and</strong> apoptosis <strong>of</strong> cells. They alsoplay a role in neuronal signaling <strong>and</strong> are linked to age - related diseases, blood coagulation, immunity,<strong>and</strong> inflammatory responses. In particular, sphingolipids <strong>and</strong> their derivatives are considered highlybioactive components possessing anticancer, cholesterol - lowering, <strong>and</strong> antibacterial activities.Thesepromising results from cell culture <strong>and</strong> animal - model studies warrant further confirmation <strong>and</strong>human clinical studies but suggest that sphingolipid - rich foods or supplements could be beneficial inthe prevention <strong>of</strong> breast <strong>and</strong> colon cancers <strong>and</strong> bowel - related diseases (Korhonen, 2010).18


Technological <strong>and</strong> Nutritional Aspects <strong>of</strong> Milk PhospholipidsProperties <strong>of</strong> milk phospholipidsMilk phospholipids are different from all other commercial lecithin <strong>and</strong> phospholipid products,both in phospholipid pattern <strong>and</strong> fatty acid pr<strong>of</strong>ile (Tables 1 <strong>and</strong> 2). Both differences make them veryattractive for a variety <strong>of</strong> new <strong>and</strong> innovative applications.Technological applications <strong>of</strong> milk phospholipidsBecause <strong>of</strong> the relatively high degree <strong>of</strong> saturated (50%) or mono-unsaturated fatty acids(approximately 35%) milk phospholipids are quite stable against oxidation <strong>and</strong> are• Very Important for food applications• Very stable against hydrolytic break-down in aqueous environments.• Hence, the taste <strong>and</strong> flavour pr<strong>of</strong>ile is not negatively affected by liberated free fatty acids (aswith soya phospholipids which are richer in PUFA).• Milk phospholipids are versatile ingredients for functional cosmetics. They are excellentemulsifiers, creating a very good <strong>and</strong> s<strong>of</strong>t skin feel, avoid trans-epidermal water loss <strong>and</strong> allowpreparing efficient Iiposomal systems with good entrapment stability.Milk phospholipids nowhave a clear advantage over all other phospholipids used so far for liposome production.• They are relatively stable against oxidation• They have a phase transition temperature <strong>of</strong> approximately 28°C, ideal for a lot <strong>of</strong> cosmetic <strong>and</strong>food applications.• (The phase transition temperature is the temperature at which the membrane undergoestransition from an organized fatty acid region (a kind <strong>of</strong> crystalline structure) to an unorganizedone (a kind <strong>of</strong> liquid structure).• At ambient temperature milk phospholipids liposome membranes are crystalline with excellententrapment characteristics . At higher temperature they tend to release their payload – a simpleapproach to protect sensitive ingredients <strong>and</strong> to release them at targeted conditions (Schneider,2007).Preparation <strong>of</strong> liposomes from milk fat globule membrane phospholipidsusing a micr<strong>of</strong>luidizerThe isolation <strong>of</strong> MFGM material from buttermilk on a commercial scale has provided a newingredient rich in phospholipids <strong>and</strong> sphingolipids. An MFGM-derived phospholipid fraction wasused to produce liposomes via a high-pressure homogenizer (Micr<strong>of</strong>luidizer). This technique does notrequire the use <strong>of</strong> solvents or detergents, <strong>and</strong> is suitable for use in the food industry. The liposomedispersion had an average hydrodynamic diameter <strong>of</strong> 95 nm, with a broad particle-size distribution.Increasing the number <strong>of</strong> passes through the Micr<strong>of</strong>luidizer, increasing the pressure, or reducingthe phospholipid concentration all resulted in a smaller average liposome diameter. Changing thesevariables did not have a significant effect on the polydispersity <strong>of</strong> the dispersion. Electron microscopyshowed that the dispersions formed had a range <strong>of</strong> structures, including unilamellar, multilamellar,<strong>and</strong> multivesicular liposomes. The composition <strong>of</strong> the MFGM phospholipid material is different fromthat <strong>of</strong> the phospholipids usually used for liposome production in the pharmaceutical <strong>and</strong> cosmeticindustries. The MFGM-derived fraction comprises approximately 25% sphingomyelin, <strong>and</strong> the fattyacids are primarily saturated <strong>and</strong> monounsaturated These differences are likely to affect the properties<strong>of</strong> the liposomes produced from the phospholipid material, <strong>and</strong> it may be possible to exploit the uniquecomposition <strong>of</strong> the MFGM phospholipid fraction in the delivery <strong>of</strong> bioactive ingredients in functionalfoods ( Thompson <strong>and</strong> Singh, 2006).19


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceNutritional applicationsPhospholipidsThe consumption <strong>of</strong> the MFGM alone as a nutraceutical or as a dairy food, or the consumption <strong>of</strong>food products enriched by the MFGM has health benefits due to the presence <strong>of</strong> phospholipids in theMFGM. Phospholipids <strong>of</strong> bovine MFGM constitute almost 30% <strong>of</strong> the total MFGM lipids. The threemain MFGM phospholipids are sphingomyelin, phosphatidyl choline, <strong>and</strong> phosphatidyl ethanolaminecomprising (weight %) 19.2 to 23.0, 25.7 to 41.1, <strong>and</strong> 27.0 to 35.0% <strong>of</strong> total MFGM phospholipids,respectively. Currently, it is considered that phospholipids, including milk-derived, affect numerouscell functions including growth <strong>and</strong> development, molecular transport systems, absorption processes,memory, stress responses, development <strong>of</strong> Alzheimer’s disease, <strong>and</strong> myelination in the central nervoussystem . Phospholipids also affect the development <strong>of</strong> colon cancer as discussed above (Spitsberg,2005).Phospholipids <strong>and</strong> glycosphingolipidsPhospholipids <strong>and</strong> glycosphingolipids accounts to about 1% <strong>of</strong> total milk lipids. They havefunctional roles in a number <strong>of</strong> reactions, such as binding enzymes on the globule surface, cellcellinteractions, differentiation, proliferation, immune recognition. Gangliosides are one <strong>of</strong> thesecomponents found in milk. The small amount <strong>of</strong> gangliosides (very complex neuraminic acid derivatives<strong>of</strong> a glycosylatcd ceramide) in milk polar lipid fractions has triggered interest to incorporate milkphospholipid compounds into infant formula products. Gangliosides have been confirmed as havingimmune stimulating effects <strong>and</strong> can modulate the binding <strong>of</strong> microbial toxins in the intestinal tract( Haug, 2007).SphingomyelinSphingomyelin (N-acylsphingosine-l phosphocho line or ceramide phosphocholine) is a phospholipid preferentially located in the outer leaflet <strong>of</strong> the plasma membrane <strong>of</strong> most mammalian cells. Inbovine milk, phospholipids account for 0.2-1.0 g/l00 g <strong>of</strong> total lipids, where they are as sociated withthe milk fat globule membrane. Sphingomyelin represents about one third <strong>of</strong> total milk phospholipids,variation in content is influenced by season <strong>and</strong> the stage <strong>of</strong> lactation, Digestion products <strong>of</strong>sphingomyelin <strong>and</strong> other sphingolipids, the ceramides(fatty acid amides <strong>of</strong> sphingosine), sphingosines<strong>and</strong> sphingosine-phosphates are highly bioactive compounds that are associated with cell regulation.They arrest cell growth <strong>and</strong> induce differentiation <strong>and</strong> apoptosis mechanisms that are deregulatedin carcinogenesis. Ceramide <strong>and</strong> sphingosine are referred to as tumor sup¬pressor lipids. The majormetabo-lites, ceramide <strong>and</strong> sphingosine, pass from the lumen to intestinal cells where they are utilizedto resynthesize sphingomyelin <strong>and</strong> other sphingolipids, which than largely pass to the circulation.Because ceramide <strong>and</strong> sphingosine participate in major anti proliferative pathways <strong>of</strong> cell regulationthat suppress oncogenesis, they have been termed tumor suppressor lipids. Both sphingolipids <strong>and</strong>their active metabolites, ceramides <strong>and</strong> sphingosines, were determined as effective bactericidal agentson pathogens like Listeria monocytogenes. In addition, studies with experimental animals haveshown that feeding sphingolipids inhibits colon carcinogenesis, reduces serum LDL cholesterol <strong>and</strong>regulates immune system. A series <strong>of</strong> study showed that dietary milkderived sphingomylein (0.025to 0.1%) <strong>of</strong> diet inhibited chemically induced colon tumors development in mice, reduced aberrantcrypt foci (ACF) (ACF -early precursors <strong>of</strong> colon cancer) formation <strong>and</strong> suppressed the conversion <strong>of</strong>benign adenomas to malignant adenocarcinomas. Feeding the milk derived sphingolipids, ceramidemonohexoside (glucosyl) ceramide dihexoside (lactosyl) <strong>and</strong> the ganglioside to mice at 0.025 to 1.0g/100g diet has shown that there complex sphingolipids were hydrolysed to ceramide by colonicenzymes. Supplementation reduced proliferation particularly in the upper-half <strong>of</strong> the colonic cryptcells <strong>and</strong> reduced the number <strong>of</strong> ACF by 50-60 per cent. The reduction in the ACF formation is similarto that previously obtained with sphingomyelin. Another aspect confirmed in human clinical trialsis sphingomyelin cholesterol lowering activity by inhibiting intestinal absorption <strong>of</strong> food basedcholesterol (Sibel et al, 2006; Schneider, 2007; Chaudhary et al, 2008).20


Technological <strong>and</strong> Nutritional Aspects <strong>of</strong> Milk PhospholipidsConclusionMilk phospholipids are a new class <strong>of</strong> natural phospholipids now commercially available. They<strong>of</strong>fer a broad spectrum <strong>of</strong> both technological <strong>and</strong> nutritional properties which are unique to this kind <strong>of</strong>polar lipid extract <strong>and</strong> which are different from all other phospholipid products on the market. Theseare potent emulsifier, stable liposome forming compound, cholesterol lowering, improving cognitiveperformance, stress dampening effects, colon cancer preventive effects, additive for infant formulae.ReferencesChaudhry, I; Kathirvelan, C; Tyagi, A.K. (2008).Anticancer property <strong>of</strong> milk. Indian <strong>Dairy</strong>man, 60(5)37-53.Haug, A; Hestmark, A.T; Harstad, O.M. (2007).Bovine milk in human nutrition-a review.Lipids in health <strong>and</strong> disease.p1-26.Korhonen, H.J. (2010).Bioactive components in bovine milk. Chapter2 p.15-42.cited from book- Bioactive componentsin milk <strong>and</strong> dairy products Edt. By Young W.Park. Willey blackwell A John Wiley & Sons, Ltd., Publication.Schneider, M.(2007). Milk phospholipids - technological <strong>and</strong> nutritional aspects.Bulletin <strong>of</strong> the IDF 413/2007.p.35-39.Sibel Akal, Gönç <strong>and</strong> Gülfem Ünal (2006). Functional Properties <strong>of</strong> Bioactive Components <strong>of</strong> Milk Fat in Metabolism.Pakistan Journal <strong>of</strong> Nutrition 5 (3): 194-197.Spitsberg,V.L.(2005).Bovine MFGM as a potential nutraceutical. J. <strong>Dairy</strong> Sci. 88:2289-2294.Thompson, A.K <strong>and</strong> Singh, H.(2006). Preparation <strong>of</strong> Liposomes from Milk Fat Globule Membrane Phospholipids Usinga Micr<strong>of</strong>luidizer. J.<strong>Dairy</strong> Sci. 89:410-419.21


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceIntroduction:Methods <strong>of</strong> Cholesterol Removal to DevelopLow – Cholesterol <strong>Dairy</strong> <strong>Products</strong>Darshan Lal <strong>and</strong> Vivek Sharma<strong>Dairy</strong> Chemistry Division, NDRI, KarnalThe importance <strong>of</strong> milk <strong>and</strong> milk products, in India, has been recognized since Vedic times.Milk is considered to be a complete food as it contains almost all essential nutrients required forhuman health <strong>and</strong> growth. Lipids, the most important constituent <strong>of</strong> milk, play significant role in thenutrition, flavour <strong>and</strong> physico-chemical properties <strong>of</strong> milk <strong>and</strong> milk products. They are also rich source<strong>of</strong> fat-soluble vitamins (A, D, E & K) <strong>and</strong> essential fatty acids, apart from having pleasant sensoryattributes. Milk fat is easily digestible than other oils <strong>and</strong> fats. It contains number <strong>of</strong> componentswhich show anticarcinogenic activity, e.g. sphingomyeline, conjugated linoleic acid, β-carotene etc.So one (especially vegetarians) cannot avoid it in one’s diet. But recent trend, in the society, is againstfat-rich dairy products due to the presence <strong>of</strong> saturated fat & cholesterol as these are known to increasethe incidence <strong>of</strong> coronary heart disease (CHD).CHD is one <strong>of</strong> the common causes <strong>of</strong> heart attack. Through a period <strong>of</strong> time, many researchers haveshown that dietary cholesterol, serum cholesterol <strong>and</strong> occurrence <strong>of</strong> coronary heart disease (CHD)have positive correlation. Milk fat contains about 0.25 to 0.40% cholesterol. Consumption <strong>of</strong> ghee<strong>and</strong> other fat-rich dairy products makes appreciable contribution to cholesterol intake. Furthermore,some cholesterol oxidation products (COPs) have been reported to be more harmful than cholesterolitself as they are cytotoxic, atherogenic, mutagenic <strong>and</strong> carcinogenic. Recent wave against cholesterolcontainingfoods has damaged the image <strong>and</strong> market growth <strong>of</strong> fat-rich dairy products. The educated<strong>and</strong> urban society, in particular, is more conscious about the presence <strong>of</strong> cholesterol in their diet.This segment <strong>of</strong> the society is the major consumer <strong>of</strong> dairy <strong>and</strong> other food items manufactured by theorganized sector. In recent years, dem<strong>and</strong> <strong>of</strong> cholesterol-free foods has increased tremendously. Thishas led to increase in market <strong>of</strong> margarine, vegetable fat filled dairy products, milk fat replaced dairyproducts, etc.Owing to the adverse affects <strong>of</strong> cholesterol on human health, various physical, chemical <strong>and</strong>biological methods have been developed for reducing cholesterol in foods. These include blending <strong>of</strong>milk fat with vegetable oils, extraction with organic solvent, adsorption with activated charcoal <strong>and</strong>saponin, vacuum distillation, molecular distillation, degradation <strong>of</strong> cholesterol by enzyme (cholesteroloxidase) <strong>and</strong> removal <strong>of</strong> cholesterol by supercritical carbon dioxide. Recently, β- cyclodextrin (a starchhydrolysed product) has been effectively used for cholesterol removal from milk, cream, cheese, lard<strong>and</strong> egg-yolk. Beta cyclodextrin is reported to be non-toxic, non-hygroscopic, chemically stable <strong>and</strong>edible.Cholesterol:Cholesterol is a waxy material found in all cells <strong>of</strong> the body<strong>and</strong> is a necessary part <strong>of</strong> cell membranes, some hormones<strong>and</strong> other body components. In particular, it participates inthe formation <strong>of</strong> myelin sheaths in the brain <strong>and</strong> peripheralnerves, <strong>and</strong> modulates the absorption <strong>of</strong> dietary fats in theintestine. It also acts as a precursor in the biosynthesis <strong>of</strong>bile acids, steroid hormones <strong>and</strong> vitamin D. The body makesall the cholesterol it needs; it is not necessary to get anycholesterol from the diet. A high level <strong>of</strong> cholesterol in theblood is a major risk factor for CHD <strong>and</strong> heart attack.22


Methods <strong>of</strong> Cholesterol Removal to Develop Low – Cholesterol <strong>Dairy</strong> <strong>Products</strong>Structure <strong>and</strong> properties <strong>of</strong> cholesterol:The term cholesterol was derived from the Greek words chole <strong>and</strong> stear, which mean “bile”<strong>and</strong> “hard fat,” respectively. The origin <strong>of</strong> the term is a reflection <strong>of</strong> the fact that the substance wasfirst identified as a hard & white solid in gallstones. Though discovered by Poulletier de la Salle in1769, cholesterol was not named until 1818, when Michel Chevreul rediscovered it <strong>and</strong> dubbed it ascholesterine, believing that the material was like a fat (Sabine, 1977). Cholesterol is a hydrophobic sterolconsisting <strong>of</strong> a four-ring structure (Figure A) with molecular weight 386.66 <strong>and</strong> molecular formula:C 27H 46O.Cholesterol is insoluble in water, sparingly soluble in cold alcohol or petroleum ether, <strong>and</strong> solublein hot alcohol <strong>and</strong> most other organic solvents. Cholesterol melts at 148.5ºC. It can be sublimed <strong>and</strong>distilled under high vacuum. The polar hydroxyl group, which gives cholesterol a slightly hydrophilicnature, can be esterified to a fatty acid, producing cholesterol ester. Both cholesterol <strong>and</strong> cholesterolester are important structural components <strong>of</strong> cell membranes. Cholesterol is also a major determinant<strong>of</strong> membrane fluidity due to its hydrophobic <strong>and</strong> hydrophilic regions (Webb et al, 1987).Sources <strong>of</strong> cholesterol in body:In the body, cholesterol appears through endogenous synthesis <strong>and</strong> from the diet. Cholesterolsynthesis in the body is most active in the liver <strong>and</strong> intestine <strong>and</strong> averages 11 mg per kg body weightper day. This equals 770 mg for a 70 kg man on a low (less than 300 mg per day) cholesterol diet(McNamara, 1987). Normally, liver makes 80% <strong>of</strong> the total blood cholesterol <strong>and</strong> only 20% comes fromthe diet (Renner <strong>and</strong> Gurr, 1991; Allred, 1993). Cholesterol is not considered as an essential dietarynutrient because <strong>of</strong> its endogenous synthesis. On the other h<strong>and</strong>, Thomas <strong>and</strong> Holub (1994) reportedthat if less dietary cholesterol is consumed, the body compensates by making more cholesterol.Digestion, absorption <strong>and</strong> transportation <strong>of</strong> cholesterol in the blood:Digestion <strong>and</strong> absorption <strong>of</strong> cholesterol occurs in the small intestine (Grundy, 1983). Cholesterolester is broken down by a pancreatic cholesterol esterase into free cholesterol, which, absorbed into thecells lining <strong>of</strong> the intestine. The absorption <strong>of</strong> endogenous cholesterol (as bile acids) is more efficientthan dietary cholesterol absorption.Fat, including cholesterol, absorbed from the diet, is insoluble in the aqueous medium <strong>of</strong> theblood. To enable transport through blood system, the various fat components are incorporated intoparticles called lipoproteins (Grundy, 1983; Mahley <strong>and</strong> Innerarity, 1983). Lipoproteins consist <strong>of</strong> alipid core <strong>of</strong> triglyceride <strong>and</strong> cholesterol ester with a surface <strong>of</strong> mainly phospholipids, protein <strong>and</strong>some free cholesterol. The four major lipoprotein fractions found in the blood are chylomicrons, verylowdensity lipoprotein (VLDL), low-density lipoprotein (LDL) <strong>and</strong> high-density lipoprotein (HDL).Chylomicrons are very rich in triglycerides (about 85%) but also contain absorbed cholesterol inthe free or esterified form. VLDL is also rich in triglyceride (about 50%) <strong>and</strong> contains a substantialportion <strong>of</strong> cholesterol mainly as cholesterol ester. VLDL transport about 15% <strong>of</strong> the total cholesterolfound in the blood.LDL is enriched in cholesterol <strong>and</strong> accounts for about 60% <strong>of</strong> the total blood cholesterol level. It isdeposited in artery walls, increasing the buildup <strong>of</strong> plaque <strong>and</strong> hence also known as bad cholesterol.HDL carries as much as 20% <strong>of</strong> the total blood cholesterol level. HDL is thought to be antiatherogenicsince it picks up cholesterol from peripheral tissues for delivery to the liver <strong>and</strong> excretion. Consequently,HDL is called good cholesterol. A better indicator <strong>of</strong> risk for CHD is the LDL/HDL cholesterol ratio(Thomas <strong>and</strong> Holub, 1994; Gurr, 1995).Synergistic effect <strong>of</strong> cholesterol with saturated fatty acids on plasma cholesterol level:Some saturated fatty acids are reported to affect total plasma cholesterol concentration. While,stearic acid has little effect on plasma cholesterol concentration, myristic <strong>and</strong> palmitic acids havebeen reported to have the greatest cholesterol raising potential (Hegsted et al., 1965). Some evidencesuggests that the effect <strong>of</strong> myristic <strong>and</strong> palmitic acids depends on the concomitant intake <strong>of</strong> dietary23


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assurancecholesterol (National Academy <strong>of</strong> Sciences, 1989). Such an interaction is clear in several experimentalmammals (Spady et al., 1993) <strong>and</strong> has also been found in some human studies (Fielding et al., 1995).The above reports suggesting an interaction between cholesterol <strong>and</strong> saturated fat intake; provide afurther reason to limit dietary cholesterol.Coronary heart disease <strong>and</strong> atherosclerosis:Coronary heart disease (CHD) is a condition in which the main coronary arteries which supplyblood to the heart are no longer able to supply sufficient blood <strong>and</strong> oxygen to the heart muscle. CHD,the common cause <strong>of</strong> heart attack, is one <strong>of</strong> the most frequent causes <strong>of</strong> death in the developed <strong>and</strong>developing countries (AHA, 1989). The rates <strong>of</strong> mortality due to CHD throughout the world vary.For example, in one study among men aged 40-59 years, the annual incidence rate varied from 15 per100,000 in Japan to 198 per 100,000 in Finl<strong>and</strong> (Lovegrove <strong>and</strong> Jackson, 2003). According to Chopra(1997), 2.5 million Indians become victims <strong>of</strong> heart disease every year, <strong>and</strong> Indian women are thefastest rising group <strong>of</strong> coronary patients in the world. He further observed that 33 per 1000 Indianshave a greater chance <strong>of</strong> requiring treatment <strong>and</strong> intervention for heart disease than either Europeanor Americans.Atherosclerosis is a silent, painless process <strong>and</strong> the main cause <strong>of</strong> CHD characterized by build up<strong>of</strong> cholesterol-rich fatty deposits on the inner lining <strong>of</strong> the coronary arteries, which decrease bloodflow to the heart muscle by narrowing the arteries substantially (Tabas, 2002). The atherosclerosisplaques usually develop at a point <strong>of</strong> minor injury in the arterial wall.Cholesterol in milk <strong>and</strong> milk products:Animal food products like milk <strong>and</strong> milk products, meat <strong>and</strong> meat products <strong>and</strong> eggs are themajor sources <strong>of</strong> cholesterol in our diet. Among these, chicken egg contains highest amount (about 215mg/egg) <strong>of</strong> cholesterol. Normally, most <strong>of</strong> the dieticians believe milk fat as a main source <strong>of</strong> dietarycholesterol <strong>and</strong> the main culprit for CHD disease. Cholesterol accounts for 0.25-0.45% <strong>of</strong> the totallipids in milk. Cholesterol concentrates in the milk fat globule membrane (MFGM). In milk, 80% <strong>of</strong> thecholesterol is associated with the milk fat globules <strong>and</strong> the remaining 20% is partitioned into the skimmilk phase where it is associated with fragments <strong>of</strong> cell membrane (Patton & Jensen, 1975). However,any event disrupting the membrane structure, e.g. churning <strong>of</strong> cream will result in the partial passing<strong>of</strong> cholesterol alongwith ruptured membrane material to the aqueous phase. Arul et. al., (1987) studiedthe distribution <strong>of</strong> cholesterol in various milk fat fractions viz., solid fraction (m. pt. 39ºC), semisolidfraction (m. pt. 21°C) <strong>and</strong> liquid fraction (m. pt. 12ºC) <strong>and</strong> reported that 80% <strong>of</strong> the total cholesterolcontent was present in the liquid fraction <strong>of</strong> the milk fat. 80-90% <strong>of</strong> the cholesterol is present in milk inthe free form, while 10-20% is esterified (Bindal <strong>and</strong> Jain, 1973; Wood <strong>and</strong> Bitman, 1986; Jensen, 1987;Schlimme & Kiel, 1989).Pantulu <strong>and</strong> Murthy (1982) observed 8-10 times higher content <strong>of</strong> cholesterol in whey than inwhole milk. Srinivasan (1984) reported the average cholesterol content <strong>of</strong> cow <strong>and</strong> buffalo milk as2.8 <strong>and</strong> 1.9 mg/g fat, respectively. However, Prasad <strong>and</strong> P<strong>and</strong>ita (1990) showed that buffalo milk (20mg%) contained more cholesterol than cow milk (15.5 mg%). Similarly, they found that dahi frombuffalo milk contained more cholesterol as compared to dahi from milk <strong>of</strong> different breed <strong>of</strong> cows. Ingeneral, dahi had lower cholesterol values than the fresh milk (Ismail <strong>and</strong> Ahmad, 1978; Prasad <strong>and</strong>P<strong>and</strong>ita, 1990). Cholesterol in channa samples exhibited a highly significant variation, being minimumin buffalo, while such species variations were not observed in case <strong>of</strong> khoa calculated on dry weightbasis (Prasad <strong>and</strong> P<strong>and</strong>ita, 1990).Cheese was found to contain 52.3-76.6 (av. 69.3) mg <strong>of</strong> cholesterol/100 g <strong>of</strong> cheese <strong>and</strong> 198-298(av. 273) mg/100g fat in cheese (Fuke <strong>and</strong> Matsuoka, 1974). Tylkin et al., (1975) reported 9 timeshigher cholesterol/g fat in butter milk than butter. Aristova <strong>and</strong> Bekhova (1976) observed cholesterolcontent in unsalted butter as 244 mg/100 g. Vyshemirskii et al., (1977) reported that 80-90% cholesterolinitially present in cream passed into butter <strong>and</strong> 10-20% to butter milk. Masson <strong>and</strong> Martinez (1984)reported cholesterol content as 177–208 mg/100 g fat in butter. Bindal <strong>and</strong> Jain (1972) estimated free24


Methods <strong>of</strong> Cholesterol Removal to Develop Low – Cholesterol <strong>Dairy</strong> <strong>Products</strong><strong>and</strong> esterified cholesterol in Desi ghee, using TLC method <strong>and</strong> reported their contents as 0.288 <strong>and</strong>0.038% <strong>and</strong> 0.214 <strong>and</strong> 0.056% in cow <strong>and</strong> buffalo ghee, respectively. Prasad <strong>and</strong> P<strong>and</strong>ita (1987) observedcholesterol content <strong>of</strong> ghee prepared from milk <strong>of</strong> Haryana, Sahiwal <strong>and</strong> Sahiwal X Friesian cows <strong>and</strong>from Murrah buffaloes, to be 303, 310, 328 <strong>and</strong> 240 mg/100 g fat, respectively.Factors affecting level <strong>of</strong> cholesterol in milk <strong>and</strong> milk productsEffect <strong>of</strong> Species/Breeds:Bindal <strong>and</strong> Jain (1973) reported that cow ghee (0.31%) contained higher cholesterol than buffalo ghee(0.267%). Bernolak (1979) observed that cow milk, with 2.8% fat, contained 237 mg total sterols/100 g fat(92.8% cholesterol <strong>of</strong> total sterols). Prasad <strong>and</strong> P<strong>and</strong>ita (1987, 1990) also reported higher cholesterol contentin cow ghee compared to that in buffalo ghee. Singh <strong>and</strong> Gupta (1982) observed that goat ghee containhigher cholesterol (0.236 g/100 g fat) than cow (0.230 g/100 g fat) <strong>and</strong> buffalo (0.196 g/100 g fat) ghee.Effect <strong>of</strong> Season/Stage <strong>of</strong> lactation:Season has also been reported to affect the cholesterol content <strong>of</strong> milk fat. Treiger (1979) reportedthat total cholesterol content <strong>of</strong> cow milk fat ranged from 0.24-0.29 g/100 g fat in spring <strong>and</strong> 0.18-0.25g/100 g fat in summer season. Prasad <strong>and</strong> P<strong>and</strong>ita (1987, 1990) observed that cholesterol content <strong>of</strong>ghee was higher in winter than in summer (301 vs 291 mg/100g fat). Krzyzewski et al. (2003) alsoobserved a significantly lower (by about 16%) concentration <strong>of</strong> cholesterol in milk during winterseason. Ghee prepared from milk <strong>of</strong> old animals (Lal, 1982) <strong>and</strong> late lactation milk (Nigam, 1989) wasfound to contain highest level <strong>of</strong> cholesterol.Effect <strong>of</strong> Heat:Bector <strong>and</strong> Narayanan (1975) observed that when cow <strong>and</strong> buffalo ghee were heated at 225°C for 2h, respectively 26.1 <strong>and</strong> 27.3% <strong>of</strong> cholesterol was lost. Similarly, Rai <strong>and</strong> Narayanan (1984) also reported28.2 <strong>and</strong> 49% loss <strong>of</strong> cholesterol after 12 h <strong>of</strong> intermittent frying in aluminium <strong>and</strong> iron container.Methods <strong>of</strong> cholesterol removal from milk fat:Since dairy products contain significant amounts <strong>of</strong> cholesterol, a number <strong>of</strong> processes for removal<strong>of</strong> cholesterol have been developed to produce low-cholesterol dairy products. These include steamstripping, molecular distillation, solvent or super-critical extraction, reaction with cyclic anhydride,enzymatic method <strong>and</strong> treatments with adsorbents like saponin, activated charcoal <strong>and</strong> cyclodextrin.These are briefly discussed below.1. Steam strippingThis process is similar to that used in the deodorization <strong>of</strong> vegetable oils <strong>and</strong> removal <strong>of</strong>unsaponifiable matter. To remove cholesterol by steam stripping, the fat is first deairated undervacuum after which it is heated with steam upto 232ºC <strong>and</strong> then subjected to steam at low pressurein cylindrical tall chamber. The anhydrous milk fat (AMF) passing over a series <strong>of</strong> plates is spreadin many thin layers, which increases the stripping efficiency. The steam rises <strong>and</strong> carries with it theevaporated cholesterol to be condensed <strong>and</strong> collected with other volatiles. This process can removeupto 93% <strong>of</strong> cholesterol though with 5% fat losses. The major disadvantage to the process is that itremoves flavouring compounds also (Schlimme & Kiel, 1989).2. Molecular distillationIn this process, AMF is molecularly distilled at temperature 190 <strong>and</strong> 210ºC at a vacuum <strong>of</strong> 10-4Torr. Fractions distilled at 190 <strong>and</strong> 210ºC represented 3.43 <strong>and</strong> 3.99 % <strong>of</strong> the initial mass <strong>and</strong> containedmore than 93% <strong>of</strong> the total cholesterol (Lanzani et al, 1994 <strong>and</strong> Sharma et al., 1999). Arul et al. (1988)fractionated AMF into four fractions at temperatures <strong>of</strong> 245 <strong>and</strong> 265ºC <strong>and</strong> pressure <strong>of</strong> 220 <strong>and</strong> 100 mmHg. Two low melting point fractions were blended together to yield a total <strong>of</strong> three fractions (liquid,intermediate <strong>and</strong> solid). About 78% <strong>of</strong> the total cholesterol was found in the liquid fraction while theremaining was found in the intermediate (18%) <strong>and</strong> solid (4%) fractions in the esterified form. But,because <strong>of</strong> the high heat used in the process, the quality <strong>of</strong> the end product is adversely affected.25


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assurance3. Solvent extraction:In this process butter oil is mixed with propane <strong>and</strong> ethanol in the mixing vessel. The low viscousmixture <strong>of</strong> butter fat, ethanol <strong>and</strong> propane is fed into the extraction column. A mixture <strong>of</strong> ethanol <strong>and</strong>water, containing a small amount <strong>of</strong> propane is used as extractant. The extract, a solution <strong>of</strong> cholesterol<strong>and</strong> butter fat in a mixture <strong>of</strong> ethanol, water <strong>and</strong> some propane is withdrawn at the bottom <strong>of</strong> theextraction column, which is splitted into two phases. The upper phase consists <strong>of</strong> fat <strong>and</strong> cholesterol,which are subsequently separated, in a further processing step. Around 90 to 95% <strong>of</strong> the cholesterol isextracted in this counter-current procedure operated at 30ºC <strong>and</strong> 10 bar (Czech et al., 1993).4. Supercritical carbon dioxide extraction:Some studies have shown that supercritical carbon dioxide (SC-CO 2) can be used to fractionateAMF with evidence that cholesterol can be concentrated into selected fractions. Kaufmann et al., (1982)obtained two fractions <strong>of</strong> milk fat by SC-CO 2extraction at a pressure <strong>of</strong> 200 bars <strong>and</strong> temperature <strong>of</strong>80ºC. In this process, the liquid fractions were enriched in total cholesterol. However, Huber et al.(1996) observed that direct supercritical extraction <strong>of</strong> cholesterol from AMF is not feasible because<strong>of</strong> the low selectivity <strong>of</strong> cholesterol <strong>and</strong> poor solubility <strong>of</strong> AMF. Moreover, under these conditions,important milk flavours also get separated with the cholesterol. Therefore, they proposed anotherprocess for cholesterol removal from AMF, dissolved in SC-CO 2under high solubility conditions forAMF (40 MPa at 70ºC) to achieve rapid extraction. In this process, the dissolved AMF in SC-CO 2ispassed isobarically <strong>and</strong> isothermally through a high-pressure column, filled with a suitable adsorbent(e.g. silica gel) to eliminate cholesterol. Finally, the supercritical mixture is fractionated by eitherdescending or ascending temperature pr<strong>of</strong>ile in separators connected in series. Karkare <strong>and</strong> Alkio(1993) found that over 99% <strong>of</strong> cholesterol from milk fat could be removed using an SC-CO 2extractionsystem equipped with a silica gel column.5. Reaction with cyclic anhydride:Gu et al. (1994) developed a method for cholesterol removal from milk fat based on the reactionbetween the hydroxyl group <strong>of</strong> cholesterol <strong>and</strong> a cyclic anhydride such as succinic anhydride. Theconversion <strong>of</strong> cholesterol into an acid derivative makes it possible to remove these from fats byextraction with aqueous alkali. Addition <strong>of</strong> acetic acid increases the rate <strong>of</strong> reaction <strong>and</strong> prevents thedistillation <strong>of</strong> cyclic anhydride from reaction mixture. They removed 50% cholesterol from animal fatsbut alongwith it α- tocopherol (50%), γ- <strong>and</strong> δ- lactones also get removed.6. Enzymatic method:McDonald et al. (1983) have described an enzymatic process using cholesterol reductase forconversion <strong>of</strong> cholesterol to biologically inactive, e.g., non-toxic, non-absorbable products likecoprosterol, which is either not or is only poorly adsorbed by the body. This approach, which istheoretically suitable for reducing the cholesterol content <strong>of</strong> milk fat, has been verified biologicallyat least in part, by the finding that a portion <strong>of</strong> the intestinal cholesterol is reduced to coprosterol byintestinal bacteria <strong>and</strong> subsequently eliminated.7. Adsorption methodsCholesterol can be removed by its adsorption on certain material. Adsorbents, which are used toremove cholesterol, are activated charcoal, saponins <strong>and</strong> β cyclodextrin.(A) Activated charcoalBindal et al., (1994) could remove half <strong>of</strong> the cholesterol present in milk fat through treatment<strong>of</strong> liquid fat with activated charcoal. Another activated charcoal method claimed 95% <strong>of</strong> cholesterolremoval from AMF but many other compounds including yellow pigments were also removedsimultaneously (Sharma et al., 1999).(B) SaponinsSaponins are naturally occurring plant compounds that can be used to selectively bind tocholesterol <strong>and</strong> precipitate it out. 80% <strong>and</strong> 90% cholesterol reduction in cream <strong>and</strong> anhydrous milk26


Methods <strong>of</strong> Cholesterol Removal to Develop Low – Cholesterol <strong>Dairy</strong> <strong>Products</strong>fat was obtained by using this method (Riccomini et al., 1990). Oh et al. (1998) found 70.5% <strong>of</strong> thecholesterol removal when milk was treated with 1.5% saponin at 45ºC for 30 min. Further, addition<strong>of</strong> 0.25% celite increased cholesterol removal to 72%. However, the methods using activated charcoalor saponins are relatively non-selective <strong>and</strong> remove flavour <strong>and</strong> nutritional components also whencholesterol is removed (Lee et al., 1999; Sharma et al., 1999).(C) β-cyclodextrinBeta cyclodextrin, one <strong>of</strong> the well known members <strong>of</strong> cyclodextrin family, is a cyclic oligosaccharide<strong>of</strong> seven glucose units joined ‘head to tail’ by α-1, 4 linkage <strong>and</strong> is produced by the action <strong>of</strong> enzymecyclodextrin glycosyl transferase (CGT) on hydrolyzed starch syrup. Beta cyclodextrin has torus likestructure. The central cavity is hydrophobic, giving the molecule its affinity for non-polar moleculessuch as cholesterol (Szejtli, 2004). The radius <strong>of</strong> the cavity can accommodate a cholesterol moleculealmost exactly, explaining the highly specific nature <strong>of</strong> β-cyclodextrin’s ability to form an inclusioncomplex with cholesterol (Hettinga, 1996).References:AHA (1989) Heart Facts. American Heart Association. Dallas, A. Heart. A.Ahn, J. <strong>and</strong> Kwak, H. S. (1999) Optimizing cholesterol removal in cream using beta-cyclodextrin <strong>and</strong> response surfacemethodology. J. Food Sci. 64(4): 629-632.Allred, J. B. (1993) Lowering serum cholesterol. Who benefits? J. Nutr. 123: 1453.Aristova, V. P. <strong>and</strong> Bekhova, E. K. (1976) Cholesterol in milk <strong>and</strong> milk products. Trudy, Vsesoyuznyi Nanchnoissledovatel’skiiInstitut Malochoi Promyshlennosti No. 42: 45 (cf. DSA 1977(39), 2748).Arul, J. A., Boudreau, A., Makhlouf, J., Tardif, R. <strong>and</strong> Grenier, B. (1988). Distribution <strong>of</strong> cholesterol in milk fat fractions.J. <strong>Dairy</strong> Res. 55: 361-371.Bector, B.S. <strong>and</strong> Narayanan, K.M. (1975) Comparative stability <strong>of</strong> unsaponifiable constituents <strong>of</strong> ghee during thermaloxidation. Indian J. Nutr. Dietetics. 12(6): 178-180.Bindal, M. P. <strong>and</strong> Jain, M. K. (1973) Studies on cholesterol content <strong>of</strong> cow <strong>and</strong> buffalo ghee. Indian J. Anim. Sci. 43(10):918-924.Bindal, M. P., Wadhwa, B. K., Lal, D., Rai, T. <strong>and</strong> Aggarwal, P. K. (1994) Removal <strong>of</strong> cholesterol from milk <strong>and</strong> milkproducts: Application <strong>of</strong> biotechnical processes. NDRI Annual Report. pp. 98-99.Czech, B., Peter, S. <strong>and</strong> Weidner E. (1993) Effective removal <strong>of</strong> cholesterol from butter fat. Sc<strong>and</strong>inavian <strong>Dairy</strong> Information,7(4): 56-58.Fielding, C. J., Havel, R. J., Todd, K. M., Yeo, K. E., Schloetter, M.C., Weinberg, V. <strong>and</strong> Frost, P. H. (1995) Effects <strong>of</strong>dietary cholesterol <strong>and</strong> fat saturation on plasma lipoproteins in an ethnically diverse population <strong>of</strong> healthy youngmen. J. Clin. Invest. 95: 611-618.Fuke, Y. <strong>and</strong> Matsuoka, H. (1974) Cholesterol content <strong>and</strong> identification <strong>of</strong> foreign fats in processed cheese. J. Jap Soc.Food Nutr. 27: 269.Grundy, S. M. (1983) Absorption <strong>and</strong> metabolism <strong>of</strong> dietary cholesterol. Annu. Rev. Nutr. 3: 71-96.Gu, Y. F., Chen, Y. <strong>and</strong> Hammond, E. G. (1994) Use <strong>of</strong> cyclic anhydrides to remove cholesterol <strong>and</strong> other hydroxycompounds from animal fats <strong>and</strong> oils. J. Am. Oil Chem. Soc. 71: 1205-1207.Gurr, M. I. (1995) Dietary lipids in health <strong>and</strong> disease. In Advanced <strong>Dairy</strong> Chemistry-2: Lipids, 2nd edn, (eds P. F. Fox),Chapman & Hall, New York, pp. 349-402.Hegsted, D.M., McG<strong>and</strong>y, R.B., Myers, M.L. <strong>and</strong> Stare, F.J. (1965) Quantitative effects <strong>of</strong> dietary fat on serum cholesterolin man. Am. J. Clin. Nutr. 17: 281-95.Hettinga, D. (1996) Butter. in Bailey’s industrial oil <strong>and</strong> fat products, Vol. 3, 5th edn, (eds Y. H. Hui), John Wiley & Sons,INC. New York, pp. 1-23.Huber, W., Molero, A., Pereyra, C. <strong>and</strong> Martinez de la Ossa E. (1996) Dynamic supercritical carbon dioxide extractionfor removal <strong>of</strong> cholesterol from anhydrous milk fat. Int. J. Food Sci. Tech. 31: 143-151.Ismail, A.A. <strong>and</strong> Ahmad, N.S. (1978) Cholesterol content in buffalo milk <strong>and</strong> its distribution in some dairy products.Egypt. J. <strong>Dairy</strong> Sci. 6: 92-95.Jensen, R. J. (1987) Cholesterol in human milk. in Human Lactation. 3. The effect <strong>of</strong> human milk on the recipient infant(eds A. S. Goldman, S. A. Atkinson <strong>and</strong> S. S. Hanson), Plenum Press, New York, pp. 151.Karkare, V. <strong>and</strong> Alkio, M. (1993) Removal <strong>of</strong> cholesterol during milk fat fractionation by supercritical carbon dioxide.Agric. Sci. Finl<strong>and</strong>. 2(5): 387-393. (Cited in DSA, 56: 1522).Kaufmann, W. , Biernoth, G., Frede, E., Merk, W., Precht, D. <strong>and</strong> Timmens, W. (1982) Fractionation <strong>of</strong> butter fat byextraction with supercritical carbon dioxide. Milchwissenschaft. 37: 92-96.Krzyzewski, J., Strzakowska, N., Jozwik, A., Bagnicka, E. <strong>and</strong> Ryniewicz, Z. (2003) Effect <strong>of</strong> nutrition <strong>and</strong> season oncholesterol level in milk <strong>of</strong> Holstein-Friesian cows. Annals Anim. Sci. 3: 45-49.Lal, D. (1982) Effect <strong>of</strong> lactation number on the physicochemical status <strong>of</strong> milk lipids. Ph.D. Thesis, Kurukshetra Univ.,Kurukshetra.Lanzani, A., Bondioli, P. Mariai, C., Folegatti, L., Venturii, S., Fedeli, E. <strong>and</strong> Barreteau, P. (1994) A new short-pathdistillation system applied to the reduction <strong>of</strong> cholesterol in butter <strong>and</strong> lard. J. Am. Oil Chem. Soc. 71(6): 609-614.27


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceLee, D. K., Ahn, J. <strong>and</strong> Kwak, H. S. (1999) Cholesterol removal from homogenized milk with beta-cyclodextrin. J. <strong>Dairy</strong>Sci. 82: 2327-2330.Lovegrove, J. <strong>and</strong> Jackson, K. (2003) Coronary heart disease. In Functional <strong>Dairy</strong> <strong>Products</strong> (eds Tina Mattila- S<strong>and</strong>holm<strong>and</strong> Maria Saarela), CRC Press, Boca Raton, pp: 54-93.Masson, L <strong>and</strong> Martinez, M. (1984) Determination <strong>of</strong> cholesterol content in butter. International <strong>Dairy</strong> Federation Bulletinno 7: 165.McDonald, I. A., Bokkenheuser, V. D., McErnon, A. M., Mosbach, E. H. <strong>and</strong> Winter, J. (1983) Degradation <strong>of</strong> steroids inhuman gut. J. Lipid Res. 24: 675-700.McNamara, D. J. (1987) Diet <strong>and</strong> heart disease: The role <strong>of</strong> cholesterol <strong>and</strong> fat. J. Am. Oil Chem. Soc. 64: 1565-74.Mahley, R. W. <strong>and</strong> Innerarity, T. L. (1983) Lipoprotein receptors <strong>and</strong> cholesterol homeostasis. Biochim. Biophys. Acta,737: 197-222.Nigam, S. (1989) Studies on the physico-chemical status <strong>of</strong> milk lipids from cross breed cattle. Ph.D. Thesis, KurukshetraUniv., Kurukshetra.Oh, H. I., Chang, E. J. <strong>and</strong> Kwak, H. S. (1998) Conditions <strong>of</strong> the removal <strong>of</strong> cholesterol from milk by treatment withsaponin. Korean J. <strong>Dairy</strong> Sci. 20: 253-260.Pantulu, P. C. <strong>and</strong> Murthy, M. K. R. (1982) Lipid composition <strong>of</strong> skimmed milk <strong>and</strong> whey. Asian. J. <strong>Dairy</strong> Res. 1(1): 17-20.Patton, S. <strong>and</strong> Jensen, R.G. (1975). Lipid metabolism <strong>and</strong> membrane functions <strong>of</strong> the mammary gl<strong>and</strong>. In Progress in thechemistry <strong>of</strong> fats <strong>and</strong> other lipids (eds R.T. Holman), Pergamon Press Oxford. pp. 163-277.Prasad, R. <strong>and</strong> P<strong>and</strong>ita, N. N. (1990) Cholesterol content <strong>of</strong> milk <strong>and</strong> its fractionation during processing. Indian J. <strong>Dairy</strong>Sci. 43(2):190-193.Prasad, C.R., Subramanian, R. <strong>and</strong> Ramaprasad, C. (1992) Qualitative <strong>and</strong> comparative studies <strong>of</strong> cholesterol oxides incommercial <strong>and</strong> home-made Indian ghee. Food Chemistry. 45(1): 71-73.Prasad, R. <strong>and</strong> P<strong>and</strong>ita, N. N. (1987) Variations in the cholesterol content <strong>of</strong> dairy fat. Indian J. <strong>Dairy</strong> Sci. 40(1): 55-57.Rai, T. <strong>and</strong> Narayanan, K.M. (1986) Unsaponifiable constituents <strong>of</strong> ghee as affected by intermittent frying. Indian j.Anim. Sci. 56 (5): 610-611.Renner, E. <strong>and</strong> Gurr, M.I. (1991) Do we need cholesterol reduced dairy products? <strong>Dairy</strong> Industry International. 56: 34.Riccomini, M. A., Wick, C., Peterson, A, Jimenez-Flores, R. <strong>and</strong> Richardson, T. (1990) Cholesterol removal from cream<strong>and</strong> anhydrous milk fat using saponins. J. <strong>Dairy</strong> Sci. 73(1): 107.Sabine, J. R. (1977) Methods in cholesterol research. in Cholesterol, (eds J.R. Sabine) Marcel Dekker, Inc. New York <strong>and</strong>Basel. pp. 29-55.Schlimme, E. <strong>and</strong> Kiel, D. (1989) Removal <strong>of</strong> cholesterol from milk fat. European <strong>Dairy</strong> Magazine, 12-21.Seth, R. <strong>and</strong> Singh, A. (1994-95) Removal <strong>of</strong> cholesterol from milk using β-cyclodextrin <strong>and</strong> preparation <strong>of</strong> milk productsfrom such treated milk. NDRI Annual Report. pp. 95.Sharma, R., Nath, B. S. <strong>and</strong> Lal D. (1999) Approaches for cholesterol removal from milk fat: An overview. Indian J. <strong>Dairy</strong><strong>and</strong> Biosciences. 10:138-146.Singh, I. <strong>and</strong> Gupta, M. P. (1982) Physico-chemical characteristics <strong>of</strong> ghee prepared from Goat milk. Asian J. <strong>Dairy</strong> Res.1: 201-205.Spady, D. K. Woollett, L. A. <strong>and</strong> Dietschy, J. M. (1993) Regulation <strong>of</strong> plasma LDL-cholesterol levels by dietary cholesterol<strong>and</strong> fatty acids. Annual. Rev. Nutr. 13: 355-381..28


IntroductionFortification <strong>of</strong> Milk <strong>and</strong> Milk<strong>Products</strong> for <strong>Value</strong> AdditionSumit Arora<strong>Dairy</strong> Chemistry Division, NDRI, KarnalFortification <strong>of</strong> Milk <strong>and</strong> Milk <strong>Products</strong> for <strong>Value</strong> AdditionFood fortification is thought to be a highly effective solution <strong>and</strong> among the most cost effectivepublic health interventions currently available. It may be defined as the addition <strong>of</strong> one or moreessential nutrients to food whether or not it is normally contained in the food, for the purpose <strong>of</strong>preventing /correcting a demonstrated deficiency <strong>of</strong> one / more nutrients in the population or specificpopulation groups (Codex Alimentarius Commission, 1994). It is practiced in those areas where theproblems <strong>of</strong> malnutrition are prevalent.According to FAO/WHO guidelines (1995) essential nutrients may be added (i) to replace lossesthat occur during manufacture, storage <strong>and</strong> h<strong>and</strong>ling <strong>of</strong> food (restoration). For example the removal<strong>of</strong> cream from milk takes almost all the natural vitamins A <strong>and</strong> D <strong>and</strong> therefore skimmed milk may befortified with the same vitamins at levels as fluid whole milk. (ii) To ensure nutritional equivalence inimitation or substitute foods. (iii) To compensate for naturally occurring variations in nutrient levels.For instance, milk <strong>and</strong> butter are subjected to seasonal variations in vitamins A & D contents. Somedairy products are fortified with the vitamins A & D in order to maintain constant vitamin levels. (iv)To provide levels higher that those normally found in a food. For example, margarine is fortified withvitamins A & D (in western countries) to render it nutritionally equivalent to butter, <strong>and</strong> (v) to providea balanced intake <strong>of</strong> micronutrient in special case (dietetic foods) for example infant formulas, specialfood for athletics, medical food etc.General criteria for fortification• The intake <strong>of</strong> nutrients is below the desirable level in the diet <strong>of</strong> significant number <strong>of</strong> people.• The vehicle used for fortification should be consumed in significant quantities by targetpopulation.• Addition <strong>of</strong> nutrient should not create an imbalance <strong>of</strong> essential nutrients.• The added nutrients should be stable under proper conditions <strong>of</strong> storage <strong>and</strong> use.• Biological availability <strong>of</strong> added nutrients should be high.• There should be reasonable insurance against excessive intake to a level <strong>of</strong> toxicity.(Food <strong>and</strong>Nutrition Board, 1973)Milk <strong>and</strong> milk products as a suitable vehicle for fortificationMilk in its natural form is almost unique as a balanced source <strong>of</strong> man’s dietary need (Table 1). Thevarious steps in processing <strong>and</strong> storage have a measurable impact on some specific nutrients. Milkalso provides a convenient <strong>and</strong> useful vehicle for addition <strong>of</strong> certain nutrients to man’s diet <strong>and</strong> hasfollowing benefits:- Since milk is centrally processed so that the quality control can be effectively implemented.- Milk <strong>and</strong> milk products are widely consumed regularly in predictable amounts by people <strong>of</strong> allage groups.- Cost is affordable by target population.- The stability <strong>and</strong> bioavailability <strong>of</strong> the added micronutrients to the milk remains high.- Since milk is nearly a complete food <strong>and</strong> all nutrients exist in almost fully available form, thebioavailability <strong>of</strong> added nutrients remains high.- Addition <strong>of</strong> fortificants usually caused minimum change in colour, taste <strong>and</strong> appearance.29


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceNutrients generally added to milkLiquid milk fortification with vitamins A <strong>and</strong>/D is m<strong>and</strong>ated in several countries. β-carotene isadded as a colour-enhancing agent to some milk products such as butter. Dried milk is <strong>of</strong>ten fortifiedwith vitamins A <strong>and</strong> D, calcium, <strong>and</strong> iron. Milk based infant formula <strong>and</strong> weaning foods are fortifiedwith a range <strong>of</strong> vitamins, minerals, <strong>and</strong> other nutrients such as polyunsaturated fatty acids. Powderedmilk used for complementary feeding in Chile is fortified with vitamin C, iron, copper <strong>and</strong> zinc.Fortification <strong>of</strong> milk & milk products with vitaminsUnder ambient conditions the water soluble vitamin C <strong>and</strong> vitamins <strong>of</strong> the B-complex groupsuch as thiamin, rib<strong>of</strong>lavin, vitamin B6, niacin, pantothenic acid, folic acid, biotin <strong>and</strong> vitamin B12 arepowdered <strong>and</strong> thus relatively easy to work with when producing most dairy products. The fat solublevitamins which include vitamin A, D, E <strong>and</strong> K, however, exist either as an oil or as crystals, which maycause processing difficulties during the production <strong>of</strong> certain types <strong>of</strong> dairy products (Mortensen <strong>and</strong>Gotfredson, 1996).One <strong>of</strong> the problem encountered with the vitamins, is their limited stability in presence <strong>of</strong> heat,humidity <strong>and</strong> oxygen. Among the water soluble vitamins, vitamin C, folic acid, vitamin B6 <strong>and</strong> vitaminB12 are the less stable. While in the case <strong>of</strong> fat soluble vitamins vitamin A, D <strong>and</strong> E are least stable.In order to improve the stability <strong>of</strong> these vitamins, a number <strong>of</strong> different coating technologieshave been developed. One <strong>of</strong> the most important methods to protect the fat soluble vitamins ismicroencapsulation, which results in a highly sophisticated powder, where the vitamin is kept protectedfrom degradation by the coating material used for the encapsulation. During microencapsulation, thefat soluble vitamins are brought from the form <strong>of</strong> oil or a crystal – which in some processes would bedifficult to h<strong>and</strong>le – to the form <strong>of</strong> a free flowing powder much easier to h<strong>and</strong>le <strong>and</strong> mix with otherdry ingredients (Mortensen <strong>and</strong> Gotfredson, 1996).When two or more vitamins are added to a food product at the same manufacturing stage, thisis commonly done in the form <strong>of</strong> premix or as blend. Premix is a homogenous mixture <strong>of</strong> desiredvitamins in a dry powder from, whereas a blend is the same for the fat soluble vitamins, but in an oilyform. A premix can consist <strong>of</strong> both water soluble <strong>and</strong> fat soluble vitamins <strong>and</strong> carotenoids, in whichcase the fat soluble vitamins have to be microencapsulated.Fortification <strong>of</strong> milk <strong>and</strong> milk products with iron, calcium <strong>and</strong> other mineralsSelection <strong>of</strong> an appropriate mineral fortificant (iron, calcium etc) is based on its organolepticconsiderations, bioavailability, cost <strong>and</strong> safety. The colour <strong>of</strong> iron compounds is <strong>of</strong>ten a critical factorwhen fortifying milk <strong>and</strong> milk products. The use <strong>of</strong> more soluble iron compounds <strong>of</strong>ten leads tothe development <strong>of</strong> <strong>of</strong>f-colours <strong>and</strong> <strong>of</strong>f-flavours due to reactions with other components <strong>of</strong> the foodmaterial. Infant cereals have been found to turn grey or green on addition <strong>of</strong> ferrous sulphate. Offflavourscan be the result <strong>of</strong> lipid oxidation catalysed by iron. The iron compounds themselves maycontribute to a metallic flavour. Some <strong>of</strong> these undesirable interactions with the food matrix can beavoided by coating the fortificant with hydrogenated oils or ethyl cellulose (Jackson <strong>and</strong> Lee, 1991).Bioavailability <strong>of</strong> iron compounds is normally stated relative to a ferrous sulphate st<strong>and</strong>ard. Thehighly water soluble iron compounds have superior bioavailability (Richardson, 1990). Bioavailability<strong>of</strong> the insoluble or very poorly soluble iron compounds can be improved by reducing particle size.Unfortunately this is accompanied by increased reactivity in deteriorative processes. The problem<strong>of</strong> low bioavailability <strong>of</strong> some <strong>of</strong> the less reactive forms <strong>of</strong> iron is <strong>of</strong>ten circumvented by the use <strong>of</strong>absorption enhancers like, ascorbic acid, sodium acid sulphate <strong>and</strong> orthophosphoric acid, added alongwith the fortificant.The other important mineral for the fortification <strong>of</strong> milk <strong>and</strong> milk products, which has been studied,is calcium. Several commercial calcium salts are available for calcium fortification, which includecarbonate, phosphate, citrate, lactate <strong>and</strong> gluconate. In general, organic acid salts <strong>of</strong> calcium are morebioavailable than inorganic salts (Labin-Godscher <strong>and</strong> Edelstein, 1996). The pH <strong>of</strong> the milk should be30


Fortification <strong>of</strong> Milk <strong>and</strong> Milk <strong>Products</strong> for <strong>Value</strong> Additiontaken care <strong>of</strong> during Ca fortification. Manufacturers <strong>of</strong> calcium fortified milk products should consideradding, magnesium, rib<strong>of</strong>lavin <strong>and</strong> perhaps vitamin D as well, in amounts that would normally beobtained in a serving <strong>of</strong> vitamin D fortified milk (Weaver, 1998).Milk <strong>and</strong> milk products can also be fortified with a range <strong>of</strong> other mineral salts such as Mg, P,Zn, Cu <strong>and</strong> Mn. Prudent selection <strong>of</strong> mineral compounds is based largely on consideration <strong>of</strong> mineralreactivity <strong>and</strong> solubility <strong>of</strong> the salt. To overcome problems <strong>of</strong> flavour, texture <strong>and</strong> colour deteriorationdue to addition <strong>of</strong> minerals, some companies have engineered new fortificant preparations, whichgenerally involve the use <strong>of</strong> stabilisers <strong>and</strong> emulsifiers to maintain the mineral in solution (FAO,1995).Technology for fortification:1. Liquid milkThe technology <strong>of</strong> milk fortification is relatively simple <strong>and</strong> no additional equipments are neededor can be practiced with minor modifications in the existing plant. Mineral/vitamin fortification can bepracticed at several stages in the production. But liquid milk is usually fortified prior to pasteurizationor ultra-heat treatment. Homogenization is essential for oily preparations <strong>of</strong> vitamins. Usually twomethods <strong>of</strong> additions are practiced i.e. batch process for small operations <strong>and</strong> metered additions forcontinuous process. A metered injection <strong>of</strong> the vitamin preparation upstream to the homogenizer hasbeen the st<strong>and</strong>ard set up in continuous operation plants (Cornell University, 1994).Oily preparations are diluted with 10 parts <strong>of</strong> warm oil (45 – 50°C), usually butter oil <strong>and</strong>homogenized with a suitable quantity <strong>of</strong> skim milk or it can be mixed with appropriate quantity <strong>of</strong> milk<strong>and</strong> cream <strong>and</strong> finally homogenized. In the case <strong>of</strong> water soluble or water dispersible micronutrients,a premix can be made by diluting the nutrients to 20 times their weight with milk at 45°C, followed bystirring <strong>and</strong> thorough mixing (USAID, 2001).A simple procedure for fortification <strong>of</strong> skim milk with vitamins A without using homogenizer wasdeveloped by Bector <strong>and</strong> Rani (1998). This process is basically a batch process <strong>and</strong> is suitable for smallplants <strong>of</strong> low capital cost.Many iron compounds have been assessed in the fortification <strong>of</strong> pasteurised whole milk. Thebest fortification procedure was judged to be the addition <strong>of</strong> ferric ammonium citrate followed bypasteurisation at 81 °C. In this way fortified milk containing 30 ppm iron was found to be acceptableafter 7 days storage. Levels <strong>of</strong> vitamin E, vitamin A <strong>and</strong> carotene were not affected by the presence<strong>of</strong> iron. At pasteurisation temperatures below 79 °C <strong>of</strong>f-flavours developed due to lipolytic rancidity(Edmondson et al, 1971). De-aeration <strong>of</strong> the milk prior to the addition <strong>of</strong> iron compounds was also foundto reduce flavour problems. In the production <strong>of</strong> iron fortified evaporated milk, ferric orthophosphatewas shown to be useful (FAO, 1995).Calcium fortificant preparations including stabilizers <strong>and</strong> emulsifiers have been used forfortification <strong>of</strong> milk <strong>and</strong> milk-based beverages. It maintains calcium in suspension so as to improvemouth feel <strong>and</strong> appearance <strong>of</strong> products (FAO, 1995). In Germany a milk-based fruit beverage has beenmarketed which is fortified with calcium, phosphorous as well as vitamins A, E, B <strong>and</strong> C.Dried milkHere particle size <strong>of</strong> the fortificant as well as density <strong>of</strong> the fortificant has to be taken care as large<strong>and</strong> heavier size particles will lead to separation. In order to achieve stability <strong>of</strong> vitamins, the safest wayto fortify dried milk is to blend dry forms <strong>of</strong> premix with the dried milk powder, thereby protectingthe effect <strong>of</strong> microencapsulation. However, this requires an effective mixing system. If blends are used,they are added directly to milk, provided homogenization is done before spray drying. If vitamins areadded before spray drying, overage addition (Table 2) will be necessary in order to compensate thelosses (Mortensen <strong>and</strong> Gotfredsen, 1996).31


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceIron fortification <strong>of</strong> powdered non-fat dry milk, ferrous sulphate at a level <strong>of</strong> 10 ppm was found tobe stable for a period <strong>of</strong> 12 months. Ferric ammonium citrate <strong>and</strong> ferric chloride at a level <strong>of</strong> 20 ppmiron in the reconstituted product gave acceptable results (FAO, 1995).Infant formulasThe mineral content <strong>of</strong> cow milk, from which many formulas are produced, is highly variable.Production methods have been adapted to control this source <strong>of</strong> variability. Operations have beenincluded which remove most <strong>of</strong> the minerals, but at the same time some vitamins <strong>and</strong> other components<strong>of</strong> the milk are lost: technologies used include ion exchange, ultra filtration, electrodialysis, reverseosmosis <strong>and</strong> gel filtration. Mineral compounds are then added at the required levels. There must becareful selection <strong>of</strong> mineral compounds added to the formulas, as cereal products are highly susceptibleto lipid oxidation during storage. The use <strong>of</strong> ferrous fumarate <strong>and</strong> ferrous succinate is recommendedfor fortification <strong>of</strong> infant cereals as they gave rise to no objectionable flavours/odours or colours onstorage. Ferrous sulphate coated with hydrogenated fats, mono- or di-glycerides <strong>and</strong> ethyl cellulosecaused discolouration on reconstitution with hot milk <strong>and</strong> hot water.Although some allowance is made for the natural vitamin content <strong>of</strong> the ingredients used, most <strong>of</strong>the vitamins are added to the formula. The Codex Alimentarius Commission (FAO/WHO, 1994) haspublished an advisory list <strong>of</strong> mineral salts <strong>and</strong> vitamin compounds which can be added to formulas.Predetermined excesses <strong>of</strong> vitamins have to be added to allow for processing <strong>and</strong> storage losses. UHTprocessing followed by aseptic packaging has been preferred to in-can sterilisation since less nutrientlosses occur in the former case. Losses have been noted particularly for vitamin C, thiamin, folic acid<strong>and</strong> vitamin B6.Iron absorption from formulas has been reported to be 5-10% compared to 50% for human milk.It has been suggested that bovine milk proteins or elevated calcium <strong>and</strong> phosphorus levels accountfor this difference. Zinc levels in formulas are also higher than in human milk to make up for reducedbioavailability.Ice-cream:The unit operations used in the manufacture <strong>of</strong> ice-cream is not highly destructive to vitamins.Vitamins are added in the dry form to the mix. Since whipping <strong>and</strong> consequent operation <strong>of</strong> the mixis carried out around freezing temperature, oxidative losses <strong>of</strong> vitamins are minimized. The greatestprocessing losses, which occur during manufacture <strong>of</strong> fortified ice-cream, are during pasteurization <strong>of</strong>ice cream mix. Calcium enriched ice-cream is also available in USA <strong>and</strong> is marketed under the name<strong>of</strong> TruCal.Fermented milk products:In the production <strong>of</strong> yoghurt, the low pH renders it unsuitable as a carrier <strong>of</strong> vitamins suchas vitamin A. Water soluble vitamins are best used in a encapsulated form, protected for odour<strong>and</strong> flavour considerations. Some vitamin losses can occur through metabolism by microorganismsduring fermentation (O'Brien <strong>and</strong> Roberton, 1993). The sensory quality <strong>of</strong> iron fortified yoghurt wasacceptable to when tested by a consumer panel. No significant difference in the appearance, mouthfeel,flavour, or overall quality was observed between iron fortified <strong>and</strong> unfortified yoghurts (Hekman <strong>and</strong>McMahon, 1997). In Germany, enrichment <strong>of</strong> cheese with iodine through the use <strong>of</strong> iodised salt hasbeen approved.Considerations while fortification <strong>of</strong> milk & milk products1. Bioavailability <strong>of</strong> commercial preparations: Bioavailability <strong>of</strong> different compounds facilitatesthe selection <strong>of</strong> the optimal compound. Bioavailability refers to the rate <strong>of</strong> absorption <strong>and</strong>utilization <strong>of</strong> a nutrient from a given matrix.2. Nutrient–nutrient reaction: Interaction among the nutrients <strong>and</strong> other food components isa key factor in nutrient addition. For example, Vitamin C will improve the absorption <strong>of</strong> iron32


Fortification <strong>of</strong> Milk <strong>and</strong> Milk <strong>Products</strong> for <strong>Value</strong> Addition(Kiran et al, 1977). On the other h<strong>and</strong>, the iron will accelerate vitamin degradation. Fortification <strong>of</strong>calcium in milk may interfere with absorption <strong>of</strong> iron or zinc (Weaver, 1998).3. Nutrient-matrix reaction: The added nutrient must not react with any component <strong>of</strong> the milk.For example, iron is a pro-oxidant <strong>and</strong> can accelerate the development <strong>of</strong> fat rancidity, destroysome <strong>of</strong> the vitamins <strong>and</strong> form coloured products.4. Shelf-life & packaging: Many <strong>of</strong> the fortified milk <strong>and</strong> milk products may have limited shelflife <strong>and</strong> thus may need different types <strong>of</strong> packaging which can be either oxygen impermeableor opaque to light. This is particularly true for the fortification <strong>of</strong> liquid milk with vitamin A asvitamin A fortified milk develops <strong>of</strong>f flavour within 6 h when exposed to light, compared to 12 hfor control (Fellman et al, 1991). All the fortified products require proper labelling on the pack.5. Process considerations: The stability <strong>of</strong> all the vitamins is well known during various processingconditions <strong>and</strong> the same knowledge can be applied while processing the vitamin fortified milk.6. Cost factor: Cost may not be a crucial factor in the manufacture <strong>and</strong> marketing <strong>of</strong> fortified milk<strong>and</strong> milk products.7. Safety factor: There should be sufficient insurance against excessive intake <strong>of</strong> the fortificant.Unlike water soluble vitamins, fat soluble vitamins exhibited toxicity at higher concentrations.ConclusionFortification should not alter the organoleptic properties (taste, smell, colour, consistency) <strong>and</strong> shelflife (conditions related to storage, transport) <strong>of</strong> the product. Often there is a delicate balance betweenbioavailability <strong>and</strong> other properties <strong>of</strong> fortified food. Milk <strong>and</strong> milk products provide a convenient <strong>and</strong>useful vehicle for fortification with micronutrients. The risks associated with fortification are minimalexcept if good manufacturing practices are not followed <strong>and</strong> only isolated incidents <strong>of</strong> this type haveever been reported. Improved underst<strong>and</strong>ing <strong>of</strong> interactions between food ingredients <strong>and</strong> health <strong>and</strong>ingenuity <strong>of</strong> food technologists in food formulation <strong>and</strong> fabrication will contribute to the advances infood fortification.Table 1: Micronutrient content <strong>of</strong> cow milk vs recommended dietary allowances (RDA)Micronutrient Quantity /Litre RDAMenWomenVitamin A (IU) 1300 1000 800Vitamin D (IU) 42 5-10 5-10Vitamin E (IU) 1.5 10 8Vitamin K (μg) 41 45-80 45-65Vitamin B1(mg) 0.4 1.5 1.1Vitamin B2 (mg) 1.7 1.7 1.3Vitamin B6 (mg) 0.4 2 1.6Folic acid (μg) 62 200 180Niacin (mg) 1 19 15Vitamin B12 (mg) 3 2 2Vitamin C (mg) 15 60 60Iron (mg) 0.52 28 30Calcium (mg) 1300 400 400Copper (mg) 0.1 2.2 2.2Zinc (mg) 4 15.5 15.5(OMNI, 2001)33


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceTable 2: Micronutrient content <strong>of</strong> cow milk vs recommended overagesMicronutrient Quantity /Litre Recommended Overages (%)34Pasteurised UHT Dry Milk Milk DessertsVitamin A (IU) 1300 20 30 40 20Vitamin D (IU) 42 20 30 40 20Vitamin E (IU) 1.5 10 30 20 10Vitamin K (μg) 41 - - - -Vitamin B1(mg) 0.4 25 50 20 25Vitamin B2 (mg) 1.7 15 40 20 15Vitamin B6 (mg) 0.4 30 30 20-30 30Folic acid (μg) 62 20 40 40 20Niacin (mg) 1 15 20 20 15Vitamin B12 (mg) 3 15 30 40 20Vitamin C (mg) 15 30 100 50 30Iron (mg) 0.52 5 5 5 5Calcium (mg) 1300 5 5 5 5Copper (mg) 0.1 - - - -Zinc (mg) 4 - - - -Phosphorus (mg) 960 - - - -Iodine (ųg) 237 - - - -References(OMNI, 2001)Anderson, H. C. <strong>and</strong> Thomas, E. L. (1974) Fortification <strong>of</strong> fluid milk products with ascorbic acid. J <strong>Dairy</strong> Sci. 57:5.Bector, B.S. <strong>and</strong> Rani, S. (1998) A methodology to fortify low fat milk with vitamin A without using a homogenizer.Indian J. <strong>Dairy</strong> Sci. 51: 69-72.Bender, A. E. (1993) Food fortification. In. Encyclopedia on Food Science, Food Technology <strong>and</strong> Nutrition. Vol 3. p.1990-1993.Bullock, D. H., Singh, S. <strong>and</strong> Pearson, A. M. (1968) Stability <strong>of</strong> vitamin C in enriched commercial evaporated milk. J.<strong>Dairy</strong> Sci. 51: 921-923.Conochie, J. (1958) The stability <strong>of</strong> sodium ascorbate in evaporated milk. Australian J. <strong>Dairy</strong> Technol. 80-82.Cornell University: <strong>Dairy</strong> Science Facts (1999) Vitamin fortification <strong>of</strong> fluid milk. Department <strong>of</strong> Food Science, StockingHall, New York.Edmondson, L. F., Douglas, F. W. <strong>and</strong> Avants, J. K. (1971) Enrichment <strong>of</strong> pasteurized whole milk with iron. J. <strong>Dairy</strong> Sci.54: 1422-1426.Elliott, J. G. (1999) Application <strong>of</strong> antioxidant vitamins in foods <strong>and</strong> beverages. Food Technol. 53: 46-48.El-Sayed, M. M., Abd-Rabou, N. S., Sayed, A. F. <strong>and</strong> El-Samragy, Y. A. (1995) Iron fortification <strong>of</strong> processed Ras cheese.Egyptian J. <strong>Dairy</strong> Sci. 35: 289-298.FAO (1995) Micronutrient fortification <strong>of</strong> food: Technology <strong>and</strong> quality control. FAO Technical Consultation <strong>of</strong> FoodFortification: Technology <strong>and</strong> <strong>Quality</strong> Control. Rome, Italy, 20-23 November.Fellman, R.L., Dimick, P,S <strong>and</strong> Hollender, R. (1991) Photooxidative stability <strong>of</strong> vitamin A fortified 2% low fat milk <strong>and</strong>skim milk. J. Food Protection 54:113-116.Food <strong>and</strong> Nutrition Board (1973) General policies in regard to improvement <strong>of</strong> nutritive quality <strong>of</strong> foods: policystatement. National academy <strong>of</strong> Sciences Washington DC. p. 6.Food Fortification Roundtable. (1996) Food Technol. 86-94.Ford, J. E., Porter, J. W. G. <strong>and</strong> Thompson, S. Y. (1974) Influence <strong>of</strong> added ascorbic acid on the stability <strong>of</strong> folic acid <strong>and</strong>vitamin B12 in milk during UHT processing <strong>and</strong> subsequent storage. Proceedings 19 th Intr. <strong>Dairy</strong> Congress, 567-569.Goldscher, R. L. <strong>and</strong> Edelstein, S. (1996) Calcium citrate: A revised look at calcium fortification. Food Technol. 96-98.Graham, D. M. (1974) Alteration <strong>of</strong> nutritive value resulting from processing <strong>and</strong> fortification <strong>of</strong> milk <strong>and</strong> milk products.J. <strong>Dairy</strong> Sci. 57: 738-745.Head, M. K. <strong>and</strong> Hansen, A. P. (1979) Stability <strong>of</strong> L- ascorbic acid added to whole, chocolate, <strong>and</strong> low fat milks. J. dairySci. 62: 352-354.Hekmat, S <strong>and</strong> McMahon, D.J. (1997) Manufacture <strong>and</strong> quality <strong>of</strong> iron fortified yoghurt. J. <strong>Dairy</strong> Sci. 80: 3114-3122.


Fortification <strong>of</strong> Milk <strong>and</strong> Milk <strong>Products</strong> for <strong>Value</strong> AdditionHekmat, S. <strong>and</strong> McMahon, D. J. (1997) Manufacture <strong>and</strong> quality <strong>of</strong> iron fortified yoghurt. J. <strong>Dairy</strong> Sci. 80: 3114-3122.Hicks, T. Hansen, A. P. <strong>and</strong> Rushing, J. E. (1996) Procedures used by north Carolina dairies for Vitamins A <strong>and</strong> Dfortification <strong>of</strong> milk. J. <strong>Dairy</strong> Sci. 79: 329-333.Ilic, D. B. <strong>and</strong> Ashoor, S. H. (1988) Stability <strong>of</strong> vitamins A <strong>and</strong> C in fortified yoghurt. J. <strong>Dairy</strong> Sci. 71:1492-1498.Indyk, H., Littlejohn, V. <strong>and</strong> Woodl<strong>and</strong>, D. C. (1996) Stability <strong>of</strong> Vit D3 during spray drying <strong>of</strong> milk. Food Chem. 57:283-286.Jackson, L. <strong>and</strong> Lee, K. (1991) Microencapsulated iron for food fortification. J. Food Sci. 56: 1047-1050.Johnson, L. E. (1994) Vitamin <strong>and</strong> mineral fortification in foods. Food Technol. 124.Kiran, R., Amma. M. K. P. <strong>and</strong> Sareen, K. N. (1977) Milk fortification with a system containing both iron <strong>and</strong> ascorbicacid. The Indian J. Nutr. Dietet. 14:260-266.Kiran, R., Kaur, I. P. <strong>and</strong> Vaneja, K. (19860 Studies on the acceptability <strong>and</strong> availability <strong>of</strong> fortificants present in milk<strong>and</strong> whey. J. Food Sci. 23: 110-111.Labin-Goldscher, R <strong>and</strong> Edelstein, S (1996) Calcium citrate: a-revised look at calcium fortification. Food Technol. 96-97.Lopez, G. B., Terre, J. M. Q., Lopez, B. G. <strong>and</strong> Terre, J. M. Q. (1996) Calcium enrichment <strong>of</strong> skim milk subjected to UHTtreatment. Almentaria 34: 79-82.McNamara, S. H. (1995) Food fortification in United States: a legal <strong>and</strong> regulatory perspective. Nutr. Reviews 53: 140-144.Mertz, W. (1997) Food fortification in United States. Nutr. Reviews 55: 44-49.Mortensen, B. L. <strong>and</strong> Gotfredsen, P. (1996) Fortification- nutritional improvement <strong>of</strong> dairy products. Danish <strong>Dairy</strong> FoodIndustry..worldwide 64-65.Newsome, R.L. (1997) Use <strong>of</strong> vitamins as additives in processed food. Food Technol. 163-168.Nordmark, B. (1999) A brief history <strong>of</strong> fortification. Food Technol.15-16.O’Brien, A. <strong>and</strong> Robertson. D. (1993) In. The technology <strong>of</strong> vitamins in Food. P. Berry Ottaway (Ed.) p-30.Olivares, m., Pizarro, F., Pineda, O., Name, J. J. Hertrampf, E. <strong>and</strong> Walter, T. (1997) Milk inhibits <strong>and</strong> ascorbic acidfavors ferrous bis-glycine chelate bioavilability in humans. American Society Nutr. Sci. 1407-1411.OMNI/Roche/USAID (2001) Fortification basics: Milk. http://www. roche.comRao, B. V. R. <strong>and</strong> Mathur, B. N. (1988) Stability <strong>of</strong> vitamins A, D <strong>and</strong> E in spray dried infant formula during storage.Indian J. <strong>Dairy</strong> Sci. 41:86-88.Richardson, D. P (1990) Food fortification. Proceedings <strong>of</strong> the Nutrition Society. 49: 39-50.Rosenthal, I., Rosen, B. <strong>and</strong> Bernstein, S. (1993) effects <strong>of</strong> milk fortification with ascorbic acid <strong>and</strong> iron. Milchwissenschaft48: 676-679.Saini, S. P. S., Jain, S. C. <strong>and</strong> Bains, G. S. (1987) Effect on iron fortification on flavour <strong>of</strong> buffalo milk. Indian J. <strong>Dairy</strong> Sci.40: 88-93.Sloan, A. E. <strong>and</strong> Stiedemann, M. K. Food Technol. 100-108.Subbulakshmi, G. <strong>and</strong> Nai(1996) Food fortification: from public health solution to contemporary dem<strong>and</strong>. l, M. (1999)Food fortification in developing countries- current status <strong>and</strong> strategies. J. Food Sci. Technol. 36: 371-395.Sweeney, M. A. <strong>and</strong> Ashoor, S. H. (1989) Fortification <strong>of</strong> cottage cheese with vitamins A <strong>and</strong> C. J. <strong>Dairy</strong> Sci. 72: 587-590.Tateo, F., Bononi, M., Testolin, G., Ybarra, L. <strong>and</strong> Fumagalli, M. (1997) Experiments in the use <strong>of</strong> calcium <strong>and</strong> magnesiumlactates in milk enrichment. Industrie-Almentari 36: 614-617.Vahcic, N., Palic, A. <strong>and</strong> Ritz, M. (1992) Mathematical evaluation <strong>of</strong> relationship between copper, iron, ascorbic acid<strong>and</strong> redox potential <strong>of</strong> milk. Milchwissenschaft 47:228-230.Weaver, C.M. (1998) Calcium in food fortification strategies. Int. <strong>Dairy</strong> J. 8: 443-449.Ziegler, E. E. <strong>and</strong> Fomon, S. J. (1996) Strategies for the prevention <strong>of</strong> iron deficiency: iron in infant formulas <strong>and</strong> babyfoods. Nutr. Reviews. 54: 348-354.35


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceIntroductionPackaging <strong>of</strong> <strong>Value</strong> <strong>Added</strong> Foods<strong>and</strong> <strong>Their</strong> Storage StabilityP. P. GothwalCentral Food Technological Research Institute, Reseach Centre, LucknowIndia produces nearly 300 million MT <strong>of</strong> food products which comprise cereals, pulses, fruits,vegetables, mushrooms, algae, spices <strong>and</strong> plantation, meat, fish, poultry, milk <strong>and</strong> dairy basedproducts. It is estimated that nearly 30% <strong>of</strong> produce is lost due to poor h<strong>and</strong>ling, processing <strong>and</strong>packaging. In the present scenario packaging has been identified as an integral part <strong>of</strong> processing inthe food industry. Packaging sector is an important global industry representing about 2% <strong>of</strong> GNP <strong>of</strong>developed countries. The value <strong>of</strong> packaging industry is expected about 345 Million Euros world widewith 50% for packaging <strong>of</strong> food materials. Scientific method <strong>of</strong> packaging <strong>and</strong> safe transportation <strong>of</strong>food materials plays a significant role in reducing the post harvest processing losses. Food, both in itsfresh <strong>and</strong> processed form needs appropriate packaging to facilitate storage, preservation, transportation<strong>and</strong> distribution. Packaged foods <strong>of</strong>fer enormous export opportunities <strong>and</strong> foreign exchange earningsto the country. Research <strong>and</strong> development in the area <strong>of</strong> food packaging has resulted in building up adatabase on deteriorative characteristics <strong>and</strong> packaging needs <strong>of</strong> a large number <strong>and</strong> varieties <strong>of</strong> foodproducts stored under different environmental conditions. Accelerated testing conditions drasticallycut down the time required to identify suitable packaging materials to increase shelf life <strong>of</strong> processedfood products under various controlled conditions.Packaging is a coordinated system <strong>of</strong> preparing food for transportation, distribution, storage,retailing <strong>and</strong> end use. It is mean to ensure safe delivery <strong>of</strong> product to the ultimate consumer in soundcondition at minimum cost. Projected growth rate <strong>of</strong> dem<strong>and</strong> <strong>and</strong> consumption for packaging in Indiais 10%. <strong>Value</strong> added processed food products comprising <strong>of</strong> fruits & vegetables based, cereal <strong>and</strong>pulses based, meat/fish/poultry based products, milk <strong>and</strong> dairy based products need specializedtypes <strong>of</strong> packages depending upon the type <strong>of</strong> preservation method used <strong>and</strong> extent <strong>of</strong> storage desired.All successful food processing industries continually develop <strong>and</strong> launch new value added productswith new attracting packaging. To ensure that these new value added products perform well in themarket, the food industries have to follow product development with food packaging procedures,which maximize their chances <strong>of</strong> success <strong>and</strong> reduce their risk <strong>of</strong> failure. Some food is made possibleby the introduction <strong>of</strong> new technology <strong>and</strong> new packaging technologies. New or latest technologiesunder active development or in the early stages <strong>of</strong> adoption as such can be expected to impact on thetype <strong>of</strong> value added products developed in the future.Different packaging materials:Packaging <strong>of</strong> fresh produce in consumer unit packs at the producing centers or terminal marketsprotects the produce against damage <strong>and</strong> excess moisture loss. The packaging materials used i) shouldhave sufficient permeability to oxygen, carbon dioxide <strong>and</strong> water vapor ii) should have desiredprotective physical properties, iii) should be transparent. The permeability requirement dependsupon rate <strong>of</strong> respiration <strong>of</strong> the produce, the package bulk density <strong>and</strong> temperature <strong>of</strong> storage. Foodpackaging can be categorized in to primary, secondary <strong>and</strong> tertiary types.• Primary packaging is the material that first envelopes the product <strong>and</strong> holds it. This usuallyis the smallest unit <strong>of</strong> distribution or use <strong>and</strong> is the package which is in direct contact with thecontents. Primary packaging is the main package that holds the food that is being processed.• The secondary packaging is outside the primary packaging, perhaps used to group primarypackages together. Secondary packaging combines the primary packages into one box being made.Corrugated fiber board is most commonly used to make secondary shipping cartons.36


Packaging <strong>of</strong> <strong>Value</strong> <strong>Added</strong> Foods <strong>and</strong> <strong>Their</strong> Storage Stability• Tertiary packaging is used for bulk h<strong>and</strong>ling, warehouse storage <strong>and</strong> transport shipping. Themost common form is a palletized unit load that packs tightly into containers. Tertiary packagingcombines all <strong>of</strong> the secondary packages into one pallet. Examples-• Form-Fill-Seal packaging• Bag-in-box• Dip-a- sauca packaging• Combi system <strong>of</strong> packaging• Boil in bag packs• Metals cans• Retort able pouches <strong>and</strong> traysPackaging material consumption pattern:With changing consumer preferences, the composition <strong>of</strong> substrate used in packaging industryhas also changed. The consumption pattern <strong>of</strong> various packaging material is shown below:Selection <strong>of</strong> packaging system for processed foods:• Drastic changes are seen in the system <strong>of</strong> foodsupply. The conventional means <strong>of</strong> harvesting Material India% Global%processing <strong>and</strong> h<strong>and</strong>ling are slowly replaced byPaper <strong>and</strong> paperboard 40 29improved systems, bringing in modernization. ItGlass 16 8is obvious that the produce in its natural or valueadded processed form should also be properlystored, so that it is available during non-seasonalperiod <strong>and</strong> in emergency.MetalPlasticOthers51524193905• The selection <strong>of</strong> package for a food product is to Source: Indian Institute <strong>of</strong> Packaging, New Delhiidentify the properties <strong>of</strong> the food, its sensitivityto environment, the length <strong>of</strong> life desired, the(2010 report)market condition, consumer needs <strong>and</strong> existing regulation. The technological need is to evaluatethe ‘product-package compatibility’. A product can be sensitive <strong>and</strong> susceptible to differentfactors like bio-chemical changes <strong>and</strong> microbial changes; physical <strong>and</strong> chemical (including toxic<strong>and</strong> traces elements), flavor loss, odor pick up, texture, moisture <strong>and</strong> gases.Packaging used for fresh produce:Corrugated Fiber Board boxes (CFB):These are most commonly used shipping container. <strong>Their</strong> major attributes are;• Low cost to strength <strong>and</strong> weight ratio• Smooth non abrasive surface that is minimum bruising damage• Good cushioning characteristics• Excellent printability• Easy to set up <strong>and</strong> collapsible for storage• Reusability <strong>and</strong> recycle• Easy h<strong>and</strong>ling <strong>and</strong> stack ability• Can be turned out quickly in to highly precise <strong>and</strong> accurate sizes; can be appropriately punchedfor ventilation <strong>and</strong> the most acceptable form in international markets.• Most <strong>of</strong> the perishables exported from India are packed in CFB cartons.• Plastic corrugated boxes: In recent years plastic corrugated boxes made <strong>of</strong> polypropylene (PP)<strong>and</strong> high density polyethylene (HDPE) are partly replacing CFB. Its advantage over CFB is lowweight to strength ration high degree <strong>of</strong> wet resistance <strong>and</strong> its reusability.37


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceModified atmosphere packaging:MAP is the method for extending the shelf life <strong>of</strong> perishables by altering the relative proportion <strong>of</strong>atmospheric gases that surround the food. This is becoming increasingly popular technique to meetboth distribution <strong>and</strong> retailing needs <strong>of</strong> fruits <strong>and</strong> vegetables. Modified atmospheric conditions arecreated inside the packages by the commodities themselves by controlling respiration <strong>and</strong> selectingsuitable permeable films or by using carbon dioxide <strong>and</strong> ethylene absorbers (scavengers) withinthe package to prevent the build up <strong>of</strong> a particular gas. Compounds like hydrated lime, activatedcharcoal, <strong>and</strong> magnesium oxide are used to absorb carbon dioxide, iron powder for absorbing oxygen<strong>and</strong> potassium permanganate, squalene <strong>and</strong> phenyl methyl silicone for absorbing ethylene within thepackage. The modified atmosphere desirable for vegetables comprises reduced oxygen (2-3%) <strong>and</strong>increased carbon dioxide levels (10%).Future scope <strong>of</strong> tinplate container:• As long as the tin metal exists in the earth’s crust, tinplate continues to be an ideal packagingmaterial for processed foods <strong>and</strong> beverages. There is a good scope in reducing the thickness<strong>of</strong> tin coating if suitable lacquer is coated, which may help in reducing the cost <strong>of</strong> container.Recycling <strong>of</strong> tinplate container is another important aspect to be considered.Packages for specific processed food products:Bakery based processed food such as breads, buns, cakes, biscuits, pastries, etc. ensured by veryshort life. The goal <strong>of</strong> these products packaging is partial moisture control especially in breads, but themain purpose is to allow the product to be distributed safely <strong>and</strong> hygienically. Still cakes <strong>and</strong> pastriesare <strong>of</strong>ten packs in cardboard boxes. The packaging material recommended for bakery industry is<strong>of</strong> good quality waked papers, cellophane etc. There is a good scope in the development <strong>of</strong> goodpackaging material for bakery <strong>and</strong> confectionary products.Statutory marking, international packaging regulations:St<strong>and</strong>ards <strong>and</strong> Regulatory issues are dealt with by multiple agencies: Most <strong>of</strong> the packaging relatedregulatory initiatives are concerned with the product quality, public health <strong>and</strong> hygiene, safety, Exportpromotion, transportation <strong>and</strong> consumer protection.BIS : All Agricultural productsDMI : Spices, walnuts, casings, fruits <strong>and</strong> vegetablesPFA : Pesticides residues, contaminantsEIC : Only export inspectionAPEDA: Only export st<strong>and</strong>ardsPPA : Issue <strong>of</strong> phytosanitary certificatesCodex : International st<strong>and</strong>ards on processed foodsAreas <strong>of</strong> research <strong>and</strong> development in food packaging:• Design <strong>and</strong> development <strong>of</strong> suitable packages based on processed food products characteristics<strong>and</strong> performance properties <strong>of</strong> packaging materials, <strong>and</strong> finished package forms• Development <strong>of</strong> economical, flexible packages for processed food/agro based products• Development <strong>of</strong> indigenous aluminum containers for processed food/agro based productsfoods <strong>and</strong> beverages• Pre-packaging <strong>and</strong> bulk-packaging <strong>of</strong> fresh as well as processed produce• Safety evaluation <strong>of</strong> packaging components <strong>and</strong> plastic packaging materials for food contactapplicationsDevelopment <strong>of</strong> environment-friendly packaging materials today need• Utilization <strong>of</strong> agricultural waste materials <strong>and</strong> eco-friendly natural <strong>and</strong> synthetic materials• Development <strong>of</strong> bio-film from secretion <strong>of</strong> insects38


Packaging <strong>of</strong> <strong>Value</strong> <strong>Added</strong> Foods <strong>and</strong> <strong>Their</strong> Storage Stability• Design <strong>and</strong> fabrication <strong>of</strong> packaging machinery such as bio-plate making machine• Development <strong>of</strong> vacuum packaging equipment; volumetric machine for filling free-flowingsolid materials; continuous heat sealers for flexible films; <strong>and</strong> vibration testers with variableamplitude• Functional <strong>and</strong> economical (<strong>and</strong> suitable for marketing <strong>and</strong> distribution) package design fora variety <strong>of</strong> processed food products including traditional foods, infant foods, bakery <strong>and</strong>confectionery products• Design <strong>of</strong> transport packages for fresh produce <strong>and</strong> processed foods, <strong>and</strong> development <strong>of</strong> costreductiontechniques in transport package design• Development <strong>of</strong> computer-aided package design techniques• Modeling <strong>and</strong> computer simulation <strong>of</strong> package performance• St<strong>and</strong>ardization <strong>of</strong> process schedules for thermal processing <strong>of</strong> foods in cans, glass, tin-freesteel <strong>and</strong> aluminum containers, <strong>and</strong> retort able pouches based on heat penetration studies <strong>and</strong>sterilization value• Development <strong>of</strong> quality st<strong>and</strong>ards <strong>and</strong> government regulationWork carried out at CFTRI:• Technology packages for convenient <strong>and</strong> ready-to-eat foods• Economical <strong>and</strong> functional packages to contain edible oils <strong>and</strong> fats• Shelf-life prediction methods <strong>and</strong> generation <strong>of</strong> data on flexible packaging• Materials• Process modification <strong>and</strong> in-retort exhaust-cum-sterilization system for• Heat processing <strong>of</strong> food products in plastic containers• Transport package from traditional indigenous materials• Improvements in metal containers for processed food products <strong>and</strong> beverages• Migration aspects <strong>of</strong> plastic constituents into food simulants under use conditions• Development <strong>of</strong> rigid aluminum containers for packaging <strong>of</strong> processed foods <strong>and</strong> beverages• Development <strong>of</strong> bulk packages for storage <strong>and</strong> transportation <strong>of</strong> commercially important fruit<strong>and</strong> vegetables• Studies on the suitability <strong>of</strong> alternatives to tin plate containers for packing processed foodproductsTechnical services <strong>of</strong>fered for:• Unit packages, transport packages, fresh-produce packages; packaging materials; computeraided<strong>and</strong> graphic package designs; fabrication <strong>of</strong> canning <strong>and</strong> other packaging machinery• Sorption isotherm studies <strong>and</strong> shelf-life studies in controlled environments for inl<strong>and</strong> <strong>and</strong> exportmarkets• Thermal processing <strong>of</strong> foods: Establishment <strong>of</strong> processes <strong>and</strong> evaluation <strong>of</strong> containers• Testing <strong>of</strong> packaging materials for their physico-chemical properties, safety <strong>and</strong> transportworthiness• Migration testing for food-grade quality <strong>of</strong> plastic packaging materials• Evaluation <strong>of</strong> finished packages for performance under simulated storage <strong>and</strong> distributionconditions• Routine quality control services39


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceIntroductionNovel Technologies for Processing <strong>and</strong>Packaging <strong>of</strong> Health Foods <strong>and</strong> BeveragesH. N. MishraIndian Institute <strong>of</strong> Technology, KharagpurFood is basically energy – a form <strong>of</strong> solar energy - stored in plant <strong>and</strong> animal foods in chemicalforms. On consumption, this stored form gets converted to physiological energy. Processing <strong>and</strong> storage<strong>of</strong> food become imperative because availability <strong>of</strong> food is mostly seasonal, whereas its consumptiongoes on throughout the year unfettered by any types <strong>of</strong> seasonal bounds. Over the last five decades,India has made great strides in the production <strong>of</strong> food grains, milk, fruits <strong>and</strong> vegetables etc., <strong>and</strong>there is semblance <strong>of</strong> self-sufficiency, albeit fragile in view <strong>of</strong> the burgeoning population. Even so,the net amount <strong>of</strong> the produce for consumption is further reduced due to insufficient storage <strong>and</strong>processing.Food processing industry is one <strong>of</strong> the largest manufacturing industries worldwide <strong>and</strong> possessesglobal strategic importance. With the advancement <strong>of</strong> science <strong>and</strong> technology, new food processingtechnologies are capturing the attention <strong>of</strong> many scientists in academia <strong>and</strong> industry. Consumersprefer high-quality foods with longer shelf life <strong>and</strong>, clearly, some <strong>of</strong> the new technologies can meetthese dem<strong>and</strong>s. Newer strategies have been devised to modify the existing food processing techniques<strong>and</strong> the adoption <strong>of</strong> novel processing technologies.In industrialized countries the market for processed foods is changing. Consumers no longerrequire a shelf life <strong>of</strong> several months at ambient temperature for the majority <strong>of</strong> their foods. Changes infamily lifestyle, <strong>and</strong> increased ownership <strong>of</strong> freezers <strong>and</strong> microwave ovens, are reflected in dem<strong>and</strong>sfor foods that are convenient to prepare, are suitable for frozen storage or have a moderate shelf life atambient temperature. There is also an increased dem<strong>and</strong> by some consumers for foods that have fewerchanges during processing <strong>and</strong> thus either closely resemble the original material or have a healthyimage. New preservation technologies, such as high pressure processing <strong>and</strong> pulsed electric fields<strong>of</strong>fer advantages in meeting consumer dem<strong>and</strong>s <strong>of</strong> freshness, convenience <strong>and</strong> safety.Minimally processed foodsIn recent years the consumers have become more health conscious in their food choices but haveless time to prepare healthful meals. As a result the market dem<strong>and</strong> for “minimally processed” or“lightly processed” foods has rapidly increased. Consumers increasingly dem<strong>and</strong> foods which retaintheir natural flavor, colour <strong>and</strong> texture <strong>and</strong> contain fewer additives such as preservatives. In responseto these needs, one <strong>of</strong> the most important recent developments in the food industry has been thedevelopment <strong>of</strong> minimal processing technologies designed to limit the impact <strong>of</strong> processing onnutritional <strong>and</strong> sensory quality <strong>and</strong> to preserve food without the use <strong>of</strong> synthetic additives.Minimal processed foods have been defined as products that include all the operations whichadd some value to conventional food preservation processes like washing, selecting, peeling, slicing,chopping, coring <strong>and</strong> packaging that cause fewer possible changes in food quality <strong>and</strong> maintain theirquality attributes similar to those <strong>of</strong> fresh produce, but at the same time provide the food enoughuseful life to transport it from production site to the consumer. Minimal processed foods may bemeant for direct consumption or can be later transformed in to the final products by any conventionaltechniques.The dem<strong>and</strong> for minimally processed, easily prepared <strong>and</strong> ready-to-eat ‘fresh’ food products,globalization <strong>of</strong> food trade, <strong>and</strong> distribution from centralized processing pose major challenges forfood safety <strong>and</strong> quality. Recent food-borne microbial outbreaks are driving a search for innovative40


Novel Technologies for Processing <strong>and</strong> Packaging <strong>of</strong> Health Foods <strong>and</strong> Beveragesways to inhibit microbial growth in the foods while maintaining quality, freshness, <strong>and</strong> safety. Oneoption is to use packaging to provide an increased margin <strong>of</strong> safety <strong>and</strong> quality. The next generation<strong>of</strong> food packaging may include materials with antimicrobial properties. These packaging technologiescould play a role in extending shelf-life <strong>of</strong> foods <strong>and</strong> reduce the risk from pathogens. Antimicrobialpolymers may find use in other food contact applications as wellTraditional thermal processing techniques can be both beneficial to foods in such areas aspreservation <strong>and</strong> flavor formation but detrimental in damaging other sensory <strong>and</strong> nutritionalproperties. Minimizing undesirable changes can be achieved in a number <strong>of</strong> ways, whether throughmore effective process control, the use <strong>of</strong> High Temperature Short Time (HTST) techniques such asaseptic processing, or newer technologies such as volume heating methods. The various approaches <strong>and</strong>the range <strong>of</strong> technologies such as infrared heating, dielectric methods such as the use <strong>of</strong> microwaves,<strong>and</strong> ohmic heating is complemented by the following alternatives to thermal processing, ranging fromirradiation to high pressure processing <strong>and</strong> the use <strong>of</strong> pulsed electric fields.Ultrasound method (USM)Ultrasound is probably the most simple <strong>and</strong> most versatile method for the disruption <strong>of</strong> cells<strong>and</strong> for the production <strong>of</strong> extracts. It is efficient safe <strong>and</strong> reliable. Ultrasound techniques have therelatively low cost <strong>and</strong> robust process. Ultrasound cavitation creates shear forces that break cell wallsmechanically <strong>and</strong> improves material transfer. This effect is being used in the extraction <strong>of</strong> liquidcompounds from solid cells. The compound to be dissolved into a solvent is enclosed in an insolublestructure. In order to extract it, the cell membrane must be destructed. For the purpose, ultrasound isfaster <strong>and</strong> more completed than maceration or stirring. The particle size reduction by the ultrasoniccavitation increases the surface area in contact between thesolid <strong>and</strong> liquid phase, significantly. The mechanical activity<strong>of</strong> this technique enhances the diffusion <strong>of</strong> the solvent intothe tissue; Ultrasound breaks the cell wall mechanically bythe cavitation shear forces at it facilitate the transfer from thecell into the solvent. This technique has potential advantagesover other techniques including freedom from radiationhazards, which may appear in some <strong>of</strong> the existing nondestructivemethods. The presence <strong>of</strong> the small gas bubblesin a sample can greatly attenuate ultrasound making signaldetection impossible. This can be solved by using reflectionFigure 1 Ultrasound set up for crystallization measurements rather than transmission measurement.Figure 1 shows an ultrasound set up for crystallization.In United States, ultrasound techniques are being used for processing <strong>of</strong> fresh juices like oranges,mango, grape fruit, plum, purees, sauces <strong>and</strong> dairy products. Oil extraction from oil seed, cell membranepermeabilization <strong>of</strong> fruits like grapes, plums <strong>and</strong> mango, extraction <strong>of</strong> lipids <strong>and</strong> proteins from plant seedssuch as soybean, extraction <strong>of</strong> phenolic compounds from vascular structures by disrupting plant tissuesetc are also achieved by this method. The most effective use is for microbial <strong>and</strong> enzyme inactivation. Thistechnique is used even in the emulsification, dispersing <strong>and</strong> homogenizing as well as to improve chemicalreactions <strong>and</strong> surface chemistry or to influence crystallization process.Oscillating Magnetic Fields (OMF)Inactivating microbes has the potential to pasteurize food with an improvement in the quality <strong>and</strong>shelf-life compared to conventional pasteurization processes. Strong static or oscillating magnetic fields(5-50 TesLa) have the potential to inactivate the vegetative microorganisms. The impulse duration is inbetween 10us <strong>and</strong> several milliseconds <strong>and</strong> the frequencies are maximally 500 MHz because above thisitems begin to warm up noticeably. The preservation <strong>of</strong> foods with oscillating magnetic field involvessealing <strong>of</strong> foods in a plastic bags <strong>and</strong> subjecting it into 1-100 pulses in can OMF at temperature <strong>of</strong> 0°C to50°C for a total exposure time ranging from 25 to 100 minutes <strong>and</strong> for this no special preparation <strong>of</strong> food41


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assuranceis required. Magnetic field treatments are carried out at atmospheric pressure <strong>and</strong> at a temperaturethat stabilizes the food material. It does not have any influence on the organoleptic properties as thetemperature raises only 2-5°C.High pressure processing (HPP)In this food processing method the food is subjected to very high pressure (up to 8.4 kg/cm2) tokill bacteria present in the raw food. This technique can improve food safety by destroying the bacteriathat can cause food borne illness <strong>and</strong> spoilage <strong>and</strong> parasitesthat causes diseases. High pressure works like heat to killbacteria, but the food remains fresh <strong>and</strong> rich. In a typicalprocess, pre-packaged raw product is placed in a pressurechamber <strong>and</strong> subjected to very high pressures for specifictime (< 10 minutes). This process causes high changes in thecharacteristics <strong>of</strong> food. The foods can be kept for a longerperiod under better condition. Small molecules which arethe characteristics <strong>of</strong> flavouring <strong>and</strong> nutritional componentstypically remain unchanged by pressure. These pressureprocessed foods have better texture, nutrient retention<strong>and</strong> colour compared to heat processed foods. Any foodwith sufficient moisture can be subjected to high pressureprocessing. This technique can be used to process both the Figure 2 : A typical high-pressure processingsystem for treating pre-packaged foodsliquid <strong>and</strong> solid foods expect for food materials containinglarge quality <strong>of</strong> air pockets.This technique was first time used by Royer (1895) to kill bacteria <strong>and</strong> subsequently in 1899 byHite to see its effect on milk, meat, fruits <strong>and</strong> vegetables. In Japan, in 1990 first commercial productslike fruit juices, jams, fruit topping <strong>and</strong> tenderized meats were introduced. HPP treatment consumesless energy e.g. energy required pressurization at 400 MPa is equivalent to heating the same materialat 300 °C. The main benefits <strong>of</strong> HPP in food processing include inactivation <strong>of</strong> microorganisms,structural modification <strong>of</strong> biopolymers <strong>and</strong> depression <strong>of</strong> freezing point <strong>of</strong> water. These could be usedadvantageously in several segments <strong>of</strong> food industry including sea food meat <strong>and</strong> meat industry.Since 1990 onwards, in Japan, HPP treatedjam prepared from strawberries, kiwifruit <strong>and</strong> apples are available withoutany application <strong>of</strong> heat treatment. HPPtreated orange juices, pickles, soybeanpaste, rice, seaweeds are available inJapanese markets. The key components <strong>of</strong>a high-pressure system are the pressurevessel, pressurizing system, <strong>and</strong> ancillarycomponents (Figure 2).The processing by HPP is carried outusually in a low compressibility liquidsuch as water. The second principleis that <strong>of</strong> Lechatelier which states thatphenomenon <strong>of</strong> phase transition chemicalFigure 3: Schematic representation <strong>of</strong> microwave drying processchanges etc are accompanied by decreasein volume are favoured by pressure <strong>and</strong>vice versa. Pressure influences most biochemical reactions occurring in foods since they <strong>of</strong>ten involvea change in volume. Pressure may also inhabit the availability <strong>of</strong> energy by affecting energy producingenzymatic reactions.42


Novel Technologies for Processing <strong>and</strong> Packaging <strong>of</strong> Health Foods <strong>and</strong> BeveragesMicrowave processingThe increasing consumer dem<strong>and</strong>s for foods which <strong>of</strong>fer more convenience in usage <strong>and</strong> timesavings in preparation made microwave over as an alternative for conventional thermal ovens. Themicrowave processing has been made use <strong>of</strong> for drying <strong>of</strong> fruit juices, pulps, apple segments <strong>and</strong>finished drying <strong>of</strong> potato chips. Microwaves are endowed with some special characteristics such as, highpenetrating quality which results in the uniform heating <strong>of</strong> materials, selective absorption <strong>of</strong> radiationby liquid water <strong>and</strong> capacity for easy control. These impart some unique effects to the dehydratedmaterial such as improved quality <strong>and</strong> good texture. In the wider field <strong>of</strong> preservation, microwaveshave been used in drying, blanching <strong>and</strong> vacuum drying. Typical product areas where microwaveshave been used commercially include blanching <strong>of</strong> vegetables, where it is claimed that there is lessneed for mechanical h<strong>and</strong>ling with consequent better product. Also, microwaves in combination withhot air have been shown to be a positive route to drying <strong>of</strong> food stuffs, in selective product areas,where, other methods cannot be employed. Finally, microwave vacuum drying has found some outletsin producing fruit juices <strong>and</strong> meat extracts. By aim <strong>of</strong> using microwave processing in preservationin general <strong>and</strong> pasteurization or sterilization in particular is to deliver a more homogeneous heattreatment at a faster rate than conventional method <strong>of</strong> heating. Figure 3 is a schematic representation<strong>of</strong> a microwave drying system.Ohmic heatingThis technology has been around since early 1900s. Thefood processing researcher, however, began investigating thepotential <strong>of</strong> ohmic heating on food quality <strong>and</strong> cost <strong>and</strong> energysavings in 1980s. In this method an AC current is pass througha food sample which leads to generate internal energy in foods.As a result an inside out heating patterns is generated. Ohmicheating is some what similar to microwave heating but withFigure 4: Ohmic heating equipmentvery different frequencies. The advantage <strong>of</strong> this technique isthat it uniformly heats food with different densities such as chicken soup. The quality product withminimal structural nutritional <strong>and</strong> organoleptic changes can be produced. Potential application <strong>of</strong>this technique includes blanching, evaporation, dehydration, fermentation <strong>and</strong> extraction. It savessignificant time energy in hot air <strong>and</strong> freeze drying <strong>of</strong> foods <strong>and</strong> enhances extraction yields someprocessing operations. The parameters used during ohmic heating such as frequency <strong>of</strong> alternatingcurrent applied voltage <strong>and</strong> the temperature to which the sample was heated have a significant effecton it’s success. The electrical conductivity is also a significant factor. The ohmic heating is useful forvalue added processing, <strong>and</strong> it has great potential for use in wide variety <strong>of</strong> food processing operationsinvolving a heat <strong>and</strong> mass transfer. Ohmic heating equipment is shown in figure 4.Ohmic heating is currently used in Europe, Asia <strong>and</strong> North America to produce a variety <strong>of</strong> highquality low <strong>and</strong> high acid products containing particulates. Electrical resistance heating allows particles<strong>and</strong> liquids to heat at the same rate <strong>and</strong> permits the rapid heating <strong>of</strong> mixtures <strong>of</strong> high solid fractions.The technique has been applied to a number <strong>of</strong> food processes, <strong>and</strong> has recently been developed intoa commercial process for the sterilization <strong>of</strong> food mixtures. Ohmic heating occurs, when an electriccurrent is passed through an electrically conducive product. Low frequency current from domesticsupply could be effectively used for ohmic heating. The ohmic heating has many advantages overconventional heating. Continuous processing is possible without any heat transfer surface. Liquid-solidmixture can be rapidly <strong>and</strong> evenly heated with minimal heat damage <strong>and</strong> residence time difference.Nutrient retention will also be more. This process can obtain fresher-tasting, high quality products withhigh microbiological safety. Maintenance cost is minimum due to absence <strong>of</strong> any moving parts. Theprocess is easy to control. Ambient temperature storage <strong>and</strong> distribution is possible when combinedwith an aseptic filling system.43


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceMembrane technologyWith the inception <strong>of</strong> new composite membranes <strong>and</strong> tubular system, reverse osmosis (RO) <strong>and</strong>ultra filtration (UF) are being used extensively in food <strong>and</strong> dairy industries. RO is a single phaseconcentration process which uses a pressure gradient across a semi permeable membrane to squeezewater through membrane. RO process is extremely energy efficient compared to both evaporation<strong>and</strong> freeze concentration. Ultra filtration uses much lower pressure 1 to 10 bars <strong>and</strong> much more openmembranes, which pass salts, sugars <strong>and</strong> organics in the molecular range typically from 5,000 to1,00,000 depending on the membrane type. It is limited by osmotic pressures, since the sugars are notconcentrated.Both RO <strong>and</strong> UF have promising uses in fruit <strong>and</strong> vegetable juice industry as a unit operationfor concentration or aromarecovery <strong>and</strong> clarification<strong>of</strong> juices respectively. Theprimary goal <strong>of</strong> UF infruit industry is to replacethe holding filtration<strong>and</strong> decantation steps <strong>of</strong>traditional process. Enzymetreatment is required toreduce viscosity <strong>of</strong> juice bypartially hydrolyzing. It isa clarification process toremove pectin, enzyme <strong>and</strong>other fibrous components,constituting the clear juice. For separation<strong>of</strong> molecules, semi permeable membraneis used at a temperature <strong>of</strong> 50 -55 °C (high)on 10-15 °C (low), depending on the type <strong>of</strong>juice <strong>and</strong> sensitivity. Tubular modules canbe used for viscous partially depectinizedjuice whereas where as pre filtration <strong>of</strong> juiceis necessary when this channel on boiled fibreUF system is used. Many case studies havedone on apple juice. UF system generates costsavings <strong>and</strong> manpower reduction, uses onlyelectrical energy to raise the pressure <strong>of</strong> juicefeed, operating costs are typically 5-10 timeslower than normal operations, process controlis simple, no cooling water equipment isneeded <strong>and</strong> products have better flavour.In nutshell, UF has become economicalviable alternative for clarification <strong>of</strong> juicein comparison to conventional method <strong>of</strong>clarification. RO is a well established processfor concentration/pre concentration <strong>of</strong> raw<strong>and</strong> clear depectinized juice from fruits <strong>and</strong>vegetable. It consumes 10 times less energyfor renouncing water when compared withconventional evaporators.44Figure 5: A simplified general design <strong>of</strong> a pulsed electric field apparatus.Figure 6: Treatment chamber with different electrode geometries<strong>and</strong> enhanced electric fields in the insulator channelFigure 7: Continuous PEF chamber with baffles


Novel Technologies for Processing <strong>and</strong> Packaging <strong>of</strong> Health Foods <strong>and</strong> BeveragesPulsed electric field (PEF)It was in US where in 1920s first attempt to treat milk with electro impulse was made. Further,experimentations followed in the 1960s primarily with in molecular biological research for incorporation<strong>of</strong> foreign gene materials into microorganisms. This technique involves application <strong>of</strong> pulse <strong>of</strong> highvoltage (typically 20-80 KV/cm) to foods placed between two electrodes. Only pumpable food productscan be treated. This is the more novel process. PEF imposes a strong electric field on a flowering fluidfor a very short time. Above critical field strength <strong>of</strong> about 15,000 V/cm, vegetable cells are killed.Generally higher field strength up to about 35,000 V/cm for disinfection like destruction <strong>of</strong> bacteria,fungi <strong>and</strong> other microbes. When exposed to high electric field pulses, cell membranes develop poreseither by enlargement <strong>of</strong> existing pores or by creation <strong>of</strong> new ones. The pores increase membranepermeability allowing loss <strong>of</strong> cell contents or inclusion <strong>of</strong> surrounding media either <strong>of</strong> which can causecell death. It has limited effect on pores <strong>and</strong> only appears to affect a few enzymes. Figure 5 shows asimplified design <strong>of</strong> pulsed electric field <strong>and</strong> figures 6 <strong>and</strong> 7 describe different electrode geometries inthe treatment chamber <strong>and</strong> Continuous PEF chamber with baffles respectively.PEF <strong>of</strong>fers a five log reduction <strong>of</strong> most pathogens <strong>and</strong> is considered as a pasteurization processso products must be refrigerated. PEF also applies to fruit <strong>and</strong> vegetables cell well, concentration <strong>of</strong>sewage sludge. It kills live cells <strong>and</strong> reduces their ability to retain water, greatly improves filtration.Extraction <strong>of</strong> sugars from beats <strong>and</strong> starches from potatoes can also be improved by PEF. The importantprocess variables <strong>of</strong> PEF include the electric field, temperature, pressure <strong>and</strong> time <strong>of</strong> exposure. PEFunits differ primarily in their fluid h<strong>and</strong>ling capacity: OSU-4, has 0.5-1.0 cm diameter tubing; OSU-5,has 1 cm diameter tubing; <strong>and</strong> OSU-6, has 1-1.2 cm diameter tubing.Food irradiationFood Irradiation is the new addition to the methods <strong>of</strong> food preservation. A great deal <strong>of</strong> workis being carried out at the utilization <strong>of</strong> ionizing radiation. The irradiation <strong>of</strong> foods does destroy themicroorganisms <strong>and</strong> enzymes. It may be desirable to inactivate some enzymes by other means, incomplementation to irradiation action. Irradiation does not leave any residue in foods like chemical<strong>and</strong> hence is safe. The sterilization <strong>of</strong> food with ionizing radiation involves a major consideration,the food products <strong>and</strong> suitable radiation source, since the temperature remains 4-50C. It is also called“cold sterilization” technique. These techniques in controlling the ripening process <strong>of</strong> fruits <strong>and</strong> als<strong>of</strong>or checking sprouting <strong>of</strong> roots, tubers <strong>and</strong> bulbs apart from general food preservation techniques.Modified atmosphere packaging (MAP) <strong>and</strong> controlled atmosphere storage(CAS)The main objective <strong>of</strong> modified atmosphere packaging (MAP) is to interrupt or slow downthe derivative processes <strong>and</strong> also to prevent the attack <strong>of</strong> pathogens until the food is consumed.Controlled atmosphere (CA) is the alteration <strong>of</strong> the natural gaseous environment <strong>and</strong> maintenance <strong>of</strong>this atmosphere at pre specified conditions throughout the storage time. Modified atmosphere (MA)is the initial alteration <strong>of</strong> the gaseous environment in the immediate vicinity <strong>of</strong> stored <strong>and</strong> packagedproduct. These are used for retail distribution <strong>and</strong> for consumer product packages. The CA <strong>and</strong> MAPextend the shelf life <strong>of</strong> the product. Lot <strong>of</strong> work has been carried out <strong>and</strong> further research is on.RTE health foodsIn our country processed food product are available in both organized <strong>and</strong> unorganized sectors.Developments in production technology, emergence <strong>of</strong> new products like ready-to-eat (RTE) mixes,enhancement <strong>of</strong> product shelf life <strong>and</strong> packaging are driving the shift from the non organized toorganized commercial business. Due to growing urbanization <strong>and</strong> changing food habits, thedem<strong>and</strong> has been rising at a good pace <strong>and</strong> there is enough latent market potential waiting to beexploited through developmental efforts. It is high time for the organized sector to take initiativein technology improvement, process modeling <strong>and</strong> automation, overall improvement in quality,investment in R&D to develop new products <strong>and</strong> enhance shelf life <strong>of</strong> existing products <strong>and</strong> further45


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assuranceimprovement in packaging. The size <strong>of</strong> the industry might increase substantially if the productportfolio were to include at least one each <strong>of</strong> the daily staples; ready chapatti from the chapatti-subzistaple <strong>and</strong> precooked or concentrated dal from the dal–chawal combination. India is a vast countrywith different eating habits <strong>and</strong> yet North Indian cuisine is an acceptable restaurant fare <strong>and</strong> theubiquitous idli <strong>and</strong> dosa are available in every part <strong>of</strong> country. From dishes consumed throughoutthe country at different eating occasions <strong>of</strong> breakfast, lunch, tea time <strong>and</strong> dinner, it should be possibleto systematically examine similarities <strong>and</strong> come up with a short list <strong>of</strong> products that would find aplace in the menu <strong>of</strong> a major part <strong>of</strong> the country, which could then be developed as processed food.The Western concept <strong>of</strong> hamburger or a s<strong>and</strong>wich <strong>and</strong> its local equivalent chapatti-subzi takeawayscooked in perceived hygienic surrounding are a boon for the working women <strong>and</strong> can be nurtured intobig business. With the increasing dominance <strong>of</strong> large <strong>and</strong> technically more sophisticated companiesin food processing, attention also should be paid to small operations, which do not enjoy the sameeconomies <strong>of</strong> scale. To this end, an increase in the number <strong>of</strong> regionally centralized facilities <strong>of</strong>feringthe latest processing technique <strong>and</strong> advice should be encouraged. It would be necessary to develop theappropriate technology to produce an authentic product, with low cost or reusable packaging <strong>and</strong> anefficient distribution system to market them at an acceptable price. The prime aim will be to provideall consumers with increasing levels <strong>of</strong> convenience.Health / nutritional benefits <strong>of</strong> functional foodsDuring recent years importance <strong>of</strong> B-complex vitamins, beta-carotene <strong>and</strong> vitamin C has beenrealized in terms <strong>of</strong> their antioxidative <strong>and</strong> anticarcinogenic properties. Fruits <strong>and</strong> vegetables arethe rich sources <strong>of</strong> these vitamins. Fermented foods <strong>and</strong> beverages possess various nutritional <strong>and</strong>therapeutic properties. Lactic acid bacteria play a major role in determining the positive health effects<strong>of</strong> fermented milks <strong>and</strong> related products. The L. acidophilus <strong>and</strong> Bifidobacteria spp are known fortheir use in probiotic dairy foods. Cultured products sold with any claims <strong>of</strong> health benefits shouldmeet the criteria <strong>of</strong> suggested minimum number <strong>of</strong> more than 106 cfu / g at the expiry date. Otherhealth benefits <strong>of</strong> fermented milk products include prevention <strong>of</strong> gastrointestinal infections, reduction<strong>of</strong> serum cholesterol levels <strong>and</strong> anti -mutagenic activity. They are recommended for lactose intolerantindividuals <strong>and</strong> patients suffering from atherosclerosis.Health claimsHealth claims describe a relationship between a food, food component, or dietary supplementingredient, <strong>and</strong> reducing risk <strong>of</strong> a disease or health-related condition. There are three ways by whichFDA exercises its oversight in determining which health claims may be used on a label or in labeling fora food or dietary supplement: (i) the 1990 Nutrition Labeling <strong>and</strong> Education Act (NLEA), (ii) the 1997Food <strong>and</strong> Drug Administration Modernization Act (FDAMA) <strong>and</strong> (iii) the 2003 FDA Consumer HealthInformation for Better Nutrition Initiative. Such health claims must be qualified to assure accuracy <strong>and</strong>non-misleading presentation to consumers. FDA authorizes these types <strong>of</strong> health claims based on anextensive review <strong>of</strong> the scientific literature, generally as a result <strong>of</strong> the submission <strong>of</strong> a health claimpetition, using the significant scientific agreement st<strong>and</strong>ard to determine that the nutrient/ diseaserelationship is well established.Nutrient content claimsNutrient content claims describe the level <strong>of</strong> a nutrient or dietary substance in the product, usingterms such as free, high, <strong>and</strong> low, or they compare the level <strong>of</strong> a nutrient in a food to that <strong>of</strong> anotherfood, using terms such as more, reduced etc. An accurate quantitative statement (e.g., 200 mg <strong>of</strong>sodium) that does not “characterize” the nutrient level may be used to describe any amount <strong>of</strong> anutrient present.Structure/ function claimsStructure/ function claims describe the role <strong>of</strong> a nutrient or dietary ingredient intended to affectnormal structure or function in humans, for example, “calcium builds strong bones”. In addition, they46


Novel Technologies for Processing <strong>and</strong> Packaging <strong>of</strong> Health Foods <strong>and</strong> Beveragesmay characterize the means by which a nutrient or dietary ingredient acts to maintain such structure orfunction, for example, “fiber maintains bowel regularity,” or “antioxidants maintain cell integrity,” orthey may describe general well-being from consumption <strong>of</strong> a nutrient or dietary ingredient. Structure/function claims may also describe a benefit related to a nutrient deficiency disease (like vitamin C <strong>and</strong>scurvy), as long as the statement also tells how widespread such a disease is in the United States.Technology <strong>of</strong> formulation <strong>of</strong> health foodsThere are several methods <strong>of</strong> manufacturing functional foods, based either on the method used toproduce them or on their purpose. Functional foods may be processed by modification or they may befortified with different substances <strong>and</strong> the functionality <strong>of</strong> a product can be targeted to a special diseaseor just to improve overall well being. A particular food may be made more functional by increasing oradding a potential health promoting entity. Alternatively concentration <strong>of</strong> adverse components may bereduced or there may be a partial interchange between toxic <strong>and</strong> beneficial ingredients. Health drinksare formulated taking into account the nutritional requirements or recommended dietary allowancesfor the target group. It is not only essential to balance the energy protein <strong>and</strong> vitamin requirements,but also to make it palatable, sparkling <strong>and</strong> thirst quenching.Challenges in formulation <strong>of</strong> health foodsThere are many obstacles within food system that hinder the development processes <strong>of</strong> these specificfoods. There are considerable processing losses <strong>of</strong> vitamins, <strong>and</strong> information on vitamin contents<strong>of</strong> processed foods is essential for assessing the adequacy <strong>of</strong> vitamin intakes. Problems associatedwith the iron fortification <strong>of</strong> fruit juices <strong>and</strong> drinks have been outlined as: accelerated loss <strong>of</strong> vitaminC, flavour <strong>and</strong> taste deterioration in the presence <strong>of</strong> thiamine, folic acid, vitamin A <strong>and</strong> vitamin C,levels <strong>of</strong> fortification beyond 2.7 mg per serving result in metallic <strong>of</strong>f-flavors, decolourisation <strong>of</strong> somepigments.Fortification <strong>of</strong> beverages with calcium has become a popular practice. Insoluble Ca <strong>and</strong> Mg saltscause lightening <strong>of</strong> food colour, whereas soluble salts may interact with other food components such astannins to cause darkening. The prooxidant effect <strong>of</strong> many minerals has caused rancidity developmentin lipid containing beverages. In beverages with high protein content, the addition <strong>of</strong> Ca or Mg saltshave caused destabilization <strong>of</strong> the protein component. The use <strong>of</strong> soy lecithin to coat calcium ions foruse in the calcium fortification <strong>of</strong> soymilk prevented the Ca induced precipitation <strong>of</strong> soy proteins. Inthe production <strong>of</strong> yoghurt, the low pH conditions render it unsuitable as a carrier for vitamins suchas vitamin A.Health foods for control <strong>of</strong> cardiovascular disease (CVD) & diabetesFunctional foods that are marketed with claims to reduce heart disease focus primarily on the riskfactors <strong>of</strong> blood cholesterol, homocysteine <strong>and</strong> hypertension. This can be done by a reduced content <strong>of</strong>food components that are known to increase risk, saturated fat or sodium. More recently products havebeen designed that are enriched in components thought to reduce risk. The most common protectiveingredients include fibres, ώ-3 fatty acids, phytostanols, phytosterols <strong>and</strong> (antioxidant) vitamins.Replacement <strong>of</strong> saturated or trans fat in the diet by carbohydrates or other types <strong>of</strong> fat reduces the risk<strong>of</strong> coronary heart disease (CHD). High intakes <strong>of</strong> tea rich in catechins <strong>and</strong> other flavonoid polyphenolshave also been associated with a reduced risk <strong>of</strong> CHD. Many well-controlled trials have documentedthe efficacy <strong>of</strong> sterols <strong>and</strong> stanols for lowering low density lipoprotein (LDL) cholesterol. A highconsumption <strong>of</strong> soy protein has been associated with a low risk <strong>of</strong> cardio vascular disease (CVD) inecological studies. Besides soy protein, is<strong>of</strong>lavonones (phytoestrogens) such as genistein might beresponsible for the effects on CVD risk. Thus, any dietary pattern combining a high intake <strong>of</strong> naturalantioxidants, a low intake <strong>of</strong> saturated fatty acids, a high intake <strong>of</strong> oleic acid, a low intake <strong>of</strong> ώ-6 fattyacids <strong>and</strong> a high intake <strong>of</strong> ώ-3 fatty acids would logically produce a highly cardio protective effect.Diabetes mellitus is a heterogeneous metabolic syndrome with several different causes characterizedby chronic hyperglycaemia with partial or total lack <strong>of</strong> insulin secretion <strong>and</strong> a reduced sensitivity to47


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assurancethe hormone in peripheral tissues. If monitored inadequately <strong>and</strong> associated with other lipid <strong>and</strong>protein disorders, long term complications may develop in several organs <strong>and</strong> systems, resulting inboth high morbidity <strong>and</strong> mortality rates. Type 1 diabetes is the result <strong>of</strong> complete β-cell destruction.Type 2 diabetes is the primary result <strong>of</strong> either insulin resistance or deficiency in insulin secretion,<strong>and</strong> having a completely different clinical perspective <strong>and</strong> presentation is usually characterized bya mixture <strong>of</strong> the two. It has been suggested that for type 1 diabetes an early exposure to cows’ milkproteins may play a role in triggering the immune response that destroys pancreatic β-cells. In generala good nutritional diet that is low in fat <strong>and</strong> salt is important. For someone with type 1 diabetes,regular meal times <strong>and</strong> snacks <strong>and</strong> the right proportion <strong>of</strong> nutrients should be emphasized. Someonewith type 2 diabetes, where in most cases weight reduction is necessary, not only should considercalorie intake but also the component <strong>and</strong> type <strong>of</strong> food that is eaten.ConclusionImproving food technology not only improves health, but reduces poverty. When food productsare safe, nutritious, well marketed, <strong>and</strong> competitively priced thanks to efficient manufacturing, theyattract consumers. Rising consumer dem<strong>and</strong>, in turn, exp<strong>and</strong>s a nation’s entrepreneurial base in foodproducts, creating jobs <strong>and</strong> raising family incomes. Larger family food budgets then contribute to afurther drop in malnutrition. New preservation technologies, such as high pressure processing <strong>and</strong>pulsed electric fields <strong>of</strong>fer advantages in meeting consumer dem<strong>and</strong>s <strong>of</strong> freshness, convenience <strong>and</strong>safety. There is no single process that will allow the high-quality production <strong>of</strong> every food productwhile ensuring safety; all <strong>of</strong> these processes, as well as thermal processing, have their own set <strong>of</strong>limitations <strong>and</strong> advantages.ReferencesCánovas, B. G. V, Gongora-Nieto, M.M., Pothakamury, U. R. <strong>and</strong> Swanson, B. G. (1999). Preservation <strong>of</strong> foods with pulsedelectric fields. 1-9, 76-107, 108-155. Academic Press Ltd. London.Ch<strong>and</strong>rasekhar, U. (2004) Soy proteins - an ideal functional food for growth promotion.Proc Nutr Soc Aust , Vol. 28. Asia Pac J Clin Nutr 2004; 13 (Suppl):S118.Gonçalo,E. B. (2003) Certificação de sistemas de qualidade na indústria de laticínios, Revista do Instituto de LaticiniosCândido Tostes 58 , (333): 9–14http://www.fao.org/ ag/ags/agsi/Nonthermal/nonthermal_1.htmIlbery, B. <strong>and</strong> Kneafsey, M. (2000). Producer constructions <strong>of</strong> quality in regional speciality food production: a casestudy from South West Engl<strong>and</strong>. Journal <strong>of</strong> Rural Studies 16 2 (2000), pp. 217–230.Ruecr<strong>of</strong>t, G. (2007) Power Ultrasound, Crystals <strong>and</strong> Particle Engineering, Paper presented in “Chemsource Symposium2007” during 27th & 28th June at RAI, Amsterdam.Zhang, M <strong>and</strong> Xu, Y. Y. (2003) Research developments <strong>of</strong> combination drying technology for fruits <strong>and</strong> vegetables athome <strong>and</strong> abroad, Journal <strong>of</strong> Wuxi University <strong>of</strong> Light Industry 22, (6): 103–106.48


Glycomacropeptide – Biological Properties <strong>and</strong> its ApplicationIntroductionGlycomacropeptide – BiologicalProperties <strong>and</strong> its ApplicationRajan Sharma <strong>and</strong> Neelima Sharma<strong>Dairy</strong> Chemistry Division, NDRI, KarnalWhey proteins have been singled out as a super star ingredient for health promoting productsincluding ones formulated for weight loss, infant nutrition <strong>and</strong> immune support. The major wheyproteins are α-lactalbumin (α-la), β-lactoglobulin (β-lg), bovine serum albumin, immunoglobulins<strong>and</strong> lact<strong>of</strong>errin. In addition, sweet whey/rennet whey also contains glycomacropeptide (GMP) whichis a C-terminal hydrophilic glycopeptide released from κ-casein (κ-CN) by the action <strong>of</strong> chymosinduring cheese making. GMP lacks aromatic amino acids (phenylalanine, tyrosine, <strong>and</strong> tryptophan),<strong>and</strong> contains varying amounts <strong>of</strong> sugars which are made up <strong>of</strong> N-acetylneuraminic acid (sialic acid orNANA), galactose, <strong>and</strong> N-acetylgalactosamine.GMP found in sweet whey is an acidic glycopeptide. The bond sensitive to chymosin (rennin)hydrolysis occurs between the phenylalanine (Phe) residue at position 105 <strong>and</strong> the methionine (Met)residue at position 106. The hydrolytic products are para κ-CN (residue 1-105) <strong>and</strong> macropeptide(residue 106-169). Next to β-lg <strong>and</strong> α-la, GMP is the most abundant protein/peptide in wheyprotein isolate (WPI) <strong>and</strong> whey protein concentrate (WPC) produced from cheese whey with typicalconcentrations between 20-25% <strong>of</strong> the proteins (Thoma-Worringer et al., 2006). It is a heterogeneouspeptide <strong>of</strong> 64 amino acids formed by κ-CN (Delfour et al., 1964). It contains 47% (w/w) indispensableamino acids, but contains no histidine (His), tryptophan (Trp), tyrosine (Tyr), arginine (Arg), cysteine(Cys) or Phe (Laclair et al. 2009). There are four hydrophobic domains in GMP <strong>and</strong> most <strong>of</strong> them aremasked by the strong charge density <strong>of</strong> the glutamic acid (Glu) <strong>and</strong> asparatic acid (Asp) residuesover a wide range <strong>of</strong> neutral <strong>and</strong> basic pH, therefore the hydrophobic domains cannot interact. Onlythe N-terminal hydrophobic domain (amino acid 1-5) is not covered by the negative charge <strong>and</strong> isavailable for interaction (Kreub et al., 2009).GMP has received much attention in recent years because <strong>of</strong> its several biological properties.The various biological activities <strong>of</strong> GMP include its ability to bind cholera toxin <strong>and</strong> Escherichia colienterotoxins, inhibition <strong>of</strong> bacterial <strong>and</strong> viral adhesion, modulation <strong>of</strong> immune system responses,promotion <strong>of</strong> bifido-bacterial growth, suppression <strong>of</strong> gastric secretions <strong>and</strong> regulation <strong>of</strong> bloodcirculation etc. Further, GMP can find application in various food systems because <strong>of</strong> its functionalcharacteristics, mainly its high solubility <strong>and</strong> emulsifying properties.<strong>Chemical</strong> properties <strong>of</strong> GMPGMP is one <strong>of</strong> the various names given to the peptide formed by κ-CN rupture. This peptide is alsoknown as caseinomacropeptide (CMP) or casein-derived peptide (CDP). Usually GMP refers to theglycosylated form, due to its high carbohydrate content, <strong>and</strong> CMP to the peptide´s non-glycosylatedform. Its composition varies <strong>and</strong> depends particularly on the whey source <strong>and</strong> on the technology usedfor its isolation (Martín-Diana et al., 2006). The major chemical properties <strong>of</strong> GMP include:• Glycosylation;• Isoelectric point <strong>and</strong> UV absorption;• Molecular weight;• UV Characteristic1. Glycosylation: The glycosylated form represents 50 to 60% <strong>of</strong> total GMP <strong>and</strong> the carbohydratepart is composed <strong>of</strong> galactose, (Gal) N-acetylgalactosamine (GalNAc) <strong>and</strong> N-acetylneuraminic acid(NeuAc) (Thoma et al., 2006). The most predominant is NeuAc, known as sialic acid. GMP purified to49


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assurance90% is highly glycosylated with 7 to 8% sialic acid (Martín-Diana et al., 2003). Sialic acid present in theGMP gives the peptide anionic character <strong>and</strong> may react with other compounds like thiobarbituric acid(TBA) <strong>and</strong> ninhydrin to give chromophores which can be spectrophotometrically determined. Thisproperty can be utilized for the estimation <strong>of</strong> GMP as the sialic acid content <strong>and</strong> can be correlated withthe GMP concentration. In one approach Nakano <strong>and</strong> Ozimek (1999) determined the sialic acid contentfor the estimation <strong>of</strong> GMP in cheese whey by using TBA. The other approach for the determination<strong>of</strong> sialic acid content in GMP has been given by the use <strong>of</strong> acidic ninhydrin by spectrophotometricmethod (Fukuda et al., 2004).2. Isoelectric point <strong>and</strong> UV absorption: The exact isoelectric point <strong>of</strong> GMP is still unclear. Usinganion exchange chromatography Nakano <strong>and</strong> Ozimek (2000) suggested that all sialylated GMP hadan apparent pI < 3.8. GMP is rich in branched-chain amino acids (valine <strong>and</strong> isoleucine) <strong>and</strong> it lacksaromatic amino acids, including phenylalanine, tryptophan <strong>and</strong> tyrosine (Oliva et al., 2002).3. Molecular weight: Several works have informed that the theoretical molecular weight <strong>of</strong> GMPis between 7 <strong>and</strong> 8 kDa. Some authors suggest that GMP has the ability <strong>of</strong> associating <strong>and</strong> dissociatingunder selected pH conditions. Kawasaki et al. (1993a) proposed that the monomer <strong>of</strong> k-casein GMP <strong>of</strong>molecular weight 9 kDa is obtained at pH ≤ 4 <strong>and</strong> the polymer <strong>of</strong> k-casein GMP <strong>of</strong> molecular weightbetween 45- 50 kDa is obtained at pH higher than 4. Later, Nakano <strong>and</strong> Ozimek (1998) also studiedthe influence <strong>of</strong> pH on GMP behaviour. Using chromatography in Sephacryl S-200 gel, the authorscollected fractions that were monitored for sialic acid. The results suggested that GMP is an aggregate<strong>of</strong> three monomers <strong>and</strong> the molecular weight was not affected by changes in pH. Farias et al. (2009)studied self assembly <strong>of</strong> 3-5% (w/w) GMP at pH 3-6.5 using DLS (Dynamic Light Scattering). Thehydrodynamic diameter increased when decreasing the pH from 6.5 to 3. GMP solution at a pH below4.5 shows time dependent self assembly at room temperature, which over time leads to gelation.Currently there is an overall consensus that the experimental molecular weight <strong>of</strong> GMP is higher thanthe theoretical weight.4. UV Characteristic: Because <strong>of</strong> the absence <strong>of</strong> aromatic amino acids, GMP has no absorptionat 280 nm. It is known that GMP is only detected in the range <strong>of</strong> 205-217 nm <strong>and</strong> differences in theabsorption at 210/280 nm are frequently used to characterize GMP (Oliva et al., 2002).Biological activities <strong>and</strong> nutritional propertiesBiological activity <strong>of</strong> bovine GMP has received much attention in recent years. The variousphysiological functions attributed to GMP include:• Binding <strong>of</strong> cholera toxin (CT);• Inhibition <strong>of</strong> bacterial <strong>and</strong> viral adhesion;• Suppression <strong>of</strong> gastric secretions;• Promotion <strong>of</strong> Bifidobacterial growth;• Modulation <strong>of</strong> immune system response;• Regulation <strong>of</strong> blood circulation through antihypertensive <strong>and</strong> antithrombotic activity;1. Binding <strong>of</strong> cholera toxin (CT): Kawasaki et al. (1992) showed that GMP is capable <strong>of</strong> bindingCT. Normal Chinese hamster ovary (CHO)-K1 cells are spherical but in the presence <strong>of</strong> CT, CHO-K1cells take on a spindle shape. As little as 20 ppm GMP is enough to cause considerable rounding <strong>of</strong>CHO-K1 cells <strong>and</strong> 100 ppm GMP results in almost completely rounded CHO-K1 cells which indicatethat GMP has bound to CT. When the GMP was treated with sialidase, which hydrolyses the sialicacid, complete loss <strong>of</strong> CT inhibiting activity occurred. The peptide chain must also participate in thebinding as partial loss <strong>of</strong> CT inhibiting activity occurred after treatment with proteases. CT bindingactivity <strong>of</strong> purified GMP from bovine κ-CN was also detected by Oh et al. (2000) using ELISA. The CTbinding activity is rapidly lost by carbohydrase treatment.50


Glycomacropeptide – Biological Properties <strong>and</strong> its Application2. Inhibition <strong>of</strong> bacterial <strong>and</strong> viral adhesion: Many bacteria <strong>and</strong> viruses bind themselves totheir hosts as a part <strong>of</strong> the colonization process. Binding to the intestine or other mucosal surfaces isachieved by adhesins, capsular material on the bacterial cell surface or hair-like fimbriae or pili whichare specific for the various ceramide <strong>and</strong> ganglioside glycoconjugates which make up epithelial cellmembranes (Simon, 1996). Nakajima et al. (2005) studied the prevention <strong>of</strong> intestinal infection by GMP.The binding ability <strong>of</strong> GMP to intestinal pathogenic bacteria was evaluated by a binding assay withbiotinylated bacteria. GMP showed the ability to bind to Salmonella enteritidis <strong>and</strong> enterohemorrhagicE.coli O157:H7. This binding ability was decreased by a sialidase treatment <strong>and</strong> completely eliminatedby periodate oxidation indicating that sialic acid in GMP are involved in binding to the bacteria.Neeser et al. (1988a) investigated the mechanism by which milk components prevent dental caries.They evaluated the role <strong>of</strong> GMP in inhibiting adhesion <strong>of</strong> cariogenic bacteria (Streptococcus mutans,S. sanguis, S. sobrinus <strong>and</strong> Actinomyces viscosus) to oral surfaces. Haemagglutination by S. mutans, S.sanguis <strong>and</strong> A. viscosus is prevented by GMP with a disaccharide (Gal β1 → 3GalNAc - O – R).3. Suppression <strong>of</strong> gastric secretions: Guilloteau et al. (1994) while investing the effect <strong>of</strong> GMPon gastric secretion in preruminant calves found that intravenous injection <strong>of</strong> GMP had no inhibition<strong>of</strong> gastric secretion. Beucher et al. (1994b) found that feeding GMP fraction, stimulated the intestinalhormone cholecystokinin which, in turn, regulates gastrointestinal functions. Yvon et al. (1994)demonstrated that GMP acts by triggering receptors on the intestinal mucosa.4. Promotion <strong>of</strong> bifidobacterial growth: Supplementation <strong>of</strong> milk with 2% GMP, either <strong>of</strong>bovine, ovine or caprine origin increased the counts <strong>of</strong> Bifidobacterium lactis by 1.5 log cycles after 24h incubation at 37°C when compared with unsupplemented milk (Janer et al., 2004).5. Modulation <strong>of</strong> immune system response: Splenocyte (spleen lymphocyte) proliferation is astep in the inflammatory response. Inhibition <strong>of</strong> splenocyte proliferation can be used to demonstratesuppression <strong>of</strong> an immune response such as an allergic reaction. Research by Otani et al. (1992)demonstrated that casein inhibits mouse splenocyte proliferation induced by the mitogen Salmonellatyphimurium lipopolysaccharide (LPS). Inhibitory activity was due to κ-casein, which upon rennethydrolysis, results in inhibitory activity being found in the GMP fraction. Para- κ-casein had noinhibitory activity. Upon sialidase digestion, GMP lost its inhibitory activity, indicating that sialic acidis critical to the phenomenon (Otani <strong>and</strong> Monnai, 1993). Inhibitory activity was reduced after GMPdigestion with chymotrypsin but inhibitory activity increased after GMP digestion with trypsin orpronase so the peptide chain must also participate.6. Regulation <strong>of</strong> blood circulation through antihypertensive <strong>and</strong> antithrombotic activity:Bovine, ovine, <strong>and</strong> caprine GMP can inhibit platelet aggregation <strong>and</strong>, therefore, the formation <strong>of</strong>thrombi, because the region 106–116 <strong>of</strong> κ-casein (casoplatelin) is analogous to the fragment 400–411<strong>of</strong> fibrinogen γ-chain (Jolles et al., 1986). Peptides with in vitro angiotensin I converting enzyme(ACE)-inhibitory activity were liberated from bovine, ovine <strong>and</strong> caprine GMP either by proteolysiswith trypsin or simulation <strong>of</strong> the GMP digestion under gastrointestinal conditions (Manso <strong>and</strong>Lopez-F<strong>and</strong>ino, 2003). This suggests that intact GMP <strong>and</strong> its tryptic peptides may play a role in thephysiological regulation <strong>of</strong> blood pressure, although tryptic hydrolysates exhibited higher levels <strong>of</strong>ACE inhibitory activity than did intact GMP during subsequent digestion, which justifies their use asfood components.Along with the above mentioned physiological effects GMP has been found to be beneficial foroverall growth <strong>and</strong> development. GMP is rich in branched-chain amino acids <strong>and</strong> low in Met, whichmakes it a useful ingredient in diets for patients suffering from hepatic diseases (Abd El-Salam et al.,1996). Additionally, the fact that GMP has no Phe in its amino acid composition makes it suitable fornutrition in cases <strong>of</strong> phenylketonuria. Nevertheless, because <strong>of</strong> its high content <strong>of</strong> Thr, GMP can causehyperthreoninemia (Fanaro <strong>and</strong> Vigi, 2002; Rigo et al., 2001). GMP supplementation has also beenfound to increas zinc absorption (Kelleher et al., 2003). The sialic acid content <strong>of</strong> GMP is also interestingin terms <strong>of</strong> bioactivity. Large amounts <strong>of</strong> this carbohydrate are found in the brain <strong>and</strong> in the centralnervous system in the form <strong>of</strong> gangliosides <strong>and</strong> glycoproteins, which contribute to the functioning <strong>of</strong>51


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assurancecell membranes <strong>and</strong> membrane receptors <strong>and</strong> to normal brain development. An in vivo experimentwith laboratory animals has shown that the exogenous administration <strong>of</strong> sialic acid increased theproduction <strong>of</strong> ganglioside sialic acid in the brain, improving learning ability (Wang et al., 2001). Thiseffect could also be achieved with dietary GMP (Wang et al., 2004).Functional <strong>and</strong> technological properties/applications <strong>of</strong> GMPGMP can also be taken up as a functional ingredient in various speciality products like infantformulas, nutrition bars, medical foods (PKU), diet foods, oral care products <strong>and</strong> dietary supplementsbecause the development <strong>of</strong> innovative foods with an additional health benefit is a goal for the foodindustry.The characteristics <strong>of</strong> GMP not only permit medicinal <strong>and</strong> dietary applications, but also givethe molecule a great potential as a structural agent for food, since its glycosidic structure suggestsemulsifying <strong>and</strong> foaming properties (Kulozik <strong>and</strong> Guilmineau, 2003). GMP showed to be stable in thepH range <strong>of</strong> 1 to 10, with minimal solubility (88%) between pH 1-5 <strong>and</strong> maximum (98%) between pH5-10. The emulsifying activity was stronger at acid pH rather than alkaline. After letting the emulsionst<strong>and</strong> for 24 hours <strong>and</strong> heating a decrease in the emulsifying activity (22-60%) at pH below 4 (Chobertet al., 1989) was observed. Wong et al. (2006) determined the functionality, foaming capacity <strong>and</strong>emulsifying activity <strong>of</strong> GMP after conjugation to fatty acids. The authors observed that the foamingcapacity was lost, whereas the emulsifying activity enhanced. The addition <strong>of</strong> GMP to fermentedgoat milk favored gel formation in a more orderly <strong>and</strong> structured manner compared to the addition<strong>of</strong> whey protein concentrate (Martín-Diana et al., 2003). However, Veith <strong>and</strong> Reynolds (2004) verifiedin their work that the presence <strong>of</strong> GMP had a negative impact on gel strength <strong>and</strong> water retentioncapacity. On the other h<strong>and</strong>, Martín-Diana et al. (2005) studied GMP <strong>of</strong> cow, ewe <strong>and</strong> goat cheesewhey, concluding that GMP had an emulsifying activity, more stable to pH variation, compared towhey protein concentrate. This suggests the possibility to use GMP as an emulsifier in foods thatundergo great pH variation during processing, such as fermented dairy products. GMP obtainedfrom goat milk was modified with lactose through Maillard reaction under relative humidity 44% <strong>and</strong>temperature <strong>of</strong> 40°C for periods <strong>of</strong> 0 to 11 days, thus obtaining different forms <strong>of</strong> lactosylated GMP.At these conditions, the most abundant form <strong>of</strong> lactosylated GMP was the Monolactosylated (55-60%),followed by the di-, tri- <strong>and</strong> tetralactosylated species. Solubility, heat stability <strong>and</strong> emulsifying capacity<strong>of</strong> native <strong>and</strong> modified GMP were investigated. Lactosylation enhanced emulsifying capacity but didnot improve the outst<strong>and</strong>ing solubility <strong>and</strong> heat stability <strong>of</strong> native GMP (Moreno et al., 2002).ReferencesAbd El-Salam, M.H.; El-Shibini, S. <strong>and</strong> Buchheim, W. (1996). Characteristics <strong>and</strong> potential uses <strong>of</strong> the casein macropeptide.Int. <strong>Dairy</strong> J. 6:327–341.Beucher, S.; Levenez, F.; Yvon, M. <strong>and</strong> Corring, T. (1994b) Effect <strong>of</strong> caseinomacropeptide (CMP) on cholecystokinin(CCK) release in rat. Reproduction Nutrition Development. 34: 613-614.Chobert, J.; Touati, A.; Bertr<strong>and</strong>harb, C.; Dalgalarrondo, M. <strong>and</strong> Nicolas, M. (1989) Solubility <strong>and</strong> emulsifying properties<strong>of</strong> kappa-casein <strong>and</strong> its caseinomacropeptide. J. Food Biochem. 13:457-473.Eigel, W.N.; Butler, J.E.; Ernstrom, C.A.; Farrel, H.M.Jr.; Harwalkar, V.R.; Jennes, R. <strong>and</strong> Whitney, R.M. (1984)Nomenclature <strong>of</strong> proteins <strong>of</strong> cow’s milk: Fifth Revision. J. <strong>Dairy</strong> Sci. 67:1599-1631.Fanaro, S. <strong>and</strong> Vigi, V. (2002). Protein quality <strong>and</strong> quantity in infant formulas: A critical look. Minerva Pediatrica. 54:203–209.Farias, M.E.; Martinez, M.J. <strong>and</strong> Pilos<strong>of</strong>, A.M.R. (2010) Casein Glycomacropeptide pH-dependent self assembly <strong>and</strong>cold gelation. Int. <strong>Dairy</strong> J. 20:79-88.Fukuda, S.P.; Roig, S.M. <strong>and</strong> Prata, L.F. (2004) Correlation between acidic ninhydrin <strong>and</strong> HPLC methods to evaluatefraudulent addition <strong>of</strong> whey in milk. Le Lait. 84:502-512.Guilloteau, P.; Le Huerou-Luron, I.; Chayviaille, J.A.; Toullec, R.; Legeas, M.; Bernard, C.; Roger, L. <strong>and</strong> Mendy, F. (1994)Effect <strong>of</strong> caseinomacropeptide (CMP) on gastric secretion <strong>and</strong> plasma gut regulatory peptides in preruminantcalves. Reproduction Nutrition Development. 34:612-613.Janer, C.; Pelaez, C. <strong>and</strong> Requena, T. (2004) Caseinomacropeptide <strong>and</strong> whey protein concentrate enhance Bifidobacteriumlactis growth in milk. Food Chem. 86: 263-267.Jolles, P.; Levy-Toledano, S.; Fiat, A. M.; Soria, C.; Gillensen, D.; Thomaidis, A.; Dunn, F.W.; Caen, J.P. (1986). Analogybetween fibrinogen <strong>and</strong> casein: Effect <strong>of</strong> an undecapeptide isolated from k-casein on platelet function. EuropeanJ. Biochem. 158:379–382.52


Glycomacropeptide – Biological Properties <strong>and</strong> its ApplicationKawasaki, Y., Isoda, H., Tanimoto, M.; Dosako, S. Idota, T. <strong>and</strong> Ahiko, K. (1992) Inhibition by lact<strong>of</strong>errin <strong>and</strong> kappacaseinglycomacropeptide <strong>of</strong> binding <strong>of</strong> cholera toxin to its receptor. Biosci. Biotech. Biochem. 56: 195-198.Kawasaki, Y.; Kawakami, H.; Tanimoto, M.; Dosako, S.; Tomizawa, A.; Kotake, M. <strong>and</strong> Nakajima, I. (1993a) pHindependent molecular weight changes <strong>of</strong> k-casein glycomacropeptide <strong>and</strong> its preparation by ultrafiltration.Milchwissenschaft. 48:191-195.Kelleher, S.L.; Chatterton, D.; Nielsen, K. <strong>and</strong> Lonnerdal, B. (2003) Glycomacropeptide <strong>and</strong> α-lactalbuminsupplementation <strong>of</strong> infant formula affects growth <strong>and</strong> nutritional status in infantis rhesus monkeys. Am. J. Clin.Nutr. 77:1261-1268.Kulozik, U. <strong>and</strong> Guilmineau, F. (2003) Food process engineering <strong>and</strong> dairy technology at the Technical University <strong>of</strong>Munich. Int. J. <strong>Dairy</strong> Tech. 56:191-198.Manso, M. A. <strong>and</strong> Lopez-F<strong>and</strong>ino, R. (2003). Angiotensin I converting enzyme-inhibitory activity <strong>of</strong> bovine, ovine <strong>and</strong>caprine k-casein macropeptides <strong>and</strong> their tryptic hydrolyzates. J. Food Protection. 66:1686–1692.Martin-Diana, A. B.; Frias J. <strong>and</strong> Fontecha J. (2005) Emulsifying properties <strong>of</strong> whey protein concentrate <strong>and</strong>aseinomacropeptide <strong>of</strong> cow, ewe <strong>and</strong> goat. Milchwissenschaft. 60:363-366.Martín-Diana, A.B.; Gomez-Guillén, M.C.; Montero, P. <strong>and</strong> Fontecha, J. (2006) Viscoelastic properties <strong>of</strong>caseinmacropeptide isolated from cow, ewe <strong>and</strong> goat cheese whey. J. Sci. Food Agric. 86:1340-1349.Martín-Diana, A.B.; Pelaez, C. <strong>and</strong> Requena, T. (2003) Rheological <strong>and</strong> structural properties <strong>of</strong> fermented goat’s milksupplemented with caseinomacropeptide <strong>and</strong> whey protein concentrate. J. <strong>Dairy</strong> Sci. 86:1535-1540.Moreno, F.J.; López-F<strong>and</strong>iño, R. <strong>and</strong> Olano, A. (2002) Characterization <strong>and</strong> functional properties <strong>of</strong> lactosylcaseinomacropeptide conjugates. J. Agric. Food Chem. 50:5179-5184.Nakajima, K.; Tamura, N.; Kobayashi-Hattori, K.; Yoshida, T.; Hara-Kudo, Y.; Ikedo, M.; Sugita-Konishi, Y. <strong>and</strong> Hattori,M. (2005) Prevention <strong>of</strong> intestinal infection by Glycomacropeptide. Biosci. Biotechnol. Biochem. 69:2294-2301.Nakano, T. <strong>and</strong> Ozimek, L. (1998) Gel chromatography <strong>of</strong> glycomacropeptide (GMP) from sweet whey on SephacrylS-200 at different pH’s <strong>and</strong> on Sephadex G-75 in 6M guanidine hydrochloride. Milchwissenschaft. 53:629-632.Nakano, T. <strong>and</strong> Ozimek, L. (1999) Purification <strong>of</strong> glycomacropeptide from non-dialyzable fraction <strong>of</strong> sweet whey byanion exchange chromatography. J. Biotech. Tech. 13:739-742.Nakano, T. <strong>and</strong> Ozimek, L. (2000) Purification <strong>of</strong> glycomacropeptide from caseinate hydrolysate by gel chromatography<strong>and</strong> treatment with acidic solution. J. Food Sci. 65:588-590.Neeser, J.R.; Chambaz, A.; Vedovo, S.D.; Prigent, M.J. <strong>and</strong> Guggenheim, B. (1988a) Specific <strong>and</strong> nonspecific inhibition <strong>of</strong>adhesion <strong>of</strong> oral actinomyces <strong>and</strong> streptococci to erythrocytes <strong>and</strong> polystrene by caseinoglycopeptide derivatives.Infection <strong>and</strong> Immunity. 56:3201-3208.Oliva, Y., Escobar, A. <strong>and</strong> Ponce, P. (2002) Caseinomacropéptido bovino: una alternative para la salud. Rev. Salud Anim.24:73-81.Oh, S.; Worobo, R.D.; Kim, B.C.; Rheem, S. <strong>and</strong> Kim, S. (2000) Detection <strong>of</strong> cholera toxin binding activity <strong>of</strong> κ-caseinmacropeptide <strong>and</strong> optimization <strong>of</strong> its production by the response surface methodology. Biosci. Biotechnol. Biochem.64:516-522.Otani, H. <strong>and</strong> Monnai, M. (1993) Inhibition <strong>of</strong> proliferative responses <strong>of</strong> mouse spleen lymphocytes by bovine milkk-casein digests. Food <strong>and</strong> Agricultural Immunology. 5:219-229.Otani, H.; Monnai, M. <strong>and</strong> Hosono, A. (1992) Bovine κ-casein as inhibitor <strong>of</strong> the proliferation <strong>of</strong> mouse splenocytesinduced by lipopolysaccharide stimulation. Milchwissenschaft. 47:512-515.Rigo, J.; Boehm, G.; Georgi, G.; Jelinek, J.; Nyambugabo, K.; Sawatzki, G. <strong>and</strong> Studzinski, F. (2001). An infant formulafree <strong>of</strong> glycomacropeptide prevents hyperthreoninemia in formula-fed preterm infants. J. Pediatr. GastroenterolNutr. 32:127–130.Saito, T.; Yamaji, A. <strong>and</strong> Itoh, T. (1991) A new isolation method <strong>of</strong> caseinoglycopeptide from sweet cheese whey. J. <strong>Dairy</strong>Sci. 74: 2831-2837.Simon, P.M. (1996) Pharmaceutical oligosaccharides. Drug Discovery Today. 1:522-528.Thomä-Worringer, C.; Sorensen, J. <strong>and</strong> López-F<strong>and</strong>inõ, R. (2006) Health effects <strong>and</strong> technological features <strong>of</strong>caseinomacropeptide. Int. <strong>Dairy</strong> J. 16: 1324-1333.Tolkach, A. <strong>and</strong> Kulozik, U. (2005) Fractionation <strong>of</strong> whey proteins <strong>and</strong> caseinomacropeptide by means <strong>of</strong> enzymaticcrosslinking <strong>and</strong> membrane separation techniques. J. Food Eng. 67: 13-20.Tullio, L. T.; Karkle, E. N. L. <strong>and</strong> C<strong>and</strong>ido, L.M.B. (2007) Review: Isolation <strong>and</strong> Purification <strong>of</strong> Milk WheyGlycomacropeptide. B. CEPPA. 25:121-132.Wang, B.; Br<strong>and</strong>-Miller, J.; McVeagh, P. <strong>and</strong> Petocz, P. (2001). Concentration <strong>and</strong> distribution <strong>of</strong> sialic acid in humanmilk <strong>and</strong> infant formulas. Am. J. Clin. Nutr. 74:510-515.Wang, B.; Staples, A.; Sun, Y.; Karim, M. <strong>and</strong> Br<strong>and</strong>-Miller, J. (2004). Effect <strong>of</strong> dietary sialic acid supplementation onsaliva content in piglets. Asia <strong>and</strong> Pacific J. Clin. Nutr. 13:75.Wong, P.Y.Y.; Nakamura, S. <strong>and</strong> Kitts, D.D. (2006) Functional <strong>and</strong> biological activities <strong>of</strong> casein glycomacropeptide asinfluenced by lipophilization with medium <strong>and</strong> long chain fatty acid. Food Chem. 97:310-317.Xu, Y.; Sleigh, R.; Hourigan, J. <strong>and</strong> Johnson, R. (2000) Separation <strong>of</strong> bovine immunoglobulin G <strong>and</strong> glycomacropeptidefrom dairy whey. Process Biochem. 36:393-399.Yvon, M.; Beucher, S.; Guilloteau, P.; Huerou-Luron, I.L. <strong>and</strong> Corring, T. (1994) Effects <strong>of</strong> caseinomacropeptide (CMP)on digestion regulation. Reprod. Nutr. Dev. 34:527-537.53


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assurance54New Approaches to Detect the Adulteration <strong>of</strong> Gheewith Animal Body Fats <strong>and</strong> Vegetable Oils/ FatsIntroductionVivek Sharma, Darshan Lal, Arun Kumar <strong>and</strong> Amit Kumar<strong>Dairy</strong> Chemistry Division, NDRI, KarnalGhee is the most widely used milk product in the Indian sub- continent. It is a valuable source <strong>of</strong>fat-soluble vitamins <strong>and</strong> essential fatty acids, apart from having rich <strong>and</strong> pleasant sensory attributes.Due to its increased dem<strong>and</strong>, cost <strong>and</strong> variable chemical composition, the unscrupulous people gettempted to adulterate it with cheaper foreign fats like vegetable oils ⁄ fats <strong>and</strong> animal body fats, etc.,which is an unethical practice. Earlier, ghee used to be adulterated with foreign oils <strong>and</strong> fats, <strong>and</strong>accordingly several methods were developed for detection <strong>of</strong> adulteration in ghee. These methodswere based on differences in the nature <strong>and</strong> contents <strong>of</strong> major/minor components <strong>of</strong> ghee <strong>and</strong>adulterant fats/oils. Methods presently used for detecting foreign fats in milk fat are mainly based onthe physico-chemical constants, fatty acid pr<strong>of</strong>ile, sterol analysis, <strong>and</strong> partial solidification behavior.However, all these methods fail when milk fat is adulterated with a mixture <strong>of</strong> body fats <strong>and</strong> vegetableoils. In addition to this, now a days tailored vegetable oils with R.M/ P.V <strong>and</strong> B.R close to that <strong>of</strong> milkfat are available to the unscrupulous people in the unspecified market for adulteration purposes. Tocounter this approach some new methods have been developed, though these methods are also notfool pro<strong>of</strong>, but can be h<strong>and</strong>y in the testing laboratories.MethodologyThere are two approaches for the detection <strong>of</strong> adulteration <strong>of</strong> milk fat. First approach is based onthe classical methods like B.R reading, R.M- value, P.V – value, Phytosterol acetate test, Gas – liquidchromatographic analysis. Second approach is based on some innovative <strong>and</strong> rapid methods likefurfural test for vanaspati, Opacity test, crystallization test, Number <strong>of</strong> carbons by GLC <strong>of</strong> triglycerides, color based test for vegetable oil detection, apparent solidification time test <strong>and</strong> complete liquificationtime test. In all the cases, tests are applied on the extracted fat, accept the modified Gerber test, whereaspecially designed dual purpose Gerber butyrometer is used <strong>and</strong> B.R reading <strong>of</strong> the fat is measured.Hence, the first step is to isolate the fat <strong>and</strong> then apply the test (Kumar et al, 2002). In this article thefollowing methods have been discussed.1. Detection <strong>of</strong> animal body fats <strong>and</strong> vegetable oils/fats by the Opacity TestMelt the sample <strong>of</strong> fat (5 gm) isolated by heat clarification method at 50 +1ºC in a test tube <strong>and</strong>maintain for 3 min to equilibrate. Then transfer the test tube at 23 + 0.2ºC water bath <strong>and</strong> record theopacity time (Time taken by fat sample to acquire either O.D. at 570 nm between 0.14-0.16 or Klettreading using red filter between 58-62 after adjusting the instrument to 100% transmittance). Theopacity time <strong>of</strong> pure buffalo ghee is 14-15 min, cow ghee is 18-19 min <strong>and</strong> that <strong>of</strong> ghee from cotton tractarea is 11-12 min. The opacity time <strong>of</strong> buffalo ghee adulterated at 10% level with vanaspati is 10-11min, with pig body fat is 8-9 min, with buffalo body fat is 2-3 min, with cow body fat is 3-4 min <strong>and</strong>with refined oils is 20-25 min (Singhal, 1980).2. Detection <strong>of</strong> vanaspati in gheeIsolate the fat from milk by heat clarification method. Take about 5 g <strong>of</strong> the melted fat in a testtube. Add 5 ml <strong>of</strong> concentrated HCl. Add 0.4 ml furfural solution (2% in alcohol) <strong>and</strong> shake the tubethoroughly for 2 min. Allow the mixture to separate. The development <strong>of</strong> pink or red colour in the acidlayer indicates presence <strong>of</strong> vanaspati. Confirm by adding 5 ml distilled water <strong>and</strong> shaking again. If thecolour in acid layer persists, vanaspati is present. If the colour disappears, it is absent [SP:18 (1987)].3. Detection <strong>of</strong> vegetable oils by B.R. ReadingClean the prisms <strong>of</strong> the Butyro-refractometer with petroleum ether. Allow the ether to evaporate


New Approaches to Detect the Adulteration <strong>of</strong> Ghee with Animal Body Fats <strong>and</strong> Vegetable Oils/ Fatsto dryness. Maintain temperature <strong>of</strong> the prisms at 40ºC by circulating water. Calibrate the B.R.apparatus by applying a drop <strong>of</strong> fluid <strong>of</strong> known B.R. <strong>and</strong> adjusting B.R. by moving the adjustmentscrew. Clean the prisms. Apply a drop <strong>of</strong> sample <strong>of</strong> clear fat obtained by any <strong>of</strong> the three methodsbetween the prisms. Wait for 2 min before taking the reading so that sample should attain the constanttemperature <strong>of</strong> about 40ºC.B.R. reading decreases <strong>and</strong> increases with the rise <strong>and</strong> fall <strong>of</strong> temperature, respectively. Normally,the temperature <strong>of</strong> observation should not deviate by more than 2ºC. A correction <strong>of</strong> 0.55 is added tothe observed B.R. reading for each degree above 40ºC or subtracted for each degree below 40ºC to getcorrected B.R. reading <strong>of</strong> the sample.If fat is isolated by the Gerber method, B.R. is depressed due to hydrolytic effect <strong>of</strong> H 2SO 4on thefat. Therefore, observed B.R. reading is corrected as follows:Corrected B.R. = 1.08 x observed B.R.B.R. reading <strong>of</strong> milk fat isolated by one <strong>of</strong> the above mentioned methods should be consistentwith the values given for ghee as per PFA requirement. Any deviation from the st<strong>and</strong>ard valueindicates adulteration <strong>of</strong> milk with vegetable oils. However, this method has limitation <strong>of</strong> detection<strong>of</strong> adulteration with two oils i.e. coconut oil <strong>and</strong> palm oil whose values are close to that <strong>of</strong> milk fat(Arora et al, 1996).4. Detection <strong>of</strong> animal body fats <strong>and</strong> vegetable oils by crystallization testTake 0.8 ml <strong>of</strong> melted fat in a stoppered test tube (10 x 1.0 cm internal diameter). Add 2.5 ml <strong>of</strong>solvent mixture consisting <strong>of</strong> acetone <strong>and</strong> benzene (3.5:1.0). Mix the contents slowly. Place the testtube in a water bath maintained at 20ºC for 3 min to equilibrate the temperature. Then transfer thetube in another water bath maintained at 17 + 0.2ºC till the onset <strong>of</strong> crystallization. Note the time foroccurrence <strong>of</strong> crystallization. The crystallization time <strong>of</strong> pure buffalo ghee is 18-20 min <strong>and</strong> that <strong>of</strong>cotton tract ghee is 10.5-12.5 min, whereas that <strong>of</strong> buffalo ghee adulterated at 10% level with pig bodyfat is 11.5-12.5 min, with cow body fat 4.5-5.5 min <strong>and</strong> buffalo body fat 3.0-4.0 min, <strong>and</strong> with vegetableoils is 26 to 36 min (P<strong>and</strong>a, 1996).5. Detection <strong>of</strong> adulteration <strong>of</strong> vegetable oils in ghee by iodine valueIodine value, which is a measure <strong>of</strong> extent <strong>of</strong> unsaturation <strong>of</strong> fat, can be determined by the Wij’smethod as described in SP:18 (Part XI)1981. This property is particularly useful for detection <strong>of</strong>adulteration in ghee with vegetable oils, as these oils have higher iodine values than milk fat <strong>and</strong> bodyfats. It can be measured, as follows:Accurately 0.4 g <strong>of</strong> sample is weighed in a clean <strong>and</strong> dry iodine flask <strong>and</strong> is dissolved in 15 ml <strong>of</strong>carbon tetrachloride. Then 25 ml <strong>of</strong> the Wij’s reagent are added <strong>and</strong> the flask is stoppered. The contentsare then mixed <strong>and</strong> kept in dark for one hour. After one hour, 20 ml <strong>of</strong> 10 per cent potassium iodidesolution <strong>and</strong> about 150 ml <strong>of</strong> distilled water are added to the iodine flask <strong>and</strong> mixed. The contents aretitrated against 0.1 N sodium thiosulphate solution using starch solution as an indicator. A blank testis also carried out using the same quantities <strong>of</strong> the reagents. From this, the iodine value is calculatedas follows:Iodine <strong>Value</strong> = 12.69 (B – S) N / WWhere;B = Vol. (in ml) <strong>of</strong> st<strong>and</strong>ard sodium thiosulphate solution required for the blankS = Volume (in ml) <strong>of</strong> st<strong>and</strong>ard sodium thiosulphate solution required for the sampleN = Normality <strong>of</strong> the st<strong>and</strong>ard sodium thiosulphate solution, <strong>and</strong>W = Weight (in g) <strong>of</strong> the sample taken for the testThe iodine values for cow <strong>and</strong> buffalo pure ghee ranges between 30.12 to 40.26. Any deviationfrom these values indicates adulteration (Kumar, 2008).55


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assurance6. Detection <strong>of</strong> adulteration by apparent solidification time (AST) test.The apparent solidification time (AST) <strong>of</strong> the fat sample is defined as the time taken by the meltedfat sample to get solidified apparently at a particular temperature. The test can be carried out as:Take 3.0 gm <strong>of</strong> completely melted fat sample in a test tube (10 × 1.0 cm ID) <strong>and</strong> maintain at 60°C for5 min. Transfer the test tube in a refrigerated water bath maintained at 18 ± 0.2°C <strong>and</strong> simultaneouslystart the stop watch. Observe the test tube constantly till the apparent solidification <strong>of</strong> the fat sampletakes place which is confirmed by non- movement <strong>of</strong> fat sample on tilting the test tube. At this stagestop the stopwatch <strong>and</strong> record the time taken for the apparent solidification <strong>of</strong> the fat. Pure gheesample <strong>of</strong> both cow <strong>and</strong> buffalo shows AST in the range <strong>of</strong> 2 min 31 sec to 3 min 25 sec. Any deviationfrom these values gives an indication <strong>of</strong> adulteration <strong>of</strong> milk fat (Kumar, 2009)7. Detection <strong>of</strong> adulteration using dry fractionation technique coupled with ASTBy employing dry fractionation technique, the different fractions enriched with body fats orvegetable oils are obtained <strong>and</strong> subsequently used to estimate AST. The aim is to enrich the solidfraction with animal body fats <strong>and</strong> liquid fraction with vegetable oils. Vanaspati, if added, will also befractionated along with animal body fats.Take 100 gm <strong>of</strong> clarified melted fat <strong>and</strong> keep it in a BOD incubator maintained at 20 ± 0.1°C. Afterabout 1.50 to 1.75 h <strong>of</strong> incubation, approximately one third <strong>of</strong> the whole fat gets solidified. Separate thesolid fraction (S 20) from the remaining liquid portion by filtration inside a BOD incubator maintained at20 ± 0.1°C. Further fractionate the liquid portion thus obtained in another BOD incubator maintainedat 18 ± 0.1°C. for 2 hr so as to obtain another solid (S 18) <strong>and</strong> liquid (L 18) fraction by filtering inside aBOD incubator maintained at 18 ± 0.1°C. Analyze S 20, S 18<strong>and</strong> L 18fractions <strong>of</strong> ghee for AST as describedabove. S 20, S 18<strong>and</strong> L 18fractions <strong>of</strong> pure ghee <strong>of</strong> both cow <strong>and</strong> buffalo show AST values <strong>of</strong> 1 min 40sec to 2 min 50 sec; 2 min 30 sec to 3 min 40 sec <strong>and</strong> 2 min 50 sec to 3 min 50 sec, respectively. Anydeviation from these values gives an indication <strong>of</strong> adulteration (Kumar, 2003).8. Detection <strong>of</strong> adulteration by complete liquification time (CLT) testThe complete liquification time (CLT) test <strong>of</strong> the fat sample is defined as the time taken by thesolidified fat sample to get melted completely at a particular temperature. The test can be performed,as follows:Take 3.0 gm <strong>of</strong> completely melted fat sample in a test tube (10 × 1.2 cm) <strong>and</strong> maintain at 60°C for 5min. Keep the test tube containing fat sample in a refrigerator (6- 8ºC) for 45 min for solidification <strong>of</strong> themelted fat sample. Transfer the test tube in a water bath maintained at 44 ± 0.1ºC <strong>and</strong> simultaneouslystart the stop watch. Observe the test tube constantly till the fat sample is completely liquefied. Atthis stage stop the stopwatch <strong>and</strong> record the time taken for complete liquification <strong>of</strong> the fat. Pure gheesample <strong>of</strong> both cow <strong>and</strong> buffalo shows CLT in the range <strong>of</strong> 2 min 12 sec to 3 min 15 sec. Any deviationfrom these values gives an indication <strong>of</strong> adulteration <strong>of</strong> milk fat (Kumar, 2008).9. Detection <strong>of</strong> adulteration using solvent fractionation technique coupled with CLT <strong>and</strong> Iodine valueUsing solvent fractionation technique, the different fractions enriched with body fats or vegetableoils can be obtained <strong>and</strong> used subsequently to estimate CLT. Here also, the aim is to concentrateanimal body fats in to solid fraction <strong>and</strong> vegetable oils into liquid fraction. Vanaspati, if added, willalso be concentrated in solid fraction along with animal body fats.Take 30 gm <strong>of</strong> melted ghee sample in a 100 ml graduated glass tube, <strong>and</strong> then add 60 ml acetone<strong>and</strong> mix well to dissolve the fat. After mixing, keep the sample at 40°C for equilibration for 5 min. Thensubject the sample in a refrigerated water bath to three temperatures/time combinations, viz., 16 ±0.1°C/25 min, 8 ± 0.1°C/25 min <strong>and</strong> 4 ± 0.1°C/60 min, successively, after filtration at each stage <strong>of</strong> time/temperature combination. After about 25 min at 16 ± 0.1°C, approximately one-fourth <strong>of</strong> the wholefat gets solidified. This first solid fraction (S 16) obtained at 16 ± 0.1°C is separated from the remainingliquid portion (L 16) <strong>of</strong> the whole fat by filtration through ordinary filter paper. The remaining liquidportion (L 16) thus obtained after filtration is further fractionated at 8 ± 0.1°C. in refrigerated water bath.56


New Approaches to Detect the Adulteration <strong>of</strong> Ghee with Animal Body Fats <strong>and</strong> Vegetable Oils/ FatsAfter about 25 min, it gets partitioned into two fractions, one solid (S 8) <strong>and</strong> one liquid (L 8), which canbe separated by filtration through ordinary filter paper. At last, L 8fraction is further fractionated at4 ± 0.1°C for 60 min <strong>and</strong> filtered to get two fractions, one solid (S 4) <strong>and</strong> one liquid (L 4). Finally at theend <strong>of</strong> fractionation, three solid fractions (S 16, S 8<strong>and</strong> S 4) <strong>and</strong> one liquid fraction (L 4) are obtained fromghee sample containing a mixture <strong>of</strong> adulterants. Solvent from liquid fraction is removed by usingrotary evaporator at about 40ºC, followed by nitrogen flushing to evaporate solvent completely fromthe liquid fraction. To get rid <strong>of</strong> entrapped acetone, respective solid fractions are heated to 110ºC forabout 2 hr in an oven.(a) <strong>Analysis</strong> <strong>of</strong> first fraction (S 16) for CLT at 46ºCAnalyse S 16fraction for CLT at 46 ± 0.1ºC (instead <strong>of</strong> 44± 0.1ºC used for CLT <strong>of</strong> whole fat) asdescribed above. CLT values <strong>of</strong> S 16fraction at 46ºC range between 4 min 5 sec to 9 min for both cow<strong>and</strong> buffalo pure ghee. Any deviation from these values gives an indication <strong>of</strong> adulteration <strong>of</strong> milk fat(Kumar, 2008).(b) <strong>Analysis</strong> <strong>of</strong> last fraction (L 4) for Iodine valueAnalyse L 4fraction for iodine value as described above. The iodine values for L 4fraction <strong>of</strong> purecow <strong>and</strong> buffalo ghee are found to vary between 37.85- 46. 48. Any deviation from these values givesan indication <strong>of</strong> adulteration <strong>of</strong> milk fat (Kumar, 2008).10. Detection <strong>of</strong> liquid paraffin in milk fatIsolate the fat from milk by heat clarification method as described above. Saponify 1 g <strong>of</strong> fat takenin a test tube with 5 ml <strong>of</strong> 0.5 N ethanolic KOH solutions by heating on direct flame, using wire gaugefor 5 min. Add about 5 ml <strong>of</strong> distilled water to the hot saponified solution. Appearance <strong>of</strong> turbidityindicates the presence <strong>of</strong> mineral oil (Kumar, 2005)11. Rapid color based test for detection <strong>of</strong> vegetable oilsOne ml <strong>of</strong> clear molten fat was dissolved with 1.5 ml <strong>of</strong> hexane in a tightly capped test tube. To thiswas added 1.0 ml <strong>of</strong> color developing reagent (distilled water, Sulphuric acid - Sp.gr.1.835 <strong>and</strong> Nitric acid- Sp. gr. 1.42 in the ratio <strong>of</strong> 20:6:14), shaken vigorously <strong>and</strong> kept undisturbed till it is separated into twolayers. The appearance <strong>of</strong> a distinct orange tinge in the upper layer indicates the presence <strong>of</strong> vegetableoils / fats including vanaspati (Sharma et al., 2007).12. Detection <strong>of</strong> adulteration <strong>of</strong> rice bran oil in gheeRice bran oil contains gamma oryzanol, which can be used as a marker for the detection <strong>of</strong> its additionto ghee. It can be done by thin layer chromatographic method as well as colorimetric method.a) Thin layer chromatographic methodA simple thin layer chromatographic method can be employed to detect the adulteration <strong>of</strong> gheewith rice bran oil, as follows:Gamma oryzanol is extracted from 10.0 gm <strong>of</strong> molten fat using 20.0 ml <strong>of</strong> a solvent systemconsisting <strong>of</strong> methanol: water (9:1). The contents are vortexed for 2 min <strong>and</strong> centrifuged at 2000 rpm. /10 min. The alcohol layer is drawn. Extraction protocol is repeated thrice <strong>and</strong> all the alcoholic extractsare combined <strong>and</strong> evaporated at 60 – 70°C in a rotary evaporator. The residue is finally dried. Thedried residue is redissolved in 0.5 ml <strong>of</strong> developing solvent (toluene: ethyl acetate: methanol 90:8:2;v/v) <strong>and</strong> 5-10 µl were applied on silica gel TLC plate <strong>and</strong> plates are developed in the developingsolvent. Properly developed plates are removed from the chamber <strong>and</strong> air dried followed by sprayingwith color developing reagent (50% sulfuric acid) <strong>and</strong> heating at 120°C/ 10 - 15 min. Presence <strong>of</strong> thegamma oryzanol b<strong>and</strong> confirms the adulteration <strong>of</strong> rice bran oil in milk fat. Addition <strong>of</strong> rice bran oil inghee at 5% level is easily detected by this method. (Kumar, et al., 2008).b) Colorimetric methodTake 1ml <strong>of</strong> melted ghee sample in a dry test tube. Add 1.5 ml <strong>of</strong> hexane to dissolve the fat. Then,in sequence, add 0.5 ml <strong>of</strong> dilute (25%) hydrochloric acid <strong>and</strong> 0.5 ml <strong>of</strong> 5% sodium nitrite solution57


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assurance<strong>and</strong> mix, followed by the addition <strong>of</strong> 1 ml <strong>of</strong> 10% sodium hydroxide solution. Rice bran oil producesorange-red color while other vegetable oils produce no color. Hence, this method is specific for thedetection <strong>of</strong> rice bran oil in ghee. As low as 2% rice bran oil added in ghee, can be detected by thismethod.13. Detection <strong>of</strong> beef body fat <strong>and</strong> margarine in butterfat by differential scanning calorimetry:In this case melting <strong>and</strong> crystallization curves <strong>of</strong> different fats are studied by cooling fats from70°C to - 40°C ( Aktas <strong>and</strong> Kaya, 2001). Based on new endothermic peak, more than 10 percent goatbody fat in ghee could be detected qualitatively with the help <strong>of</strong> melting diagram <strong>and</strong> determinedquantitatively from crystallization diagram. The method, however, failed to detect coconut oil, cottontract ghee <strong>and</strong> other animal body fats.14. Temperature controlled attenuated total reflectance- mid- infrared (ATR-MIR) spectroscopy:This is a spectroscopic technique used for the rapid estimation <strong>of</strong> butter adulteration. Themethodology is typically based on the infra red spectroscopic technique ( Koca et al., 2010). Theseworkers collected the Fourier transform infrared spectra <strong>of</strong> the samples between 4000 <strong>and</strong> 650 cm -1 ona FTIR spectrophotometer. Here the temperature was controlled, which allowed the stabilization <strong>of</strong>analysis temperature at 65± 2°C. The data was analyzed by using statistical tool namely Multivariatedata analysis <strong>and</strong> calibration models were developed covering all possible adulteration ratios. In thiscase adulteration <strong>of</strong> butter with margarine @ 2.5% could be predicted.15. Tryacyl glycerol analysis by evaporative light scattering detection (ELSD):This method is an HPLC method where major <strong>and</strong> minor triglyceride species could be sparated in 33min using reverse phase C 18column, ELSD <strong>and</strong> mbile pahse ( Dichloromethane: Acetonitrile) in a gradientmode.16. <strong>Analysis</strong> <strong>of</strong> triglycerides by GLC:This method is based on the principle <strong>of</strong> specific distribution <strong>of</strong> fatty acid moieties on the glycerolbackbone. Tryglycerides <strong>of</strong> 28 - 54 carbons are identified <strong>and</strong> quantified. The data generated is analysedby using multi variant analysis. The detection limit varied according to the source <strong>of</strong> fat added <strong>and</strong>found to be < 10% ( Gutierrez et al., 2009).References:Aktas.N <strong>and</strong> Kaya.M ( 2001) Detection <strong>of</strong> beef body fat <strong>and</strong> margarine in butter fat by differential scanning calorimetry.Journal <strong>of</strong> Thermal <strong>Analysis</strong> <strong>and</strong> calorimetry. 66. 795- 801.Arora, K.L.; Lal. D, Seth. R <strong>and</strong> Ram, J. (1996). Platform Test for detection <strong>of</strong> refined mustard oil adulteration in milk.Indian Journal <strong>of</strong> <strong>Dairy</strong> Sci., 49(10): 721-723.Gutierrez.R; Vega.S; Daiz. G; Sanchez.J; Coronado.M; Ramirez.A; Perez.J; Gonzalez.M <strong>and</strong> Schettino.B ( 2009) Detection<strong>of</strong> non milk fat by gas chromatography <strong>and</strong> linear discriminate analysis. J. <strong>Dairy</strong> Sci. 92: 1846- 1855.ISI (1981). H<strong>and</strong>book <strong>of</strong> Food <strong>Analysis</strong>. IS: SP:18, Part XI. <strong>Dairy</strong> <strong>Products</strong>. Bureau <strong>of</strong> Indian St<strong>and</strong>ards, New Delhi.Koca.N; Kocaogulu-Vurma.N.A; Harper.W.J; Rodriguez-Saona. L.E ( 2010) Application <strong>of</strong> temperature controlledattenuated total reflectance – mid- infrared (ATR-MIR) spectroscopy for rapid estimation <strong>of</strong> dutter adulteration.Food Chemistry. 121: 778- 782.Kumar.A; Lal.D; Seth.R <strong>and</strong> Sharma.R (2002) Recent trends in detection <strong>of</strong> adulteration in milk fat – A Review. IndianJ <strong>Dairy</strong> Sci., 55 (6): 319 - 330.Kumar. A, Lal, D, Seth, R <strong>and</strong> Sharma. V (2005) Turbidity test for detection <strong>of</strong> liquid paraffin in ghee. Indian J <strong>Dairy</strong>Sci., 58 (4): 298.Kumar. A; Sharma. V <strong>and</strong> Lal.D (2008) Development <strong>of</strong> a thin layer chromatography based method for the detection <strong>of</strong>rice bran oil as an adulterant in ghee. Ind. Journal . <strong>Dairy</strong> Sci. 61,2: 113 – 115.Kumar. Amit; (2008) Detection <strong>of</strong> adulterants in ghee. Ph. D thesis submitted to NDRI, Karnal (Deemed University).Kumar. A; Ghai, D. L; Seth, R <strong>and</strong> Sharma, V (2009) Apparent solidification time test for detection <strong>of</strong> foreign oils <strong>and</strong>fats adulterated in clarified milk fat, as affected by season <strong>and</strong> storage. International J . <strong>Dairy</strong> Tech. 62: 33 –38.Lal, D.; Seth, R.; Arora, K.L. <strong>and</strong> Ram, J. (1998) Detection <strong>of</strong> vegetable oils in milk. Indian <strong>Dairy</strong>man., 50(7): 17-18.P<strong>and</strong>a, D.K. (1996). Detection <strong>of</strong> adulteration <strong>of</strong> foreign fats in milk fat. M.Sc. thesis, submitted to N.D.R.I. DeemedUniversity, Karnal.Sharma. V; Lal, D <strong>and</strong> Sharma. R. (2007) Color based platform test for the detection <strong>of</strong> vegetable oils/fats in ghee. Ind.Journal . <strong>Dairy</strong> Sci. 60,1: 16 – 18.Singhal, O.P. (1980). Adulteration & Methods for detection. Indian <strong>Dairy</strong>man, 32: 771-774.SP:18 (1987). H<strong>and</strong>book <strong>of</strong> Food <strong>Analysis</strong> Part XI, <strong>Dairy</strong> <strong>Products</strong>. Bureau <strong>of</strong> Indian St<strong>and</strong>ards, Manak Bhawan, NewDelhi.58


Colostrum Powder <strong>and</strong> its Health BenefitsIntroductionColostrum Powder <strong>and</strong> its Health BenefitsRaman Seth <strong>and</strong> Anamika Das<strong>Dairy</strong> Chemistry Division, NDRI, KarnalSince the time immemorial, man has sought some alternative methods to enhance <strong>and</strong> improve theimmune system <strong>of</strong> human body in order to fight against diseases. Historically, Ayurvedic physicianshave used bovine colostrum for therapeutical application in Asia, particularly in India for thous<strong>and</strong>s <strong>of</strong>years. Increased awareness <strong>of</strong> the diet - health relationship in many countries has stimulated a trend innutrition science whereby more attention is given to the health effects <strong>of</strong> individual foods. Colostrumis the first lacteal secretion from the mammary gl<strong>and</strong>s after parturition during the first 24-72 hours.Colostrum is a complex fluid rich in nutrients <strong>and</strong> is also characterized by its high level <strong>of</strong> bioactivecomponents e.g. immunoglobulins (Igs), particularly IgG1, growth factors, i.e. insulin like growthfactors-1, transforming growth factor β2 <strong>and</strong> growth hormone in addition to lact<strong>of</strong>errin, lysozyme <strong>and</strong>lactoperoxidase. Because <strong>of</strong> its poor heat stability, colostrum is an under utilized product in the dairyindustry. Heat processing may affect the functionality <strong>of</strong> bioactive components present in colostrum.Knowledge concerning the influence <strong>of</strong> processing <strong>and</strong> isolation procedures on bioactive compoundsin colostrum based products is, however, limited. Due to less heat stability <strong>of</strong> colostrum, its additionin raw milk affects further processing. Colostrum addition to milk causes elevated protein <strong>and</strong> mineralcontent which might render milk unsuitable for certain dairy processing operations such as UHTor milk powder production. But, during the past three decades, there has been increased interest inhuman consumption <strong>of</strong> bovine colostrum or its supplemented products based on the prophylactic <strong>and</strong>immuno-therapeutic benefits <strong>of</strong> absorbed immunoglobulin especially IgG Thus, colostrum has beenprocessed into products designed for pharmaceutical <strong>and</strong> nutraceutical purposes which provide theconsumer with an identified health benefit over basic nutritional value. Internationally, colostrumderivedproducts have become valuable niche products <strong>and</strong> are currently being sold into highlycompetitive markets with current focus on protein components because <strong>of</strong> their physiological effects<strong>and</strong> hence their commercial value.Processes involved in drying <strong>of</strong> colostrum powderLow-heat pasteurizationThe high-heat pasteurization <strong>and</strong> drying processes used by many producers <strong>of</strong> colostrum powderscan denature the sensitive PRPs <strong>and</strong> IgG proteins in colostrum. Only low-heat flash pasteurization<strong>and</strong> low-heat indirect drying can be used to preserve the efficacy <strong>and</strong> bioactivity <strong>of</strong> colostrum. Usingflash pasteurization (161ºF or 72ºC for 15 seconds) all potentially harmful pathogens are removed,while immunoglobulins <strong>and</strong> other biologically important proteins retain their bioactivity.Low-pressure processingSimilar to high-heat processing, high-pressure processing <strong>of</strong> colostrum will denature proteins <strong>and</strong>reduce the bioactivity <strong>of</strong> the finished product. So low pressure processing is applied to manufacturecolostrum powder.Indirect steam dryingColostrum is spray dried using indirect steam <strong>and</strong> with low pressure <strong>and</strong> temperatures (less than145°F or 63ºC) to produce a high quality powder while protecting the colostral proteins. Toxic nitrogenoxides components produced in direct fired dryers used by other manufacturers are not produced inindirect steam dryer.Freeze drying (lyophilization)Freeze-drying (lyophilization) has been one <strong>of</strong> the most useful methods for producing high qualitycolostrum powder from colostrum. However, lyophilization has high capital <strong>and</strong> process costs. Freeze-59


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assurancedrying works by freezing colostrum <strong>and</strong> then reducing the surrounding pressure <strong>and</strong> adding enoughheat to allow the frozen water in the material to sublime directly from the solid phase to the gasphase.Composition <strong>of</strong> colostrum powderOften colostrum powder is priced on the basis <strong>of</strong> IgG content. St<strong>and</strong>ardized colostrum powdersare available having 10 <strong>and</strong> 40 percent IgG levels <strong>and</strong> from 45 to 80 percent minimum protein levels.Typical composition <strong>of</strong> colostrum powder is as depicted belowImmune factorsImmunoglobulinsImmunoglobulins (Igs) are a family <strong>of</strong> globular proteins with antimicrobial <strong>and</strong> other protectivebioactivities. They exist at different concentrationsin milk <strong>and</strong> colostrum. Qualitative <strong>and</strong> quantitativedifferences are dependent on species, <strong>and</strong> arefound in various isotypes, with immunologicalactivities that are dependent on the Ig class. TheIgs are the principal agents that protect the gutmucosa against pathogenic microorganisms. IgG<strong>Chemical</strong> CompositionMoistureFatProteinLactoseAsh4-5%0.5-1.5%55-80%15-23%5-7%antibodies express multifunctional activities,IgG 14-55%including complement activation, bacterialPhysical propertiesopsonisation <strong>and</strong> agglutination, <strong>and</strong> act byColourCreamy, yellowbinding to specific sites on the surfaces <strong>of</strong> mostinfectious agents or products, either inactivatingAppearanceFree fl owing spray driedpowderthem or reducing infection. In bovine colostrumBulk Density0.4 – 0.5 g/ml (when packed)<strong>and</strong> milk, immunoglobulin G (IgG; subclassesIgG1 <strong>and</strong> IgG2) is the major immune component,Sediment(25 g)A Discalthough low levels <strong>of</strong> IgA <strong>and</strong> IgM are also Microbiological propertiespresent IgG1 constitutes approximately 80%<strong>of</strong> the total Ig content <strong>of</strong> bovine milk. IgG is amonomeric glycoprotein consisting <strong>of</strong> two heavy(long) polypeptide chain <strong>of</strong> 53 KDa <strong>and</strong> twolight (short) polypeptide chains <strong>of</strong> 23 KDa thatare linked by disulfide bonds. The polypeptidechains contain both constant (Fc) <strong>and</strong> variable(Fab) regions <strong>of</strong> amino acid sequence, withthe antigen-binding sites located in the FabN-terminal region.St<strong>and</strong>ard Plate Count(1 g)Coliforms (1 g)Coagulase +ve S.aureus (1 g)Salmonella (25 g)Yeast <strong>and</strong> moulds (1 g)E. coli (1 g)Listeria Species (25 g)


Colostrum Powder <strong>and</strong> its Health Benefitslact<strong>of</strong>errin (68%) <strong>and</strong> human transferrin (60%) another iron-binding protein predominantly present inserum. Lact<strong>of</strong>errin has been shown to inhibit the growth <strong>of</strong> several microbes, including E.coli, Salmonellatyphimurium, Shigella dysenteria, Listeria monocytogenes ,Streptococcus mutans, Bacillus stearothermophilus<strong>and</strong> Bacillus subtilis. In a recent study it was shown that human <strong>and</strong> bovine lact<strong>of</strong>errin <strong>and</strong> theirN-terminal peptides were germicidal against Giardia lamblia in vitro. It has been proposed that theantimicrobial effect <strong>of</strong> lact<strong>of</strong>errin is based on its capacity to bind iron, which is essential for the growth<strong>of</strong> bacteria.. Lact<strong>of</strong>errin exerts its antimicrobial activity by modifying bacterial cell membranes. Inaddition to its antibacterial activity, lact<strong>of</strong>errin has antiviral effects against herpes simples virus type-l(HSV-1) human immunodeficiency virus-l (HIV-l) <strong>and</strong> human cytomegalovirus in vitro. Lact<strong>of</strong>errinplays a role in iron uptake in the intestine. <strong>and</strong> the activation <strong>of</strong> phacocytes <strong>and</strong> immune responses.Receptors for lact<strong>of</strong>errin are found on intestinal tissues, monocytes, macrophages, neutrophils,lymphocytes, platelets <strong>and</strong> on some bacteria .Studies have shown that lact<strong>of</strong>errin can bind DNA <strong>and</strong>activate transcription, which might explain the molecular basis <strong>of</strong> growth regulation.LysozymeLysozyme is a well-known antibacterial <strong>and</strong> lytic enzyme present in many mammalian bodyfluids, including colostrum. The concentration <strong>of</strong> lysozyme in colostrum <strong>and</strong> in normal milk is about0.14-0.7 <strong>and</strong> 0.07-0.6 mg/L, respectively. The natural substrate <strong>of</strong> the enzyme is the peptidoglycanlayer <strong>of</strong> the bacterial cell wall <strong>and</strong> its degradation results in lysis <strong>of</strong> the bacteria. Some recent resultssuggest that the antibacterial activity <strong>of</strong> lysozyme is not only due to its enzymatic activity, but also toits cationic <strong>and</strong> hydrophobic properties The presence <strong>of</strong> lact<strong>of</strong>errin enhances the antibacterial activity<strong>of</strong> lysozyme against E.coli, which also supports the hypothesis that lact<strong>of</strong>errin damages the outermembrane <strong>of</strong> Gram-negative bacteria.LactoperoxidaseLactoperoxidase is a major antibacterial enzyme in colostrum. Bovine colostrum <strong>and</strong> milk containabout 1l-45 mg/L <strong>and</strong> 13-30 mg/ L lactoperoxidase, respectively.It is a basic glycoprotein containinga heme-group with Fe 3+ <strong>and</strong> catalyzes the oxidation <strong>of</strong> thiocyanate (SCN - ) in the presence <strong>of</strong> hydrogenperoxide (H 2O 2), producing a toxic intermediary oxidation product. This product inhibits bacterialmetabolism via the oxidation <strong>of</strong> essential sulphydryl groups in proteins. The lactoperoxidase system isalso toxic to other Gram-positive <strong>and</strong> Gram negative bacteria such as Pseudomonas aeruginosa,Salmonellatyphimurium,Listeria monocytogenes, Streptococcus mutans, Staphylococcus aureus <strong>and</strong> psychrotrophicbacteria in milk. Lactoperoxidase system inactivates polio virus <strong>and</strong> human immunodeficiency virustype 1 in vitro. The single peptide chain (612 amino acids) includes 15 half-cystines <strong>and</strong> 4- 5 potentialN-glycosylation sites <strong>and</strong> the heme group is suggested to bind to the peptide chain via a disulphidelinkage. Bovine lactoperoxidase also contains a site with high affinity for calcium. The lactoperoxidaseis partly activated by forming a complex with lysozyme <strong>and</strong> this interaction appears to be quite specific.The lactoperoxidase system <strong>and</strong> lact<strong>of</strong>errin have been shown to have an additive but not a synergistic,antibacterial effect against Streptococcus mutans.Proline-Rich Polypeptides (PRP)A hormone that regulates the thymus gl<strong>and</strong>, stimulating an underactive immune system ordown-regulating an overactive immune system as seen in autoimmune disease(Multiple sclerosis,rheumatoid arthritis, lupus, scleroderma, chronic fatigue syndrome, allergies, etc.). PRP stimulatesimmature thymocytes to turn into functionally active T-cells. Studies revealed that the addition <strong>of</strong> PRPisolated from colostrum led to the inhibition <strong>of</strong> vesicular stomatitis virus (VSV) replication in residentperitoneal cells. Furthermore, PRP acts as an immuno regulator by changing surface markers <strong>and</strong>functions <strong>of</strong> cells .It is a mixture <strong>of</strong> peptides(polypeptide-clostrinin) derived from colostrum whichcould help to slow the progression <strong>of</strong> Alzheimer’s disease by reducing the build-up <strong>of</strong> beta amyloid, atoxic protein that accumulates in the brains <strong>of</strong> Alzheimer’s sufferers.61


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceGrowth factorsGrowth factors are so called because historically they have been identified by their ability tostimulate the growth <strong>of</strong> various cell lines in vitro but, in reality, the functions <strong>of</strong> these peptide basedmolecules are considerably more diverse.Concentration ranges in growth factors reported for bovine colostrum <strong>and</strong> milkEpidermal growth factorEGF is a 53–amino acid peptide produced bythe salivary gl<strong>and</strong>s <strong>and</strong> the Brunners gl<strong>and</strong>s <strong>of</strong> theConcentrationGrowth factors(ng/ml)duodenum in adults. In vitro experiments usingColostrum milkgastric juice from preterm infants indicate that milkborneEGF is not deactivated under typical gastricEpidermal growth factor 4 – 325 1- 150proteolytic conditions. In contrast, we showed Betacellulin < 5 < 5that adult gastric juice digests EGF to an EGF form Insulin like growth –I 100 - 2000 5-100that has only 25% <strong>of</strong> the biological activity <strong>of</strong> the Insulin like growth factor-II 150 – 600 5-100intact EGF molecule. Once EGF enters the small Transforming growth factor-β1 10 – 50 < 5intestine, it is susceptible to proteolytic digestion Transforming growth factor- β2 150 -1150 10-70under fasting conditions but is preserved inFibroblast growth factor NAb < 1the presence <strong>of</strong> ingested food proteins . TherePlatelet-derived growth factor NA NAis controversy over the physiologic function <strong>of</strong>EGF in the gastrointestinal lumen under normal(nondamaged) conditions. EGF acts as a “luminal surveillance peptide” in the adult gut, readily availableto stimulate the repair process at sites <strong>of</strong> injury. The EGF in colostrum <strong>and</strong> milk may therefore play a rolein preventing bacterial translocation <strong>and</strong> stimulating gut growth in suckling neonates.Transforming growth factor αIn contrast with EGF, TGF- α is produced within the mucosa throughout the gastrointestinal tract.Systemic administration <strong>of</strong> TGF- α stimulates gastrointestinal growth <strong>and</strong> repair, inhibits acid secretion,stimulates mucosal restitution after injury, <strong>and</strong> Increases gastric mucin concentrations. Within thesmall intestine <strong>and</strong> colon, TGF- α expression occurs mainly in the upper (nonproliferative) zones,which suggests that its physiologic role may be to influence differentiation <strong>and</strong> cell migration ratherthan cell proliferation. TGF-a may therefore play a complementary role to that <strong>of</strong> TGF-β in controllingthe balance between Proliferation <strong>and</strong> differentiation in the intestinal epithelium. Up-regulation <strong>of</strong>TGF-α expression has been shown to occur in the gastrointestinal mucosa at sites <strong>of</strong> injury as well asin the liver after partial hepatectomy, supporting a role for TGF-α in mucosal growth <strong>and</strong> repair. Otherfindings support the role <strong>of</strong> TGF- α in maintaining epithelial continuity but suggest that the relativeimportance <strong>of</strong> peptides such as this might vary from one region <strong>of</strong> the gut to another. Taken together,most studies suggest that the major physiologic role <strong>of</strong> TGF- α is to act as a mucosal-integrity peptide,maintaining normal epithelial function in the undamaged mucosa.Transforming growth factor βThis family <strong>of</strong> molecules is structurally distinct from TGF- α <strong>and</strong>, in most systems, actually inhibitsproliferation. There are 5 different is<strong>of</strong>orms <strong>of</strong> TGF- β <strong>and</strong> their major site <strong>of</strong> expression in the normalgastrointestinal tract is in the superficial zones, where they may inhibit proliferation once the cells haveleft the crypt region. TGF- β has many diverse functions; it is a potent chemoattractant for neutrophils<strong>and</strong> stimulates epithelial cell migration at wound sites. It is therefore likely to be a key player instimulating restitution, the early phase <strong>of</strong> the repair process during which surviving cells from theedge <strong>of</strong> a wound migrate over the denuded area to reestablish epithelial continuity. TGF- β <strong>and</strong> TGF- β-like molecules are present in high concentrations in both bovine milk (1–2 mg/L) <strong>and</strong> colostrum (20–40 mg/L). These concentrations are sufficient to prevent indomethacin-induced gastric injury in rats,suggesting that the TGF- β in colostrum may be a key component in mediating its ability to maintaingastrointestinal integrity in suckling neonates.62


Colostrum Powder <strong>and</strong> its Health BenefitsPlatelet-derived growth factorPlatelet-derived growth factor (PDGF) is an acid-stable molecule that was originally identifiedfrom platelets but is also synthesized <strong>and</strong> secreted by macrophages. It consists <strong>of</strong> 2 disulfide linkedpolypeptides: chain A (14 kDa) <strong>and</strong> chain B (17 kDa). The dimer, therefore, exists in 3 is<strong>of</strong>orms (AA,AB, <strong>and</strong> BB) that bind to tyrosine kinase–type receptors. PDGF is a potent mitogen for fibroblasts<strong>and</strong> arterial smooth muscle cells <strong>and</strong> administration <strong>of</strong> exogenous PDGF has been shown to facilitateulcer healing when administered orally to animals. Although PDGF is present in bovine milk <strong>and</strong>colostrum, most <strong>of</strong> the PDGF-like mitogenic activity in bovine milk is actually derived from bovinecolostral growth factor, which shares sequence homology with PDGF.Insulin-like growth factors (somatomedins) <strong>and</strong> their binding proteinsIGF-I <strong>and</strong> IGF-II promote cell proliferation <strong>and</strong> differentiation <strong>and</strong> are similar in structure toproinsulin <strong>and</strong> it is possible that they also exert insulin-like effects at high concentrations. Bovinecolostrum contains much higher concentrations <strong>of</strong> IGF-I whereas lowered concentrations is foundin mature bovine milk (10 mg/L). These growth factors are relatively stable to both heat <strong>and</strong> acidicconditions. They therefore survive the harsh conditions <strong>of</strong> both commercial milk processing <strong>and</strong>gastric acid to maintain their biological activity. IGF-I is known to promote protein accretion, ie, it isan anabolic agent (50) <strong>and</strong> is at least partly responsible for mediating the growth-promoting activity <strong>of</strong>growth hormone (GH). IGF-II is present in bovine milk <strong>and</strong> colostrum at much lower concentrationsthan is IGF-I, but like IGF-I, it has anabolic activity <strong>and</strong> has been shown to reduce the catabolic statein starved animals. IGFs in bovine colostrum <strong>and</strong> milk are present in both free <strong>and</strong> bound forms. Theamount <strong>of</strong> free IGF varies during the perinatal period, with most <strong>of</strong> the IGF-I in bovine colostrumsbeing present in the free form (ie, not associated with its binding protein), whereas the reverse istrue in the antepartum period <strong>and</strong> in mature milk. It was initially thought that the main function<strong>of</strong> IGFBPs was to act as carrier proteins, reducing the proteolytic digestion <strong>of</strong> IGF <strong>and</strong> limiting itsbiological activity because only the free forms <strong>of</strong> IGF are thought to have any major proliferativeactivity. Additional roles for IGFBPs have been suggested because it has been shown that differentIGFBPs have distinct patterns <strong>of</strong> distribution in different tissues <strong>and</strong> their concentrations are altered inresponse to hormonal or nutrient status.The detailed functions <strong>of</strong> IGFBPs are unclear, although it is probable that one <strong>of</strong> the roles <strong>of</strong>secreted or soluble IGFBP is to inhibit IGF-mediated proliferation or amino acid uptake by limitingthe availability <strong>of</strong> free IGF to bind to its receptors. Conversely, cell surface <strong>and</strong> cell matrix–associatedIGFBPs may potentiate the actions <strong>of</strong> IGF by increasing local concentrations <strong>of</strong> IGF-I <strong>and</strong> IGF-II nextto their receptors.Clinical applications <strong>of</strong> colostrumGut related infectionsShort-bowel syndromeSome patients have an insufficient length <strong>of</strong> bowel to digest <strong>and</strong> absorb food adequately, usuallyas a result <strong>of</strong> massive intestinal resection for vascular insufficiency or after repeated operations forinflammatory bowel disease. Current therapeutic options are unpleasant <strong>and</strong> associated with ahigh risk <strong>of</strong> morbidity or mortality, eg, long-term parenteral (intravenous) feeding <strong>and</strong> small-boweltransplantation. Strategies to optimize the function <strong>of</strong> residual bowel <strong>and</strong> ultimately wean patients<strong>of</strong>f total parenteral nutrition would therefore be <strong>of</strong> great benefit. There is evidence that growth factorscould be instrumental in achieving this goal; e.g systemic administration <strong>of</strong> individual growth factorssuch as EGF have been shown to stimulate bowel growth in rats receiving total parenteral nutrition. Inaddition, oral administration <strong>of</strong> EGF helped restore glucose transport <strong>and</strong> phlorizin binding in rabbitintestines after jejunal resection, <strong>and</strong> colostrum supplementation <strong>of</strong> piglet feeding regimens resultedin a significant increase in intestinal proliferation. Colostrum supplementation may be <strong>of</strong> particularvalue in young children who have undergone intestinal resection because gut adaptation is morelikely during early childhood than it is in adulthood.63


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceNonsteroidal antiinflammatory drug–induced gut injuryNonsteroidal antiinflammatory drugs (NSAIDs) are widely prescribed <strong>and</strong> are effective in thetreatment <strong>of</strong> musculoskeletal injury <strong>and</strong> chronic arthritic conditions. Nevertheless,


Colostrum Powder <strong>and</strong> its Health Benefits(PAF), which is produced by intestinal flora <strong>and</strong> inflammatory cells during the development <strong>of</strong> NEC.The finding that human colostrum contains the enzyme PAF acetylhydrolase, which degrades PAF,might therefore be relevant in explaining why human milk feeds protect against the development<strong>of</strong> NEC. These areas are discussed further by others (91–93). Although the molecular mechanismsunderlying the development <strong>of</strong> NEC are unclear, there is no doubt that once it is established, it isassociated with a very high mortality rate. Current treatment consists <strong>of</strong> general supportive measuresconsisting <strong>of</strong> fluid-replacement <strong>and</strong> antibiotic therapy, although intestinal resection is <strong>of</strong>ten required.There is therefore a need for novel therapeutic approaches, e.g. the use <strong>of</strong> peptides to stimulate therepair process. Support for this idea comes from a recent case study in which a continuous infusion <strong>of</strong>EGF resulted in a remarkable restorative effect on gut histology in a child with NEC.Infective diarrheaHyperimmune milk or colostrum preparations have been shown to be <strong>of</strong> benefit in the prevention<strong>and</strong> treatment <strong>of</strong> infection <strong>and</strong> to increase weight gain in both clinical <strong>and</strong> veterinary practice, eg,vaccination <strong>of</strong> cows with specific viruses or bacteria to produce hyperimmune milk has been shownto be beneficial in the prevention <strong>and</strong> treatment <strong>of</strong> enteropathic infections due to Escherichia coli <strong>and</strong>rotavirus. The use <strong>of</strong> whole hyperimmune colostrum rather than specific antibodies purified from milkor other sources has the added value <strong>of</strong> potentially stimulating the repair process (due to the presence<strong>of</strong> growth factors) as well as facilitating the eradication <strong>of</strong> the infection by mechanisms involvingnonspecific antibacterial factors in colostrum <strong>and</strong> milk.The ultimate antioxidantColostrum is rich in Glutathione, a powerful antioxidant which is <strong>of</strong>ten described as ‘the ultimateantioxidant’. Antioxidants play an important part in overall good health <strong>and</strong> the prevention <strong>of</strong> disease,by scavenging for free radicals which cause disease, muscle damage, <strong>and</strong> inflammation. It has beenshown that glutathione enhances athletic performance by increasing muscle strength, <strong>and</strong> increasingthe capacity to exercise before fatigue sets in. Oxidative stress in the form <strong>of</strong> training <strong>and</strong> exercisecontributes to muscle fatigue. Glutathione <strong>and</strong> its precursors present in colostrum, have been shownto increase the capacity <strong>of</strong> exercise prior to the onset <strong>of</strong> fatigue.Anti-inflammatoryInflammation is associated with strenuous exercise <strong>and</strong> anti-inflammatories are the most commonlyprescribed class <strong>of</strong> drug to athletes. Inflammation is typically centered in the joints <strong>and</strong> in the digestivetract. Inflammation is a protective response to an injury, invading foreign substance, or an internallyproduced substance (e.g. in auto-immune disorders like rheumatoid arthritis). Colostrum reduces theneed for damaging medication, <strong>and</strong> because it is a natural food, unlike NSAIDS, it has absolutely nonegative side-effects <strong>and</strong> has a multitude <strong>of</strong> benefits.Increased Brain FunctionPhospholipids, components <strong>of</strong> alpha lipid, help in increasing brain function <strong>and</strong> have beenassociated with improved memory. They have also shown to elevate moods <strong>and</strong> reduce the symptoms<strong>of</strong> depression.Viral illnessesAbout 75% <strong>of</strong> the antibodies in the body are produced by the GI component <strong>of</strong> the immune system.The ability <strong>of</strong> AIDS/HIV patients to fight infectious disease is severely compromised due to damage tothe gut from chronic inflammation <strong>and</strong> diarrhea. Recent studies report colostrum’s role in the reversal<strong>of</strong> this chronic problem stemming from opportunistic infections like C<strong>and</strong>ida albicans, Cryptosporidia,rotavirus, Herpes simplex, Pathogenic Strains <strong>of</strong> E. Coli <strong>and</strong> intestinal flu infections. All gut pathogensare h<strong>and</strong>led well by colostrum without side effects.Allergies <strong>and</strong> autoimmune diseasesPRP from colostrum can work as a regulatory substance <strong>of</strong> the thymus gl<strong>and</strong>. It has beendemonstrated to improve or eliminate symptomatology <strong>of</strong> both allergies <strong>and</strong> autoimmune diseases65


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assurance(Multiple Sclerosis, rheumatoid arthritis, lupus, <strong>and</strong> myasthenia gravis). PRP inhibits the overproduction<strong>of</strong> lymphocytes <strong>and</strong> T-cells <strong>and</strong> reduces the major symptoms <strong>of</strong> allergies <strong>and</strong> autoimmune disease:pain, swelling <strong>and</strong> inflammation.Heart DiseaseColostrum PRP have a role in reversing heart disease very much like it does with allergies<strong>and</strong> autoimmune diseases. Additionally, IgF-1 <strong>and</strong> GH in colostrum can lower LDL-cholesterolwhile increasing HDL-cholesterol concentrations. Colostrum growth factors promote the repair<strong>and</strong> regeneration <strong>of</strong> heart muscle <strong>and</strong> the regeneration <strong>of</strong> new blood vessels for collateral coronarycirculation.CancerThe cytokines like Interleukins 1, 6, 10, Interferon G <strong>and</strong> Lymphokines found in colostrum areinvolved in the treatment <strong>of</strong> cancer. Colostrum lactalbumin has been found to be able to cause theselective death (apoptosis) <strong>of</strong> cancer cells, leaving the surrounding non-cancerous tissues unaffected.Lact<strong>of</strong>errin has similarly been reported to possess anti-cancer activity. The mix <strong>of</strong> immune <strong>and</strong> growthfactors in colostrum can inhibit the spread <strong>of</strong> cancer cells.DiabetesJuvenile diabetes (TypeI, insulin dependent) is thought to be brought about through an autoimmunemechanism, possibly initiated by an allergic reaction to the protein GAD found in cow’s milk.Colostrum contains several factors, which can <strong>of</strong>fset this <strong>and</strong> other allergies. Human trials reportedthat IgF-1 stimulates glucose utilization, effectively treating acute hyperglycemia <strong>and</strong> lessening a TypeII diabetic dependence on insulin.Helps in weight lossIgF-1 is required by the body to metabolize fat for energy through the Krebs cycle. With aging, lessIgF-1 is produced in the body. Inadequate levels are associated with an increased incidence <strong>of</strong> TypeII diabetes <strong>and</strong> difficulty in losing weight despite a proper nutritional intake <strong>and</strong> adequate exercise.Colostrum provides a good source <strong>of</strong> IgF-1 as a complementary therapy for successful weight loss.Athletic stressExhaustive workouts <strong>and</strong> athletic competition can temporarily depress the immune system, decreasingthe number <strong>of</strong> T-lymphocytes <strong>and</strong> NK cells. Athletes are therefore, more prone to develop infections,including Chronic Fatigue Syndrome. Many <strong>of</strong> colostrum’s immune factors can help significantly reducethe number <strong>and</strong> severity <strong>of</strong> infections caused by both physical <strong>and</strong> emotional stress.Leaky Gut SyndromeOne <strong>of</strong> the major benefits <strong>of</strong> colostrum supplementation is enhanced gut efficiency due to themany immune enhancers that control clinical <strong>and</strong> subclinical GI infections. Colostral growth factorsalso play a role by keeping the intestinal mucosa sealed <strong>and</strong> impermeable to toxins. Healing leaky gutsyndrome reduces toxic load <strong>and</strong> helps in the reversal <strong>of</strong> many allergic <strong>and</strong> autoimmune conditions.For the healthy individual or athlete in training, colostrum supplementation enhances the efficiency<strong>of</strong> amino acid <strong>and</strong> carbohydrate fuel uptake by the intestine. One <strong>of</strong> the reasons for the energy boostseen in most healthy individuals who use colostrum as a food supplement is this ability <strong>of</strong> colostrumto improve nutrient availability <strong>and</strong> the correction <strong>of</strong> subclinical leaky gut syndrome.Wound healingSeveral colostrum components stimulate wound-healing. Nucleotides, EGF, TGF <strong>and</strong> IGF-1stimulate skin growth, cellular growth <strong>and</strong> repair by direct action on DNA <strong>and</strong> RNA. These growthfactors facilitate the healing <strong>of</strong> tissues damaged by ulcers, trauma, burns, surgery or inflammatorydisease. The tissues affected beneficially by colostrums wound healing properties are skin, muscle,cartilage, bone <strong>and</strong> nerve cells. Powdered colostrum can be applied topically to gingivitis, sensitiveteeth, aphthous ulcers, cuts, abrasions <strong>and</strong> burns after they have been cleaned <strong>and</strong> disinfected.66


Colostrum Powder <strong>and</strong> its Health BenefitsConclusionThe world-wide trend towards the development <strong>of</strong> health-promoting foods <strong>of</strong>fers interestingopportunities for applications which contain specific antibody ingredients derived from immunisedcows. It is anticipated that colostrums based preparations may have remarkable potential to contributeto human health care as part <strong>of</strong> health promoting diet <strong>and</strong> as an alternative or a supplement to themedical treatment <strong>of</strong> specified human diseases. Bovine colostrum virtually contain all compounds <strong>of</strong>human cellular <strong>and</strong> humoral immune defence. They are ideal sources <strong>of</strong> these defence molecules forindustrial production because <strong>of</strong> their ready availability <strong>and</strong> safety as compared with blood derivedanalogues. The ongoing success <strong>of</strong> colostrums based products speaks for itself. However, the challengefor manufacturers still remains as how to process colostrums in a cost effective way.ReferencesBlum, J. W., <strong>and</strong> Hammon, H. 2000. Colostrum effects on the gastrointestinal tract, <strong>and</strong> on nutritional, endocrine <strong>and</strong>metabolic parameters in neonatal calves. Livest. Prod. Sci., 66: 151.Chen, C.C., Tu, Y.Y., <strong>and</strong> Chang, H.M. 2000. Thermal stability <strong>of</strong> bovine milk immunoglobulin G(IgG) <strong>and</strong> the effect <strong>of</strong>added thermal protectants on the stability. J. Food Sci., 65: 188.Donovan, S. M. <strong>and</strong> Odle, J. 1994. Growth factors in milk as mediators <strong>of</strong> infant development. Ann. Rev <strong>of</strong> Nutr., 14:147.Elfstr<strong>and</strong>, L., Lindmark-Mansson, H., Paulsson, M., Nyberg, L. <strong>and</strong> Akesson, B. 2002. Immunoglobulins, growth factors<strong>and</strong> growth hormone in bovine colostrum <strong>and</strong> the effects <strong>of</strong> processing. Int. <strong>Dairy</strong> J., 12: 879.Gapper, L., Copestake D., Otter, D., Indyk, H., 2007. <strong>Analysis</strong> <strong>of</strong> bovine immunoglobulin G in milk, colostrum <strong>and</strong>dietary supplements: a review Anal Bioanal Chem.,389:93.Godden, S. M., Smith, S., Feirtag, J. M., Green, L. R., Wells, S. J., <strong>and</strong> Fetrow, J. P. 2003. Effect <strong>of</strong> on-farm commercialbatch pasteurization <strong>of</strong> colostrum on colostrum <strong>and</strong> serum immunoglobulin concentrations in dairy calves. J. <strong>Dairy</strong>Sci., 86: 1503.Korhonen, H., Marnila, P. <strong>and</strong> Gill, H. S. 2000. Bovine milk antibodies for health. Br J Nutr., 84: S135.Kurokowa, M., Lynch, K. <strong>and</strong> Podolsky, D. K. 1987. Effects <strong>of</strong> growth factors on an intestinal epithelial cell line:transforming growth factor beta inhibits proliferation <strong>and</strong> stimulates differentiation. Biochemical <strong>and</strong> BiophysicalResearch Communications 142:775-182.67


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceCow Ghee Protects from MammaryCarcinogenesis: MechanismVinod K. Kansal, Rita Rani <strong>and</strong> Ekta BhatiaAnimal Biochemistry Division, NDRI, KarnalDuring the past several years, epidemiological studies have indicated the influence <strong>of</strong> environment<strong>and</strong> life-styles on the development <strong>of</strong> certain forms <strong>of</strong> cancer. About 35 % <strong>of</strong> all cancer mortality in US maybe attributable to dietary factors. The association between dietary fat <strong>and</strong> cancer has been consistentlysupported by experimental evidence. Limiting the intake <strong>of</strong> fats <strong>and</strong> oils reduces the risk <strong>of</strong> cancer. Thishas now been exp<strong>and</strong>ed to limit saturated fat intake through reduction <strong>of</strong> animal fat intake.Epidemiological associations between dietary fat intake <strong>and</strong> cancer in humans are highlycontroversial. Some <strong>of</strong> this controversy stems from the limited ability to accurately assess total energy<strong>and</strong> fat consumption, <strong>and</strong> the difficulty in assessing the effects <strong>of</strong> dietary fat independent <strong>of</strong> totalenergy or micronutrient intake <strong>and</strong> other environmental factors such as physical activity.A chorus <strong>of</strong> establishment voices, including the American Cancer Society, the National CancerInstitute <strong>and</strong> the Senate Committee on Nutrition <strong>and</strong> Human Needs, claim that animal fat is linked notonly with heart disease, but also with cancers <strong>of</strong> various types. However, when researchers from theUniversity <strong>of</strong> Maryl<strong>and</strong> analyzed the data, they found that vegetable fat consumption was correlatedwith cancer, not the animal fat (Enig et al., 1978).The mechanisms supporting a relationship between dietary fat <strong>and</strong> cancer can be classified aseither direct or indirect. Potential direct mechanisms include: 1) peroxidation <strong>of</strong> double bond inPUFAs, leading to persistant oxidative stress <strong>and</strong> generation <strong>of</strong> reactive lipid peroxidation products(malondialdehyde, 4-hydroxyalkenals), which induce DNA damage; 2) conversion <strong>of</strong> essential fattyacids to eicosanoids (short lived hormone synthesized from n-6 unsaturated fatty acids); <strong>and</strong> 3)interaction between fatty acids with signal transduction pathways leading to altered gene expression.Potential indirect mechanisms include: 1) effect on membrane bound enzymes such as cytochromeP450 (CYP) that regulate xenobiotic <strong>and</strong> estrogen metabolism; 2) structural <strong>and</strong> functional changesin cell membranes that can alter the hormone activity <strong>and</strong> growth factor receptors; <strong>and</strong> 3) effects onimmune function.Dietary fat <strong>and</strong> breast cancerBreast cancer is the most commonly diagnosed cancer in women <strong>and</strong> is the leading cause <strong>of</strong> cancermortality in females in the world. There is strong positive correlation between fat intake <strong>and</strong> mortalityfrom breast cancer. It is likely that sex hormones especially estrogen, play a promotional role in breastcarcinogenesis, stimulating mitotic division <strong>of</strong> initiated cells <strong>and</strong> proliferation.An increased amount <strong>of</strong> both vegetable <strong>and</strong> animal fat accelerates mammary tumor growth.Different types <strong>of</strong> fat also have different effects on mammary tumorigenesis. Meta-analysis <strong>of</strong> 97reports that studied the effects <strong>of</strong> dietary fatty acids on mammary tumor incidence <strong>and</strong> found: 1) n-6polyunsaturated fatty acids have a strong tumor-enhancing effect; 2) saturated fats have weaker tumorenhancing effects; 3) n-3 polyunsaturated fatty acids have a small non-significant protective effect; 4)the effects <strong>of</strong> n-6 polyunsaturated fats are stronger than that <strong>of</strong> saturated fats even at low levels; <strong>and</strong>5) there is no effect <strong>of</strong> monounsaturated fats on mammary carcinogenesis (Fay et al., 1997). A high fatdiet rich in n-6 polyunsaturated fatty acid in animal models could enhance metastasis <strong>of</strong> human breastcancer cells (Rose et al., 1991).<strong>Dairy</strong> products <strong>and</strong> breast cancerThe major hypotheses suggesting an increased risk <strong>of</strong> breast cancer risk associated with theconsumption <strong>of</strong> dairy product include: 1) a high consumption <strong>of</strong> dairy products results high dietary68


Cow Ghee Protects from Mammary Carcinogenesis: Mechanismfat intake particularly saturated fat which in turn has been associated with breast cancer risk; 2) milkproduct may contain contaminants, such as pesticide that are potentially carcinogenic; <strong>and</strong> 3) milkmay contain growth factors, such insulin like growth factor 1 (IGF-1), which have been shown topromote breast cancer cell growth.The hypotheses suggesting inverse relation between dairy product consumption <strong>and</strong> breast cancerrisk have focused on the anticarcinogenic effects <strong>of</strong> vitamin D <strong>and</strong> calcium, conjugated linoleic acid<strong>and</strong> butyric acid. <strong>Dairy</strong> products have high calcium content <strong>and</strong> are also a major dietary source <strong>of</strong>vitamin D in countries where milk <strong>and</strong> other dairy products are fortified, such as the United States.In breast cancer cell lines, vitamin D exerts antiproliferative effects by causing arrest in phase G0 /G1 <strong>of</strong> the cell cycle (Colston <strong>and</strong> Hansen, 2002). The cellular functions <strong>of</strong> vitamin D are closely linkedto calcium. Calcium is a pivotal regulator <strong>of</strong> a wide variety <strong>of</strong> cellular functions, including cellularproliferation <strong>and</strong> differentiation. Several investigations have shown that animals fed diet deficient incalcium <strong>and</strong> vitamin D develops mammary hyperplasia <strong>and</strong> hyperproliferation (Lipkin <strong>and</strong> Newmark,1999). Furthermore, animal studies have shown that supplementation with calcium <strong>and</strong> vitamin Dreduces the risk <strong>of</strong> mammary tumors in animals fed a high fat diet <strong>and</strong> prevents the development <strong>of</strong>mammary tumors in animals induced with the carcinogen 7,12-dimethylbenz (a)anthracene (DMBA)(Mehta et al., 2000).A third potential mechanism to suggest that dairy products may reduce breast cancer risk involves CLA.Animal studies suggest that CLA confers protection against the development <strong>of</strong> mammary tumors (Ip et al.,1996). It is interesting to note that tumor formation was inhibited in animals fed CLA, regardless <strong>of</strong> the typeor amount <strong>of</strong> fat in their diets. Another compound found in dairy products, known to have protective effectagainst mammary carcinogenesis is butyric acid.Epidemiological studiesMost <strong>of</strong> the epidemiological studies showed no consistent pattern <strong>of</strong> increased or decreased breastcancer risk with a high consumption <strong>of</strong> dairy products (Moorman <strong>and</strong> Terry, 2004). Two <strong>of</strong> the cohortstudies <strong>and</strong> 10 <strong>of</strong> the case-control studies investigated the association between breast cancer <strong>and</strong> butterconsumption <strong>and</strong> no consistent pattern was observed with reported butter intake. In a cohort studyconducted in Finl<strong>and</strong> (Knekt et al., 1996), an inverse association that was not statistically significantwas reported; whereas a slight positive association was reported in a cohort study in the Netherl<strong>and</strong>s(Voorrips et al., 2002). In the case-control studies, odds ratios both > <strong>and</strong> < 1.0 were reported, butgenerally differences between cases <strong>and</strong> controls were not statistically significant. Persons with ahigh consumption <strong>of</strong> butter, cheese <strong>and</strong> other high-fat dairy products may also be more likely toconsume large amounts <strong>of</strong> meat or other high fat-foods that could also contribute to an increased risk<strong>of</strong> breast cancer. Further, milk fat is rarely used in isolation from other dietary items, <strong>and</strong> other milkcomponents (milk protein, calcium, lactic acid bacteria) also have anticarcinogenic properties; hence itis not possible to separate the effect <strong>of</strong> milk fat as such.Animal studiesThere are a few studies in which milk fat or butter was compared with vegetable oils or margarinesin animal models <strong>of</strong> carcinogenesis. The vegetable oils (soybean oil, sunflowers oil, corn oil, cotton oil)were reported to enhance DMBA induced mammary adenocarcinomas more than butter <strong>and</strong> somesaturated fats (coconut oil, tallow, lard) in rodents (Carroll <strong>and</strong> Khor, 1971; Yanagi et al., 1989; Cope<strong>and</strong> Reeve 1994). The milk fat was more effective when introduced in the diet at weaning (Klurfeld etal., 1983).The work done in this laboratory (Bhatia <strong>and</strong> Kansal, in press) showed that ghee (clarified butter fat)opposed to soybean oil attenuated the gastrointestinal <strong>and</strong> mammary carcinogenesis. Gastrointestinalcarcinogenesis was induced by DMH in weanling male rats fed diet containing at 10% level <strong>of</strong> soybeanoil or buffalo ghee or cow ghee. The incidence was considerably higher in animal on soybean oil(73.30%) than on cow ghee (55%) or buffalo ghee (40%). Tumor multiplicity <strong>and</strong> tumor volume wereless on ghee diets than on soybean oil, <strong>and</strong> cow ghee was more efficacious than buffalo ghee in reducing69


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assurancetumor volume. Increased accumulation <strong>of</strong> CLA <strong>and</strong> decreased lipid peroxidation (measured by thelevel <strong>of</strong> TARS) in liver <strong>and</strong> colorectal tissue on ghee opposed to soybean oil correlated with decreasedtumor incidence, tumor multiplicity <strong>and</strong> tumor volume on ghee diets. Similar dietary treatment wasgiven to weanling female rats <strong>and</strong> mammary carcinogenesis was induced by DMBA. Considerablenumber <strong>of</strong> animal died in all dietary groups due to acute DMBA toxicity <strong>and</strong> mortality incidence wasgreater on soybean oil than on ghee groups. Cow ghee opposed to soybean oil decreased the tumormultiplicity, tumor volume <strong>and</strong> non-neoplastic disorders.In recent studies (Rani <strong>and</strong> Kansal, 2010) we evaluated the mechanism <strong>of</strong> protective effect <strong>of</strong>cow ghee versus soybean oil in DMBA induced mammary carcinogenesis rat model. Four groups <strong>of</strong>female rats were fed for 44 weeks diet containing cow ghee or soybean oil. Mammary carcinogenesiswas induced with 7,12-dimethylbenz(a)anthracene (DMBA) given through oral intubation. The twogroups, which were not given DMBA but fed similarly, served as controls. The animals challengedwith DMBA developed tumors in both cow ghee fed <strong>and</strong> soybean oil fed rats. The tumor latencyperiod was greater on cow ghee (27 weeks) than on soybean oil diet (23 weeks). The tumor incidencewas considerably higher in animals on soybean oil (65.4%) than on cow ghee diet (26.6%). The tumorvolume <strong>and</strong> tumor weight were significantly less on cow ghee (1925 mm3, 1.67 g) than on soybeanoil diet (6285 mm3, 6.18 g). The progression <strong>of</strong> carcinogenesis was more rapid on soybean oil than oncow ghee diet. While no adenocarcinoma was observed in cow ghee group, 8% <strong>of</strong> tumors in soybeanoil group were adenocarcinoma.Cyclooxygenase-2 (COX-2) is a rate-limiting step in synthesis <strong>of</strong> prostagl<strong>and</strong>in E2, <strong>and</strong> theexcessive production <strong>of</strong> the latter promotes mammary carcinogenesis. The expression <strong>of</strong> COX-2 wasobserved in DMBA treated rats, but not in untreated rats. The expression <strong>of</strong> COX-2 was significantlygreater on soybean oil than on cow ghee diet in tumor tissue as well as in uninvolved tissue <strong>of</strong> tumorbearing animals (Rani <strong>and</strong> Kansal, 2010).The cyclin A <strong>and</strong> D up regulate cell proliferation <strong>and</strong> promote tumerogenesis in carcinogen treatedanimals. The expression <strong>of</strong> cyclin A in carcinogen treated rats was significantly greater in soybean oilfedrats than in cow ghee-fed rats, both in tumor bearing <strong>and</strong> no tumor bearing rats, <strong>and</strong> in tumortissue <strong>and</strong> in uninvolved tissue <strong>of</strong> tumor bearing rats. The expression <strong>of</strong> cyclin D was also significantlygreater on soybean oil diet than on cow ghee diet, both in control <strong>and</strong> carcinogen treated rats (Rani etal., 2010)The peroxisome proliferators activated receptor-γ (PPAR-γ) down regulates cell proliferation <strong>and</strong>up regulates apoptosis, <strong>and</strong> thus prevents tumorogenesis. The expression <strong>of</strong> PPAR-γ was significantlygreater on cow ghee diet than on soybean oil diet, both in control <strong>and</strong> carcinogen treated rats. Further,its expression was greater on cow ghee than on soybean oil both in tumor bearing <strong>and</strong> no tumor bearingrats <strong>of</strong> treated animals (Rani <strong>and</strong> Kansal, 2010).The Bax up regulates apoptosis <strong>and</strong> thus prevents progression <strong>of</strong> tumorogenesis. Its expressionwas decreased in tumor tissue <strong>and</strong> uninvolved tissue <strong>of</strong> tumor bearing rats. However, the dietarytreatment with cow ghee or soybean oil has no effect on expression <strong>of</strong> Bax (Rani et al., 2010)The expression <strong>of</strong> both bcl2 <strong>and</strong> PKC genes was not effected by dietary treatments with cow gheeor soybean oil in control as well as in no tumor bearing treated animals. However, their expressionwas significantly less on cow ghee than on soybean oil in tumor tissue as well as in uninvolved tissue<strong>of</strong> tumor bearing rats (Rani et al., 2010)Apoptotic signal decreased in tumor bearing animals. In uninvolved tissue <strong>of</strong> tumor bearinganimals the decrease was significantly more on soybean oil than on cow ghee, while in tumor tissuethe decline in apoptotic signal was similar on cow ghee <strong>and</strong> soybean oil. In control animals <strong>and</strong> notumor bearing animals, the apoptotic signal was not affected by dietary treatment with cow ghee orsoybean oil. Hence, cow ghee feeding decreases expression <strong>of</strong> genes involved in cell proliferation, <strong>and</strong>increases apoptotic signal (Rani et al., 2010)Most <strong>of</strong> carcinogens in nature occur in inactive form, <strong>and</strong> these are activated by cytochrome70


Cow Ghee Protects from Mammary Carcinogenesis: MechanismP450 activities present in liver. Several enzymes present in liver <strong>and</strong> the target tissue detoxify theactive carcinogen. The balance <strong>of</strong> these two activities determines the active carcinogen present in thebody at a given moment. Feeding cow ghee opposed to soybean oil decreased carcinogen activatingcytochrome P4501A1, CYP1A2, CYP1B1 <strong>and</strong> CYP2B1 activities in liver. Further, feeding cow gheeopposed to soybean oil also increased carcinogen-detoxifying activities, γ-glutamyltranspeptidase,uridinediphospho-glucuronosyl transferase <strong>and</strong> quinone reductase in liver <strong>and</strong> mammary gl<strong>and</strong>tissue <strong>of</strong> control as well as DMBA treated rats (Rani <strong>and</strong> Kansal, 2011) .The present study shows that compared to vegetable oil, cow ghee confers protection againstmammary gl<strong>and</strong> carcinogenesis. The mechanism involves modulation <strong>of</strong> xenobiotic metabolism <strong>and</strong>expression genes involved in cell proliferation <strong>and</strong> apoptosis. Nutraceutical importance <strong>of</strong> cow gheeover vegetable oils in conferring protection against mammary cancer has been validated. This countersthe propag<strong>and</strong>a against dairy ghee <strong>and</strong> indiscriminate promotion <strong>of</strong> vegetable oil as health food.ReferencesBhatia, E. 2005. Effects <strong>of</strong> dairy Ghee versus soybean oil on 1,2-dimethylhydrazinedihydrochloride inducedgastrointestinal tract carcinogenesis <strong>and</strong> lipid peroxidation in rats. Ind. J. Med. Res (in press)Bhatia, E. <strong>and</strong> Kansal, V. K. (2010) <strong>Dairy</strong> Ghee opposed to soybean oil attenuates diet-induced hypercholesterolemia inrats. Milchwissenschaft (Germany), in pressCarroll, K.K. <strong>and</strong> Khor, H.T. 1971. Effects <strong>of</strong> level <strong>and</strong> type <strong>of</strong> dietary fat on incidence <strong>of</strong> mammary tumors induced infemale Sprague-Dawley rats by 7,12-dimethylbenz[a] anthracene. Lipids, 6: 415-420.Colston, K.W. <strong>and</strong> Hansen, C.M. 2002. Mechanisms implicated in the growth regulatory effects <strong>of</strong> vitamin D in breastcancer. Endocr. Relat. Cancer, 9: 45-49.Cope, R.B. <strong>and</strong> Reeve, V.E. 1994. Modification <strong>of</strong> 7,12-dimethylbenzanthra-cene (DMBA) / ultraviolet radiation (UVR)co-carcinogenesis, UVR carcinogenesis <strong>and</strong> immune suppression due to UVR <strong>and</strong> cis urocanic acid by dietary fats.Photochem. Photobiol., 59: 24S.Enig, M.G., Munn, R.J. <strong>and</strong> Keeney, M. 1978. Dietary fat <strong>and</strong> cancer trends - a critique. Fed. Proc., 37(9): 2215-2220Fay, M.P., Freedman, L.S., Clifford, C.K. <strong>and</strong> Midthune, D.N. 1997. Effect <strong>of</strong> different types <strong>and</strong> amounts <strong>of</strong> fat on thedevelopment <strong>of</strong> mammary tumors in rodents : A review. Cancer Res., 57: 3979-3988.Ip, C., Briggs, S.P., Haegele, A.D., Thompson, H.J., Storkson, J. <strong>and</strong> Scimeca, J.A. 1996. The efficacy <strong>of</strong> conjugatedlinoleic acid in mammary cancer prevention is independent <strong>of</strong> the level or type <strong>of</strong> fat in the diet. Carcinogenesis.,17: 1045-1050.Klurfeld, D.M., Weber, M.M. <strong>and</strong> Kritchevsky, D. 1983. Comparison <strong>of</strong> semi-purified <strong>and</strong> skim milk protein containingdiets on DMBA-induced breast cancer in rats. Kiel. Milchwirtschaft. Forschun., 35: 421-422.Knekt, P., Jarvinen, R., Seppanen, R., Pukkala, E. <strong>and</strong> Aromaa, A. 1996. Intake <strong>of</strong> dairy products <strong>and</strong> the risk <strong>of</strong> breastcancer. Br. J. Cancer, 73: 687-691.Lipkin, M. <strong>and</strong> Newmark, H.L. 1999. Vitamin D, calcium <strong>and</strong> prevention <strong>of</strong> breast cancer : A review. J. Am. Coll. Nutr.,18: 392S-397S.Mehta, R., Hawthorne, M., Uselding, L., Albinescu, D., Moriarty, R., Christov, K. <strong>and</strong> Mehta, R. 2000. Prevention <strong>of</strong>N-methyl-N-nitrosourea-induced mammary carcinogenesis in rats by γ-hydroxy vitamin D5. J. Natl. Cancer Inst.,92(22): 1836-1840.Moorman, P.G. <strong>and</strong> Terry, P.D. 2004. Consumption <strong>of</strong> dairy products <strong>and</strong> the risk <strong>of</strong> breast cancer: A review <strong>of</strong> theliterature. Am. J. Clin. Nutr., 80: 5-14.Rani, R <strong>and</strong> Kansal, V. K. (2010) Dietary intervention <strong>of</strong> cow Ghee versus soybean oil on 7,12-dimethylbenz(a)anthracene induced mammary carcinogenesis <strong>and</strong> expression <strong>of</strong> cyclooxygenase-2<strong>and</strong> peroxisome proliferators activated receptor- γ in rats. Indan. Journal <strong>of</strong> Medical Research(in press)Rani, R., Kansal, V. K., Kaushal, D <strong>and</strong> De, D. (2010) Dietary intervention <strong>of</strong> cow Ghee <strong>and</strong> soybean oil on expression<strong>of</strong> cell cycle <strong>and</strong> apoptosis related genes in normal <strong>and</strong> carcinogen treated rat mammary gl<strong>and</strong>. Molecular BiologyReports (Netharl<strong>and</strong>s) DOI: 10.1007/S11033-010-0435-1Rani, R <strong>and</strong> Kansal, V. K. (2010) Dietary intervention <strong>of</strong> cow Ghee versus soybean oil on 7,12-dimethylbenz(a)anthraceneinduced mammary carcinogenesis <strong>and</strong> expression <strong>of</strong> cyclooxygenase-2 <strong>and</strong> peroxisome proliferators activatedreceptor- γ in rats. Indan. Journal <strong>of</strong> Medical Research (in press)Rose, D.P., Connolly, J.M. <strong>and</strong> Meschter, C.L. 1991. Effect <strong>of</strong> dietary fat on human breast cancer growth <strong>and</strong> lungmetastasis in nude mice. J. Natl. Cancer Inst., 83: 1491-1495.Voorrips, L.E., Brants, H.A.M., Kardinaal, A.F.M., Hiddink, G.J., van den Br<strong>and</strong>t, P.A. <strong>and</strong> Goldbohm, R.A. 2002. Intake<strong>of</strong> conjugated linoleic acid, fat, <strong>and</strong> other fatty acids in relation to postmenopausal breast cancer : The Netherl<strong>and</strong>sCohort Study on Diet <strong>and</strong> Cancer. Am. J. Clin. Nutr., 76: 873-882.Yanagi, S., Yamashita, M., Sakamoto, M., Kumazawa, K. <strong>and</strong> Imai, S. 1989. Comparative effects <strong>of</strong> butter, margarine,safflower oil <strong>and</strong> dextrin on mammary tumorigenesis in mice <strong>and</strong> rats. In: The Pharmacological Effects <strong>of</strong> Lipids.III. The role <strong>of</strong> Lipids in Cancer Research (J.J. Kabara, ed.). Lauricidin Inc., Galena, IL, pp.159-169.71


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceIntroductionLateral Flow Assay- Principle <strong>and</strong> itsApplication in Analytical Food ScienceThe lateral flow assay (LFA), also calledthe immunochromatographic assay or the stripassay is a simple device intended to detectthe presence (or absence) <strong>of</strong> a target analytein sample (matrix). This technique is basedon an immunochromatographic procedurethat utilizes antigen–antibody properties <strong>and</strong>enables rapid detection <strong>of</strong> the analyte. It includesseveral benefits, such as a user-friendly format,rapid results, long-term stability over a widerange <strong>of</strong> weather conditions, <strong>and</strong> relativelylow manufacturing costs. These characteristicsrender it ideally suited for on site testing byuntrained personnel. The main application <strong>of</strong>this technology had been the human pregnancytest which came in picture in the 1970s. However,to fully develop the lateral flow test platform,Rajan Sharma <strong>and</strong> Priyanka Singh Rao<strong>Dairy</strong> Chemistry Division, NDRI, KarnalFigure 1. Typical configuration <strong>of</strong> a lateral flowimmunoassay test stripa variety <strong>of</strong> other enabling technologies were also required. These include technologies as diverseas nitrocellulose membrane manufacturing, antibody generation, fluid dispensing <strong>and</strong> processingequipment, as well as the evolution <strong>of</strong> a bank <strong>of</strong> knowledge in development <strong>and</strong> manufacturingmethodologies. Many <strong>of</strong> these facilitative technologies had evolved throughout the early 1990s, thefirst lateral flow products were introduced to the market in the late 1980s. Since then, as <strong>of</strong> 2010, over200 companies worldwide are producing a range <strong>of</strong> testing formats. The world market for LF-basedtests (Rosen, 2009) is estimated at $2,270 million in 2005 <strong>and</strong>, with a compounded annual growth rate(CAGR) <strong>of</strong> 10%, it will reach $3,652 million in 2012. This estimate includes LF-based tests used inhuman <strong>and</strong> veterinary medicine, food <strong>and</strong> beverage manufacturing, pharmaceutical, medical biologics<strong>and</strong> personal care product production, environmental remediation, <strong>and</strong> water utilities.Architecture <strong>and</strong> working <strong>of</strong> a lateral flow immunoassayFigure 1 shows the typical configuration <strong>of</strong> a LFA which is composed <strong>of</strong> a variety <strong>of</strong> materials,each serving one or more purposes. The parts overlap onto one another <strong>and</strong> are mounted on a backingcard using a pressure-sensitive adhesive. The assay consists <strong>of</strong> several zones, typically constitutedby segments made <strong>of</strong> different materials. When a test is run, sample is added to the proximal end<strong>of</strong> the strip, the sample pad. Here, the sample is treated to make it compatible with the rest <strong>of</strong> thetest. The treated sample migrates through this region to the conjugate pad, where a particulateconjugate has been immobilized. The particle can typically be colloidal gold, or a colored, fluorescent,or paramagnetic monodisperse latex particle. This particle has been conjugated to one <strong>of</strong> the specificbiological components <strong>of</strong> the assay, either antigen or antibody depending on the assay format. Thesample re-mobilizes the dried conjugate, <strong>and</strong> the analyte in the sample interacts with the conjugateas both migrate into the next section <strong>of</strong> the strip, which is the reaction matrix. This reaction matrixis a porous membrane, onto which the other specific biological component <strong>of</strong> the assay has beenimmobilized. These are typically proteins, either antibody or antigen, which have been laid down inb<strong>and</strong>s in specific areas <strong>of</strong> the membrane where they serve to capture the analyte <strong>and</strong> the conjugate as72


Lateral Flow Assay- Principle <strong>and</strong> its Application in Analytical Food Sciencethey migrate by the capture lines. Excess reagents move past the capture lines <strong>and</strong> are entrapped inthe wick or absorbent pad. Results are interpreted on the reaction matrix as the presence or absence <strong>of</strong>lines <strong>of</strong> captured conjugate, read either by eye or using a reader.Lateral flow assay formatsThis test can be performed on two platforms, either direct (s<strong>and</strong>wich) or competitive (inhibition)<strong>and</strong> also can be used to accommodate qualitative, semi quantitative <strong>and</strong> in limited cases, fullyquantitative determination.Direct assay format: Direct assays (Figure 2) are typically used when testing for larger analyte withmultiple antigenic sites i.e. analyte presenting several epitopes. This system (equivalent to s<strong>and</strong>wichELISA) employs two different antibodies (polyclonal <strong>and</strong> monoclonal) that bound distinct epitopes <strong>of</strong>the analyte: a labelled polyclonal antibody is placed in a dehydrated state onto a glass-fiber membrane(conjugate pad) to serve as detector reagent <strong>and</strong> a monoclonal antibody specific to the analyte is sprayedat the test line <strong>of</strong> the nitrocellulose membrane to serve as capture reagent. An additional antibody specificto the detection antibody (species specific) could be used to produce a control signal at control line.Figure 2. Direct Lateral Flow AssayFigure 3. Competitive Lateral Flow AssayWhen a sample extract is applied to samplepad, the liquid migrates up by capillary force <strong>and</strong> the detector reagent is then released. Some <strong>of</strong> theanalyte bind to the detection antibody <strong>and</strong> some remain free in the solution. Subsequently, the mixturepasses through the capture zone (test line) <strong>and</strong> both unbound analyte <strong>and</strong> bound analyte bind to thecapture antibody. The response in the capture zone (test line) is directly proportional to the amount <strong>of</strong>analyte in the sample.Competitive assay: Competitive assay formats (Figure 2) are typically used when testing for smallmolecules with single antigenic determinants, which cannot bind to two antibodies simultaneously. Inthis format, an analyte-protein conjugate coated on the test zone <strong>of</strong> a nitrocellulose membrane capturesa labelled anti-analyte monoclonal antibody complex, allowing colour particle (e.g. colloidal gold) toconcentrate <strong>and</strong> form a visible line on the test zone. Another specific antibody coated on the controlline allows the capture <strong>of</strong> the excess antibody complex. One b<strong>and</strong> colour will therefore be visible inthe control zone regardless <strong>of</strong> the presence <strong>of</strong> target analytes, confirming correct test development.Conversely, a negative sample will result to the formation <strong>of</strong> two b<strong>and</strong> colours visible (test line <strong>and</strong>control line)Materials <strong>and</strong> processes in lateral flow immunoassay development <strong>and</strong>constructionA typical test strip consists <strong>of</strong> the following components:Membrane/Analytical Region: The purpose <strong>of</strong> the analytical region in a lateral flow immunoassayis to bind proteins at the test <strong>and</strong> control areas <strong>and</strong> to maintain their stability <strong>and</strong> activity over the73


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assuranceshelf-life <strong>of</strong> the product. The membrane material is typically a hydrophobic nitrocellulose or celluloseacetate membrane onto which anti-target analyte antibodies are immobilised in a line across themembrane as a capture zone or test line. A control zone may also be present, containing antibodiesspecific for the conjugated antibodies. Nitrocellulose, while extremely functional, the only materialthat has been successfully <strong>and</strong> widely applied for LIFA because <strong>of</strong> it’s relatively low cost, true capillaryflow characteristics, high protein-binding capacity, relative ease <strong>of</strong> h<strong>and</strong>ling.Conjugate Pad or reagent pad: This contains antibodies specific to the target analyte conjugated tocoloured particles (usually colloidal gold particles, or latex microspheres). The role <strong>of</strong> the conjugate padin a lateral flow immunoassay is to accept the conjugate, hold it stable over its entire shelf life, <strong>and</strong> releaseit efficiently <strong>and</strong> reproducibly when the assay is run. The materials <strong>of</strong> choice are glass fibers, polyesters,or rayons.Sample Pad: Sample pad is an absorbent pad onto which the test sample is applied. One <strong>of</strong> themajor advantages <strong>of</strong> the lateral flow concept is that these assays can be run in a single step with manydifferent sample types in a variety <strong>of</strong> application areas. The role <strong>of</strong> the sample pad is to accept thesample, treat it such that it is compatible with the assay, <strong>and</strong> release the analyte with high efficiency.The materials used for the sample pad depend on the requirements <strong>of</strong> the application. Examples <strong>of</strong>such materials are cellulose, glass fiber, rayon, <strong>and</strong> other filtration media.Wick or waste reservoir: The wick is the engine <strong>of</strong> the strip. It is designed to pull all <strong>of</strong> the fluidadded to the strip into this region <strong>and</strong> to hold it for the duration <strong>of</strong> the assay. It should not releasethis fluid back into the assay or false positives can occur. The material is typically a high-densitycellulose.Backing Materials: All components <strong>of</strong> the lateral flow assay are laminated to the backing materialto provide rigidity <strong>and</strong> easy h<strong>and</strong>ling <strong>of</strong> the strip. The backing material is coated with a pressuresensitiveadhesive to hold the various components in place. The backing materials are typicallypolystyrene or other plastic materials coated with a medium to high tack adhesive.Labels for Detection: The most commonly used particulate detector reagents in lateral flow systemsare colloidal gold <strong>and</strong> monodisperse latex. Latex particles coupled with a variety <strong>of</strong> detector reagents,such as colored dyes, fluorescent dyes, <strong>and</strong> magnetic or paramagnetic components, are availablecommercially.Applications <strong>of</strong> lateral flow assays in food quality assuranceIn the past 3–5 years, food safety issues <strong>and</strong> concerns for public health have led to more stringentlegislation in food safety requirements. Legislation has produced increased dem<strong>and</strong> for pathogen<strong>and</strong> toxin tests in just about every segment <strong>of</strong> the food production industry – processed food, meats,poultry, beverages, <strong>and</strong> dairy; <strong>and</strong> by all major food producers worldwide. For monitoring residuecontaminants such as veterinary, pesticide <strong>and</strong> antibiotic residues, an analytical strategy has beenrecommended using two different methods. This strategy comprises: (i) screening with a first methodoptimized to prevent false negative results, with a high sample throughput (e.g. ELISA), an acceptablepercentage <strong>of</strong> false positive results <strong>and</strong> low cost, <strong>and</strong> (ii) confirmation with an independent secondmethod optimized to prevent false positive results. Confirmatory methods are generally separativetechniques coupled with various detectors such as HPLC <strong>and</strong> GC–MS. Chromatography methodsare sensitive <strong>and</strong> specific, but suffer from being time consuming, laborious <strong>and</strong> multi-complex. Inaddition, these technologies are unaffordable to the farmers <strong>and</strong> some laboratories in the developingcountries. Therefore there have been emergent needs for developing highly accurate, rapid <strong>and</strong> cheapanalytical tools. Lateral flow tests provide advantages in simplicity <strong>and</strong> rapidity when compared tothe conventional detection methods. LFT has also been confirmed to be a rapid <strong>and</strong> sensitive methodin the detection <strong>of</strong> food borne pathogens such as Salmonella, Listeria, Campylobacter, Clostridium<strong>and</strong> Escheriachia coli. Apart form these pathogens, LFA also has been employed for the detection <strong>of</strong>bacterial toxins <strong>and</strong> zoonotic viruses such as Avian Influenza (AIV). LFA have also been used for thedetection <strong>of</strong> potentially allergenic peanut <strong>and</strong> hazelnut in raw cookie dough <strong>and</strong> chocolate. The74


Lateral Flow Assay- Principle <strong>and</strong> its Application in Analytical Food ScienceTable :- applications <strong>of</strong> lateral flow assays in food analysisAnalyte Assay format Labels Sample Sensitivities ReferenceDetection <strong>of</strong> pathogen bacteria <strong>and</strong> related toxinsStaphylococcusaureusS<strong>and</strong>wich Colloidal gold Pork, Beef, FriedChickenEscherichia coli S<strong>and</strong>wich Colloidal gold Milk Powder, Flour,Starch, EtcListeriamonocytogenes


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceTable summarizes the published reports on LFT applications in this field. A driver in the dem<strong>and</strong>for rapid <strong>and</strong> LF tests in food production is the adoption <strong>of</strong> Hazard <strong>Analysis</strong> <strong>and</strong> Critical ControlPoints (HAACP) regulations that prescribe test procedures throughout the manufacturing process.A number <strong>of</strong> manufacturers have come with LF type tests. No one company dominates the marketfor LF food tests. The leaders are Strategic Diagnostics, Inc. (Newark, DE), Neogen, Idexx Labs <strong>and</strong>Biocontrol Systems (Brownsville, CA). Other companies include Celsis International PLC (Chicago,IL), Medical Wire & Equipment Co. (Wiltshire, United Kingdom), Merck KgaA (Dermstadt, Germany),<strong>and</strong> M-Tech Diagnostics Ltd. (Cheshire, United Kingdom).ConclusionsA variety <strong>of</strong> analytical methods available for detecting pathogen organisms or hazardouschemicals related to food safety, human health <strong>and</strong> environment suffers from being time-consuming,too expensive <strong>and</strong> too complicated to use. Major advantages found on LFT are low-cost, speed,portable, do not require complicated equipment <strong>and</strong> technical expertise, which are criticalcomponents during testing in the field. Since its initial development in the 1980s, the technology <strong>of</strong>Lateral Flow Immunoassay has gained wide acceptance. The main reason for its popularity is thesimplicity <strong>of</strong> the test design. The lateral flow immunoassay devices are compact <strong>and</strong> easily portable.Most <strong>of</strong> them do not require external reagent for results. Results are quick <strong>and</strong> easy to interpret,usually without the help <strong>of</strong> an instrument. The technology is also powerful. Multiple analytes can betested simultaneously with a single device. It can also be easily combined with other technology toprovide a comprehensive analysis like simultaneous drug <strong>and</strong> alcohol determinations by the policeforce in a roadside testing situation. Manufacturing <strong>of</strong> the test is relatively easy <strong>and</strong> inexpensive.Advancement in the detection moieties, improvement in material components, availability <strong>of</strong> betterprocessing equipment, <strong>and</strong> increased attention to quality manufacturing all these factors contributeto increase in the reliability, accuracy, <strong>and</strong> applications <strong>of</strong> the technology. However, the continuingdem<strong>and</strong> for quantitative result <strong>and</strong> sensitivity has presented great challenge for assay developer.References1. Blaskoza M, Koet M, Rauch P, Amerogen AV (2009) Eur Food Res Technol 229:867–8742. Chenggang S, Suqing Z, Kun Z, Guobao H, Zhenyu Z (2008) J Environ Sci 20:1392–13973. Geertruida A, Posthuma T, Jakob K, Amerogen AV (2008) Anal Bioanal Chem 392:1215-12234. Huang S-H, Wei H-C, Lee Y-C (2007) Food Control 18:893–8975. Khreich N, Lamourette P, Boutal H, Deveilliers K, Creminon C, Vollad H (2008) Anal Biochem 377:182–1886. Kolosova AY, De Saeger S, Sib<strong>and</strong>a L, Verheijen R, Peteghem CV (2007) Anal Bioanal Chem 389:2103–21077. Martı´n-Herna´ndez, C.; Mun˜oz, M.; Daury, C.; Weymuth, H.; Kemmers-Voncken, A.E.M,; Corbato´n, T.; Toribio,T. <strong>and</strong> Bremer, M.G.E.G. (2009). Int <strong>Dairy</strong> J. 19:205–208.8. Molinelli A, Grossalber K, Krska R (2009) Anal Bioanal Chem 395:1309–13169. Ngom, B., Guo, Y. Wang, X <strong>and</strong> Bi, D. (2010) Anal. Bioanal. Chem. 397: 1113-1135.10. O’Farrell, B. (2009) Evolution in lateral flow-based systems. In: Lateral flow immunoassay. (Ed. R.C. Wong <strong>and</strong>H.Y. Tse). Springer, NY, USA.11. Ponti, J.S. (2009)Material platform for the assembly <strong>of</strong> lateral flow immunoassay test strips. In: Lateral flowimmunoassay. (Ed. R.C. Wong <strong>and</strong> H.Y. Tse). Springer, NY, USA.12. Q. Rao, Y.-H. Peggy Hsieh. (2007) Meat Science. 76: 489–49413. Röder M , Vieths S, Holzhauser T (2009) Anal Bioanal Chem 395:103–10914. Rosen, S. (2009) Market Trends in Lateral Flow Immunoassays. In: Lateral flow immunoassay. (Ed. R.C. Wong <strong>and</strong>H.Y. Tse). Springer, NY, USA.15. Seo K-H, Holt PS, Gast RK, Stone HD (2003) Int J Food Microbiol 87:139–14416. Smidova Z, Blazkova M, Fukal L, Rauch P (2009) Czech J Food Sci 27:S414–S41617. Tang D, Sauceda JC, Lin Z, Basova SOE, Goryacheva I, Biselli S, Lin J, Niessner R, Knopp D (2009) Biosens Bioelectron25:51418. Wang J, Chen WN, Hu KX, Li W (2006) Chinese J 35:439–44119. Wang XH, Liu T, Xu N, Zhang Y, Wang S (2007) Anal Bioanal Chem 389:903–91120. Wang S, Zhang C, Wang J, Zhang Y (2005) Anal Chim Acta 546:161–16621. Wang J, Yu F-Y (2008) Anal Chem 80:7029–703522. Xu Y, Huang Z-B, He QH, Deng SZ, Li LS, Li YP (2010) J Food Chem 119:834–83923. Xiulan S, Xiaolian Z, Jian T, Xiaohong G, Jun Z, Chu FS (2006) Food Control 17:256–26276


Separation Strategies for Bioactive Milk ProteinsSeparation Strategies for Bioactive Milk ProteinsIntroduction:Rajesh Kumar<strong>Dairy</strong> Chemistry Division, NDRI, KarnalOver the past three decades, the dairy industry globally has moved from being based solely oncommodity food production to earning a significant income from specialty proteins. The introduction<strong>of</strong> large scale membrane processing in the early 1970’s made it possible not only to reduce waste but toproduce new products such as lactose <strong>and</strong> whey protein concentrate. A logical extension <strong>of</strong> the latterproduct is whey protein isolate (WPI), produced by single-stage batch capture <strong>of</strong> proteins on anionexchange resins. WPI is a crude mixture <strong>of</strong> acidic whey proteins, containing mainly α-lactalbumin,β-lactoglobulin, bovine serum albumin <strong>and</strong> immunoglobulins. Two whey proteins not capturedduring WPI production by anion exchange chromatography because <strong>of</strong> their high isoelectric pointsare lact<strong>of</strong>errin (LF) <strong>and</strong> lactoperoxidase (LP). These basic proteins are instead captured from whey orskim milk by cation exchange chromatography <strong>and</strong> sold as specialty ingredients.Although production <strong>of</strong> high-value whey proteins is a commercial reality, two aspects <strong>of</strong> dairyprocessing may not be optimal for their production. First, the proteins are subjected to a series <strong>of</strong>processing steps prior to being extracted. It is a generally accepted principle <strong>of</strong> bioseparation processdesign that proteins should be separated from a source material as fast <strong>and</strong> in as few steps as possible toavoid loss <strong>of</strong> activity <strong>and</strong> yield. Currently, high-value dairy proteins are viewed as a by-product, withthe major income <strong>of</strong> the industry coming from commodity dairy foods such as milk powder, cheese<strong>and</strong> butter. Economies <strong>of</strong> scale for production <strong>of</strong> commodity dairy products mean that centralizedprocessing is the industry norm.Separation technologies provide the basis for adding value to milk through the production <strong>of</strong> bioactivecomponents that provide the food industry with nutraceuticals to develop functional foods. The globalfunctional food <strong>and</strong> nutraceutical market is currently worth about US$50 billion <strong>and</strong> is growing at some8 – 10 % annually. This huge <strong>and</strong> rapidly growing market, driven by consumer dem<strong>and</strong>s for healthpromotingfoods, is creating an almost insatiable desire on the part <strong>of</strong> food manufacturers for new <strong>and</strong>novel ingredients with which to formulate these foods. <strong>Dairy</strong> constituents, notably the proteins <strong>and</strong>peptides, provide the food technologist with a rich selection <strong>of</strong> potential ingredients for functional foods.<strong>Dairy</strong> proteins <strong>and</strong> peptides are truly multi-functional components, providing desirable features suchas physical functional traits, nutritional qualities <strong>and</strong> an increasing array <strong>of</strong> substantiated bioactivities.<strong>Their</strong> promise is clear. The challenge for science <strong>and</strong> technology is to isolate these ingredients in a costeffectivemanner while maintaining their inherent bio functional traits.Protein bioseparation:Protein bioseparation refers to the recovery <strong>and</strong> purification <strong>of</strong> protein products from variousbiological feed streams is an important unit operation in the food pharmaceutical <strong>and</strong> biotechnologicalindustry. Protein bioseparation is at present more important than at any time before due tophenomenonal developments in recent years in the frontiers <strong>of</strong> separation technology.Novel separation techniques:Separation technologies used to produce protein ingredients derived from milk includescreening based on size differences: centrifugation based on density differences; membraneprocesses based on size differences, such as ultrafiltration, diafiltration, nan<strong>of</strong>iltration, <strong>and</strong> reverseosmosis; ion exchange based primarily on charge differences; <strong>and</strong> affinity chromatography based onspecific binding to a matrix. Owing to unique functional <strong>and</strong> biological properties <strong>of</strong> many <strong>of</strong> the wheyproteins, a number <strong>of</strong> pilot <strong>and</strong> industrial scale technological methods have been developed for theirisolation in a purified form. Improved separation technologies <strong>and</strong> emerging markets have resulted77


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assurancein fractionation <strong>of</strong> milk proteins into ingredients that are enriched in specific proteins, or peptides, orboth to fill those new opportunities. This is especially true for milk protein fractions that are in verylow concentrations in the native state that require further concentration. These ingredients may beespecially useful in the developing market <strong>of</strong> physiologically functional foods, or nutraceuticals.Separation technologies are available to prepare fractions that are enriched in the followingmilk components: alpha-CN, beta-CN, beta-LG, alpha-LA, casein phosphopeptides, lact<strong>of</strong>errin,lactoperoxidase <strong>and</strong> immunoglobulins <strong>and</strong> other minor proteins with special functional properties.Many <strong>of</strong> these products are commercially available in limited quantities. Bioactive peptides derivedfrom food proteins are <strong>of</strong>ten intermediates <strong>and</strong> are isolated from a very complex peptidic hydrolysatesin which their concentration are very low. The preparation <strong>of</strong> such peptides generally requires timeconsuming steps. Accordingly commercial production <strong>of</strong> bioactive peptide from milk proteins hasbeen limited by lack <strong>of</strong> suitable large scale techniques. Until now membrane based separation tech. hasprovided best technique for enrichment <strong>of</strong> peptides.Chromatographic techniques:Chromatographic techniques have been widely used for the isolation <strong>of</strong> milk proteins, <strong>and</strong> highperformance methodology now forms the basis for several accurate methods <strong>of</strong> analysis. Differenttypes <strong>of</strong> separation chemistries are used for chromatographic separation <strong>of</strong> milk proteins. In its simplestform, a chromatographic separation system consists <strong>of</strong> a column filled with separation adsorbentbeads. Chromatography has been known since the turn <strong>of</strong> the century, but its primary use has beenin the analytical sector, where the excellent separation capability has been a valuable investigativetool. The industrial use <strong>of</strong> this technology has however, been fairly limited <strong>and</strong> mainly used for highvalue added products in the pharmaceutical industry. Low processing rates <strong>and</strong> difficulties in scalingup chromatographic separation from laboratory to production scales has hampered the broader use<strong>and</strong> acceptance <strong>of</strong> the technology. However, now with the advancement in chromatography basedseparation technology, it has greatly improved the pr<strong>of</strong>itability <strong>of</strong> dairy industry through the bestpossible utilization <strong>of</strong> raw material especially whey in a cost effective manner.Chromatographic systems:The chromatographic systems are in many ways similar to ion-exchange systems. The varietyin adsorbent types <strong>and</strong> the range <strong>of</strong> applications are however far beyond what is known for ionexchange, <strong>and</strong> this has created a need for more sophisticated systems such as membrane adsorberbased chromatography, stirred tank batch process <strong>and</strong> exp<strong>and</strong>ed bed chromatography.Ion-exchange ChromatographyIon-exchange chromatography is the most popular method for protein purification.The theory <strong>of</strong> it is to use the difference <strong>of</strong> charges on proteins at a given pH. The solid adsorbentsare charged, positive or negative. Then the charged protein will be adsorbed by the charged adsorbents.According to the difference <strong>of</strong> the interaction forces between the protein <strong>and</strong> adsorbent, differentprotein is bounded differently by the adsorbent. Then, when we use some other buffer to replacethe protein, they (the proteins) will be washed out <strong>of</strong> the adsorbents in different velocity: the less theinteraction between the adsorbent <strong>and</strong> the proteins, the faster they will be washed out. Then, proteinscan be separated according to the sequence <strong>of</strong> their elution. There are two kinds <strong>of</strong> ion exchangers:anion exchangers, which have positively charged matrix, <strong>and</strong> will adsorb the proteins with negativecharge; cation exchanger, which have negative charged matrix, <strong>and</strong> will adsorb the proteins withpositive charge. The most common anion exchangers are DEAE- ,TEAE- <strong>and</strong> QAE-, <strong>and</strong> the cationexchangers <strong>of</strong>ten being used are CM- , S-.Membrane Chromatography:In order to overcome the limitations <strong>of</strong> traditional beads column, synthetic microporous ormacroporous membranes have been used as chromatography media. This method is called membranechromatography. Membrane chromatography can overcome the limitations associated with packed78


Separation Strategies for Bioactive Milk Proteinsbeds based chromatography. In membrane chromatographic processes, the transport <strong>of</strong> solutes to theirbinding sites take place predominantly by convection <strong>and</strong> the pore diffusion is very small comparingwith the beads column, thereby the mass transfer resistance is tremendously reduced. The result <strong>of</strong>this advantage is to reduce process time including adsorption, washing, elution <strong>and</strong> regenerationtime, which save time <strong>and</strong> improve efficiency. Most importantly, fast process can avoid the inactivity<strong>of</strong> biomolecules. As we all know, all the biomolecules have activities. The faster is the process, the lesspossibility for the biomolecules lose activity. The id ea <strong>of</strong> membrane chromatography is especiallysuited for large scaleprocess since the column volume <strong>of</strong> membrane can be made from less than 0.1ml <strong>and</strong> larger than thous<strong>and</strong>s <strong>of</strong> liters. Due to the macroporous structure <strong>of</strong> the membrane support,membrane chromatography has a lower pressure drop, higher flow rate <strong>and</strong> higher productivity.There are many advantages <strong>of</strong> using membrane chromatography over column chromatography. Therate <strong>of</strong> association between target proteins <strong>and</strong> functional groups in ion exchange membranes is veryrapid, unlike the slow rate <strong>of</strong> diffusion through packed columns. The fast convective flow combinedwith negligible pressure drop lim itations exhibited by the thin membranes mean that processingtimes are dramatically reduced compared with packed columns. A distinct advantage <strong>of</strong> pressuredriven ion exchange processes is that there are no heat-treatments, extremes <strong>of</strong> pH, or chemicalpretreatment that could compromise protein structure <strong>and</strong> functionality. Hence, development <strong>of</strong> ionexchange membranes would be most desirable in terms <strong>of</strong> purifying individual whey proteins for usein functional foods <strong>and</strong> pharmaceutical products (Goodall et al., 2008).Application <strong>of</strong> membrane chromatography for protein purificationUsually, the membranes used for membrane chromatography have functional lig<strong>and</strong>s attached totheir inner pore surface as adsorbents. There are many types <strong>of</strong> adsorptive membranes including ionexchangemembranes, affinity membranes, reverse-phase membranes <strong>and</strong> hydrophobic interactionmembranes. All these membranes have been developed for the purification <strong>of</strong> proteins, enzymes, <strong>and</strong>antibodies from various sources.The stirred tank system:In the stirred tank system for protein fractionation, the liquid to be treated is slurried with thechromatographic adsorbent material, in this case an ion-exchange resin, - until adsorption has occurred.The deproteinised solution is then draining from the stirred tank. The adsorbent is then washed withwater, prior to desorption <strong>of</strong> the proteins using an acid, alkali <strong>and</strong>/ or mineral salt solution. Comparedto the column system, the disadvantage <strong>of</strong> the stirred tank system is the fact that all the target proteinsare not removed, due to the equilibrium conditions. This problem can be partly solved by refeeding thedeproteinised solu tion to the adsorbent material, before the next batch <strong>of</strong> whey is treated. The stirredtank system allows the use <strong>of</strong> larger adsorbent particles, since the contact time between adsorbent <strong>and</strong>liquid can be increased. This facilitatesthe removal <strong>of</strong> the process solu tion, <strong>and</strong> makes the process less sensitive to fat <strong>and</strong> suspendedsolids. Also less overall changes in pH are required during the complete adsorption / desorptioncycle, which reduces the risk <strong>of</strong> protein denaturation, improving the final p roduct quality.Exp<strong>and</strong>ed bed chromatography:In exp<strong>and</strong>ed bed chromatography, viscous <strong>and</strong> particu late-containing feeds that would foul atraditional packed column are accommodated by introducing the feed upward through a column packedwith media designed to be suspended <strong>and</strong> dispersed in the upward flow. The bed expansion createsan increased void space between adsorbent particles allowing passage <strong>of</strong> particulate contaminants inthe feed <strong>and</strong> preventing unacceptable pressure buildup within the column. Once the feed is loaded<strong>and</strong> the target product is bound to the adsorbent, a wash step is performed, also in exp<strong>and</strong>ed bedupward flow mode, to remove particulates <strong>and</strong> unbound contaminants. Elution <strong>of</strong> the target productis then performed via downward flow in traditional packed bed mode. Some studies relate elutionperformed with an exp<strong>and</strong>ed bed upward flow mode. This tends to increase the elution volume. Aclean-in-place procedure is normally required after elution to prepare the column for another loading79


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assurancestep. An exp<strong>and</strong>ed bed is essentially a cross between a packed bed, with stationary p articles <strong>and</strong> lowflu id dispersion, <strong>and</strong> a fluidized bed, with r<strong>and</strong>omly mixing particles <strong>and</strong> high flu id dispersion.Process design variables for optimizing exp<strong>and</strong>ed bed chromatographic separations include chemical<strong>and</strong> physical properties <strong>of</strong> the packing media <strong>and</strong> <strong>of</strong> the feed solutions. Chromatographic media withthe appropriate density, particle size distribution, <strong>and</strong> mechanical stability required for exp<strong>and</strong>ed bedoperation are commercially available with several different chemistries including anion <strong>and</strong> cationexchange. The chemical properties <strong>of</strong> the feed such as pH, ionic strength, <strong>and</strong> buffer type that affectselectivity <strong>and</strong> capacity <strong>of</strong> the process have essentially the same effect in exp<strong>and</strong>ed bed mode as theydo in traditional packed bed chromatography.High Gradient Magnetic Fishing (HGMS):Heeboll-Nielsen et al., (2004) described the process for separation <strong>of</strong> lact<strong>of</strong>errin <strong>and</strong> lactoperoxidasefrom whey using superparamagnetic ion exchangers. HGMS is employed to simply remove productor contaminants from process or waste streams in mineral processing. The term HGMF covers theintegrated process from product adsorption to magnetic separation <strong>and</strong> finally recovery <strong>of</strong> the productin a clarified <strong>and</strong> partly purified form, in contrast to merely the collection <strong>of</strong> particles in HGMS. Theobjectives <strong>of</strong> the individual steps in HGMF are similar to those <strong>of</strong> any chromatographic purificationprocess, <strong>and</strong> the process generally consists <strong>of</strong>: (i) mixing <strong>of</strong> the feedstock with the superparamagneticadsorbents to bind the target protein; (ii) separation <strong>of</strong> the protein laden supports from the spentfeedstock supernatant using high gradient magnetic separation technology; (iii) washing <strong>of</strong> theadsorbents <strong>and</strong> elu tion <strong>of</strong> boundprotein from the adsorbents using multip le cycles <strong>of</strong> support capture <strong>and</strong> release <strong>and</strong> finally (iv)a procedure for cleaning <strong>and</strong> regeneration <strong>of</strong> the supports. In contrast to chromatography all steps areoperated in a batchwise manner, <strong>and</strong> each operation contains a step to capture the supports in highgradient magnetic field s. For such operation the HGMF system may be +designed with stirred reactortanks <strong>and</strong> closed recycled loops.Conclusion:<strong>Dairy</strong> manufacturing technology has exp<strong>and</strong>ed tremendously in recent years <strong>and</strong> the emphasison identifying, recovering, <strong>and</strong>/ or supplementing bioactive proteins <strong>and</strong> peptides as functionalingredients will remain at forefront <strong>of</strong> future. Ultimately these approaches will improve the quality <strong>of</strong>food products containing such constituents.References:Bajaj, R.K. <strong>and</strong> Sangwan, R.B. (2002) Health enhancing potential <strong>of</strong> whey proteins – a review. Indian J. <strong>Dairy</strong> Sci., 55(5):253-260.Bargemana,G., Koopsb, G.-H. , Houwinga , J. , Breebaartb, I. , van der Horsta, H.C. <strong>and</strong> Wessling, M. (2002). Thedevelopment <strong>of</strong> electro-membrane filtration for the isolation <strong>of</strong> bioactive peptid es: the effect <strong>of</strong> membrane selection<strong>and</strong> operating parameters on the transport rate. Desalination. 149: 369–374.Clare, D.A. , Catignani, G.L. <strong>and</strong> Swaisgood, H.E. (2003) Biodefense properties <strong>of</strong> milk: The role <strong>of</strong> antimicrobial proteins <strong>and</strong> p eptid es. Current Pharmaceutical Design, 9: 1239- 1255.Exp<strong>and</strong>ed bed adsorption; princip les <strong>and</strong> methods, Amersham Pharmacia Biotech, (1997).Goodall, S., Gr<strong>and</strong>ison, A. S., Jauregi, P. J. <strong>and</strong> Price J. (2008). Selective separation <strong>of</strong> the major whey proteins u sing ionexchange membranes. J. <strong>Dairy</strong> Sci. 91: 1-10Hauffman, L.M. <strong>and</strong> Harper, W.J (1999). Maximizing the value <strong>of</strong> milk through separation technologies. J. <strong>Dairy</strong> Sci.,82(10): 2238-2244Heebøll-Nielsen,A., Justesen,S.F.L, Hobley,T.J. <strong>and</strong> Thomas, O.R.T. (2004). High Gradient Magnetic Fishing recovery <strong>of</strong>basic whey proteins using superparamagnetic cation-exchangers. J. Biotech. 113: 247-262.Korhonen, H. (1998) Colostrum immunoglobulins <strong>and</strong> the complement system- potential ingredients <strong>of</strong> functionalfoods. IDF bulletin, 336: 36-40.Nielsen, W.K., Morten, A.O. <strong>and</strong> Lihme, A. Exp<strong>and</strong>ing the fronteiers in separation technology in Sc<strong>and</strong>inavian dairyInformation 2 / 02.Ol<strong>and</strong>er, M.A., Jakobsen, U.L., Hansen M.B. <strong>and</strong> Lihme, A. Fractionation <strong>of</strong> high value whey Proteins. in Sc<strong>and</strong>inavi<strong>and</strong>airy Information 2 / 01.Roper, D.K. <strong>and</strong> Lightfoot, E.N. (1995) Separation <strong>of</strong> biomolecules using adsorptive membranes. J. <strong>of</strong> ChromatographyA 702: 380


SDS-PAGE – Principle <strong>and</strong> ApplicationsSDS-PAGE – Principle <strong>and</strong> ApplicationsY. S. Rajput 1 <strong>and</strong> Rajan Sharma 21Animal Biochemistry Division, 2 <strong>Dairy</strong> Chemistry Division, NDRI, KarnalIntroduction <strong>and</strong> PrincipleThe purpose <strong>of</strong> sodium dodecyl sulphate – polyacrylamide gel electrophoresis (SDS-PAGE) is toseparate proteins according to their size. SDS-PAGE is the most widely used method for analyzingprotein mixture qualitatively. It is particularly useful for monitoring protein purification <strong>and</strong>, becausethe method is based on the separation <strong>of</strong> proteins according to size, it can be used to determine therelative molecular mass <strong>of</strong> proteins. SDS (CH 3-(CH 2) 10-CH 2OSO 3-Na + ) is an anionic detergent <strong>and</strong> whenproteins are treated with SDS in presence <strong>of</strong> a reducing agent like β-mercaptoethanol or dithiothreitol,SDS binds to hydrophobic regions <strong>of</strong> protein molecule <strong>and</strong> provides net negative charge on proteinmolecule. The binding <strong>of</strong> SDS to per-unit-length <strong>of</strong> protein molecules is almost constant for largenumber <strong>of</strong> different proteins <strong>and</strong> this brings charge-to–mass ratio almost constant for most proteins.The electrophoretic movement <strong>of</strong> protein in acrylamide gel is determined by molecular weight <strong>of</strong>proteins. Lower molecular weight proteins move faster than high molecular weight proteins. Themethod described by Laemmli (1970) is widely used. In this method, discontinuous buffer systemis employed. A continuous buffer system has only single separating gel <strong>and</strong> uses same buffer in thetanks <strong>and</strong> gel. In discontinuous buffer system, large pore gel (stacking gel) is layered over small poregel (separating or running gel). For preparation <strong>of</strong> stacking gel <strong>and</strong> separating gel, different buffers areused <strong>and</strong> also tank buffers are different from gel buffers. When electrophoresis is started, ions fromstacking gel (leading ion), ions from buffer tank (trailing ion) <strong>and</strong> proteins start moving into stackinggel. In stacking gel, protein moves between leading ion <strong>and</strong> trailing ion <strong>and</strong> this leads to concentration<strong>of</strong> protein in a thin zone referred as stack. The protein molecules continue to move in the stack untilthey reach the separating gel.Formation <strong>of</strong> Polyacrylamide Gels: Crosslinked polyacrylamide gels are formed from thepolymerization <strong>of</strong> acrylamide monomer in the presence <strong>of</strong> smaller amounts <strong>of</strong> N,N’-methylene-bisacrylamide(normally referred to as “bis-acrylamide”) (Fig. 1). Note that bis-acrylamide is essentiallytwo acrylamide molecules linked by a methylene group <strong>and</strong> is used as a crosslinking agent.Acrylamide monomer is polymerized in a head-to-tail fashion into long chains, <strong>and</strong> occasionally a bisacrylamidemolecule is built into the growing chain, thus introducing a second site for chain extension.Proceeding in this way, a crosslinked matrix <strong>of</strong> fairly well-defined structure is formed (Figure 1). Thepolymerization <strong>of</strong> acrylamide is an example <strong>of</strong> free-radical catalysis, <strong>and</strong> is initiated by the addition <strong>of</strong>ammonium persulfate <strong>and</strong> the base N,N,N’,N’tetramethylenediamine (TEMED). TEMED catalyzes thedecomposition <strong>of</strong> the persulfate ion to give a free radical (i.e., a molecule with an unpaired electron):2-S 2O 8+ e - 2- -.------ → S 2O 8+ SO 4(1)If this free radical is represented as R . (where the dot represents an unpaired electron) <strong>and</strong> M as anacrylamide monomer molecule, then the polymerization can be represented as follows:R . + M → RM .RM . + M → RMM .RMM . + M → RMMM. <strong>and</strong> so forth (2)In this way, long chains <strong>of</strong> acrylamide are built up, being crosslinked by the introduction <strong>of</strong> theoccasional bis-acrylamide molecule into the growing chain. Oxygen “mops up” free radicals, <strong>and</strong>therefore the gel mixture is normally degassed (the solutions are briefly placed under vacuum toremove loosely dissolved oxygen) prior to addition <strong>of</strong> the catalyst.Use <strong>of</strong> Stacking Gels: For both SDS-PAGE <strong>and</strong> native-PAGE, samples may be applied directly tothe top <strong>of</strong> the gel in which protein separation is to occur (the separating gel). However, in these cases,81


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assurancethe sharpness <strong>of</strong> the protein b<strong>and</strong>s produced in the gel islimited by the size (volume) <strong>of</strong> the sample applied to the gel.Basically the separated b<strong>and</strong>s will be as broad (or broader,owing to diffusion) as the sample b<strong>and</strong> applied to the gel.For some work, this may be acceptable, but most workersrequire better resolution than this. This can be achieved bypolymerizing a short stacking gel on top <strong>of</strong> the separating gel.The purpose <strong>of</strong> this stacking gel is to concentrate the proteinsample into a sharp b<strong>and</strong> before it enters the main separatinggel, thus giving sharper protein b<strong>and</strong>s in the separating gel.This modification allows relatively large sample volumesto be applied to the gel without any loss <strong>of</strong> resolution. Thestacking gel has a very large pore size (4% acrylamide) whichFigure 1. Polymerization <strong>of</strong> acrylamideallows the proteins to move freely <strong>and</strong> concentrate, or stackunder the effect <strong>of</strong> the electric field. Sample concentration is produced by isotachophoresis <strong>of</strong> thesample in the stacking gel. The b<strong>and</strong>-sharpening effect (isotachophoresis) relies on the fact that thenegatively charged glycinate ions (in the reservoir buffer) have a lower electrophoretic mobility thanthe protein-SDS complexes, which in turn, have lower mobility than the C1 - ions if they are in a region<strong>of</strong> higher field strength. Field strength is inversely proportional to conductivity, which is proportionalto concentration. The result is that the three species <strong>of</strong> interest adjust their concentrations so that [C1 - ]> [protein-SDS] > [glycinate]. There are only a small quantity <strong>of</strong> protein--SDS complexes, so theyconcentrate in a very tight b<strong>and</strong> between the glycinate <strong>and</strong> C1 - ion boundaries. Once the glycinatereaches the separating gel, it becomes more fully ionized in the higher pH environment <strong>and</strong> itsmobility increases. (The pH <strong>of</strong> the stacking gel is 6.8 <strong>and</strong> that <strong>of</strong> the separating gel is 8.8.) Thus, theinterface between glycinate <strong>and</strong> the C1 - ions leaves behind the protein-SDS complexes, which are leftto electrophorese at their own rates.Procedure: The below mentioned procedure is for the separation <strong>of</strong> proteins using glycine-SDS-PAGE. For the separation <strong>of</strong> low molecular weight proteins, Tricine-SDS-PAGE is used <strong>and</strong> procedureis mentioned in the compendium.Equipments <strong>and</strong> <strong>Chemical</strong>sMini-vertical gel electrophoresis dual model with glass plates, spacer, comb <strong>and</strong> power-supply;orbital shaker; 1 ml glass syringe with 2”22G needle; acrylamide, N,N1 methylene bisacrylamide;ammonium persulfate; β-mercaptoethanol; sodium dodecyl sulfate; molecular weight markers;coomassie brilliant blue R-250; TEMED; tris; glycine; dithiothreitol.Stock SolutionsAcrylamide / Bisacrylamide (30%): 29.2 g acrylamide <strong>and</strong> 0.8 g bisacrylamide are dissolved indistilled water <strong>and</strong> total volume was made to 100 ml. The solution is filtered <strong>and</strong> filtered solution canbe stored at 4ºC in dark bottle up to 3 months.4x Running Gel Buffer (1.5 M Tris-HCl, pH 8.8): 18.15 g Tris is dissolved in about 80 ml distilledwater. pH is adjusted to 8.8 with 1 N HCl <strong>and</strong> total volume is made to 100 ml with distilled water.Prepared buffer can be stored up to 3 months at 4ºC in dark bottle.4x Stacking Gel Buffer (0.5M Tris-HCl, pH 6.8): 3.0 g Tris is dissolved in about 40 ml distilledwater. pH is adjusted to 6.8 with 1 N HCl <strong>and</strong> total volume is made to 50 ml with distilled water.Prepared buffer can be stored up to 3 months at 4ºC in dark bottle.10% SDS: 10 g sodium dodecyl (lauryl) sulfate is dissolved in distilled water <strong>and</strong> total volume ismade to 100 ml with distilled water. Prepared solution can be stored at room temperature.5 x Electrode Buffer (125 mM Tris, 960 mM Glycine, 0.5 % SDS, pH 8.3: 15 g Tris, 72 g glycine <strong>and</strong> 5g SDS are dissolved in distilled water <strong>and</strong> total volume is made to 1 litre with distilled water. The pH<strong>of</strong> buffer should be 8.3 ± 0.2. Stock electrode buffer is diluted five times with distilled water before use.82


SDS-PAGE – Principle <strong>and</strong> ApplicationsThe stock buffer can be stored at room temperature up to 1 month. The diluted stock buffer is 25 mMtris, 192 mM glycine, <strong>and</strong> 0.1% SDS.10% Ammonium Persulfate: 100 mg ammonium persulfate is dissolved in 1.0 ml distilled water.The solution is always prepared fresh.2 x Sample Buffer (0.125 M Tris, 4% SDS, 20% glycenol 0.2 M DTT, 0.02% bromophenol blue, pH6.8: 2 x sample buffer is prepared by mixing following solutions/chemical.4 x stacking gel buffer - 2.5 mlglycerol - 2.0 ml10% SDS - 4.0 mlBromophenol blue - 2.0 mgDithiothreitol (DTT) - 0.31 gDistilled water - 1.5 ml2 x sample buffer can be stored in small aliquots at - 200C up to 6 months. Instead <strong>of</strong> DTT, 1.0 ml<strong>of</strong> β-mercaptoethanol can be used but the volume <strong>of</strong> water is reduced to 0.5 ml.Overlay Buffer (0.375 M Tris, 0.1%, SDS, pH 8.8): Overlay buffer is prepared by mixing 25 mlrunning gel buffer, 1 ml 10% SDS <strong>and</strong> 74 ml distilled water. This buffer can be stored up to 3 monthsat 4ºC in the dark bottle.ProcedureGlass S<strong>and</strong>wich: One notched glass plate is placed on a flat surface. One spacer (1.0 mm) each isthen placed along the each <strong>of</strong> two edges so that spacer aligns with the notch. Subsequently, rectangularglass-plate is placed over it. The s<strong>and</strong>wich is held firmly between thumb <strong>and</strong> fingers. Side-ways <strong>of</strong>both spacers were sealed with appropriate tape to overcome any possible gel-leak during gel platepreparation. There is always the possibility <strong>of</strong> leakage at the bottom <strong>of</strong> the plate. This is taken careby placing molted agar (1% in water) up to 5 mm height in trough <strong>of</strong> gel-casting unit. The plate inst<strong>and</strong>ing position is then quickly placed in casting unit <strong>and</strong> screws are finger tightened.Preparation <strong>of</strong> Running Gel: Running gel <strong>of</strong> desired concentration is prepared by mixingappropriate volumes <strong>of</strong> solutions as shown belowAcrylamide / bisacrylamide, running gelbuffer, SDS <strong>and</strong> distilled water are added toconical flask <strong>and</strong> degassed. Then ammoniumpersulfate <strong>and</strong> TEMED are added <strong>and</strong>contents mixed gently. With the help <strong>of</strong> glasspipette, the running gel solution is deliveredto s<strong>and</strong>wich to a level about 3 cm below thetop <strong>of</strong> rectangular plate. Air should not betrapped while filling s<strong>and</strong>wich with runninggel solution. A small volume <strong>of</strong> water oroverlay-buffer (~ 200 µl) is layered over gelsolution with the help <strong>of</strong> glass syringe with 22G needle. This prevents exposure to oxygen.SolutionsFinal Gel Concentrations7.5% 10% 12.5% 15%Acrylamide / 5.0 ml 6.7 ml 8.3 ml 10.0 mlbisacrylamide (30%)4 x Running gel 5.0 ml 5.0 ml 5.0 ml 5.0 mlbuffer10% SDS 0.2 ml 0.2 ml 0.2 ml 0.2 mlDistilled water 9.7 ml 8.0 ml 6.4 ml 4.7 ml10% Ammonium 0.1 ml 0.1 ml 0.1 ml 0.1 mlpersulfateTEMED 6.7 µl 6.7 µl 6.7 µl 6.7 µlPreparation <strong>of</strong> Stacking Gel: Stacking gel <strong>of</strong> 4% concentration is prepared by mixing appropriatevolumes <strong>of</strong> solutions as shown belowThe preparation <strong>of</strong> stacking-gel solution is similar to preparation <strong>of</strong> running-gel solution. Afterremoval <strong>of</strong> water or overlay buffer, stacking-gel solution is layered over running gel. Appropriatecomb is inserted into the stacking gel to make wells for sample application. Comb is removed afterpolymerization <strong>of</strong> gel.83


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceSample Preparation: Protein samples (1 mg/ml) are SolutionsVolumecentrifuged (10,000 g, 5 min.) to remove any insoluble material Acrylamide / bisacrylamide (30%) 1.3 ml<strong>and</strong> are mixed with equal volume <strong>of</strong> 2 X sample buffer. The4 x Stacking gel buffer 2.5 mlresultant solution is boiled for 3 to 5 min. Molecular weight10% SDS 0.1 mlmarkers are also prepared in a similar way.Distilled water6.1 mlElectrophoresis: Gel plates are then tightly attached10% Ammonium persulfate 50 µlto electrophoresis unit. Stock electrode buffer is five timesTEMED 10 µldiluted with cold water. Anode <strong>and</strong> cathode chambers arefilled with buffer. 5 to 20 µl <strong>of</strong> sample is applied to eachwell. Electrophoresis is carried out at constant voltage <strong>of</strong> 50V till sample crosses stacking gel. Whensample enters running gel, voltage is increased to 100V. Complete electrophoretic run takes around2.5 to 3.0 h. During electrophoresis, temperature is kept low by circulating water in electrophoreticassembly. After electrophoretic run, stacking gel is removed. Small cut on top left side in runninggel is made to remember the orientation <strong>of</strong> the gel.Staining <strong>of</strong> proteins in gel: The gel is placed in glass tray containing coomassie brilliant blue solution(0.25%) prepared in methanol : acetic acid : water (40:7:53) mixture. Glass tray is then placed on orbitalshaker for 4 h at room temperature. After staining for 4 h, the gel is transferred to the destaining solutionI (methanol, acetic acid <strong>and</strong> water mixture in ratio <strong>of</strong> (40:7:53) for 30 min. Subsequently gel is placedin destaining solution II (methanol, acetic acid <strong>and</strong> water mixture in ratio <strong>of</strong> 7:5:88) till b<strong>and</strong>s becomevisible against light background. During staining <strong>and</strong> destaining, gel should float free in glass tray.Helpful-hints84• A particular concentration <strong>of</strong> acrylamide gel is used Per Cent Molecular weight <strong>of</strong> proteinsfor separating proteins <strong>of</strong> particular range <strong>of</strong> molecularweights. Whereas low acrylamide gel concentration isused for separating high molecular weight proteins,low molecular weight proteins are resolved in highgel concentration. Use following table in deciding gelconcentration in separating gel.gel7.510.012.515.0to be separated (KD)24 – 20514 – 20514 – 6614 – 45• Spacers can absorb heat <strong>and</strong> thus lowers the temperature <strong>of</strong> gel at edges. If the gel is hotter inthe middle than at the edges, the mobility <strong>of</strong> dye front at edges will be lower as compared tomobility in the middle. This can be avoided by (i) using cooled electrode buffer <strong>and</strong> (ii) notallowing buffer to warm up during run. Thus, during electrophoretic run either use coolingdevice or use low current.• If gel is not polymerized properly at edges, current can leak down the edges resulting in moremobility at edges. Air- bubbles at the bottom <strong>of</strong> glass plates can block current flow resultingabnormal dye front.• While placing comb in stacking gel, care should be taken not to allow air-trap. Air inhibitspolymerization <strong>and</strong> sample wells will be distorted.• All stock solutions required for gel preparation are stored at refrigerated temperature <strong>and</strong> theseshould be brought to room temperature. At low temperature, polymerization is inhibited. Oxygenalso inhibits polymerization <strong>of</strong> acrylamide <strong>and</strong> these solutions should be degassed before use.• Sometimes boiling <strong>of</strong> sample in sample buffer may lead to irreversible precipitation <strong>and</strong> suchsamples remain at the top <strong>of</strong> separating gel. For such samples one can try incubating sample insample buffer at 70ºC instead <strong>of</strong> 100ºC.Reference:Laemmli, U.K. (1970) Cleavage <strong>of</strong> structural proteins during the assembly <strong>of</strong> the head <strong>of</strong> bacteriophage T 4. Nature, 227L680-685.Walker, J.M. (2006) Electrophoretic techniques. In Principles <strong>and</strong> Techniques <strong>of</strong> Biochemistry <strong>and</strong> Molecular biology (K.Wilson & J. Walker Eds). Cambridge University Press, New York.


Western Blot: Theoretical AspectsWestern Blot: Theoretical AspectsY. S. Rajput 1 <strong>and</strong> Rajan Sharma 21Animal Biochemistry Division, 2 <strong>Dairy</strong> Chemistry Division, NDRI, KarnalWestern blotting is the transfer <strong>of</strong> proteins from the SDS-PAGE gel to a solid supporting membrane.For analysis based on antibody reactivity or nucleic acid hybridization, the separated molecules aremade free <strong>of</strong> electrohoretic matrix. This can be simply achieved by slicing the gel followed by elution inbuffer. But, this process is slow <strong>and</strong> resolution is also poor. An alternative efficient method is ‘blotting’technique in which molecules are separated on a slab gel <strong>and</strong> separated molecules are eluted throughthe broad face <strong>of</strong> the gel onto a membrane that binds the molecules as they emerge. Proteins <strong>and</strong>nucleic acids stay on the surface <strong>and</strong> can be detected.The membrane materials frequently employed in blotting are nitrocellulose, nylon <strong>and</strong>polyvinylidene difluoride (PVDF). The choice <strong>of</strong> membrane depends on the type <strong>of</strong> analysis <strong>and</strong>characteristics <strong>of</strong> detection system. Nitrocellulose is the most widely used since it works well withboth protein <strong>and</strong> nucleic acids. Some nylons do not bind protein reliably. PVDF, is <strong>of</strong>ten used whenbound proteins are analysed for sequencing.The transfer <strong>of</strong> the proteins or nucleic acids from the gel to the membrane can be achieved bycapillary flow <strong>of</strong> buffer or by transverse’ electrophoresis. The use <strong>of</strong> capillary flow to transfer DNAfrom agarose gels to nitrocellulose membrane was first described by Southern (1975) <strong>and</strong> thus referredas Southern blotting. Using the same method for transfer <strong>of</strong> RNA is referred as Northern blotting.Western blot refers to transfer <strong>of</strong> protein from gel to membrane <strong>and</strong> this technique was described in1979-80 by many workers but the method described by Towbin et al. (1979) is most cited.Western blotting essentially comprises <strong>of</strong> three techniques which are applied in sequence. Thefirst one is referred as SDS-PAGE through which proteins are separated based on the molecular size<strong>of</strong> molecules in acrylamide gel. Sodium dodecyl sulphate (SDS) is an anionic detergent that denaturesproteins by wrapping around the polypeptide backbone. This results in net negative charge topolypeptide in proportion to its length. Laemmli system (Laemmli, 1970) employing discontinuousbuffer is most widely used electrophoretic system. The resolution in Laemmli’s method is excellentbecause treated peptides are concentrated in stacking gel before entering the separating gel. Thetechnique, which follows SDS-PAGE, is transfer <strong>of</strong> protein/from gel to membrane. There are twotypes <strong>of</strong> equipments for electrophoretic transfer <strong>of</strong> proteins: the semi-dry blotting apparatus <strong>and</strong>‘tank’ buffer apparatus. The third technique used in sequence is for identification <strong>of</strong> protein (antigen)by performing” antigen-antibody (first antibody) reactions on the membrane itself. Second antibodyenzyme conjugates were then allowed to interact with immobilized first antibody <strong>and</strong>, then usingappropriate substrate, protein b<strong>and</strong>s are detected. Although, antigen-antibody interactions are widelyemployed in Western blot, other kind <strong>of</strong> interactions such as glycoprotein-lectin <strong>and</strong> biotin-avidinhave allowed research workers to employ this technique for other applications including carbohydratestaining <strong>of</strong> glycoprotein, protein sequencing etc.Semi-dry electrophoretic transferIn semi-dry electrophoretic transfer, a stack <strong>of</strong> wetted filter papers surrounding the gel <strong>and</strong> theblotting membrane is used as a buffer reservoir, instead <strong>of</strong> tank as in conventional electrophoretictransfer. The electrodes, consist <strong>of</strong> conductive plates made <strong>of</strong> graphite or stainless steel or a conductingpolymer. The size <strong>of</strong> the plates is at least the same size as that <strong>of</strong> gel to provide homogeneous electricfield. The main advantages with semi¬dry transfer are the ease <strong>of</strong> h<strong>and</strong>ling, the short time (30 min, to1 h) required for the transfer <strong>and</strong> low buffer consumption. Another important feature is that differentbuffers can be used at the anodic <strong>and</strong> cathodic sides to improve the transfer. The short electrodedistance gives a high voltage gradient despite low power. Cooling is not normally required since heatproduction is negligible. Transfer can be performed from several gels at a time, either by placing them85


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assurancebeside each other if the electrodes are large enough or by placing several transfer units on top <strong>of</strong> eachother. Because <strong>of</strong> the short electrode distance, voltage applied is most <strong>of</strong>ten 10-20V. On the other h<strong>and</strong>,because <strong>of</strong> large cross-sectional area, the current passing through the transfer s<strong>and</strong>wich is fairly high,in the range 0.1-1A.Tank-buffer electrophoretic transferIn tank-buffer electrophoretic transfer, transfer cassette is submerged in a ‘tank’ <strong>of</strong> buffer. Gel,membrane, filter paper, porous foam sheet are arranged in cassette as per instructions <strong>of</strong> manufacturer.The details have been provided in write-up for practicals.Blot membranesNumerous types <strong>of</strong> papers <strong>and</strong> membranes have been utilized for protein blotting. Nitrocellulosepaper (film <strong>of</strong> nitric acid esterified cellulose) has been the most frequently used membrane.The binding<strong>of</strong> proteins to nitrocellulose is probably hydrophobic. For electrophoretic transfer <strong>of</strong> small proteins,membranes with 0.1or 0.2 µm pore size are selected. If membranes stick to low concentration gels aftertransfer, membranes with pore size <strong>of</strong> 0.45 µm are selected. A drawback with nitrocellulose membraneis, however, that they are very brittle when dry.The other membrane, which is in use, is polyvinylidene fluoride (PVDF). PVDF membrane is ateflon-type polymer composed <strong>of</strong> the basic repeating unit (- +δ CH 2- -δ CF 2-) n<strong>and</strong> has good mechanicalstrength. Proteins interact with the polymer non-covalently through dipolar <strong>and</strong> hydrophobicinteractions. PVDF is chemically compatible with the aqueous buffer systems. Since PVDF is resistant tomost organic solvents, it can withst<strong>and</strong> harsh chemical conditions in which nitrocellulose membranesdissolve or decompose. These membranes are expensive. Some PVDF membranes have additionalcomponents. Western consists <strong>of</strong> PVDF cast on a polyester web. The web does not interfere withelectroblotting or alter the characteristics <strong>of</strong> the PVDF. Immobilon-CD is PVDF membrane in whichsurface is chemically modified to have a cationic charge. Although hydrophobic <strong>and</strong> dipolar interactionswith the Immobilon-CD may contribute to protein binding, the primary binding interaction is ionic.The membranes with high internal surface area (>2000 cm 2 per cm 2 <strong>of</strong> frontal area) bind substantiallymore protein (400 µg BSA/cm 2 ) as compared to membrane with low internal surface area (~400 cm 2per cm 2 <strong>of</strong> frontal area) that binds to around 130 µg BSA/cm 2 . Low internal surface area membranesusually function better in immunodetection. They are comparatively easy to block <strong>and</strong> antibodies arebetter able to penetrate the more open pore structure. Membranes with high internal surface structureare more difficult to block effectively <strong>and</strong> less open pore structure <strong>of</strong>ten limits antibody accessibility.Besides immunodetection, PVDF membranes are used for amino acid sequencing, amino acid analysis<strong>and</strong> peptide mapping. For these applications, blocking is not required <strong>and</strong> there is no steric hindranceencountered by antibodies. Higher internal surface membranes <strong>and</strong> Immobilon-CD are suitable foramino acid sequencing <strong>and</strong> amino acid analysis. Peptide mapping is more effective on low internalsurface area membranes. PVDF membrane is compatible with protein staining <strong>and</strong> immune-chemicalprotocols.Positively charged nylon membranes arc mechanically strong <strong>and</strong> have a high binding capacity.A disadvantage is their high non-specific binding which results in a high background afterimmunodetection. Most general protein stains are anionic dyes <strong>and</strong> can not be used with nylonmembranes since they bind to these membranes.Transfer bufferA major concern in transferring proteins onto nitrocellulose membrane is the composition <strong>of</strong> thetransfer buffer. The original protocol <strong>of</strong> Towbin et al. (1979) uses a transfer buffer containing methanol,which was added to, counteract swelling <strong>of</strong> the gel. Methanol also decreases gel pore size, removes SDSfrom proteins. Methanol may precipitate the proteins within the gel, however, it increases the capacity<strong>and</strong> the affinity <strong>of</strong> nitrocellulose membrane for proteins. PVDF membrane is activated by placingit in 100% methanol for 1-2 sec. This allows the hydrophobic surface <strong>of</strong> PVDF to wet with aqueous86


Western Blot: Theoretical Aspectssolvent. Addition <strong>of</strong> 20% methanol to transfer buffer is recommended for low molecular weightproteins. Methanol is not required for transfer to charged nylon membranes. Methanol facilitates thedissociation <strong>of</strong> SDS-Protein complexes <strong>and</strong> increases the hydrophobic interaction between protein <strong>and</strong>membrane. On the other h<strong>and</strong>, for high molecular weight proteins, methanol can decrease the elutionefficiency by denaturing the proteins or retarding the elution from the gel. In contrast to low molecularweight proteins, high molecular weight proteins do not require methanol for adequate binding to themembrane.The presence <strong>of</strong> SDS in transfer buffer increases the mobility <strong>of</strong> protein from gel to membrane. Thisis especially useful for transfer <strong>of</strong> protein after isoelectric focussing, when proteins have no net charge.However, SDS decreases the binding <strong>of</strong> the protein to both nitrocellulose <strong>and</strong> PVDF membrane. It issometimes necessary to add SDS (0.01-0.02%) to aid transfer <strong>of</strong> high molecular weight proteins. Transferbuffer generally used is 25 mM Tris, 192 mM glycine, pH 8.3 <strong>and</strong> 20% methanol. If membrane is tobe used for protein sequencing or amino acid, analysis, CAPS buffer (10 mM 3-(cyclohexylamino)-1¬propanesulfonic acid, 10% methanol, pH 11.0 is recommended. Application <strong>of</strong> protein blotting forcharacterization <strong>of</strong> antigens will require antigen specific antiserum. By simultaneously runningmolecular weight markers <strong>and</strong> proteins (extracted from biological materials) in SDS-PAGE <strong>and</strong>subsequent detection after electrophoretic transfer provides information about molecular weight <strong>of</strong>antigen. Antibodies should be specific otherwise cross-reaction is observed <strong>and</strong> interpretation is moredifficult. Affinity purified antibodies or monoclonalantibodies provide good result. Through thesereactions, one can detect presence or absence <strong>of</strong>such antigens in related <strong>and</strong> unrelated biologicalmaterials. Now tools are available for ascertainingcarbohydrate moiety in proteins on membrane.These proteins can be oxidized by periodateresulting in generation <strong>of</strong> free aldehyde groups(Figure 1). The generated groups are reacted withbiocytin hydrazide leading to biotinylation <strong>of</strong>glycoproteins. Using appropriate probe such asavidin-peroxidase <strong>and</strong> substrate, glycoproteinsare detected. Alternately lactins specific forcarbohydrate residues can be employed. In thisapproach antibody (against lectins) enzymeconjugates or lactin - enzyme conjugates canbe used for staining glycoproteins. Asn-linked oligosaccharides can be cleared from protein ontomembrane by hydrazinolysis. The released oligosaccharides can be characterized by using biochemicaltechniques. Proteins onto membrane can be hydrolyzed for determining amino acid composition.Peptide mapping <strong>and</strong> protein sequencing are other useful applications where proteins on membraneare the starting material for subsequent steps.References:Figure 1. Detection <strong>of</strong> Biotin Labeled Glycoproteins onWestern blotsKurien, B.T <strong>and</strong> ScoWeld, R. H. (2006) Western blotting. Methods: 38 (2006) 283–293.Towbin, H.; Stachelin, T. <strong>and</strong> Gordon, J. (1979) Electrophoretic transfer <strong>of</strong> proteins from polyacrylamide gels tonitrocellulose sheets: procedure <strong>and</strong> some applications. Proc. Nat. Acad. Sci. USA. 76: 4350-4354.87


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceEnzyme Linked Immunosorbent Assay - TheoryRajeev Kapila <strong>and</strong> Suman KapilaAnimal Biochemistry Division, NDRI, KarnalEnzyme immunoassay (EIA) <strong>and</strong> enzyme-linked immunosorbent assay (ELISA) have becomehousehold names for medical laboratories, manufacturers <strong>of</strong> in vitro diagnostic products, regulatorybodies, <strong>and</strong> external quality assessment <strong>and</strong> pr<strong>of</strong>iciency-testing organizations. Analytes such aspeptides, proteins, antibodies <strong>and</strong> hormones can be detected selectively <strong>and</strong> quantified in lowconcentrations by ELISA. ELISAs are rapid, sensitive, cost effective <strong>and</strong> can be performed in a highthroughputmanner. In contrast, techniques like immun<strong>of</strong>luorescence <strong>and</strong> RIA are tedious, timeconsuming, having short shelf-life <strong>of</strong> the reagents, requiring sophisticated expensive equipments <strong>and</strong>the strict regulatory controls on the use <strong>of</strong> isotope. Though, this technique is relatively less sensitive ascompared to radio-immuno-assay (RIA) but efforts are continuing to increase its sensitivity.An ELISA is used in a vast variety <strong>of</strong> different types <strong>of</strong> assays (e.g. direct ELISA, indirect ELISA,s<strong>and</strong>wich ELISA, competitive ELISA). Nevertheless, all ELISA variants are based on the same principle,the binding <strong>of</strong> one assay component – antigen or specific antibody – to a solid surface <strong>and</strong> the selectiveinteraction between both assay components. Molecules not specifically interacting with the assaycomponent are washed away during the assay. For the detection <strong>of</strong> the interaction, the antibody orantigen is labeled or linked to an enzyme (direct ELISA). Alternatively, a secondary antibody conjugatecan be used (indirect ELISA). The assay is developed by adding an enzymatic substrate to produce ameasurable signal (colorimetric, fluorescent or luminescent). Such a substrate is called a chromogenicor luxogenic substrate. The strength <strong>of</strong> the signal indicates the quantity <strong>of</strong> analytes in the sample.A number <strong>of</strong> enzymes have been employed for ELISA, including alkaline phosphatase, horseradishperoxidase <strong>and</strong> β-galactosidase. These assays approach the sensitivity <strong>of</strong> Radioimmunoassay (RIA)<strong>and</strong> have the advantage <strong>of</strong> being safer <strong>and</strong> less costly.Direct ELISAThe direct ELISA uses the method <strong>of</strong> directly labeling the antibody itself. Microwell plates arecoated with a sample containing the target antigen, <strong>and</strong> the binding <strong>of</strong> labeled antibody is quantitatedby a colorimetric, chemiluminescent, or fluorescent end-point. This technique has advantages <strong>of</strong>direct detection, quick methodology since only one antibody is used. Cross-reactivity <strong>of</strong> secondaryantibody is eliminated. Major disadvantages <strong>of</strong> direct detection is reduced Immunoreactivity <strong>of</strong> theprimary antibody as the result <strong>of</strong> labeling. Labeling <strong>of</strong> every primary antibody is time-consuming <strong>and</strong>expensive. No flexibility in choice <strong>of</strong> primary antibody label from one experiment to another. Littlesignal amplificationIndirect ELISAThe indirect ELISA utilizes an unlabeled primary antibody in conjunction with a labeled secondaryantibody. Since the labeled secondary antibody is directed against all antibodies <strong>of</strong> a given species(e.g. anti-mouse), it can be used with a wide variety <strong>of</strong> primary antibodies (e.g. all mouse monoclonalantibodies). Indirect detection method <strong>of</strong> ELISA is versatile, since many primary antibodies can bemade in one species <strong>and</strong> the same labeled secondary antibody can be used for detection. Moreover,wide variety <strong>of</strong> labeled secondary antibodies are available commercially. Immunoreactivity <strong>of</strong> theprimary antibody is not affected by labeling. Sensitivity is increased because each primary antibodycontains several epitopes that can be bound by the labeled secondary antibody, allowing for signalamplification. Cross-reactivity may occur with the secondary antibody, resulting in nonspecificsignal.88


Enzyme Linked Immunosorbent Assay - TheoryS<strong>and</strong>wich ELISAThe s<strong>and</strong>wich ELISA measures the amount <strong>of</strong> antigen between two layers <strong>of</strong> antibodies. Theantigens to be measured must contain at least two antigenic sites, capable <strong>of</strong> binding to antibody,since at least two antibodies act in the s<strong>and</strong>wich. So s<strong>and</strong>wich assays are restricted to the quantitation<strong>of</strong> multivalent antigens such as proteins or polysaccharides. S<strong>and</strong>wich ELISAs for quantitation <strong>of</strong>antigens are especially valuable when the concentration <strong>of</strong> antigens is low <strong>and</strong>/or they are containedin high concentrations <strong>of</strong> contaminating protein.Competitive ELISAIn this unlabeled antibody is incubated in the presence <strong>of</strong> its antigen. These bound antibody/antigen complexes are then added to an antigen coated well. The plate is washed <strong>and</strong> unboundantibody is removed. The secondary antibody, specific to the primary antibody is added. This secondantibody is coupled to the enzyme. A substrate is added, <strong>and</strong> remaining enzymes elicit a chromogenicor fluorescent signal. For competitive ELISA, the higher the original antigen concentration, the weakerthe eventual signal.Selection <strong>of</strong> enzymes for labellingAntigen-antibody interaction is basis on which Elisa works <strong>and</strong> extent <strong>of</strong> interaction is measuredby measuring the activities <strong>of</strong> enzyme linked to antigen or antibody. In ELISA, a soluble substrate thatis converted to soluble coloured product is used. Absorbance <strong>of</strong> colour is read in ELISA plate reader,which can read samples in 96-well microtitre plates. Enzymes are selected on the basis <strong>of</strong> availability <strong>of</strong>purified enzyme at cheaper rate, turn over number <strong>and</strong> availability <strong>of</strong> cheaper chromogenic substrates.The most common enzymes used are horseradish peroxidase <strong>and</strong> alkaline phosphate.Applications in dairySince the advent <strong>of</strong> pasteurization, the dairy industry has been a leader in food safety <strong>and</strong>aggressively proactive in its commitment to ensure the safety <strong>of</strong> dairy products. Few areas <strong>of</strong> attentionare pathogens, toxins, adulterants <strong>and</strong>, more recently, allergens. Thanks to new technological advancesin convenient-to-use, rapid screening tests, these safety issues can now be addressed as part <strong>of</strong> a totaldairy quality control program.Detection <strong>of</strong> pathogensBacterial pathogen contamination <strong>of</strong> dairy products is usually monitored via agar plate countingtechniques, which generally take from one to five days—too long to be an effective pathogen screeningtool. One <strong>of</strong> the most popular immunoassay techniques for screening milk for pathogens <strong>and</strong> toxins isthe enzyme-linked immunosorbent assay (ELISA) method. Highly automated <strong>and</strong> sensitive bench-topinstruments based on immunoassay methods are now available <strong>and</strong> have significantly reduced thetime <strong>and</strong> labor required to obtain results. According to Vasavada (2001), the rapidity <strong>and</strong> sensitivity<strong>of</strong> immunoassay-based test kits <strong>and</strong> systems have come a long way in the past few years due todevelopment in immunoprecipitation devices, lateral flow devices <strong>and</strong> immunomagnetic separation(IMS) techniques. Immunoassay tests <strong>of</strong>fer three important advantages: speed <strong>of</strong> analysis, sensitivity<strong>and</strong> high specificity for detecting the target pathogen.Detection <strong>of</strong> allergensAllergens are another area <strong>of</strong> food safety concern. Approximately 2 to 3% <strong>of</strong> adults <strong>and</strong> 5 to 8%<strong>of</strong> children are allergic to foods. Food allergies are caused by proteins that can trigger an immuneresponse in sensitized individuals. As the number <strong>of</strong> different ingredients used in formulatedfoods continues to grow, it is becoming more common for dairy processing plants to h<strong>and</strong>le awider spectrum <strong>of</strong> ingredients than they did a few years ago. This has increased the likelihood <strong>of</strong>cross-contamination <strong>of</strong> products with inappropriate ingredients—i.e., ingredients that can causeallergic reactions <strong>and</strong> are not indicated on product labels. Whether it’s peanuts, tree nuts, milk,eggs, wheat or soybeans, nearly every processed food has an identified allergen in it. Currently,89


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assurancethe most popular type <strong>of</strong> food allergen testing is based on s<strong>and</strong>wich enzyme-linked immunoassays(S-ELISAs). A target allergen protein is extracted from samples with a buffered salt solution. Theextracted protein is sampled <strong>and</strong> added to antibody-coated microwells, where it binds to theantibody during an incubation period. After a wash step, enzyme-labeled antibody (conjugate) isadded to the antibody wells <strong>and</strong> is allowed to attach to the bound allergen, forming an “antibodys<strong>and</strong>wich” around the allergen. After another wash step, substrate is added which reacts with theconjugate to produce blue color. The intensity <strong>of</strong> color is proportional to the amount <strong>of</strong> allergen.It is important to realize some <strong>of</strong> the limitations inherent in this type <strong>of</strong> testing. Because hightemperature may denature protein, test antibodies may not capture a sample’s allergenic component.This is especially true with egg products, which denature at a relatively low time <strong>and</strong> temperaturecombination. Since denatured protein may remain allergenic, it is recommended that products betested prior to baking or cooking. Another problem can occur when testing samples that have high oilcontent. Although low levels <strong>of</strong> protein may be present in edible oils, they may be difficult to extractwith st<strong>and</strong>ard extraction solutions <strong>and</strong> may not be detected by the test. Also, it is important to notethat using a test kit designed for testing the presence <strong>of</strong> peanut protein is not appropriate to use forscreening samples for almonds, pecans or other tree nuts. Care must be exercised when testing foregg allergens. Some test kits only test for egg white proteins; egg yolk proteins can also cause allergicreaction in people sensitized to egg yolk proteins.Detection <strong>of</strong> <strong>of</strong> Aflatoxin M1 (AFM1) in milk <strong>and</strong> milk productsKim et al (2000) examined the occurrence <strong>of</strong> aflatoin M1 in pasteurized milk <strong>and</strong> dairy productslike milk infant formula, milk powders <strong>and</strong> yoghurt. Recoveries <strong>of</strong> AFM1 from sample spiked at levelsbetween 5 <strong>and</strong> 500pg/ml were 88-106% for pasteurized milk <strong>and</strong> 84-94% for yoghurt by ELISA. Limits<strong>of</strong> detection were 2pg/ml. The occurrence <strong>of</strong> Aflatoxin M1 (AFM1) contamination in Indian infantmilk products <strong>and</strong> liquid milk samples was investigated by competitive ELISA technique. The range <strong>of</strong>contamination <strong>of</strong> AFM1 was comparatively higher in infant milk products (65–1012 ng/l) than liquidmilk (28–164 ng/l). Almost 99% <strong>of</strong> the contaminated samples exceeded the European Communities/Codex Alimentarius recommended limits (50 ng/l), while 9% samples exceeded the prescribed limit<strong>of</strong> US regulations (500 ng/l). The extrapolation <strong>of</strong> AFM1 data to estimate the Aflatoxin B1 (AFB1)contamination in dairy cattle feedstuffs indicate that the contamination may range from 1.4 to 63.3 μg/kg with a mean <strong>of</strong> 18 μg/kg which is substantially higher than the directive <strong>of</strong> European Communitiesregulation (5 μg/kg).Detection <strong>of</strong> adulteration <strong>of</strong> goat, sheep <strong>and</strong> buffalo milk <strong>and</strong> cheeseAn indirect ELISA successfully developed for the detection <strong>of</strong> defined amounts <strong>of</strong> cows’ milk(1-50%) in sheeps’ milk <strong>and</strong> cheese. The assay used polyclonal antibodies raised in rabbits against bovinecaseins (BC). The antibodies were biotinylated <strong>and</strong> rendered cows’ milk specific by mixing them withlyophilized ovine <strong>and</strong> caprine caseins. Extravidin- peroixidase used to detect the biotinylated anti-BCantibodies bound to BC immobilized on 96-well plates. Subsequent enzymic conversion <strong>of</strong> substrategave clear absorbance differences when assaying mixtures <strong>of</strong> sheeps’milk <strong>and</strong> cheese containingvariable amounts <strong>of</strong> cows’ milk. The indirect competitive ELISA had a lower sensitivity when appliedto cheese, compared with milk. A s<strong>and</strong>wich ELISA was developed utilising the monoclonal antibodyin combination with a polyclonal goat anti-bovine IgG antibody. Once optimised, the ELISA wasfound to be highly specific. Detection limits in milk were 0.001% cows’ milk adulteration <strong>of</strong> sheepor buffalo milk, <strong>and</strong> 0.01% cows’ milk adulteration <strong>of</strong> goat milk. Detection limits in s<strong>of</strong>t cheese were0.001% in goat cheese <strong>and</strong> 0.01% in sheep or buffalo cheese. The ELISA performance makes it suitablefor development as a kit for use in routine surveillance <strong>of</strong> milk <strong>and</strong> s<strong>of</strong>t cheese.Detection <strong>of</strong> insecticide <strong>and</strong> pesticide in milkPolyclonal antibodies against an aldrin/dieldrin immunogen have been raised in rabbits <strong>and</strong> usedas the basis <strong>of</strong> an enzyme-linked immunosorbent assay (ELISA). This assay can detect dieldrin in milk90


Enzyme Linked Immunosorbent Assay - Theoryin the range 5 μg/ml to 1ng/ml reliably. This range differs in skimmed <strong>and</strong> semi-skimmed milk, <strong>and</strong>in cream, reflecting the differences in fat content between these samples (Ibrahim et al, 1993).Detection <strong>of</strong> melamineRecent food safety scares, such as the discovery <strong>of</strong> melamine in milk, have sharpened the globalawareness <strong>of</strong> the links between pr<strong>of</strong>it, the food chain <strong>and</strong> the global food supply. A cheap industrialchemical, melamine has been used to artificially increase the amount <strong>of</strong> protein content in dilutedmilk, thereby increasing the price forthe milk. The combination <strong>of</strong> melamine<strong>and</strong> a degradation product, cyanuricacid, results in crystals that can createblockages in the kidneys. In March2007, public awareness <strong>of</strong> melaminecontamination was heightened whenFigure: General principle <strong>of</strong> the competitive ELISA assay. Enzymeconjugatedmelamine competes with the melamine from thesample for binding to melamine antibody. This enzyme activity <strong>and</strong>absorbance values decrease according to increasing amount <strong>of</strong> theunlabeled melamine from the unknown sample.the contaminant was found in pet foodingredients imported from China,causing the death <strong>of</strong> many animals.Following this scare, it was revealed thatmelamine-tainted fodder may have beenused to feed animals, including chickens, swine <strong>and</strong> catfish intended for human consumption. Asmelamine is still being found in eggs, fish <strong>and</strong> a variety <strong>of</strong> processed foods imported from China, thescrutiny <strong>of</strong> products for melamine is intense.ELISA, is a high-throughput technique for screening food for melamine. The general principle <strong>of</strong>these competitive ELISA assays is shown in Figure .Detection <strong>of</strong> histamine in cheeseAygun et al. (1999) used a competitive direct ELISA for determining histamine in cheese. Cheesewas homogenized with phosphate buffered saline, centrifuged <strong>and</strong> filtered <strong>and</strong> the supernatant wasdiluted with phosphate buffered saline. Detection limit <strong>and</strong> mean recoveries were 2 mg/kg <strong>and</strong> 93%.Quantification <strong>of</strong> immunoglobulins <strong>and</strong> cytokine in milk <strong>and</strong> colostrumA double s<strong>and</strong>wich enzyme-linked immunosorbent assay (ELISA) procedure for the quantification<strong>of</strong> IgG in bovine milk was developed for detecting the concentration <strong>of</strong> IgG in various homogenizedHTST, UHT, evaporated <strong>and</strong> raw milk samples as well as skim milk powder. Using this procedure,homogenized, HTST pasteurized milk was found to contain from 65 to 79% <strong>of</strong> the IgG found in rawmilk. Skim milk powder also retained a major portion <strong>of</strong> IgG, while evaporated <strong>and</strong> UHT pasteurizedmilk were virtually devoid <strong>of</strong> IgG (Kummer et al., 1992)Colostrum contains factors that are protective for the neonate <strong>and</strong> may be a source <strong>of</strong>immunomodulary molecules that positively influence the immune status <strong>of</strong> the neonate. To confirmthat colostrum contains a variety <strong>of</strong> cytokines with immunomodulatory properties, a bovine cytokinespecific ELISA <strong>and</strong> five cytokines (IL-1β, IL-6, TNF-α, INF-γ or IL-1 receptor antagonist, IL-1ra) inthe whey samples from cows at different stages <strong>of</strong> lactation were monitored. The concentrations<strong>of</strong> cytokines in colostrum were significantly higher concentrations than those in the mature milk.Colostrum contains high levels <strong>of</strong> cytokines that could be produced <strong>and</strong> secreted in the mammarygl<strong>and</strong> <strong>and</strong> that may have an immunomodulatory activity <strong>and</strong> influence neonatal immunity (Hagiwaraet al., 2000)Detection <strong>of</strong> antibiotics in milkβ-Lactam antibiotics, particularly penicillins are widely used in medicine <strong>and</strong> veterinary medicine,this being the reason why residual amounts <strong>of</strong> penicillins may be found in foodstuffs <strong>of</strong> animal origin.Antibiotics contained in milk may adversely affect the health <strong>of</strong> human consumers (e.g., by inducing91


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assuranceallergic reactions). Moreover, the presence in milk <strong>of</strong> antibiotics <strong>and</strong> other compounds suppressing thedevelopment <strong>of</strong> microorganisms disrupts technological processes <strong>of</strong> production <strong>of</strong> cheese (includings<strong>of</strong>t cheese) <strong>and</strong> sour milk beverages by retarding or blocking lactic acid fermentation. Therefore,milk should be carefully controlled for the presence <strong>of</strong> residual amounts <strong>of</strong> penicillins, <strong>and</strong> suchcontrol requires reliable <strong>and</strong> readily available analytical methods. ELISAs are widely used abroadfor determining penicillin in milk (Usleber et al., 1994; Rohner, et al., 1995) including as commerciallyavailable kits (Sternesjo <strong>and</strong> Johnsson, 1998). Determination <strong>of</strong> penicillin G, ampicillin, <strong>and</strong> isoxazolylpenicillins (cloxacillin <strong>and</strong> dicloxacillin) in milk has been described, with detection limits in therange 10–30 ng/ml A modification <strong>of</strong> an ELISA in which a fluorescent probe replaces conventionalchromogens <strong>and</strong> capillaries are used for simultaneous determination <strong>of</strong> six penicillins in milk has beendescribed (Huth, 2002).ConclusionThe increase in food borne illnesses <strong>and</strong> specific types <strong>of</strong> pathogens is due to various consumer,manufacturing <strong>and</strong> regulatory trends that may set the stage for contamination or minimal screeningmethods. For example, there are changes in consumer consumption habits <strong>and</strong> preferences for minimallyprocessed convenience foods, as well as an increase in certain risk groups who are most vulnerable todiseases. Also adding to the problem are changes in food production, distribution <strong>and</strong> globalization <strong>of</strong>supply that exp<strong>and</strong>s the potential for imports tainted with pathogens or pesticide residues. Compoundingthe problem are new types <strong>of</strong> pathogens, as well as new strains <strong>of</strong> recognized pathogens, <strong>and</strong> both areappearing in food products where they have never before been identified. It is likely that technologiesbased on immunoassays <strong>and</strong> PCR methods will emerge as the two favorite types <strong>of</strong> rapid pathogenscreening tests for dairy products because <strong>of</strong> their enhanced specificity, sensitivity <strong>and</strong> efficiencycompared to other methods. PCR tests that measure pathogen DNA or RNA are more sensitive butalso are more expensive than immunoassay methods. To continue to deliver safe dairy products to thepublic, dairy processors will be increasingly dependent on new rapid, accurate, sensitive <strong>and</strong> specificscreening tests for pathogens, toxins, adulterants <strong>and</strong> allergens.References:Aygun,o.,Schneider,E.,Suhener,R. <strong>and</strong> Usleber, E. <strong>and</strong> Martlbauer, E. J. agril. & food Chem.,1999, 47(5):1961-1964.Hagiwara, K.i Kataoka, S. ,Yamanaka, H.. Kirisawa, R. <strong>and</strong> Iwai, H. Veterinary Immunology & Immunopathology,2000, 76(3-4):183-190Huth, S.P., Warholic, P.S., Devou, J.M., Chaney, L.K.,<strong>and</strong> Clark, G.H., J. AOAC Int., 2002, 85 (2): 355–364.Ibrahim,A.M.A., Hewedi, M.M. <strong>and</strong> Smith, C.J. Food <strong>and</strong> Agril Immunol, 1993 5 (3): 145 - 154Kim, E.K., Shon, D.A. Dyer, D., Park, J.W., Hwang, H.J. <strong>and</strong> Kim, Y.B.. Food additives <strong>and</strong> Contaminants, 2000, 17(1):59-64.Kummer, A., Kitts, D.D.,Li-Chan, E., Losso, J.N., Skura, B.J.<strong>and</strong> Nakai, S. Food <strong>and</strong> Agricultural Immunology, 1992, 4(2): 93 - 102Rastogi, S., Dwivedi, P. D., Khanna, S. K., Das, M. Food control, 2004 15(4)287-290Rohner, P., Schallibaum, M., <strong>and</strong> Nicolet, J., J. Food Prot., 1995, 48(1):59–62.Sternesjo, A. <strong>and</strong> Johnsson, G., J. Food Prot., 1998, 61 (7) :808–811.Usleber, E., Lorber, M., Straka, M., Terplan, G., <strong>and</strong> Martlbauer, E., Analyst, 1994, 119 (12): 2765–2768Vasavada, P.C. Food Safety, 2001; 7(3):29-3892


Experimental Determination <strong>of</strong> Thermal Stability <strong>of</strong> Proteins: A Theoretical BackgroundExperimental Determination <strong>of</strong> Thermal Stability<strong>of</strong> Proteins: A Theoretical BackgroundJai K. KaushikAnimal Biotechnology Centre, NDRI, KarnalOne <strong>of</strong> the most crucial aspects in protein science is the solution properties affecting the structure,stability <strong>and</strong> activity <strong>of</strong> proteins in solutions. Most <strong>of</strong> the enzymes <strong>and</strong> many structural proteins areglobular while some structural proteins are fibrous in structure. The stability <strong>of</strong> proteins originates fromtheir detailed three dimensional structures. The covalently linked amino acids in a linear fashion results inthe primary structure that folds into a unique 3-D structure, which is responsible for the specific function<strong>and</strong> activity <strong>of</strong> a protein molecule. The 3-D structure <strong>of</strong> proteins is defined by weak intermolecularinteractions <strong>and</strong> therefore the native state <strong>of</strong> proteins is only marginally stable by ca 5-15 kcal/mol.The small free energy is the difference <strong>of</strong> large changes, which can be several hundreds <strong>of</strong> kcal/mol, inenthalpy <strong>and</strong> entropy over folding. Therefore, determining these large changes in enthalpy <strong>and</strong> entropyaccurately is the central problem in protein physical chemistry to evaluate the precise free energy (Gibbsenergy) <strong>of</strong> stabilization <strong>of</strong> proteins.With the great advancement in generation <strong>and</strong> production <strong>of</strong> recombinant proteins, there hasbeen a new interest in underst<strong>and</strong>ing the molecular basis <strong>of</strong> protein stability so that more rugged <strong>and</strong>stable proteins functional over a wide range <strong>of</strong> environmental conditions can be designed. Thereforeit is critically important to evaluate the stability <strong>of</strong> proteins precisely <strong>and</strong> accurately to compare <strong>and</strong>relate the experimentally determined stability data to theoretically determined stability for a set <strong>of</strong>mutant proteins to underst<strong>and</strong> the role <strong>of</strong> molecular interactions. There are two st<strong>and</strong>ard methods todetermine the protein stability, viz. kinetic methods, which include chemical denaturant jump, pH jump<strong>and</strong> temperature jump to determine the rate <strong>of</strong> folding <strong>and</strong> unfolding, <strong>and</strong> equilibrium methods whichinclude the solvent denaturation <strong>and</strong> thermal denaturation procedures. The easiest <strong>and</strong> the most widelyused method is the thermal denaturation <strong>of</strong> proteins <strong>and</strong> determining the equilibrium thermodynamicparameters linked with the process. The obtained thermodynamic parameters like enthalpy, heatcapacity <strong>and</strong> entropy evaluated at the midpoint <strong>of</strong> denaturation can be used to determine the stabilitypr<strong>of</strong>ile (Free Energy versus temperature) for a given protein.There are several techniques to monitor the denaturation <strong>of</strong> proteins under varying external agentslike increasing concentration <strong>of</strong> chemical denaturants or increasing temperature or changing the pH. Tomonitor the changes in thermodynamic parameters related to thermal denaturation, the most direct methodis the calorimetry, which measures the enthalpy <strong>of</strong> denaturation as a function <strong>of</strong> temperature. Calorimetrycan provide the precise enthalpy, entropy <strong>and</strong> heat capacity <strong>of</strong> denaturation. Figure 1 shows a typicalthermal denaturation <strong>and</strong> renaturation scans as a function <strong>of</strong> temperature measured by (A) calorimetry<strong>and</strong> (B) spectrophotometry. In acalorimetrically measured phasetransition (Native ↔ Denatured)pr<strong>of</strong>ile <strong>of</strong> a protein the peak <strong>of</strong> theendotherm indicates the midpoint<strong>of</strong> transition. The total area underthe curve provides a direct measure<strong>of</strong> enthalpy <strong>of</strong> transition, whereasthe differences in the baselines forFigure 1: Typical thermal denaturation pr<strong>of</strong>iles <strong>of</strong> a protein determined by (A)differential scanning calorimetry (DSC) measuring the excess heat capacityas a function <strong>of</strong> temperature, <strong>and</strong> (B) spectrophotometry measuring changein absorbance.pure native <strong>and</strong> pure denaturedspecies measured at the midpoint <strong>of</strong>transition provide the heat capacity <strong>of</strong>denaturation.93


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceFor a two state transition N ↔ D, where N is the native state <strong>and</strong> D the denatured state, the ∆H(T)- the enthalpy <strong>of</strong> transition at a temperature (T) can be directly evaluated using equation 1:∆H(T) = ∆Hº + ∆C p(T – T m) (1)where, ∆Hº is the enthalpy <strong>of</strong> transition at T m; ∆C p- the heat capacity <strong>of</strong> transition; <strong>and</strong> Tm, themidpoint <strong>of</strong> transition. This is the most direct method <strong>of</strong> evaluating the thermodynamic parameterslike enthalpy, while the entropy can be evaluated using the relation:∆S(T) = ∆Sº + ∆C pln (T/T m) (2)where ∆Sº is the entropy at the midpoint <strong>of</strong> transition <strong>and</strong> can be derived using the relation:∆Sº = ∆Hº/T m(3)The Gibbs energy <strong>of</strong> protein folding (free energy <strong>of</strong> stabilization) therefore can be defined by theequation:∆G(T) = ∆H(T) – T ∆S(T) (4)Substituting the values <strong>of</strong> ∆H <strong>and</strong> ∆S from equations (1-3) in to (4) <strong>and</strong> rearranging we obtain:∆G(T) = ∆Hº (1 – T/T m) – ∆Cp (T m– T + T ln (T/T m)) (5)which is a modified form <strong>of</strong> Gibbs Helmholtz equation <strong>and</strong> can be used to determine the proteinstability at any given temperature.Similarly, using the indirect methods which can measure the change in conformation <strong>of</strong> the nativestate <strong>of</strong> protein, we can determine the thermodynamic parameters linked with a phase transition(N↔D). The change in conformation can be monitored by various spectroscopic methods; e.g. circulardichroism, spectrophotometry, fluorescence, IR, light scattering, hydrogen exchange or anythingwhich are sensitive enough to record the phase transitions in proteins; even viscometric or volumetricmethods which can measure the solution properties <strong>of</strong> proteins due to phase transitions can alsobe used. Figure 1B shows the typical change in tertiary interactions <strong>of</strong> RNase A over denaturationmeasured by change in absorbance in the aromatic region. For a two state reversible phase transitionundergoing equilibrium conditions, the equilibrium constant can be defined as follows:K = [Unfolded] / [Native] = α/ 1– α (6)orα = K / 1+K (7)where α is the fractional denatured state concentration <strong>and</strong> K is the equilibrium constant.Also we know,K = e –∆Gº/RT (8)Substituting the values <strong>of</strong> ∆Gº, the st<strong>and</strong>ard free energy, <strong>and</strong> K from equation (5) <strong>and</strong> (8),respectively, in to equation (7), we obtain:{–1/R[∆Hº (1/T – 1/Tm) – DCp (Tm/T – 1 + ln (T/Tm))]}eα(T) ={–1/R[∆Hº (1/T – 1/Tm) – ∆Cp (Tm/T – 1 + ln (T/Tm))]}(9)1 + eEquation (9) can be used to fit the experimental data to directly evaluate the thermodynamicparameters like ∆Hº, ∆C P, <strong>and</strong> Tm to evaluate the Gibbs energy <strong>of</strong> protein denaturation. The enthalpy<strong>of</strong> denaturation (∆Hº) is known as van’t H<strong>of</strong>f enthalpy (∆H vH) distinct from the calorimetric enthalpy(∆Hcal) determined by DSC. For a two state reversible denaturation process for a single domain <strong>and</strong>/ormonomer protein the ratio <strong>of</strong> ∆H vH<strong>and</strong> ∆H calshould be equal to unity. The solid lines shown in Figure1B are the nonlinear least square fittings to the experimentally determined data points representedby solid <strong>and</strong> open symbols. It is important to use good quality <strong>of</strong> data to evaluate the free energy <strong>of</strong>stabilization. Even small differences in the free energy <strong>of</strong> stabilization due to single amino acid changein proteins can be reliably evaluated by using any <strong>of</strong> the methods mentioned above. These methodsalso require that phase transition must be reversible <strong>and</strong> undergoing equilibrium conditions.94


Experimental Determination <strong>of</strong> Thermal Stability <strong>of</strong> Proteins: A Theoretical BackgroundApart from the above mentioned methods which depend upon the heat-denaturation, other isothermalmethods employing the chemical denaturant to induce the phase transition <strong>of</strong> protein conformation canalso be used to evaluate the Gibbs energy <strong>of</strong> protein folding. It has been known for years that proteinscan be unfolded in aqueous solutions by high concentrations <strong>of</strong> urea or guanidine hydrochloride.Denaturation with these chemicals is one <strong>of</strong> the primary ways <strong>of</strong> measuring the conformational stability<strong>of</strong> proteins <strong>and</strong> comparing the stabilities <strong>of</strong> mutant proteins. Figure 2 shows the typical denaturationreaction mediated by guanidine hydrochloride. It has been observed that the free energy <strong>of</strong> denaturation,∆Gº = – RT ln K, depends upon the denaturant concentration as follows:d(∆Gº)/d(GdnCl) = RTn/(GdnCl) ½(10)where (GdnCl) ½is the midpoint <strong>of</strong> transition <strong>and</strong> n the slope <strong>of</strong> the curve. Later linear extrapolationmethod (LEM) became popular as ∆Gº was found to vary linearly with denaturant concentration asfollows:∆Gº = ∆G(H 2O) – m[denaturant] (11)where ∆G(H 2O) is an estimate <strong>of</strong> the conformational stability <strong>of</strong> a protein that assumes that thelinear dependence continues to 0 M denaturant concentration, <strong>and</strong> m the slope <strong>of</strong> the line measuresthe dependence <strong>of</strong> ∆Gº on denaturant concentration. The values <strong>of</strong> K can be calculated from thecurve plotted in Figure 2A to calculate the ∆Gº as a function <strong>of</strong> denaturant concentration followed byestimation <strong>of</strong> ∆G(H 2O) using the LEM. However, an equation to directly fit the raw data can also bewritten by substituting the value <strong>of</strong> K <strong>and</strong> ∆Gº from equations 8 <strong>and</strong> 11, respectively, in to equation7 to give:e –(∆G(H2O) – m[denaturant] ) /RTα(T) = (12)1 + e –(∆G(H2O) – m[denaturant] ) /RTNonlinear least square fitting <strong>of</strong> the above equation to the raw data provide us the value <strong>of</strong> m <strong>and</strong>∆G(H 2O ).Figure 2A showsthe typical equilibriumdenaturation <strong>and</strong>renaturation curves <strong>of</strong> aprotein as monitored bychange in fluorescence, itis clear that the process isin equilibrium <strong>and</strong> highlyreversible, while the Figure2B shows the increase in thestability <strong>of</strong> wild type (WT)due to engineering (MutantsNuG1 <strong>and</strong> NuG2).Figure 2. Typical equilibrium transition curves for protein unfolding <strong>and</strong> refoldinginduced by guanidine hydrochloride. (A) The open triangles <strong>and</strong> solid circles are theunfolding curves while the open squares represent the refolding equilibrium curves.Panel (B) shows the increase in the midpoint <strong>of</strong> transition [GdnHCl] ½due to proteinengineering (mutants NuG1 <strong>and</strong> NuG2) <strong>of</strong> the wild type protein (WT).All the above methods are based on equilibrium conditions; however, it is also possible to evaluatethe free energy <strong>of</strong> protein stability using the kinetic methods which can measure the rates <strong>of</strong> folding <strong>and</strong>unfolding, since equilibrium constant K is the ratio <strong>of</strong> rate <strong>of</strong> unfolding (k u) <strong>and</strong> rate <strong>of</strong> folding (k f):K = k u/ k f(13)K can be used to calculate ∆Gº <strong>and</strong> various other thermodynamic parameters using the sameprocedure mentioned above. The value <strong>of</strong> rate constants can be known by unfolding <strong>and</strong> refoldingreactions induced by jump studies using temperature, pH or denaturant concentrations (Figure 3). Fora two state process N↔D, all these methods should provide the same value <strong>of</strong> Gibbs energy <strong>of</strong> proteinfolding within the experimental errors <strong>and</strong> therefore any <strong>of</strong> the technique available at ones disposalcan be used reliably for analysis <strong>of</strong> protein stability.95


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceFigure 3: Temperature dependence <strong>of</strong> kinetic <strong>and</strong> thermodynamic parameters <strong>of</strong> Pyrrolidone carboxyl peptidase (a)Temperature dependence <strong>of</strong> ku <strong>and</strong> k f<strong>and</strong> relaxation (k r= k u+ k f) rate constants. Dashed line represents kr values, (b)Solid circles represent the unfolding Gibbs energies obtained from the equilibrium constant (K = k u/k f). The solid line is thestability curve fitted to the data points using equation 5, whereas the dashed line is that generated from the thermodynamicparameters obtained by DSC, mk(c) log <strong>of</strong> rates <strong>of</strong> folding (circles) <strong>and</strong> unfolding (squares) as a function <strong>of</strong> urea conc. k f=3600sec -1 <strong>and</strong> k u= 27 sec -1 were obtained by extrapolation to 0 M urea. In the inset, the dotted line shows the denaturationcurve simulated by using the kinetic parameters <strong>and</strong> crosses indicate the experimentally obtained equilibrium data.ReferenceHughues-Despointes, B. M. Scholtz, J. M. <strong>and</strong> Pace, C. N. (1999). Protein conformational stabilities can be determinedfrom hydrogen exchange rates. Nat. Struct. Biol. 6: 910-912.Kaushik, J. K. <strong>and</strong> Bhat, R. (1998). Thermal stability <strong>of</strong> proteins in aqueous polyol solutions. J. Phys. Chem. Sect. B. 102:7058-7066.Kaushik, J. K. <strong>and</strong> Bhat, R. (1999). A mechanistic analysis <strong>of</strong> the increase in the thermal stability <strong>of</strong> proteins in aqueouscarboxylic acid salt solutions. Protein Science. 8: 222-233.Kaushik, J. K., Ogasahara, K. <strong>and</strong> Yutani, K. (2002). The unusually slow relaxation kinetics <strong>of</strong> the folding-unfolding <strong>of</strong>pyrrol.idone carboxyl peptidase from a hyperthermophile, Pyrococcus furiosus. J. Mol. Biol. 316: 989-1001.Kaushik, J. K. <strong>and</strong> Bhat, R. (2003). Why is trehalose an exceptional protein stabilizer?: An analysis <strong>of</strong> the thermal stability <strong>of</strong>proteins in the presence <strong>of</strong> compatible osmolyte trehalose. J Biol Chem, 278: 26458-26465.Kaushik et al. (2006) Completely-buried, Non-ion-paired glutamic acid contributes favorably to the conformationalstability <strong>of</strong> pyrrolidone carboxylic peptidases from hyperthermophiles, Biochemistry. 45: 7100-7112.Nauli, S., Kuhlman, B. <strong>and</strong> Baker, D. (2001). Computer-based redesign <strong>of</strong> a protein folding pathway. Nat. Struct. Biol.8: 602-605.Pace, C. N. (1986). Determination <strong>and</strong> analysis <strong>of</strong> urea <strong>and</strong> guanidine hydrochloride denaturation curves. MethedEnzymol. 131: 266-280.Pace, C. N. <strong>and</strong> Shaw, K. L. (2000). Linear extrapolation method <strong>of</strong> analyzing solvent denaturation curves. Proteins:Struct. Funct. Genet. (Suppl). 4: 1-7.Santoro, M. M. <strong>and</strong> Bolen, D. W. (1988). Unfolding free energy changes determined by the linear extrapolation method.1. Unfolding <strong>of</strong> phenylmethanesulphonyl α-chymotrypsin using different denaturants. Biochemistry. 27: 8063-8068.Tanford, C. (1970). Protein denaturation. C. Theoretical models for the mechanism <strong>of</strong> denaturation. Adv. Protein Chem.24: 1-95.96


Species-Specific Identification <strong>of</strong> Milk <strong>and</strong> Milk <strong>Products</strong>: A Molecular ApproachIntroductionSpecies-Specific Identification <strong>of</strong> Milk <strong>and</strong>Milk <strong>Products</strong>: A Molecular ApproachArchana Verma<strong>Dairy</strong> Cattle Breeding Division, NDRI, KarnalIntermixing <strong>of</strong> milk from different species <strong>of</strong> origin is a common practice depending on the dem<strong>and</strong><strong>of</strong> the consumer for liquid milk or the manufacturing <strong>of</strong> milk products. Different methods basedon protein analysis are currently used for milk species identification, including chromatographic,electrophoretic <strong>and</strong> immunological techniques. Among these, capillary electrophoresis, twodimensionalelectrophoresis, isoelectric focusing <strong>of</strong> milk caseins, HPLC, mass spectrometry <strong>and</strong> ELISAare widely reported. All techniques are based on strategies suited to evaluate the protein patternsoriginating from the major whey proteins or casein fraction. All these analytical methods are able todetect bovine milk proteins to the minimum level <strong>of</strong> 0.5–1 %. Still, the success <strong>of</strong> analytical tools thatrely on protein detection for species identification may be in some cases is affected by proteolysis ordenaturation <strong>of</strong> milk proteins as a result <strong>of</strong> heat treatment during processing.In the last years, full attention has been turning towards application <strong>of</strong> DNA-based approaches forthe authentication <strong>of</strong> food. Particularly, the polymerase chain reaction (PCR) is increasingly used for thespecific detection <strong>of</strong> the animal origin in milk <strong>and</strong> milk products. DNA from somatic milk cells, principallyrepresented by leucocytes persists in milk products <strong>and</strong> may be analysed for species identification.Several PCR-based techniques (DNA hybridization assay; restriction enzyme analysis, RFLP; singlestr<strong>and</strong>edconformation polymorphism analysis, SSCP; duplex polymerase chain reaction, duplex-PCR)have been reported to be performed to amplify nuclear genome obtained from milk <strong>and</strong> milk products.These methods currently represent valid complements to protein electrophoretic <strong>and</strong> immunochemicalanalyses. <strong>Their</strong> reliability <strong>and</strong> very low thresholds <strong>of</strong> detection make them promising as routine tools.The methods developed so far rely mostly on PCR-amplification <strong>of</strong> various regions <strong>of</strong> the mitochondrialgenome. Only 2 <strong>of</strong> them assure protection from false negative results, as the mix contains primers for allthe identified species in a single tube. Other published methods use primers for single species or applyrestriction analysis <strong>of</strong> the obtained PCR-product. On the basis <strong>of</strong> various studies demonstrating that DNAis not degraded after thermal <strong>and</strong> enzymatic processes, this has come up as a new strategy for the detection<strong>of</strong> low amounts <strong>of</strong> interspecies milk. Present paper will focus on DNA based techniques.Basic methodologyDNA Extraction from whole blood /milk is isolated using st<strong>and</strong>ard protocol <strong>of</strong> lysis, proteinaseK digestion, phenol - chlor<strong>of</strong>orm extraction, ethanol-precipitation.Primers Designing <strong>of</strong> specific primer pairs for detection <strong>of</strong> cow <strong>and</strong> buffalo genomic/mitochondrialDNA is done taking care to avoid significant Tm differences between the primers, thereby preventingthe generation <strong>of</strong> unspecific products. Some <strong>of</strong> the primer pairs from literature have been tabulated:Table: Some <strong>of</strong> the Primer Pairs with respective Annealing Temperatures <strong>and</strong> PCR <strong>Products</strong> *S.NoForward Primer5’------------3’Reverse Primer5’--------------3’Ta°CPCR Product(bp)1 GGTAAATCTCGTGCCAGCCA TCCAGTATGCTTACCTTGTTACGAC 56 3002 GAACTCTGCTCGGAGACGAC AGCACCAATTATTAGGGGAAC 56 1343 CAATAACTCAACACAGAATTTGC CGTGATCTAATGGTAAGGAATA 52 3004 CCAACATGCGTATCCCGT AGCGGATGCATGATGAAATG 52 4445 CTAGAGGAGCCTGTTCTATAATCGATAA TGGTTTCATAATAACTTTCGCGCT 63 223Lo´ pez-Calleja, et al. (2004); .2. FELIGINI et al.(2005); 3-4: Kotowicz et al. (2007)l 5. D´ıaz et al., (2007)97


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceFigure 1: Comparison <strong>of</strong> Qualitative <strong>and</strong> Quantitative PCR based species Identification (Ballin et al., 2009)[Some workers used universal primer, cytochrome b (cytb; cytochrome b1 <strong>and</strong> cytochromeb2). to differentiate milk from animal species (cattle, buffalo, goat <strong>and</strong> sheep) each according to itsmitochondrial DNA (mtDNA). The PCR product was digested by restriction endonuclease <strong>and</strong>yielded a species-specific restriction pr<strong>of</strong>ile. The assay was more rapid than conventional methods<strong>and</strong> showed considerable sensitivity.]PCR amplification performed in a 50 L reaction mixture containing template DNA, 200 µM dNTPs,10 mM Tris-HCl, pH=8.3, 50 mM KCl, 1.5 mM MgCl 2, 100 nM primers, 1.5 U DNA polymerase withPCR conditions <strong>of</strong> initial denaturation step at 95 °C for 10 min followed by 35 cycles <strong>of</strong> 95 °C for 30 s,annealing temperatures indicated against each primer <strong>and</strong> 72 °C for 30 s; final extension step at 72 °Cfor 10 min. Agarose Gel Electrophoresis is carried out to check for the amplicons.<strong>Analysis</strong> is carried out based on nucleotide-nucleotide BLAST similarity search (http://www.ncbi.nlm.nih.gov/ BLAST) was conducted with the bovine <strong>and</strong> bubaline specific primer sequences.98


Species-Specific Identification <strong>of</strong> Milk <strong>and</strong> Milk <strong>Products</strong>: A Molecular ApproachConclusionModern molecular techniques based on DNA analysis have found good applicability in detectingadulteration <strong>and</strong> they represent valid complements to the methods relying on protein analysis for theidentification <strong>of</strong> animal species. DNA-based techniques have become effective <strong>and</strong> reliable also forcommercial dairy products. Possible applications in DNA analysis includes traditional <strong>and</strong> real timePCR. PCR amplified sequence can originate from either mitochondrial or genomic DNA, where bothsingle copy <strong>and</strong> repetitive sequences can be used. The choice <strong>of</strong> analytical technique <strong>and</strong> especially theDNA sequence has a large influence on the limit <strong>of</strong> detection. However, quantitative methods basedon genome/genome equivalents that rely on a fixed copy number <strong>and</strong> use <strong>of</strong> repetitive sequences isalso an option.ReferencesBallin N.Z., et al. (2009). Species determination – Can we detect <strong>and</strong> quantify meat adulteration? Meat Science. 83:165–174.El-Rady, A. et al., (2006). Identification <strong>of</strong> milk source by polymerase chain reaction-restriction fragment lengthpolymorphism analysis. Journal <strong>of</strong> Rapid Methods <strong>and</strong> Automation in Microbiology 14 (2) 146–155.Feligini M., et al. (2005). Detection <strong>of</strong> Adulteration in Mozzarella Cheese, Food Technol. Biotechnol. 43 (1) 91–95.Kotowicz M, et al. (2007). Application <strong>of</strong> a duplex-PCR for detection <strong>of</strong> cows’ milk in goats’ milk. Ann Agric EnvironMed 2007, 14, 215-218.Lo´ pez-Calleja I., et al. (2004). Rapid Detection <strong>of</strong> Cows’ Milk in Sheeps’ <strong>and</strong> Goats’ Milk by a Species-SpecificPolymerase Chain Reaction Technique. J. <strong>Dairy</strong> Sci. 87:2839–2845.L´opez-Calleja I., et al., (2007). Application <strong>of</strong> a polymerase chain reaction to detect adulteration <strong>of</strong> ovine cheeses withcaprine milk. Eur Food Res Technol. 225: 345–349.99


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceProteomic Techniques for Application in Food ScienceIntroduction100Ashok K. MohantyAnimal Biotchnology Centre, NDRI, KarnalIn recent years, a number <strong>of</strong> ‘‘omics’’ technologies (genomics, proteomics, metabolomics, <strong>and</strong>others) have become available that hold promise for increasing the underst<strong>and</strong>ing <strong>of</strong> the complexities<strong>of</strong> pathogen behavior at the molecular level <strong>and</strong> for the development <strong>of</strong> improved pathogen detection<strong>and</strong> typing systems. Genomics is the study <strong>of</strong> genes <strong>and</strong> their function, transcriptomics refers to globalanalyses <strong>of</strong> gene expression, <strong>and</strong> proteomics is the study <strong>of</strong> the complete set <strong>of</strong> proteins produced bya species <strong>and</strong> their modifications, expression, involvement in metabolic pathways, <strong>and</strong> interactions.Omics-based tools enable researchers to explore complex biological processes in a quantitative <strong>and</strong>integrative manner via a systems biology approach. These methods <strong>of</strong> analysis are facilitating theidentification <strong>of</strong> genes that are responsible for survival <strong>and</strong> persistence in specific environments, <strong>and</strong>revealing genes that are potential targets for interventions <strong>and</strong> that play a role in pathogenesis, stressresponses, <strong>and</strong> bi<strong>of</strong>ilm formation.Proteomics is the study <strong>of</strong> the proteome, the protein complement <strong>of</strong> the genome. Proteomics or, moreappropriately functional proteomics refers to the branch <strong>of</strong> discovery <strong>of</strong> science focusing on proteins.The term ‘proteome’ is used to describe the complete set <strong>of</strong> proteins that is expressed, <strong>and</strong> modifiedfollowing expression, by the entire genome in the lifetime <strong>of</strong> a cell. The term “proteomics” <strong>and</strong> “proteome”were coined by Marc Wilkins <strong>and</strong> colleagues in the early 1990s <strong>and</strong> mirror the terms “genomics” <strong>and</strong>“genome”, which describe the entire collection <strong>of</strong> genes in an organism. Today, proteomics is a scientificdiscipline that promises to bridge the gap between our underst<strong>and</strong>ing <strong>of</strong> genome sequence <strong>and</strong> cellularbehaviour. It can be viewed as more <strong>of</strong> a biological assay or tool for determining gene function.Initially the term was used to describe the study <strong>of</strong> the expressed proteins <strong>of</strong> a genome using twodimensional(2D) gel electrophoresis, <strong>and</strong> massspectrometry (MS) to separate <strong>and</strong> identify proteins<strong>and</strong> sophisticated informatics approaches for deconvoluting <strong>and</strong> interrogating data. This approach isnow referred to as “expression” or “global pr<strong>of</strong>iling” proteomics. The scope <strong>of</strong> proteomics has nowbroadened to embrace the study <strong>of</strong> “protein-protein” interactions (protein complexes), referred to ascell-mapping proteomics (Blackstock <strong>and</strong> Weir, 1999).The many faces <strong>of</strong> proteomicsProteomic analysis (or analytical protein chemistry). The large-scale identification <strong>and</strong>characterization <strong>of</strong> proteins, including their posttranslational modifications, such as phosphorylation<strong>and</strong> glycosylation. <strong>Analysis</strong> is done with the aid <strong>of</strong> mass spectrometry or Edman degradation.Expression proteomics (or differential display proteomics). Two-dimensional gels are used forglobal pr<strong>of</strong>iling <strong>of</strong> expressed proteins in cell lysates <strong>and</strong> tissues. This conventional approach is beingchallenged by non-2D gel methods, such as liquid-based isoelectric focusing (IEF) or ion-exchangechromatography / reversed-phage high-performance liquid chromatography (RP-HPLC). Proteins aretypically identified by massspectrometry (MS). In many situations, these methods are complementedby DNA-based array methods.Cell-mapping proteomics (or cataloging <strong>of</strong> protein-protein interactions). Protein-protein interactions<strong>and</strong> intracellular signaling are determined by identification <strong>of</strong> protein complexes (obtained by affinitypurification <strong>and</strong> protein identification by MS) or by direct DNA readout (e.g. yeast two-two hybrid,phage display, ribosome display, <strong>and</strong> RNA-peptide fusions).Proteomics vis-a vis GenomicsLarge-scale genome sequencing:One <strong>of</strong> the most biological achievements to emerge during the last 40 years has been the completion


Proteomic Techniques for Application in Food Science<strong>of</strong> draft DNA sequences <strong>of</strong> the human genome, published bythe International Human Genome Sequencing Consortium(a publicly) funded project <strong>and</strong> by Celera Genomics (acommercial effort). This has provided a blue print <strong>of</strong> theinformation needed to create a human being <strong>and</strong> revealedfor the first time the organization <strong>of</strong> a vertebrate’s DNA.The public project estimates that there are 31, 000 proteinencodinggenes, where as Celera finds ~26,000, with manymore still to be found (a current estimate suggests that thenumber <strong>of</strong> protein-encoding genes may be on the order <strong>of</strong>60,000).Interestingly, the number <strong>of</strong> coding genes in the humansequence is not dramatically different from the numbers Biological context <strong>of</strong> Genomics <strong>and</strong> Proteomicsreported for phylogenetically remote organisms: 6, 000 fora yeast cell, 13,000 for a fly, 18,000 for a worm, <strong>and</strong> 26,000 for a plant (Genomes Online Databasesat http://wit.integratedgenomics.com/GOLD). The number <strong>of</strong> genes reported for multicellularorganisms is not highly accurate because <strong>of</strong> limitations <strong>of</strong> existing abinitio gene prediction methods usedto identify genes. The existence <strong>of</strong> an open reading frame (ORF) in genomic data does not necessarilyimply the existence <strong>of</strong> functional gene. In human DNA, gene prediction by abinitio methods is difficultbecause <strong>of</strong> extensive alternative splicing, lower density exons, <strong>and</strong> high proportions <strong>of</strong> interspersedrepetitive sequences. Given the unreliability <strong>of</strong> abinitio gene prediction s<strong>of</strong>tware, all genes will needto be experimentally identified <strong>and</strong> annotated. Hence, verification <strong>of</strong> a gene product by proteomicanalysis is an important first step in annotating the genome.Disparity between mRNA Pr<strong>of</strong>iling <strong>and</strong> protein pr<strong>of</strong>iling:There is no simple correlation between changes in mRNA expression levels (transcriptomics) <strong>and</strong>those in protein levels (proteomics). The link between transcript levels <strong>and</strong> protein levels in a given cellor tissue is difficult. It is also understood that array-based gene expression monitoring or other geneexpression methods for measuring mRNA abundances, alone are insufficient for analyzing the cell’sprotein complement. There is a marked disparity between the relative expression levels <strong>of</strong> mRNAs<strong>and</strong> those <strong>of</strong> their corresponding proteins. Differing stability <strong>of</strong> mRNAs <strong>and</strong> different efficienciesin translation can affect the generation <strong>of</strong> new proteins. Once formed, proteins differ significantlyin stability <strong>and</strong> turnover rates. Many proteins involved in signal transduction, transcription factorregulation, <strong>and</strong> cell-cycle control are rapidly turned over as a means <strong>of</strong> regulating their activities.Also mRNA levels tell us nothing about the regulatory status <strong>of</strong> the corresponding proteins, whoseactivities <strong>and</strong> functions are subject to many endogenous posttranslational modifications <strong>and</strong> othermodifications by environmental agents. Therefore, the complication arises when considering thecomplementarity <strong>of</strong> genomics <strong>and</strong> proteomics. Despite the notion that one gene gives rise to oneprotein, the situation in eukaryotic cells is more likely six to eight proteins per gene. Thus, theremay be several hundred thous<strong>and</strong> human proteins after splice variants <strong>and</strong> essential posttranslationalmodifications are included. For example, 22 different forms <strong>of</strong> human α-1-antitrypsin have beenobserved in human plasma. Such biological complexities can be unraveled using proteomic studies tounderst<strong>and</strong> how cells modulate <strong>and</strong> integrate signals.Identification <strong>and</strong> analysis <strong>of</strong> proteinsFour key platform technologies are crucial to any proteomics strategy aimed at elucidating thefunction <strong>of</strong> an unknown gene.• Sample preparation & h<strong>and</strong>ling• Determination <strong>of</strong> partial amino acid sequence information• Protein identification <strong>and</strong> quantification• Cell mapping101


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceSEC: size exclusion chromatography; IEX: ion-exchange chromatography; RP-HPLC: reversed–phase high-performance liquid chromatography; HIC: hydrophobic interaction chromatography;2DE: two-dimensional gel electrophoresis; 1DE: one dimensional gel electrophoresis; FFE: free-flowelectrophoresis; CZE: capillary zone electrophoresis; FRET: fluorescence resonanace energy transferProtein separation strategies:One <strong>of</strong> the rate-limiting stepsin any proteomic analysis studyis obtaining, <strong>and</strong> then h<strong>and</strong>ling,sufficient quantities <strong>of</strong> target protein(s) from its original biological source.The classical method <strong>of</strong> quantitative<strong>and</strong> qualitative expressionTechnology platforms for Proteomicsproteomics combines protein separation by high-resolution 2D gel electrophoresis with MS or MS/MSidentification <strong>of</strong> selected protein spots. Because, even the best 2D gels can routinely separate no morethan 1500 proteins, this technique is limited to the most abundant proteins if a crude protein mixture(whole-cell lysate) is used. 2D electrophoresis is limited by the amount <strong>of</strong> material that can be applied tothe first-dimension immobilized pH gradient gel (~150 ug to low milligram quantities). Hence 2D gelshave limited ‘scale up’ capability. For this reason, it is <strong>of</strong>ten desirable to “trace enrich” for a particularsubclass <strong>of</strong> proteins. Byanalyzing proteins in a cellularcompartment or organelle,it is possible to reduce thecomplexity <strong>and</strong> differencesin abundance <strong>of</strong> a subset <strong>of</strong>proteins within a cell.Two-Dimesional SDS-PAGE: This separation methodhas become synonymouswith proteomics <strong>and</strong> remainsthe single best method forresolving highly complexprotein mixtures. TwodimensionalSDS-PAGE isactually a combination <strong>of</strong> two Proteomics strategies for the identification <strong>and</strong> analysis <strong>of</strong> proteinsdifferent types <strong>of</strong> separations.In the first, the proteins areresolved on the basis <strong>of</strong> isoelectric point by IEF. In the second, focused proteins are then are furtherresolved by electrophoresis on a polyacrylamide gel. Thus 2D-SDS-PAGE resolves proteins in the firstdimension by isoelectric point <strong>and</strong> in the second dimension by molecular weight. Dedicated 2D-SDS-PAGE systems are available that use immobilized pH gradient (IPG) strips <strong>and</strong> relatively foolpro<strong>of</strong>hardware to facilitate the transfer <strong>of</strong> proteins from the IPG strip into the SDS-PAGE slab gel. The IPGstrip is based on the use <strong>of</strong> immobilized pH gradients, in which polycarboxylic acid ampholytes areimmobilized on supports to reproducibly create stable pH gradient. The use <strong>of</strong> narrow pH rangesfacilitates the separation <strong>of</strong> proteins with highly similar isoelectric points. Proteins separated by 2Dgels are visualized by conventional staining techniques, including silver, Coomassie, amido blackstains <strong>and</strong> fluorescent staining. Silver-staining <strong>and</strong> newer fluorescent dyes are the most sensitive.Cell mapping <strong>and</strong> identification <strong>of</strong> proteins in complexesOne way to observe interacting proteins involved in a given biological process is to specificallyenrich for these proteins. Typically, this requires knowledge <strong>of</strong> the activity <strong>of</strong> atleast one protein in102


Proteomic Techniques for Application in Food Sciencethe multiprotein complex. Under nondenaturing conditions, interacting proteins can be enriched fromcomplex protein mixtures (e.g., cell lysates) using methods such as:• Coimmunoprecipitation or “pull-down” techniques using antibodies directed against one <strong>of</strong> thecomponent proteins.• Coprecipitation using affinity-tagged recombinant proteins <strong>and</strong> antibodies directed against the“tag” epitope• Protein-affinity-interaction chromatography (e.g using recombinant glutathione S-transferase (GST)-fusion proteins <strong>and</strong> glutathione-affinity chromatography).• Isolation <strong>of</strong> intact multiprotein complexes (e.g., nuclear pore complex, ribosome complexes,spliceosomes).Determination <strong>of</strong> Partial Amino Acid SequenceUsually, the final step <strong>of</strong> most proteomic studies, independent <strong>of</strong> the purification methodemployed, utilizes either SDS-PAGE or 2D acrylamide gels to separate the proteins for identification<strong>and</strong> characterization. Following electroblot <strong>and</strong> transfer to an inert membrane, such as polyvinylidinedifluoride (PVDF), intact proteins can be identified directly by amino- or carboxy-terminal aminoacid sequence analysis or indirectly from peptides generated by in-gel or on-membrane digestion<strong>of</strong> the protein with a protease usually trypsin. MS-based methods usually identify a protein, not byanalyzing it directly, but by analyzing the peptides derived from proteolytic digestion. Usually, asmall number <strong>of</strong> peptides yield sufficient information to permit protein identification (by peptide massfinger printing (PMF) <strong>and</strong>/or MS/MS <strong>of</strong> individual peptides. In contrast to peptides, the molecularmass <strong>of</strong> intact proteins is usually insufficient to allow database identification.MALDI-MS is used todetermine the accurate mass<strong>of</strong> a group <strong>of</strong> peptides derivedfrom a protein by digestionwith a sequence-specificprotease, usually trypsin,thus generating a peptidemass map or peptide massfingerprint. Because trypsincleaves proteins at the aminoacids arginine <strong>and</strong> lysine, themasses <strong>of</strong> tryptic peptides canbe predicted theoretically forany entry in a protein sequenceCell mapping: affinity capturedatabase. Electrospray ionization <strong>and</strong> t<strong>and</strong>em mass spectrometry is used to sequence the isolatedpeptides from a peptide mixture.Differential display proteomicsA fundamental aspect <strong>of</strong> proteomic research is the determination <strong>of</strong> protein expression levelsbetween two different states <strong>of</strong> a biological system (e.g. relative quantification <strong>of</strong> protein levels), suchas that encountered between a normal <strong>and</strong> diseased cells or tissues. This is referred to as differentialdisplay or comparative proteomics. This can be done in two ways such as running <strong>and</strong> comparingsamples in 2D-SDS-PAGE or with LC-MS <strong>and</strong> Isotope tags.For differences in the protein-expression pr<strong>of</strong>iling, we compare 2D-gels from two differentsamples for differences in the occurrence or intensity <strong>of</strong> protein spots. This approach provides a usefulmeans <strong>of</strong> comparing proteomes. However, identification <strong>of</strong> protein is cumbersome <strong>and</strong> difficult bythis procedure. Application <strong>of</strong> peptide mass fingerprinting <strong>and</strong> LC-MS-MS analysis now makes itpossible to identify essentially any protein one can detect by staining the gel. Therefore, the critical103


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assurancetask in comparative proteomics with 2D gels is identifying the features that differ between the gels.The LC-MS approach to proteome comparisions is conceptually the opposite <strong>of</strong> the 2D gel approach.Whereas the 2D gel approach separates proteins <strong>and</strong> begins with an image comparision, the LC-MSapproach separates peptides <strong>and</strong> ends with data mining to assess differences between samples. Twoprotein samples are treated with reagents to “tag” them. The tags are chemically identical, exceptthat one contains heavy isotopes (e.g. 2 H, 15 N, 13 C, 18 O etc.) <strong>and</strong> the other contains light isotopes. Thesamples are digested <strong>and</strong> the peptides are analyzed by LC-MS-MS. <strong>Analysis</strong> <strong>of</strong> the MS-MS data allowsidentification <strong>of</strong> the protein present. Examination <strong>of</strong> the full-scan spectra corresponding to each MS-MS scan then allows measurement <strong>of</strong> the ratio <strong>of</strong> the light- <strong>and</strong> heavy- isotope tagged peptides. Thisratio corresponds to the ratio <strong>of</strong> that protein in the two samples. This approach provides a relativequantification <strong>of</strong> the level <strong>of</strong> a particular protein in two samples.Mapping protein modifications:Vast majority <strong>of</strong> all eukaryotic proteins are posttranslationally modified <strong>and</strong> more than 200posttranslational modifications (PTMs) <strong>of</strong> amino acids have been reported so far. Practically all PTMsare associated with either an increase or a decrease in molecular mass. The two major PTMs <strong>of</strong> proteinsare phosphorylation <strong>and</strong> glycosylation. Phosphorylation <strong>of</strong> proteins is a ubiquitous regulatorymechanism in both eukaryotes <strong>and</strong> prokaryotes. Intracellular phosphorylation is regulated by proteinkinases (dephosphorylation is regulated by protein phosphatases), which are activated in responseto extracellular signals <strong>and</strong> trigger cells to switch on or <strong>of</strong>f many diverse processes such as metabolicpathways, kinase cascade activation, membrane transport, gene transcription, <strong>and</strong> motor mechanisms.Protein phosphorylation can be examined in several ways such as ‘phosphopeptide mapping <strong>of</strong> 32Plabelledproteins <strong>and</strong> peptides’, amino-terminal sequencing using Edman degradation procedure <strong>and</strong>Mass spectrometry. While all the three methods are equally good, MS is an ideal tool in proteomicsstudies <strong>of</strong> PTM identification <strong>and</strong> characterization because <strong>of</strong> its high sensitivity.Application in food scienceMicroarray-based comparative genomics research, which takes advantage <strong>of</strong> informationavailable from whole genome sequences, is leading to an increased underst<strong>and</strong>ing <strong>of</strong> the evolution<strong>and</strong> pathogenesis <strong>of</strong> food-borne pathogens <strong>and</strong> is providing critical information for the development<strong>of</strong> improved detection <strong>and</strong> genotyping methods.DNAmicroarray technology provides accuratemeasurements <strong>of</strong> gene expression for every gene in a genome <strong>and</strong> allows this expression to beanalyzed in response to specific environmental variables. Further, this technology can be utilizedto identify genes that are controlled by specific regulators by comparing gene expression in mutant<strong>and</strong> wild-type bacteria. However, the potential for the analysis <strong>of</strong> gene expression <strong>of</strong> pathogens infood environments has not yet been completely realized due to the substantial technical challengesassociated with accurately measuring bacterial gene expression in complex matrices. Genomotypinginvolves the comparison <strong>of</strong> whole genomes <strong>of</strong> bacteria using DNA microarrays <strong>and</strong> has been utilizedto identify potential genes associated with virulence, disease severity, <strong>and</strong> adaptation to differenthosts <strong>and</strong> ecological niches. Used as diagnostic tools, DNA microarrays <strong>of</strong>fer the capability to detect<strong>and</strong> characterize a broad spectrum <strong>of</strong> pathogens simultaneously in a relatively short period <strong>of</strong> time.Various food grade bacteria with specific reference to lactic acid bacteria are used for production<strong>of</strong> fermented foods. Different lactic acid bacteria produce different proteins in the system duringfermentation. Global analysis <strong>of</strong> proteome <strong>of</strong> useful lactic acid bacteria using proteomic approacheswill help to identify various proteins expressed in the system. Systematic analysis <strong>of</strong> the proteinsexpressed will give an idea about the importance <strong>of</strong> various proteins during fermentation. Differentialexpression proteomics in between various useful microorganisms will help us to identify usefulbiomolecules specific for a particular microorganism. This will help us to identify organism specificcellular markers for future application in food product development.Milk constitutes an important ingredient <strong>of</strong> food system. This is constituted <strong>of</strong> number <strong>of</strong> growth104


Proteomic Techniques for Application in Food Sciencepromoting proteins,enzymes <strong>and</strong> signalingmolecules. Global <strong>and</strong>differential expressionanalysis <strong>of</strong> proteinsin milk <strong>of</strong> variousanimal species willhelp us to identifyvarious new proteins<strong>of</strong> health importance.Until now, most <strong>of</strong>the abundant proteinshave been studied inmilk. However, manylow abundant proteinswhich are secretedin milk are generallyignored <strong>and</strong> have notbeen studied in detail.Proteomic approaches will help to identify useful low abundant proteins, which can be studied furtherfor underst<strong>and</strong>ing their beneficial properties. Thus proteomic techniques are extremely useful fordiscovery <strong>of</strong> novel biomolecules for future applications in food science. Global genetic-based analysesprovide information regarding which genes an organism contains or which genes are expressed underspecific conditions; however, examining the posttranslational protein output <strong>of</strong> an organism allowsone to query the ultimate outcome <strong>of</strong> the organism’s genetic <strong>and</strong> regulatory activities. Techniquesthat fall within the category <strong>of</strong> either proteomics or protein arrays are used for global analysis <strong>of</strong>cellular protein output under different conditions <strong>and</strong> potentially those relevant to food <strong>and</strong> foodprocessingenvironments. The integration <strong>of</strong> both genetic- <strong>and</strong> protein based approaches provides aglobal analysis <strong>of</strong> treatment- or environment-related changes at the molecular level, thus presentinga more comprehensive view <strong>of</strong> cellular activities. The development <strong>of</strong> high-throughput analysistechniques will make possible multi-omics approaches to underst<strong>and</strong>ing complete biological systems,a field known as systems (integrated) biology. Although omics technologies are becoming st<strong>and</strong>ardresearch tools that <strong>of</strong>fer tremendous opportunities, there are also significant challenges. There is aneed to properly manage the large quantity <strong>of</strong> complex raw data generated by these technologies ina manner such that it can be adequately analyzed, scrutinized, <strong>and</strong> compared for the benefit <strong>of</strong> thescientific community. There are various omics st<strong>and</strong>ardization activities underway, which are criticalfor the integration <strong>and</strong> interpretation <strong>of</strong> data from different data sources. Lastly, there is a need tobridge the gap between knowledge <strong>of</strong> the genome, proteome, <strong>and</strong> metabolome, <strong>and</strong> results obtainedin relevant systems by studying the behavior <strong>of</strong> pathogens in foods <strong>and</strong> in the animal host, not onlyin model systems under laboratory conditions. The knowledge garnered from omics-based researchin the coming years will play an important role in underst<strong>and</strong>ing how pathogens survive food safetybarriers <strong>and</strong> interact with host species. Each new advance in our underst<strong>and</strong>ing will potentially giverise to improved <strong>and</strong> novel strategies for detection, identification, <strong>and</strong> control <strong>of</strong> food-borne pathogens,as well as for diagnosis <strong>and</strong> control <strong>of</strong> infections.105


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assurance106Evaluation <strong>of</strong> Probiotic Attributes <strong>of</strong> <strong>Dairy</strong>Starter Cultures Using Various Test MethodsRameshwar Singh<strong>Dairy</strong> Microbiology Division, NDRI, KarnalProbiotics – friendly bacteria with a host <strong>of</strong> benefits“Let food be the medicine <strong>and</strong> medicine be the food,” the age-old quote by Hippocrates, is certainlythe dogma <strong>of</strong> today. With the growing interest in self-care, recognition <strong>of</strong> the link between diet <strong>and</strong>health is becoming stronger day by day. As a result, the market for functional foods, or foods thatpromote health beyond providing basic nutrition, is flourishing. Within the functional foods is therapidly exp<strong>and</strong>ing arena <strong>of</strong> probiotics.Probiotics (according to the currently adopted definition by FAO/WHO) are: “Live microorganismswhich when administered in adequate amounts confer a health benefit on the host”. The term probioticsis derived from the Greek word ‘pro’ means ‘for’ <strong>and</strong> ‘bio’ means ‘life’. Lilly <strong>and</strong> Stillwell were thefirst one to introduce the term probiotics in the year 1965 to describe the growth promoting factorsproduced by the microorganisms. However over the years, the term probiotics has been linked toseveral definitions. As per the version <strong>of</strong> Parker, probiotics can be defined as those organisms <strong>and</strong>substances, which contribute to the intestinal microbial balance. Later, Fuller redefined probiotics asfoods containing live microorganisms, which actively enhance the health <strong>of</strong> consumers by improvingthe balance <strong>of</strong> micr<strong>of</strong>lora in the gut, when ingested live in sufficient numbers.Types <strong>of</strong> probioticsMany types <strong>of</strong> bacteria have been used as probiotics since time immemorial. Today food productscontaining probiotics are almost exclusively dairy products – fluid milk, dahi, soy yogurt, yogurt due tothe historical association <strong>of</strong> lactic acid bacteria with fermented milk. The most frequently used bacteriain these products include the Lactobacillus <strong>and</strong> Bifidobacterium species. Some Enterococcus species, yeastslike Saccharomyces species too find a place in the long list <strong>of</strong> probiotics. In particular lactobacilli aregenerally used as probiotics. This may have historical reasons since Metchnik<strong>of</strong>f proposed that thelactobacilli present in yoghurt would have a health promoting effect.Potential health benefits <strong>of</strong> probioticThe list <strong>of</strong> potential health promoting traits attributed in particular to LAB is quite impressive.Health benefit: proposed mechanism(s)1. Alleviation <strong>of</strong> lactose intolerance:Bacterial β-galactosidase acts on lactose2. Positive influence on intestinal flora:a. Lactobacilli influence activity <strong>of</strong> overgrowth flora, decreasing toxic metabolite productionb. Antibacterial characteristics3. Prevention <strong>of</strong> intestinal tract infections:a. Adjuvant effect increasing antibody productionb. Stimulation <strong>of</strong> the systemic or secretory immune responsec. Competitive exclusiond. Alteration <strong>of</strong> intestinal conditions to be less favorable for pathogenicity (pH, short chain fattyacids, bacteriocins)e. Alteration <strong>of</strong> toxin binding sitesf. Gut flora alterationg. Adherence to intestinal mucosa, preventing pathogen adherenceh. Competition for nutrients


Evaluation <strong>of</strong> Probiotic Attributes <strong>of</strong> <strong>Dairy</strong> Starter Cultures Using Various Test Methods4. Improvement <strong>of</strong> the immune system:a. Strengthening <strong>of</strong> non-specific defense against infectionb. Increased phagocytic activity <strong>of</strong> white blood cellsc. Increased serum IgA after attenuated Salmonella typhimurium challenged. Increase in IgA productione. Proliferation <strong>of</strong> intra-epithelial lymphocytesf. Adjuvant effect in antigen-specific immune responsesg. Regulation <strong>of</strong> the Th1/Th2 balance, induction <strong>of</strong> cytokines5. Reduction <strong>of</strong> inflammatory or allergic reactions:a. Restoration <strong>of</strong> the homeostasis <strong>of</strong> the immune systemb. Regulation <strong>of</strong> cytokine synthesisc. Prevention <strong>of</strong> antigen translocation into blood6. Anti-colon cancer effecta. Mutagen bindingb. Carcinogen deactivationc. Alteration <strong>of</strong> activity <strong>of</strong> colonic microbesd. Immune responsee. Influence on secondary bile salt concentration7. Blood lipids, heart disease :a. Assimilation <strong>of</strong> cholesterolb. Alteration <strong>of</strong> activity <strong>of</strong> bile salt hydrolase enzymec. Antioxidative effect8. Antihypertensive effect:a. Peptidase action on milk results in antihypertensive tripeptides (angiotensin convertingenzyme inhibitors)b. Cell wall components act as angiotensin converting enzyme inhibitors9. Urogenital infections:a. Adhesion to urinary <strong>and</strong> vaginal tract cellsb. Competitive exclusionc. Inhibitor production (H 2O 2, bio-surfactants)10. Infection caused by Helicobacter pylori:a. Competitive exclusionb. Lactic acid productionc. Decreased urease activity <strong>of</strong> H. pylori in humans after administration <strong>of</strong> a supernatant <strong>of</strong> aLactobacillus culture11. Regulation <strong>of</strong> gut motility (constipation)Characteristics expected <strong>of</strong> potential probiotic strains• Non toxic <strong>and</strong> non-pathogenic• Accurate taxonomic identification• Normal inhabitant <strong>of</strong> the targeted species• Capable <strong>of</strong> survival, proliferation <strong>and</strong> metabolic activity in the target site, which implies:• resistance to gastric acid <strong>and</strong> bile• ability to persist, albeit for short periods, in the gastrointestinal tract• adherence potential preferred• ability to compete with the resident flora• Production <strong>of</strong> antimicrobial substances• Antagonism towards pathogenic bacteria• Ability to modulate immune responses• Ability to exert at least one clinically documented health benefit107


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assurance• Genetically stable• Amenability <strong>of</strong> the strain <strong>and</strong> stability <strong>of</strong> the desired characteristics during processing, storage<strong>and</strong> delivery• Viability at high populations• Desirable organoleptic <strong>and</strong> technological properties when included in fermentationprocessesEvaluation <strong>of</strong> the probiotic attributes <strong>of</strong> lactic acid bacteria(1) Acid tolerance: The ability <strong>of</strong> lactic acid bacteria (LAB) to resist acidic conditions (Clark et al., 1997) istested. The LAB are grown in their respective broth overnight at their respective growth temperatures.The actively grown cells (8 log10 cfu ml-1) are harvested by centrifugation <strong>and</strong> resuspended in equalvolume <strong>of</strong> broth with pH adjusted to pH 4.0, pH 3.0, pH 2.0 with 1 M HCl <strong>and</strong> simultaneously in brothwith pH 7.0 as control. Survival is evaluated by determining the viable counts <strong>of</strong> the samples seriallydiluted in peptone water after 0, 30, 60 <strong>and</strong> 120 min in acidic conditions, which is subsequently platedon their respective agar <strong>and</strong> incubated at their respective temperature.(2) Bile tolerance : Tolerance for bile acids is tested according to the method <strong>of</strong> Gillil<strong>and</strong> et al. (1984).The LAB are grown in their respective broth overnight at their respective growth temperature. Theactively grown cells (8 log 10cfu/ ml) are harvested by centrifugation <strong>and</strong> resuspended in equal volume<strong>of</strong> their broth supplemented with 0.5%, 1%, 2% w/v ox bile <strong>and</strong> without supplement as a control .Survival is evaluated by plate count on their respective agar, after 0, 1, 3 <strong>and</strong> 12h <strong>of</strong> incubation in brothcontaining bile salts reflecting the time spent by food in the small intestine <strong>and</strong> subsequently the plateswere incubated at their respective temperature.(3) Cell surface hydrophobicity : Ability <strong>of</strong> the organisms to adhere to hydrocarbons is a measure<strong>of</strong> their adherence to the epithelial cells in the gut i.e. cell surface hydrophobicity. Cell surfacehydrophobicity <strong>of</strong> LAB is determined according to the method described by Rosenberg et al., (1980)with slight modification using n-Hexadecane, n-Octane <strong>and</strong> Xylene. Cultures <strong>of</strong> the strains are grownin their respective broth overnight at their respective growth temperatures. The cells (8 log 10cfu ml -1 )are harvested in their early log phase by centrifugation at 12,000 x g for 5 min at 5ºC, washed twice<strong>and</strong> resuspended in 5 ml phosphate urea magnesium (PUM) buffer (pH 6.5) <strong>and</strong> the cell suspensionis adjusted to an absorbance value (A 610) <strong>of</strong> approx. 0.8 - 1.0. Three ml <strong>of</strong> the bacterial suspension areput in contact with 1 ml <strong>of</strong> each <strong>of</strong> the hydrocarbons. The cells are pre-incubated at their respectivetemperature for 10 min <strong>and</strong> then vortexed for 120 s. The suspension is then kept undisturbed at theirrespective temperatures for 1h to allow phase separation <strong>and</strong> the hydrocarbon layer is allowed to risecompletely. After 1h, aqueous phase is removed carefully with a Pasteur pipette <strong>and</strong> the absorbance(A 610) is measured using Spectrophotometer . The decrease in the absorbance is taken as a measure <strong>of</strong>the cell surface hydrophobicity (%H) calculated with the given equation.Where, ODinitial <strong>and</strong> ODfinal are the absorbance (at 610nm) before <strong>and</strong> after extraction with thethree hydrocarbons.(4) Antibiotic susceptibility : Pattern <strong>of</strong> resistance/susceptibility to antibiotic <strong>of</strong> LAB is studied bydisc diffusion method. Various antibiotic discs <strong>of</strong> ampicillin, amoxycillin, bacitracin, chloramphenicol,cipr<strong>of</strong>loxacin, cotrimoxazole, erythromycin, gentamicin, kanamycin, nalidixic acid, penicillinG,rifampicin, streptomycin, tetracycline, <strong>and</strong> vancomycin are used. Mueller Hinton agar 2 (Himedia)plates are poured in petri plates <strong>and</strong> allowed to solidify. These are subsequently over laid with 4 ml <strong>of</strong>Mueller Hinton agar 2 s<strong>of</strong>t agar tempered at 45ºC <strong>and</strong> seeded with 200 µL <strong>of</strong> active cultures. Petriplatesare allowed to st<strong>and</strong> at room temperature for 15 min <strong>and</strong> then the antibiotic discs are dispensed ontoagar using forceps under aseptic conditions. The agar plates are incubated at 37ºC aerobically for 24 h.Diameter (mm) <strong>of</strong> zone <strong>of</strong> inhibition is measured using antibiotic zone scale <strong>and</strong> results are expressed108


Evaluation <strong>of</strong> Probiotic Attributes <strong>of</strong> <strong>Dairy</strong> Starter Cultures Using Various Test Methodsin terms <strong>of</strong> resistance, moderate susceptibility or susceptibility by comparing with the interpretativezone diameters given by Performance St<strong>and</strong>ards for Antimicrobial Disk Susceptibility tests (CLSI,2007) for disc diffusion antibiotic susceptibility test.(5) Antimicrobial activity : LAB are screened for their antibacterial activity <strong>and</strong> inhibitory spectraagainst a broad range <strong>of</strong> Gram-positive <strong>and</strong> Gram-negative strains by spot-on-lawn assay (Uhlmanet al., 1992). Active pure cultures <strong>of</strong> LAB are grown in broth for 16-18 h at 37ºC. Cell free culturesupernatants (CFCS) are prepared by centrifuging the broth at 10,000 rpm for 10 min at 4ºC. Theculture supernatants thus obtained are heat treated (90ºC, 5-7 min) to kill any live cell. Fresh culture <strong>of</strong>indicator bacteria grown for 16-18 h are further inoculated for its active growth at optimum temperaturefor 3-4 h (absorbance at 660 nm = 0.01). Fifty microlitres <strong>of</strong> this culture is mixed with 7 ml <strong>of</strong> melted <strong>and</strong>tempered (45ºC) TGE s<strong>of</strong>t agar <strong>and</strong> poured onto the previously surface dried TGE agar plates. The s<strong>of</strong>tagar is allowed to solidify <strong>and</strong> 5 μl <strong>of</strong> CFCS is directly spotted on the lawns <strong>of</strong> indicator organism. Theplates are kept undisturbed for 2 h <strong>and</strong> subsequently incubated at 37oC. After 24 h <strong>of</strong> incubation, a 5mm or more diameters (mm) <strong>of</strong> the growth inhibition zones are considered positive inhibition.(6) Cholesterol reduction test : For the ability <strong>of</strong> probiotic culture to reduce cholesterol present in themedia, 20 mL <strong>of</strong> respective broth (containing 3% oxgall <strong>and</strong> 1% lipid cholesterol rich) is inoculatedwith culture <strong>and</strong> incubate at respective temperature for 16 h. Uninoculated broth (control) is processedin the same way. Cells are removed by centrifugation at 8000 g for 5 min. 0.5 mL supernatant is placedinto a clean glass tube <strong>and</strong> 3 mL <strong>of</strong> 95% ethanol is added to each tube, followed by 2 mL <strong>of</strong> 50%potassium hydroxide <strong>and</strong> mixed. Tubes are placed in water bath at 60°C for 10 min. <strong>and</strong> cooled atroom temperature (20°C). After this, 5 mL <strong>of</strong> hexane is carefully added <strong>and</strong> mixed vigorously with avortex for 20s. A 3 mL H 2O is added <strong>and</strong> mixing is done with the vortex. Then the tubes are allowed tosettle at room temperature for 15 min or until complete phase separation (aqueous <strong>and</strong> organic phase).Next, 2.5 mL <strong>of</strong> the hexane layer (upper phase) is transferred into a clean tube <strong>and</strong> dried at 60°C undernitrogen gas flow. The residues formed are resuspended in 4 mL <strong>of</strong> o-phthalaldehyde reagent. Tubesare kept at room temperature for 10 min <strong>and</strong> then 2 mL <strong>of</strong> concentrated sulfuric acid is pipette slowlydown the inside <strong>of</strong> each tube. These tubes are mixed thoroughly. After st<strong>and</strong>ing at room temperaturefor an additional 10 min, absorbance is recorded at 550 nm (A550) against the reagent blank. Theresults are expressed as micrograms (μg) <strong>of</strong> cholesterol per milliliter.ReferencesClark, P.A., Cotton, L.N. <strong>and</strong> Martin, J.H. 1997. Selection <strong>of</strong> bifidobacteria for use as delivery adjuncts in cultured dairyfoods. II. Tolerance to stimulated pH <strong>of</strong> human stomachs. Cult. <strong>Dairy</strong> Prod. J., 28(4): 11-14.Gillil<strong>and</strong>, S.E., Staley, T.E. <strong>and</strong> Bush, L.J. 1984. Importance <strong>of</strong> bile tolerance <strong>of</strong> Lactobacillus acidophilus used as dietaryadjunct. J. <strong>Dairy</strong> Sci., 67: 3045-3051.Rosenberg, M., Gutnick, D. <strong>and</strong> Rosenberg, E. 1980. Adherence <strong>of</strong> bacteria to hydrocarbons: A simple method formeasuring cell-surface hydrophobicity. FEMS Microbiol. Lett., 9: 29-33.Performance St<strong>and</strong>ards for Antimicrobial Disk Susceptibility tests, Clinical <strong>and</strong> Laboratory St<strong>and</strong>ards Institute (CLSI),27(1), 2007.Uhlman, U., Schillinger, U., Rupnow, J.R. <strong>and</strong> Holzapfel, W.H. 1992. Identification <strong>and</strong> characterization <strong>of</strong> twobacteriocin-producing strains <strong>of</strong> Lactococcus lactis isolated from vegetables, Int. J. Food Microbiol., 16: 141-151.Spencer, J. <strong>and</strong> Spencer, A. 2001. Methods in Biotechnology: Food Microbiology protocols, 14: 174-181.109


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assurance110Identification <strong>of</strong> Lactobacillus spp byPCR based Molecular MethodologySachin<strong>and</strong>an De <strong>and</strong> Rupinder KaurAnimal Biotechnology Centre, NDRI, KarnalLactic Acid Bacteria (LAB) constitute an important class <strong>of</strong> organism widely distributed in nature<strong>and</strong> occurring naturally as indigenous micr<strong>of</strong>lora in raw milk. They play an important role in food <strong>and</strong>feed fermentation. Lactobacillus forms the most numerous genus in the -heterogeneous group <strong>of</strong> LAB.Members <strong>of</strong> the genus Lactobacillus are also found in plants <strong>and</strong> in plant-derived materials, such assilage, grains <strong>and</strong> foods, but also in the gastrointestinal tract (GIT) <strong>of</strong> humans <strong>and</strong> animals (Stewart,1997). Lactobacillus species are used industrially for the production <strong>of</strong> yogurt, cheese, sauerkraut,pickles, beer, wine, cider, kimchi, chocolate <strong>and</strong> other fermented foods, as well as animal feeds, such assilage. The genus Lactobacillus currently consists <strong>of</strong> over 149 species <strong>and</strong> 29 subspecies <strong>and</strong> encompassesa wide variety <strong>of</strong> organisms (http://www.bacterio.cict.fr/l/lactobacillus.html). Members <strong>of</strong> the genusLactobacillus are Gram positive, non motile, non spore forming rods or cocci bacteria that producemainly lactic acid after carbohydrate fermentation (K<strong>and</strong>ler <strong>and</strong> Weiss 1986).<strong>Quality</strong> assurance programs associated with research, development, production <strong>and</strong> validation<strong>of</strong> the health or technological benefits <strong>of</strong> these bacteria require their relevant isolation, counting <strong>and</strong>identification. The precise identification <strong>of</strong> these bacteria to the genus <strong>and</strong> species level is quite laborious.At present the identification <strong>of</strong> Lactobacilli largely depend on selective growth in microaerophilicMRS (deMan Rogosa - Sharpe) media <strong>and</strong> an array <strong>of</strong> biochemical tests like Gram staining, catalasetest, carbohydrate fermentation. These microbiological / culture based methods are time consuming<strong>and</strong> <strong>of</strong>ten give rise to ambiguous results. Polyphasic approaches combining biochemical, molecular,<strong>and</strong> morphological data are important for the accurate classification <strong>of</strong> lactic acid bacteria (Klein etal., 1998). Lactobacillus species may be difficult to identify by conventional biochemical methods,although simplified approaches are useful for presumptively assigning organisms to this genus.Many DNA based methods have been applied to the identification <strong>of</strong> Lactobacilli. The ribosomalRNA gene sequences (16 S rRNA <strong>and</strong> 23S rRNA) have been used by many workers for the identification<strong>of</strong> LAB. This is possible because <strong>of</strong> the conserved nature <strong>of</strong> the 16S rRNA gene sequence <strong>and</strong> a vastrepertoire <strong>of</strong> online rRNA gene sequences reported by the scientific community against which the rRNAcould be compared. The 16S rRNA gene based classification has revealed considerable diversity in thisgenus (Vela et al. 2008). New Lactobacillus species are continually being described (www.bacterio.cict.fr), with 10 new species in 2007 <strong>and</strong> four in 2008. Some Lactobacillus species have been renamedover the years. These changes cause confusion <strong>and</strong> some previous identification <strong>of</strong> Lactobacilli mayyet be subject to change . Dubernet et al (2002) have developed a PCR assay using a genus specificprimer, targeted to the genes encoding the 16S rRNA. As we enter into the genomics era the rRNAbased microbial phylogeny is under critical scrutiny. Other useful genotypic studies using proteinencoding genes tuf gene (encoding elongation factor Tu, involved in protein biosynthesis, Chavagnatet al 2002), rpoB (RNA polymerase beta subunit) , gyr B (B subunit <strong>of</strong> DNA gyrase), hsp 65, ( heatshock protein 65) dnaJ (asoociated with DnaK chaperone machinery) , recA (encoding recombinase A),groEL (groEL, encoding a 60-kDa heat shock protein) pheS (phenylalanyl-tRNA synthase) have beenpublished recently. Being housekeeping genes from biosynthetic pathways, they retained the aminoacid structure more or less conserved without modifying the product <strong>of</strong> translation substantially bytolerating silent point mutations, which lead to a greater degree <strong>of</strong> variability at the nucleotide level.Characterisation <strong>and</strong> identification <strong>of</strong> lactobacilli from genus level tostrain levelFor decades, differentiation between genera has been based on phenotypic characters. Under alight microscope, lactobacilliare generally regularly shaped, non-motile, non-spore-forming, Gram-


Identification <strong>of</strong> Lactobacillus spp by PCR based Molecular Methodologypositive rods. However, cell morphology varies widely, from long, straight or slighty crescentshaped rods to coryneform coccobacilli. Numerous genera display such morphological features.However, we can separate by simple tests such as tests for the oxygen tolerance, presence <strong>of</strong> catalase<strong>and</strong> growth on acidified MRS. Classical phenotypic tests for identification <strong>of</strong> lactobacilli are basedon physiological characteristics such as respiratory type, motility, growth temperature <strong>and</strong> growthin NaCl, <strong>and</strong> on biochemical characteristics such as homo/hetero-fermentative, production <strong>of</strong> lacticacid isomers, metabolism <strong>of</strong> carbohydrate substrates, coagulation <strong>of</strong> milk <strong>and</strong> presence <strong>of</strong> particularenzymes (e.g. arginine dihydrolase, antibiotic susceptibilities, <strong>and</strong> so on). Lactobacilli are typicallychemoorganotrophic <strong>and</strong> ferment carbohydrates, producing lactic acid as a major end product.<strong>Analysis</strong> at genus levelThe genus Lactobacillus is heterogeneous, with the G+C content <strong>of</strong> the DNA <strong>of</strong> its species varyingfrom 33 to 55% (Hammes <strong>and</strong> Vogel 1995). However, it is generally thought that G+C content shouldvary by no more than a 10% range within a well-defined genus (V<strong>and</strong>amm et al., 1996). The nucleotidesequences <strong>of</strong> Lactobacillus 16S ribosomal DNA (rDNA) provide an accurate basis for identification. Thesequence obtained from an isolate can be compared with those <strong>of</strong> Lactobacillus species held in databases.Recently, Dubernet et al. (Dubernet et al., 2002) defined a genus-specific primer by analysing similaritiesbetween the nucleotide sequences <strong>of</strong> the spacer region between the 16S <strong>and</strong> 23S ribosomal RNA genes<strong>of</strong> Lactobacillus. The specificity <strong>of</strong> this genus-specific primer combined with a universal primer wastested against 23 strains <strong>of</strong> lactobacilli <strong>of</strong> varied origin (corresponding to 21 species) Escherichia coli, twoleuconoctocs species, Carnobacterium piscicola, Pediococcus pentosaceus, Bifidobacterium bifidum, Weissellaconfusa, Enterococcus faecalis, Staphylococcus aureus <strong>and</strong> Listeria monocytogenes. Positive amplificationwas only obtained with the lactobacilli strains.<strong>Analysis</strong> at species level Phenotypical micro methodsSeveral combinations <strong>of</strong> tests <strong>and</strong> ready-to-inoculate identification kits such as API 50 CH, LRAZym <strong>and</strong> API Zym enzymatic tests can be used for the rapid <strong>and</strong> theoretically reproducible phenotypicidentification <strong>of</strong> pure cultures. They have been used for the characterisation <strong>and</strong> identification <strong>of</strong>lactobacilli in milks [Medina et al., 2001], yoghurts <strong>and</strong> other fermented milks (Andrighetto et al., 1998)<strong>and</strong> in cheeses (Andrighetto et al., 1998, Tilsala <strong>and</strong> Alatossava 1997). However, the reliability <strong>of</strong> thesetests has been questioned, especially for API 50 CH, initially developed for the identification <strong>of</strong> medicalLactobacillus strains. In addition, the manufacturer’s database is not updated <strong>and</strong> some Lactobacillusspecies are missing. Andrighetto et al.(Andrighetto et al., 1998) used API 50 CH to analyse 25 strains <strong>of</strong>thermophilic lactobacilli isolated from yoghurt <strong>and</strong> from semi-hard <strong>and</strong> hard cheeses (Lb. delbrueckiissp. lactis <strong>and</strong> ssp. bulgaricus, Lb. helveticus <strong>and</strong> Lb. acidophilus). For most <strong>of</strong> the strains, clear assignmentto a particular species or subspecies was not possible because ambiguous results were obtained for thesugar fermentation pr<strong>of</strong>ile. Nigatu (Nigatu 2000) also reported a lack <strong>of</strong> agreement between the API50 CH grouping pattern <strong>of</strong> isolates <strong>and</strong> RAPD clusters. Tynkkynen et al. (Tynkkynen et al., 1999) usedAPI 50 CH for identifying strains <strong>of</strong> the Lb. casei group (Lb. rhamnosus, Lb. zeae <strong>and</strong> Lb. casei). The exactidentifications <strong>of</strong> these closely related species were not reliable; some were doubtful or unacceptable<strong>and</strong> some strains were misidentified with a good identification level. Furthermore, variability maybe observed within a single strain. For example, the Lb. rhamnosus GG strain has traditionally beendetected, counted <strong>and</strong> identified on the basis <strong>of</strong> cultures in selective anaerobic conditions on MRS orRogosa agar (37°C for 78 h), colony morphology (large, white, creamy <strong>and</strong> opaque), Gram staining<strong>and</strong> cell morphology (Gram-positive <strong>and</strong> uniform rods in chains) <strong>and</strong> the carbohydrate fermentationpr<strong>of</strong>ile in the API 50 CHL test. However, it has been pointed out that the colony morphology <strong>and</strong> thecarbohydrate fermentation pattern <strong>of</strong> strain GG are not always typical, due to variation (Charteris etal 1997). This variation may result from the loss or gain <strong>of</strong> plasmids, leading to inconsistency in themetabolic traits <strong>of</strong> a strain, as most <strong>of</strong> the proteins involved in carbohydrate fermentation are plasmidencoded(Arhné et al., 1989).111


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceSequencingComparison <strong>of</strong> rRNA gene sequences is currently considered to be the most powerful <strong>and</strong> accuratemethod for determining the degree to which microorganisms are phylogenetically related (Woese1987). Advances in molecular biological techniques have made it possible to sequence long stretches <strong>of</strong>rRNA genes. Initially, reverse transcriptase was used to generate DNA from rRNA, <strong>and</strong> this DNA wasthen sequenced. It is now possible to sequence 16S or 23S rDNA molecules by direct PCR sequencing,<strong>and</strong> this method has generated large sequence databases. Although the speciesspecific sequences arelocated in the first half <strong>of</strong> the 16S rRNA gene (V1-V3 region), identification is more accurate if the wholegene is sequenced (Stackebr<strong>and</strong>t <strong>and</strong> Goebel 1994). This requires the sequencing <strong>of</strong> about 1.5 kb <strong>of</strong>DNA. Tannock et al. (Tannock et 1999) showed that comparison <strong>of</strong> the16S-23S spacer region sequences<strong>of</strong> lactobacilli can be used in practical situations for strain identification. The spacer region sequencesis sequencing rapidly <strong>and</strong> accurately identifies Lactobacillus isolates obtained from gastrointestinal,yoghurt <strong>and</strong> silage samples. The 16S-23S spacer sequences <strong>of</strong> lactobacilli are small, only about 200 bpin length. These short sequences are easy to sequence on both str<strong>and</strong>s <strong>and</strong> provide reliable informationforcomparative work. The spacer region method has the advantage <strong>of</strong> distinguishing between Lb.rhamnosus <strong>and</strong> Lb. casei strains . (Tannock et 1999) It can be used to distinguish Lb. plantarum, fromLb. paraplantarum, these two closely related species belonging to the Lb. plantarum group [12]. Chenet al. (Chen et al., 2000) analysed the 5S-23S rRNA intergenic spacer regions (ISRs) <strong>of</strong> the Lactobacillusgroup. This method was found to be an effective way <strong>of</strong> discriminating Lb. rhamnosus from Lb. casei/Lb. paracasei because spacer length polymorphism results in a 76/80 bp insertion with respect to the16S V2-V3 sequences.ConclusionIt is widely recognised that the identification <strong>of</strong> lactobacilli to species or strain level on the basis<strong>of</strong> physiological <strong>and</strong> biochemical criteria is very ambiguous <strong>and</strong> complicated. Numerous taxonomicchanges have been observed in the Lactobacillus genus as qualification <strong>of</strong> old species in new generaor description <strong>of</strong> new species. This leads to a problematic genus characterization by phenotypic tests<strong>and</strong> to an increasing use <strong>of</strong> classical culture-based molecular methods. New molecular techniques formicrobial community analysis that do not require isolation <strong>of</strong> the microorganisms are very promising.They provide a complementary picture <strong>of</strong> the population obtained using culture-based techniqueswhen applied to the analysis <strong>of</strong> milks <strong>and</strong> dairy products. However, these molecular approaches haveseveral limitations, including the design <strong>of</strong> adequate primers, <strong>and</strong> the possibility that DNA isolation,amplification <strong>and</strong> cloning might be biased by certain strains <strong>and</strong> sequences. There is also dependenceon the detection threshold <strong>and</strong> on the number <strong>of</strong> lactobacilli, unfortunately low in high quality rawmilks.Numerous techniques, culture- dependent or culture-independent, are based on the use <strong>of</strong> probes<strong>and</strong> primers. For these techniques the discrimination level depends on the existence or not <strong>of</strong> the probes<strong>and</strong> primers at the taxonomic level desired. To date we are very far from having specific primers <strong>and</strong>probes for the 88 lactobacilli species, <strong>and</strong> regarding those which have been designed, their specificity<strong>and</strong> validity should be checked one by one with closed genera, species or strains. Another problemresults from the given list <strong>of</strong> 88 lactobacilli species since it is not an <strong>of</strong>ficial list (it does not exist) <strong>and</strong>thus to bypass possible misidentification all probes <strong>and</strong> primers should be validated against the samereference strain at the beginning to ensure their common specificity. Moreover, all the techniquesmentioned in this review have not been applied to the lactobacilli using the same objectives.The genus primer designed by Dubernet et al. (2002), has been used for PCR <strong>and</strong> PCR-TGGE,but not for hybridisation, but it is clear that it could be used. The difficulty <strong>of</strong> choosing a techniquethat has good discrimination power depends not only on the techniques but also on the speciesor strains. Results also depend on the quality <strong>and</strong> exhaustivity <strong>of</strong> a database. Finally, only a fewlimited techniques can be applied with a high degree <strong>of</strong> confidence although they are dependent on112


Identification <strong>of</strong> Lactobacillus spp by PCR based Molecular Methodologydatabase robustness: sequencing to identify at genus <strong>and</strong> species level, <strong>and</strong> sequencing or pulsedfield gel electrophoresis to discriminate strains. In conclusion, analysis <strong>of</strong> lactobacilli in cheeses <strong>and</strong>other dairy products is very complicated <strong>and</strong> the use <strong>of</strong> different techniques, especially molecularbasedphenotypic or genomic techniques, is recommended.ReferenceHammes W.P., Vogel R.F., The genus Lactobacillus, in: Wood B.J.B., Holzapfel W.H. (Eds.), The lactic acid bacteria. Thegenera <strong>of</strong> lactic acid bacteria, Blackie Academic, London, UK, 1995, pp. 19–54.V<strong>and</strong>amme P., Pot B., Gillis M., de Vos P., Kersters K., Swings J., Polyphasic taxonomy, a consensus approach tobacterial systematics, Microbiol. Rev. 60 (1996) 407–438.Dubernet S., Desmasures N., Guéguen M., A PCR-based method for identification <strong>of</strong> lactobacilli at genus level, FEMSMicrobiol. Lett. 214 (2002) 271Medina R., Katz M., Gonzalez S., Oliver G., Characterization <strong>of</strong> the lactic acid bacteria in ewe’s milk <strong>and</strong> cheese fromnorthwest Argentina, J. Food Prot. 64 (2001) 559–563Andrighetto C., De Dea P., Lombardi A., Neviani E., Rossetti L., Giraffa G., Molecular identification <strong>and</strong> cluster analysis<strong>of</strong> hom<strong>of</strong>ermentative thermophilic lactobacilli isolated from dairy products, Res. Microbiol. 149 (1998) 631–643Tilsala-Timisjarvi A., Alatossava T., Development <strong>of</strong> oligonucleotide primers from the 16S-23S rRNA intergenicsequences for identifying different dairy <strong>and</strong> probiotic lactic acid bacteria by PCR, Int. J. Food Microbiol. 35 (1997)49–56Nigatu A., Evaluation <strong>of</strong> numerical analyses <strong>of</strong> RAPD <strong>and</strong> API 50 CH patterns to differentiate Lactobacillus plantarum,Lact. fermentum, Lact. rhamnosus, Lact. sake, Lact. parabuchneri, Lact. gallinarum, Lact. casei, Weissella minor <strong>and</strong> relatedtaxa isolated from kocho <strong>and</strong> tef, J. Appl. Microbiol. 89 (2000) 969–978.Tynkkynen S., Satokari R., Saarela M., Mattila-S<strong>and</strong>holm T., Saxelin M., Comparison <strong>of</strong> ribotyping, r<strong>and</strong>omly amplifiedpolymorphic DNA analysis, <strong>and</strong> pulsed-field gel electrophoresis in typing <strong>of</strong> Lactobacillus rhamnosus <strong>and</strong> L. caseistrains, Appl. Environ. Microbiol. 65 (1999) 3908–3914Charteris W.P., Kelly P.M., Morelli L., Collins J.K., Selective detection, enumeration <strong>and</strong> identification <strong>of</strong> potentiallyprobiotic Lactobacillus <strong>and</strong> Bifidobacterium species in mixed bacterial populations, Int. J. Food Microbiol. 35 (1997)1–27Arhné S., Molin G., Stahl S., Plasmids in Lactobacillus strains isolated from meat <strong>and</strong> meat products, Syst. Appl. Microbiol.11 (1989) 320–325.Woese C.R., Bacterial evolution, Microbiol. Rev. 51 (1987) 221–271Stackebr<strong>and</strong>t E., Goebel B.M., Taxonomic note: a place for DNA-DNA reassociation <strong>and</strong> 16S rRNA sequence analysisin the present species definition in bacteriology, Int. J. Syst. Bacteriol. 44 (1994) 846–849Tannock G.W., Tilsala-Timisjarvi A., Rodtong S., Ng J., Munro K., Alatossava T., Identification <strong>of</strong> Lactobacillus isolatesfrom the gastrointestinal tract, silage, <strong>and</strong> yoghurt by 16S-23S rRNA gene intergenic spacer region sequencecomparisons, Appl. Environ. Microbiol. 65 (1999) 4264–4267113


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceIntroductionAntimicrobial Substances producedby Lactic Acid Bacteria (LAB)Shilpa Vij, Subrota Hati <strong>and</strong> Minakshi Dahiya<strong>Dairy</strong> Microbiology Division, NDRI, KarnalLactic acid bacteria (LAB) are found in many nutrient rich environments <strong>and</strong> occur naturally in variousfood products such as dairy, meat products <strong>and</strong> vegetables. They have traditionally been used as naturalbiopreservatives <strong>of</strong> food <strong>and</strong> feed. Biopreservation refers to extended shelf life <strong>and</strong> enhanced safety <strong>of</strong>foods obtained by using the natural or added micr<strong>of</strong>lora <strong>and</strong> their antimicrobial products. Lactic acidbacteria have traditionally been used as natural biopreservatives in food <strong>and</strong> animal feed, sauerkraut <strong>and</strong>silage. <strong>Their</strong> preserving effect relates mainly to the formation <strong>of</strong> organic acids <strong>and</strong> hydrogen peroxide,competition for nutrients <strong>and</strong> production <strong>of</strong> antimicrobial substances. Lactic acid bacteria are able toproduce antimicrobial compounds such as organic acids, hydrogen peroxides, bacteriocins etc. Antifungalcompounds such as proteinaceous compounds, phenyllactic acid, cyclic dipeptides <strong>and</strong> hydroxylatedfatty acids <strong>and</strong> Bacteriocin-like substances (BLIS) <strong>and</strong> other low <strong>and</strong> medium molecular weight masscompounds are also produced by LAB.Organic acidsOrganic acids occurring in foods are additives or end-products <strong>of</strong> carbohydrate metabolism <strong>of</strong> LAB.Lactic <strong>and</strong> acetic acids are the main products <strong>of</strong> the fermentation <strong>of</strong> carbohydrates by LAB. Acetic acidis the strongest inhibitor <strong>and</strong> has wide range <strong>of</strong> inhibiting activity against bacteria, yeast <strong>and</strong> molds.These acids generally recognised as safe agents for the preservation <strong>of</strong> foods (El-Ziney, 1998), diffusethrough the membrane <strong>of</strong> the target organisms because they are lipid soluble. After entering the cell,the acid gets dissociated. The release <strong>of</strong> protons in the cytoplasm leads to acidification <strong>and</strong> inhibition<strong>of</strong> the cell growth.Hydrogen peroxide (H 2O 2)Most LAB have flavoprotein oxidases, enabling them to produce hydrogen peroxide (H 2O 2)in the presence <strong>of</strong> oxygen. Hydrogen peroxide accumulates in the environment since LAB do notproduce catalase. The antimicrobial effect <strong>of</strong> hydrogen peroxide attributes to a strong oxidizingeffect on the bacterial cell, <strong>and</strong> to the destruction <strong>of</strong> basic molecular structures <strong>of</strong> cellular proteins.The antimicrobial effect <strong>of</strong> hydrogen peroxide at non-inhibitory concentrations is potentiated bylactoperoxidase <strong>and</strong> thiocyanate present in milk <strong>and</strong> saliva (Condon, 1987). The lactoperoxidase–thiocyanate–peroxide system involves the reaction <strong>of</strong> hydrogen peroxide <strong>and</strong> thiocyanate throughcatalysed by lactoperoxidase. Hypothiocyanate (OSCN – ) <strong>and</strong> other intermediary products then inhibitother microorganisms. The structural damage <strong>and</strong> changes in bacterial membrane due to exposure toOSCN – . Occurs. It inhibits glucose transport <strong>and</strong> some enzyme activity due to oxidation <strong>of</strong> sulfahydralin the metabolic enzymes.SCN – + H 2O 2→ OSCN – +H 2OThe Gram –negative bacteria are rapidly killed whereas, the Gram-positive bacteria are inhibited.Lactoperoxidase <strong>and</strong> thiocyanate are present in milk, <strong>and</strong> when some LAB are grown in milk or milkproducts, the third needed component, hydrogen peroxide, is added.DiacetylDiacetyl (2, 3-butanedione), the characteristic aroma compound <strong>of</strong> butter, has antimicrobial effectsat low pH (Jay, 1982) <strong>and</strong> is produced by strains <strong>of</strong> some genera <strong>of</strong> LAB during citrate fermentation.However, the amounts <strong>of</strong> diacetyl needed to exert antimicrobial activity (close to 200 mM) dramaticallyalters both the taste <strong>and</strong> aroma <strong>of</strong> the product. It has antimicrobial activity against Bacillus sp.114


Antimicrobial Substances produced by Lactic Acid Bacteria (LAB)BacteriocinsBacteriocins are bacterial ribosomally synthesized peptides or proteins with antimicrobial activity<strong>and</strong> kill very closely related bacteria upon binding to the inner membrane or other cytosolic targets.Nowadays, the term bacteriocin is mostly used to describe the small, heat-stable cationic peptidessynthesized by Gram positive bacteria, namely lactic acid bacteria (LAB), which display a widerspectrum <strong>of</strong> inhibition. Based on their cationic <strong>and</strong> their hydrophobic nature, most <strong>of</strong> these peptidesact as membrane permeabilizers. Pore formation leads to the total or partial dissipation <strong>of</strong> the protonmotive force, ultimately causing cell death. Bacteriocin pore formation seems to be target mediated.Nisin <strong>and</strong> other lantibiotics use the cell wall precursor lipid II as a docking molecule. Thereby, twomodes <strong>of</strong> action, i.e. inhibition <strong>of</strong> cell wall biosynthesis <strong>and</strong> pore formation, are combined within onemolecule for potent antimicrobial activity.Class General Features Produced by LABI-lantibiotics: la-Linear, lb-Globular<strong>and</strong> lc-Multi componentII-Unmodifi ed peptides:lla-Pediocinlike, llb-Miscellaneous, llc-MulticomponentIII-Large Proteins: llla-Bacteriolytic,lllb-Non-lyticModifi ed, heat stable,


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceLactococcus sp. <strong>and</strong> Leuconostoc sp. (BD type cultures), Propionibacterium sp. Lactobacillus sp. as well asLactobacillus acidophilus <strong>and</strong> Bifidobacterium.Antifungal compounds <strong>of</strong> LABProteinaceous compounds: Ribosomally synthesized antimicrobial peptides generally have ahydrophobic <strong>and</strong> a hydrophilic end, a size <strong>of</strong> 20–50 amino acids, <strong>and</strong> cationic properties. Many LABproduce bacteriocins, antibacterial, ribosomally synthesized peptides or proteins. Antifungal activity<strong>of</strong> the compounds produced by LAB are well known. Lactococcus lactis subsp. lactis <strong>and</strong> Lactobacilluscasei produced proteinaceous compounds with antagonistic activity against several filamentous fungi.The anti-aflatoxigenic properties <strong>of</strong> LAB depend on adherence <strong>of</strong> fungal toxins to cells <strong>of</strong> LAB. Aproteinaceous compound from Lactobacillus coryniformis subsp. coryniformis strain Si3 as antifungaleffect against several moulds <strong>and</strong> yeasts. The peptide is small (approximately 3 kDa), heat stable,active in the pH range 3–6 <strong>and</strong> totally inactivated by proteinase K. Similar characteristics are foundamong the heat stable, unmodified bacteriocins <strong>of</strong> subclass II.Phenyllactic acid: Phenyllactic acid <strong>and</strong> 4-hydroxy-phenyllactic acid from L. plantarum 21B haveantifungal activity against several species <strong>of</strong> filamentous fungi (Lavermicocca et al. (2000). Phenyllacticacid has also been identified from culture supernatants <strong>of</strong> L. plantarum MiLAB 393, L. coryniformis strainSi3, <strong>and</strong> strains <strong>of</strong> Pediococcus pentosaceus <strong>and</strong> L. sakei. Phenyllactic acid is only active against yeasts<strong>and</strong> moulds. However, this metabolite certainly contributes to the overall antifungal effect in synergywith other compounds produced by LAB.Cyclic dipeptides <strong>and</strong> other low-molecular-mass inhibitory compounds: New types <strong>of</strong> antimicrobialcompounds from the culture filtrate <strong>of</strong> L. plantarum VTT E-78076 was found (Niku-Paavola et al. (1999). The active fraction include benzoic acid, 5-methyl-2,4-imidazolidinedione (methylhydantoine),tetrahydro-4-hydroxy-4-methyl-2H-pyran-2- one (mevalonolactone), <strong>and</strong> cyclo(glycyl-L-leucyl). Twocyclic dipeptides are cyclo (Phe-Pro) <strong>and</strong> cyclo (Phe-OH-Pro) in the supernatant <strong>of</strong> L. plantarum MiLAB393. The antimicrobial effect <strong>of</strong> several different cyclic dipeptides has been found that cyclo(Phe-Pro)<strong>and</strong> cyclo(Phe-OH-Pro) are also produced by strains <strong>of</strong> P. pentosaceus, L. sakei <strong>and</strong> L. coryniformis <strong>and</strong>thus might be common LAB metabolites.Phenolic compounds: This phenolic compound produced by P. acidilactici LAB 5 <strong>and</strong> showedvarying degrees <strong>of</strong> antifungal activity against a number <strong>of</strong> foods <strong>and</strong> plant pathogenic fungi.Hydroxy fatty acids: Some LAB can produce antimicrobial fatty acids that improve the sensoryquality <strong>of</strong> fermented products. Caproic acid isolated from Lb. sanfrancisco CB1 is a potent antifungalsubstance produced by this strain. This compound can act in synergy with other acids such as propionic,butyric <strong>and</strong> valeric acids. Among these fatty acids, the most active is shown to possess a 12-carbonatom chain length. Hydroxylated fatty acid compounds present a very broad inhibition spectrum <strong>and</strong>are efficient against moulds <strong>and</strong> yeasts. The minimum inhibitory concentration (MIC) <strong>of</strong> hydroxylatedfatty acids ranges between 10 <strong>and</strong> 100 µg/ml (Sjögren et al., 2003).Reference:Heng, N. C. K. <strong>and</strong> Tagg, J. R. (2006). What is in a name? Class distinction for bacteriocins. Nature Reviews Microbiology,4. doi:10.1038/nrmicro1273-c1. Correspondence (February 2006).El-Ziney, M. (1998). Antimicrobial activity <strong>of</strong> lactic acid bacteria metabolites: The role <strong>of</strong> lactic acid enterocin 5701 <strong>and</strong> reuterin.Ph.D. Thesis, University <strong>of</strong> Gent (pp. 3– 23).Sjögren, J., Magnusson, J., Broberg, A., Schnürer, J. <strong>and</strong> kenne, L. (2003). Antifungal 3 - hydroxyl fatty acids fromLactobacillus plantarum MiLAB14. Applied <strong>and</strong> Environmental Microbiology, 69, 7554–7557.Meisel, H. <strong>and</strong> Bocklmann W. (1999). Bioactive pepitdes encrypted in milk proteins; proteolytic activation <strong>and</strong> throph<strong>of</strong>untionalproperties. Antonie van Leeuwenhoek, 76: 207-215.Magnusson, J., Ström, K., Roos, S., Sjögren, J. <strong>and</strong> Schnürer, J. (2003). Broad <strong>and</strong> complex antifungal activity amongenvironmental isolates <strong>of</strong> lactic acid bacteria. FEMS Microbiology Letters, 219, 129–135.Lavermicocca, P., Valerio, F. <strong>and</strong> Visconti, A. (2003). Antifungal activity <strong>of</strong> phenyllactic acid against molds isolatedfrom bakery products. Applied <strong>and</strong> Environmental Microbiology, 69, 634–640.Niku-Paavola, M. L., Laitila, A., Mattila-S<strong>and</strong>holm, T. <strong>and</strong> Haikara, A. (1999). New types <strong>of</strong> antimicrobial compoundproduced by Lactobacillus plantarum. Journal <strong>of</strong> Applied Microbiology, 86, 29–35.Condon, S. (1987). Responses <strong>of</strong> lactic acid bacteria to oxygen. FEMS Microbiology Reviews, 46, 269–280.Jay, J.M. 1982. Antimicrobial properties <strong>of</strong> diacetyl. Applied <strong>and</strong> Environmental Microbiology, 44, 525– 532.116


Microbiological Risk Assessment: A New Concept to Ensure Food SafetyMicrobiological Risk Assessment: A NewConcept to Ensure Food SafetyNaresh Kumar <strong>and</strong> Raghu H. V.<strong>Dairy</strong> Microbiology Division, NDRI, KarnalThe significance <strong>of</strong> milk in human nutrition in now well established as it is considered as thebest, ideal <strong>and</strong> complete food for all age groups. Milk can also serve not only as a potential vehiclefor transmission <strong>of</strong> some pathogens but also allows these organisms to grow, multiply <strong>and</strong> producetoxins. A variety <strong>of</strong> pathogenic organisms may gain access in milk <strong>and</strong> milk products from differentsources <strong>and</strong> cause different types <strong>of</strong> food born illnesses which includes food infection, intoxication<strong>and</strong> toxio-infection (Aneja et al., 2002). Recent development regarding <strong>Quality</strong> <strong>and</strong> safety managementsystems such as ISO <strong>and</strong> Hazard <strong>Analysis</strong> Critical Control Point (HACCP) has reduced such incidences.The safety <strong>of</strong> milk <strong>and</strong> milk products has been extensively reviewed by regulatory agencies in India<strong>and</strong> internationally. A large number <strong>of</strong> risk assessments <strong>and</strong> risk pr<strong>of</strong>iles have been undertaken,examining the risks across the entire dairy supply chain <strong>and</strong> conducting in-depth evaluations <strong>of</strong>specific pathogen-product combinations. This risk assessment will summarize the major body <strong>of</strong>relevant work undertaken to date.Evolution <strong>of</strong> food safety systems: When it was accepted that people can contract disease from contaminatedfood, hygiene control laws were introduced <strong>and</strong> examples can be seen in old legal records.Table 1 gives an overview <strong>of</strong> the more important milestones in developing food safety systems. Inthe absence <strong>of</strong> knowledge about the causes <strong>of</strong> serious foodborne diseases <strong>and</strong> their etiology, use wasmade <strong>of</strong> the ‘prohibition’ principle. This means that it was prohibited to produce <strong>and</strong>/or to consumecertain type <strong>of</strong> food after it was realized that the foods could be a cause <strong>of</strong> high mortality. The principlewas used particularly to protect special groups <strong>of</strong> individuals within society, such as soldiers. Afterthe recognition at the end <strong>of</strong> the nineteenth century that microbial agents were <strong>of</strong>ten responsible forfoodborne illness, systems for controlling the safety <strong>of</strong> the food supply began to be introduced. First,use was made <strong>of</strong> microbiological testing <strong>of</strong> foods <strong>and</strong> this became widely accepted as a means <strong>of</strong>assessing food safety during the early part <strong>of</strong> the twentieth century. Eventually, statutory microbiologicalrequirements relating to food safety were established in many parts <strong>of</strong> the world. Furtherprogress occurred when Esty <strong>and</strong> Meyer (1922) developed the concept <strong>of</strong> setting process performancecriteria for heat treatment <strong>of</strong> low-acid canned food products to reduce the risk <strong>of</strong> botulism. Later,many other foods processed in this way were controlled in the same manner. An outst<strong>and</strong>ing exampleis the work <strong>of</strong> Enright et al. (1956, 1957) who established performance criteria for the pasteurization <strong>of</strong>milk that provided an appropriate level <strong>of</strong> protection against Coxiella burnetii, the causative agent <strong>of</strong>Q fever. Studies for tuberculosis have been carried out earlier. The work is an early example <strong>of</strong> the use<strong>of</strong> risk assessment principles in deriving process criteria.The ability <strong>of</strong> different bacteria to multiply in foods is influenced by several key factors, includingpH, water activity <strong>and</strong> storage temperature. The effects <strong>of</strong> these factors, both singly <strong>and</strong> in combination,have been studied extensively in laboratory media <strong>and</strong> model food systems, <strong>and</strong> this has led to thedevelopment <strong>of</strong> mathematical models for predicting bacterial growth in commercial food products.Although not a food safety system on its own, predictive modelling is a valuable tool, which has helpedto make possible the introduction <strong>of</strong> QRA. The latter has been used for many years in other disciplines<strong>and</strong> its use in food microbiology has been stimulated by the decision <strong>of</strong> the World Trade Organisation(WTO) to promote free trade in safe food (Anon, 1995). It has been emphasized, however, that control<strong>of</strong> food safety in this context must be based on the application <strong>of</strong> sound scientific principles, <strong>and</strong> riskanalysis is seen as the basis for ensuring that the requirement is met.Setting public health goals – The concept <strong>of</strong> Appropriate Level <strong>of</strong> Protection (ALOP): Duringthe past decade, there has been increased interest <strong>and</strong> effort in developing tools to more effectively link117


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assurancethe requirements <strong>of</strong> food safety programs with their expected public health impact. This documentintroduces two such tools, the "Food Safety Objective" (FSO) <strong>and</strong> the “Performance Objective” (PO).These can be used to communicate food safetyrequirements to industry, trade partners, consumers<strong>and</strong> other countries. Good practices <strong>and</strong> HACCPremain essential food safety management systems toachieve FSOs or POs. Setting goals for public healthare the right <strong>and</strong> responsibility <strong>of</strong> governments.These goals may specify the maximum number<strong>of</strong> harmful bacteria that may be present in a food.Where possible, the determination <strong>of</strong> this numbershould be based on scientific <strong>and</strong> societal factors.The level <strong>of</strong> risk can be expressed in a qualitativeway (e.g., high, medium or low risk), or whenSeverityModerateSeriousSevereDescriptionNot usually life threatening; nosequelae; normally short duration;symptoms are self-limiting; can besevere discomfortIncapacitating but not lifethreatening; sequelae infrequent;moderate durationLife threatening, or substantialsequelae, or long durationpossible, as the number <strong>of</strong> cases <strong>of</strong> foodborne disease per number <strong>of</strong> people per year. The ICMSFranking scheme categorizes hazards by the severity <strong>of</strong> the threat they pose to human health, takinginto consideration the: likely duration <strong>of</strong> illness; likelihood <strong>of</strong> death; <strong>and</strong> potential for ongoing adversehealth effects. The severity <strong>of</strong> adverse health effects caused by a hazard is ranked as moderate, seriousor severe according to the following definitions:Under the ICMSF ranking, severe hazards are further divided into those applying to the generalpopu-lation <strong>and</strong> those applying to specific sub-populations, that is, susceptible individuals (forexample, the very young <strong>and</strong> old, the immunocompromised, <strong>and</strong> pregnant women <strong>and</strong> their unbornchildren). This takes into account those situations where a hazard considered to be <strong>of</strong> moderate orserious to the general population may cause a severe illness in certain susceptible sub-populations.The estimates <strong>of</strong> the risk level have to be based on clinical information available (e.g., how many stoolsamples have been found to contain salmonellae) in combination with results from microbiologicalsurveys <strong>of</strong> foods, evaluations <strong>of</strong> the types <strong>of</strong> foods that are produced, how they are produced <strong>and</strong> howthey are stored, prepared <strong>and</strong> used. A few countries may use scientific techniques such as QuantitativeMicrobiological Risk Assessment (QMRA) to estimate the risk <strong>of</strong> illnesses using detailed knowledge<strong>of</strong> the relationship between the number <strong>of</strong> microorganisms in foods <strong>and</strong> the occurrence <strong>of</strong> foodbornediseases. Whatever method is used to estimate the risk <strong>of</strong> foodborne illness, the next step is to decidewhether this risk can be tolerated or needs to be reduced. The level <strong>of</strong> risk a society is willing to acceptis referred to as the "Appropriate Level Of Protection" (ALOP). Importing countries with more strictrequirements for a particular hazard (e.g., harmful bacteria) may be asked to determine a value for theALOP according to the SPS agreement. When a country is willing to accept the current risk <strong>of</strong> illnesses,that level is the ALOP. However, most countries will wish to lower the incidence <strong>of</strong> foodborne disease<strong>and</strong> may set targets for future ALOPs. For instance, the current level <strong>of</strong> listeriosis could be 6 permillion people per year <strong>and</strong> a country may wish to reduce this to 3 per million people per year.A Food Safety Objective (FSO):When a government expresses public health goals relative to the incidence <strong>of</strong> disease, this does notprovide food processors, producers, h<strong>and</strong>lers, retailers or trade partners with information about whatthey need to do to reach this lower level <strong>of</strong> illness. To be meaningful, the targets for food safety setby governments need to be translated into parameters that can be assessed by government’s agencies<strong>and</strong> used by food producers to process foods. The concepts <strong>of</strong> food safety objectives (FSOs) <strong>and</strong> performenceobjectives (POs) have been proposed to serve this purpose. The position <strong>of</strong> these conceptsappearing in the food chain can be seen in Figure 1. An FSO is “The maximum frequency <strong>and</strong>/orconcentration <strong>of</strong> a hazard in a food at the time <strong>of</strong> consumption that provides or contributes to theap-propriate level <strong>of</strong> protection (ALOP)” It transforms a public health goal to a concentration <strong>and</strong>/or fre-quency (level) <strong>of</strong> a hazard in a food. The FSO sets a target for the food chain to reach, but doesnot specify how the target is to be achieved. Hence, the FSO gives flexibility to the food chain to use118


Microbiological Risk Assessment: A New Concept to Ensure Food Safetydif-ferent operations <strong>and</strong> processing techniques that best suit their situation, as long as the maximumhazard level specified at consumption is not exceeded.FSO <strong>and</strong> Product/pathogen/Pathway <strong>Analysis</strong>:The ICMSF has introduced a simple equation that summarises the fate <strong>of</strong> a hazard along the foodchain as follows:Ho - SR + SI = FSOWhere:FSO = Food Safety ObjectiveHo = Initial level <strong>of</strong> the hazardSR = the cumulative (total) decrease in levelSI = the cumulative (total) increase in level≤ = preferably less than, but at least equal toFSO, Ho, R, <strong>and</strong> I are expressed in log10 unitsI (increase) is determined by growth (G) as well as by recontamination (RC). Since the FSO is thelevel <strong>of</strong> a hazard at themoment <strong>of</strong> consumption,another term is neededto describe the levelat another point in thefood chain. The termPerformance Criterionhas been proposed bythe ICMSF, but thisterm is also used to describe the outcome <strong>of</strong> a processing step (for example a 6 decimal reduction <strong>of</strong> apathogen). For this reason the term Performance St<strong>and</strong>ard is used in this document to reflect the level<strong>of</strong> a hazard <strong>and</strong> Performance Criterion to describe the impact <strong>of</strong> a process on the level <strong>of</strong> a hazard.As a consequence <strong>of</strong> this, the following equation is proposed:Where:FSO = Food Safety ObjectivePS = Performance St<strong>and</strong>ardHo = Initial level <strong>of</strong> the hazardSR = the cumulative (total) decrease <strong>of</strong> the hazardSIRC = the cumulative (total) recontamination with the hazardSI G = the cumulative (total) growth <strong>of</strong> the hazard≤ = preferably less than, but at least equal toNote that the PS <strong>of</strong> one point <strong>of</strong> the food chain may be the Ho <strong>of</strong> the following one.This equation is helpful to determine the effect <strong>of</strong> control measures necessary to meet a FSO. Itis im-portant to recognise that data used in PPP analyses that can be used to determine the variousvalues <strong>of</strong> Ho, R, IRC, IG <strong>and</strong> PS, may differ according to their source <strong>and</strong> use.A Performance Objective (PO): For some food hazards, the FSO is likely to be very low, sometimesreferred to as "absent in a serving <strong>of</strong> food at the time <strong>of</strong> consumption". For a processor that makesingredients or foods that require cooking prior to consumption, this level may be very difficult to useas a guideline in the factory. Therefore, it is <strong>of</strong>ten required to set a level that must be met at earliersteps in the food chain. This level is called a performance objective (PO). A PO may be obtained froman FSO, as will be explained below, but this is not necessarily always the case. Foods that need to be119


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assurancecooked before consumption may contain harmful bacteria that can contaminate other foods in a kitchen.Reducing the likelihood <strong>of</strong> cross-contamination from these products could be important in achievinga public health goal. The level <strong>of</strong> contamination that should not be exceeded in such a situation is aPO. For example, raw chicken may be contaminated with Salmonella. Although thorough cooking willmake the chicken safe (absence <strong>of</strong> Salmonella in a serving), the raw chicken may contaminate otherfoods during preparation <strong>of</strong> a meal. A PO <strong>of</strong> “no more than a specified percentage <strong>of</strong> raw chickencarcasses may contain Salmonella” may reduce the likelihood that Salmonella will contaminate otherfoods. In products, such as ready-to-eat foods, the POs can be calculated from the FSO by subtractingexpected bacterial contamination <strong>and</strong>/or growth between the two points.Process performance criteria for heat pasteurisation <strong>of</strong> milk: The work <strong>of</strong> Enright et al. (1957) ledto the development <strong>of</strong> process st<strong>and</strong>ards for controlling Cox. burnetii in milk. The heat treatments usedinitially for milk were designed to inactivate any tubercle bacilli present <strong>and</strong> these were considered tobe the most heat-resistant <strong>of</strong> the nonsporing pathogenic bacteria likely to occur in the product. Thetreatments were based on information from many studies on the heat-resistance <strong>of</strong> both human <strong>and</strong>bovine strains (Mycobacterium tuberculosis <strong>and</strong> Myc. bovis respectively). In the USA, the heating regimeadopted in 1924 for the conventional process was 142°F (61.1°C) - 145°F (62.8°C) for 30 min. In 1933 aheating regime was introduced for the High-Temperature, Short-Time (HTST) process: 161°F (71.7°C)for 15 s. In practice, Cox. burnetii appears to be slightly more heat-resistant than the tubercle bacilli <strong>and</strong>,following recognition that the organism, which causes Q fever in man, could be transmitted by rawmilk, it was necessary to check on the adequacy <strong>of</strong> existing pasteurisation processes for inactivatingthe organism. The work undertaken by Enright <strong>and</strong> colleagues (1956, 1957) fulfilled this requirement<strong>and</strong>, although no formal MRA was employed,elements <strong>of</strong> the MRA approach were implicit intheir studies. These aspects are discussed below.Meeting the FSO: Since the FSO is themaximum level <strong>of</strong> a hazard at the point <strong>of</strong>consumption, this level will frequently be verylow. Because <strong>of</strong> this, measuring this level isimpossible in most cases. Compliance with POsset at earlier steps in the food chain can sometimesbe checked by microbi-ological testing. However,in most cases, validation <strong>of</strong> control measures,verification <strong>of</strong> the results <strong>of</strong> monitoring criticalcontrol points, as well as auditing good practices<strong>and</strong> HACCP systems, will provide the reliableevidence that POs <strong>and</strong> thus the FSO will be met.Microbiological criteria can be derived fromFSOs <strong>and</strong> POs, if such levels are available. If suchlevels are not stated, microbiological criteria canbe developing, if appropriate. The ICMSF (2002)has provided guidance on the establishment <strong>of</strong>microbiological criteria.Risk assessment & HACCP: The relationbetween Risk assessment <strong>and</strong> Hazard analysis <strong>and</strong>critical control point (HACCP) system has beenthe source <strong>of</strong> much confusion. HACCP is the foodsafety management tool applied in a production,processing, used to continuously control hazards<strong>and</strong> thus, to reduce risks. Control measures areput into place at critical control points in theFigure 1. Model food chain indicating the position <strong>of</strong> afood safety objective <strong>and</strong> derived performance objectivesFigure 2. FSOs <strong>and</strong> POs are means <strong>of</strong> communicatingpublic health goals to be met by food processors by goodpractices <strong>and</strong> HACCP. Also, industry can set POs to ensurethat FSOs are met.120


Microbiological Risk Assessment: A New Concept to Ensure Food Safetyproduction process to prevent or eliminate a food safety hazard or reduce it to an acceptable level.Risk assessment, on the other h<strong>and</strong>, is scientific processes <strong>of</strong> compiling <strong>and</strong> analysing informationobjectively, systematically <strong>and</strong> transparently estimate risk. A HACCP study is done for a particularproduct on a particular process line, sold <strong>and</strong> used under a specific set <strong>of</strong> conditions.It is some times thought that Risk Assessment is a part <strong>of</strong> a HACCP study, may be because thefirst activity in HACCP is Called “Hazards <strong>Analysis</strong>”. In HACCP this includes identifying potentialhazards <strong>and</strong> determining which are significant, i.e. those that need to be controlled. In Risk Assessmentthe first activity is called”Hazard identification”. This is one <strong>of</strong> the reasons for confusion.Coxiella burnetii is a small, Gram-negative bacterium, originally classified as a rickettsia that cannotbe grown in axenic culture but can now be cultivated in vitro in various cell lines (Maurin <strong>and</strong> Raoult,1999). Q fever is characterised by fever, chills <strong>and</strong> muscle pain, with occasional long-term complications.It was first described by Derrick (1937). And is known to occur worldwide. The organism infectsmany wild <strong>and</strong> domestic animals, which <strong>of</strong>ten remain asymptomatic. Domestic animals, such ascattle, sheep <strong>and</strong> goats, are considered the main sources <strong>of</strong> infection for humans (Maurin <strong>and</strong> Raoult,1999) <strong>and</strong>, when shed in milk, Coxiella burnetii is <strong>of</strong>ten present in relatively high numbers.Contact with infected animals was known to result in transmission <strong>of</strong> Coxiella burnetii to man,with subsequent development <strong>of</strong> illness, <strong>and</strong> the likelihood <strong>of</strong> the organism contaminating raw milkwas recognised. Early on, there was a lack <strong>of</strong> epidemiological evidence for transmission via milk, butthis was suspected in several outbreaks <strong>and</strong> there was strong supporting evidence from a UK outbreakin 1967 (Brown et al. 1968). Thus, the hazard was the presence <strong>of</strong> Coxiella burnetii in milk intended forhuman consumption.To determine the significance <strong>of</strong> potential hazards, the HACCP study team assesses the probability<strong>of</strong> contamination, survival <strong>and</strong> growth <strong>of</strong> the pathogen in the food during <strong>and</strong> after processing, as wellas in the production environment. This part <strong>of</strong> the HACCP study is similar to the product pathogenpathway analysis that is used in risk assessment; however, the aim <strong>and</strong> output are different. In HACCP,it is done to introduce control measures at critical control point to prevent, eliminate or reduce hazards.In risk assessment, it is done to assess exposure. In HACCP, the input is product <strong>and</strong> population linespecific. After implementation <strong>of</strong> HACCP plan, a “residual” level <strong>of</strong> a hazard can remain <strong>and</strong> this isthe input for exposure assessment in risk assessment.A full risk assessment as defined by the Codex can be useful when acceptable level (or Food SafetyObjectives) have not been established, <strong>and</strong> when dealing with a production line that does not reducepathogens (i.e. when HACCP is not fully effective). The risk assessor may estimate the effectiveness<strong>of</strong> changes in control measures or the introduction <strong>of</strong> new control measures in terms <strong>of</strong> reduction <strong>of</strong>estimated illnesses. The result <strong>of</strong> such a risk assessment might help the HACCP-team to determineCCPs or the critical limits at CCPs. This limited form <strong>of</strong> Risk Assessment could better be called SafetyAssessment, <strong>and</strong> can be used as a tool for product <strong>and</strong> process development.This approach is not normally taken in industrial settings. CCPs <strong>and</strong> critical limits are determinedon the basis <strong>of</strong> previous experience. Such experience includes both incidents that initiated correctiveactions <strong>and</strong> the safety record for the particular product <strong>and</strong> processing line. For new products, theexperiences with similar products, or challenge <strong>and</strong> storage tests, are used.Hazard analysis <strong>and</strong> critical control point (HACCP) technique is the foremost system for the control<strong>of</strong> microbiological hazards in food. The first phase <strong>of</strong> both MRA <strong>and</strong> HACCP is the identification <strong>of</strong>Hazard. Consequently, there is potential confusion between the two concepts. However, HACCP isreally a risk management system, thus the role <strong>of</strong> MRA is to provide the information that HACCPsystem developers need to make more informed decisions on. In addition to enhancing the hazardidentification phase <strong>of</strong> HACCP, Risk Assessment can be used to help identify critical control points(CCPs), establish the critical limits, <strong>and</strong> determine the extent <strong>of</strong> hazard associated with a product duringperiods <strong>of</strong> CCP deviation (ICMSF, 1998).Microbiological Risk Pr<strong>of</strong>ile: Risk analysis (RA) <strong>and</strong> its component parts (risk assessment, risk121


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assurancemanagement <strong>and</strong> risk communication) should be used as a tool in evaluating <strong>and</strong> controlling microbiologicalhazards. A risk-management based approach is required to develop recommendations toensure consumer protection <strong>and</strong> facilitate fair practices in the food trade. This structured approachmay employ microbiological risk assessment <strong>and</strong> may utilize a spectrum <strong>of</strong> risk communicationproducts including guidance documents, codes <strong>of</strong> hygiene practice, food safety objectives (FSO) <strong>and</strong>microbiological criteria (CCFH, 2004).Principle <strong>of</strong> Risk assessment described by Codex Alimentarius Commission: Protocol for Riskassessment originally developed to manage chemical hazards. Principle <strong>of</strong> microbiological Risk Assessmentas described by Codex Alimentarius <strong>and</strong> the FAO/WHO report on Risk management. Accordingto the principle the risk manager who selects the hazards (Figure 3), while the risk assessor describesthe behavior <strong>and</strong> other important characteristics <strong>of</strong> the selected hazards. Subsequently, the riskassessor determines the level <strong>of</strong> exposure to the hazard either by analyzing products or by describingthe complete route from the raw materials, transport, processing, <strong>and</strong> storage to consumption. Thisis called a Dynamic Flow Tree model, process risk Model, Pathogen –Product Pathway or Farm-toFork-Model. It allows to estimate the various levels <strong>of</strong> hazards in various situations/circumstances<strong>and</strong> the probability that the population is exposed to them. Finally risk assessor combine the exposuredata with data on the dose response relationship <strong>and</strong> severity <strong>of</strong> the effects, in a final risk estimate theprobability <strong>and</strong> the severity <strong>of</strong> the illness due to a particular pathogen in a particular food, in a specificgroup <strong>of</strong> consumers.Some general guidelines used to manage pathogens in foods have been described by ICMSF (2002),indicating the respective roles <strong>of</strong> industry <strong>and</strong> government. A series <strong>of</strong> steps is described, including:a) analysis <strong>of</strong> epidemiological data which may give rise to concern for public health or a need forim-proved controls; b) risk evaluation by an expert panel or through quantitative risk assessment; c)es-tablishment <strong>of</strong> a FSO when necessary; d) assessing whether the FSO is technologically achievablethrough preliminary process <strong>and</strong>/or product formulation criteria; <strong>and</strong> e) if the FSO is achievable, establishment<strong>of</strong> process/product requirements.An explicit description <strong>of</strong> an ALOP may be in terms <strong>of</strong> the probability <strong>of</strong> an adverse publichealth consequence or the incidence <strong>of</strong> disease (e.g. the number <strong>of</strong> cases per 100,000 populationsper year). Translation <strong>of</strong> an ALOP into a Food Safety Objective (FSO), expressed in terms <strong>of</strong> therequired level <strong>of</strong> hazard control in food, provides a measurable target for producers, manufacturers<strong>and</strong> control au-thorities. An FSO is defined as “the maximum frequency <strong>and</strong>/or concentration<strong>of</strong> a microbiological hazard in a food at the time <strong>of</strong>consumption that provides an appropriate level <strong>of</strong>protection” (ICMSF, 2002). An alternative definition<strong>of</strong> an FSO might be a limit to the prevalence <strong>and</strong>the average concen-tration <strong>of</strong> a microbial hazardin food, at an appropriate step in the food chainat or near the point <strong>of</strong> consumption that providesthe appropriate level <strong>of</strong> protection (Havelaar et al.,2004). The assessment <strong>of</strong> risks to public health <strong>and</strong>safety from microbiological hazards in milk <strong>and</strong>milk products has been undertaken in the form <strong>of</strong>a Microbiological Risk Pr<strong>of</strong>ile. It provides a broadoverview <strong>of</strong> risks asso-ciated with consumption <strong>of</strong>dairy products. The risk pr<strong>of</strong>ile identifies key foodFigure. 3 Principle <strong>of</strong> Risk assessment described bysafety hazards <strong>and</strong> as-sesses where in the primaryproduction <strong>and</strong> processing supply chain theseCodex Alimentarius Commissionhazards might be introduced, increased, reducedor eliminated.The WTO/SPS agreement (WHO, 1997) describes the rules for the international trade in safe food122


Microbiological Risk Assessment: A New Concept to Ensure Food Safety<strong>and</strong> has introduced the term "appropriate level <strong>of</strong> protection" (ALOP) to express what is mentionedin the first bullet point above. This ALOP has also been called "acceptable level <strong>of</strong> risk". This term issimilar to the expression "tolerable level <strong>of</strong> risk" (TLR) preferred by the ICMSF, because it recognisesthat risks related to the consumption <strong>of</strong> food are seldom accepted, but at best tolerated. Also impliedis that for a number <strong>of</strong> food safety hazards, “zero risk” does not exists <strong>and</strong>/or too costly (financial,societal) to achieve.Risk Characterization in <strong>Dairy</strong> <strong>Products</strong>: The risk involved in consuming raw milk could not beestimated because <strong>of</strong> the absence <strong>of</strong> dose response data. The data for the prevalence <strong>of</strong> contaminatedmilk, the maximum level <strong>of</strong> contamination <strong>and</strong> the fact that milk would have been consumedregularly by the majority <strong>of</strong> the population were probably implicit factors in an assumption that therisks associated with inadequate heat treatment were high.The studies <strong>of</strong> Enright et al. (1956, 1957) led to the conclusion that heating at “143°F for 30 minwas wholly inadequate to eliminate viable Coxiella burnetii from whole, raw milk, while heating at145°F ensures elimination <strong>of</strong> these organisms with a high level <strong>of</strong> confidence” (Enright et al., 1957).This led to the adoption <strong>of</strong> the higher temperature for vat pasteurisation in the USA. The work onthe HTST process indicated that the recommended st<strong>and</strong>ard <strong>of</strong> 161°F for 15 s was sufficient for totalelimination.In preparing the <strong>Dairy</strong> Risk Pr<strong>of</strong>ile, previous risk assessments conducted by other scientific agencieswere reviewed <strong>and</strong> evaluated in this document. There have been few assessments undertaken fordairy products, <strong>and</strong> typically they address specific pathogen: commodity pairs. This pr<strong>of</strong>ile considersthe entire dairy supply chain, including the wide range <strong>of</strong> milk <strong>and</strong> milk products. <strong>Dairy</strong> productslikely to support the growth <strong>of</strong> pathogens <strong>and</strong> prone to contamination after pasteurization may becategorised as higher risk than other dairy products. Alternatively, dairy products that do not supportthe growth <strong>of</strong> pathogens, if correctly formulated, can be classified as low risk.The actual ranking <strong>of</strong> the dairy products is quite variable. Once a shelf-stable UHT product isopened, it may become contaminated <strong>and</strong> when subjected to temperature abuse it could become ahigh-risk food. In contrast, the low pH <strong>and</strong> low water activity <strong>of</strong> extra hard cheese means its will bevery robust <strong>and</strong> unlikely to support the growth <strong>of</strong> any pathogen that adventitiously contaminates thesurface. Dried milk powders <strong>and</strong> infant formulae are inherently stable products due to their low wateractivity, however these products may be prone to contamination, <strong>and</strong> upon reconstitution becomehigher risk, especially if improperly reconstituted <strong>and</strong> stored. Following criteria in food matrix maybe considered while characterizing the risk:• Intrinsic properties <strong>of</strong> the product (i. e. the impact <strong>of</strong> a , pH, salt concentration, <strong>and</strong> their effectwon the growth <strong>of</strong> contaminating microorganism)• Extent to which food is exposed to factory environment or h<strong>and</strong>ling after heat treatment• Hygiene <strong>and</strong> control during distribution <strong>and</strong> retail sale• Degree <strong>of</strong> reheating or cooking before consumption (many dairy products are RTE, so this israrely a factor).Attribution <strong>of</strong> Food-borne Illness to <strong>Dairy</strong> <strong>Products</strong>: While there is enhanced quantitativedata on the incidence <strong>of</strong> illness due to specific pathogens, there is <strong>of</strong>ten not the ability or capacity toidentify or distinguish specific food vehicles. The causative agent <strong>of</strong> an illness is usually determinedthrough epidemiological studies, but confirming the identity <strong>of</strong> a key ingredient or the original source<strong>of</strong> product contamination, or critical factors contributing to their occurrence is problematic. Thisinability to attribute cases <strong>of</strong> food-borne illness to causal vehicles is a major issue internationally, <strong>and</strong>is especially difficult where illness is linked to foods with multiple ingredients. Critical in this processis the capacity to link epidemiological data to animal <strong>and</strong> food monitoring data. The development<strong>of</strong> public health interventions requires accurate data defining the source from which humans areacquiring pathogens <strong>and</strong> how specific foods contribute to the total burden <strong>of</strong> food-borne illness.However, outbreak data represents only a small component <strong>of</strong> actual cases <strong>of</strong> food-borne illness, as123


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assurancemany outbreaks go unrecognized. People do not always seek medical attention for mild forms <strong>of</strong>gastroenteritis, <strong>and</strong> not all food-borne illnesses require notification to health authorities.Dose response: There was no information on the dose response in humans, since challenge trialshad not been carried out <strong>and</strong> epidemiological data were lacking in this respect.Exposure assessment: Information relevant to this step in MRA was obtained by injecting guineapigs to determine the presence <strong>and</strong> titre <strong>of</strong> Coxiella burnetii in milk. The organism was found in33% <strong>of</strong> 376 samples <strong>of</strong> raw milk from California, USA. “The maximum number <strong>of</strong> Coxiella burnetiidemonstrated in the milk <strong>of</strong> an infected dairy cow was the number <strong>of</strong> organisms contained in 10,000infective guinea pig doses <strong>of</strong> Coxiella burnetii per millilitre” (Enright et al., 1957). Similar titres werefound in milk that had been frozen <strong>and</strong> thawed. However, the study did not involve testing <strong>of</strong> allbreeds <strong>of</strong> dairy cattle, <strong>and</strong> it is possible that even higher levels <strong>of</strong> shedding may have occurred in somebreeds that were not examined. Nevertheless, it was concluded that the maximum level <strong>of</strong> consumerexposure would be represented by the highest infective dose demonstrated in this study <strong>and</strong> thatthe pasteurisation process should bring about thermal inactivation <strong>of</strong> such a number (Enright et al.,1957).Risk Management Issues <strong>and</strong> Control Strategies for <strong>Dairy</strong> foods: The critical factors having themost significant impact on the safety <strong>of</strong> processed dairy products are as follows:• The quality <strong>of</strong> raw materials• Correct formulation• Effective processing• The prevention <strong>of</strong> recontamination <strong>of</strong> product• Maintenance <strong>of</strong> temperature control through the dairy supply chain.Risk ranking <strong>of</strong> pathogen:Product L. Monocytogenes EHEC Campylobacter S. Aureus TBEV<strong>Dairy</strong> Normal SusceptiblePasteurized Milk Cheese Medium High low low low lowRaw milk cheese Medium High high medium medium lowWhile pathogenic microorganisms may contaminate raw milk supplies, pasteurization is a very effectiveCritical Control Point (CCP) in eliminating pathogens; good manufacturing practices must alsobe employed to ensure that post-pasteurization contamination does not occur. The effectiveness <strong>of</strong>pasteurization is dependentupon the microbiologicalstatus <strong>of</strong> the incomingraw milk. Controlmeasures at the primaryproduction level involveminimizing the likelihood<strong>of</strong> microbiologicalhazards contaminatingthe raw milk. This isachieved through theimplementation <strong>of</strong> afood safety programincorporating goodagricultural practices The relative risk from dairy products may also be expressed graphically as a(GAP). These measures arecontinuum:124


Microbiological Risk Assessment: A New Concept to Ensure Food Safetyeffective in reducing the microbial load <strong>of</strong> milk being sent for processing.However, should microbial contamination <strong>of</strong> raw milk occur, it is critical that milk is stored ata temperature that minimizes the opportunity for the bacteria to multiply. Temperature abuse <strong>of</strong> themilk may allow growth <strong>of</strong> pathogenic bacteria to the extent where the pasteurization process may noteliminate all pathogenic bacteria <strong>and</strong>/or toxins. The Aflatoxins can be formed <strong>and</strong> ingested by dairycattle during feeding, eventually contaminating the milk. Aflatoxin contamination <strong>of</strong> milk is morecommon where intensive supplementary feeding <strong>of</strong> dairy herds is conducted.Concluding Remarks: FSOs <strong>and</strong> POs are new concepts that have been introduced to further assistgovernment <strong>and</strong> industry in communicating <strong>and</strong> complying with public health goals. These tools areadditional to the existing programmes <strong>of</strong> GAPs, GHPs <strong>and</strong> HACCP which are the means by which thelevels <strong>of</strong> POs <strong>and</strong> FSOs will be met. Hence FSOs <strong>and</strong> POs build on, rather than replace, existing foodsafety practices <strong>and</strong> concepts.References:Aneja, R. P., B. N. Mathur, R. C. Ch<strong>and</strong>an, A. K. Banerjee, 2002. Technology <strong>of</strong> Indian Milk <strong>Products</strong>. A <strong>Dairy</strong> IndiaPublication, Delhi.Brown G L, Colwell D C <strong>and</strong> Hooper, W L, ‘An outbreak <strong>of</strong> Q fever in Staffordshire. Journal <strong>of</strong> Hygiene, Cambridge 196866 649-655.Codex Committee on Food Hygiene (CCFH, CX/FH 04/5/6), 2004. Proposed draft process by which the committee onfood hygiene could undertake its work in microbiological risk assess-ment/risk management, Alinorm 04/27/13.Derrick E H, ‘”Q” fever, A new fever entity: Clinical features, diagnosis, <strong>and</strong> laboratory investi-gation. Med J Australia,1937 2 281-299Enright, J. B., Sadler, W. W. <strong>and</strong> Thomas, R. C. ‘Thermal inactivation <strong>of</strong> Coxiella burnetii <strong>and</strong> its relation to pasteurisation<strong>of</strong> milk’, Public Health Service Publication No. 517. United States Gov-ernment Printing Office, Washington, D C,1957Enright, J. B., Sadler, W. W. <strong>and</strong> Thomas, R. C. ‘Observations on the thermal inactivation <strong>of</strong> the organism <strong>of</strong> Q fever inmilk’, J Milk Food Technol, 1956 10 313-318.Havelaar, A. H., Nauta, M. J., Jansen, J. T., 2004. Fine-tuning food safety objectives <strong>and</strong> risk as-sessment. InternationalJournal <strong>of</strong> Food Microbiology 93, 11–29ICMSF, 1998, Principles for the establishment <strong>of</strong> microbiological food safety objectives <strong>and</strong> related control measures.Food Control 9, 379-384.ICMSF, 2002. Microorganisms in Foods 7. Microbiological testing in food safety management. Kluwer Academic /Plenum Publishers, New York, USA.Jansson, E., Moir, C., Richardson, K., 1999. Final Report Review <strong>of</strong> Food Safety Systems devel-oped by the NSW <strong>Dairy</strong>Corporation. Food Science Australia Report.Maurin M <strong>and</strong> Raoult D, ‘Q Fever’. Clinical Microbiology Reviews, 1999 12 518-553.WHO, 1997. Food Safety <strong>and</strong> Globalization <strong>of</strong> Trade in Food, a challenge to the public health sector. WHO/FSF/FOS/97.8 Rev. 1, WHO, Geneva.Zottola, E.A., Smith, L.B., 1991. Pathogens in cheese. Food Microbiology 8, 171-182.125


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assurance126Biopreservation <strong>of</strong> <strong>Dairy</strong> <strong>Products</strong>: Role <strong>of</strong>Bacteriocins <strong>of</strong> Lactic Acid BacteriaR. K. Malik <strong>and</strong> Gurpreet Kaur<strong>Dairy</strong> Microbiology Division, NDRI, KarnalIn spite <strong>of</strong> modern advances in technology, the preservation <strong>of</strong> foods is still a debated issue, notonly for developing countries (where implementation <strong>of</strong> food preservation technologies are clearlyneeded) but also for the industrialized world. Amelioration <strong>of</strong> economic losses due to food spoilage,lowering the food processing costs <strong>and</strong> avoiding transmission <strong>of</strong> microbial pathogens through thefood chain while satisfying the growing consumers dem<strong>and</strong>s for foods that are ready to eat, freshtasting,nutrient <strong>and</strong> vitamin rich, <strong>and</strong> minimally-processed <strong>and</strong> preserved, are major challenges forthe food industry. The extent <strong>of</strong> microbiological problems in food safety was clearly reflected in theWHO food strategic planning meeting (WHO, 2002):• The emergence <strong>of</strong> new pathogens <strong>and</strong> pathogens not previously associated with foodconsumption is a major concern;• Microorganisms have the ability to adapt <strong>and</strong> change, <strong>and</strong> changing modes <strong>of</strong> food production,preservation <strong>and</strong> packaging have, therefore, resulted in altered food safety hazards.The consumers in the developed world <strong>of</strong>ten question the safety <strong>of</strong> the thous<strong>and</strong>s <strong>of</strong> non-foodpreservatives <strong>and</strong> other additives that are incorporated in food. It has also encouraged them to voicetheir feelings against the use <strong>of</strong> these chemicals in foods <strong>and</strong> also to look for foods that are “natural”,“healthy” <strong>and</strong> not treated with harsh contaminants. At the same time they are also concerned aboutthe loss <strong>of</strong> nutritional value <strong>of</strong> the “harshly processed foods” <strong>and</strong> the possible health risks <strong>of</strong> foodpreserved with chemicals.The empirical use <strong>of</strong> microorganisms <strong>and</strong>/or their natural products for the preservation <strong>of</strong> foods(biopreservation) has been a common practice in the history <strong>of</strong> mankind (Ross et al., 2002). Foodfermentations have a great economic value <strong>and</strong> it has been accepted that these products contributein improving human health. Lactic Acid Bacteria (LAB) have contributed in the increased volume <strong>of</strong>fermented foods world wide especially in foods containing probiotics or health promoting bacteria.Potential risk from psychrotrophic pathogenic <strong>and</strong> spoilage organismsUntil relatively recently it was assumed that refrigeration at or below 4 o C was sufficient to preventthe growth <strong>of</strong> infectious <strong>and</strong> toxigenic food borne organisms. However, this assumption has changedwith the reports that several food borne pathogens are psychotrophs e.g. Listeria monocytogenes,Yesinia enterocolitica, Aeromonas hydrophila, some enterotoxigenic E. coli <strong>and</strong> Clostridium botulinumB & E. Moreover, it has been <strong>of</strong>ten observed that during distribution <strong>and</strong> before consumption <strong>of</strong>refrigerated foods, some temperature abuse may occur which may permit conditions for the growth<strong>of</strong> several other pathogens that can grow at 5 <strong>and</strong> 12 o C. (Del Giudice, 1991; Snyder et al., 1991). Longstorage <strong>of</strong> refrigerated foods, even at low temperatures will allow the psychrotrophic <strong>and</strong> spoilagemicroorganisms to multiply <strong>and</strong> reach a high level even from a very low initial population.Safety concerns <strong>of</strong> the chemical preservativesThe consumers’ preference for the refrigerated foods that do not contain any preservative(s) isbased on their perception <strong>of</strong> these foods to be nutritious, healthy <strong>and</strong> closed to natural as opposed toharshly processed <strong>and</strong> chemically preserved foods. This is because the safety <strong>of</strong> some preservativesas well as some other additives has been questionable such as NO 2, sulphides, sodium diacetate, betapropiolactones <strong>and</strong> therapeutic antibiotics. Reports on possible health hazard from the consumption<strong>of</strong> some preservatives <strong>and</strong> other additives currently being used such as nitrite <strong>and</strong> saccharine, <strong>and</strong>additives previously used but currently not been permitted for use such as cyclomate <strong>and</strong> some dyeshave shaken the faith <strong>of</strong> consumers, thus prompting them to question the safety <strong>and</strong> wholesomeness


Biopreservation <strong>of</strong> <strong>Dairy</strong> <strong>Products</strong>: Role <strong>of</strong> Bacteriocins <strong>of</strong> Lactic Acid Bacteria<strong>of</strong> food they eat.Antimicrobial chemical preservatives inhibit or retard the growth <strong>of</strong> spoilage <strong>and</strong> pathogenicmicroorganisms <strong>and</strong> are used to enhance the safety <strong>and</strong> shelf life <strong>of</strong> foods. They produce theirantimicrobial effect by interfering with the structural <strong>and</strong> functional components <strong>of</strong> microorganisms.<strong>Their</strong> effectiveness is dependant on the type <strong>of</strong> chemical, the concentration <strong>of</strong> chemicals used, themicroorganism present, the type <strong>of</strong> microorganisms <strong>and</strong> their physiological state (vegetative cell orspore), the composition <strong>and</strong> pH <strong>of</strong> food, <strong>and</strong> the temperature <strong>and</strong> duration <strong>of</strong> storage. Moreover, inrecent years the chemicals used in food items have increased exponentially to several thous<strong>and</strong>s. Theeffect <strong>of</strong> actual consumption <strong>of</strong> these chemicals in multiple products over substantial length <strong>of</strong> timeshould be an important consideration in judging their safety.Therefore, the basis <strong>of</strong> selection <strong>of</strong> antimicrobial biopreservatives to be used in foods should notonly be their effectiveness against both Gram positive <strong>and</strong> Gram negative pathogens <strong>and</strong> spoilageorganisms <strong>and</strong> other desired characteristics <strong>of</strong> preservatives but also their proven safety records<strong>and</strong> their acceptance by the health conscious consumers <strong>and</strong> health regulatory agencies. Among thecompounds that have generated considerable interest in the recent years are several antimicrobialmetabolites <strong>of</strong> lactic acid bacteria used to produce, or associated with, fermented foods.Lactic acid bacteriaLactic acid bacteria belong to a group <strong>of</strong> Gram-positive anaerobic bacteria that excrete lactic acidas their main fermentation product into the culture medium. LAB were among the first organisms tobe used in food manufacturing. Today LAB play crucial role in the manufacturing <strong>of</strong> fermented milkproducts, vegetables <strong>and</strong> meat, as well as in the processing <strong>of</strong> other products such as wine. Lactic acidbacteria which include the genera Lactococcus, Streptococcus, Lactobacillus, Pediococcus, Leuconostoc,<strong>and</strong> Carnobacterium (Nettles <strong>and</strong> Barefoot, 1993), play an essential role in food fermentations. The mostimportant contribution <strong>of</strong> these microorganisms to the product is to preserve the nutritive qualities <strong>of</strong>Fig.1 Production <strong>of</strong> various metabolites by a lactic culture including acid, H2O2, diacetyl <strong>and</strong> bacteriocinthe raw material through an extended shelf life <strong>and</strong> the inhibition <strong>of</strong> spoilage <strong>and</strong> pathogenic bacteria.This is due to competition for nutrients <strong>and</strong> the presence <strong>of</strong> inhibitors produced by the starter. TheLactic Acid Bacteria produce an array <strong>of</strong> antimicrobial substances (such as organic acids, diacetyl,acetoin, hydrogen peroxide, reuterin, reutericyclin, antifungal peptides, <strong>and</strong> bacteriocins (Holzapfel etal., 1995; El-Ziney et al., 2000; Holtzel et al., 2000; Magnusson <strong>and</strong> Schnürer, 2001).Bacteriocins <strong>of</strong> lactic acid bacteriaThere are several examples <strong>of</strong> the inhibition <strong>of</strong> spoilage <strong>and</strong> pathogenic bacteria by LAB. Extensiveinvestigations, over the last few decades, into the antagonistic behaviour <strong>of</strong> such strains have led tothe identification <strong>and</strong> characterization <strong>of</strong> numerous bacteriocins produced by LAB (Jack et al, 1995;127


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceNettles <strong>and</strong> Barefoot, 1993; Klaenhammer, 1993). Such investigations have led to the discovery <strong>of</strong> arange <strong>of</strong> different bacteriocin-producing strains, many <strong>of</strong> which have potential in food applications.Given the ease with which bacteriocin-producing strains can be isolated from food sources, it is clearthat many <strong>of</strong> these bacteriocins have been safely consumed for decades <strong>and</strong> thus it could be arguedthat reintroduction <strong>of</strong> such cultures should have negligible associated safety or toxicological problemswhen consumed (Kelly et al., 1996).Bacteriocin could be highly advantageous as even in small amount; these peptides are sufficient tokill or inhibit bacteria competing for the same ecological niche or the same nutrient food. Bacteriocinsproduced by bacteria can be defined as biologically active protein <strong>and</strong> protein complex (proteinaggregates), lipo-carbohydrate proteins, glycoproteins, etc displaying a bactericidal mode <strong>of</strong> actionexclusively towards Gram positive bacteria <strong>and</strong> particularly against closely related species. They form aheterogenous group with respect to producing bacterial species, molecular size, physical <strong>and</strong> chemicalproperties, stability, anti microbial spectrum <strong>and</strong> mode <strong>of</strong> action, etc. The bacteriocins produced byLAB are <strong>of</strong> particular interest to the food industry (Nettles <strong>and</strong> barefoot, 1993), since these bacteriahave generally been regarded as safe (GRAS status). Moreover, majority <strong>of</strong> bacteriocin producing LABare natural food isolates, they are ideally suited for food preservation. The production <strong>of</strong> bacteriocinsby LAB is not only advantageous to the bacteria themselves but could also be exploited by the foodindustry as a tool to control undesirable bacteria in a food grade <strong>and</strong> natural manner, which is likelyto be more acceptable to consumers.Bacteriocins are antimicrobial peptides or small proteins which inhibit, by a bactericidal orbacteriostatic mode <strong>of</strong> action, micro-organisms that are usually closely related to the producer strain(De Vuyst <strong>and</strong> V<strong>and</strong>amme 1994; Schillinger <strong>and</strong> Holzapfel 1996). A bacteriocin producer protectsitself against its own antimicrobial compound by means <strong>of</strong> a system referred to as immunity, whichis expressed concomitantly with the antimicrobial peptide (Nes et al., 1996). The bacteriocin familyincludes a diverse group <strong>of</strong> proteins in terms <strong>of</strong> size, microbial targets, modes <strong>of</strong> action, <strong>and</strong> immunitymechanisms. The bacteriocins produced by LAB <strong>of</strong>fer several desirable properties that make themsuitable for food preservation:Inhibitory spectrum <strong>of</strong> bacteriocins <strong>of</strong> lactic acid bacteriaIn the original definition <strong>of</strong> Jacob et al (1953), bacteriocins were characterized by predominate intraspecies killing activity. While this is true for most <strong>of</strong> the bacteriocins <strong>of</strong> LAB especially those producedby a large number <strong>of</strong> lactococci <strong>and</strong> lactobacilli, others have been found to exhibit a broad range <strong>of</strong>inhibitory activity extending across numerous Gram positive bacteria. Thus Klaenhammer (1998)defined two types <strong>of</strong> bacteriocins <strong>of</strong> lactic acid bacteria; one type exhibiting a classical bacteriocinantibacterial spectrum affecting only closely related bacteria <strong>and</strong> the second type effective against awide range <strong>of</strong> Gram positive bacteria. Inhibition <strong>of</strong> Gram negative bacteria in their native state has notbeen reported for any <strong>of</strong> the purified <strong>and</strong> thoroughly characterized bacteriocins. Similarly, inhibition<strong>of</strong> yeast <strong>and</strong> molds has not been observed.Classification <strong>of</strong> bacteriocins <strong>of</strong> lactic acid bacteriaMost LAB bacteriocins are small (< 6 kDa), cationic, heat-stable, amphiphilic, membranepermeabilizingpeptides that may be divided into three main groups: the modified bacteriocins, knownas lantibiotics (Class I), the heat-stable unmodified bacteriocins (Class II), <strong>and</strong> the larger heat-labilebacteriocins (Class III) as proposed by Klaenhammer (1993). A fourth group (Class IV) with complexbacteriocins carrying lipid or carbohydrate moieties is <strong>of</strong>ten included in bacteriocins classifications.Recently a fifth class <strong>of</strong> circular bacteriocins has been included in the classification scheme with lesseramount <strong>of</strong> modified amino acids (Table 2).128


Biopreservation <strong>of</strong> <strong>Dairy</strong> <strong>Products</strong>: Role <strong>of</strong> Bacteriocins <strong>of</strong> Lactic Acid BacteriaTable 2. General classification <strong>of</strong> LAB Bacteriocins. a Category excluded from Nes’classification (Nes et al., 1996) but included in Garneau’s (Garneau et al., 2002)CLASSClass I. LantibioticsClass II. Nonlantibiotics—Unmodifi ed Bacteriocins.CHARACTERISTICS AND SUBCATEGORIESRibosomally synthesized peptides that undergo posttranslational modifi cations.Molecular weight 2– 5 kDa. Contain lanthionine <strong>and</strong> β-methyl lanthionine.Heat stable peptides formed exclusively by unmodifi ed amino acids.Ribosomally synthesized as inactive pre peptides to get activated byposttranslational cleavage <strong>of</strong> the N- terminal leader peptide. Molecular weight< 10 kDa.Class III. Nonlantibiotics—Large, Heat-labile proteins. Molecular weight >30 kDa.Heat-labile Bacteriocins.Class IVaComplex bacteriocins carrying lipid or carbohydrate moietiesClass V Circular BacteriocinsBacteriocins <strong>of</strong> LAB as potentialfood biopreservativesThe term “biopreservative” includes theantimicrobial compounds that are <strong>of</strong> plant,animal <strong>and</strong> microbial origin <strong>and</strong> have beenused in human food for long time, withoutany adverse effect on human health. Theyare used to enhance safety <strong>and</strong> extendshelf life <strong>of</strong> food <strong>and</strong> can thus be regardedas “biopreservatives”. Fermented foodsare good examples <strong>of</strong> biopreserved foodsin which the starter cultures are allowedto grow so that they can produce antimicrobial metabolites. In fermentation theraw materials are converted by desirableFig 2. Influence <strong>of</strong> different factors on the efficacy <strong>of</strong> in situ bacteriocinproduction for biopreservation. (Galvez et al., 2007)microorganisms such as bacteria, yeast <strong>and</strong> molds to products that have acceptable qualities <strong>of</strong> food.In controlled fermentation, the starter cultures are added to the raw material in large number <strong>and</strong>then incubated under conditions to stimulate the growth <strong>and</strong> production <strong>of</strong> desirable products. Anexample <strong>of</strong> food produced by controlled fermentation is yoghurt in which Lactobacillus bulgaricus<strong>and</strong> Streptococcus thermophilus are added to achieve the fermentations. The lactic acid <strong>and</strong> othermetabolites produced by these desirable bacteria in ‘Sauerkraut’ <strong>and</strong> yoghurt prevent the growth<strong>of</strong> undesirable microorganisms present in the non sterile raw materials <strong>and</strong> make the products shelfstable. (Ray, 1992)Biopreservation by bacteriocins <strong>of</strong> LABThe small heat-stable bacteriocins <strong>of</strong> lactic acid bacteria have been recognized as perhaps themost promising entities for use in applications <strong>of</strong> food preservation for a number <strong>of</strong> reasons. Theyare widely distributed <strong>and</strong> established as food-grade bacteria <strong>and</strong> <strong>of</strong>ten have a suitable spectrum<strong>of</strong> bacterial targets, for example, strains <strong>of</strong> Listeria, Clostridium <strong>and</strong> other Gram-positive bacteriaincluding LAB. Furthermore, these Bacteriocins can endure harsh treatments, such as boiling, withoutloosing much <strong>of</strong> their activity.Bacteriocins produced by lactic acid bacteria have received particular attention in recent yearsdue to their potential application in the food industry as natural preservatives. This trend reflects theincreasing consumer awareness <strong>of</strong> the risks derived not only from food borne pathogens, but als<strong>of</strong>rom the artificial chemical preservatives used to control them (Abee et al., 1994). Some bacteriocinshave well established their action as potential antimicrobial <strong>and</strong> also their possible applications in food129


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assurancepreservation systems. Nisin A already showed effective inhibitory activity on the Listeria monocytogenesgrowth in cheese up to eight weeks. Enterocin, when inoculated in ham, pig meat, meat chicken, <strong>and</strong>sausage, showed inhibitory capacity on the L. monocytogenes growth. Lactocin also had inhibitorycapacity on the same microorganism, when applied in ground meat (Vignolio et al., 1996; Davies, 1999;Aymerich et al., 2000). There are numerous applications <strong>of</strong> nisin as food preservative, including shelflifeextension <strong>of</strong> dairy products, canned foods, vacuum-packed meat <strong>and</strong> cold smoke salmon (Hurst,1981; Davies, 1999; Nilsson et al., 2000).Nisin presents almost all the desirable characters <strong>of</strong> a potential biopreservative like:1. It is non toxic2.3.4.5.130It is natural <strong>and</strong> safe (produced by Lactococcus lactis having GRAS status)Heat <strong>and</strong> storage stableIt can be degraded by digestive enzymes so pose no harmful side-effect to humanIt does not confer any undesirable taste <strong>and</strong> flavor to foods <strong>and</strong>It show prominent antimicrobial spectrum against Gram-positive microorganisms (Kominsky, 1999;Fiorentini et al., 2001).The accumulation <strong>of</strong> studies carried out in recent years clearly indicate that the application <strong>of</strong>bacteriocins in food preservation can <strong>of</strong>fer several benefits, still the use <strong>of</strong> food grade bacteriocinsas biopreservative is in its infancy. Civilization has reaped the benefits <strong>of</strong> Bacteriocins unknowinglyfor 1000s <strong>of</strong> years, yet nisin is the only bacteriocin bio-preservative that has received acceptance incountries worldwide. Among the major bacteriocins apart from nisin, pediocin, acidocin, bavaracin,curavaticin, <strong>and</strong> sakacin, can be other alternatives though there is need to well characterize themwith respect to their use in food preservation along with safety issues associated with them. Nisinis the single bacteriocin commercially used as natural agent <strong>of</strong> food conservation (biopreservation)<strong>and</strong> considered safe by World Health Organization (WHO) <strong>and</strong> has received the denomination <strong>of</strong>Generally Recognized as Safe (GRAS) <strong>and</strong> also by Food <strong>and</strong> Drug Administration (FDA). Nisin isproduced by Lactococcus lactis subsp. lactis <strong>and</strong> is used in various countries (Abee et al., 1994).<strong>Dairy</strong> <strong>Products</strong>Nisin is used in pasteurized, processed cheese products to prevent outgrowth <strong>of</strong> spores suchas those <strong>of</strong> Clostridium tyrobutyricum that may survive heat treatments as high as 85–105°C. Use <strong>of</strong>nisin allows these products to be formulated with high moisture levels <strong>and</strong> low NaCl <strong>and</strong> phosphatecontents, <strong>and</strong> also allows them to be stored outside chill cabinets without risk <strong>of</strong> spoilage. The level <strong>of</strong>nisin used depends on food composition, likely spore load, required shelf life <strong>and</strong> temperatures likelyto be encountered during storage. (Hirsch et al., 1951).Nisin is also used to extend the shelf life <strong>of</strong> dairy desserts which cannot be fully sterilized withoutdamaging appearance, taste or texture. Nisin can significantly increase the limited shelf life <strong>of</strong> suchpasteurized products.Nisin is added to milk in the Middle East where shelf-life problems occur owing to the warm climate,the necessity to transport milk over long distances <strong>and</strong> poor refrigeration facilities. It can double theshelf life at chilled, ambient <strong>and</strong> elevated temperatures <strong>and</strong> prevent outgrowth <strong>of</strong> thermophilic heatresistantspores that can survive pasteurization. It can also be used in canned evaporated milk.Canned foodsNisin may also be added to canned foods at levels <strong>of</strong> 100–200 IU g –1 to control thermophilic sporeformerssuch as Bacillus stearothermophilus <strong>and</strong> Clostridium thermosaccharolyticum which may survive <strong>and</strong>grow in canned foods stored at high temperatures. It also allows a reduction in heat processing requiredwithout compromising food safety. It is used in canned potatoes, peas, mushrooms, soups, <strong>and</strong> cerealpuddings. It increased activity at acid pH levels makes it ideally suitable in low pH foods such as cannedtomatoes, to inhibit acid-tolerant spoilage flora such as B. macerans <strong>and</strong> C. pasteurianum. (Eckner, 1992).


Biopreservation <strong>of</strong> <strong>Dairy</strong> <strong>Products</strong>: Role <strong>of</strong> Bacteriocins <strong>of</strong> Lactic Acid BacteriaMeatConcern about the toxicological safety <strong>of</strong> nitrite used in cured meat has led to investigation into theuse <strong>of</strong> nisin to allow a reduction in nitrite levels. However, uneconomically high levels are requiredto achieve good control <strong>of</strong> Clostridium botulinum, perhaps as a consequence <strong>of</strong> nisin binding to meatparticles, uneven distribution, poor solubility in meat systems, or possibly interference in activity bymeat phospholipids. (Nielson et al., 1990; Eckner, 1992).CerealsLittle research has been conducted on the use <strong>of</strong> bacteriocins in cereal or cereal related products.Delves- Broughton (1996) discussed the use <strong>of</strong> bacteriocins in cereal puddings. Another possibleuse could be foreseen in pasta. Pasta dough is susceptible to contamination <strong>and</strong> growth <strong>of</strong> S. aureus.Bacteriocins, with their activity against Gram positive microbes, may be able to inhibitgrowth <strong>of</strong> thispathogen in the dough. (Eckner, 1992).WineThe insensitivity <strong>of</strong> yeasts to nisin allows its use to control spoilage lactic acid bacteria in beer orwine. It can maintain its activity during fermentation without any effect on growth <strong>and</strong> fermentativeperformance <strong>of</strong> brewing yeast strains <strong>and</strong> with no deleterious effect on taste. It can therefore be usedto reduce pasteurization regimens <strong>and</strong> to increase shelf life <strong>of</strong> beers. It has similar applications in wineexcept for those that require a desirable malolactic fermentation. However, nisin-resistant bacterialstarter cultures such as resistant strains <strong>of</strong> Leuconostoc oenos, in conjunction with nisin, can be used toactually control the malolactic fermentation. Nisin may also be used to reduce the amount <strong>of</strong> sulphurdioxide used in winemaking to control bacterial spoilage. (Todorov et al., 2003).Pediocin-like bacteriocinsPediocin-like bacteriocins are members <strong>of</strong> the Class II bacteriocins, a group <strong>of</strong> bacteriocins inwhich there is considerable commercial interest. They are small, heat-resistant peptides that are notpost-translationally modified to the same extent as the Class I bacteriocins, apart from the cleavage<strong>of</strong> a leader sequence from a double glycine site upon export <strong>of</strong> the bacteriocin from the cell, <strong>and</strong> thepresence <strong>of</strong> disulphide bridges in some molecules. All <strong>of</strong> the pediocins share certain features,includinga seven amino acid conserved region in the N-terminal <strong>of</strong> the active peptide (-Tyr-Gly-Asn-Gly-Val-Xaa-Cys-). Perhaps the best-known is pediocin PA-1, which is produced by Pediococcus acidilactici. Acommercial formulation has been introduced under the trade name ALTA. Pediococci are importantin the fermentation <strong>of</strong> vegetables <strong>and</strong> meat for both acid production <strong>and</strong> flavour development. Thepediocin-like bacteriocins (which are also produced by genera other than the pediococci) are activeagainst other lactic acid bacteria but are particularly effective against Listeria monocytogenes, a foodbornepathogen <strong>of</strong> increasing concern to the food industry. Listeria may be found in raw milk,dairy products, vegetables <strong>and</strong> meat products <strong>and</strong> can grow under conditions such as refrigerationtemperatures (growth has been reported at temperatures as low as –1°C), high salt concentrations (upto 10%), low pH (pH 5.0), <strong>and</strong> high temperatures (44°C). Pediocin PA-1 has been observed to inhibitListeria in dairy products such as cottage cheese, ice cream, <strong>and</strong> reconstituted dry milk. It has alsobeen demonstrated as a biocontrol agent on meat systems. In situ production in dry fermented sausageinhibits L. monocytogenes throughout fermentation <strong>and</strong> drying, possibly owing to a combination <strong>of</strong> thereduction in pH <strong>and</strong> bacteriocin production. Pediococcus acidilactici is also used as a low-level inoculumin reduced-nitrite bacon to prevent the outgrowth <strong>of</strong> Clostridium botulinum spores <strong>and</strong> subsequenttoxin production.Potential uses for other bacteriocinsAs more <strong>and</strong> more bacteriocin producers are being isolated <strong>and</strong> characterized, usuallyfrom food environments, the potential for their use increases. Lactobacillus plantarum producesplantaricins S <strong>and</strong> T in the Spanish-style green olive fermentation. Many traditional Africanfoods are fermented by lactic acid bacteria before consumption. Naturally occurring bacteriocin-131


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assuranceproducing strains in these products may have the potential to improve the quality <strong>and</strong> shelf life<strong>of</strong> other African fermented foods which are <strong>of</strong>ten plagued by problems such as inconsistentquality, hygienic risks <strong>and</strong> premature spoilage.Other bacteriocins which have been isolated from food environments include plantaricin F, fromchilled processed channel catfish; acidocin B, produced by Lactobacillus acidophilus with a narrowspectrum <strong>of</strong> activity which includes Clostridum sporogenes <strong>and</strong> a narrow range <strong>of</strong> other lactobacilli;<strong>and</strong> salivaricin B, produced by Lactobacillus salivarus with a very broad host range including Listeriamonocytogenes, Bacillus cereus, Brochothrix thermosphacta, Enterococcus faecalis <strong>and</strong> many lactobacilli,which may have a more widespread application. Another recently identified bacteriocin with abroad host range similar to that <strong>of</strong> nisin is lacticin 3147, produced by a strain <strong>of</strong> Lactococcus lactis.Since lacticin 3147 is also an effective inhibitor <strong>of</strong> many Gram-positive food pathogens <strong>and</strong> spoilagemicroorganisms, these starters may provide a very useful means <strong>of</strong> controlling the proliferation <strong>of</strong>undesirable microorganisms during Cheddar cheese manufacture.Microgard (Wesman Foods Inc., USA) is commercially produced from grade A skim milkfermented by a strain <strong>of</strong> Propionibacterium shermanii, <strong>and</strong> has a wide antimicrobial spectrum includingsome Gram-negative bacteria, yeasts <strong>and</strong> fungi. This product is added to 30% <strong>of</strong> the cottage cheeseproduced in the USA as an inhibitor against psychrotrophic spoilage bacteria. It is added to a variety<strong>of</strong> dairy products such as cottage cheese <strong>and</strong> yoghurt <strong>and</strong> a nondairy version is also available for use inmeat <strong>and</strong> bakery goods. The inhibitory activity almost certainly depends primarily on the presence <strong>of</strong>propionic acid, but there has also been a role proposed for a bacteriocin-like protein produced duringthe fermentation. This use <strong>of</strong> milk fermented by a bacteriocin producer as an ingredient in milk-basedfoods may be a useful approach for introducing bacteriocins into foods at little cost.Bacteriocins <strong>and</strong> hurdle technologyHurdle technology refers to the manipulation <strong>of</strong> multiple factors (intrinsic <strong>and</strong> extrinsic) designed toprevent bacterial contamination or control growth <strong>and</strong> survival in food. A combination <strong>of</strong> preservationmethods may work synergistically or at least provide greater protection than a single method alone,thus improving the safety <strong>and</strong> quality <strong>of</strong> a food. While in certain foods intrinsic properties such as highsalt may provide adequate protection, the conscious addition <strong>of</strong> an extra hurdle(s) can ensure safety.(Leistner, 2000)The concept <strong>of</strong> hurdle technology began to apply in the food industry in a rational way after theobservation that survival <strong>of</strong> microorganisms greatly decreased when they were confronted with multipleantimicrobial factors (Leistner, 1978; Leistner <strong>and</strong> Gorris, 1995; Leistner, 2000). Over 60 potentialhurdles have been described to improve food stability <strong>and</strong>/or quality (Leistner, 1999). The application <strong>of</strong>bacteriocins as part <strong>of</strong> hurdle technology has received great attention in recent years (Chen <strong>and</strong> Hoover,2003; Ross et al., 2003; Deeganet al., 2006), since bacteriocinscan be used purposely incombination with selectedhurdles in order to increasemicrobial inactivation (Fig3). The combination <strong>of</strong>hurdles to be applied willdepend greatly on the type<strong>of</strong> food <strong>and</strong> its microbialcomposition. This must becarefully considered, sincedifferent hurdles usuallyhave different effects onthe members <strong>of</strong> a microbialcommunity.Fig 3. Application <strong>of</strong> bacteriocins as part <strong>of</strong> hurdle technology.132


Biopreservation <strong>of</strong> <strong>Dairy</strong> <strong>Products</strong>: Role <strong>of</strong> Bacteriocins <strong>of</strong> Lactic Acid BacteriaAntimicrobial packagingBio-active packaging is a further potential application in which bacteriocins can be incorporatedinto packaging destined to be in contact with food. This system combines the preservation function <strong>of</strong>bacteriocins with conventional packaging materials, which protects the food from external contaminants.Spoilage <strong>of</strong> refrigerated foods usually begins with microbial growth on the surface, which reinforcesthe attractive use <strong>of</strong> bacteriocins being used in conjunction with packaging to improve food safety <strong>and</strong>improve shelf-life (Collins-Thompson & Hwang, 2000). Bio-active packaging can be prepared by directlyimmobilizing bacteriocin to the food packaging, or by addition <strong>of</strong> a sachet containing the bacteriocininto the packaged food, which will be released during storage <strong>of</strong> the food product. Studies investigatingthe effectiveness <strong>of</strong> bio-active cellulose- based packaging inserts <strong>and</strong> a vacuum packaging pouch madewith polyethylene/polyamide to improve shelflife <strong>and</strong> safety aspects have proved promising. Whenconsidering bio-active packaging, the stability <strong>and</strong> the ability to retain activity while immobilised to thepackaging film is <strong>of</strong> vital importance.While many LAB bacteriocins possess significant antimicrobial qualities that could greatly enhancethe safety <strong>of</strong> a food, it may yet emerge that industrially they will be most frequently applied as a ‘finalhurdle’in a food system where another hurdle(s) already exists to eliminate pathogens <strong>and</strong> spoilersthat survive only in adventitious circumstances.Bacteriocin resistance among pathogens <strong>and</strong> food spoilage bacteriaAlthough the use <strong>of</strong> bacteriocins for preservation is a novel approach to eliminating or controllingpathogens in food, the development <strong>of</strong> highly tolerant or resistant strains remains the main concern<strong>and</strong> decreases the efficiency <strong>of</strong> bacteriocins as biopreservatives. Resistant food-borne pathogens areposing a global problem which is further facilitated by international trade <strong>of</strong> raw <strong>and</strong> processed foods.In foods with a long shelf life, even a small number <strong>of</strong> these resistant cells can multiply to very highnumber <strong>and</strong> thus may lead to food-borne outbreaks <strong>and</strong> food spoilage.Future prospectsA large number <strong>of</strong> bacteriocins from LAB have been characterized to date, <strong>and</strong> many differentstudies have indicated the potential usefulness <strong>of</strong> bacteriocins in food preservation. Bacteriocins are adiverse group <strong>of</strong> antimicrobial proteins/peptides, <strong>and</strong>, therefore, are expected to behave differently ondifferent target bacteria <strong>and</strong> under different environmental conditions. Since the efficacy <strong>of</strong> bacteriocinsin foods is dictated by environmental factors, there is a need to determine more precisely the mosteffective conditions for application <strong>of</strong> each particular bacteriocin. Bacteriocinogenic cells may also actas living factories in foods. The antimicrobial effects <strong>of</strong> bacteriocins <strong>and</strong> bacteriocinogenic culturesin food ecosystems must be understood in terms <strong>of</strong> microbial interactions. Among the food bornepathogens, knowledge <strong>of</strong> the characteristics <strong>of</strong> bacteriocin resistant variants <strong>and</strong> the conditions thatprevent their emergence will help in determining the optimal conditions for application <strong>of</strong> bacteriocinsin foods <strong>and</strong> minimize the incidence <strong>of</strong> resistance.ReferencesAbee T., Rombouts FM., Hugenholtz J., Guihard G., <strong>and</strong> Letellier L. 1994. Mode <strong>of</strong> action <strong>of</strong> nisin Z against Listeriamonocytogenes Scott A grown at high <strong>and</strong> low temperatures. Applied Environmental Microbiology, 60, 1962-1968.Aymerich T., Garriga M., Ylla J., Vallier J., Monfort JM., <strong>and</strong> Hugas M. 2000. Effect <strong>of</strong> sausage ingredients <strong>and</strong> additiveson the production <strong>of</strong> enterocin A <strong>and</strong> B by Enterococcus faecium CT492. Optimization <strong>of</strong> in vitro production <strong>and</strong>anti-listerial effect in dry fermented sausages. Journal <strong>of</strong> Applied Microbiology, 88, 686-694.Chen H., <strong>and</strong> Hoover DG. 2003. Bacteriocins <strong>and</strong> their food applications. Comprehensive Reviews in Food Science <strong>and</strong>Food Safety, 2, 82–100.Collins-Thompson D., <strong>and</strong> Hwang CA. 2000. Packaging with antimicrobial properties. In Robinson RK., Batt CA.,<strong>and</strong>Patel PD. (eds.), Encyclopedia <strong>of</strong> food microbiology,. Academic press, London, UK, Pp. 416–420.Davies EA. 1999. Effective use <strong>of</strong> nisin to control lactic acid bacterial spoilage in vacuum-packed bologna-type sausage.Journal <strong>of</strong> Food Protection, 9, 1004-1010.Deegan LH., Cotter PD., Hill C., <strong>and</strong> Ross P., 2006. Bacteriocins: biological tools for bio-preservation <strong>and</strong> shelf-lifeextension. International <strong>Dairy</strong> Journal, 16, 1058–1071.Del Giudice, VJ. 1991. We must need the 21st century st<strong>and</strong>ards, Natl. Provisioner, 204 (6), 12133


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceDelves-Broughton, J., Blackburn, P., Evans, RJ. <strong>and</strong> Hugenholtz, J. 1996. Applications <strong>of</strong> the bacteriocin, nisin. AntonieLeeuwenhock, 69: 193-202.DeVuyst L. <strong>and</strong> V<strong>and</strong>amme E. 1994. Bacteriocins <strong>of</strong> Lactic acid bacteria: microbiology, genetics <strong>and</strong> application.Chapman & Hill Ltd., London, UK.Eckner KF. Bacteriocins <strong>and</strong> food applications. 1992. <strong>Dairy</strong> Food <strong>and</strong> Environment Sanitation,12 (4), 204-209El-Ziney MG., Debevere J., <strong>and</strong> Jakobsen M. 2000. Reuterin. 2000. In: Naidu AS. (ed.), Natural Food Antimicrobial Systems,CRC Press, London, Pp. 567–587.Fiorentini, AM., Ernani SS., Porto ACS., Jaciara ZM., <strong>and</strong> Franco BDGM. 2001. Influence <strong>of</strong> bacteriocins produced byLactococcus plantarum BN in the shelf-lie <strong>of</strong> refrigerated bovine meat. Brazilian Journal <strong>of</strong> Microbiology, 32, 42-46Gálvez A., Abriouel H., López ., <strong>and</strong> Ben Omar N. 2007. Bacteriocin-based strategies for food biopreservation, Int. J.Food Microbiol. 120, 51–70.Hirsch A., Grimstead E., Chapman HR., <strong>and</strong> Mattic ATR. 1951. A note on the inhibition <strong>of</strong> an anaerobic sporeformer inSwiss cheese by a nisin producing streptococcus, Journal <strong>of</strong> <strong>Dairy</strong> Science, 18, 205-206Holtzel A., Ganzle MG., Nicholso, G.J., Hammes W.P., <strong>and</strong> Jung G. 2000. The first low-molecular-weight antibiotic fromlactic acid bacteria: reutericyclin, a new tetramic acid. Angew<strong>and</strong>te Chemie, International Edition, 39, 2766–2768.Holzapfel WH., Geisen R., <strong>and</strong> Schillinger U. 1995. Biological preservation <strong>of</strong> foods with reference to protective cultures,bacteriocins <strong>and</strong> food-grade enzymes. International Journal <strong>of</strong> Food Microbiology, 24, 343–362.Hurst A. 1981. Nisin. Applied Microbiology, 27, 85-122.Jack RW., Tagg JR. <strong>and</strong> Ray B. 1995 Bacteriocins <strong>of</strong> Gram-Positive Bacteria. Microbiology Reviews, 59, 171-200.Jacob F., Lwaff A., Siminonvich A., <strong>and</strong> Wallman E. 1953. Definition de qualques terms relatifs à la lysogenie. Annalesde Institut Pasteur, 84, 222-224.Kelly WJ., Asmundson RV., <strong>and</strong> Huang CM. 1996. Isolation <strong>and</strong> characterization <strong>of</strong> bacteriocin-producing lactic acidbacteria from ready-to-eat food products. International Journal <strong>of</strong> Food Microbiology, 33, 209–218.Klaenhammer TR. 1993. Genetics <strong>of</strong> bacteriocins produced by lactic acid bacteria. FEMS Microbiology Reviews, 12,39–86.Klaenhammer TR.1998. Bacteriocins <strong>of</strong> lactic acid bacteria, Biochimie 70, 337–349.Kominsky GMR. 1999, Avaliação da sensibilidade de microrganismos selecionados a diferentes concentrações de nisinaem salsichas comuns e de frango. Higiene Alimentar, 13, 56-62.Leistner L. 1978. Hurdle effect <strong>and</strong> energy saving. 1978 In: Downey, WK. (ed.), Food <strong>Quality</strong> <strong>and</strong> Nutrition. AppliedScience Publishers, London, UK, Pp. 553–557.Leistner L. 1999. Combined methods for food preservation. 1999 In: Shafiur Rahman M. (ed.), H<strong>and</strong>book <strong>of</strong> FoodPreservation. Marcel Dekker, New York, Pp. 457–485.Leistner L. 2000. Basic aspects <strong>of</strong> food preservation by hurdle technology. International Journal <strong>of</strong> Food Microbiology, 55,181–186.Leistner L., <strong>and</strong> Gorris LGM. 1995. Food preservation by hurdle technology. Trends in Food Science & Technology, 6,41–46.Magnusson J., <strong>and</strong> Schnürer J. 2001. Lactobacillus coryniformis subsp. coryniformis strain Si3 produces a broadspectrumproteinaceous antifungal compound. Applied <strong>and</strong> Environmental Microbiology, 67, 1–5.Nes IF., Bao Diep D., Havarstein LS., Brurberg MB., Eijsink V., Holo H. 1996. Biosynthesis <strong>of</strong> bacteriocins <strong>of</strong> lactic acidbacteria. Antonie van Leeuwenhoek 70, 113-128.Nettles CG., <strong>and</strong> Barefoot SF. 1993 Biochemical <strong>and</strong> genetic characteristics <strong>of</strong> bacteriocins <strong>of</strong> food-associated lactic acidbacteria. Journal <strong>of</strong> Food Protection, 56, 338-346.Nielsen JW., Dickson JS., <strong>and</strong> Crouse JD. 1990. use <strong>of</strong> bacteriocin product by Pediococcus acidilactici to inhibit Listeriamonocytogenes associated with fresh meat, Applied <strong>and</strong> Environmental Microbiology, 56, 2142-2145Nilsson L., Chen Y., Chikindas ML., Huss HH., Gran L., <strong>and</strong> Monteville TJ. 2000.Carbon dioxide <strong>and</strong> nisin actsynergistically on Listeria monocytogenes. Applied <strong>and</strong> Environmental Microbiology, 66, 769-774.Ray B., <strong>and</strong> Daeschel MA. 1992. Food Biopreservatives <strong>of</strong> Microbial Origin. CRC Press, Boca Raton, FL.Ross AIV., Griffiths MW., Mittal G.S., <strong>and</strong> Deeth HC. 2003. Combining on thermal technologies to control foodbornemicroorganisms. International Journal <strong>of</strong> Food Microbiology, 89, 125–138.Schillinger, U. <strong>and</strong> Holzapfel, W.H. 1996. Guidelines for manuscripts on bacteriocins <strong>of</strong> lactic acid bacteria. Int. J. FoodMicrobiol., 33: 3–5.Snyder, op., <strong>and</strong> Pol<strong>and</strong>, DM. 1991. America’s safe food-Part II, <strong>Dairy</strong> Food Environment Sanit., 11, 14Todorov S., Vaz-Velho M., <strong>and</strong> Dicks LMT. 2003. Isolation <strong>and</strong> partial characterization <strong>of</strong> bacteriocins produced by fourlactic acid bacteria isolated from traditional South African Beer. Electronic Journal <strong>of</strong> Environmental <strong>and</strong> AgriculturalFood Chemistry, 2(4), 1-6.Vignolio G., Fadda S., Kairuz MN., Ruizholgado AA., <strong>and</strong> Oliver G. 1996. Control <strong>of</strong> Listeria monocytogenes in groundbeef by lactocin 705, a bacteriocin produced by lactobacillus casei CRL 705. International Journal <strong>of</strong> Food Microbiology,29, 3997-4002.WHO. 2002. Food safety strategic planning meeting: report <strong>of</strong> a WHO strategic planning meeting, WHO headquarters,Geneva, Switzerl<strong>and</strong>.134


Regulatory Aspects <strong>of</strong> Functional FoodsIntroduction:Regulatory Aspects <strong>of</strong> Functional FoodsBimlesh mann , Rajesh Kumar <strong>and</strong> Prerna Saini<strong>Dairy</strong> Chemistry Division, NDRI, KarnalThe term “Functional Foods” was first introduced in Japan in the mid-1980s <strong>and</strong> refers to processedfoods containing ingredients that aid specific body functions, in addition to being nutritious. Currently,there is no universally accepted term for functional foods. A variety <strong>of</strong> terms have appeared worldwidesuch as nutraceuticals, medifoods, vita foods <strong>and</strong> the more traditional dietary supplements <strong>and</strong>fortified foods. However, the term Functional foods have become the predominant one even thoughseveral organizations have attempted to differentiate this emerging food category. Consumer interest inthe relationship between diet <strong>and</strong> health has increased substantially. There is much greater recognitiontoday that people can help themselves <strong>and</strong> their families to reduce the risk <strong>of</strong> illness <strong>and</strong> disease <strong>and</strong>to maintain their state <strong>of</strong> health <strong>and</strong> well being through a healthy lifestyle, including the diet. Ongoingsupport for the important role <strong>of</strong> foods such as fruits <strong>and</strong> vegetables <strong>and</strong> wholegrain cereals in diseaseprevention <strong>and</strong> the latest research on dietary antioxidants <strong>and</strong> combinations <strong>of</strong> protective substancesin plants has helped to provide the impetus for further developments in the functional food market.Current research suggests that functional foods can make a positive contribution to addressing thosechallenges. Behind functional food research <strong>and</strong> development, the key drivers are the food industry,consumers <strong>and</strong> governments. The growth <strong>of</strong> the functional foods sector not only represents significantbenefits to the health sector but also <strong>of</strong>fers opportunities for processing <strong>and</strong> manufacturing companies.Manufacturers <strong>and</strong> their search for added-value, higher margin products provided key impetusfor the growth <strong>of</strong> functional products. However, the potential for financial gain resulted in manyunsupported claims for functional ingredients by commercial enterprises whose interests lie more inpr<strong>of</strong>it rather than sound science. As a result, the functional foods field has been tarnished <strong>and</strong> suffers acredibility gap. Many academic, scientific <strong>and</strong> regulatory organizations are actively working on waysto establish the scientific basis to support claims for functional components or the foods containingthem. Any regulatory framework will need to protect consumers from false <strong>and</strong> misleading claims<strong>and</strong> to satisfy the needs <strong>of</strong> industry for innovation in product development, marketing <strong>and</strong> promotion.For functional foods to deliver their potential public health benefits, consumers must have a clearunderst<strong>and</strong>ing <strong>of</strong>, <strong>and</strong> a strong confidence level in, the scientific criteria that are used to documenthealth effects <strong>and</strong> claims. As interest in this category <strong>of</strong> foods has grown, new products have appeared<strong>and</strong> interest has turned to the development <strong>of</strong> st<strong>and</strong>ards <strong>and</strong> guidelines for the development <strong>and</strong>promotion <strong>of</strong> such foods.Existing national <strong>and</strong> international regulatory systems governing theproduction <strong>and</strong> distribution <strong>of</strong> functional foods:WHO (1991) published a seminal report “Guidelines for the Assessment <strong>of</strong> Herbal Medicines”which set out “to define basic criteria for the evaluation <strong>of</strong> quality, safety <strong>and</strong> efficacy” <strong>of</strong> all herbal(including mushrooms) medicines. “As a general rule in this assessment, traditional experience meansthat long-term use as well as the medical, historical <strong>and</strong> ethnological background <strong>of</strong> those productsshall be taken into account.” Depending on each country’s situation, “the definition <strong>of</strong> long-term usemay vary, but would be at least several decades … Prolonged <strong>and</strong> apparently uneventful use <strong>of</strong> asubstance usually <strong>of</strong>fers testimony <strong>of</strong> its safety”. The Guidelines call for various assessments <strong>of</strong> quality,efficacy <strong>and</strong> the intended use, <strong>and</strong> reference should be made to pharmacopoeia monographs wherethey exist. If none exist, then the manufacturer should be required to produce a similar statement.Procedures should all correspond to Good Manufacturing Practices <strong>and</strong> include stability testing <strong>of</strong> thefinal product as packaged. With regard to safety “A guiding principle should be that if the product hasbeen traditionally used without demonstrated harm, no specific restrictive regulatory action shouldbe undertaken unless new evidence dem<strong>and</strong>s a revised risk-benefit assessment” (Alkerele, 1992).135


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceIt is recommended that consumer product information should include a quantitative list <strong>of</strong> activeingredients, dosage, dosage form, indications, mode <strong>of</strong> administration, duration <strong>of</strong> use, any majoradverse effects, contraindications, warnings, etc. (Wasser et al., 2000a). In this article the preliminaryrecommendations by FAO about regulation <strong>of</strong> functional foods followed by an overview <strong>of</strong> thefunctional foods regulatory systems <strong>of</strong> Europe, USA, Canada, Australia, Japan , other Asian countries<strong>and</strong> guidelines <strong>of</strong> Codex Alimentarius as well as food safety act 2006 (India) are presented.Some preliminary recommendations:Some recommendations have previously been made by FAO (FAO, 2004).1. Functional foods should be clearly defined:An international definition for functional foods should be adopted: Functional foods should be “afood similar in appearance to a conventional food (beverage, food matrix), consumed as part <strong>of</strong> theusual diet which contains biologically active components with demonstrated physiological benefits<strong>and</strong> <strong>of</strong>fers the potential <strong>of</strong> reducing the risk <strong>of</strong> chronic disease beyond basic nutritional functions”;• An international database from dietary active compounds should be encouraged:• The basic principles for the addition <strong>of</strong> dietary active compounds in foods could be based on theprinciples for the addition <strong>of</strong> essentials nutrients to foods as stated by the Codex AlimentariusCommission:2. Health claims vs structure/functions claims vs nutrition claims should be clearly defined• Nutrition Claims could be referred to what the product contains;• Health Claims: could be related to what the food or food components does or do. The CodexAlimentarius guidelines for use <strong>of</strong> nutrition <strong>and</strong> health claims in foodlabelling should beencouraged.3. Health claims should require scientific validation <strong>and</strong> substantiation Substantiation <strong>of</strong> a claimshould be based on human data using rigorous scientific protocols:• There is a need to define guidelines for safety <strong>and</strong> efficacy assessment <strong>of</strong> functional foods.EUROPE :In December 2006, the regulation on the use <strong>of</strong> nutrition <strong>and</strong> health claims for foods was adoptedby the Council <strong>and</strong> Parliament <strong>of</strong> Europe.For the purposes <strong>of</strong> this regulation, the following definitions have been proposed:• “Claim”: any message or representation, which is not m<strong>and</strong>atory under Community or nationalLegislation, including pictorial, graphic or symbolic representation, in any form, which states,suggests or implies that a food has particular characteristics;• “Nutrition claim”: means any claim which states, suggests or implies that a food has particularbeneficial nutritional properties due to: a) the energy (calorific value) it (i) provides; (ii) providesat a reduced or increased rate; or (iii) does not provide; <strong>and</strong>/or b) the nutrients or other substancesit (i) contains; (ii) contains in reduced or increased proportions; or (iii) does not contain;• “Health claim”: means any claim that states, suggests or implies that a relationship existsbetween a food category, a food or one <strong>of</strong> its constituents <strong>and</strong> health;• “Reduction <strong>of</strong> disease risk claim”: means any health claim that states, suggests or implies thatthe consumption <strong>of</strong> a food category, a food or one <strong>of</strong> its constituents significantly reduces a riskfactor in the development <strong>of</strong> a human disease.• European Agencies: European Commission, European Food Safety Authority (EFSA), EuropeanFood Information Council (EUFIC) <strong>and</strong> International Life Sciences Institute (ILSI)• USA: Currently, Food <strong>and</strong> Drug Administration (FDA) has neither a definition nor a specificRegulatory rubric for foods being marked as “functional foods”, they are regulated under the136


Regulatory Aspects <strong>of</strong> Functional Foodssame regulatory framework as other conventional foods under the authority <strong>of</strong> the Federal FoodDrug <strong>and</strong> Cosmetic Act. There are three categories <strong>of</strong> claims that can be used on food:• Health Claims - Health claims describe a relationship between a food substance <strong>and</strong> a disease orhealth-related conditions. There are three sets <strong>of</strong> legislation by which FDA exercises its oversightin determining which health claims may be used on a label or in labeling for a food or dietarysupplement:• NLEA Authorized Health Claims – Under the provisions <strong>of</strong> the Nutrition Labeling <strong>and</strong> EducationAct (NLEA) <strong>of</strong> 1990, the Dietary Supplement Act <strong>of</strong> 1992, <strong>and</strong> the Dietary Supplement Health<strong>and</strong> Education Act <strong>of</strong> 1994 (DSHEA), FDA may authorize a health claim for a food or dietarysupplement based on an extensive review <strong>of</strong> the scientific literature, generally as a result <strong>of</strong> thesubmission <strong>of</strong> a health claim petition, using the significant agreement st<strong>and</strong>ard to determine thenutrient/disease relationship is well established• Health Claims Based on Authoritative Statements – Under the 1997 Food <strong>and</strong> DrugAdministration Modernization Act (FDAMA), a health claim may be authorised for a foodbased on an authoritative statement <strong>of</strong> a scientific body <strong>of</strong> the U.S. government or the NationalAcademy <strong>of</strong> Sciences. FDA has prepared a guide on how a firm can make use <strong>of</strong> authoritativestatement-based health claims on food• Qualified Health Claims – FDA’s 2003 Consumer Health Information for Better NutritionInitiative provides for the use <strong>of</strong> qualified health claims when there is emerging evidence fora relationship between a food, food component, or dietary supplement <strong>and</strong> reduced risk <strong>of</strong> adisease or health-related condition.• Nutrient Content Claims - The Nutrition Labelling <strong>and</strong> Education Act <strong>of</strong> 1990 (NLEA) permitsthe use <strong>of</strong> label claims that characterize the level <strong>of</strong> a nutrient in a food (i.e., nutrient contentclaims) made in accordance with FDA’s authorizing regulations.• Structure/Function Claims - Structure/function claims have historically appeared on the labels <strong>of</strong>conventional foods <strong>and</strong> dietary supplements as well as drugs. However, the Dietary SupplementHealth <strong>and</strong> Education Act <strong>of</strong> 1994 (DSHEA) established somespecial regulatory procedures forsuch claims for dietary supplement labels. Manufacturers <strong>of</strong> dietary supplements that makestructure/function claims on labels or in labelling must submit a notification to FDA no laterthan 30 days after marketing the dietary supplement that includes the text <strong>of</strong> the structure/function claim.• Agencies: The Food <strong>and</strong> Drug Administration (FDA), American Heart Association (AHA), TheInstitute <strong>of</strong> Medicine (IOM).CANADA:• In Canada, Health Canada regulates the functional foods <strong>and</strong> nutraceutical industry <strong>and</strong> theCanadian Food Inspection Agency enforces these regulations. Within Health Canada’s Health<strong>Products</strong> <strong>and</strong> Food Branch, the Food Directorates regulates functional foods, while the NaturalHealth <strong>Products</strong> Directorate regulates other natural health products including vitamins, minerals;herbal remedies; homeopathic medicines; traditional medicines such as traditional Chinesemedicines; probiotics, <strong>and</strong> other products like amino acids <strong>and</strong> essential fatty acids. Briefly, theterm “health claim”is not defined in Canada but currently, there are 3 types <strong>of</strong> nutrition claimsallowed:• Nutrient Content Claims- Nutrient content claims are the simplest label statement as theyidentify/quantify the amount <strong>of</strong> a nutrient contained in a food. In addition, comparativenutrient content claims (e.g. reduced, less, light) are allowed based on thest<strong>and</strong>ardized referenceamount.• Biological Role/ Structure Function Claims – The second category <strong>of</strong> nutrition claims are referredto as biological role or structure/function claims. Biological role claims are for nutrients, not a137


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assurancefood containing the nutrient. These statements identify the generally recognized function <strong>of</strong> anutrient as an aid in maintaining the functions <strong>of</strong> the body necessary for the maintenance <strong>of</strong>good health, or for normal growth <strong>and</strong> development.• Risk Reduction Health Claims – Health Canada began to consider the possibility <strong>of</strong> risk reductionclaims for foods in 1999, by reviewing the ten U.S. approved health claims. In 2003, the Food<strong>and</strong> Drug Regulations were amended to introduce the first series <strong>of</strong> authorized health claimsin Canada. In the meantime Health Canada developed a proposed regulatory framework forproduct-specific authorization <strong>of</strong> health claims In Canada, the most <strong>of</strong> nutraceuticals fall underthe Natural Health <strong>Products</strong> Regulations <strong>of</strong> the Food <strong>and</strong> Drugs Act which came into effect onJanuary 1, 2004. In addition, a compliance policy is in place to ensure the safety <strong>of</strong> Canadiansuntil all natural health products have undergone Health Canada’s approval process.• Agencies: Health Canada, the Canadian Food Inspection AgencyJAPAN:The Japanese Ministry <strong>of</strong> Health, Labour, <strong>and</strong> Welfare (MHLW) set up ‘Foods for Specified HealthUse’ (FOSHU) in 1991 as a regulatory system to approve the statements made on food labels concerningthe effect <strong>of</strong> the food on the human body. FOSHU refers to foods containing ingredient with functionsfor health <strong>and</strong> <strong>of</strong>ficially approved to claim its physiological effects on the human body. The regulatoryrange <strong>of</strong> FOSHU was broadened in 2001 to accept the forms <strong>of</strong> capsules <strong>and</strong> tablets in addition tothose <strong>of</strong> conventional foods. FOSHU increased the total to about 330 items in January 2003. In April2001, the MHLW enacted a new regulatory system, ‘Foods with Health Claims’, which consists <strong>of</strong> theexisting FOSHU system <strong>and</strong> the newly established ‘Foods with Nutrient Function Claims’ (FNFC).FNFC refers to all food that is labeled with the nutrient function claims specified by the MHLW.The labelling <strong>of</strong> functional foods should always be based on scientific evidence <strong>and</strong> be in harmonywith international st<strong>and</strong>ards. The nutrient–function claim was adopted in the guidelines for nutritionclaims by the Codex Alimentarius in 1997. The claims <strong>of</strong> the Japanese FNFC are equivalent to thenutrient function claims st<strong>and</strong>ardized by The Codex Alimentarius.• Agencies: Ministry <strong>of</strong> Health, Labour <strong>and</strong> WelfareOther asian countries:Recently, the Asian-Pacific Network for Food <strong>and</strong> Nutrition (ANFN) <strong>of</strong> the FAO regional <strong>of</strong>fice forAsia <strong>and</strong> the Pacific held its regional expert consultation on functional foods <strong>and</strong> their implications inthe daily diet <strong>and</strong> published a report on the development <strong>and</strong> status <strong>of</strong> Functional foods in differentasian countries including China, India, Bangladdesh, Indonesia, Nepal, Malaysia, Philippines,Thail<strong>and</strong>, Sri Lanka, <strong>and</strong> Vietnam (FAO, 2004). In Korea, the term “health/functional food” (HFF)refers to food supplements containing nutrients or other substances (in a concentrated form) that havea nutritional or physiological effect whose purpose is to supplement the normal diet. The KoreanHealth/Functional Food Act that came into effect in 2004 requires these products to be marketed inmeasured doses, such as in pills, tablets, capsules, <strong>and</strong> liquids.Codex Alimentarius: The Codex Alimentarius Commission (CAC) was created in 1961/62 byFood <strong>and</strong> Agriculture Organization <strong>of</strong> the United Nations (FAO) <strong>and</strong> the World Health Organization(WHO), to develop food st<strong>and</strong>ards, guidelines <strong>and</strong> related texts such as codes <strong>of</strong> practice under theJoint FAO/WHO Food St<strong>and</strong>ards Programme. The main purpose <strong>of</strong> this Programme is to protectthe health <strong>of</strong> consumers, ensure fair practices in the food trade, <strong>and</strong> promote coordination <strong>of</strong> all foodst<strong>and</strong>ards work undertaken by international governmental <strong>and</strong> non-governmental organizations.“Codex India” the National Codex Contact Point (NCCP) for India, is located at the DirectorateGeneral Of Health Services, Ministry <strong>of</strong> Health <strong>and</strong> Family Welfare (MOH&FW), Government <strong>of</strong>India. It coordinates <strong>and</strong> promotes Codex activities in India in association with the National CodexCommittee <strong>and</strong> facilitates India’s input to the work <strong>of</strong> Codex through an established consultationprocess.The Codex Alimentarius has defined two types <strong>of</strong> nutrition claims- Nutrition content claim138


Regulatory Aspects <strong>of</strong> Functional Foods<strong>and</strong> Nutrient comparative claim- <strong>and</strong> three types <strong>of</strong> health claims- nutrient function claims; enhancedfunction claims <strong>and</strong> reduction <strong>of</strong> disease risk (Codex Alimentarius Commission, 2004).• Nutrition Claims -Guidelines for the use <strong>of</strong> nutrition claims by the Codex Committee on FoodLabeling proposed that ‘nutrient claim means any representation which states, suggests orimplies that a food has particular nutritional properties including but not limited to the energyvalue <strong>and</strong> to the content <strong>of</strong> protein, fat <strong>and</strong> carbohydrate, as well as the content <strong>of</strong> vitamins<strong>and</strong> minerals’. Nutrition Claims include two types: (i) Nutrient content claim that is a nutritionclaim that describes the level <strong>of</strong> a nutrient contained in a food <strong>and</strong> (ii) Nutrient comparativeclaim is a claim that compares the nutrient levels <strong>and</strong>/or energy value <strong>of</strong> two or more foods.• Health Claims - Guidelines for the use <strong>of</strong> nutrition claims by the Codex Committee in FoodLabelling proposed that “health claim means any representation which states, suggestsor implies that a relationship exits between a food or a constituent <strong>of</strong> that food <strong>and</strong> health”.Health claims include three types: (i) Nutrient Function Claim that is the claim that describesthe physiological role <strong>of</strong> the nutrient in growth, development, <strong>and</strong> the normal function <strong>of</strong> thebody’; (ii) Enhanced Function Claim concerns specific beneficial effects <strong>of</strong> the consumption <strong>of</strong>foods <strong>and</strong> their constituents in the context <strong>of</strong> the total diet <strong>and</strong> relate to a positive contributionto health or to improvement <strong>of</strong> a function or to modifying or preserving health <strong>and</strong> (iii) DiseaseRisk Reduction Claim relates to the consumption <strong>of</strong> a food or food constituent, in the content<strong>of</strong> the total diet, to the reduced risk <strong>of</strong> developing a disease or a health-related condition. Riskreduction means significantly altering a major risk factor(s) for a disease or a health relatedcondition. Diseases have multiple factors <strong>and</strong> altering one <strong>of</strong> these risk factors may or may nothave a beneficial effect. The presentation <strong>of</strong> Risk Reduction Claims must ensure, for example, byuse <strong>of</strong> appropriate language <strong>and</strong> reference to other risk factors, that consumers do not interpretthem as prevention claims.’Food Safety <strong>and</strong> St<strong>and</strong>ards Act, 2006 (India): Several Acts <strong>and</strong> orders prevailed in India tosafeguard food safety <strong>and</strong> the health <strong>of</strong> the consumer. They were introduced to complement <strong>and</strong>supplement each other in achieving total food safety <strong>and</strong> quality. However due to variation in thespecifications/st<strong>and</strong>ards in different Acts/Orders, <strong>and</strong> administration by different Departments <strong>and</strong>Ministries, there were implementation problems <strong>and</strong> the lack <strong>of</strong> importance given to safety st<strong>and</strong>ardsover a period <strong>of</strong> time. The food industries were facing problems as different products were governedby different orders <strong>and</strong> ministries <strong>and</strong> the rules <strong>and</strong> regulations in the Country needed consolidation.The Food Safety <strong>and</strong> St<strong>and</strong>ards Act 2006 was introduced to overcome these shortcomings <strong>and</strong> to givemore importance to safety st<strong>and</strong>ards. This Act consolidates the laws relating to food <strong>and</strong> establishesthe Food Safety <strong>and</strong> St<strong>and</strong>ards Authority <strong>of</strong> India (FSSAII) for laying down science-based st<strong>and</strong>ardsfor articles <strong>of</strong> food <strong>and</strong> to regulate their manufacture, storage, distribution, sale <strong>and</strong> import, toensure availability <strong>of</strong> safe <strong>and</strong> wholesome food for human consumption. This Act provides for theestablishment <strong>of</strong> the FSSAII which is an autonomous body under the Ministry <strong>of</strong> Health <strong>and</strong> FamilyWelfare, Government <strong>of</strong> India. FSSAII’s work programs ensure the provision <strong>of</strong> appropriate scientific,technical <strong>and</strong> administrative support for scientific committees <strong>and</strong> scientific panels, ensuring that theFSSAII carries out its tasks in accordance with the requirements <strong>of</strong> its users, prepares statements <strong>of</strong>revenue <strong>and</strong> expenditure <strong>and</strong> executes the budget, while developing <strong>and</strong> maintaining contact withthe Central Government <strong>and</strong> ensuring a regular dialogue with its relevant committees. The FSSAIalso constitutes scientific panels <strong>and</strong> scientific committees to address various technical issues suchas food additives, pesticides <strong>and</strong> antibiotics, genetically modified foods, functional foods, biologicalhazards, contaminants, labeling <strong>and</strong> methods <strong>of</strong> sampling. The Scientific Committee is responsiblefor providing scientific opinions to FSSAI. Finally the FSSAI is also responsible for regulating <strong>and</strong>monitoring the manufacture, processing, distribution, sale <strong>and</strong> import <strong>of</strong> food so as to ensure safe<strong>and</strong> wholesome food to consumers. The general principles to be followed by the Central Government,State Governments <strong>and</strong> FSSAI while implementing the provisions <strong>of</strong> this Act shall be guided by thefollowing seven principles:139


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assurance1. To endeavour to achieve appropriate levels <strong>of</strong> protection <strong>of</strong> human life <strong>and</strong> health <strong>and</strong> protection<strong>of</strong> consumers’ interests including fair practices in all kinds <strong>of</strong> food;2. Carry out risk management based on risk assessment;3. Adopt risk management measures necessary to ensure appropriate levels <strong>of</strong> health protection;4. Measures adopted shall be proportionate <strong>and</strong> no more trade restrictions shall be imposed thanrequired;5. Measures adopted shall be revised within a reasonable period;6. In case <strong>of</strong> suspected risks <strong>of</strong> the public consuming contaminated food, the FSSAI shall takeappropriate steps to inform the general public <strong>of</strong> the risk to health; <strong>and</strong>7. If any lot <strong>of</strong> food fails to comply with food safety requirements it shall be presumed that thewhole consignment fails to comply with these requirements.Genetically modified foods, organic foods, functional foods, nutraceuticals <strong>and</strong> proprietory foodsare regulated by this Act. Packaged foods, labelling requirements <strong>and</strong> advertising requirements areadequately covered along with import regulations for food articles. There is a provision for the FSSAIto establish various Scientific Panels such as:• Food additives, flavours, processing aids, materials in contact with food;• Pesticides <strong>and</strong> antibiotic residues;• Genetically modified organisms <strong>and</strong> foods;• Functional foods, nutraceuticles <strong>and</strong> foods for special dietary purposes;• Biological hazards, other contaminants; <strong>and</strong>• Food labelling <strong>and</strong> methods <strong>of</strong> sampling <strong>and</strong> analysis.The Act has laid down certain broad principles for implementing the food safety, viz;1. To lay down food safety st<strong>and</strong>ards <strong>and</strong> to ensure fair trade practices while achieving anAppropriate Level <strong>of</strong> Protection (ALOP) <strong>of</strong> human life <strong>and</strong> health; for contaminants <strong>and</strong>hazards,2. To carry out risk analysis so as to ensure an appropriate level <strong>of</strong> protection to the consumers aswell to see that such measures are least trade restrictive <strong>and</strong> are in accordance with SPS <strong>and</strong> TBTmeasures <strong>of</strong> WTO;3. Wherever appropriate, food st<strong>and</strong>ards are to be specified on the basis <strong>of</strong> risk analysis;4. Risk assessment is to be based on the available toxicological evaluation (e.g. JECFA) <strong>and</strong> extensiveopen <strong>and</strong> transparent discussion with all stakeholders, <strong>and</strong> the underlying principle is to ensureprotection <strong>of</strong> consumers by preventing fraudulent, deceptive or unfair trade practices.The Act also prescribes general provisions for articles <strong>of</strong> food:• Food additives / processing aids are to be added only in accordance with provisions / regulationsunder the Act;• Foods are not to contain any contaminants such as toxic metals, toxins, pesticide residues,antibiotics <strong>and</strong> veterinary drugs, in excess <strong>of</strong> limits prescribed under the regulation;• Regulations will be made for the manufacture, distribution or trade <strong>of</strong> any novel foods, GM foods,irradiated foods, organic foods, foods for special dietary uses, functional foods, nutraceuticals,health supplements, proprietary foods etc.The onus <strong>of</strong> safety <strong>of</strong> food production, processing, import, distribution <strong>and</strong> sale lies with the foodbusiness operator. The Commissioner <strong>of</strong> Food Safety <strong>of</strong> the state will implement rules under this Act atstate level. The FSSAI <strong>and</strong> the State Food Authorities will maintain a system <strong>of</strong> control, involving riskcommunication, food safety surveillance <strong>and</strong> other monitoring activities covering all stages <strong>of</strong> foodbusiness. The FSSAI is empowered to recognise any agency to conduct food safety audits which are140


Regulatory Aspects <strong>of</strong> Functional Foodsa systematic <strong>and</strong> functionally independent examination <strong>of</strong> food safety measures based on food safetymanagement systems consisting <strong>of</strong> Good Manufacturing Practices, Good Hygienic Practices, Hazard<strong>Analysis</strong> <strong>and</strong> Critical Control Points or any other such measures specified by regulation. Food testinglaboratories are required to be accredited by any accreditation agency so that the analytical results arereliable <strong>and</strong> consistent. The FSSAI <strong>and</strong> State Food Safety Authorities are responsible for enforcement<strong>of</strong> this Act. Both shall monitor <strong>and</strong> verify that the relevant requirements <strong>of</strong> law are fulfilled by foodbusiness operators at all stages <strong>of</strong> food business. There is provision for food recall by the businessoperator if the food does not comply with the Act. The Food Safety Authority in the State (HealthMinistry) appoints a Commissioner <strong>of</strong> Food Safety, designated <strong>of</strong>ficers (district level) <strong>and</strong> food safety<strong>of</strong>ficers to implement the programmes under the provisions <strong>of</strong> this Act. The FSSIA will notify foodlaboratories <strong>and</strong> research institutions accredited by the National Accreditation Board for testing <strong>and</strong>calibration laboratories. It may also recognise more referral food laboratories by this Act. This Act givesmore importance for ensuring a very safe food product to consumers by providing quicker disposal <strong>of</strong>cases within the state. Punishments <strong>of</strong>fered are very severe which would make the retailer/wholesalerbe more cautious in their dealings. The st<strong>and</strong>ards for quality <strong>and</strong> safety laid down in this Act areharmonised st<strong>and</strong>ards <strong>and</strong> applicable throughout the country, <strong>and</strong> all other st<strong>and</strong>ards/specificationsbecome null <strong>and</strong> void. This system provides for quicker corrective actions by the regulators as theproblems are localised <strong>and</strong> traceable.Conclusion/ Recommendatrions:Several approaches to the use <strong>of</strong> health claims on foods have been made around the world, <strong>and</strong>the common theme is that any health claim will require scientific validation <strong>and</strong> substantiation. Thereis also broad consensus that any regulatory framework should protect the consumer, promote fairtrade <strong>and</strong> encourage innovation in the food industry. However, there is a clear need to have uniformunderst<strong>and</strong>ing, terminology <strong>and</strong> description <strong>of</strong> types <strong>of</strong> nutrition <strong>and</strong> health claims.References:Food Safety <strong>and</strong> St<strong>and</strong>ards Act , 2006 <strong>of</strong> India Ministry <strong>of</strong> Health <strong>and</strong> Family Welfare, New Delhi, Government <strong>of</strong> Indiahttp://www.mohfw.nic.in/pfa.htmFood Safety in India Ministry <strong>of</strong> Health <strong>and</strong> family Welfare, New Delhi, Government <strong>of</strong> India http://www.foodsafetyindia.nic.in/P. Roupas_ P. G. Williams (2007) Regulatory aspects <strong>of</strong> bioactive dairy ingredients . Food Science Australia University<strong>of</strong> Wollongong, http://ro.uow.edu.au/Report on Functional Foods Food <strong>Quality</strong> <strong>and</strong> St<strong>and</strong>ards Service (AGNS) Food <strong>and</strong> Agriculture Organization <strong>of</strong> theUnited Nations (FAO) November, 2007141


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assurance142Nanomaterials - <strong>Their</strong> Applications<strong>and</strong> Safety Aspects in FoodsBimlesh Mann , Rajesh Kumar <strong>and</strong> Prabhakar Padgham<strong>Dairy</strong> Chemistry Division, NDRI, KarnalNanomaterials which include nanoparticles, nano-emulsions <strong>and</strong> nano-capsules are nowbeing used in processed foods, food packaging <strong>and</strong> food contact materials. Because <strong>of</strong> their uniqueproperties, nanomaterials <strong>of</strong>fer many new opportunities for the food industries, as potent colourings,flavourings, nutritional additives <strong>and</strong> antibacterial ingredients. Due to their very large surface area,thenanoparticles have better chemical reactivity, biological activity <strong>and</strong> catalytic behaviour as comparedto larger particles <strong>of</strong> the same chemical composition (Garnett <strong>and</strong> Kallinteri, 2006).The <strong>Chemical</strong> Selection Working Group <strong>of</strong> the U.S. Food <strong>and</strong> Drug Administration (FDA) definednanomaterials as “particles with dimensions less than micrometer scale [i.e. less then 1,000 nm]that exhibit unique properties not recognized in micron or larger sized particles” (U.S. FDA 2006).Australia’s Commonwealth Scientific <strong>and</strong> Industrial Research Organisation (CSIRO) food scientistshave also defined nanomaterials as measuring up to 1,000 nm (Sanguansri <strong>and</strong> Augustin, 2006). Inanother report on nanomaterials FDA chose not to <strong>of</strong>fer a size-based definition at all (U.S. FDA, 2007).Nanomaterials also have far greater bioavailability than larger particles, resulting in greater uptakeinto individual cells, tissues <strong>and</strong> organs. Materials which measure less than 300 nm can be taken up byindividual cells (Garnett <strong>and</strong> Kallinteri, 2006), while nanomaterials which measure less than 70 nm caneven be taken up by cells’ nuclei, where they can cause major damage (Chen <strong>and</strong> Mikecz, 2005).Nanotechnology has potential applications in all aspects <strong>of</strong> food processing, food packaging <strong>and</strong>food monitoring.These includes:• Developments <strong>of</strong> the methods for the production <strong>of</strong> foods such as s<strong>of</strong>t drinks, ice cream,chocolate or chips to be marketed as ‘health’ foods by reducing fat, carbohydrate or caloriecontent or by increasing protein, fibre or vitamin content.• Production <strong>of</strong> stronger flavourings, colourings, <strong>and</strong> nutritional additives.• Development <strong>of</strong> foods capable <strong>of</strong> changing their colour, flavour or nutritional propertiesaccording to a person’s dietary needs, allergies or taste preferences.• Development <strong>of</strong> packaging materials to increase food shelf life <strong>and</strong> which can detect spoilage,bacteria, or the loss <strong>of</strong> food nutrient.One <strong>of</strong> the earliest commercial applications <strong>of</strong> nanotechnology within the food sector is in packaging(Roach, 2006). Between 400 <strong>and</strong> 500 nanopackaging products are estimated to be in commercial usenow. A key purpose <strong>of</strong> nano packaging is to deliver longer shelf life by improving the barrier functions<strong>of</strong> food packaging to reduce gas <strong>and</strong> moisture exchange <strong>and</strong> UV light exposure (Sorrentino et al., 2007).Nano packaging can also be designed to release antimicrobials, antioxidants, enzymes, flavours <strong>and</strong>nutraceuticals to extend shelf-life (Cha <strong>and</strong> Chinnan, 2004; LaCoste et al., 2005). Packaging equippedwith nano sensors is designed to track either the internal or the external conditions <strong>of</strong> food products,pellets <strong>and</strong> containers throughout the supply chain. The use <strong>of</strong> nanomaterials to strengthen bioplastics(plant-based plastics) may enable bioplastics to be used instead <strong>of</strong> fossil-fuel based plastics for foodpackaging <strong>and</strong> carry bags (Sorrentino et al., 2007; Technical University <strong>of</strong> Denmark, 2007).Unfortunately, the greater chemical reactivity <strong>and</strong> bioavailability <strong>of</strong> nanomaterials may also resultin greater toxicity <strong>of</strong> nanoparticles compared to the same unit <strong>of</strong> mass <strong>of</strong> larger particles <strong>of</strong> the samechemical composition (Hoet et al., 2004; Oberdörster et al., 2005b).Other properties <strong>of</strong> nanomaterialsthat influence toxicity include: chemical composition, shape, surface structure, surface charge, catalyticbehaviour, extent <strong>of</strong> particle aggregation (clumping) or disaggregation, <strong>and</strong> the presence or absence <strong>of</strong>other groups <strong>of</strong> chemicals attached to the nanomaterial (Brunner et al., 2006; Magrez et al., 2006; Sayeset al., 2006).The potential health risks associated with nanomaterials in foods has mainly focused on


Nanomaterials - <strong>Their</strong> Applications <strong>and</strong> Safety Aspects in Foodsmanufactured nanomaterial food or food packaging additives but ignored the nanoparticles createdduring processing. Thus nanoparticles are also present in many foods because <strong>of</strong> the technologyused to process the foods, rather than because they are food additives or ingredients. Although foodprocessing technologies that produce nanoparticles are not new, the rapidly exp<strong>and</strong>ing consumption <strong>of</strong>highly processed foods is most certainly increasing our exposure to nanoparticles in foods. Processingtechniques which produce nanoparticles, particles up to a few hundred nanometres in size, <strong>and</strong> nanoscaleemulsions are used in the manufacture <strong>of</strong> salad dressings,chocolate syrups, sweeteners, flavouredoils, <strong>and</strong> many other processed foods (Sanguansri <strong>and</strong> Augustin, 2006). The formation <strong>of</strong> nanoparticles<strong>and</strong> nanoscale emulsions can result from food processing techniques such as high pressure valvehomogenisation, dry ball milling, dry jet milling <strong>and</strong> ultrasound emulsification. Although many foodmanufacturers may remain entirely unaware that their foods contain nanoparticles, it is likely thatthese processing techniques are used precisely because the textural changes <strong>and</strong> flow properties theyproduce are attractive to manufacturers.Recent research has found that many food products contain insoluble, inorganic nanoparticles<strong>and</strong> microparticles that have no nutritional value, <strong>and</strong> which appear to have contaminated foodsunintentionally, for example as a result <strong>of</strong> the wear <strong>of</strong> food processing machines or throughenvironmental pollution. The health implications <strong>of</strong> food processing techniques that producenanoparticles <strong>and</strong> nanoscale emulsions also warrant the attention <strong>of</strong> food regulators. The potential forsuch foods to pose new health risks must be investigated in order to determine whether or not relatednew food safety st<strong>and</strong>ards are required. Just as a better underst<strong>and</strong>ing <strong>of</strong> the health risks <strong>of</strong> incidentalnanoparticles in air pollution have resulted in efforts to reduce air pollution, improved underst<strong>and</strong>ing<strong>of</strong> the health risks associated with incidental nanoparticle contaminants in foods may also warrantefforts to reduce incidental nanoparticles’ contamination <strong>of</strong> processed foods.The commercial manufacturing <strong>of</strong> food products, food packaging <strong>and</strong> food contact materials shouldbe after the introduction <strong>of</strong> nanotechnology specific regulation which protects the public workers <strong>and</strong>the environment from their risks. Because <strong>of</strong> their potentially serious health risks, environmental risks<strong>and</strong> social implications, the following points have to be ascertained, before the commercial applications<strong>of</strong> these nanomaterials.• These manufactured food nanomaterials must be subject to new safety assessments as newsubstances, even where the properties <strong>of</strong> their larger scale counterparts are well-known.• The manufactured nanomaterials must be subject to rigorous nano-specific health <strong>and</strong>environmental impact assessment <strong>and</strong> demonstrated to be safe prior to approval for commercialuse in foods, food-packaging <strong>and</strong> food contact materials.• All particles up to 300nm in size must be considered to be ‘nanomaterials’ for the purposes <strong>of</strong>health <strong>and</strong> environment assessment, given the early evidence that they pose similar health risksas particles less than 100nm in size which have to date been defined as ‘nano’.• The data related to safety assessments, <strong>and</strong> the methodologies used to obtain them, must beplaced in the public domain.• The nano ingredients must be clearly indicated on product labels to allow the public to make aninformed choice about product use.• The public, including all stakeholder groups affected, must be involved in all aspects <strong>of</strong> decisionmaking regarding nanotechnology in food. This includes in the development <strong>of</strong> regulatoryregimes, labeling systems, <strong>and</strong> prioritization <strong>of</strong> public funding for food <strong>and</strong> agriculturalresearch.References:Cha D, Chinnan M. 2004. Biopolymer-based antimicrobial packaging: A review. Critic RevFood Sci Nutrit 44:223-237.Chen M, von Mikecz A. 2005. Formation <strong>of</strong> nucleoplasmic protein aggregatesimpairs nuclear function in response toSiO 2nanoparticles. Experiment Cell Res 305:51-62.Friends <strong>of</strong> the Earth International. 2009. OUT OF THE LABORATORY AND ON TO OUR PLATES Nanotechnology inFood & Agriculture Amsterdam. Available at: http://www.foei.org143


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceGarnett M, Kallinteri P. 2006. Nanomedicines <strong>and</strong> nanotoxicology: some physiological principles. Occup Med 56:307-311. Gatti A. Undated. “Nanopathology : a new vision <strong>of</strong> the interaction environment-human life”. Available at:http://ec.europa.eu/research/quality<strong>of</strong>life/ ka4/pdf/report_nanopathology_en.pdf (accessed 11 September2007).Hoet P, Bruske-Holfeld I, Salata O. 2004. Nanoparticles – known <strong>and</strong> unknown health risks. J Nanobiotechnol 2:12.Hund-Rinke K, Simon M. 2006. Ecotoxic effect <strong>of</strong> photocatalytic active nanoparticles (TiO2) on algae <strong>and</strong> daphnids.Environ Sci Poll Res 13(4):225-232.Invest Australia. 2007. Nanotechnology: Australian Capability Report, Third Edition.Commonwealth <strong>of</strong> Australia, Canberra. Available at: http://www. investaustralia.gov.au/media/NANOREPORT07.pdf(accessed 17 January 2008).LaCoste A, Schaich K, Zumbrunnen D, Yam K. 2005. Advanced controlled release packaging through smart blending.Packag Technol Sci 18:77-87.Oberdörster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, Carter J, Karn B, Kreyling W, Lai D,Olin S, Monteiro-Riviere N, Warheit D, Yang H. 2005b. Principles for characterising the potential human healtheffects from exposure to nanomaterials: elements <strong>of</strong> a screening strategy. Particle Fibre Toxicol 2:8Roach S. 2006. Most companies will have to wait years for nanotech’s benefits. Foodproductiondaily.com 21 August2006. Available at: http://www.foodproductiondaily.com/news/ng.asp?id=69974 (accessed 17 January 2008).Sanguansri P, Augustin M. 2006. Nanoscale materials development – a food industry perspective. Trends Food SciTechnol 17:547-556.Sayes C, Wahi R, Kurian P, Liu Y, West J, Ausman K, Warheit D, Colvin V. 2006. Correlating nanoscale titania structurewith toxicity: A cytotoxicity <strong>and</strong> inflammatory response study with human dermal fibroblasts <strong>and</strong> human lungepithelial cells. Toxicol Sci 92(1):174–185.Sorrentino A, Gorrasi G, Vittoria V. 2007. Potential perspectives <strong>of</strong> bio-nanocomposites for food packaging applications.Trends Food Sci Technol 18:84-95.Technical University <strong>of</strong> Denmark. 2007. Bioplastic developed into food packaging through nanotechnology. News 23March 2007. Available at: http://risoe-staged.risoe.dk/News_archives/News/2007/0322_bioplast.aspx (accessed17 January 2008).U.S. FDA. 2006. Nanoscale Materials [no specified CAS] Nomination <strong>and</strong> Review <strong>of</strong> Toxicological Literature. December8, 2006. Prepared by the <strong>Chemical</strong> Selection Working Group, U.S. Food & Drug Administration. Available at:http://ntp.niehs.nih.gov/ntp/htdocs/Chem_Background/ExSumPdf/Nanoscale_materials.pdf (accessed 15January 2008).U.S. FDA. 2007. Nanotechnology: A Report <strong>of</strong> the U.S. Food <strong>and</strong> Drug Administration Nanotechnology Task Force. July25, 2007. Available at: http://www.fda.gov/ nanotechnology/taskforce/report2007.html (accessed 15 January2008).144


Strategies for Animals Studies to Assess the Safety Aspects <strong>and</strong> Bioavailability <strong>of</strong> NetraceuticalsStrategies for Animals Studies to Assess the SafetyAspects <strong>and</strong> Bioavailability <strong>of</strong> NetraceuticalsAyyasamy Manimaran 1 <strong>and</strong> Bimlesh Mann 21Livestock Production Management <strong>and</strong> 2 <strong>Dairy</strong> Chemistry Division, NDRI, KarnalIntroductionThe word “nutraceutical” was first coined by DeFelice (2007) who defined it as “a substance that isa food or a part <strong>of</strong> food <strong>and</strong> provides medical <strong>and</strong> health benefits, including prevention <strong>and</strong> treatment<strong>of</strong> disease.” Research <strong>and</strong> awareness about nutraceuticals has been increased in last few decades<strong>and</strong> expected to continue to increase. Basic research using laboratory animals is critical to furtheringunderst<strong>and</strong>ing <strong>of</strong> the impact <strong>of</strong> nutraceuticals on health promotion <strong>and</strong> disease management, apartfrom regulatory prerequisite for conducting further human clinical trials. A variety <strong>of</strong> laboratory<strong>and</strong>small-animals are used for evaluation <strong>of</strong> functional food <strong>and</strong> nutraceutical efficacy/metabolicevaluation. These pre-clinical trials can be conducted utilizing either immune competent orimmunocompromised animals like nude mice which are not having cell mediated immune response.Although significant evidence exists that functional foods <strong>and</strong> nutraceuticals can play key roles indisease prevention <strong>and</strong> health promotion, as in decreasing the risk <strong>of</strong> certain chronic diseases, safetyconsiderations must not be ignored. Safety pharmacology studies for developing nutraceuticals arenecessary <strong>and</strong> compulsory to support human clinical trials <strong>of</strong> a given scope <strong>and</strong> duration as wellas marketing authorization for pharmaceuticals. The objective is to identify possible, undesirablepharmacodynamic effects <strong>of</strong> the nutraceuticals which are unrelated to the main pharmacologicalactivity, after therapeutic administration or overdose. Safety pharmacology <strong>and</strong> pharmacodynamicstudies includes the assessment <strong>of</strong> effects on cardiovascular, central nervous <strong>and</strong> respiratorysystems <strong>and</strong> should generally be conducted before human exposure. Safety pharmacology studiescan be performed as independent studies or can be incorporated as a part <strong>of</strong> toxicological studiesthus reducing the number <strong>of</strong> animals used in accordance with the 3R’s principles. Incorporation intotoxicological studies may <strong>of</strong>fer the additional advantage that the effect <strong>of</strong> the nutraceuticals can beevaluated not only after a single administration but also after repeated administration for a givenperiod <strong>of</strong> time. However, one objection is that the dose levels involved can be much higher than thetherapeutic dose. In safety pharmacology studies, the low dose should be equal to or slightly higherthan the therapeutic dose. The purpose <strong>of</strong> toxicity testing <strong>of</strong> animals is to know the biological effects<strong>of</strong> substances, so that precautions can be taken to protect humans, animals <strong>and</strong> the environment.Mice are the most widely used species accounting for more than 50% <strong>of</strong> animals use. Mice biology iswell known than any other laboratory animal <strong>and</strong> this is widely used by immunologist, oncologist<strong>and</strong> geneticist. Rats are second most widely used a laboratory animal species <strong>and</strong> they are generallypreferred over mice by toxicologist <strong>and</strong> pharmacologists due to convenient size <strong>and</strong> they do not havemany virally-induced tumors as mice. Rabbits have been widely used for antisera production, pyrogentesting <strong>and</strong> reproductive studies particularly for teratogenicity.<strong>Analysis</strong> <strong>of</strong> nutraceuticalsMilk <strong>and</strong> dairy products are important source for proteins, peptides <strong>and</strong> amino acids. Theyhave angiotension converting enzymes (ACE) inhibitory activities, antibacterial, antioxidant,immunomodulating, antithrombotic, absorption <strong>of</strong> minerals <strong>and</strong> anti-inflammatory activities. Thesehealth promoting effects make these compounds as nutraceuticals for prevention <strong>and</strong> treatment <strong>of</strong>hypertension, diabetes <strong>and</strong> hepatitis etc. <strong>Their</strong> identification requires advanced analytical techniquesdue to complexity <strong>of</strong> these compounds. In general, analysis <strong>of</strong> milk compounds are carried out by liquidchromatography coupled to mass spectrometry (LC-MS) or capillary electrophoresis (CE) (Campanellaet al., 2009; Contreras et al., 2008; Meltretter et al., 2008; Simone et al., 2009) <strong>and</strong> immunosensors forparticular determination <strong>of</strong> lact<strong>of</strong>errin <strong>and</strong> immunoglobulin G in milk (Campanella et al., 2009).145


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceFurther, an omics-rooted study <strong>of</strong> milk proteins has been carried out using advanced analyticaltechniques (HPLC-MS/MS, 2D-PAGE, MALDI-TOFMS) showing the great potential <strong>of</strong> this modernapproach (Casado et al., 2009). Polyacrylamide gel electrophoresis (PAGE), sodium dodecyl sulfatePAGE (SDS-PAGE) <strong>and</strong> 2D-PAGE have been employed to analyze proteins in milk, (Casado et al.,2009). However, these more classical techniques do not provide an identification <strong>of</strong> these biomoleculesas accurate as CE or HPLC coupled to mass spectrometry. Thus, mass spectrometry alone or coupledto HPLC has been used to characterize, identify <strong>and</strong> analyze proteins, peptides <strong>and</strong> amino acids inseveral sources including milk. Gas chromatography (GC) <strong>and</strong> HPLC are preferred analytical toolsfor analyzing bioactive compounds, probably due to their versatility, generalized availability, lowcost<strong>and</strong> simplicity. Other techniques such as CE, MS, Nuclear Magnetic Resonance (NMR) or FourierTransformed Infrared Spectroscopy (FTIR) have also given good results, although their use is not aswidespread as GC or HPLC.Table.1 Nutraceutical <strong>and</strong> analytical techniques employed for their analysisNutraceutical Source Possible health effect AnalyticaltechniquesPhytosterols <strong>and</strong>phytostanolsMilk <strong>and</strong>yoghurtReferenceDecrease cholesterol levels GC-MS Santos et al., 2007Milk lipids(triglycerides,diacylglycerides,saturated fatty acids<strong>and</strong> PUFAs).MilkImmuno-suppressive, antiinflammatory, <strong>and</strong>antimicrobialproperties.HPLC-MS/MS,GC/LC.Casado et al., 2009Gangliosides<strong>Dairy</strong>products(milk)Protect against entericpathogens, <strong>and</strong> prebioticfunctions.MALDI-TOFMS,HPTLC, HPLC-MSLacomba, et al., 2010;Mocchetti, 2005Milk proteins, peptides,Lact<strong>of</strong>errin <strong>and</strong>immunoglobulin G.Milk <strong>and</strong>derivedproductsAntihypertensive, antimicrobial,antiinfl ammatory <strong>and</strong>inmunostimulating activities.Important source <strong>of</strong> aminoacidsHPLC-MS/MS, 2D-PAGE,MALDI-TOFMS,Inmunosensors,CE (UV, MS),Lacomba, et al., 2010;Campanella et al., 2009;Contreras et al., 2008;Meltretter et al., 2008;Simone et al., 2009Pharmacological characterizationThe pharmacological characterization <strong>of</strong> a nutraceutical is simply the determination <strong>of</strong> its efficacy<strong>and</strong> safety. Since many nutraceuticals are considers as food items (Dietary Supplement Health <strong>and</strong>Education Act, 1994), currently, many nutraceuticals (e.g., botanicals) do not require efficacy <strong>and</strong>safety testing before marketing. However, Morrow et al. (2005) reported that there is a concern thatmany nutraceuticals have pharmacological activity that can endanger the public health <strong>and</strong> that certainnutraceuticals (e.g., botanicals) should be regulated similarly to prescription nutraceuticals. Therefore,future marketing <strong>of</strong> nutraceuticals may require more rigorous testing <strong>of</strong> safety <strong>and</strong> efficacy beforemarketing. In fact, the FDA (2007) developed a current good manufacturing practice requirement fordietary supplements that obligates manufacturers to evaluate the composition, identity, quality, <strong>and</strong>strength <strong>of</strong> their marketed products. With future increased regulation <strong>of</strong> nutraceuticals on the horizon,pharmacological characterization <strong>of</strong> nutraceuticals will be useful.Drug development, testing <strong>and</strong> review processThe drug review process is roughly divided into preclinical <strong>and</strong> clinical testing. The preclinical testis primarily in vitro <strong>and</strong> animal studies, whereas clinical are human studies.Preclinical testing in animal model (one rodent, one non-rodent) is useful to evaluate acute <strong>and</strong>short term toxicity. Doses will be at normal levels for short <strong>and</strong> long term or increasingly high levelsto induce toxicity. It is useful to determine lethal dose. Pre-clinical studies will be useful to assesshow drug/chemicals is absorbed, distributed, metabolized, <strong>and</strong> excreted in animals. Further, clinicalstudies will be conducted in human being in order to verify the mechanism <strong>and</strong> efficacy. It includes146


Strategies for Animals Studies to Assess the Safety Aspects <strong>and</strong> Bioavailability <strong>of</strong> Netraceuticalsthe following phases (FDA, 2002; Berkowitz, 2007).• Phase I: 20–80 human subjects, safety, pharmacokinetics• Phase II: 36–300 human subjects, efficacy• Phase III: 300–3,000 human subjects, efficacy, double-blind studies• Phase IV: post-marketing surveillancePreclinical testingPreclinical safety testing assesses the potential toxicity <strong>of</strong> a drug in in vitro <strong>and</strong> animal studies(FDA, 1985; Berkowitz, 2007). Preclinical testing involves pharmacological pr<strong>of</strong>ile tests <strong>and</strong> it can befurther divided into the following (Berkowitz, 2007)1. Molecular: receptor binding, enzyme inhibition2. Cellular: cell cultures, isolated tissues3. Disease models: pain, seizuresSafety studies required by the FDA1. Pharmacology studies: determine ED502. Acute toxicity studies: determine LD503. Multi-dose toxicity studiesa. Subchronic toxicity: duration <strong>of</strong> one to three monthsb. Chronic toxicity: duration <strong>of</strong> six monthsc. Carcinogenicity: duration <strong>of</strong> two years4. Special toxicity studies: route <strong>of</strong> administration5. Reproduction studies: birth defects6. Mutagenicity studies: Ames test7. Pharmacokinetics studies: absorption, distribution, metabolism <strong>and</strong> excretion (ADME)Acute toxicityAcute toxicity tests are generally provide data on the relative toxicity likely to arise from a singleor fractionated doses up to 24 hrs for oral <strong>and</strong> dermal studies, while 4-hr exposure for inhalationstudies. Rats are preferred for oral <strong>and</strong> inhalation tests where as rabbits preferred for dermal tests.Young adults <strong>of</strong> 5 <strong>of</strong> each sex per dose level with minimum three dose levels were recommended.Animals should be monitored for 14 days for any clinical symptoms.Subacute study (repeated dose exposure)It is performed to obtain dose for subchronic studies typical protocol is to give 3-4 dosages, <strong>and</strong>10 animals for each sex per dose are <strong>of</strong>ten used. For non-rodents species, usually dogs (3-4 <strong>of</strong> each sexper dose).Subchronic toxicitySubchronic toxicity tests are employed one month to three months (90 days are common).Detailed clinical observations <strong>and</strong> pathology examinations should be conducted. Two species arerecommended (rodents <strong>and</strong> non-rodents). Young adult rodents’ (10-20 animals for each sex per dose)<strong>and</strong> non-rodents species, usually dogs (4 <strong>of</strong> each sex per dose) should be used for experimentation. Atleast 3 dose levels, in which high dose produce toxicity but not more than 10 per cent mortality, lowdose not produce toxicity <strong>and</strong> intermediate dose. The principal goal <strong>of</strong> this test is development <strong>of</strong> NoObservable Adverse Effects Level (NOAEL) <strong>and</strong> sometimes these protocols can be used for furtherlike chronic <strong>and</strong> developmental toxicity studies.147


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceChronic toxicityLong-term or chronic toxicity tests determine toxicity from exposure for a substantial portion <strong>of</strong> asubject’s life. They are similar to the subchronic tests except that they extend over a longer period <strong>of</strong>time, which is depend upon intended period (short or long) <strong>of</strong> exposure to human <strong>and</strong> involve largergroups <strong>of</strong> animals. In rodents, chronic exposures are usually for 6 months to 2 yrs <strong>and</strong> in non rodents1 yr or more. It is useful to assess the cumulative toxicity <strong>of</strong> chemicals particularly carcinogencity.Dose selection for the chronic study is generally based on the results <strong>of</strong> a series <strong>of</strong> subchronic (90 day)toxicity studies. Result <strong>of</strong> weight gain, survival information, pharmacokinetic, metabolism data, <strong>and</strong>histopathology from these experiments that are used for the dose selection. Highest dose employedshould be the maximum tolerated dose (MTD) which is defined as “the highest dose <strong>of</strong> the test agentduring the chronic study that can be predicted not to alter the animals’ normal longevity from effectsother than carcinogenicity”. Carcinogenicity tests are similar to chronic toxicity tests. Testing in tworodent species (mice <strong>and</strong> rats), 50 <strong>of</strong> each sex per dose level are preferred due to short life span. Theexposure period is at least 18 months for mice <strong>and</strong> 24-30 month for rats. They should be observed for18-24 months for mice <strong>and</strong> 24-30 month for rats.Developmental <strong>and</strong> reproductive toxicityDevelopmental toxicity testing detects the potential for substances to produce embryotoxicity<strong>and</strong> birth defects. Developmental toxicity is the study <strong>of</strong> adverse effects on the developing organismoccurring at any time during life span form before conception, during prenatal development orpostnatally until puperty. Teratology study involves from conception to birth. Reproductive toxicitytesting is intended to determine the effects <strong>of</strong> substances on gonadal function, conception, birth, <strong>and</strong>the growth <strong>and</strong> development <strong>of</strong> the <strong>of</strong>fspring. The oral route is preferred.Pharmacological studiesApart from safety <strong>and</strong> efficacy <strong>of</strong> nutraceuticals, the bioavailability studies are important.Bioavailability is the measurement <strong>of</strong> the rate <strong>and</strong> extent <strong>of</strong> the active ingredient that reaches thesystemic circulation. This can be determined by measuring the active ingredient <strong>of</strong> nutraceuticals orits metabolites from the blood. Active ingredient can be accurately quantitated pharmacokineticallyin the plasma (tmax, Cmax <strong>and</strong> AUC) or urine (rate <strong>of</strong> drug excretion) gives the most objectivedata on bioavailability. Pharmacokinetic studies are preferred over pharmacodynamic (deals aboutmechanism <strong>of</strong> action) studies. When both pharmacokinetic <strong>and</strong> pharmacodynamical studies are notpossible, then a clinical study can be used in human or suitable animals model with assumption<strong>of</strong> therapeutic success occurred because there was enough bioavailability when the nutraceuticalswas administered. However, various factors such as diet, disease, or genetics, which can make itdifficult to underst<strong>and</strong> the success or failure (Shargel, 1993; FDA, 2003). Whenever potentially activemetabolites found during human cell culture studies, these metabolites can be studied in laboratoryanimals to determine their safety <strong>and</strong> efficacy, which can help determine future in vitro or in vivohuman studies. Moreover, animal studies can be used to examine nutraceuticals-drug interactionswith regard to parent drug <strong>and</strong> its metabolites. Since several nutraceuticals (example, Grapefruit<strong>and</strong> St. John’s Wort) are inhibit or induce a cytochrome P 450which could affect subsequentlyadministrated drug concentrations.Assays for ACE-inhibitory <strong>and</strong> antihypertensive activityDetermination <strong>of</strong> the ACE inhibitory activity is the most common strategy followed in the selection <strong>of</strong>antihypertensive peptides derived from milk proteins. In order to facilitate the characterisation <strong>of</strong> ACEinhibitory peptides, the establishment <strong>of</strong> a simple, sensitive <strong>and</strong> reliable in vitro ACE inhibition assaylike, spectrophotometric, fluorimetric, radiochemical, HPLC <strong>and</strong> capillary electrophoresis methodscan be used to measure ACE activity. This is usually expressed as the IC50, i.e. concentration neededto inhibit 50% <strong>of</strong> the enzyme activity. The spectrophotometric method <strong>of</strong> Cushman <strong>and</strong> Cheung (1971)is most commonly utilized. The in vivo effects are tested in spontaneously hypertensive rats (SHR),148


Strategies for Animals Studies to Assess the Safety Aspects <strong>and</strong> Bioavailability <strong>of</strong> Netraceuticalswhich constitute an accepted model for human essential hypertension. In addition, in many in vivostudies it is also checked that antihypertensive peptides from milk proteins do not modify the arterialblood pressure <strong>of</strong> Wistar-Kyoto (WKY) rats that are the normotensive control <strong>of</strong> the SHR. The results<strong>of</strong> hypotensive effects caused by the short-term administration to SHR <strong>of</strong> milk protein hydrolysates,fermented products <strong>and</strong> isolated milk-derived peptides have been shown to lack <strong>of</strong> correlation betweenthe in vitro ACE inhibitory activity <strong>and</strong> the in vivo action. This poses doubts on the use <strong>of</strong> the in vitroACE inhibitory activity as the exclusive selection criteria for potential antihypertensive substances,as it does not take into consideration <strong>of</strong> the bioavailability <strong>of</strong> the peptides or other mechanism likeantioxidant effects. On other h<strong>and</strong>, long-term intake <strong>of</strong> milk products on blood pressure <strong>of</strong> SHR wasshown that dose dependent attenuation <strong>of</strong> the development <strong>of</strong> hypertension in SHR during 14 weeks<strong>of</strong> treatment with milk containing the potent ACE inhibitory peptides (Nakamura et al., 1995; Sipolaet al., 2002).Hypertension animal modelsRats are the most popular species in hypertension. The rat models <strong>of</strong> hypertension thusprovide ample opportunity not only to investigate the mechanisms involved in the pathogenesis<strong>of</strong> hypertension, but also to learn about the critical balance between stress <strong>and</strong> coping. Amongrats spontaneously hypertensive rat (SHR) is most widely used rat model, although it reflects onlya rare subtype <strong>of</strong> primary human hypertension, which is due to genetic inheritance. SHR strokeprone (SHR-SP) is a further developed sub-strain, with even higher levels <strong>of</strong> blood pressure,<strong>and</strong> a strong tendency to die from stroke. Other rat models <strong>of</strong> hypertension are Dahl (due togenetic inheritance like SHR), deoxycorticosterone acetate (DOCA)-salt, cause hypertension dueto hormonal alterations (Contreras et al., 2009).Type 2 diabetic animal models<strong>Chemical</strong> induced diabetes model can be produced by administrating drugs like alloxan in rat(40-200 mg/kg, iv or ip), mice (50-200 mg/kg, iv or ip), rabbit (100-150 mg/kg, iv), dog (50-75 mg/kg, iv) can cause diabetes. Administration <strong>of</strong> streptozotocin to rat (35-65 mg/kg, iv or ip), mice (100-200 mg/kg, iv or ip), hamster (50 mg/kg, ip), dog (20-30 mg/kg, iv) can induce diabetus in theseanimals. Selective loss <strong>of</strong> pancreatic beta cells, residual insulin secretion <strong>and</strong> ketosis makes lessmortality. Comparatively cheaper, easier to make <strong>and</strong> maintenance <strong>of</strong> animals. Disadvantages are,direct cytotoxic action on the beta cells <strong>and</strong> insulin deficiency rather than consequence <strong>of</strong> insulinresistance, less stable <strong>and</strong> reversible. Further, toxic actions on other body organs are constraints inlong-term experiments. Though spontaneous type 2 diabetic models are resemble to human being<strong>and</strong> minimum variability <strong>of</strong> results with minimum sample size, they are limited availability, costly<strong>and</strong> required sophisticated maintenance. In dietary or nutrition induced type 2 diabetic models as aresult <strong>of</strong> overnutrition, toxicity <strong>of</strong> other vital organ can be avoid. However, long period is requiredto create diabetes <strong>and</strong> no frank hyperglycaemia develops upon simple dietary treatment. Surgical,transgenic <strong>and</strong> knock out models <strong>of</strong> diabetes animals are need cumbersome technical procedure <strong>and</strong>costly procedure (Srinivasan <strong>and</strong> Ramarao, 2007).ConclusionExperiments using laboratory animals should be well designed, efficiently executed, correctlyanalyzed, clearly presented, <strong>and</strong> correctly interpreted if they are to be ethically acceptable. Laboratoryanimals are nearly always used as models or surrogates <strong>of</strong> humans or other species. Animals should beused only if the scientific objectives are valid (i.e. high probability <strong>of</strong> meeting the stated objectives <strong>and</strong>reasonable contributing to human or animal welfare, possibly in the long term), no other alternative,<strong>and</strong> the cost to the animals is not excessive. The reason for choosing their particular animal model<strong>and</strong> the species, strain, source, <strong>and</strong> type <strong>of</strong> animal used should be clear. The “3Rs” rules (replacement,refinement <strong>and</strong> reduction) should be followed to humane use <strong>of</strong> animals. However, it is important torecognizing biological effects with sufficient numbers animals in experiments. The number <strong>of</strong> animalsto be used in an experiment depends on a variety <strong>of</strong> factors, including experiment objectives, degree149


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assurance<strong>of</strong> precision required, the expected difference between the effects <strong>of</strong> treatments <strong>and</strong> structure <strong>and</strong>methods <strong>of</strong> analysis. Development <strong>and</strong> application <strong>of</strong> the biomarkers to clarify functionality <strong>and</strong>risk are important to underst<strong>and</strong> the fundamental molecular mechanism concerning health care <strong>and</strong>disease prevention <strong>of</strong> nutraceuticals. Through use <strong>of</strong> advanced technologies to study the relationshipbetween nutrition intake <strong>and</strong> health associated with genes can be useful for better underst<strong>and</strong>ing <strong>of</strong>nutraceuticals.ReferencesBerkowitz, B. A. 2007. Development <strong>and</strong> Regulation <strong>of</strong> Drugs. In Basic <strong>and</strong> Clinical Pharmacology. 10 th edition. Edited byKatzung, B. G. New York, NY: McGraw-Hill, pp. 64–73.Campanella, L., Martini, E., Pintore, M. <strong>and</strong> Tomassetti, M. (2009). Determination <strong>of</strong> lact<strong>of</strong>errin <strong>and</strong> immunoglobulin Gin animal milks by new immunosensors. Sensors, 9: 2202-2221.Casado, B., Affolter, M. <strong>and</strong> Kussmann, M. (2009). OMICS-rooted studies <strong>of</strong> milk proteins, oligosaccharides <strong>and</strong> lipids,J. Proteomics, 73: 196-208.Contreras, M. del. M., Carro´n, R., Montero, M. J., Ramos, M. <strong>and</strong> Recio, I. (2009). Novel casein-derived peptides withantihypertensive activity. International <strong>Dairy</strong> Journal, 19: 566–573.Contreras, M. M., López-Expósito, I., Hernández-Ledesma, B., Ramos, M. <strong>and</strong> Recio, I. (2008). Application <strong>of</strong> massspectrometry to the characterization <strong>and</strong> quantification <strong>of</strong> food bioactive peptides. J. AOAC Int., 91 (4): 981-994.Cushman, D.W. <strong>and</strong> Cheung, H. S. (1971). Spectrophotometric assay <strong>and</strong> properties <strong>of</strong> the angiotensin-convertingenzyme <strong>of</strong> rabbit lung. Biochem.Pharmacol., 20: 1637–1648.DeFelice, S. 2007. The Foundation for Innovation in Medicine. http://www.fi mdefelice.org.Food <strong>and</strong> Drug Administration. (1985). Guidance for industry: Guideline for the format <strong>and</strong> content <strong>of</strong> the nonclinicalpharmacology/toxicology section <strong>of</strong> an application. http:// www.fda.gov/cder/guidance/old032fn.pdf.Food <strong>and</strong> Drug Administration. (2002). The FDA’s drug review process: Ensuring drugs are safe <strong>and</strong> effective. http://www.fda.gov/fdac/features/2002/402_drug.html.Food <strong>and</strong> Drug Administration. (2003). Guidance for industry. Bioavailability <strong>and</strong> bioequivalence for orally administereddrug products: General considerations. http://www.fda. gov/cder/guidance/5356fnl.pdf.Food <strong>and</strong> Drug Administration. (2007). Final rule promotes safe use <strong>of</strong> dietary supplements. http://www.fda.gov/consumer/updates/dietarysupps062207.html.Meltretter, J., Schmidt, A., Humeny, A., Becker, C.M. <strong>and</strong> Pischetsrieder, M. (2008). <strong>Analysis</strong> <strong>of</strong> the peptide pr<strong>of</strong>ile <strong>of</strong>milk <strong>and</strong> its changes during thermal treatment <strong>and</strong> storage, J. Agric. Food Chem., 56: 2899-2906.Morrow, J., T. Edeki, M. El Mouelhi, R. Galinsky, R. Kovelesky, <strong>and</strong> C. Preuss. (2005). American Society for ClinicalPharmacology <strong>and</strong> Therapeutics position statement on dietary supplement safety <strong>and</strong> regulation. Clin. Pharmacol.Ther. 77:113–122.Nakamura, Y., Yamamoto, N., Sakai, K. <strong>and</strong> Takano, T. (1995). Antihypertensive effect <strong>of</strong> sour milk <strong>and</strong> peptidesisolated from it that are inhibitors to angiotensin I-converting enzyme. J. <strong>Dairy</strong> Sci., 78: 1253–1257.Shargel, L. <strong>and</strong> A. Yu. (1993). Bioavailability <strong>and</strong> Bioequivalence. In Applied Biopharmaceutics <strong>and</strong> Pharmacokinetics.3rd edition. Norwalk, CT: Appleton <strong>and</strong> Lange, pp. 193–223.Simone, C. D., Picariello, G., Mamone, G., Stiuso, P., Dicitore, A., Vanacore, D., Chianese, L., Addeo, F. <strong>and</strong> Ferranti, P.(2009). Characterisation <strong>and</strong> cytomodulatory properties <strong>of</strong> peptides from Mozzarella di Bufala Campana cheesewhey. J. Pept. Sci., 15: 251-258.Sipola, M., Finckenberg, P., Korpela, R., Vapaatalo, H., <strong>and</strong> Nurminen, M.-L. (2002). Effect <strong>of</strong> long-term intake <strong>of</strong> milkproducts on blood pressure in hypertensive rats. J. <strong>Dairy</strong> Res., 69: 103–111.Srinivasan K. <strong>and</strong> Ramarao P. (2007). Animal models in type 2 diabetes research: An overview Indian J Med Res 125:451-472.150


Recent Advances in Synbiotic <strong>Dairy</strong> Foods <strong>and</strong> <strong>Their</strong> Safety EvaluationIntroductionRecent Advances in Synbiotic <strong>Dairy</strong>Foods <strong>and</strong> <strong>Their</strong> Safety EvaluationCh<strong>and</strong> Ram, Manju <strong>and</strong> Santosh An<strong>and</strong><strong>Dairy</strong> Microbiology Division, NDRI, KarnalThe human gut habitats >500 species <strong>of</strong> bacteria <strong>and</strong> their proper balance is pre requisite for wellbeing <strong>of</strong> humans <strong>and</strong> animals. It is established that beneficial micr<strong>of</strong>lora must be viable <strong>and</strong> shouldremain adhered to the inner surface <strong>of</strong> the epithelial cells to confer desired health benefits to the host.Various factors such as nutritional requirements, transit time, infections, availability <strong>of</strong> metabolizablesubstrates affect microbial ecology <strong>of</strong> large intestine. Dietary habits influence gut micr<strong>of</strong>lora e.g.bifidobacteria dominate breast fed infants which gradually decrease with advancement in age. Inaddition, food substrate form also plays vital role in determining composition <strong>of</strong> gut micr<strong>of</strong>lora forinstance, presence <strong>of</strong> N- acetyglucosamine, galactose, certain glycoproteins <strong>and</strong> fucose oligomersin human milk act as specific growth factors for bifidobacteria. Further, low protein <strong>and</strong> highlact<strong>of</strong>errin content in human milk elevate growth <strong>of</strong> bifidobacteria <strong>and</strong> inhibit growth <strong>of</strong> undesirablemicroorganisms, respectively. Elie Metchnik<strong>of</strong>f (1907) hypothesized longevity <strong>of</strong> Bulgarian peasantsassociated with continuous consumption <strong>of</strong> fermented milks, the concept <strong>of</strong> probiotics as knowntoday. Imbalance <strong>of</strong> microbial ecology <strong>of</strong> gut can be restored by administration <strong>of</strong> probiotics. WorldHealth Organization (WHO) has advocated application <strong>of</strong> probiotics in the form <strong>of</strong> functional foodsfor treatment <strong>and</strong>/or prevention <strong>of</strong> various ailments. This decade has witnessed advancement in thefield <strong>of</strong> probiotics in the form <strong>of</strong> synbiotic dairy foods. Hence, it is worth to discuss safety issuesrelated to probiotic vis a vis synbiotic dairy foods.Functional foods <strong>and</strong> related concepts:<strong>Dairy</strong> foods have always been a choice <strong>of</strong> innovation to remain competitive in the market aswell as changes in the consumer preference. The primary role <strong>of</strong> these foods is to provide nutrition<strong>and</strong> satisfaction feeling to the consumer. However, in recent times apart from nutrition, the trend istowards consumption <strong>of</strong> functional foods with beneficial microbes to have a state <strong>of</strong> good health <strong>and</strong>reduce risk <strong>of</strong> disease. <strong>Dairy</strong> products have a distinct role in delivering the probiotics to the host, asthese products provide suitable environment for survival <strong>and</strong> growth.Functional food- Food that satisfactorily demonstrate beneficial effect on one or more targetfunctions in the host, beyond the adequate nutritional effects in a way that is relevant to either animproved state <strong>of</strong> health <strong>and</strong> well-being <strong>and</strong>/or reduction <strong>of</strong> risk <strong>of</strong> disease (European FunctionalFood Science programme, Diplock, 1999).Probiotics- Live microorganisms, which when administrated in adequate amount confer healthbenefits to the host (FAO/WHO,2002).Probiotic food- That contains viable probiotic microorganisms in adequate numbers incorporatedin a suitable matrix so that upon ingestion claimed health effect is obtained in the host beyond regularnutrition. Probiotics adhere to epithelial cell <strong>and</strong> colonise thereby, improve metabolism, immunity<strong>and</strong> gut physiology.Prebiotics- Non digestible food ingredients that beneficially affect the host by selectively stimulatingthe growth <strong>and</strong>/or activity <strong>of</strong> one or a limited number <strong>of</strong> bacteria in the colon. Synbiotics- A mixtures<strong>of</strong> pro <strong>and</strong> prebiotics that beneficially affect the host by improving the survival <strong>and</strong> implantation <strong>of</strong>selected live microbial strains in the gastrointestinal tract.Probiotics:Lactic acid bacteria (LAB) including bifidobacteria, natural inhabitant <strong>of</strong> human gut have been inuse for preparation <strong>of</strong> various functional foods. The product can be called probiotic functional only if151


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assurancethe effective dose <strong>of</strong> live organisms present <strong>and</strong> its health benefit has been shown upon consumption.As per WHO recommendations food must contain 106 cfu/g or 108 cfu/day <strong>of</strong> viable microorganismsin-take for better probiotic efficacy. Health benefits can be ascribed to probiotics/synbiotics i.e.alleviation <strong>of</strong> lactose intolerance, improvement in Ca, Fe <strong>and</strong> Mg absorption, cardiovascular health,anticancer effect, cholesterol assimilation, modulation <strong>of</strong> immune function, constipation alleviation,prevention/ treatments <strong>of</strong> diarrhoea <strong>and</strong> infections, increase in nutrient bioavailability, regularisation<strong>of</strong> intestinal flow, production <strong>of</strong> vitamins etc. Some <strong>of</strong> commercially available probiotics foods inglobal market are enlisted in Table 1.Prerequisite <strong>of</strong> probiotic cultures:Probiotic cultures should be selected on the following criteria, irrespective <strong>of</strong> the intended host orsite <strong>of</strong> application:• Survival in GIT <strong>and</strong> exhibit health effects in the host.• Proliferation <strong>and</strong> colonization under the host environmental condition.• Survival in association with the host immune system <strong>and</strong> non inflammatory.• Immuno-stimulatory for the mucosal immune system.• Production <strong>of</strong> antimicrobial substances against food spoilage <strong>and</strong> pathogenic bacteria.• Non-pathogenic, non-toxic, non-allergic, non-mutagenic or anti-carcinogenic, even in immunecompromisedhosts.• Genetically stable, non-plasmid transfer <strong>and</strong> technologically suitable for process applications.• Potential for delivery <strong>of</strong> recombinant proteins <strong>and</strong> peptides.• Desirable metabolic activity <strong>and</strong> antibiotic resistance / sensitivity.New generation probiotics:Due to advancement in health <strong>and</strong> nutrition science, new cultures <strong>and</strong> novel probiotic productsare being introduced in market. These will require well established safety assessment procedures, e.g.in the European Novel Foods Directive <strong>and</strong> in the US Premarketing Approval Clearances are must.• Novel probiotic species: Majority <strong>of</strong> probiotics belong to the genera Lactobacillus, Bifidobacterium,Lactococcus, Leuconostoc, <strong>and</strong> Propionibacterium with GRAS status. However, other organisms suchas Oxalobacter formigenes, Enterococcus fecalis <strong>and</strong> Escherichia coli do not enjoy the same status <strong>and</strong>possibly more strict safety assessments are necessary to give clearance to novel probiotics forincorporation into synbiotic products.• Genetically modified probiotics: <strong>Dairy</strong> food containing genetically modified (GM) probioticshave low consumer acceptance in many countries e.g. Europe. However, GM probiotics possespotential in clinical applications e.g. delivery <strong>of</strong> antigens for vaccines <strong>and</strong> thus are morereadily accepted. This would provide a safer method <strong>of</strong> vaccination than the use <strong>of</strong> attenuatedpathogens e.g. GM, Lactococcus lactis, produce IL-10 in the mouse intestine. This may providenew treatment strategies for inflammatory bowel disease, <strong>and</strong> similar applications may beuseful for other diseases. The safety <strong>of</strong> such organisms that produce very powerful bioactivesubstances is <strong>of</strong> major concern as excess production <strong>of</strong> these substances in a healthy individualmay be detrimental.• Non-viable probiotics: Generally probiotics are live microbes, however, non-viable probioticsmay also have beneficial health effects. These are likely to be in the market due to practical <strong>and</strong>economic advantages; longer shelf-life, transportation <strong>and</strong> storage, safety etc. These could beconsidered safe when used in extremely high-risk immune-suppressed patients.• Novel applications: The main application for probiotics is their use in foods, aiming at affectingthe composition or activity <strong>of</strong> the intestinal micr<strong>of</strong>lora or directly affecting the function <strong>of</strong>the intestine. However, the probiotic principle should be expected to work in any part <strong>of</strong> thebody that has a normal micr<strong>of</strong>lora. With the exception <strong>of</strong> the urogenital tract, extra-intestinal152


Recent Advances in Synbiotic <strong>Dairy</strong> Foods <strong>and</strong> <strong>Their</strong> Safety Evaluationapplications <strong>of</strong> probiotics have received little attention. Such probiotic preparations wouldclearly need different safety requirements.• Animal probiotics: Probiotics application in animals requires more strict safety assessment <strong>and</strong>should be safe to both. Because <strong>of</strong> probiotics application in farm animals, these may enter thefood chain. Intimate relationship between pet <strong>and</strong> its owner result spread <strong>of</strong> probiotic fromanimal to human is possible. Enterococci are commonly used in animal preparations <strong>and</strong> thismay be reason for some concern. The safety requirements for animals are different from thosefor humans. Few studies suggest that Lactococcus garvieae is associated with mastitis in cows <strong>and</strong>septicaemia in fish as well as disease in humans. However, its true pathogenesis for humansremains to be determined.Challengages for use <strong>of</strong> probiotics in food systems:• Acid sensitivity is principal factors for poor viability <strong>of</strong> probiotic cultures particularlybifidobacteria in fermented dairy foods. However, microencapsulation technique can be used toimprove viability <strong>of</strong> acid sensitive cultures in food systems.• Oxygen sensitivity is <strong>of</strong> particular relevance to bifidobacteria as they are strict anaerobes. Toxiceffects <strong>of</strong> oxygen can be overcome; milk may be deaerated prior to fermentation. Alternatively,use <strong>of</strong> impermeable packaging may eliminate the toxic effects <strong>of</strong> oxygen during product storage.Addition <strong>of</strong> reducing agents such as cysteine or oxygen scavengers such as ascorbic acid <strong>and</strong>selection <strong>of</strong> oxygen tolerating strains may also improve the tolerance <strong>of</strong> probiotic cultures tooxygen sensitivity.• Processing parameters such as thermo tolerance is an important parameter when consideringmicrobial survival in food processes such as spray-drying. Within the genera most <strong>of</strong>ten employedas probiotics, certain strains <strong>and</strong> species are more heat tolerant than others e.g. “thermophilic”lactobacilli.Safety issues <strong>of</strong> probiotics for humans:• Probiotic cultures used for preparation <strong>of</strong> functional dairy foods should be safe even in immunecompromisedindividuals. Long history <strong>of</strong> LAB usage in preparation <strong>of</strong> fermented food providesthem generally regarded as safe (GRAS) status. WHO <strong>and</strong> LABIP outlined following parametersfor their safety (Table 2.).Table 1. Commercial probiotic foods in the global marketSN Commercial preparation Probiotic cultures1 Acidophilus milk Lactobacillus acidophilus2 Sweet acidophilus milk Lb. acidophilus3 Acidophilin Lb. acidophilus, Lc. lactis subsp. lactis, kefi r yeasts.4 Nu-Trish A/B Lb. acidophilus, Bifi dobacterium spp5 Diphilus milk Lb. acidophilus, B. bifi dum6 Biomild Lb. acidophilus, B. bifi dum7 Cultura ® or A/Bmilk Lb. acidophilus, B. bifi dum8 Bifi ghurt ® B. longum (CKL 1969) or B. longum (DSM2054)9 Acidophilus buttermilk Lb. acidophilus, Lactococcus lactis subsp. lactis, subsp.cremoris, subsp. lactis biovar. diacetylactis10 Acidophilus-yeastmilk Lb. acidophilus, Saccharomyces lactis11 Bifi dus milk B. bifi dum or longum12 Yakult Lb. casei Shirota13 Yakult Miru-Miru Lb. casei, B. bifi dum or B. bereve, Lb. acidophilus14 A-38 fermented milk Lb. acidophilus, mesophilic lactic cultures15 Onaka He GG, Str. thermophilus,Lb. delbrueckii subsp. bulgaricus,16 Gefi lus (Valio Ltd) Lactobacillus rhamnosus GG153


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assurance17 CHAMYTO Lb. johnsonii, Lb. helveticus18 Vitagen Lb. acidophilus19 Procult drink B. longum BB536, Str. thermophilus,Lb. delbrueckii subsp. bulgaricus20 Actimel Lactobacillus casei ImmunitasTM21 AKTfi t, Biola, BioAktiv, YOMO, LGG+, Lb. rhamnosus GGActif Yoplait 360º , Kaiku22 Gaio Lb. casei F1923 Verum Lb. rhamnosus LB2124 ProViva Lactobacillus plantarum 299vAdopted from Ozer <strong>and</strong> Kirmaci, 2009Guidelines for evaluation <strong>of</strong> probiotics (FAO/WHO, 2002):• Strain identification by phenotypic <strong>and</strong> genotypic methods (Section 3.1)•Genus, species, strain•Deposit strain in international culture collection• Functional characterization (Section 3.2)• In vitro tests• Animal studies• Safety assessment (Section 3.3)• In vitro <strong>and</strong>/or animal• Phase 1 human study• Double blind, r<strong>and</strong>omized, placebo-controlled (DBPC) phase 2 human trial or other appropriatedesign with sample size <strong>and</strong> primary outcome appropriate to determine if strain/product isefficacious (Section 3.4)• Preferably second independent DBPC study to confirm results• Phase 3, effectiveness trial is appropriate to compare probiotics with st<strong>and</strong>ard treatment <strong>of</strong> aspecific condition• Labeling (Section 3.5)•Contents – genus, species, strain designation•Minimum numbers <strong>of</strong> viable bacteria at end <strong>of</strong> shelf-life•Proper storage conditions•Corporate contact details for consumer information.Table 2. Safety assessment scheme for probiotic culturesSN Attribute Safety issues for assessment1 Intrinsic strain properties Adhesion factors, antibiotic résistance, plasmid transfer, enzyme pr<strong>of</strong>i le2 Metabolic products Concentrations, safety, <strong>and</strong> other effects3 Toxicity Acute <strong>and</strong> sub acute effect <strong>of</strong> ingestion <strong>of</strong> large amounts <strong>of</strong> cultures4 Infective properties In vitro with cell lines ; in vivo with animal models5 Dose- response effects Oral administration in volunteers6 Clinical assessments Potential for side effects <strong>and</strong> disease-specifi c effects; nutritional studies7 Epidemiological studies Surveillance <strong>of</strong> large populations following introduction <strong>of</strong> new strains <strong>and</strong> productsPrebiotics:The prebiotic application is directed to support growth <strong>of</strong> LAB due to their proposed health promotingproperties. The latest definition results in an equalization <strong>of</strong> ‘prebiotic’ <strong>and</strong> ‘bifidogenic’ which includes154


Recent Advances in Synbiotic <strong>Dairy</strong> Foods <strong>and</strong> <strong>Their</strong> Safety Evaluationin the definition the prebiotic index (i.e. absolute increase in fecal bifidobacteria concentration/g <strong>of</strong> dailyconsumed prebiotics. Some <strong>of</strong> the properties <strong>of</strong> food ingredient to be classified as prebiotic are listed inthe Table 3.Table 3. Desirable attributes <strong>of</strong> functional prebioticsDesirable attribute in prebioticActive at low dosage <strong>and</strong> lack <strong>of</strong> side effectsPersistence through the colonProtection against colon cancerEnhance the barrier effect against pathogensInhibit adhesion <strong>of</strong> pathogensTargeting at specifi c probioticsProperties <strong>of</strong> oligosaccharidesSelectively <strong>and</strong> effi ciently metabolised by ‘benefi cial’ bacteriabut not by gas producers, putrefactive organisms, etc.Controlled molecular weight distributionStimulate butyrate production in the colonStructural basis unknownPossess receptor sequenceSelectively metabolised by restricted species <strong>of</strong> Lactobacillus<strong>and</strong>/or Bifi dobacteriumTable 4: List <strong>of</strong> some selected prebioticsSN Recognized prebiotics Emergent prebiotics1 Fructo-oligosaccharides (FOS) Genti-oligosaccharides2 Galactooligosaccharides (GOS) Gluco-oligosaccharides3 Galacto-oligosaccharides (GOS)/ transgalactosylatedoligosaccharidesIsomalto-oligosaccharides (IMO)(GOS/TOS)4 Inulin Lactosucrose5 Isomalto-oligosaccharides Levans6 Lactulose Pectic-oligosaccharides7 Pyrodextrins Resistant starch8 Soy-oligosaccharides (SOS) Sugar alcohols9 Xylo-oligosaccharides (XOS)Synbiotics:Another promising approach to manage correct balance <strong>of</strong> gut micr<strong>of</strong>lora is the use <strong>of</strong> synbiotics.These also improve survival <strong>of</strong> bacteria during storage <strong>and</strong> passage <strong>of</strong> upper part <strong>of</strong> GIT, therebyenhancing their health effects in the large intestine. The combined effects <strong>of</strong> synbiotics can be additiveor even synergistic.Synbiotics foods with defined health benefits:All the commercial probiotics are highly selected to have useful properties such as resistanceto acid <strong>and</strong> bile <strong>and</strong> technological stability to freeze-drying <strong>and</strong> product preparation. However, totransfer health benefits to the host synbiotic approach holds promise such as immune stimulation,cancer prevention, anti-pathogen activity etc. It would be expected that synbiotic versions <strong>of</strong> probioticstrains made with targeted prebiotics would display better survival <strong>and</strong> colonisation in the gut. Itwould be highly desirable to develop targeted prebiotics at particular species <strong>of</strong> microorganisms.Infant formulae <strong>and</strong> weaning foods: Bifidogenic factors in milk stimulate the growth <strong>of</strong> bifidobacteriathat result health benefits to the infant, including a decreased susceptibility to microbial infections. Breastfed infants’ gut is dominated by bifidobacteria while <strong>of</strong> formula-fed with mixed micr<strong>of</strong>lora resemble that<strong>of</strong> an adult. The supplementation <strong>of</strong> infant milk formula with non-digestible compounds would supportgrowth <strong>of</strong> bifidobacteria. Hence, it would be <strong>of</strong> great interest to produce prebiotics with high selectivitytowards growth <strong>of</strong> bifidobacteria that are present in the gut <strong>of</strong> breast-fed infants as the basis <strong>of</strong> novelinfant food formulations.155


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceFunctional foods for healthy ageing: Bifidobacterial population decreased markedly in the colon<strong>of</strong> elderly person (55–60 years <strong>of</strong> age) as compared with those <strong>of</strong> young adults. Species <strong>of</strong> Bifidobacteriumare reasonable target for prebiotic viz., B. infantis <strong>and</strong> B. breve are predominant in infants, whereasB. adolescentis <strong>and</strong> B. longum in adults. Decrease in bifidobacterial numbers results in reduction inresistance to gastrointestinal infections <strong>and</strong> thus elderly people suffer more with such ailments.Development <strong>of</strong> targeted prebiotic that promotes the probiotic strains able to inhibit gastrointestinalpathogens viz., E. coli, Salmonella sp. <strong>and</strong> Campylobacter jejuni.Development <strong>of</strong> targeted prebiotics:Targeted prebiotics for probiotic can be developed firstly by screening a wide range <strong>of</strong>oligosaccharide for their prebiotic attributes which will provide information about their selectivitytowards particular species. Structural diversity <strong>and</strong> cost effective manufacture technology for complexoligosaccharides is most important. The second approach is enzymes expressed probiotics which canact as synthetic catalysts. These enzymes will produce a mixture <strong>of</strong> oligosaccharide, which inturnmay be more readily metabolised by the producing organism, resulting in higher selectivity. Novelβ-galacto-oligosaccharide mixtures have been synthesised from lactose using β-galactosidases from arange <strong>of</strong> prebiotics.Technologies for manufacturing prebioticsFirst generation prebiotics are either extracted from plants or manufactured from cheap, readilyavailable sources, generally by means <strong>of</strong> enzymatic hydrolysis or synthesis reactions.Second approach is enzyme hydrolysis <strong>of</strong> polysaccharide. Fungal inulinase is used to hydrolysechicory inulin to oligosaccharides with low monosaccharide contents. Fructo-oligosaccharides <strong>and</strong>xylo-oligosaccharides are both manufactured by hydrolysis <strong>of</strong> their parent polysaccharides. Fructooligosaccharidescan also manufactured by synthesis from sucrose. Consequently, FOS producedfrom inulin have reducing activity. The probiotic like Galactooligosaccharides, lactosucrose, isomaltooligosaccharides(IMO) <strong>and</strong> some fructooligosaccharides are manufactured by enzymic glycosyltransfer reactions from cheap sugars such as sucrose <strong>and</strong> lactose or from starch. All <strong>of</strong> the sucrosederivedFOS terminate in a non-reducing glucose residue. Ion-exchange chromatography can be usedto remove glucose <strong>and</strong> sucrose.Second generation prebiotics: If the full potential <strong>of</strong> enhanced prebiotics is to be realised, newtechnological innovations will be required. The challenge, as ever, for biotechnologists is to achieve themanufacturing technologies at economically viable costs. Two areas <strong>of</strong> development are being exploredin laboratories in Europe at the current time. Controlled polysaccharide hydrolysis: Polysaccharidehydrolysis is a commercial manufacturing approach for prebiotics. In this a more controlled partialhydrolysis carried out in order to achieve control over the molecular weight distribution <strong>of</strong> the products.Different IMO with average molecular weights up to 12,000 Da can be prepared by controlled partialhydrolysis <strong>of</strong> dextran <strong>and</strong> pectins by endo-dextranase in an enzyme membrane reactor by controllingresidence time <strong>and</strong> ratio <strong>of</strong> enzyme to substrate. The fractions displayed good prebiotic fermentationin vitro.Safety <strong>of</strong> pre & probiotics:Probiotics mainly belongs to genera <strong>of</strong> Lactobacillus or Bifidobacterium, have been in use to conferhealth effects as they enjoy status <strong>of</strong> Generally Regarded as Safe (GRAS) due to their long history<strong>of</strong> safe use. Various in vitro tests are available to evaluate efficacy <strong>and</strong> safety <strong>of</strong> pro <strong>and</strong> prebiotics.However, most probiotics do not have a documented history <strong>of</strong> safe use hence, safety evaluation isquite necessary. Some <strong>of</strong> the issues <strong>of</strong> probiotics concerned to safety are as below:• Antibiotic resistance: Presence <strong>of</strong> antibiotic resistance encoding genes must be determinedin order to prevent transmission <strong>of</strong> drug resistance to undesirable organism. The antibioticresistance gene specially vancomycin resistance should not be unstable plasmid encoded inprobiotic organisms as this is one <strong>of</strong> the last antibiotics used as an effective tool against multidrug-156


Recent Advances in Synbiotic <strong>Dairy</strong> Foods <strong>and</strong> <strong>Their</strong> Safety Evaluationresistant staphylococci. It is recommended not to use any vancomycin-resistant Enterococci aseither human or animal probiotics.• Strain Identification: This is not possible that all strains genus would confer probiotic healthbenefits to the host. Proper identification <strong>of</strong> the organism is desirable by using internationallyaccepted molecular tools such as DNA-DNA hybridization, 16S rRNA, pulsed field gelelectrophoresis (PFGE) or r<strong>and</strong>omly amplified polymorphic DNA (RAPD), newer system suchas terminal restriction fragment-length polymorphism (T-RFLP) etc to give proper designationso that it can be easily accessible by researcher. After identification the strain must be depositedin a collection centre so that it can be easily available for workers.• Metabolic activities: Certain probiotics are capable to convert food components or biologicalsecretions into secondary metabolites which could be potentially harmful to the host. Hence,these should be assessed for the following parameters:• Biogenic amines: These are produced during degradation <strong>of</strong> food proteins by certain LAB dueto deaminase activity, whish is considered as detrimental effects <strong>of</strong> probiotics. The c<strong>and</strong>idateprobiotic can be evaluated for this activity decarboxylase broth using Bover-Cid <strong>and</strong> Holzapfel’smethod.• Bile salt deconjugation: Bile salts are water soluble end products <strong>of</strong> cholesterol metabolismin liver <strong>and</strong> assist in the lipid digestion. They are absorbed actively in the terminal ileum <strong>and</strong>are subsequently re-secreted, thereby form an enterohepatic cycle. During the microbial bileacid metabolism first step is deconjugation as these are less effective in solubilisation <strong>of</strong> dietarylipids. Further, too early <strong>and</strong> too much deconjugation, particularly in the upper small intestinemay disturb the lipid digestion <strong>and</strong> subsequent uptake <strong>of</strong> fat-soluble vitamins. Primary bileacids can subsequently be dehydroxylated to yield secondary bile acids. The latter are mosthydrophobic <strong>and</strong> toxic to hepatocytes <strong>and</strong> the gastric <strong>and</strong> intestinal mucosa, <strong>and</strong> have beensuggested to be cancer promoters <strong>and</strong> to be involved in the formation <strong>of</strong> gal stones. Consideringthe detrimental properties <strong>of</strong> secondary bile acids, no increase in 7α- dehydroxylase activity canbe accepted anywhere in the intestine. Potential probiotics <strong>and</strong> starters should not exhibit thisproperty.• D (-) lactic acid Production: Mammalian tissues lack D-lactate dehydrogenase (DLDH) enzymeto metabolize D(-)-lactic acid. Production <strong>of</strong> D(-)-lactic acid by probiotic bacteria, is also aconcern to use them in children, due to D(-)-lactic acidosis. Acidosis is a pathologic conditioncharacterized by neurological alterations.• Others-binding: The binding <strong>of</strong> probiotics to mucosal layer is one <strong>of</strong> the prime selectioncriteria as it is more important for immune modulation by competitive exclusion <strong>of</strong> pathogens.However, binding is also a first step for the pathogenesis. Probiotics adhere to the extracellularmatrix (ECM) proteins typically exposed in wound tissue. Pathogens <strong>of</strong>ten have affinity forthese proteins, which also serve as receptors for invading microbes. Many lactic acid bacteriahave been observed to be able to reduce bioavailability <strong>of</strong> certain toxins by absorption viz.,absorb environmental toxins; mycotoxins, heterocyclic amines etc. Although, absorbingthese compounds is desirable trait, it is important that such organisms do not be able bind totherapeutic compound or essential nutrients.• If the strain under evaluation belongs to a species with known hemolytic potential,determination <strong>of</strong> hemolytic activity is required• Assessment <strong>of</strong> lack <strong>of</strong> infectivity by a probiotic strain in immunocompromized consumers(add a measure <strong>of</strong> confidence in the safety <strong>of</strong> a probiotic)• Animal <strong>and</strong> human studies: Assessment <strong>of</strong> side-effects, epidemiological surveillance (postmarket)<strong>and</strong> degradation <strong>of</strong> mucines must be carried out.157


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceEvaluation <strong>of</strong> prebiotic:• Prebiotic characterisation: The component which is claimed to have prebiotic attribute(s) mustbe characterised for source, origin, purity, chemical structure, composition, concentration <strong>and</strong>amount required to be delivered to the host.• Functionality evaluation: Correlation <strong>of</strong> physiological effect <strong>and</strong> modulation <strong>of</strong> intestinalmicr<strong>of</strong>lora should be substantiated based on studies tested in the target host with the finalproduct type alongwith time framework. A prebiotic can be a fiber but a fiber need not be aprebiotic.FAO has recommended the following guidelines for safety evaluation <strong>and</strong> substantiation <strong>of</strong>prebiotic (Figure 1):• If the product has long history <strong>of</strong> safe usage then it should be considered as GRAS status <strong>and</strong>thus no need for further human <strong>and</strong> animal trials. If it is a new c<strong>and</strong>idate, safe levels must bedetermined.• Levels <strong>of</strong> consumption for safe <strong>and</strong> minimum side effects must be established.• The product must be free from contaminants <strong>and</strong> impurities, characterisation <strong>of</strong> contaminantshould be done with toxicological studies.• The prebiotic must not alter the gut microbiota in a way detrimental to the host.Global regulatory status:The dietary supplement market for probiotics/synbiotic is gaining momentum at a very fast paceover the globe, hence, regulation <strong>of</strong> these products is must consumers safety.UNITED STATES: FDA controls the safety <strong>of</strong> foods <strong>of</strong> dietary supplements <strong>and</strong> probiotics thatare sold as components <strong>of</strong> conventionalfoods or as dietary supplements. The safety<strong>of</strong> traditional LAB has been granted GRASstatus. However, new <strong>and</strong> less traditionalstrains <strong>of</strong> microbes have to be more carefullyassessed prior to distribution to consumerswith potentially compromised health. In theUS, Title 21 <strong>of</strong> the Code <strong>of</strong> Federal Regulations(21 CFR).EUROPEAN UNION: Probiotics/synbiotic dairy foods fall under EC NovelFoods Regulation (258/97) to ensure the freemovement <strong>of</strong> novel foods, while protectingthe interests <strong>of</strong> consumers, especially withrespect to safety, health <strong>and</strong> information.GERMANY: Occupational foundation <strong>of</strong>chemical industry has established an expertgroup to assess the safety <strong>of</strong> microbiology<strong>and</strong> biotechnology. This expert group hasalso assessed the safety <strong>of</strong> microbes <strong>and</strong>Figure1 Guidelines to evaluate <strong>and</strong> substantiate a product aspublished a list containing the classification <strong>of</strong> prebiotic (FAO Technical Meeting, 2007)bacteria used by different industries includingfood <strong>and</strong> feed industries (Berufsgenossenschaft der chemischen Industrie, 1998).JAPAN: Probiotics/ functional foods fall under the Food for Specified Health Uses (FOSHU)regulation. FOSHU regulations do not specifically define the safety aspects for probiotic microbes butfor functional foods in general <strong>and</strong> to get FOSHU status company has to get it from Ministry <strong>of</strong> Health<strong>and</strong> Welfare.158


Recent Advances in Synbiotic <strong>Dairy</strong> Foods <strong>and</strong> <strong>Their</strong> Safety EvaluationInternational <strong>Dairy</strong> Federation(IDF): An expert action team has been constituted in collaborationwith European Food <strong>and</strong> Feed Culture Association to prepare a position document on properties <strong>of</strong>dairy starters <strong>and</strong> probiotics to be used by the dairy industry..Conclusion <strong>and</strong> future perspectives:The current safety record <strong>of</strong> food starter cultures <strong>and</strong> probiotics appears to be excellent in developedcountries. Although, safety regulation related to functional/ probiotic / symbiotic foods yet to beformulated in India. The future development <strong>of</strong> probiotics/ synbiotics <strong>and</strong> also industrial dairy startersrequires stringent guidelines for safety assessment <strong>of</strong> such organisms. Hence, constant surveillance <strong>of</strong>probiotics/synbiotics is essential specially in clinical applications. Development <strong>of</strong> safety assessmenttools is extremely important for both premarket safety assessment <strong>and</strong> post-marketing surveillance <strong>of</strong>human populations to guarantee safety <strong>of</strong> future products in humans <strong>and</strong> animals including immunecompromised.This will enable the future use <strong>of</strong> microbes <strong>and</strong> microbial fermentations for a wideningarea in food technology <strong>and</strong> in functional <strong>and</strong> clinical food areas.References:Diplock A. T. 1999. Scientific concepts <strong>of</strong> functional foods in Europe: Consensus Document. Br J Nutr, 81(Suppl 1),S1–S27.Granato D., Branco, G.F., Cruz, A. G., Faria, J.A.F. <strong>and</strong> Shah, N.P. 2010. Probiotic dairy products as functional foods.Comp. Rev. Food Sci. Safety.9:455-470Ozer, B.H. <strong>and</strong> Kirmaci, H.A. 2009. Functional milks <strong>and</strong> dairy beverages. Int. J. <strong>Dairy</strong> Tech. 63(1):1-15.Ross, R.P., Desmond, C., Fitzgerald, G.F. <strong>and</strong> Stanton, C. 2005. Overcoming the technological hurdles in the development<strong>of</strong> probiotic foods. J. Appl. Micro. 98:1410-1417.Suvarna, V.C. <strong>and</strong> Boby, V.U. 2005. Probiotics in human health: A current assessment. Curr. Sci. 88(11):1744-1748.159


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssurancePhysical Characterization <strong>of</strong> <strong>Dairy</strong> Foods withReference to Viscosity, Colour <strong>and</strong> Water ActivityR. R. B. Singh <strong>and</strong> Prateek Sharma<strong>Dairy</strong> Technology Division, NDRI, KarnalPhysical properties <strong>of</strong> foods are manifestations <strong>of</strong> its inherent compositional make up <strong>and</strong> structuralorganization <strong>of</strong> its molecules. While the intrinsic properties <strong>of</strong> the foods are largely determined byfactors controlled by the material itself, the extrinsic factors are influenced by external conditions. Thecomposition <strong>of</strong> foods could be determined by either genetically or technologically induced factors.The physical properties <strong>of</strong> milk components affect the functional properties <strong>of</strong> the processed foods<strong>and</strong> are therefore <strong>of</strong> significant importance with regard to new product development or selection<strong>of</strong> new processing technologies for designing a new product formulation or packaging condition.The principal physical properties <strong>of</strong> processed dairy foods could include rheology, color, <strong>and</strong> wateractivity.Viscosity:Texture <strong>and</strong> rheology are two important physical properties <strong>of</strong> foods. While texture refers to sensoryperception <strong>of</strong> the force-deformation relationship, rheology generally refers to response <strong>of</strong> foods asexemplified by flow properties to application <strong>of</strong> definite stress or strain. Therefore instrumental datacan be usefully related to sensory data for interpreting the consumer assessment <strong>of</strong> the sensory quality<strong>of</strong> a product. Instrumental data can be alternatively also used for designing equipments, packagingrequirements, processing conditions <strong>and</strong> evaluation <strong>of</strong> the finished product quality.Instrumental methods measuring rheology can be classified as (i) empirical or (ii) fundamentalmethods based on the test conditions in relation to the applied force <strong>and</strong> the resulting deformation(or flow) coupled with the sample geometry. The empirical methods represent large-deformationdata (destructive tests) generated under specified test conditions <strong>and</strong> are highly product-specific. Thedata generated are useful when a comparison is to be made between different products tested underidentical test conditions. Therefore these data are relevant when effect <strong>of</strong> processing variables or storageconditions on the rheological properties is to be evaluated <strong>and</strong> are also appropriate for quality testscarried out routinely. On the other h<strong>and</strong> the fundamental methods are based on small deformations(non-destructive tests) <strong>and</strong> the data are generated in well defined (physical or engineering) units<strong>of</strong> mechanical properties viz., viscosity for fluids <strong>and</strong> various modulii for solids. The results areindependent <strong>of</strong> the test conditions <strong>and</strong> appropriate for engineering design considerations. However,rheological parameters measured using fundamental methods are relevant to pure engineeringmaterials rather than complex materials such as foods. Furthermore, while the fundamental rheologicalmeasurements are made in a compression, tension, torsion or shear mode, empirical methods makemeasurements in terms <strong>of</strong> penetration, extrusion, pressing etc.Liquid foods are <strong>of</strong>ten characterized in terms <strong>of</strong> viscosity. The rheological behavior <strong>of</strong> fluids maybe Newtonian, pseudoplastic, or Bingham, depending upon the manner in which shear stress varieswith shear rate <strong>and</strong> time (Fig. 1). While the Newtonian fluids exhibit a viscosity which does not varywith the shear rate, the viscosity <strong>of</strong> non-Newtonian foods is shear-dependent. Non-Newtonian foodsare hence classified as either shear-thinning type (decreasing viscosity with increasing shear rate) orshear-thickening (dilatant) type (viscosity increases with increasing shear rate), the former being mostcommon to fluid foods. For example, milk with 30% or more total solids is shear-thinning. Alternately,a series <strong>of</strong> measurements may be made on a non-Newtonian product using a range <strong>of</strong> shear rates <strong>and</strong>the stress-shear rate relationship from the set <strong>of</strong> data generated expressed in terms <strong>of</strong> parameters <strong>of</strong> anappropriate mathematical expression, such as ‘consistency coefficient’ <strong>and</strong> ‘flow behaviour index’ inthe most frequently used ‘power law’ model.160


Physical Characterization <strong>of</strong> <strong>Dairy</strong> Foods with Reference to Viscosity, Colour <strong>and</strong> Water Activityη=K.γ n-1Where η=viscosity, γ= shear rate, K=consistency co-efficient <strong>and</strong> n=flow behaviour indexPseudoplastic fluids which exhibit shearthinning are the most common among the non-Newtonian fluids <strong>and</strong> include emulsions <strong>and</strong> manytypes <strong>of</strong> dispersions (Fig. 2). Dilatant fluids containhigher levels <strong>of</strong> deflocculated solids such as cornstarch in water. Plastic fluids behave as a solid whenstatic <strong>and</strong> flow only upon application <strong>of</strong> certainamount <strong>of</strong> force referred as yield value. Tomatoketch up is a good example <strong>of</strong> such fluids. Plasticfluids may display Newtonian, pseudoplastic ordilatant properties. Many high viscosity fluidsexhibit thixotrophic behaviour which impliesthat the viscosity drops even at constant shearrate as a result <strong>of</strong> structural breakdown <strong>of</strong> foodcomponents until a point when it attains a constantFig. 1. Typical time independent fluids curvesvalue. Subsequently upon quiescent storage <strong>of</strong>such fluids, structure rebuilds <strong>and</strong> the viscosityis restored to a limited extent generally below theoriginal value. Rheopexy fluids which are rarelyencountered behave opposite to thixotrophya n dviscosity increases with time when it is shearedat constant rate. In many cases both rheopexya n dthixotrophy may occur in combination with any o fthe flow behaviours described above. Howevertimeis a critical factor when shear rate is constant<strong>and</strong> therefore while some fluids may take onlyf e wseconds for the viscosity to become constant,othermay take much longer time. Most pseudoplasticliquidfoods follow the power law but the value <strong>of</strong>t h eexponent, which reflects the extent <strong>of</strong> digression from Newtonian flow, has not been determined for manydairy <strong>and</strong> food components. These flow properties Fig 2. Rheogram <strong>of</strong> pseudoplastic fluids<strong>of</strong> these fluid foods affect the mouthfeel <strong>and</strong>therefore are very important in determining the acceptability <strong>of</strong> food.Colour:Colour is another important physical parameter that is important from the point <strong>of</strong> view <strong>of</strong>characterizing the dairy products. This is also an indicator <strong>of</strong> chemical reactions that occur leading t<strong>of</strong>ormation <strong>of</strong> chemical compounds during processing or subsequent storage <strong>of</strong> the processed foods.These compounds are generally absent or are present in negligible quantities in the raw products <strong>and</strong>are formed when these are thermally processed. Therefore <strong>of</strong>ten the formation <strong>of</strong> these compoundsis linked to measurement <strong>of</strong> severity <strong>of</strong> heat treatment. Storage induced enzymatic or non-enzymaticchanges are also associated with formation <strong>of</strong> compounds that lead to change in the colour pr<strong>of</strong>ile <strong>of</strong>the products. Color measurement techniques are used for recording desirable color changes in canningsalmon with higher oil content, defining translucency <strong>of</strong> the tissues <strong>and</strong> green pigment degradationafter blanching treatment <strong>of</strong> green peas, studying browning kinetics, or determining the influence <strong>of</strong>particle sizes in the final color <strong>of</strong> powders. Characterization <strong>of</strong> the color <strong>of</strong> ingredients can also help topredict the color <strong>of</strong> the final product—for example, control <strong>of</strong> raw strawberries for processing into jam.In red wine, the percentage <strong>of</strong> brown component <strong>and</strong> the relative loss <strong>of</strong> anthocyanin can be followedby reflectance measurement during storage.161


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceThe color <strong>of</strong> foods as perceived by the human eye is related to the factors such as the spectralcomposition <strong>of</strong> the source <strong>of</strong> light, the food properties, <strong>and</strong> the spectral sensitivity properties <strong>of</strong> the eye.Therefore instrumental measurement <strong>of</strong> colour <strong>of</strong> any food requires that at least two <strong>of</strong> these factors arest<strong>and</strong>ardized. As such the human eye can give fairly good estimate <strong>of</strong> the colour properties <strong>of</strong> the foodhowever replacing it with instrumental sensor or photocell is known to give a more consistent <strong>and</strong>reproducible measure <strong>of</strong> this attribute. Early instrumental methods for color measurement were basedon transmission, or reflection, spectrophotometry. However modern system <strong>of</strong> color measurement isbased on CIE, Munsell, Hunter, <strong>and</strong> Lovibond systems. The important factors in these systems aresource <strong>of</strong> light, geometry <strong>of</strong> viewing, <strong>and</strong> background colour. Colour may be specified in terms <strong>of</strong>three characteristics <strong>of</strong> light: Hue, saturation <strong>and</strong> brightness. Hue represents dominant wave-length ina mixture <strong>of</strong> light waves <strong>and</strong> therefore relates to the dominant color as perceived by the eye. Saturationmeasures relative purity or the amount <strong>of</strong> white light whereas brightness refers to chromaticity <strong>of</strong> theintensity. Hue <strong>and</strong> saturation are together called chromaticity.In CIE system, spectral curves as illustrated in Fig. 3 indicate the response <strong>of</strong> observers eyes tovarious spectral light types in the visible portion <strong>of</strong> the spectrum. It demonstrates that any colourcan be matched by mixing different proportion <strong>of</strong> red, green, <strong>and</strong> blue. These primary combinationsare called tristimulus values <strong>of</strong> color. The definite colour <strong>of</strong> an object can be thus defined in terms <strong>of</strong>chromacity coordinates x <strong>and</strong> y, <strong>and</strong> by the luminous transmittance or lightness. A chromacity diagramdefines different color points that define the st<strong>and</strong>ard color<strong>of</strong> a food. The Munsell system (Fig. 4) describes all colorsby three attributes: hue (or type <strong>of</strong> color), lightness (relativeto the proportion <strong>of</strong> light emitted), <strong>and</strong> saturation or purity(associated with clear to dark perception). The hue scale hasten hues distributed on a circumference (scaled 1 to 10); thelightness ranges from black to white (0 to 10) <strong>and</strong> is distributedon a perpendicular line; the purity is <strong>of</strong> irregular lengthbeginning with 0 for the central gray to the limit <strong>of</strong> purityobtainable by available pigments in the Munsell book <strong>of</strong> color.The Hunter system is also a three-dimensional system usingparameters L*, a*, <strong>and</strong> b* in each dimension: L* is the lightness(nonlinear), a* is redness or greenness, <strong>and</strong> b* is yellownessor blueness. Combination <strong>of</strong> L*, a*, <strong>and</strong> b* can be convertedto a single color. The Lovibond system is generally used fordetermining the color <strong>of</strong> vegetable oils. It makes comparison Fig. 3 CIE color system<strong>of</strong> visual light transmitted through a glass couvette usingcolor filters. The oil samples oils are generally expressed interms <strong>of</strong> red to yellow. The Lovibond index are also used tomeasure color in wines <strong>and</strong> juices. Modern instruments uses<strong>of</strong>tware to convert light transition spectra into CIE, Munsell,Hunter, <strong>and</strong> Lovibond color indices.Color can be measuredinstrumentally with Colorimeters are also frequently used tomeasure colour <strong>and</strong> can be broadly classified as tristimuluscolorimeters <strong>and</strong> spectrophotometers. The difference betweenspectrophotometers <strong>and</strong> colorimeters is that the formermeasures intensity <strong>of</strong> light through the completely visiblespectrum, <strong>and</strong> colorimeters are designed to measure onlysome parameters related to sensory colors. Colorimeters areparticularly suitable for quality control <strong>of</strong> foods, <strong>and</strong> giveresults correlated with visual measurements.Fig. 4. Munshell colour system162


Physical Characterization <strong>of</strong> <strong>Dairy</strong> Foods with Reference to Viscosity, Colour <strong>and</strong> Water ActivityWater activity:The water activity <strong>of</strong> food can be conveniently expressed as the equilibrium water vapour pressure(P W) over the food system divided by the vapour pressure <strong>of</strong> pure water (Pow) at the same temperature<strong>and</strong> atmospheric pressure:The water activity is correlated to the moisture content <strong>of</strong> foods. This relationship is known as watersorpition isotherm. The water sorption isotherm for most <strong>of</strong> the food products is sigmoid in shape. Itcan be divided into segments representing the aw ranges in which the three principal types <strong>of</strong> waterbinding predominates. The region lying between aw value <strong>of</strong> 0 <strong>and</strong> 0.25 is believed to be dominatedby water bound by ionic groups such as NH3 associated withproteins <strong>and</strong> -COO- groups associated with proteins, pectins<strong>and</strong> other polyuronic acids. The moisture in this region istightly bound (known as monolayer moisture), which isgenerally not available for either chemical or microbiologicalactivities. The region lying between aw values <strong>of</strong> 0.25 <strong>and</strong> 0.75appears to be related primarily to covalently bound water, suchas amide groups in proteins <strong>and</strong> -OH groups in proteins <strong>and</strong>carbohydrate polymers such as pectins, starch, hemicellulose<strong>and</strong> cellulose. In this region, water is bound sufficientlytightly that it is unavailable to most <strong>of</strong> the microorganisms butavailable for chemical activity. The region lying between awvalues <strong>of</strong> 0.75 <strong>and</strong> 1.0 is believed to represent water multilayerson protein <strong>and</strong> carbohydrate polymers, in addition to waterin which the vapour pressure is reduced by dissolved solutes,such as free amino-acids, sugars, <strong>and</strong>/or capillary attraction inthe microstructure.The water in this region is loosely bound<strong>and</strong> is available for chemical <strong>and</strong> microbial activities. The wateractivity <strong>of</strong> various dairy products is presented in Table 1.Table 1. Approximate a wlevels<strong>of</strong> some dairy productsPRODUCT a Wat 25°CDried Milk <strong>Products</strong> 0.1-0.3Butter, Unsalted >0.99Salted 0.91-0.93Sweetened Condensed Milk 0.77-0.85Cheese, Hard 0.86-0.97S<strong>of</strong>t 0.96-0.98Fresh 0.98-0.99Cream >0.99Frozen Desserts 0.98-0.99Fermented Milk <strong>Products</strong> 0.97-0.99Milk And Whey 1Khoa 0.96Paneer >0.99Fried Paneer 0.97Information on water binding is helpful in determining the energy requirements <strong>and</strong> conditionsfor drying <strong>of</strong> specific materials; controlling the growth <strong>of</strong> microorganisms to minimize qualitydeterioration; ensure safety, <strong>and</strong> selecting the appropriate micr<strong>of</strong>lora in certain foods, e.g. ripeningcheese; for evaluation <strong>of</strong> water uptake, porosity, sorption/desorption enthalpies; estimation <strong>of</strong> specificsurface area, crystalline state <strong>of</strong> components (lactose), <strong>and</strong> facilitating control <strong>of</strong> several chemical,physical <strong>and</strong> quality attributes <strong>of</strong> stored foods in addition to ensuring microbial stability. Besidesdeterminant role played by aw in influencing the stability <strong>of</strong> quality parameters, aw has many otherpractical applications such as prediction <strong>of</strong> packaged product moisture gain/loss <strong>and</strong> prediction <strong>of</strong>shelf-life <strong>of</strong> packed food.Measurement <strong>of</strong> water activity: Analytical instruments or methods for aw value determinationare many. The important ones are: Hair hygrometers, Isopiestic methods, Electronic hygrometersetc.Hair Hygrometry: Measurements is based on the magnitude <strong>of</strong> longitudinal change in length <strong>of</strong>water-sorbing fibre in the same container at equilibrium. This measurement is based on the principlethat the keratinaceous proteins in hair str<strong>and</strong>s stretch under tension, when they absorb moisture. Ifthe hair str<strong>and</strong> is fixed at one end <strong>and</strong> attached to an indicating lever arm at the other end, the relativehumidity within an enclosure can be read directly. The hair hygrometer is a dial-type polyamidethread hygrometer. This type <strong>of</strong> hygrometer is relatively inexpensive. Its accuracy is comparable toothers (i.e. + 0.02 upto 0.01).163


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceIsopiestic Methods: This method provides the measurement <strong>of</strong> equilibrium relative humidity <strong>of</strong>any aqueous systems in a closed container at a specified temperature. This is based on a principlethat most food substances are consistently adjusting their moisture content through absorption ordesorption processes depending upon the moisture condition <strong>and</strong> temperature <strong>of</strong> the environmentuntil the food substances approach equilibrium. In other words, the equilibrium vapour pressure <strong>of</strong>the reference salt slush will be identical to the vapour pressure <strong>of</strong> the sample at equilibrium condition.In this method, multiple samples must be measured at different equilibrium conditions using differentsalt slushes in desiccators. Upon equilibrium the sorption isotherm is drawn <strong>and</strong> the aw is measuredagainst moisture content <strong>of</strong> the food.Electronic Hygrometers: This type <strong>of</strong> instrument features the use <strong>of</strong> calibrated aluminium oxideor lithium chloride humidity sensors. Recalibration or st<strong>and</strong>ardization <strong>of</strong> sensor response is by a set <strong>of</strong>reference salt slushes. Water activity measurement is carried out by connecting the appropriate sensorto an airtight food sample container <strong>and</strong> equlibrated at a specified temperature. Since the sensoris sealed in a small container, it usually takes less than 2 hr for a sample to approach equilibriumconditions. These instruments provide a better <strong>and</strong> convenient means <strong>of</strong> a wmeasurement withadequate accuracy <strong>and</strong> precision. However, they are susceptible to contaminants such as SO 2, H 2S,Chlorine <strong>and</strong> oil vapours. Temporary contaminants include ammonia, acetic acid, alcohols, glycol,glycerols, etc. depending upon the sensor material used. Foods usually contain these contaminants,thereby reducing the useful life <strong>of</strong> the sensors.The instrument using principle <strong>of</strong> chilled mirror dew point measurement to calculate aw <strong>of</strong> a givenfood sample is one <strong>of</strong> the frequently used systems. When a sample is placed in the instrument, a stainlesssteel mirror within the chamber is repeatedly cooled <strong>and</strong> heated. The mirror temperature is controlled bya thermoelectric (Peltier) cooler. A fan placed in the instrument continually circulates air in the sensingchamber to hasten the equilibration process. The precise determination <strong>of</strong> the temperature at whichthe condensation first appears is done with a photoelectric cell. The photodetector senses the changein reflectance when condensation occurs on the mirror. The temperature at which the condensationoccurs is recorded with the help <strong>of</strong> a thermocouple attached to the mirror. Simultaneously, the sampletemperature is also measured. Both the temperature <strong>of</strong> sample <strong>and</strong> the mirror temperature are usedfor calculating the a w. The a wis calculated <strong>and</strong> compared with the previous measurement <strong>and</strong> theprocess terminates with a beep only when two consecutive readings does not differ by more than0.001. The instrument thus displays the temperature <strong>of</strong> sample <strong>and</strong> a w.References:Sogi D. S (2008). Fundamentals <strong>of</strong> rheology. In compendium <strong>of</strong> the short course on “Sensory <strong>and</strong> related techniques forevaluation <strong>of</strong> dairy products” under Centre <strong>of</strong> Advanced studies held at Karnal from June 17-July 07, 2008214-220,pp.66-71.Rao M. A (2005) Rheological properties <strong>of</strong> liquid foods. In: Engineering properties <strong>of</strong> foods (Ed M. A. Rao, A. K. Datta<strong>and</strong> S. S. H. Rizvi) CRC Press, USA.Patil G. R. (2003) Water activity <strong>of</strong> foods in relation to packaging. In compendium <strong>of</strong> the short course on “Advancesin Packaging <strong>of</strong> <strong>Dairy</strong> <strong>and</strong> Food <strong>Products</strong>” under Centre <strong>of</strong> Advanced studies held at Karnal from February 13 –March 05, 2003, pp.66-71.Francis F J (2005) Color properties <strong>of</strong> foods. In: Engineering properties <strong>of</strong> foods (Ed M. A. Rao, A. K. Datta <strong>and</strong> S. S. H.Rizvi) CRC Press, USA.164


Malt Based Milk Foods as “<strong>Value</strong> <strong>Added</strong> Functional <strong>Dairy</strong> <strong>Products</strong>”Introduction:Malt Based Milk Foods as “<strong>Value</strong> <strong>Added</strong>Functional <strong>Dairy</strong> <strong>Products</strong>”Laxmana Naik, Rajan Sharma, Manju G. <strong>and</strong> Amit K. BaruiDariy Chemestry Division, NDRI, KarnalFood is a basic nutritional requirement, but as a result <strong>of</strong> subst<strong>and</strong>ard diet, approximately 925million people are suffering from undernutrition in different regions <strong>of</strong> the world. Consequently alarger population in the underdeveloped world fall prey to the protein deficiency On the other h<strong>and</strong>busy lifestyles fragmented eating habits, change in consumer perception towards physical appearance,dietary choices <strong>and</strong> more importantly dem<strong>and</strong>ing an ideal wholesome food that address many diet <strong>and</strong>health related issues. Thus there is a need for developing a value added nutritional food supplement.Much <strong>of</strong> scientific evidence has shown that there is a strong positive relationship between consumedfoods <strong>and</strong> human health, <strong>and</strong> that there is a beneficial correlation between the function <strong>of</strong> variousfood components to the treatment <strong>and</strong> prevention <strong>of</strong> specific illnesses. Therefore, consumer interesthas focused on a diet with the capability to promote good health <strong>and</strong> to extend a healthy life span, thisstrongly promoted in the functional foods development.What makes a Functional food <strong>and</strong> what is the best source?Functional foods may be defined as any food, in a natural or processed form, that contains, inaddition to its nutritional components, substances which favor the good health, physical capacity <strong>and</strong>mental wellbeing <strong>of</strong> an individual. (Vasconcelles, 2001). Most <strong>of</strong> the individual foods are deficient in oneor other type <strong>of</strong> constituents which are very essential to human health. To prepare a diet nutritionallycomplete it is essential to make a complement <strong>of</strong> two or more foods which synergistically makeup thedeficiency <strong>of</strong> each other. Milk is an ideal food but milk proteins are deficient in sulfur containing aminoacids like methionine <strong>and</strong> cystein. Cereals on the other h<strong>and</strong> are generally deficient in lysine, threonine<strong>and</strong> tryptophan. Thus in order to develop a balanced food cereal protein should be supplemented withmilk protein. Nutritional merits <strong>of</strong> milk are well acclaimed. The malted barley is rich source <strong>of</strong> readilydigestible carbohydrates, proteins <strong>and</strong> provides a carbohydrate splitting α-amylase enzyme whichhydrolyses the insoluble starch ingredients into readily soluble sugars like maltose, dextrose, glucoseetc. This is also a good source <strong>of</strong> soluble fiber like β-Glucans <strong>and</strong> other health-promoting components.Recently U.S. Food <strong>and</strong> Drug Administration finalized a rule that allows foods containing barley tocarry a claim that they may reduce the risk <strong>of</strong> coronary heart disease. Hence special supplement <strong>and</strong>enrichment is made by use <strong>of</strong> milk <strong>and</strong> malted barely. These major ingredients synergistically fulfillmost <strong>of</strong> the nutritional <strong>and</strong> technological requirements in making an ideal wholesome food.Malt based milk foods fall in the category <strong>of</strong> nutritional functional health foods, these are preparedby a mixture consisting <strong>of</strong> st<strong>and</strong>ardized milk or milk solids with the fluid separated from the mash <strong>of</strong>ground barley malt. Depending on the intended use these foods are prepared either in liquid form fordirect consumptions or in dried powdered form to be use as an ingredient for reconstitution <strong>and</strong> sometimes a base material for other food recipe.Historical background <strong>of</strong> Malted Milk:In 1878 William Horlick <strong>and</strong> James Horlick, brothers, established a Horlick Food plant in theoutskirts <strong>of</strong> Racine, Wisconsin USA. They began to manufacture a product known as Horlick’s Foodby enriching milk with malted barley, they under took a research on this product at the request <strong>of</strong>some physician who wanted to have an infant food combining milk <strong>and</strong> cereal, First successful maltedmilk food was developed in 1883 <strong>and</strong> the product commercially marketed in 1887. This productgained favorable attention from the medicinal pr<strong>of</strong>essionals <strong>and</strong> public due to its nutritional value,convenience, digestibility <strong>and</strong> palatability.165


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceMyth about Malted Barley:Barley is one <strong>of</strong> the seven internationally grown cereal grains, currently ranking fourth in worldproduction (FAO 2006). Belongs to the genus Hordeum <strong>and</strong> the major cultivated barley species isHordeum vulgare. Malted barley means the product obtained from soaking or steeping the wholebarley kernel followed by germination <strong>and</strong> drying in a controlled environment.What makes barley so special; Barley is a rich source <strong>of</strong> both soluble <strong>and</strong> insoluble fiber <strong>and</strong> it isone <strong>of</strong> the dieter’s delight” component. However, researchers have identified β-glucan as the primarycomponent in barley that is responsible for lowering cholesterol. Based on scientific evidence, the Food<strong>and</strong> Drug Administration (FDA) finalized a rule in 2006 allowing barley foods to carry a health claimspecific to soluble fiber <strong>and</strong> relating to both for reducing cardiovascular disease risk <strong>and</strong> modifyingglycemic responses for treatment <strong>and</strong> prevention <strong>of</strong> diabetes (Lazaridou <strong>and</strong> Biliaderis 2007).Qualifying products may use the following claim: “Soluble fiber from foods such as [name <strong>of</strong>food], as part <strong>of</strong> a diet low in saturated fat <strong>and</strong> cholesterol, may reduce the risk <strong>of</strong> heart disease. Aserving <strong>of</strong> [name <strong>of</strong> food] supplies [x] grams <strong>of</strong> the soluble fiber necessary per day to have this effect.”Specifically, a food made from eligible barley sources must contain at least 0.75 g <strong>of</strong> β-glucan (solublefiber) per serving (FDA 2006).Malt based milk food: DefinationDefined as “Malt based milk food means the product obtained by mixing whole milk, partlyskimmed milk or milk powder with the wort separately from a mash <strong>of</strong> ground barley malt, anyother malted cereal grain <strong>and</strong> wheat flour or any other cereal flour or malt extract with or withoutaddition <strong>of</strong> flavouring agents <strong>and</strong> spices, emulsifying agents, eggs, protein isolates, edible commonsalt, sodium or potassium bicarbonate, minerals <strong>and</strong> vitamins <strong>and</strong> without added sugar in such amanner as to secure complete hydrolysis <strong>of</strong> starchy material <strong>and</strong> prepared in a powder or granule orflake form by roller drying, spray drying, vacuum drying or by any other process. It may contain cocoapowder. It shall be free from dirt <strong>and</strong> other extraneous matter. It shall not contain any added starch(except starch natural to cocoa powder) <strong>and</strong> added non-milk fat. It shall not contain any preservativeor added colour. Malted milk food containing cocoa powder may contain added sugar” (PFA 1955).The requirements according to PFA 1955 <strong>and</strong> Bureau <strong>of</strong> Indian St<strong>and</strong>ards (IS-1806-1975) itshall confirm the fallowing st<strong>and</strong>ards.Characteristics166Malted Milk Food withoutCocoa powderMalted Milk Food with CocoapowderMoisture, % by mass Not More Than 5.0 Not More Than 5.0Total Protein (Nx6.25), % by weight Not Less Than12.5 Not Less Than 11.25Fat, % by weight Not Less Than7.5 Not Less Than 6.0Total Ash, % , dry basis Not More Than 5.0 Not More Than 5.0Acid Insoluble ash, in Dilute HCl, % Not More Than 0.1 Not More Than 0.1Alcoholic Acidity, % H 2SO 4in 90% alcohol Not More Than 0.3 Not More Than 0.3Solubility, % by weight Not Less Than 85.0 Not Less Than 85.0Cocoa Powder, % dry basis N/A* Not Less Than 5.0Test for Starch Negative N/A*Bacterial Count, Per gram Not More Than 50000 Not More Than 50000Coliform Count, Per gram Not More Than 10 Not More Than 10Yeast <strong>and</strong> Mold Count, per gram Not More Than 100 Not More Than 100Salmonella <strong>and</strong> Shigella Absent in 25 gm Absent in 25 gmE. Coli Absent in 10.0 gm Absent in 10.0 gmVibrio cholera <strong>and</strong> V. paraheamolyticus Absent in 0.1 gm Absent in 0.1 gmFaecal streptococci <strong>and</strong> StaphylococcusAbsent in 0.1 gmAbsent in 0.1 gmaureas* N/A: Not applicable.


Malt Based Milk Foods as “<strong>Value</strong> <strong>Added</strong> Functional <strong>Dairy</strong> <strong>Products</strong>”Basic Ingredients <strong>of</strong> malted dairy foods:1.2.3.4.Malted Barley: Provide appropriate levels <strong>of</strong> α-amylase enzyme required to convert all the starchinto simple sugars <strong>and</strong> also imparts typical malty flavor to the finished product.Malt Extract: This is a concentrated extract from roasted malted barley with a solid <strong>of</strong>approximately 80 per cent, imparts desired level <strong>of</strong> colour <strong>and</strong> typical caramelized flavor.Milk <strong>and</strong> Milk solids: Enhance nutritional value <strong>of</strong> the product by providing high quality protein,vitamins, minerals <strong>and</strong> milk fat provides unique flavor.Wheat flour, wheat gluten, isolated soy protein, malto dextrin, vitamin premixes, salts <strong>and</strong> othermicro ingredients are supplemented to improve the nutritional requirement, provide optimumpH for better digestibility, enhancing flavor <strong>and</strong> for value addition.Method <strong>of</strong> Preparation:In the manufacturing <strong>of</strong> malt based milk food (Figure 1) mashing is the first step fallowed bymix preparation, pasteurization <strong>of</strong> mix <strong>and</strong> concentration <strong>of</strong> mix in first stage up to 50 per cent solidsthen this base material can be directly spray dried or further concentrated up to 80 per cent solids inmultiple effect evaporator then vacuum oven dried or either b<strong>and</strong> dried (Dhillon, 2005).Figure 1: Flow chart for production <strong>of</strong> malt based milk food.167


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assurance<strong>Quality</strong> related Issues:<strong>Quality</strong> related issue either <strong>of</strong> physical, chemical or microbiological problems hampersmanufacturing <strong>and</strong> business performance <strong>and</strong> ultimately to the safety <strong>of</strong> consumer health. Hence itis very much essential to address at the root level. Critical to quality issue arises mainly due to 5 Mfactors; these are Man, Machine, Methods <strong>of</strong> preparation, Materials quality <strong>and</strong> Mother nature <strong>of</strong>products. It is <strong>of</strong>ten overlooked fact that just about every food item we eat is biological in origin,consumer expect our food should to be fresh, wholesome, <strong>and</strong> not to contain any unnecessary addedadditives. In ordered to preserve food from microbes; processing at high temperature is essential butleads to loss <strong>of</strong> nutritional <strong>and</strong> volatile compounds, hence it is optimally processed so that nutritionalidentity is retained but many <strong>of</strong> these components are very heat sensitive, creates problem duringprocessing, major bottleneck are their bioactivity will diminishes <strong>and</strong> loss <strong>of</strong> volatile aroma compoundsbut fortification in final stage is possible. Encapsulation <strong>of</strong> sensitive ingredients helps in protectingfrom thermal shock.Functional ingredients <strong>and</strong> Health benefits <strong>of</strong> malted milk foods:Malted barley has received attention from health pr<strong>of</strong>essionals hence barley is used as the maincereal grain for the development <strong>of</strong> functional foods, as it contains two classes <strong>of</strong> compounds <strong>of</strong> strongnutritional interest: β-glucans (dietary fiber) <strong>and</strong> tocols (antioxidant - vitamin E).Dietary fibers, such as β-glucans, are defined as the edible parts <strong>of</strong> plants <strong>and</strong> analogouscarbohydrates that are resistant to digestion <strong>and</strong> absorption in the human small intestine with completeor partial fermentation in the large intestine. Dietary fiber includes polysaccharides, oligosaccharides,lignin, <strong>and</strong> associated plant substances (AACC 2001). A diet rich in fiber has health benefits includinglowered energy density, prolonged satiety, <strong>and</strong> effects related to an increase in fecal bulk. Foodscontaining soluble dietary fiber have been shown to lower serum cholesterol levels, postpr<strong>and</strong>ialblood glucose, <strong>and</strong> insulin response (Jenkins et al., 2000).There are three mechanisms for barley’s hypocholesterolemic effects are: (1) reduced absorption<strong>of</strong> dietary lipids including cholesterol; (2) reduced absorption <strong>of</strong> bile acids; <strong>and</strong> (3) production <strong>of</strong>volatile fatty acids in the large intestine that are reabsorbed, <strong>and</strong> act as inhibitors <strong>of</strong> β-hydroxy-βmethylglutaril coenzyme A (HMG-CoA) reductase in the liver (McIntosh <strong>and</strong> Oakenfull 1990).It is important for diabetics to know the glycemic potential <strong>of</strong> food carbohydrates. The glycemicindex (GI) is a powerful method for nutritional characterization <strong>of</strong> carbohydrates <strong>and</strong> has beenproposed to diabetic subjects as a tool for managing their diet. Epidemiological data indicates that adiet characterized by a low GI reduces insulin resistance <strong>and</strong> improves certain metabolic consequences<strong>of</strong> insulin resistance. This suggests a potential role against both the development <strong>of</strong> non-insulindependentdiabetes mellitus (NIDDM) <strong>and</strong> cardiovascular diseases (Björck et al., 2000).Tocols (tocopherols <strong>and</strong> tocotrienols) are well recognized for their biological effects, includingantioxidant activity (Kamal-Eldin <strong>and</strong> Appelvist 1996) <strong>and</strong> reduction <strong>of</strong> serum LDL-cholesterol.While tocopherols, mainly α-tocopherol, are considered to have the greater biological activity,tocotrienols have been the focus <strong>of</strong> growing research interest as unique nutritional compounds fortheir hypocholesterolemic action. Among the four tocotrienol isomers, γ-tocotrienol <strong>and</strong> δ-tocotrienolseem to be more effective than α-tocotrienol. Tocotrienols are reported to be capable <strong>of</strong> reducingserum LDL-cholesterol in chickens, swine, <strong>and</strong> human subjects. They may act as inhibitors <strong>of</strong> theHMG-CoA reductase, a rate-limiting enzyme <strong>of</strong> cholesterol biosynthesis (Qureshi et al., 1991). Somestudies indicate that the antioxidant potential <strong>of</strong> tocotrienols is even greater than that <strong>of</strong> α-tocopherolin certain types <strong>of</strong> fatty cell membranes <strong>and</strong> in some brain cells. Moreover, recent studies suggestthat tocotrienols may affect the growth <strong>and</strong>/or proliferation <strong>of</strong> several types <strong>of</strong> human cancer cells(Nesaretnam et al., 1998).168


Malt Based Milk Foods as “<strong>Value</strong> <strong>Added</strong> Functional <strong>Dairy</strong> <strong>Products</strong>”Conclusion:There is no room for second thought to it that food is going to be a medicine, consumersdem<strong>and</strong>ing that they need a food which can overcome all the health related risk. Opportunities beforethe technologist is that formulation <strong>and</strong> design <strong>of</strong> a product containing bioactive substances, but many<strong>of</strong> these components are very heat sensitive, creates problem during processing, major bottleneckare their bioactivity will diminishes <strong>and</strong> loss <strong>of</strong> volatile aroma compounds. Some efforts are madelike; Probiotic malted milk made by encapsulation <strong>of</strong> probiotics <strong>and</strong> subsequent drying. At presentIndian malted milk industry growing at a rate <strong>of</strong> 8 to10 per cent, because <strong>of</strong> marketing strategy <strong>and</strong>advertising, br<strong>and</strong> image, the health claims, variants, ease <strong>of</strong> convenience.References:1. AACC (American Association <strong>of</strong> Cereal Chemists). 2001. The definition <strong>of</strong> dietary fiber. AACC Report., 46:3,112-126.2. Baldwin, A.J., Baucke, A.G. <strong>and</strong> S<strong>and</strong>erson, W. B. 1980. New Zeal<strong>and</strong> J. <strong>Dairy</strong> Sci.Tec., 15: 286.3. Björck, I., Liljeberg, H. <strong>and</strong> Ostman, E. 2000. Low glycemic-index foods. British Journal. <strong>of</strong> Nutrition., 83:149-155.4. Dhillon, L.S. 2005. Manufacturing <strong>of</strong> malt based food products. Ind. <strong>Dairy</strong>man., 57:4, 59-66.5. FAO. 2006. World crop production. Published online at http://www.faostat.fao.org.6. FDA (U.S. Food <strong>and</strong> Drug Administratin). 2006. Food labeling: health claims; soluble dietary fiber from certainfoods <strong>and</strong> coronary heart disease. Fed. Reg. 71:29248–29250.7. Food Safety <strong>and</strong> St<strong>and</strong>ards Regulations, 2010. Final Regulations H<strong>and</strong> Book, 349-351.8. Jenkins, D.J.A., Axelsen, M., Kendall, C.W.C., Augustin, L.S.A, Vuksan, V. <strong>and</strong> Smith, U.2000. Dietary fibre, lentecarbohydrates <strong>and</strong> the insulin-resistant diseases. British Journal <strong>of</strong> Nutrition., 83:S1,157-163.9. Kamal-Eldin, K. <strong>and</strong> Appelqvist, L.A. 1996. The chemistry <strong>and</strong> antioxidant properties <strong>of</strong> tocopherols <strong>and</strong>tocotrienols. Lipids., 31:7, 671-701.10. Lazaridou <strong>and</strong> Biliaderis. 2007. Barley products to carry heart health claim. Food Navigator-USA. Published onlineat http://www.foodnavigator-usa.com.11. McIntosh, G.H. <strong>and</strong> Oakenfull, D. 1990. Possible health benefits from barley grain. Chemistry in Australia., 57: 294-296.12. Nesaretnam, K., Stephen, R. Dils, R <strong>and</strong> Dabre, P. 1998. Tocotrienols inhibit the growth <strong>of</strong> breast cancer cells,irrespective <strong>of</strong> estrogen status. Lipids., 33: 461-469.13. PFA. 1955. The Prevention <strong>of</strong> Food Adulteration Act & Rules H<strong>and</strong> Book, as on 1.10.2004. 329-330.14. Qureshi, A.A., Qureshi, N. Wright, J.J. Shen, Z. Kramer, G. Gapor, A. Chong, Y.H. DeWitt, G. Ong, A. <strong>and</strong>Peterson, D.M. 1991. Lowering serum cholesterol in hypocholesterolemic humans by tocotrienols. The AmericanJournal <strong>of</strong> Clinical Nutrition., 53: 1021s-1026s.15. Rosemary, K. N <strong>and</strong> Walter, C.N. 2008. Text Book <strong>of</strong>: Barley for Food <strong>and</strong> Health: Science, Technology, <strong>and</strong> <strong>Products</strong>.John Wiley & Sons Inc. pub.16. Salooja, M. K <strong>and</strong> Balach<strong>and</strong>ran, R. 1988. Physical properties <strong>of</strong> spray dried malted milk powder, Ind. J. <strong>of</strong> <strong>Dairy</strong>Sci., 41:4, 456-461.17. The Hindu, 2010. U. N. Warns <strong>of</strong> food crisis. 15-09-2010, ISSN 0971-751X 133:220:9.18. Vasconcellos, J.A. 2001. Functional foods. Concepts <strong>and</strong> benefits. The World <strong>of</strong> Food Science.. www.worldfoodscience.org:80/vol.1_3/feature1-3b.html.169


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssurancePreparation <strong>and</strong> Characterization <strong>of</strong> GoldNanoparticles, <strong>Their</strong> Conjugation with Antibodies<strong>and</strong> Construction <strong>of</strong> Lateral Flow DevicesPriyanka Singh Rao 1 , Swapnil Sonar 2 , Y.S. Rajput 2 <strong>and</strong> Rajan Sharma 11<strong>Dairy</strong> Chemistry Division, 2 Animal Biochemistry Division, NDRI, KarnalLateral Flow Assays also known as Immunochromatographic assays are a simple device intendedto detect the presence (or absence) <strong>of</strong> a target analyte in sample (matrix). Traditionally designed assaysare composed <strong>of</strong> a variety <strong>of</strong> materials, each serving one or more purposes. Colloidal gold is the mostwidely used label today in commercial lateral flow immunoassays for many reasons. It is fairly easy <strong>and</strong>inexpensive to prepare in the laboratory. The color is intense, <strong>and</strong> no development process is neededfor visualization. A large body <strong>of</strong> protocols exist in the literature for its conjugation <strong>and</strong> application.Gold colloids are formed by the reduction <strong>of</strong> gold tetrachloric acid through a “nucleation” process.The size <strong>and</strong> shape <strong>of</strong> the colloids depend on the type <strong>and</strong> amount <strong>of</strong> reducer used. The label is verystable in liquid or dried form <strong>and</strong> is non-bleaching after staining on membranes. An accurate <strong>and</strong>reproducible lateral-flow assay requires the use <strong>of</strong> high-quality gold conjugates. Gold particles canbe produced that range in size from 5 to 100 nm in diameter. The most common size <strong>of</strong> colloidal goldparticle used is 40 nm. In addition, colloidal gold in unconjugated forms (which are ready for labeling)<strong>and</strong> conjugated forms (conjugated with biologicals) are now readily available from many commercialsources. In addition to the dry parts <strong>of</strong> a lateral-flow assay, there are also the biological components thatallow the visualization <strong>of</strong> the results. By virtue <strong>of</strong> their high levels <strong>of</strong> specificity <strong>and</strong> binding affinities,antibodies are the ideal choice <strong>of</strong> agent for detection. In Lateral Flow Assay an antibody molecule isconjugated to a colloidal gold particle. Antibodies can be polyclonal or monoclonal. Once the antibodyhas been conjugated, the quality <strong>of</strong> the gold conjugate must be assessed before incorporation into therapid-test assay. Usually, electron microscopy is employed as a quality-control measure. Conjugation<strong>of</strong> colloidal gold particles <strong>and</strong> antibodies depends on the availability <strong>and</strong> accessibility <strong>of</strong> three aminoacid residues—lysine, tryptophan, <strong>and</strong> cysteine. Once a high-quality antibody–gold conjugate isformed, it can be applied to the conjugate pad either by soaking or by spraying. The drying process thatfollows is essential. The lateral flow immunoassay devices are compact <strong>and</strong> easily portable. A test striptypically consists <strong>of</strong> a plastic backing holding together a sample pad for deposition <strong>of</strong> sample fluids,a conjugate pad pre treated with sample detection particles, a microporous membrane containingsample capturing reagents, <strong>and</strong> an absorbent pad at the distal end serving to collect excess fluids.A. Preparation <strong>of</strong> Gold Nano ParticleMaterial: All the chemicals required for the preparation for gold nanoparticles can be procuredfrom Sigma-Aldrich Ltd.Reagents:1. Stock gold chloride (tetrachloroauric acid trihydrate, Mol.Wt. 393.83; 200 mM) solution- 787.6mg <strong>of</strong> HAuCl 4.3H 2O is dissolved in Millipore water <strong>and</strong> volume is made up to 10 ml. The stocksolution is stored at room temperature.2. Working gold chloride solution (50 mM) - Stock gold chloride solution is diluted four times withMillipore water.3. Trisodium citrate dihydrate (38.8 mM; M.W. 294) - 114 mg <strong>of</strong> trisodium citrate dihydrate isdissolved in 10 ml Millipore water.Procedure:1. 1. Prepare aqua regia by mixing 3:1 concentrated HCl:HNO in a large beaker in a fume hood.3Be extremely careful when preparing <strong>and</strong> working with aqua regia. Wear goggles <strong>and</strong> gloves,170


Preparation <strong>and</strong> Characterization <strong>of</strong> Gold Nanoparticles, <strong>Their</strong> Conjugation with Antibodies <strong>and</strong> Construction <strong>of</strong> Lateral Flow Devices<strong>and</strong> perform the experiment in a fume hood. Aqua regia should be freshly prepared <strong>and</strong>should never be stored in a closed vessel. The capped aqua regia bottle may explode. Renderit safe by dilution <strong>and</strong> neutralization.2. Soak the 200 ml two-neck flask, magnetic stir bar, stopper <strong>and</strong> condenser in aqua regia for atleast 15 min. Rinse the glassware with copious amount <strong>of</strong> deionized water <strong>and</strong> then Milliporefilteredwater. Obtaining high-quality nanoparticles is the first important step towardsthe success <strong>of</strong> the experiment. Care should be taken to make sure that no contamination isintroduced during nanoparticle synthesis.3. Load 98 ml <strong>of</strong> Millipore water into the two-neck flask. Add 2 ml <strong>of</strong> 50 mM HAuCl solution so4that the final HAuCl 4concentration is 1 mM.4. Connect the condenser to one neck <strong>of</strong> the flask, <strong>and</strong> place the stopper in the other neck. Put theflask on the hot plate to reflux while stirring.5. When the solution begins to reflux, remove the stopper. Quickly add 10 ml <strong>of</strong> 38.8 mM sodiumcitrate, <strong>and</strong> replace the stopper. The color should change from pale yellow to deep red in 1min. Allow the system to reflux for another 20 min.6. Turn <strong>of</strong>f heating <strong>and</strong> allow the system to cool to room temperature (23–25°C) under stirring.B. Characterization <strong>of</strong> gold nanoparticlesThe diameter <strong>of</strong> such prepared nanoparticles is ~13 nm. The extinction value <strong>of</strong> the 520 nm plasmonpeak is 3.8, <strong>and</strong> the nanoparticle concentration is ~13 nM. The colour should be burgundy red, <strong>and</strong>the nanoparticle shape should be spherical under transmission electron microscopy (TEM). All goldsols display a single absorption peak in the visible range between 510 <strong>and</strong> 550 nm, <strong>and</strong> the absorptionmaximum shifts to a longer wavelength with increasing particle size. The relative uniformity <strong>of</strong> theparticles or the range <strong>of</strong> particles can be gauged by the width <strong>of</strong> the absorption spectra: the sharper theb<strong>and</strong>, the more uniform the particles. The relative concentration <strong>of</strong> each batch <strong>of</strong> colloidal gold can bedetermined by absorbance at 520 nm. Various batches can be brought to the same relative concentrationby the addition <strong>of</strong> de-ionized water.C. Labelling <strong>of</strong> gold nanoparticles with antibodyReagentsi. NaOH (0.2 N)ii. Carbonate Buffer (5 mM)iii. Tris-HCl buffer (pH 8.2) containing 1% BSA <strong>and</strong> 0.1 sodium azideProcedure: Adjust the pH <strong>of</strong> Gold nanoparticle using 0.2 N NaOH to 8.5. 6 µl (20 µg) <strong>of</strong> affinitypurified antibody (against glycomacropeptide) is diluted to 160 µl with carbonate buffer <strong>and</strong> added tonanoparticles. The mixture is incubated overnight at 4ºC. Centrifuge the contents at 7,000 rpm at 15ºCfor 15 minutes. Suspend the pellet in carbonate buffer <strong>and</strong> again centrifuge at 7,000 rpm at 15ºC for15 minutes. Decant the supernatant <strong>and</strong>dissolve the pellet in Tris-HCl buffer.Store the antibody labelled nanoparticlesat 4°C till further use.D. Construction <strong>and</strong> working<strong>of</strong> lateral flow stripMaterials: All the material requiredfor the construction <strong>of</strong> lateral flow strip,can be purchased from Milipore IndiaPvt. Ltd. Bangalore.Procedure: Lateral flow assays areSide view <strong>of</strong> test-strip construction171


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assurancecomposed <strong>of</strong> a variety <strong>of</strong> materials, each serving one or more purposes. The parts overlap onto oneanother <strong>and</strong> are mounted on a backing card using a pressure-sensitive adhesive. Each component <strong>of</strong> thetest, including membrane, backing substrate, <strong>and</strong> each <strong>of</strong> the pad materials, has a defined dimension. Onconjugation pad Gold nanoparticles are coated with antigen specific antibodies.Test line is also coatedwith the antigen specific antibody <strong>and</strong> Control line with species specific anti-antibody for the antibodyin the particulate conjugate.The sample is treated to make it compatible with the rest <strong>of</strong> the test. The treated sample migratesthrough this region to the conjugate pad, where a particulate conjugate has been immobilized. Thesample interacts with the conjugate as both migrate into the next section <strong>of</strong> the strip, which is themembrane. Excess reagents move past the capture lines <strong>and</strong> are entrapped in the wick or absorbentpad. The control line indicates that the test developed properly <strong>and</strong> test line indicates that the test ispositive.172


Use <strong>of</strong> Lateral Flow Technique for Detecting Melamine in MilkIntroductionUse <strong>of</strong> Lateral Flow Technique forDetecting Melamine in MilkRaman Seth <strong>and</strong> Anamika Dass<strong>Dairy</strong> Chemistry Division, NDRI, KarnalMonitoring <strong>of</strong> milk <strong>and</strong> milk product for quality <strong>and</strong> safety during entire food chain is <strong>of</strong> majorconcern to the food producers <strong>and</strong> to the consumers. In the present scenario, consumers always preferhigh quality <strong>and</strong> safe foods. <strong>Dairy</strong> industry always looks forward for innovative tests to access dairyproduct for their quality. Therefore a holistic approach for checking the quality <strong>of</strong> any food productis an essential requirement. The Indian dairy industry is passing through a phase <strong>of</strong> adulterationin milk <strong>and</strong> milk product. Poor quality raw milk is either neutralized or preserved with differentpreservatives. Recently the menace <strong>of</strong> melamine addition in milk powder in order to enhance its proteincontent has been reported in China which caused death <strong>of</strong> many infants. Nitrogenous compounds likeurea, ammonium salts can be detected by simple <strong>and</strong> rapid test but presence <strong>of</strong> melamine cannot bedetected by simple test. In recent years incidence <strong>of</strong> melamine addition in infant milk formula hasbeen reported in media especially in China.Melamine is a chemical used primarily for the production <strong>of</strong> melamine resins. Because <strong>of</strong> its highnitrogen level (66% by mass), melamine is illegally added to milk product especially to milk powderin order to compensate for protein content when estimated on the basis <strong>of</strong> total nitrogen. Ingestion <strong>of</strong>melamine at levels above the safe limit (2.5 ppm in the USA <strong>and</strong> 1 ppm in European Union for infantmilk powder) can induce renal failure <strong>and</strong> even death in infants. Melamine, a non protein nitrogensubstance when added to any food product increases the total nitrogen content. Adulteration <strong>of</strong> proteinrich foods with melamine increases the crude protein content .This reminds us the recent sc<strong>and</strong>alin China where attempts were made to increase the nitrogen content in infant food with melaminewhich accumulates in the body on feeding melamine contaminated milk <strong>and</strong> caused toxicity problem,there by forming solid stone deposit within kidneys or bladder which ultimately damage kidneys.Infants fed regularly with milk containing melamine were more susceptible to urinary infections.Thous<strong>and</strong>s <strong>of</strong> infants were affected <strong>and</strong> several died in China due to melamine contamination in milk.However, the existing analytical methods for estimation <strong>of</strong> melamine in milk such as low temperatureplasma probe combined with t<strong>and</strong>em mass spectroscopy (LTP/MS), liquid chromatography–massspectrometry (LC/MS), Electrospray ionization coupled with mass spectrometry (EESI-MS), Enzymelinked immunosorbent assay (ELISA) <strong>and</strong> High performance liquid chromatography (HPLC) methodsinvolves cumbersome steps along with expensive instrumentation thus making difficult to take decisionwhether to accept or reject the milk for further processing into milk products. Therefore there is anurgent need to develop a simple test for detection <strong>of</strong> melamine in milk to stop unscrupulous person toadulterate milk with such harmful chemicals. Development <strong>of</strong> simple <strong>and</strong> rapid test for detection <strong>of</strong>melamine in milk <strong>and</strong> food has become a challenge for researchers. Color indicator for the presence <strong>of</strong>melamine in milk using gold nanoparticles may find important application in detecting melamine. In2008 in China, reports appeared in media where attempts were made to increase the protein contentin infant milk food using melamine .Thous<strong>and</strong>s <strong>of</strong> infants were affected <strong>and</strong> several died in China.Milk protein contributes 30% <strong>of</strong> total milk solids. At present in India, the payment <strong>of</strong> milk indairy industry is made on the basis <strong>of</strong> fat, <strong>and</strong> SNF. Milk supplier’s uses various adulterants suchas urea, ammonium salts, starch, sugar, skim milk powder, maltodextrin, etc to increase the totalsolids in milk. <strong>Chemical</strong> tests are available to detect such common adulterants. Melamine is one <strong>of</strong> therecent adulterant which is reported in China <strong>and</strong> is used as a source to enhance the protein content ininfant milk powder. Melamine contains high nitrogen level (66% by weight),easily available <strong>and</strong> is notmuch costlier. For such reasons melamine adulteration in milk is rampant. Melamine is commercially173


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assuranceavailable as white powder, odourless <strong>and</strong> does not impart any undesirable sensory attributes whenadded to milk. So it becomes very difficult to detect its presence when organoleptic <strong>and</strong> platform testsare performed at the reception dock <strong>of</strong> milk plant.MelamineMelamine is an organic base <strong>and</strong> a trimer Properties <strong>of</strong> melamine<strong>of</strong> cyanamide, with a 1,3,5-triazine skeleton. 1 Other name Cyanurotriamide , cyanurotriamine,Like cyanamide, it contains 66% nitrogencyanuramideby mass <strong>and</strong> when mixed with resins, has 2 IUPAC Name 1,3,5 triazine 2,4,6 triaminefire retardant properties due to release <strong>of</strong>3 Molecular formula C3H6N6nitrogen gas when burned or charred.It hasseveral other industrial uses also.4 Molar mass 126.125 Density 1574 kg/ m3The chemical term melamine wascoined by combining the names <strong>of</strong> two 6 Melting point 3500Cgerman words Melam (a distillation 7 Solubility in water 3.240 g / L at 200 Cderivative <strong>of</strong> ammonium thiocyanate)<strong>and</strong> amine .Melamine when combined with formaldehyde produces melamine resin, a very durablethermosetting plastic used in formica, <strong>and</strong> melamine foam, a polymeric cleaning product. Melamineresin is used in the production <strong>of</strong> dry erase boards, fabrics, glues, kitchen housewares <strong>and</strong> flameretardants. Melamine is one <strong>of</strong> the major component in pigment yellow 150, a colorant in ink <strong>and</strong>plastic Melamine is also used in the fabrication <strong>of</strong> melamine poly-sulfonate as a superplasticizer formaking high-resistance concrete (www. Wikipedia. com).Sulfonated melamine formaldehyde (SMF)is a polymer used as cement admixture to reduce the water content in concrete while increasing thefluidity <strong>and</strong> the workability <strong>of</strong> the mix during its h<strong>and</strong>ling <strong>and</strong> pouring. It results in concrete witha lower porosity <strong>and</strong> a higher mechanical strength exhibiting an improved resistance to aggressiveenvironments <strong>and</strong> therefore has a longer durability. The use <strong>of</strong> melamine as a fertilizer for crops hadbeen envisaged during 1960 because <strong>of</strong> its high nitrogen content. To be effective as a fertilizer, it isessential that the plant nutrients should be made available in a manner that matches the needs <strong>of</strong>the growing crop. The nitrogen mineralization process for melamine is extremely slow, making thisproduct both economically <strong>and</strong> scientifically impractical for use as a fertilizer. Melamine derivatives<strong>of</strong> arsenical drugs are potentially important in the treatment <strong>of</strong> African trypanosomiasis. In 1958,melamine was used as a source <strong>of</strong> Non-Protein Nitrogen (NPN) for cattle.Melamine toxicityMelamine is described as being harmful if swallowed, inhaled or absorbed through the skin.Chronic exposure may cause cancer or reproductive damage. Melamine can also affect eye, skin <strong>and</strong>respiratory system. However, the toxic dose is at par with common table salt with an LD50 <strong>of</strong> morethan 3 grams per kilogram <strong>of</strong> bodyweight. Melamine <strong>and</strong> cyanuric acid can also be absorbed intothe bloodstream, concentrate <strong>and</strong> interact in the urine-filled renal microtubules, then crystallize <strong>and</strong>form large numbers <strong>of</strong> round, yellow crystals, which in turn block <strong>and</strong> damage the renal cells that linethe tubes, causing kidneys failure. The European Union has set a st<strong>and</strong>ard for acceptable humanconsumption <strong>of</strong> melamine at 0.5 milligrams per kg <strong>of</strong> body weight, Canada has declared a limit <strong>of</strong> 0.35mg <strong>and</strong> the USFDA’s limit was put at 0.63 mg, but was later reduced to 0.063 mg/kg body weightdaily. The amount <strong>of</strong> melamine a person could withst<strong>and</strong> per day known as the "tolerable daily intake"(TDI), is 0.2 mg per kg <strong>of</strong> body mass without incurring a major health risk.Melamine is reported to have an oral LD50 <strong>of</strong> 3248 mg/kg body weight in rats, while in rabbits itwas reported to be more than 1000 mg/ kg body weight for rabbits . A melamine cyanurate commonlyused as an fire retardant could be more toxic than either melamine or cyanuric acid alone. For rats <strong>and</strong>mice, the reported LD50 for melamine cyanurate was 4.1 g/kg body weight <strong>and</strong> 3.5 g/kg body weightwhen compared to 6.0 g <strong>and</strong> 4.3 g/kg body weight for melamine <strong>and</strong> 7.7 g <strong>and</strong> 3.4 g/kg body weightfor cyanuric acid, respectively. .174


Use <strong>of</strong> Lateral Flow Technique for Detecting Melamine in MilkIngestion <strong>of</strong> melamine may lead to reproductive damage or bladder or kidney stones, which canlead to bladder cancer . Dogs when fed with 3% melamine in diet regularly for one year showedchanges in their urine i.e. reduced specific gravity, increased urine output, melamine crystalluria,protein occult blood (WHO Report 1999). Crystals were formed in the kidneys when melaminecombined with cyanuric acid was fed to dogs.In April 2007,the newspaper The New York Times reported that the addition <strong>of</strong> "melamine scrap"into fish <strong>and</strong> livestock feed gave the false appearance <strong>of</strong> a higher level <strong>of</strong> protein which became an"open secret" in many parts <strong>of</strong> China.In China, several companies were implicated in a sc<strong>and</strong>al involving milk <strong>and</strong> infant formulawhich had been adulterated with melamine, leading to kidney stones <strong>and</strong> other renal failure especiallyamong young children. Melamine may have been added to milk to fool government with regard toprotein content test after water was added to fraudulently to dilute the milk. Because <strong>of</strong> melamine'shigh nitrogen content (66% by mass), it can cause the protein content <strong>of</strong> food to appear higher thanthe true value. About 20 percent <strong>of</strong> the dairy companies tested in China sell products tainted withmelamine (Guan et. al 2009).2.1.4 Methods for testing melamine in milkUntil 2007, melamine had not been routinely monitored in food, except in the context <strong>of</strong> plasticsafety or insecticide residue. This could be due to the previously assumed low toxicity <strong>of</strong> melamine<strong>and</strong> the relatively expensive method <strong>of</strong> detection. Different methods for the analysis <strong>of</strong> melamine infood <strong>and</strong> milk developed by (USFDA 2008 ,http://www.wikipedia.org/wiki/melamine) have beenmentioned in Table1Table1: different methods for the analysis <strong>of</strong> melamine in food <strong>and</strong> milk developed by(usfda 2008 ,http://www.Fsis.Usda.Gov )Method Application Limit <strong>of</strong> detection Analogues detectedGC / MS Various foods 2ppm Melamine,Ammeline AmmelideCyanuric AcidELISA Used for wheat gluten, moistpet food, dried pet food, milk<strong>and</strong> milk powder10 ppm for wheat gluten, 2 ppmfor moist pet food, 4 ppm fordried pet food, 2 ppm for milk<strong>and</strong> 10 ppm for milk powderMelamineHPLC/UV USFDA for meat 25 ppb Melamine / Cyanuric AcidHPLC/UV Used for wheat Gluten <strong>and</strong>rice protein100ppmMelamine, Ammeline, <strong>and</strong> CyanuricacidHPLC/UV Used for beverage 50 ppb MelamineHPLC/UV Used for cereal fl our 5 ppm for Melamine, Ammeline,Ammelide, 90ppm for CyanuricacidMelamineHPLC/UV Used for meat <strong>and</strong> pet food 10 ppb Melamine,Cyanuric acidDetection <strong>of</strong> melamine in milk using melamine stripMelamine strips procured from cusabiotech were used for detection <strong>of</strong> melamine in milk. Presence<strong>of</strong> melamine in milk was detected with the appearance <strong>of</strong> one pink or purple b<strong>and</strong> in the test regionwhile two pink or purple b<strong>and</strong>s were observed in case <strong>of</strong> control milk. This test is very simple, rapid<strong>and</strong> could detect up to 100ppm melamine in milk .Fig 1 <strong>and</strong> 2 shows the pattern <strong>of</strong> pink b<strong>and</strong>sappearing on melamine strip when prepared milk filtrate were applied. Another advantage <strong>of</strong> thistest is that only 3-4 drops <strong>of</strong> sample is required <strong>and</strong> no instrument is required.175


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssurancePreparation <strong>of</strong> sample for melamine stripSkim Milk Powder extraction protocol:1. Add 1ml <strong>of</strong> methanol: water mixture ( 60:40) to 1g skim milk powder sample <strong>and</strong> Vortex thetube vigorously.2. Sonicate for 1min <strong>and</strong> then shake for 1 min. Allow it to st<strong>and</strong> for 5 min.3. Transfer the supernatant to another tube, centrifuge at 10000 rpm for 5min.4. Filter the supernatant through Whatman filter paper No 1, the filtrate is ready for the assay.Liquid milk extraction protocol (1:2.5)1. Add 150μl <strong>of</strong> methanol : water mixture ( 60:40) to 100μl liquid milk sample.Vortex the tubevigorously.2. Sonicate for 1min <strong>and</strong> then shake for 1 min. Allow it to st<strong>and</strong> for 5 min3. Transfer the supernatant to another tube, centrifuge at 10000 rpm for 5min.4. Filter the supernatant through Whatman filter paper No 1, the filtrate is ready for the assay.Detection procedure for melamine in milk filtrate using strip.1. Bring the melamine test strip <strong>and</strong> samples to room temperature (25-30ºC).2. Add four drop the prepared sample to the sample area <strong>of</strong> the test strip.3. Observed the formation <strong>of</strong> pink b<strong>and</strong> in assay area within 5 min.Fig 1. Photograph showing pattern <strong>of</strong> pink or purple b<strong>and</strong>s on melamine strip in control milk <strong>and</strong>melamine adulterated milk samples.Fig 2. Photograph showing different level <strong>of</strong> detection <strong>of</strong> melamine in milk using strip.176


Rancimat (Accelerated <strong>and</strong> Automated) Method for Evaluation <strong>of</strong> Oxidative Stability <strong>of</strong> Fats <strong>and</strong> OilsRancimat (Accelerated <strong>and</strong> Automated) Method forEvaluation <strong>of</strong> Oxidative Stability <strong>of</strong> Fats <strong>and</strong> OilsIntroductionSumit Arora<strong>Dairy</strong> Chemistry Division, NDRI, KarnalRancimat is a modern, computer controlled analytical instrument for the comfortable determination<strong>of</strong> oxidative stability index to predict oxidation stability <strong>of</strong> oils <strong>and</strong> fats, <strong>and</strong> hence, their shelf life. It wasdeveloped by Hador <strong>and</strong> Zurcher in 1974 to replace the time consuming active oxygen method (AOM)<strong>and</strong> other such methods. Oxidative stability is an important criterion for evaluating the quality <strong>of</strong> oils, fats<strong>and</strong> fatty acid methyl esters (biodiesel). Lipid oxidation in foodstuffs is one <strong>of</strong> the most important criticalfactors affecting major quality parameters such as colour, flavour, aroma <strong>and</strong> nutritive value, whichreduces their shelf life <strong>and</strong> influence its suitability for consumption. Therefore, it has great importancein food industry to predict the shelf life <strong>of</strong> foods especially fatty foods. Determining oxidative stability isa tedious <strong>and</strong> time-consuming process when performed at room temperature, thus it is necessary to useaccelerated methods to obtain the oxidative stability in a shorter time. For this reason, several acceleratedmethods have been developed such as Schaal oven test, Active Oxygen Method (AOM) <strong>and</strong> RancimatMethod. AOM <strong>and</strong> Schaal oven test are non-reproducible <strong>and</strong> time-consuming methods, however,Rancimat method is comparatively more popular because <strong>of</strong> its ease <strong>of</strong> h<strong>and</strong>ling <strong>and</strong> reproducibility <strong>of</strong>results. The unique temperature extrapolation allows an approximate estimation <strong>of</strong> the storage stability<strong>of</strong> a product, thus saving both time <strong>and</strong> money.Advantages:• Automated computer-controlled instrument, therefore, is easy to operate• Conversion <strong>of</strong> induction time to other temperatures i.e. extrapolation to predict the shelf life <strong>of</strong>samples• Excellent data security <strong>and</strong> reproducibility• Time <strong>and</strong> money saving• Evaluation can be done at two different temperatures simultaneously• Independent heating blocks having individual start <strong>of</strong> each positionPrinciple:Oil or fat sample is heated at higher temperature in a sealed reaction vessel. Stream <strong>of</strong> air is passedthrough the oil or fat sample which results in oxidation <strong>of</strong> lipid molecules. The volatile productsformed upon oxidation are transported through the stream <strong>of</strong> air to a second vessel containing distilledwater, whose conductivity increases with increase in content <strong>of</strong> oxidation products. A graph is plottedbetween conductivity <strong>and</strong> time which can be used to estimate the induction time or oxidative stabilityindex <strong>of</strong> oil or fat, thus predicting the shelf life <strong>of</strong> sample.St<strong>and</strong>ardsThe Rancimat method is included in various national <strong>and</strong> internationals st<strong>and</strong>ards, such as:• AOCS Cd 12b-92 (Sampling <strong>and</strong> analysis <strong>of</strong> commercial fats <strong>and</strong> oils: Oil Stability Index)• ISO 6886 (Animal <strong>and</strong> vegetable fats <strong>and</strong> oils– Determination <strong>of</strong> oxidation stability by acceleratedoxidation test)• 2.4.28.2-93 (Fat stability test on Autoxidation. CDM, Japan)• Swiss Food Manual (Schweizerisches Lebensmittelbuch), section 7.5.4177


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceDetermination <strong>of</strong> Oxidation Stability:Prepare fat/oil sampleSwitch on 743 Rancimat as suggested by the manufacturerSelect methodStart heatingInsert <strong>and</strong> connect reaction vessels when temperature is reachedStart determinationDetermination finished when stop criteria* is reachedFigure 1: Flow diagram showing working <strong>of</strong> 743 RancimatResult displayClean vessels <strong>and</strong> accessories*Stop criteria may be induction time, conductivity or end point (point at which conductivity startsincreasing abruptly)RANCIMAT:A. Instrumentation:A. Heating blocks:The 743 Rancimat has two independent heating blocks that allow up to eight samples to beanalyzed at one or two temperatures. Up to four Rancimats can be connected to one computer, sothat the maximum number <strong>of</strong> samples that can be analyzed in parallel can be increased to 32. Eachmeasuring position can be started individually. As soon as the measurement has been completed themeasuring position is immediately ready for a new sample, which means that the instrument can beused to its full capacity.B. Reaction vessel:Weighing out the sample <strong>and</strong> assembling the reaction vessel are extremely simple <strong>and</strong> safe. Reactionvessel does not need to be expensively cleaned at the end <strong>of</strong> the measurement, thus reducing the analysiscosts.C. Measuring vessel:178Figure 2: Reaction Vessel Figure 3: Measuring Vessel Figure 4: Conductivity cell


Rancimat (Accelerated <strong>and</strong> Automated) Method for Evaluation <strong>of</strong> Oxidative Stability <strong>of</strong> Fats <strong>and</strong> OilsEasy-to-clean polycarbonate beakers are used for the automatic conductivity measurement. Glassbeakers are available as an alternative.D. Cover with built-in conductivity cell:The conductivity cell is incorporated in the measuring vessel cover. When the cover is placed inposition the cell is immersed in the water. At the same time electrical contact is made to the electronicsin the instrument. The use <strong>of</strong> fragile glass conductivity electrodes with lengthy connecting cables wentout <strong>of</strong> fashion a long time ago. The new conductivity cell is also very easy to clean.e. Connections:In order to make operation as simple as possible, there are no controls at all on the instrument.All its functions are controlled from the computer. Apart from the power switch, the only featuresyou will find on the instrument are the RS-232 socket for connection to a computer <strong>and</strong> a socket forconnecting the Pt-100 temperature sensor.Figure 5: Connections Figure 6: Air inlet filter <strong>and</strong> molecular sieve Figure 7: GLP Setf. Air inlet filter <strong>and</strong> molecular sieve:The air used for the measurement is aspirated through a filter that prevents particles from enteringthe instrument. The molecular sieve removes water vapour from the aspirated air; as water contributesto the hydrolytic decomposition <strong>of</strong> the fat molecules, it could interfere with the measurement.g. Air supply line:The amount <strong>of</strong> air that passes through the sample is automatically controlled via the rotationrate <strong>of</strong> the built-in pump according to the method settings. A separate supply <strong>of</strong> compressed air isnot necessary.B. Validation with the glp set:The optionally available GLP Set facilitates the validation <strong>of</strong> 743 Rancimat. It contains a certifiedPt-100 temperature sensor with accessories that can be used for testing the temperature regulation <strong>of</strong>the heating block. A test plug for checking the conductivity measurement inputs is also supplied.C. S<strong>of</strong>tware functions:All functions <strong>of</strong> the 743 Rancimat are controlled by the Rancimat s<strong>of</strong>tware, which excels by its userfriendliness.All the functions are clearly arranged in just a few windows, the operation is intuitive.D. Rancimat control:This is where the measuring parameters can be called up <strong>and</strong> edited. The instrument functions arecontrolled directly from here; the measurements are also started <strong>and</strong> shown in the live display field.The arrangement <strong>of</strong> this window corresponds to a view <strong>of</strong> the instrument from above. This means thatthe assignment <strong>of</strong> sample information <strong>and</strong> measuring position is perfectly clear. The timer functioncan be used to automatically switch on the heating blocks before the start <strong>of</strong> work, so that it is nolonger necessary to wait while they warm up.179


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceThe functions in a nutshell:• Individual start/stop for each position• Live display• Temperature display• Method definition• Instrument controls• Calculation formulas, automatic result transformation to other temperatures• Timer functionE. Results:At the end <strong>of</strong> each determination, the measured data is stored in a database <strong>and</strong> can be viewed bythe user in the results window. Sample information <strong>and</strong> results are shown in tabular form <strong>and</strong> can beexported in various formats. The measured curves can be shown individually or in groups. It is alsopossible to edit the automatic evaluation <strong>and</strong> recalculate the results. The temperature extrapolationfunction for estimating the storage stability is available in this section <strong>of</strong> the s<strong>of</strong>tware. All the displayeddata can be sorted or filtered <strong>and</strong> display can be adapted to meet our requirements. Results can beobtained in the following forms:• Overview table• Curve display: individual or multiple plots• Re-evaluation: induction time, stability time <strong>and</strong> manual tangent method• Report printout• Temperature extrapolation (estimation <strong>of</strong> storage stability)• Database functions: filtering, sorting• Data exportF. Applications:Determination <strong>of</strong> oxidation stability <strong>of</strong> foods:Just like the pure substances, the oils <strong>and</strong> fats contained in foods are also subject to oxidation,which contributes to their spoilage. In such cases the Rancimat can be used to determine the oxidationstability <strong>of</strong> foods containing oils <strong>and</strong> fats. Meltable foods with a high fat content, such as ghee, butter,margarine, lard or tallow, can be analyzed directly without any further sample preparation. For liquidor semi-liquid foods, such as salad dressings or mayonnaise, it is better to split the emulsion <strong>and</strong>analyze the separated fat phase. For solid, non-meltable foods it is also necessary to separate <strong>of</strong>f the fatphase. In this case the fat is normally cold-extracted with petroleum ether <strong>and</strong> the isolated fat is thenanalyzed.Following food samples can be analysed: butter, margarine, ghee, vegetable oils, baby foods, icecream,cereals, chocolate, nuts <strong>and</strong> biscuits.G. Technical specifications:1. Heating blocks:Two aluminium heating blocks; electrically heated; can be set to different temperatures2. Number <strong>of</strong> samples:Eight samples (4 measuring positions per heating block)3. Temperature control <strong>and</strong> measurementTemperature range: 50 to 220°C, adjustable in 1ºC stepsTemperature correction: -9.9 to +9.9°C, adjustable in 0.1ºC180


Rancimat (Accelerated <strong>and</strong> Automated) Method for Evaluation <strong>of</strong> Oxidative Stability <strong>of</strong> Fats <strong>and</strong> OilsstepsReproducibility <strong>of</strong> set temperature : Typically better than ±0.2 °C*Temperature variation: Typically


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssurancePrincipleEstimation <strong>of</strong> Cholesterol Content in GheeUsing a Cholesterol Estimation KitVivek Sharma <strong>and</strong> Darshan Lal<strong>Dairy</strong> Chemistry Division, NDRI, KarnalCholesterol is extracted in unsaponifiable matter as free cholesterol. The aliquot <strong>of</strong> unsaponifiablematter is made to react with the reagents <strong>of</strong> the cholesterol estimation kit <strong>and</strong> the color developedis measured at 505nm. The absorbance values in the sample <strong>and</strong> control are used to calculate thecholesterol content in a given sample <strong>of</strong> ghee.MaterialsGhee, Enzymatic Diagnostic kit, Methanol, Potassium hydroxide, Hexane, Teflon line screwcapped tubes.EquipmentWater bath, Spectrophotometer, Cuvettes.Protocol for cholesterol estimation in milk fat after saponification using enzymatic diagnostic kit:Milk fat (0.1-0.15 g) in test tube with teflon lined screw capAdd 5 ml 5% methanolic KOH <strong>and</strong> mixIncubate capped tubes in water bath for 90 °C/ 20 min with shaking every 5 min.Cool contents by tap waterAdd 1 ml distilled waterAdd 5 ml hexaneVortex the contents for 1 min182


Estimation <strong>of</strong> Cholesterol Content in Ghee Using a Cholesterol Estimation KitCentrifuge at 2000 rpm/ 2 minPipette out upper hexane layerTake 0.2 ml <strong>of</strong> aliquot in dry test tubeEvaporate solvent under nitrogen at 60-70°CAdd 10 µl <strong>of</strong> absolute ethanol to dissolve dried residueAdd 1.0 ml cholesterol reagent provided in kit <strong>and</strong> incubate at 37°C/10minCool to room temp (28 – 30°C).Calculation:Measure colour (pink) intensity at 505 nmWhere,0.02 is the concentration (mg) <strong>of</strong> cholesterol in 10 µl <strong>of</strong> st<strong>and</strong>ard solution provided in the kit.183


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assurance184Rapid Methods for Detection <strong>of</strong> Adulterants in MilkIntroductionRajan Sharma, Raman Seth <strong>and</strong> Amit K. Bauri<strong>Dairy</strong> Chemistry Division, NDRI, KarnalAddition <strong>of</strong> neutralizers <strong>and</strong> adulterants in milk has become a common feature for fulfilling the milkdem<strong>and</strong>s <strong>of</strong> over populated country. Now for dairy industry it seems to be difficult to run the plantwithout neutralization <strong>of</strong> milk. For milk vendors <strong>and</strong> shop-keepers, adulteration <strong>of</strong> milk with water toincrease the quantity in order to supply milk in large number <strong>of</strong> house-holds also has become a commonpractice. The lack <strong>of</strong> timely action against the adulterators by the Public Health Departments <strong>and</strong> lack <strong>of</strong>easier <strong>and</strong> rapid methods for detection <strong>of</strong> adulteration further encouraged this menace. Common mani.e. consumers are not aware <strong>of</strong> the methods <strong>and</strong> chemicals used in the methods. Now in NDRI Karnal,the procedures for the detection <strong>of</strong> various adulterants <strong>and</strong> neutralizers have been simplified to be easilyadopted by the house-holds. The prepared reagents as well as a KIT for the detection <strong>of</strong> adulterants <strong>and</strong>neutralizers are available in the <strong>Dairy</strong> Chemistry Division <strong>of</strong> NDRI, Karnal.PreservativesA. Test for formaldehydeFormalin (40% water solution <strong>of</strong> formaldehyde) is generally used by Public Health Departments topreserve the milk samples for chemical analysis purpose. Formaldehyde is very poisonous chemical.Though, it can preserve the milk for very long time, it should never be added to milk meant forprocessing due to its poisonous property. Moreover, it affects the quality <strong>of</strong> the milk products. If milkkept at room temperature (25 to 35ºC) for longer time, did not sour, then that milk must be tested forformaldehyde by the following simple method:Method 1: Leach test1. Take about 5 ml <strong>of</strong> milk in a test tube.2. Add to it equal volume <strong>of</strong> Conc. HCl containing 1 ml <strong>of</strong> 10% ferric chloride solution to each 500ml <strong>of</strong> the acid.3. Keep the tube in boiling water bath for about 3-4 min.4. Observe the colour <strong>of</strong> the solution in the tube. The tube containing pure sample will turnsyellowish. The positive sample (i.e. containing HCHO) will turn violet to brown black.Method II: Chromotropic acid testReagent: Saturated solution <strong>of</strong> 1,8-dihydroxynaphthalene-3,6-disulphonic acid in about 72%sulphuric acid (about 500 mg/100 ml). Light straw-coloured solution should result.1. Take one ml <strong>of</strong> milk sample in a test tube. Add 1 ml <strong>of</strong> the Chromotropic acid reagent <strong>and</strong> mix well.2. Appearance <strong>of</strong> yellow colour confirms the presence <strong>of</strong> formalin in the sample, whereas; controlsample will remain colourless.B. Test for hydrogen peroxideHydrogen Peroxide is a preservative, but as per PFA rule it is not permitted to be added in milk.Hence if it is found, then milk is said to be adulterated.Method IReagent: Para-phenylenediamine solution (2%, Aq, w/v).Procedure:1. Add to about 5 ml <strong>of</strong> milk in a test tube, an equal volume <strong>of</strong> raw milk, followed by five drops <strong>of</strong>a 2 % <strong>of</strong> para-phenylenediamine.


Rapid Methods for Detection <strong>of</strong> Adulterants in Milk2. A blue colour is developed in the presence <strong>of</strong> hydrogen peroxide.Note: It is unlikely that the addition <strong>of</strong> less than 0.1% <strong>of</strong> H 2O 2to milk could be detected after 24 h,owing to the action <strong>of</strong> peroxidase <strong>and</strong> catalase which stimulate its conversion into water. If moe than0.2% H 2O 2is added, some will persist for considerable long time. Owing to the fact that larger amount<strong>of</strong> H 2O 2are known to destroy peroxidase, it is always advisable to add to the sample an equal volume<strong>of</strong> raw unpreserved milk <strong>and</strong> to follow with a few drops <strong>of</strong> a 0.2% solution <strong>of</strong> para-phenylenediamine.Under these circumstances a blue colour will develop immediately if H 2O 2is added.Method IIA method using potassium iodide <strong>and</strong> starch was st<strong>and</strong>ardized for the detection <strong>of</strong> hydrogenperoxide in milk.Procedure: Take one ml milk sample in a test tube. Add one ml <strong>of</strong> potassium iodide-starchreagent (mix equal volumes <strong>of</strong> 20% potassium iodide solution <strong>and</strong> 1% starch solution) to the test tube.Appearance <strong>of</strong> blue colour indicates the presence <strong>of</strong> hydrogen peroxide in the milk sample whereascontrol samples remain colourless.C. Detection <strong>of</strong> NeutralizersAlkali in various forms like sodium carbonate, sodium bicarbonate, sodium hydroxide <strong>and</strong> limeare used to neutralize developed acidity in milk. Detection <strong>of</strong> such neutralizers can be made by thefollowing two tests.Method I. Rosalic Acid Test:Reagents: Ethanol (95%), Rosalic acid solution (1% in alcohol).Procedure:1. Take in test tube about 5 ml milk <strong>and</strong> mix with 5-ml ethanol followed by 2-3 drops <strong>of</strong> rosalicacid solution.2. Formation <strong>of</strong> rose red colouration indicates the presence <strong>of</strong> alkali as neutralizer. Pure milkproduces brownish or brownish yellow colour only.Rosalic acid is an organic dye, which is used as an indicator-changing colour at pH 7.0 to 8.0.Hence, milk made even faintly alkaline by addition <strong>of</strong> neutralizers can be detected due to formation <strong>of</strong>rose red colour with rosalic acid solution.Method II. Ash alkalinity testNeutralization <strong>of</strong> milk whether with lime, soda, or caustic soda, invariably increases the ashcontent <strong>and</strong> the total alkalinity <strong>of</strong> the ash from a fixed quantity.Reagent: HCl (st<strong>and</strong>ard, 0.1 N), Phenolphthalein indicator.Procedure:1. Pipette 20 ml <strong>of</strong> milk into a porcelain basin <strong>and</strong> evaporate to dryness on boiling water bath.2. Remove the basin, cool to room temperature <strong>and</strong> ignite the residue by heating over Bunsenflame until gray-white ash is obtained.3. Cool the basin to room temperature. Add to the residue 10-ml <strong>of</strong> water <strong>and</strong> disperse the ash inwater by stirring with a glass rod.4. Titrate the ash dispersate by st<strong>and</strong>ard HCl using phenolphthalein indicator. If the volume <strong>of</strong> 0.1N HCl required to neutralize the ash dispersate exceeds 1.20 ml; the milk is suspected to containneutralizers.D. Detection <strong>of</strong> starch or cereal floursReagent: Iodine solution (1%), Dissolve 2.5 g potassium iodide in 100 ml water, add to it 1 g pureiodine crystal, shake well to give a clear solution.185


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceProcedure:1. Take about 3 ml <strong>of</strong> well-mixed milk sample in a test tube.2. Heat the milk to just boiling by holding the tube over flame, <strong>and</strong> thereafter cool to room time.3. Add 1-2 drops <strong>of</strong> 1% iodine solution.4. Observe the development <strong>of</strong> colour. Formation <strong>of</strong> blue-violet colour indicates presence <strong>of</strong> starchcereal flours.E. Detection <strong>of</strong> cane sugarSugar or cane-sugar, is generally added to milk in order to raise the lactometer reading <strong>of</strong> themilk which was diluted with water, so that by lactometer reading, the detection <strong>of</strong> added water isprevented. In suspected samples, sugar can be easily detected by following method:Reagent: Resorcinol, conc. HCl. (or prepare sucrose detecting reagent by dissolving 0.5 g <strong>of</strong>resorcinol in about 40 ml <strong>of</strong> distilled water. Then add 35 ml <strong>of</strong> 12 N conc. HCl. Make up the volumeto 100 ml using distilled water.)Procedure:1. To about 5 ml <strong>of</strong> milk in a test tube, add 1 ml <strong>of</strong> conc. HCl <strong>and</strong> 0.1 g <strong>of</strong> resorcinol <strong>and</strong> mix.2. Place the tube in boiling water bath for 5 min.3. In the presence <strong>of</strong> cane sugar, red colour is produced.Note: The test can be simplified by taking 1 ml <strong>of</strong> suspected sample <strong>of</strong> milk is a test tube followed bythe addition 1 ml <strong>of</strong> sucrose detecting reagent. In the presence <strong>of</strong> cane sugar, red colour is produced.F. Detection <strong>of</strong> glucoseGlucose being a reducing sugar poses many problems in its detection. Moreover, it is easilyavailable in commercial form as concentrated syrup. These days adulteration <strong>of</strong> milk with glucose isincreasing. Now it has become possible to detect Glucose in milk by the following method:Reagents:1. Barfoed’s reagent: Dissolve 24 g cupric acetate in 450 ml boiling water <strong>and</strong> immediately add 25ml <strong>of</strong> 8.5% lactic acid to the hot solution. Shake to dissolve almost all precipitate, cool <strong>and</strong> dilutewith water to 500 ml. If necessary decant <strong>of</strong> filter to get a clear solution.2. Phosphomolybdic acid reagent: Take 35 g ammonium molybdate <strong>and</strong> 5 g sodium tungstate in alarge beaker; add 200 ml <strong>of</strong> 10% NaOH solution <strong>and</strong> 200 ml water. Boil vigorously (20-60 min)so as to remove nearly whole <strong>of</strong> ammonia. Cool, dilute with water to about 350 ml. Add 125 mlconc. H 3PO 4(85%) <strong>and</strong> dilute further to 500 ml.Procedure:1. Take 1 ml <strong>of</strong> milk sample in a test tube. Add 1 ml <strong>of</strong> modified Barefoed’s reagent.2. Heat the mixture for exact 3 min in a boiling water bath <strong>and</strong> then rapidly cool under tap water.3. Add one ml <strong>of</strong> phosphomolybdic acid reagent to the turbid solution <strong>and</strong> observe the colour.4. Immediate formation <strong>of</strong> deep blue colour indicates the presence <strong>of</strong> added glucose. In case <strong>of</strong>pure milk only faint bluish colour is formed due to the dilution <strong>of</strong> Barefoed’s reagent.G. Detection <strong>of</strong> nitrates (pond water)Pond water is heavier than the tap water; some unscrupulous persons for adulteration in milkusually prefer it. However, it can be easily detected by the following method. This method actuallydetects nitrates present in the pond water. In the pond water nitrates may come from fertilizers usedin the fields.Reagent: Diphenylamine: Prepare 2% solution <strong>of</strong> diphenylamine in conc. sulfuric acid.186


Rapid Methods for Detection <strong>of</strong> Adulterants in MilkProcedure:Take 2 ml <strong>of</strong> milk in a test tube. Rinse the tube with the milk <strong>and</strong> drain the milk from the test tube.Add two-three drops <strong>of</strong> the reagent along the side <strong>of</strong> the test tube. Deep blue colour will be formed inpresence <strong>of</strong> nitrate.H. Detection <strong>of</strong> Urea in milkUrea is a natural constituent <strong>of</strong> milk <strong>and</strong> it forms a major part <strong>of</strong> the non-protein nitrogen <strong>of</strong>milk. Urea concentration in milk is variable within herd. Urea is one <strong>of</strong> the ingredients <strong>of</strong> syntheticmilk along with caustic soda, detergent, sugar <strong>and</strong> foreign fats. Adulteration <strong>of</strong> natural milk withsynthetic milk increases the level <strong>of</strong> urea to such an extent that on consumption <strong>of</strong> this adulteratedmilk causes toxicological hazards. Estimation <strong>of</strong> urea concentration in milk may serve as a tool forchecking the menace <strong>of</strong> adulteration <strong>of</strong> natural milk with synthetic milk. The average urea contentin milk <strong>of</strong> Karan Swiss, Karan Fries <strong>and</strong> Sahiwal cows was reported to be 28.57, 28.79 <strong>and</strong> 25.39mg/100 ml (range 20 to 35 mg/100 ml). In buffalo milk, the average urea content was found to be35.10 mg (range 25 to 40 mg/100 ml). The addition <strong>of</strong> urea to milk can be detected by using DMABmethod. This method is based on the principle that urea forms a yellow complex with p-dimethylaminobenzaldehyde (DMAB) in a low acidic solution at room temperature. The intensity <strong>of</strong> yellowcolour is measured at 425 nm. Here only qualitative method is describedUrea + DMABReagent:1.6% DMAB reagent: Dissolve 1.6 g DMAB in 100-ml ethyl alcohol <strong>and</strong> add 10-ml conc. HCl.Procedure:1. Take equal quantity <strong>of</strong> milk <strong>and</strong> equal quantity <strong>of</strong> 24% TCA in a glass stoppered test tube. Mix<strong>and</strong> filter it.2. Take 3 ml <strong>of</strong> filtrate in a test tube <strong>and</strong> add 3 ml <strong>of</strong> 1.6% DMAB reagent in ethyl alcohol <strong>and</strong> HCl.Note the colour obtained.3. The occurrence <strong>of</strong> distinct yellow colour indicates the presence <strong>of</strong> added urea in milk.Note: The control (milk sample containing no added urea) showed a slight yellow colour due tothe presence <strong>of</strong> natural urea in milk.I. MaltodextrinTo 5 ml milk sample in a test tube, 2 ml <strong>of</strong> dilute iodine solution (0.05 N) is added. Appearance <strong>of</strong>chocolate red brown colour developed indicates the presence <strong>of</strong> maltodextrin.J. Sodium chlorideTake 5 ml <strong>of</strong> milk <strong>and</strong> 1 ml <strong>of</strong> silver nitrate solution (0.1 N). Mix well <strong>and</strong> add two drops <strong>of</strong> asolution <strong>of</strong> 10% potassium chromate. Yellow colour indicates the presence <strong>of</strong> added salt. Otherwise,red colour will appear.K. Ammonium saltsThe added ammonium salts e.g ammonium chloride, ammonium sulfate, ammonium nitrate <strong>and</strong>ammonium dihydrogen orthophosphate can be detected in milk by two methods i.e Nessler’s reagentmethod <strong>and</strong> turmeric paper method.Method I: Nessler’s reagent methodReagent : Nessler’s reagent: Dissolve the following chemicals separately.a. 8.0 g <strong>of</strong> mercuric chloride in 150 ml distilled water.187


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assuranceb. 60.0 g <strong>of</strong> sodium hydroxide in 150 ml distilled water.c. 16.0 g <strong>of</strong> potassium iodide in 150 ml distilled water.Add reagent a to reagent b <strong>and</strong> mix well. To this mixture, add reagent c, mix <strong>and</strong> dilute the contentsto 500 ml. Leave this solution undisturbed <strong>and</strong> decant the clear upper layer <strong>of</strong> the solution <strong>and</strong> storein a stoppered glass bottle.Procedure: Pipette 5 ml <strong>of</strong> suspected milk sample into a test tube <strong>and</strong> add 1 ml <strong>of</strong> Nessler’s reagent.Mix the contents <strong>of</strong> the tube thoroughly. Appearance <strong>of</strong> yellowish or grey colour confirms the presence<strong>of</strong> added ammonium salts in milkMethod II. Turmeric paper methodThis method is based on the principle that ammonium salts on addition <strong>of</strong> strong alkali liberateammonia <strong>and</strong> the liberated ammonia turns turmeric paper to pinkish red.Reagents:• Turmeric paper: Dissolve 10 g <strong>of</strong> pure turmeric powder in 100 ml distilled water <strong>and</strong> dipWhatman filter paper Grade 1 strips into it for 2 min. Dry the paper at room temperature. Thedried filter paper is wetted with distilled water before use.• Sodium hydroxide solution: 10% (aq.)• Procedure: Pipette 5 ml <strong>of</strong> suspected milk sample in a test tube <strong>and</strong> add 1 ml <strong>of</strong> 10% sodiumhydroxide solution in such a manner that should not touch the rim <strong>of</strong> the test tube while adding.Mix the contents <strong>of</strong> the tube. Place a piece <strong>of</strong> wet turmeric paper on the rim <strong>of</strong> the test tube<strong>and</strong> keep the test tube undisturbed. Observe the change in the colour <strong>of</strong> the turmeric paper.Appearance <strong>of</strong> pinkish red colour confirms the presence <strong>of</strong> ammonium salt in milk.L. Sulfate saltsPresence <strong>of</strong> sulfates in milk can be detected by using barium chloride.Reagents:a. Barium chloride (BaCl 2.2H 2O) solution: 5% (w/v, aq.)b. Trichloroacetic acid (TCA): 24% (w/v, aq.).Procedure: Take 10 ml <strong>of</strong> milk in a 50 ml stoppered test tube <strong>and</strong> add 10 ml <strong>of</strong> TCA solution. Filterthe coagulated milk through Whatman filter paper Grade 42. Take 5 ml <strong>of</strong> clear filtrate <strong>and</strong> add fewdrops <strong>of</strong> barium chloride solution. Formation <strong>of</strong> milky-white precipitates indicates the presence <strong>of</strong>added sulfates like ammonium sulfate, sodium sulfate, zinc sulfate <strong>and</strong> magnesium sulfate etc. tomilkM. Detection <strong>of</strong> refined oil in milkThis method is based on the principle that BR reading <strong>of</strong> milk fat is comparatively lower thanthat <strong>of</strong> most <strong>of</strong> the foreign fats/oils. Its adulteration with vegetable <strong>and</strong>/or animal body fats/oilssignificantly increases the BR reading/For taking BR reading <strong>of</strong> the milk fat the milk fat is isolated from the specially designed butyrometerwhich has both ends open. Milk fat after centrifugation is taken with the help <strong>of</strong> a capillary <strong>and</strong> BRreading is noted at 40°C. A correction factor is added to the observed BR reading. This is done toeliminate the inherent hydrolytic effect <strong>of</strong> H 2SO 4.Actual BR at 40°C = Observed BR at 40°C + (0.08X observed BR at 40°C)References:Manual in <strong>Dairy</strong> Chemistry, NDRI, Karnal.IS:1479 (Part II) – 1961 Methods <strong>of</strong> test for <strong>Dairy</strong> Industry-Part II <strong>Chemical</strong> analysis <strong>of</strong> milk.188


Detection <strong>of</strong> Foreign Fats/Oils in Milk <strong>and</strong> Ghee Using Newer ApproachesDetection <strong>of</strong> Foreign Fats/Oils in Milk<strong>and</strong> Ghee Using Newer ApproachesDarshan Lal, Vivek Sharma, Arun Kumar <strong>and</strong> Amit Kumar<strong>Dairy</strong> Chemistry Division, NDRI, KarnalIntroductionThe menace <strong>of</strong> adulteration in food products has reached an alarming stage in recent years. Eventhe milk (most sacred food) has not been spared. Milk fat, the costliest edible fat, increasingly catchesthe attention <strong>of</strong> the unscrupulous elements for an easy adulteration with far cheaper oils <strong>and</strong> fats <strong>of</strong>vegetable <strong>and</strong> animal origin. Under the circumstances, the dairy industry is in dire need for somerapid <strong>and</strong> simple methods to check the menace <strong>of</strong> adulteration in milk <strong>and</strong> milk products. Earlier, gheeused to be adulterated with foreign oils <strong>and</strong> fats, <strong>and</strong> accordingly several methods were developed fordetection <strong>of</strong> adulteration in ghee. These methods were based on differences in the nature <strong>and</strong> contents<strong>of</strong> major/minor components <strong>of</strong> ghee <strong>and</strong> adulterant fats/oils. Now days, a new trend <strong>of</strong> addition <strong>of</strong>foreign fats/oils directly into milk has been gaining momentum. Unfortunately, the tests, which areapplicable for detecting adulteration in ghee, cannot be directly applied to milk because milk is not asingle-phase emulsion. Rather, it is an oil-in-water type emulsion. Therefore, the fat phase <strong>of</strong> milk hasto be separated from its aqueous phase before applying any test for checking the adulteration <strong>of</strong> milkfat. Moreover, since no single test can detect all types <strong>of</strong> adulterants (oils <strong>and</strong> fats), therefore, <strong>of</strong>tenmore than one tests have to be employed to confirm the purity <strong>of</strong> milk fat.MethodologyThere are two approaches for the detection <strong>of</strong> adulteration <strong>of</strong> milk fat. First approach is basedon the classical methods like B.R reading, R.M value, P. value, Phytosterol acetate test, Gas – liquidchromatographic analysis. Second approach is based on some innovative <strong>and</strong> rapid methods like furfuraltest for vanaspati, Opacity test, crystallization test, color based test for vegetable oil detection, apparentsolidification time test <strong>and</strong> complete liquification time test. In all the cases, tests are applied on the extractedfat, except the modified Gerber test, where especially designed dual purpose Gerber butyrometer is used<strong>and</strong> B.R reading <strong>of</strong> the isolated fat is measured. Hence, the first step is to isolate the fat <strong>and</strong> then apply thetest (Kumar et al, 2002).A) Detection <strong>of</strong> foreign oils <strong>and</strong> fats in milk:Keeping in view the need for a rapid test which can be applied to milk for detecting the adulterationright at the platform where the milk is to be either accepted or rejected, the approach suggested byLal et al (1998) involves the isolation <strong>of</strong> fat from milk followed by determination <strong>of</strong> B.R. reading <strong>of</strong> theisolated fat. This test is specifically useful for detection <strong>of</strong> vegetable oils in milk.Isolation <strong>of</strong> fat from milkIsolation <strong>of</strong> fat from milk can be done by any <strong>of</strong> the three methods:• Solvent extraction method• Heat clarification method• Modified Gerber method.Solvent extraction methodTake 100 ml <strong>of</strong> milk sample in a 500 ml flask. Add 15 ml <strong>of</strong> NH 4OH, <strong>and</strong> shake thoroughly. Add50 ml ethyl alcohol, 100 ml solvent ether <strong>and</strong> 100 ml petroleum ether <strong>and</strong> shake thoroughly after eachaddition. Allow to st<strong>and</strong> for half an hour. Decant the ethereal layer in another conical flask <strong>of</strong> 250 mlcapacity.Add about 50 g <strong>of</strong> anhydrous Na 2SO 4to remove the traces <strong>of</strong> moisture from the ethereal layer.Collect the ether extract <strong>and</strong> add 1 or 2 glass beads. Evaporate ether extract to dryness on boiling waterbath taking care to prevent bumping <strong>and</strong> then transfer in oven maintained at 102ºC.189


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceHeat clarification methodObtain about 50g <strong>of</strong> cream by separation using cream separator or by centrifuging the milk at 4000rpm for 10 min. Convert the cream into ghee by heat clarification.Modified gerber methodIsolate the fat from milk by Gerber method using specially designed dual purpose milk butyrometer,which is open at both ends. Close the stem side opening with a good quality acid resistant silicon cork.From the neck side, add 10 ml <strong>of</strong> 90% H 2SO 4, 10.75 ml milk <strong>and</strong> 1 ml amyl alcohol. Close the neck sidewith lock stopper; mix the contents <strong>and</strong> centrifuge for 5 min to get clear fat in the column. Removethe silicon cork <strong>and</strong> take out the fat from the stem <strong>of</strong> butyrometer with the help <strong>of</strong> a capillary tube ora syringe (Lal et al, 1998).B) Detection <strong>of</strong> foreign oils <strong>and</strong> fats in ghee:Available tests:1. Detection <strong>of</strong> animal body fats <strong>and</strong> vegetable oils/fats by the opacity testMelt the sample <strong>of</strong> fat (5 gm) isolated by heat clarification method at 50 +1 o C in a test tube <strong>and</strong>maintain for 3 min to equilibrate. Then transfer the test tube at 23 + 0.2 o C water bath <strong>and</strong> record theopacity time (Time taken by fat sample to acquire either O.D. at 570 nm between 0.14-0.16 or Klettreading using red filter between 58-62 after adjusting the instrument to 100% transmittance). Theopacity time <strong>of</strong> pure buffalo ghee is 14-15 min, cow ghee is 18-19 min <strong>and</strong> that <strong>of</strong> ghee from cotton tractarea is 11-12 min. The opacity time <strong>of</strong> buffalo ghee adulterated at 10% level with vanaspati is 10-11min, with pig body fat is 8-9 min, with buffalo body fat is 2-3 min, with cow body fat is 3-4 min <strong>and</strong>with refined oils is 20-25 min (Singhal, 1980).2. Detection <strong>of</strong> vanaspati in gheeIsolate the fat from milk by heat clarification method as described above. Take about 5 g <strong>of</strong> themelted fat in a test tube. Add 5 ml <strong>of</strong> concentrated HCl. Add 0.4 ml furfural solution (2% in alcohol)<strong>and</strong> shake the tube thoroughly for 2 min. Allow the mixture to separate. The development <strong>of</strong> pink orred colour in the acid layer indicates presence <strong>of</strong> vanaspati. Confirm by adding 5 ml distilled water<strong>and</strong> shaking again. If the colour in acid layer persists, vanaspati is present. If the colour disappears, itis absent [SP:18 (1987)].3. Detection <strong>of</strong> vegetable oils byButyro-Refractometer (B.R.) ReadingClean the prisms <strong>of</strong> the Butyro-refractometer with petroleum ether. Allow the ether to evaporate todryness. Maintain temperature <strong>of</strong> the prisms at 40ºC by circulating water. Calibrate the B.R. apparatusby applying a drop <strong>of</strong> fluid <strong>of</strong> known B.R. <strong>and</strong> adjusting B.R. by moving the adjustment screw. Cleanthe prisms. Apply a drop <strong>of</strong> sample <strong>of</strong> clear fat obtained by any <strong>of</strong> the three methods between theprisms. Wait for 2 min before taking the reading so that sample should attain the constant temperature<strong>of</strong> about 40ºC.B.R. reading decreases <strong>and</strong> increases with the rise <strong>and</strong> fall <strong>of</strong> temperature, respectively. Normally,the temperature <strong>of</strong> observation should not deviate by more than 2ºC. A correction <strong>of</strong> 0.55 is added tothe observed B.R. reading for each degree above 40ºC or subtracted for each degree below 40ºC to getcorrected B.R. reading <strong>of</strong> the sample.If fat is isolated by the Gerber method, B.R. is depressed due to hydrolytic effect <strong>of</strong> H 2SO 4on thefat. Therefore, observed B.R. reading is corrected as follows:Corrected B.R. = 1.08 x observed B.R.B.R. reading <strong>of</strong> milk fat isolated by any one <strong>of</strong> the above mentioned methods should be consistentwith the values given for ghee as per PFA requirement. Any deviation from the st<strong>and</strong>ard valueindicates adulteration <strong>of</strong> milk with vegetable oils. However, this method has limitation <strong>of</strong> detection<strong>of</strong> adulteration with two oils i.e. coconut oil <strong>and</strong> palm oil whose values are close to that <strong>of</strong> milk fat(Arora et al, 1996).190


Detection <strong>of</strong> Foreign Fats/Oils in Milk <strong>and</strong> Ghee Using Newer Approaches4. Detection <strong>of</strong> animal body fats <strong>and</strong> vegetable oils by crystallization testIsolate the fat from milk by heat clarification method as described above. Take 0.8 ml <strong>of</strong> meltedfat in a stoppered test tube (10 x 1.0 cm internal diameter). Add 2.5 ml <strong>of</strong> solvent mixture consisting <strong>of</strong>acetone <strong>and</strong> benzene (3.5:1.0). Mix the contents slowly. Place the test tube in a water bath maintained at20ºC for 3 min to equilibrate the temperature. Then transfer the tube in another water bath maintainedat 17 ± 0.2ºC till the onset <strong>of</strong> crystallization. Note the time for occurrence <strong>of</strong> crystallization. Thecrystallization time <strong>of</strong> pure buffalo ghee is 18-20 min <strong>and</strong> that <strong>of</strong> cotton tract ghee is 10.5-12.5 min,whereas that <strong>of</strong> buffalo ghee adulterated at 10% level with pig body fat is 11.5-12.5 min, with cow bodyfat 4.5-5.5 min <strong>and</strong> buffalo body fat 3.0-4.0 min, <strong>and</strong> with vegetable oils is 26 to 36 min (P<strong>and</strong>a, 1996).5. Detection <strong>of</strong> adulteration <strong>of</strong> vegetable oils in ghee by Iodine valueIodine value, which is a measure <strong>of</strong> extent <strong>of</strong> unsaturation <strong>of</strong> fat, can be determined by theWij’s method as described in SP:18 (Part XI)1981. This property is particularly useful for detection <strong>of</strong>adulteration in ghee with vegetable oils, as these oils have higher iodine values than milk fat <strong>and</strong> bodyfats. It can be measured, as follows:Accurately 0.4 g <strong>of</strong> sample is weighed in a clean <strong>and</strong> dry iodine flask <strong>and</strong> is dissolved in 15 ml <strong>of</strong>carbon tetrachloride. Then 25 ml <strong>of</strong> the Wij’s reagent are added <strong>and</strong> the flask is stoppered. The contentsare then mixed <strong>and</strong> kept in dark for one hour. After one hour, 20 ml <strong>of</strong> 10 per cent potassium iodidesolution <strong>and</strong> about 150 ml <strong>of</strong> distilled water are added to the iodine flask <strong>and</strong> mixed. The contents aretitrated against 0.1 N sodium thiosulphate solution using starch solution as an indicator. A blank testis also carried out using the same quantities <strong>of</strong> the reagents. From this, the iodine value is calculatedas follows:Iodine <strong>Value</strong> = 12.69 (B – S) N / WWhere;B = Vol. (in ml) <strong>of</strong> st<strong>and</strong>ard sodium thiosulphate solution required for the blankS = Volume (in ml) <strong>of</strong> st<strong>and</strong>ard sodium thiosulphate solution required for the sampleN = Normality <strong>of</strong> the st<strong>and</strong>ard sodium thiosulphate solution, <strong>and</strong>W = Weight (in g) <strong>of</strong> the sample taken for the testThe iodine value for cow <strong>and</strong> buffalo pure ghee ranges between 30.12 to 40.26. Any deviation fromthese values indicates adulteration (Kumar, 2008).6. Detection <strong>of</strong> adulteration by apparent solidification time (AST) testThe apparent solidification time (AST) <strong>of</strong> the fat sample is defined as the time taken by the meltedfat sample to get solidified apparently at a particular temperature. The test can be carried out as:Take 3.0 gm <strong>of</strong> completely melted fat sample in a test tube (10 × 1.0 cm ID) <strong>and</strong> maintain at 60ºC for5 min. Transfer the test tube in a refrigerated water bath maintained at 18 ± 0.2ºC <strong>and</strong> simultaneouslystart the stop watch. Observe the test tube constantly till the apparent solidification <strong>of</strong> the fat sampletakes place which is confirmed by non- movement <strong>of</strong> fat sample on tilting the test tube. At this stage,stop the stopwatch <strong>and</strong> record the time taken for the apparent solidification <strong>of</strong> the fat. Pure gheesample <strong>of</strong> both cow <strong>and</strong> buffalo shows AST in the range <strong>of</strong> 2 min 31 sec to 3 min 25 sec. Any deviationfrom these values gives an indication <strong>of</strong> adulteration <strong>of</strong> milk fat (Kumar, 2009)7. Detection <strong>of</strong> adulteration using dry fractionation technique coupled with ASTBy employing dry fractionation technique, the different fractions enriched with body fats orvegetable oils are obtained <strong>and</strong> subsequently used to estimate AST. The aim is to enrich the solidfraction with animal body fats <strong>and</strong> liquid fraction with vegetable oils. Vanaspati, if added, will also befractionated along with animal body fats.Take 100 gm <strong>of</strong> clarified melted fat <strong>and</strong> keep it in a BOD incubator maintained at 20 ± 0.1ºC. Afterabout 1.50 to 1.75 h <strong>of</strong> incubation, approximately one third <strong>of</strong> the whole fat gets solidified. Separate thesolid fraction (S 20) from the remaining liquid portion by filtration inside a BOD incubator maintained at191


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assurance20 ± 0.1°C. Further fractionate the liquid portion thus obtained in another BOD incubator maintainedat 18 ± 0.1°C. for 2 hr so as to obtain another solid (S 18) <strong>and</strong> liquid (L 18) fraction by filtering inside aBOD incubator maintained at 18 ± 0.1°C. Analyze S 20, S 18<strong>and</strong> L 18fractions <strong>of</strong> ghee for AST as describedabove. S 20, S 18<strong>and</strong> L 18fractions <strong>of</strong> pure ghee <strong>of</strong> both cow <strong>and</strong> buffalo show AST values <strong>of</strong> 1 min 40sec to 2 min 50 sec; 2 min 30 sec to 3 min 40 sec <strong>and</strong> 2 min 50 sec to 3 min 50 sec, respectively. Anydeviation from these values gives an indication <strong>of</strong> adulteration (Kumar, 2003).8. Detection <strong>of</strong> adulteration by complete liquification time (CLT) testThe complete liquification time (CLT) test <strong>of</strong> the fat sample is defined as the time taken by thesolidified fat sample to get melted completely at a particular temperature. The test can be performed,as follows:Take 3.0 gm <strong>of</strong> completely melted fat sample in a test tube (10 × 1.2 cm) <strong>and</strong> maintain at 60°C for 5min. Keep the test tube containing fat sample in a refrigerator (6- 8ºC) for 45 min for solidification <strong>of</strong> themelted fat sample. Transfer the test tube in a water bath maintained at 44 ± 0.1ºC <strong>and</strong> simultaneouslystart the stop watch. Observe the test tube constantly till the fat sample is completely liquefied. Atthis stage stop the stopwatch <strong>and</strong> record the time taken for complete liquification <strong>of</strong> the fat. Pure gheesample <strong>of</strong> both cow <strong>and</strong> buffalo shows CLT in the range <strong>of</strong> 2 min 12 sec to 3 min 15 sec. Any deviationfrom these values gives an indication <strong>of</strong> adulteration <strong>of</strong> milk fat (Kumar, 2008).9. Detection <strong>of</strong> adulteration using solvent fractionation technique coupled with CLT <strong>and</strong> IodinevalueUsing solvent fractionation technique, the different fractions enriched with body fats or vegetableoils can be obtained <strong>and</strong> used subsequently to estimate CLT. Here also, the aim is to concentrateanimal body fats in to solid fraction <strong>and</strong> vegetable oils into liquid fraction. Vanaspati, if added, willalso be concentrated in solid fraction along with animal body fats.Take 30 gm <strong>of</strong> melted ghee sample in a 100 ml graduated glass tube, <strong>and</strong> then add 60 ml acetone<strong>and</strong> mix well to dissolve the fat. After mixing, keep the sample at 40°C for equilibration for 5 min. Thensubject the sample in a refrigerated water bath to three temperatures/time combinations, viz., 16 ±0.1°C/25 min, 8 ± 0.1°C/25 min <strong>and</strong> 4 ± 0.1°C/60 min, successively, after filtration at each stage <strong>of</strong> time/temperature combination. After about 25 min at 16 ± 0.1°C, approximately one-fourth <strong>of</strong> the wholefat gets solidified. This first solid fraction (S 16) obtained at 16 ± 0.1°C is separated from the remainingliquid portion (L 16) <strong>of</strong> the whole fat by filtration through ordinary filter paper. The remaining liquidportion (L 16) thus obtained after filtration is further fractionated at 8 ± 0.1°C. in refrigerated water bath.After about 25 min, it gets partitioned into two fractions, one solid (S 8) <strong>and</strong> one liquid (L 8), which canbe separated by filtration through ordinary filter paper. At last, L 8fraction is further fractionated at4 ± 0.1°C for 60 min <strong>and</strong> filtered to get two fractions, one solid (S 4) <strong>and</strong> one liquid (L 4). Finally at theend <strong>of</strong> fractionation, three solid fractions (S 16, S 8<strong>and</strong> S 4) <strong>and</strong> one liquid fraction (L 4) are obtained fromghee sample containing a mixture <strong>of</strong> adulterants. Solvent from liquid fraction is removed by usingrotary evaporator at about 40ºC, followed by nitrogen flushing to evaporate solvent completely fromthe liquid fraction. To get rid <strong>of</strong> entrapped acetone, respective solid fractions are heated to 110ºC forabout 2 hr in an oven.(a) <strong>Analysis</strong> <strong>of</strong> first fraction (S 16) for CLT at 46ºCAnalyse S 16fraction for CLT at 46 ± 0.1 o C (instead <strong>of</strong> 44± 0.1 o C used for CLT <strong>of</strong> whole fat) asdescribed above. CLT values <strong>of</strong> S 16fraction at 46 o C range between 4 min 5 sec to 9 min for both cow<strong>and</strong> buffalo pure ghee. Any deviation from these values gives an indication <strong>of</strong> adulteration <strong>of</strong> milk fat(Kumar, 2008).192


Detection <strong>of</strong> Foreign Fats/Oils in Milk <strong>and</strong> Ghee Using Newer Approaches(b) <strong>Analysis</strong> <strong>of</strong> last fraction (L 4) for Iodine valueAnalyse L 4fraction for iodine value as described above. The iodine values for L 4fraction <strong>of</strong> purecow <strong>and</strong> buffalo ghee are found to vary between 37.85- 46. 48. Any deviation from these values givesan indication <strong>of</strong> adulteration <strong>of</strong> milk fat (Kumar, 2008).10. Detection <strong>of</strong> mineral oil in gheeIsolate the fat from milk by heat clarification method as described above. Take 1 g <strong>of</strong> fat in ast<strong>and</strong>ard joint test tube <strong>and</strong> add 5 ml <strong>of</strong> 0.5 N ethanolic KOH solution <strong>and</strong> reflux by heating inboiling water bath, using condenser for 10 min. or more till saponification process is complete.Add about 5 ml <strong>of</strong> distilled water to the hot saponified solution. Appearance <strong>of</strong> turbidity indicatesthe presence <strong>of</strong> mineral oil.11. Rapid color based test for detection <strong>of</strong> vegetable oilsOne ml <strong>of</strong> clear molten fat was dissolved with 1.5 ml <strong>of</strong> hexane in a tightly capped test tube. To thiswas added 1.0 ml <strong>of</strong> color developing reagent (distilled water, Sulphuric acid - Sp.gr.1.835 <strong>and</strong> Nitric acid- Sp. gr. 1.42 in the ratio <strong>of</strong> 20:6:14), shaken vigorously <strong>and</strong> kept undisturbed till it is separated into twolayers. The appearance <strong>of</strong> a distinct orange tinge in the upper layer indicates the presence <strong>of</strong> vegetableoils / fats including vanaspati (Sharma et al, 2007).12. Detection <strong>of</strong> adulteration <strong>of</strong> rice bran oil in gheeRice bran oil contains gamma oryzanol, which can be used as a marker for the detection <strong>of</strong>its addition to ghee. It can be done by thin layer chromatographic method as well as colorimetricmethod.a) Thin layer chromatographic methodA simple thin layer chromatographic method can be employed to detect the adulteration <strong>of</strong> gheewith rice bran oil, as follows:Gamma oryzanol is extracted from 10.0 gm <strong>of</strong> molten fat using 20.0 ml <strong>of</strong> a solvent systemconsisting <strong>of</strong> methanol: water (9:1). The contents are vortexed for 2 min <strong>and</strong> centrifuged at 2000rpm. /10 min. The alcohol layer is drawn. Extraction protocol is repeated thrice <strong>and</strong> all the alcoholic extractsare combined <strong>and</strong> evaporated at 60 – 70 °C in a rotary evaporator. The residue is finally dried. Thedried residue is redissolved in 0.5 ml <strong>of</strong> developing solvent (toluene: ethyl acetate: methanol 90:8:2;v/v) <strong>and</strong> 5-10 µl were applied on silica gel TLC plate <strong>and</strong> plates are developed in the developingsolvent. Properly developed plates are removed from the chamber <strong>and</strong> air dried followed by sprayingwith color developing reagent (50% sulfuric acid) <strong>and</strong> heating at 120°C/ 10 -15min. Presence <strong>of</strong> thegamma oryzanol b<strong>and</strong> confirms the adulteration <strong>of</strong> rice bran oil in milk fat. Addition <strong>of</strong> rice bran oil inghee at 5% level is easily detected by this method. (Kumar, et al, 2008).b) Colorimetric methodTake 1ml <strong>of</strong> melted ghee sample in a dry test tube. Add 1.5 ml <strong>of</strong> hexane to dissolve the fat. Then,in sequence, add 0.5 ml <strong>of</strong> dilute (25%) hydrochloric acid <strong>and</strong> 0.5 ml <strong>of</strong> 5% sodium nitrite solution<strong>and</strong> mix, followed by the addition <strong>of</strong> 1 ml <strong>of</strong> 10% sodium hydroxide solution. Rice bran oil producesorange-red color while other vegetable oils produce no color. Hence, this method is specific for thedetection <strong>of</strong> rice bran oil in ghee. As low as 2% rice bran oil added in ghee, can be detected by thismethod.193


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceSt<strong>and</strong>ards <strong>of</strong> ghee under PFA rulesSr.No.Name <strong>of</strong> the State & U.T.BRReadingat 40ºCRMvalue(Min)% <strong>of</strong>FFA (asOleicacid)(Max)% <strong>of</strong>Moisture(Max)1.2.Bihar, Ch<strong>and</strong>igarh, Delhi, Punjab, Haryana (Areas other than cottontract areas), West Bengal (Areas other than Bishnupur sub-division),Sikkim, Jharkh<strong>and</strong>.Manipur, Meghalaya, Mizoram, Arunachal Pradesh, Orissa,Uttaranchal, Nagal<strong>and</strong>, Tripura, Assam, Goa, Kerala, HimachalPradesh, U.P., J & K, Rajasthan (Areas other than Jodhpur Divn),Haryana (Cotton tract areas), Lakshadweep, Maharashtra(Areasother than cotton tract areas).40-43 28 3 0.540-43 26 3 0.53.4.Karnataka (Belgaum district), Madhya Pradesh (Areas other thancotton tract areas), Pondicherry, Chhatisgarh. 40-44 26 3 0.5Andhra Pradesh, Daman & Diu, Dadar & Nagar Haveli, Karnataka(Areas other than Belgaum distt.) 40-43 24 3 0.55. Andaman & Nicobar Isl<strong>and</strong>, Tamil Nadu. 41-44 24 3 0.56. Gujarat (areas other than cotton tract). 40-43.5 24 3 0.57.Gujarat (cotton tract areas), Madhya Pradesh (Cotton tract areas),Maharashtra (cotton tract areas), Rajasthan (Jodhpur sub division),West Bengal (Bishnupur sub division). 41.5-45 21 3.0 0.5Baudouin test shall be negativeBy cotton tract is meant the areas in the state where cotton seed is extensively fed to the cattle <strong>and</strong> so notified by theState Govt. concerned.Usually such cotton tract areas ghee has low RM value <strong>and</strong> high BR reading compared to other areasGhee may contain BHA not more than 0.02% as antioxidant.References:Singhal, O.P. (1980). Adulteration & Methods for detection. Indian <strong>Dairy</strong>man, 32: 771-774.Arora, K.L.; Lal. D, Seth. R <strong>and</strong> Ram, J. (1996). Platform Test for detection <strong>of</strong> refined mustard oil adulteration in milk.Indian J. <strong>Dairy</strong> Sci., 49(10): 721-723.P<strong>and</strong>a, D.K. (1996). Detection <strong>of</strong> adulteration <strong>of</strong> foreign fats in milk fat. M.Sc. thesis, submitted to N.D.R.I. DeemedUniversity, Karnal.Lal, D.; Seth, R.; Arora, K.L. <strong>and</strong> Ram, J. (1998) Detection <strong>of</strong> vegetable oils in milk. Indian <strong>Dairy</strong>man., 50(7): 17-18.Kumar.A; Lal.D; Seth.R <strong>and</strong> Sharma.R (2002) Recent trends in detection <strong>of</strong> adulteration in milk fat – A Review. IndianJ. <strong>Dairy</strong> Sci., 55 (6): 319 - 330.Sharma. V; Lal, D <strong>and</strong> Sharma. R. (2007) Color based platform test for the detection <strong>of</strong> vegetable oils/fats in ghee. IndianJ. <strong>Dairy</strong> Sci. 60,1: 16 – 18.Kumar. A; Sharma. V <strong>and</strong> Lal.D (2008) Development <strong>of</strong> a thin layer chromatography based method for the detection <strong>of</strong>rice bran oil as an adulterant in ghee. Indian J. <strong>Dairy</strong> Sci. 61,2: 113 – 115.Kumar. A; Ghai, D. L; Seth, R <strong>and</strong> Sharma, V (2009) Apparent solidification time test for detection <strong>of</strong> foreign oils <strong>and</strong>fats adulterated in clarified milk fat, as affected by season <strong>and</strong> storage. International J . <strong>Dairy</strong> Tech. 62: 33 –38.Kumar. A; Lal, D.; Seth, R <strong>and</strong> Sharma, V (2010) Detection <strong>of</strong> milk fat adulteration with admixture <strong>of</strong> foreign oils <strong>and</strong>fats using a fractionation technique <strong>and</strong> the apparent solidification time test. International J . <strong>Dairy</strong> Tech. 63 (3): 457–462.Kumar. Amit; (2008) Detection <strong>of</strong> adulterants in ghee. Ph. D thesis submitted to NDRI, Karnal (Deemed University).ISI (1981). H<strong>and</strong>book <strong>of</strong> Food <strong>Analysis</strong>. IS: SP:18, Part XI. <strong>Dairy</strong> <strong>Products</strong>. Bureau <strong>of</strong> Indian St<strong>and</strong>ards, New Delhi.Lal, D.; Seth, R <strong>and</strong> Sharma, R; Kumar. A. (2005) Approaches for detection <strong>of</strong> adulteration in milk fat-An overview.Indian <strong>Dairy</strong>man 57(10): 31-43.194


Determination <strong>of</strong> Total Polyphenolic Content in Fruit Enriched <strong>Dairy</strong> ProductDetermination <strong>of</strong> Total Polyphenolic Contentin Fruit Enriched <strong>Dairy</strong> ProductIntroduction:Rajesh Kumar <strong>and</strong> Richa Singh<strong>Dairy</strong> Chemistry Division, NDRI, KarnalPolyphenols are plant secondary metabolites commonly found in herbs <strong>and</strong> fruits, such as berries,apples, citrus fruit, cocoa, grapes, vegetables like onions, olives, tomatoes, broccoli, lettuce, soybeans,grains <strong>and</strong> cereals, green <strong>and</strong> black teas, c<strong>of</strong>fee beans, propolis, <strong>and</strong> red <strong>and</strong> white wines. Many <strong>of</strong>these polyphenols are responsible for the attractive colour <strong>of</strong> leaves, fruits <strong>and</strong> flowers. Further,polyphenolics are classified as:- Simple phenols: Phenol acids are phenols that possess one carboxylicacid functionality such as the hydroxycinnamic <strong>and</strong> hydroxybenzoic acid; Flavonoids: Polyphenolpossessing at least two phenol subunits <strong>and</strong> Tannins: Polyphenol possessing three or more phenolsubunits. The quantification <strong>of</strong> polyphenol content in foods <strong>and</strong> beverages is critical for underst<strong>and</strong>ingthe potential health benefits <strong>of</strong> polyphenols.Principle: The polyphosphotungstates are colorless in the fully oxidized 6 + valance state<strong>of</strong> the metal, <strong>and</strong> the analogous molybdenum compounds are yellow. They form mixedheteropolyphosphotungstates- molybdatesthey exist in acid solution as hydrated octahedral complexes<strong>of</strong> the metal oxides coordinated around a central phosphate sequence <strong>of</strong> reversible one or two electronreductions lead to blue species such as ( PMoW 11O 40) 4- . In principle, addition <strong>of</strong> an electron to aformally nonbonding orbital reduces nominal MoO 4+ units to “isostructural” MoO 3+ . Tungstate formsare considered to be less easily reduced but more susceptible to one electron transfer. Molybdates areconsidered to be reduced more easily to blue forms. Mixed complexes as in Folin-Ciocalteu reagentare intermediate. Blue products <strong>of</strong> phosphomolybdate reduction can have Mo 6+ to Mo 5+ ratios <strong>of</strong> 9.6 to0.6. The 4 e- reduced species is the most stable blue form <strong>and</strong> develops readily from mixture <strong>of</strong> Mo 6+<strong>and</strong> Mo 5+ .Folin: Mo(VI) (yellow) + e- (from AH) → Mo(V) (blue)Reagents:a) Folins Ciocalteu’s reagent: (0.2N): The Folin-Ciocalteu reagent (FCR) is a mixture <strong>of</strong>phosphomolybdate <strong>and</strong> phosphotungstate used for the colorimetric assay <strong>of</strong> polyphenols<strong>and</strong> polypolyphenols antioxidants. 2N Folin-Ciocalteu’s phenol reagent (SRL) is diluted withdistilled water in the ratio 1:10.b) Sodium carbonate solution: (7.5% (w/v)7.5 g <strong>of</strong> sodium carbonate is dissolved in distilled water <strong>and</strong> make-up the Volume to 100mlusing volumetric flask.c) Sample: Two gm <strong>of</strong> fruit fortified dahi sample was placed in 10ml volumetric flask <strong>and</strong>diluted with distilled water <strong>and</strong> subjected to centrifugation at 4000g for 10 min at 4°C <strong>and</strong> thesupernatant was collected.d) Gallic acid stock solution (1mg/ml)1g <strong>of</strong> Gallic acid (Sigma) was dissolved in 10ml ethanol <strong>and</strong> made up the volume to 1000 mlwith distilled water using volumetric flask.Procedure:a. Take 400μl <strong>of</strong> appropriately diluted sample/gallic acid st<strong>and</strong>ard in a test tube.b. To it add 2000μl <strong>of</strong> diluted Folin-Ciocalteu’s reagent <strong>and</strong> mix with vortex mixer.195


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assurancec. After 3 minutes add 1600 μl <strong>of</strong> sodium carbonate solution <strong>and</strong> incubate under dark at roomtemperature for 30 min.d. For blank preparation take 400μl <strong>of</strong> distilled water instead <strong>of</strong> sample.e. Measure the absorbance <strong>of</strong> the samples against blank at 765nm using SPECORD-200 doublebeam spectrophotometer (Analytical zena).C. St<strong>and</strong>ard curve preparation:St<strong>and</strong>ard curve is prepared by using 10-100 μg/ml concentration <strong>of</strong> gallic acid solution.D. Results:Express the results in terms <strong>of</strong> μmol gallic acid equivalent (GAE) /g <strong>of</strong> fruit pulp.196


Separation <strong>and</strong> Identification <strong>of</strong> Low Molecular Weight Proteins Using Tricine SDS-PAGESeparation <strong>and</strong> Identification <strong>of</strong> Low MolecularWeight Proteins Using Tricine SDS-PAGENeelima Sharma 1 , Rajan Sharma 1 <strong>and</strong> Y. S. Rajput 21<strong>Dairy</strong> Chemistry Division, 2 Animal Biochemistry Division, NDRI, KarnalThe purpose <strong>of</strong> SDS-PAGE is to separate proteins according to their size. SDS-PAGE is the mostwidely used method for analyzing protein mixture quantitatively. It is particularly useful for monitoringprotein purification <strong>and</strong>, because the method is based on the separation <strong>of</strong> proteins according to size,it can be used to determine the relative molecular mass <strong>of</strong> proteins. SDS (CH 3-(CH 2) 10-CH 2OSO 3-Na + )is an anionic detergent <strong>and</strong> when proteins are treated with SDS in presence <strong>of</strong> a reducing agent likeβ-mercaptoethanol or dithiothreitol, SDS binds to hydrophobic regions <strong>of</strong> protein molecule <strong>and</strong>provides net negative charge on protein molecule. The binding <strong>of</strong> SDS to per unit length <strong>of</strong> proteinmolecules is almost constant for large number <strong>of</strong> different proteins <strong>and</strong> this brings charge-to-massratio almost constant for most proteins. The electrophoretic movement <strong>of</strong> protein in acrylamide gel isdetermined by molecular weight <strong>of</strong> proteins. Lower molecular weight proteins move faster than highmolecular weight proteins.Glycine-SDS-PAGE (also known as Laemmli-SDS-PAGE) <strong>and</strong> Tricine-SDS-PAGE, based onglycine-Tris <strong>and</strong> Tricine-Tris buffer systems, respectively are the commonly used SDS electrophoretictechniques for separating proteins.Tricine-SDS-PAGE is commonly used to separate proteins in the mass range 1-100 kDa. It is thepreferred electrophoretic system for the resolution <strong>of</strong> proteins smaller than 30 kDa. Tricine, used as thetrailing ion, allows a resolution <strong>of</strong> small proteins at lower acrylamide concentrations than in glycine-SDS-PAGE systems. A superior resolution <strong>of</strong> proteins, especially in the range between 5 <strong>and</strong> 20 kDa,is achieved without the necessity to use urea. The omission <strong>of</strong> glycine <strong>and</strong> urea prevents disturbanceswhich might occur in the course <strong>of</strong> subsequent amino acid sequencing.Requirements(A) Reagents1. Acrylamide solution (49.5% T, 3%C)• Acrylamide: 48 g• N, N’- Methylene-bis-acrylamide : 1.5 g• Dissolved in distilled water to a final volume <strong>of</strong> 100 ml. Filter the solution <strong>and</strong> refrigerate(7-10°C). Gentle warming may be required for complete dissolution after refrigeration.• %T = Total acrylamide percentage <strong>of</strong> both monomers (acrylamide <strong>and</strong> the crosslinkerbisacrylamide)• %C = Percentage concentration <strong>of</strong> the crosslinker relative to total concentration2. Gel buffer (3X)• Tris: 36.34 g• SDS: 0.3 g• HCl• Dissolve in 60 ml water. Adjust the pH to 8.45 with concentrated HCl. Make up the finalvolume upto 100 ml with water. Store at 20 – 25°C.3. Cathode buffer (1X)• Tris: 12.11 g• Tricine: 17.92 g197


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assurance• SDS: 1 g• Dissolve in distilled water <strong>and</strong> make volume upto 1 L. The pH <strong>of</strong> the solution should be approx8.2. Do not correct the pH.4. Anode buffer• Tris 6.05 g• Dissolve in 50 ml. Adjust pH upto 8.9 with conc. HCl/ 1N HCl <strong>and</strong> then makeup volume upto 500 ml with dist water.5. Sample buffer (4x)• SDS (12%, w/v) : 12 ml <strong>of</strong> 20% SDS• Glycerol (30%, w/v) : 6 g• Mercaptoethanol (6%.v/v) : 1.2 ml• Coommassie blue G 250 (0.05%) : 0.01g• Tris/HCl (pH 7) (150 mM) : 3 ml <strong>of</strong> 1 M Tris-HCl• Make up the volume upto 20 ml.6. Marker (2.5µl/well)• Take 3.5µl marker <strong>and</strong> add 10µl sample buffer (1.33x). For 1.33x sample buffer, dilute 1ml <strong>of</strong> 4xsample buffer with 2 ml distilled water.7. Ammonium persulfate• Dissolve 100 mg <strong>of</strong> ammonium persulfate in 1 ml <strong>of</strong> distilled water immediately before use.8. Separating gel solution (16%)• Acrylamide solution : 5 ml• Gel buffer : 5 ml• Glycerol : 1.5 ml• Water : 3.5 ml• APS : 30 μl• TEMED : 10 μl• TEMED - N,N,N’,N’-Tetramethylethylenediamine.• APS – This is the last to be added in the solution.9. Stacking gel solution (4%)• Acrylamide solution : 1 ml• Gel buffer : 3 ml• Water : 8 ml• APS : 60 μl• TEMED : 10 μl10. Fixing solution• 10% TCA (Trichloroacetic acid)11. Staining solution (0.025% Coommassie brilliant blue g250 in 10% acetic acid)• Dissolve 25 mg <strong>of</strong> the dye in 100 ml <strong>of</strong> 10% acetic acid.12. Destaining solution• 10% Acetic acid. Destain the gel twice. Each incubation should last for 15-60 min. Then transferthe gel to distilled water.• (B) Mini vertical gel electrophoresis unit.198


Separation <strong>and</strong> Identification <strong>of</strong> Low Molecular Weight Proteins Using Tricine SDS-PAGEMethod1. Gel preparation• Prepare gel plates <strong>of</strong> the size 8 x 10 cm in casting st<strong>and</strong> for gel electrophoresis.• Prepare the separating gel (16.5%) was, pipette it down into each <strong>of</strong> the gel cassettes to a height<strong>of</strong> 4 cm.• Overlay the gel mix with water or butanol to cuy oxygen action <strong>and</strong> to give a flat gel surface forflat sample b<strong>and</strong>s.• After polymerization carefully remove water with the help <strong>of</strong> blotting paper.• Then overlay stacking gel solution over it.• Insert preparative comb into the stacking gel solution to make troughs <strong>and</strong> wells <strong>and</strong> keep thewhole system undisturbed (1 -2 hours) for the setting <strong>of</strong> gel.2. Sample preparation• Dissolve 3 mg sample in 500 µl <strong>of</strong> Tris buffer (150 mM, pH 7.0) - Solution A.• Take 3 x 15 µl <strong>of</strong> Solution A <strong>and</strong> 3 x 5 µl <strong>of</strong> 4x buffer <strong>and</strong> load 10 µl in each well. Each wellwould contain 45 µg <strong>of</strong> protein.• Then take 100 µl <strong>of</strong> the Solution A <strong>and</strong> mix with equal volume <strong>of</strong> Tris buffer (150 mM, pH7.0). Now again take 3 x 15 µl <strong>of</strong> this sol in 3 x 5µl <strong>of</strong> 4x buffer <strong>and</strong> load 10 µl in each well.Each well would contain 22.5 µg <strong>of</strong> protein.• Incubate samples <strong>and</strong> marker at 37°C for 15 min3. Electrophoresis• Place the gel s<strong>and</strong>wich after removing the comb in the mini vertical gel electrophoresis unit.• Clamp the s<strong>and</strong>wich in place.• Load 15 µl <strong>of</strong> protein samples <strong>and</strong> molecular weight markers to these wells.• Fill the lower buffer chamber with anode buffer. Check that the lower electrode is completelysubmerged.• Fill the upper buffer chamber with cathode buffer <strong>and</strong> also layer it over the applied samplescarefully. Place the safety lid on the unit.• Run the experiment at 10°C by keeping the whole assembly in the refrigerator.• Carried out electrophoresis at constant current <strong>of</strong> 20 mA till the sample crosses the stacking gel.Then the increase the current to 25 mA <strong>and</strong> maintain throughout the remainder <strong>of</strong> the run untilthe marker dye was within 1 cm <strong>of</strong> the anodic end <strong>of</strong> the gel.• Remove the gel carefully <strong>and</strong> then transfer it to the fixative solution. Keep it over an orbitalshaker for 60 min.• Stain the gel with staining solution for twice the length <strong>of</strong> time used for fixing again using orbitalshaker.• Transfer the gel to the destaining solution till b<strong>and</strong>s become visible against light backgroundrenewing the solution every 30 min.ReferencesSchagger (2006 )Nature Protocol, 1 (1): 16-22.Shagger, H. <strong>and</strong> Jagow, G.V. (1987) Tricine-Sodium dodecyl sulfate-polyacrylamide gel electrophoresis for theseparation <strong>of</strong> proteins in the range from 1 to 100 kDa. 166:368-379.199


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceIntroductionIdentification <strong>of</strong> Proteins ThroughWestern Blotting – PracticalNeelima Sharma 1 , Amit K.Barui 1 <strong>and</strong> Y.S. Rajput 21<strong>Dairy</strong> Chemistry Division, 2 Animal Biochemistry Division, NDRI, KarnalThe technique <strong>of</strong> Western blotting refers to identification <strong>of</strong> specific proteins, which arefirst separated on acrylamide gel using electrophoresis <strong>and</strong> then subsequently transferred tonitrocellulose membrane <strong>and</strong> identified. The identification <strong>of</strong> protein (antigen) is carried out byperforming antigen-antibody (first antibody) reactions on the membrane itself. Second antibodyenzymeconjugates were then allowed to interact with immobilized first antibody <strong>and</strong> then usingappropriate substrate, protein b<strong>and</strong>s are detected. Although, antigen-antibody interactions arewidely employed in Western blot, other kind <strong>of</strong> interactions such as glycoprotein-lectin <strong>and</strong> biotinavidinhave allowed research workers to employ this technique for other applications includingcarbohydrate staining <strong>of</strong> glycoprotein, protein sequencing etc.During 1979-80, this technique was described simultaneously by many workers but the methoddescribed by Towbin et al. (1979) is most cited. The technique <strong>of</strong> Western blotting involves two distincttechniques viz. (i) SDS-PAGE <strong>and</strong> (ii) electrophoretic transfer <strong>of</strong> protein from gel to membrane <strong>and</strong>immuno-detection <strong>of</strong> proteins.For Western blot, SDS-PAGE is carried out in mini-gel units. The separation <strong>of</strong> protein in minigelunit is similar to large-gel unit. In mini-gel units, volumes <strong>and</strong> separation times are considerablyreduced. The resolution in mini-gel is adequate for most routine applications.Electrophoretic transfer <strong>of</strong> proteins from gel to membraneMini-trans blot assembly (Bio-rad), power pack, orbital shaker, tris, glycine, methanol, nitrocellulosemembrane, Whatman No. 3 paper.Transfer buffer (25 mM tris, 192 mM glycine, 20% methanol, pH 8.3)-3.03 g tris <strong>and</strong> 14.4 g glycine are dissolved in distilled water. 200 ml methanol is then added.Volume is made up to 1 litre with distilled water. The pH <strong>of</strong> buffer will range from 8.1 to 8.4 dependingon quality <strong>of</strong> tris, glycine <strong>and</strong> methanol. Methanol should be analytical grade as metallic contaminantsin low grade methanol will plate on the electrode. The pH <strong>of</strong> buffer is not adjusted with acid or base.Procedure-• Membrane <strong>and</strong> gel are h<strong>and</strong>led only after wearing gloves.• After completion <strong>of</strong> SDS-PAGE, spacer gel is removed. A small cut on top left side in runninggel is made to remember the orientation <strong>of</strong> gel.• The running gel is equilibrated with transfer buffer for 30 min. to remove salts <strong>and</strong> SDS. Transferbuffer is changed at least once during equilibration. Membrane <strong>of</strong> appropriate size is cut fromsheet. A small cut on top left side <strong>of</strong> membrane (glossy side facing worker) is made to rememberorientation <strong>of</strong> the membrane.• While the gel is equilibrating, nitrocellulose membrane is activated by placing it in transfer bufferat an angle <strong>of</strong> 450. Also, fiber pads <strong>and</strong> pre-cut filter papers (Whatman No. 3) are immersed intransfer buffer. Air bubbles trapped in fiber pads <strong>and</strong> filter papers are removed.• Gel holder cassete is opened <strong>and</strong> placed in glass vessel so that the gray panel is flat on thebottom <strong>of</strong> the vessel <strong>and</strong> clear panel rests at an angle against wall <strong>of</strong> the vessel.• Gel holder cassette is assembled in following sequence : gray panel (cathode), fiber pad,filter paper, gel, nitrocellulose membrane (glossy side facing the gel), filter paper, fiber pad,200


Identification <strong>of</strong> Proteins Through Western Blotting – Practicalclear panel (anode). For easy remembrance <strong>of</strong> orientation, cut portions <strong>of</strong> gel <strong>and</strong> membraneis aligned. This arrangement allows transfer <strong>of</strong> proteins on membrane where well positionremains the same as that in acrylamide gel. While assembling, care is taken not to allowtrapping <strong>of</strong> air-bubbles. This is achieved by assembling cassette under buffer <strong>and</strong> when eachlayer is added, all air pockets are removed by rolling clean test tube over the layer. Nearlyadhesive contact is essential between the membrane <strong>and</strong> gel otherwise swirled or missingtransfer patterns <strong>and</strong> overall high background will be observed.• Buffer tank is filled with transfer buffer (4ºC). Bio-freeze cooling unit containing ice is placed inbuffer tank.• Gel holder cassette is closed <strong>and</strong> placed in the buffer tank such that gray panel <strong>of</strong> the cassettefaces the gray cathode electrode panel. The whole <strong>of</strong> blotting assembly is then placed over themagnetic stirrer.• Electrophoretic transfer is carried out at constant voltage <strong>of</strong> 30 V overnight at 4ºC. The startingcurrent should be around 40 mA. At the end <strong>of</strong> transfer, the current should be 90 mA. In casefinal value <strong>of</strong> current is less than 90 mA, a constant voltage <strong>of</strong> 100 V is additionally applied for1 h.• After run, nitrocellulose membrane is stained with different reagents for visualization <strong>of</strong> proteinsor antigens. For ascertaining transfer <strong>of</strong> proteins from gel, the gel is also stained with coomassiebrilliant blue as described in earlier section.Detection <strong>of</strong> transferred protein on nitrocellulose membraneIn Western blot, molecular weight markers <strong>and</strong> protein (antigen) samples are loaded in separatelanes in SDS-PAGE. Whereas, methods used for staining <strong>of</strong> molecular weight markers are based onnon-specific reaction <strong>of</strong> dye with protein, antigenic proteins are detected employing antigen-antibodyinteraction. Therefore, after electrophoretic transfer, the membrane-portion containing molecularweight marker is cut from rest <strong>of</strong> membrane containing protein antigens. The molecular weightmarkers can be stained by Ponceau S or congo-red dye. The proteins (antigens) are stained usingprimary antibody <strong>and</strong> secondary antibody-enzyme conjugates.Visualization <strong>of</strong> molecular weight markers-Ponceau S Staining-Stock Ponceau S dye solution is prepared by dissolving 200 mg Ponceau S in 10 ml <strong>of</strong> 3%trichloroacetic acid. The stock dye solution can be stored at room temperature. The stock solution isdiluted ten fold with distilled water before use. The membrane is added slowly to vessel containingdiluted dye solution so that membrane absorbs dye uniformly. The membrane is then sub-merged for5 to 10 min with mild shaking. After staining, the membrane is then rinsed with water or PBS until aclear contrast between the b<strong>and</strong>s (pink) <strong>and</strong> background (white) is observed. Staining <strong>of</strong> proteins withPonceau S is reversible.Congo-red Staining-Stock Congo-red solution is prepared by dissolving 1 g Congo-red in 100 ml distilled water. Thissolution is stable at room temperature. The working congo-red solution is prepared just before use bydiluting 1 ml <strong>of</strong> stock dye solution with 9 ml <strong>of</strong> 0.2 M acetate buffer, pH 3.5. The membrane is submergedin working congo-red solution for 5 min. at room temperature. The destaining is carried outby immersing the membrane in distilled water until brown b<strong>and</strong>s become visible against light pinkbackground. During staining <strong>and</strong> destaining, mild shaking is employed.Visualization <strong>of</strong> Protein (Antigen)-Reagents-Primary antibodies directed against antigen <strong>and</strong> raised in rabbit, secondary antibody enzymeconjugates such as goat anti rabbit immunoglobulin-peroxidase goat, anti rabbit immunoglobulin-201


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assurancealkaline phosphatase, diamino benzedine, hydrogen peroxide, bovine serum albumin, nitro bluetetrazolium (NBT) bromochloroindolyl phosphate (BCIP), dimethyl formamide (DMF).Visualization <strong>of</strong> antigen using secondary antibody peroxidase conjugate-All steps are carried out at room temperature.• Membrane is washed with PBS (3x10 min.)• The membrane is treated with blocking solution (3% BSA prepared in PBS) for 1 h.• The membrane is treated with diluted rabbit antiserum for 1 h. The antiserum in rabbit is raisedagainst the antigen. The dilution is decided by antibody litre in immune serum <strong>and</strong> is carriedout in 1% BSA – PBS- (0.05%) Tween – 20. The membrane is washed with PBS -0.05% Tween 20(3x10 min.).• The membrane is treated with goat anti-rabbit immunoglobulin-peroxidase conjugate (1:1000diluted with 1% BSA – PBS – Tween 20) for 1 h. The dilution <strong>of</strong> conjugate is done as per instructionfrom manufacturer.• The membrane is washed with PBS (4 x 10 min.).• The membrane is immersed in enzyme substrate DAB - H O (6 mg diaminobenzidine in 10 ml2 2<strong>of</strong> 0.05 M Tris-HCl buffer, pH 7.6 containing 100 µl <strong>of</strong> 3% H 2O 2) till brown b<strong>and</strong>s become visible.The membrane at that stage is washed with distilled water <strong>and</strong> air-dried.• Membrane strips containing molecular weight markers <strong>and</strong> proteins (antigens) are aligned <strong>and</strong>photographed.Visualization <strong>of</strong> antigen using secondary antibody-alkaline phosphataseconjugateThe method is similar to the method described using secondary antibody-peroxidase conjugateexcept the followings.• Appropriately diluted secondary antibody-alkaline phosphatase conjugate is used instead <strong>of</strong>antibody-peroxidase conjugate.• Instead <strong>of</strong> DAB-H O , the enzyme substrate used is BCIP-NBT. Stock solutions <strong>of</strong> nitroblue2 2tetrazolium (NBT) <strong>and</strong> bromochloro indolyl phosphate (BCIP) are prepared <strong>and</strong> stored at–200C. Stock NBT is prepared by dissolving 30 mg NBT in 1 ml <strong>of</strong> 70 per cent DMF. StockBCIP is prepared by dissolving 15 mg BCIP in 1 ml <strong>of</strong> DMF. The working substrate solutionis prepared by addition <strong>of</strong> 200 µl <strong>of</strong> stock NBT <strong>and</strong> 200 µl <strong>of</strong> stock BCIP to 20 ml <strong>of</strong> 100 mMTris-HCl, pH 9.5 containing 100 mM NaCl <strong>and</strong> 5 mM MgCl 2. When membrane is treated withenzyme substrate, light violet colour blots become visible against light background.Helpful-hints• The one major problem in Western blot is incomplete transfer <strong>of</strong> protein from gel to nitrocellulosemembrane. Transfer efficiency is improved by decreasing gel concentration which leads tomore porous gel. In more porous gel, the resolution <strong>of</strong> proteins is decreased. Gel containinglow molecular weight proteins should not be excessively washed after SDS-PAGE <strong>and</strong> beforetransfer to avoid removal <strong>of</strong> these proteins in washing.• Methanol in transfer improves binding <strong>of</strong> SDS-proteins to nitrocellulose membrane but it causesacrylamide gel pores to contract resulting in fixation <strong>of</strong> large molecular weight proteins withinthe gel matrix. In case <strong>of</strong> poor transfer <strong>of</strong> large molecular weight proteins, one can try transfer intransfer buffer containing reduced concentration <strong>of</strong> methanol.• Gel <strong>and</strong> membrane must make good contact. Thus excess moisture in the gel-membrane interfaceshould be removed by rolling test tube over membrane while gel holder cassette is assembled.• Poor transfer can occur if the protein is basic (ie pI > 9) as protein will have net positive chargeat the pH <strong>of</strong> transfer buffer (pH 8.5).202


Identification <strong>of</strong> Proteins Through Western Blotting – Practical• Lower concentration <strong>of</strong> methanol (< 15%) does not facilitate removal <strong>of</strong> SDS from the gel <strong>and</strong>proteins.• Nitrocellulose membrane is compatible with enzyme immuno assay. Blocking <strong>of</strong> free proteinbinding sites is easy <strong>and</strong> thus background problems are not observed. No activation <strong>of</strong> themembrane is required. However, some proteins (


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceTyping <strong>of</strong> Milk for A1 <strong>and</strong> A2 beta CaseinSachin<strong>and</strong>an De, C. M. Hari Kishore, Ayan Mukherjee <strong>and</strong> Rupinder KaurAnimal Biotechnology Centre, NDRI, KarnalMilk contains numerous components <strong>of</strong> nutritional <strong>and</strong> health benefit. Calcium is one example.Milk is also a significant source <strong>of</strong> dietary fat. An additional risk factor present in some bovine milkrelated to the beta casein has been discovered. Initially, three variants <strong>of</strong> beta casein were discovered<strong>and</strong> denoted as A, B <strong>and</strong> C. It was later found that the A variant could be resolved into A1, A2 <strong>and</strong>A3 by gel electrophoresis. The beta casein variants now known are A1, A2, A3, B, C, D, E <strong>and</strong> F, withA1<strong>and</strong> A2 being present in the milk in the highest proportions. The debate about A1 <strong>and</strong> A2 milk typeshas been in the public arena for more than ten years. There have been lots <strong>of</strong> claims <strong>and</strong> counter claimsabout whether ‘ordinary milk’, which is a mixture <strong>of</strong> A1 <strong>and</strong> A2 milk, is linked to a range <strong>of</strong> diseaseconditions, <strong>and</strong> whether selecting for cows that produce only A2 milk can avoid these problems. Wehave successfully developed a method for typing DNA from cells available from the milk. We arealso in the process <strong>of</strong> detecting A1 A2 beta casein variants from the milk sample. This is an innovativeprocess for the isolation <strong>of</strong> DNA from milk <strong>and</strong> milk products. The DNA samples obtained fromthe milk <strong>and</strong> milk products were used for differentiation <strong>of</strong> A1 <strong>and</strong> A2 beta-casein by simple PCRtechnique.Cows’ milk b-casein contains 209 amino acids. The A1 <strong>and</strong> A2 variants differ only at position67, which is histidine in A1 or proline in A2 milk. (Another variant B b-casein also has histidine atpositive 67. It is less frequent than A1 or A2 in the milk <strong>of</strong> cows <strong>of</strong> European origin.) A bioactive sevenamino-acidpeptide, b-casomorphin-7 (BCM-7) can be released by digestion in the small intestine <strong>of</strong>A1 b-casein with pepsin, leucine aminopeptidase <strong>and</strong> elastase but the alternative proline at position67 prevents a split at this site.Tyr60-Pro61-Phe62-Pro63-Gly64-Pro65-Ile66-His67b-casomorphin-7 (BCM-7)BCM-7 has opioid <strong>and</strong> cytomodulatory properties. Synthetic BCM-7 can inhibit responses <strong>of</strong>lymphocytes to stimulants in vitro (Elliott, 1992; Elliott et al, 1997). Elliott et al (1997) reported thatNOD mice fed A1 b-casein did not develop diabetes if they were also given naloxone (the morphineantagonist). The antibody response to ovalbumin was prevented in NOD mice if they were alsogiven injections <strong>of</strong> (synthetic) BCM-7; this prevention did not happen in Swiss mice. They suggestedthat appearance <strong>of</strong> diabetes in genetically susceptible NOD mice fed A1 bcasein— not those fed A2b-casein—might be due to release from A1 b-casein <strong>of</strong> the bioactive peptide, BCM-7 which had astrong inhibitory effect on immune function.Some 75% <strong>of</strong> the world’s 300 million strong dairy herd produces milk that contains the proteinbeta casein A1. There is a somewhat controversial claim, backed by 16 years <strong>of</strong> research, that thismilk, which is drunk by most people in the western world, could be a cause <strong>of</strong> diabetes, heart disease,autism <strong>and</strong> schizophrenia in people with immune deficiencies. It is also claimed that the protein betacasein A2 is benign in this respect. Cows in the well-known dairy breeds can produce either or both<strong>of</strong> the beta casein proteins. They can be A1/A1, A1/A2, or A2/A2. Genotyping has shown that about80% <strong>of</strong> Indian (Bos indicus) cows produce only beta Casein A2. In Australia, A2 milk was launched(A2 Corporation) quietly into the world marketplace. A2’s backers believe it will help prevent disease<strong>and</strong> make them fortunes. A1 proponents argue that the evidence against ordinary milk has not beenproved <strong>and</strong> that they are the victims <strong>of</strong> a scare campaign. The New Zeal<strong>and</strong> Medical Journal publisheda paper in 2003 entitled ‘The influence <strong>of</strong> consumption <strong>of</strong> A1 ß-casein on heart disease <strong>and</strong> Type204


Typing <strong>of</strong> Milk for A1 <strong>and</strong> A2 beta Casein1 diabetes’, (http://www.nzma.org.nz/journal/116-1168/295/) by Murray Laugesen, <strong>and</strong> Robert BElliott. We all know the well documented <strong>and</strong> proven benefits <strong>of</strong> drinking milk which is a mixture<strong>of</strong> A1/A2. The general view is that there may be quite some way to go before the hypothesis can beproved by evidence <strong>of</strong> cause <strong>and</strong> effect.A PCR based method was developed to detect the A1 <strong>and</strong> A2 beta casein variant forms in cattle<strong>and</strong> buffalo milk. Buffalo milk is <strong>of</strong> A2 type so far the numbers <strong>of</strong> samples are tested in our laboratory.Different proportions <strong>of</strong> A1 <strong>and</strong> A2 alleles are found in Indian cattle milk. This A1 allele is representedin heterozygous A1A2 type as well as in A1A1 type. Some animals are homozygous for examplebovines that are A1A1 for Beta casein <strong>and</strong> those A2A2 for beta casein. In bovine, a mutation in theDNA sequence coding for the beta casein protein at nucleotide position 200 has resulted in thereplacement <strong>of</strong> a cytidine base with an adenine base. Thus, the triplet codon affected by this changecodes for histidine (CAT) rather than for proline (CCT) at amino acid position 67 <strong>of</strong> the protein. Thus,the histidine at position 67 results in the cow producing beta casein A1 type while the proline resultsin the cow producing beta casein A2 type. A high proportion <strong>of</strong> the common domestic cattle breeds,such as Holstein, express the beta casein A1type. It was estimated that in the late 1980s more than 70%<strong>of</strong> the Californian <strong>Dairy</strong> herd carried the A1 allele. If the hypothesis <strong>of</strong> undesirable role <strong>of</strong> A1 betacaseinis confirmed, consumers may wish to reduce or remove this allele from their diet. In this way,we systematically try to monitor the frequency <strong>of</strong> beta-casein alleles in bulls <strong>and</strong> indirectly in cows.205


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceEnzyme-Linked Immunosorbent Assay-PracticalSuman Kapila <strong>and</strong> Rajeev KapilaAnimal Biochemistery Division, NDRI, KarnalEnzyme-linked immunosorbent assay, commonly known as ELISA is a heterogeneous EIA basedon the same principle as the radioimmunoassay but depends on an enzyme rather than a radioactivelabel. An enzyme conjugated with an antibody reacts with a colorless substrate to generate a coloredreaction product. Such a substrate is called a chromogenic substrate. A number <strong>of</strong> enzymes are beingused for ELISA like alkaline phosphatase, horseradishperoxidase <strong>and</strong> β-galactosidase. The specificity,sensitivity <strong>and</strong> ease to perform these techniques have made these methods popular. A number <strong>of</strong>variations <strong>of</strong> ELISA have been developed.Indirect ELISACoat well with Addition <strong>of</strong> specific Addition <strong>of</strong> secondary Addition <strong>of</strong> substrateAg Ab Ab (Enzyme -conjugated) measure colorS<strong>and</strong>wich ELISACoat well with Addition <strong>of</strong> Ag Addition <strong>of</strong> secondary Addition <strong>of</strong> substrateAb Ab (Enzyme -conjugated) measure colorCompetitive ELISAIncubation <strong>of</strong> antibody Addition <strong>of</strong> Ag-Ab Addition <strong>of</strong> secondary Addition <strong>of</strong> substratewith the Ag mixture Ab(Enzyme -conjugated) measure color206


Enzyme-Linked Immunosorbent Assay-PracticalAssay for immunoglobulins in colostrums/milk/serum by s<strong>and</strong>wich ELISAReagents:Coating buffer: 50mM Carbonate-Bicabonate Buffer, pH 9.6Washing buffer : 0.05 percent Tween in PBS (PBS/T).Blocking solution : 1 percent BSA (fraction V) in PBS/T.Coating antibody : Sheep anti-Bovine IgGSt<strong>and</strong>ard : Bovine reference serumDetection antibody : Sheep anti-Bovine IgG HRP conjugateSubstrate : TMB/ H 2O 2(0.02%) substrateStop solution : H 2SO 4(2M)ProcedureCoating1. Dilute capture antibody at a ratio <strong>of</strong> 1:100 with coating buffer <strong>and</strong> add 100ul <strong>of</strong> diluted captureantibody to coat each well.2. Incubate for at least 1h at room temperature3. After incubation, aspirate the solution <strong>of</strong> each well <strong>and</strong> wash the wells three times with washingbuffer.Blocking1. Add 200ul <strong>of</strong> blocking solution to each well2. Incubate for at least 1h at room temperature.3. After incubation, aspirate the solution <strong>of</strong> each well <strong>and</strong> wash the wells three times with washingbuffer.Reacting St<strong>and</strong>ards <strong>and</strong> SamplesFor preparation <strong>of</strong> sample, take 20ml <strong>of</strong> milk/colostrums, warm it <strong>and</strong> add 0.5ml <strong>of</strong> rennet solution(0.5%). After 10 minutes, filter the coagulated sample using Whatman 42. Take filtrate for quantification<strong>of</strong> antibodies.1. Dilute the st<strong>and</strong>ards <strong>and</strong> samples in blocking solution at 1:2 serial dilutions2. Transfer 100ul <strong>of</strong> st<strong>and</strong>ard or sample to assigned wells.3. Incubate for at least 1h at room temperature.4. After incubation, aspirate the solution <strong>of</strong> each well <strong>and</strong> wash the wells five times with washingbuffer..Detection Antibody1. Dilute the detection antibody in blocking solution.2. Add 100ul per well <strong>and</strong> incubate for 1h at room temperature.3. After incubation, aspirate the solution <strong>of</strong> each well <strong>and</strong> wash the wells five times with washingbuffer.Colour reaction1. Add 150ul <strong>of</strong> substrate solution containing 50ul TMB <strong>and</strong> 100ul H O to each well. Mix well by2 2shaking slightly.2. After incubation for 10-15 minutes at room temperature add 50ul stop solution3. Using a microtiter plate reader, read the plate at 450nm.207


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceEvaluation <strong>of</strong> Biological Activity <strong>of</strong>Milk Protein IngredientsBimlesh Mann, Prerna Saini, Prabhakar Padghan, Anuradha Kumari<strong>Dairy</strong> Chemistry Division, NDRI, KarnalWith the growing popularity <strong>of</strong> high protein dairy products among health conscious consumers,many dairy manufacturers are looking for ways to boost the protein level <strong>of</strong> foods such as yoghurt,dairy beverages <strong>and</strong> frozen desserts. Milk protein ingredients which include sodium caseinate, wheyprotein concentrate (WPC), whey protein isolates (WPI) <strong>and</strong> milk protein hydrolysates, not onlyimprove the nutritional pr<strong>of</strong>ile <strong>of</strong> dairy foods, but also provide the functionality. From a nutritionalperspective, all the milk ingredients are complete, high quality protein with all the essential aminoacids required for the human nutrition. From functional perspective, WPC <strong>and</strong> WPI are highly solubleover a wide pH range <strong>and</strong> contribute emulsifying, water binding, thickening, foaming, gelling, <strong>and</strong>film forming properties to food <strong>and</strong> beverages system. While the milk protein hydrolysate are fullysoluble <strong>and</strong> less likely to gel at high concentration in the high protein beverages compared to intactmilk proteins. From the bi<strong>of</strong>unctional point <strong>of</strong> view, milk proteins are the potential sources <strong>of</strong> bioactivepeptides with antimicrobial, ACE- inhibitory, cholesterol lowering, antioxidant, immunomodulatory<strong>and</strong> opioid properties. These peptides are inactive within the protein sequence <strong>and</strong> require enzymaticproteolysis for their release. Bioactive peptides usually contain 3-20 amino acid residues per molecule.These milk derived bioactive peptides are considered as prominent ingredients for various healthpromoting functional foods targeted at heart, bone <strong>and</strong> digestive system health as well as improvingimmune defense, mood <strong>and</strong> stress control.1) Antioxidant activity:-Free radicals are generated through normal reactions within the body during respiration in aerobicorganisms, particularly vertebrates <strong>and</strong> humans. In addition to the physiological production <strong>of</strong>oxidants <strong>and</strong> their secondary reactions, there are other sources for production <strong>of</strong> oxidants. Oxidation<strong>of</strong> fats <strong>and</strong> oils during processing <strong>and</strong> storage <strong>of</strong> food products worsen the quality <strong>of</strong> their lipid content<strong>and</strong> nutritive values. Consumption <strong>of</strong> these potentially toxic products can give rise to several diseases.Under normal conditions, antioxidant defense systems can remove reactive species through enzymaticantioxidants like superoxide dismutase <strong>and</strong> glutathione peroxidase <strong>and</strong> non-enzymatic antioxidantssuch as proteins <strong>and</strong> peptides, antioxidant vitamins, trace elements, coenzymes <strong>and</strong> c<strong>of</strong>actors. Themilk derived bioactive peptides show antioxidant activity by sequestering free radicals, chelatingmetal <strong>and</strong> regulating the level <strong>of</strong> antioxidant enzymes in body.Principle:Based on the principle <strong>of</strong> interaction <strong>of</strong> antioxidant with chemically generated ABTS˙ (bluecoloured) oxidant by persulfate oxidation <strong>of</strong> 2, 2-azinobis (3-ethylbenzothiazoline-6-sulfonic acid)(ABTS2-) indicated by decrease in absorbance at 734nm with concomitant decrease in blue colour <strong>of</strong>the oxidant.Sample preparation:5% solution <strong>of</strong> whey protein concentrate preheated at 65°C /30 min is hydrolyzed by using alcalaseat 65°C for 5 hrs by maintaining pH at 8.5. The hydrolysate is centrifuge at 10000 rpm/30 min <strong>and</strong>supernatant is collected.208


Evaluation <strong>of</strong> Biological Activity <strong>of</strong> Milk Protein IngredientsReagents:a) Potassium persulphate solution (140 mM)b) ABTS [2, 2’-azinobis (3 ethyl benzothiazoline)-6-sulfonic acid] stock solutionDissolve 19.2 mg <strong>of</strong> ABTS in 5 ml <strong>of</strong> double distilled water; add 88 µl <strong>of</strong> 140 mM potassiumpersulphate <strong>and</strong> keep the solution in an amber colour bottle in dark for 12-16 hours.c) Phosphate buffer saline (pH 7.4)PBS was prepared by dissolving 8.0 g <strong>of</strong> NaCl, 0.2 g <strong>of</strong> KCl, 1.44 g <strong>of</strong> Na 2HPO 4<strong>and</strong> 0.24 g <strong>of</strong>KH 2PO 4in 800 ml distilled water, adjusted pH to 7.4 with 1 N HCl <strong>and</strong> made the volume to 1 liter withdistilled water.d) ABTS working solutionDilute 1 ml <strong>of</strong> ABTS stock solution with phosphate buffer saline (approx 1:90) till it gives anabsorbance <strong>of</strong> 0.70±0.02 at 734 nm. The stock solution <strong>of</strong> ABTS is stable upto 2 days for analyticalpurpose.e) Trolox solution (5 mM)Dissolve 12.5 mg <strong>of</strong> Trolox [6-hydroxy. 2, 5, 7, 8 – tetramethyl chroman-2-carboxylic acid] in 10 ml<strong>of</strong> ethanol. Dilute with distilled water to varying concentrations (25 - 250µM).Procedure:• Pipette out 3 ml <strong>of</strong> ABTS working solution in 3 ml cuvette• Pipette out 3 ml <strong>of</strong> phosphate buffer saline in another cuvette• Insert the curette into the respective slots in the double beam spectrophotometer• Add 10 µl <strong>of</strong> appropriate diluted sample / Trolox to both reference <strong>and</strong> ABTS solution• Mix the contents for 10 seconds• Measure the decrease in the absorbance at 734nm over a period <strong>of</strong> 10 minutes at 10 sec interval.• Plot the st<strong>and</strong>ard curve with concentration (µM) <strong>of</strong> Trolox (X-axis) vs % inhibition (Y-axis)• Express the results as trolox equivalent antioxidant capacity (TEAC) values i.e. μM troloxequivalent / mg <strong>of</strong> protein using st<strong>and</strong>ard curve.2) Antihypertensive activity:-Angiotensin I converting enzyme (ACE; kinases II peptidyldipeptide hydrolase, EC 3.4.15.1) isimportant for blood pressure regulation. In the event where decreased blood volume or decreased bloodflow to the kidneys is sensed, renin acts on angiotensinogen to form angiotensin I. ACE then catalysesthe hydrolysis <strong>of</strong> the inactive prohormone angiotensin I (decapeptide) to angiotensin II (octapeptide).The result is an increase in blood pressure through vasoconstriction, via increased systemic resistance<strong>and</strong> stimulated secretion <strong>of</strong> aldosterone resulting in increased sodium <strong>and</strong> water resorption in thekidneys. ACE also inactivates the vasodilating peptide bradykinin (nonapeptide) <strong>and</strong> endogenousopioid peptide Met-enkephalin. Biologically active peptides derived from milk proteins are having anaffinity to modulate blood pressure by inhibit ACE activity.Principle:The method is based on the liberation <strong>of</strong> hippuric acid from hippuryl-L-histidyl-L-leucine (HHL)catalyzed by ACE.Sample preparation:5% solution <strong>of</strong> whey protein concentrate preheated at 65°C /30 min is hydrolyzed by using alcalaseat 65°C for 5 hrs by maintaining pH at 8.5. The hydrolysate is centrifuge at 10000 rpm/30 min <strong>and</strong>supernatant is collected.209


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceReagents:Hippuryl- histidyl-leucine (HHL) (5 mM)10.74 mg <strong>of</strong> HHL (Sigma, U.S.A) was dissolved in 5 mL <strong>of</strong> 0.1 M sodium borate buffer (pH 8.3) with0.3 M NaCl, pH 8.3Sodium Borate buffer (0.1 M, pH 8.3) containing 0.3 M NaClSodium tetra borate 3.81 g <strong>and</strong> NaCl 1.75 g were dissolved in 80 mL <strong>of</strong> distilled water, pH wasadjusted to 8.3 <strong>and</strong> finally volume was made to 100 mL with distilled water.Angiotensin converting enzyme (ACE)ACE from rabbit lung (Sigma, U.S.A) 1 unit was dissolved in 5 mL <strong>of</strong> distilled water <strong>and</strong> stored at-20ºC.Procedure:1. Add 20 μl <strong>of</strong> sample to 110 μl <strong>of</strong> substrate (in 5 mM HHL in 0.1 M borate buffer)2. Add 20 μl ACE (4 mU), mix <strong>and</strong> incubate the mixture at 37ºC for 30 min.3. Add 250 μl <strong>of</strong> 1M HCl to terminate the reaction4. Extract the hippuric acid formed with 1.5 ml ethyl acetate centrifuging at 3000 g for 10 min5. Dry one ml <strong>of</strong> upper organic layer by heating at 95ºC for 20min <strong>and</strong> redissolve in 1 ml <strong>of</strong> distilledwater6. Measure the absorbance at 228nm7. Prepare positive control with distilled water in place <strong>of</strong> sample8. Prepared blank with substrate <strong>and</strong> water (ACE volume is replaced by equal amount <strong>of</strong> water)9. Calculate% ACE =Express the results as peptide concentration required to inhibit 50 percent <strong>of</strong> the original ACEactivity (IC50).3) Caseinophosphopeptides as mineral binding peptides:-Caseinophosphopeptides(CPPs) are casein derived peptides contains phosphorus boundvia monoester linkages to seryl residues. They contain a common motif i.e. a sequence <strong>of</strong> threephosphoseryl groups followed by two glutamic acid residues Ser (p)- Ser (p)- Ser (p)- Glu- Glu.These peptides are highly negatively charged structures <strong>and</strong> soluble at pH 4.6. The highly anionicphosphorylated regions <strong>and</strong> the a.a. sequence around this hydrophilic region part play a significantrole in mineral binding <strong>and</strong> absorption in body. These peptides are able to bind macroelements suchas Ca, Mg <strong>and</strong> Fe along with trace elements such as Zn, Ba, Cr, Ni, Co <strong>and</strong> Se.Principle:CPPs are soluble at pH 4.6 <strong>and</strong> they are aggregated with divalent cation such as calcium at neutralpH <strong>and</strong> precipitated by using ethanol.Procedure:• Prepare 5 % casein suspension by mixing casein on a magnetic stirrer• Adjust the pH to 7 using 0.5 N NaOH.• Add enzyme tripsin at Enzyme: substrate ratio <strong>of</strong> 1:25• Hydrolysis is carried out by mixing the suspension using electric stirrer in water bath at 37ºCfor 4 hours• The pH <strong>of</strong> solution is kept constant at 7.0 by addition <strong>of</strong> 0.1N NaOH solution210


Evaluation <strong>of</strong> Biological Activity <strong>of</strong> Milk Protein Ingredients• After complete hydrolysis remove the mixture from water bath• Adjust the pH <strong>of</strong> casein hydrolysate to 4.6 using 2N HCl• Centrifuge at 3000 rpm for 10 min to remove the unhydrolyze protein.• Collect the supernatant <strong>and</strong> adjust pH to 7.0 using 2.0 N NaOH.• Add calcium chloride at 1% level to the supernatant <strong>and</strong> allow it for 1 hour at roomtemperature.• Add Ethanol 50%(V/V)• The precipitate is collected by centrifugation at 6000 rpm for 10 min.• The CPPs thus obtained is lyophilized.Flow Diagram for Isolation <strong>of</strong> CPPs:Whole caseinHydrolysis with enzymes at 37ºCAdjustment <strong>of</strong> pH to 4.6 with 2N HClRemoval <strong>of</strong> unhydrolyze protein by centrifugationat 3000 rpm /10minAdjustment <strong>of</strong> pH to 7.0 using 2N NaOHCalcium chloride aggregation <strong>and</strong> ethanol extraction byCentrifuging at 6000 rpm/10minEnriched CPPs211


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssurancePurification <strong>of</strong> Bioactive Proteins from MilkNeha Mishra 1 , Rajesh Kumar 2 <strong>and</strong> Jai K Kaushik 11Animal Biotechnology Centre, 2 <strong>Dairy</strong> Chemistry Division, NDRI, KarnalColostrum secretion in the mammary gl<strong>and</strong> during the first few days after parturition provides thecalves with nourishment <strong>and</strong> passive immunity. Differences between relative protein concentrationin colostrum <strong>and</strong> milk reflect differences in immunoglobin transfer. It is a source <strong>of</strong> nutrients <strong>and</strong>contains many kinds <strong>of</strong> bioactive molecules which are essential for specific functions. The major wheyproteins are β-lactoglobulin, α-lactalbumin, lactoperoxidase, lact<strong>of</strong>errin <strong>and</strong> immunoglobins etc.Lact<strong>of</strong>errin <strong>and</strong> immunoglobin G are two <strong>of</strong> the most important bioactive components in colostrum<strong>and</strong> both are contained in over 10 fold higher concentrations in colostrum as compared to normalmilk. Several proteins with antimicrobial activity, such as immunoglobulins, κ-casein, lysozyme,lact<strong>of</strong>errin, haptocorrin, β-lactalbumin, <strong>and</strong> lactoperoxidase, are relatively resistant against proteolysisin the gastrointestinal tract. Lact<strong>of</strong>errin is nearly 80-kDa glycoprotein belonging to transferin familywith characteristic red color due to iron binding. Apart from being present in high concentrationin colostrum, lact<strong>of</strong>errin is also an important component <strong>of</strong> many external secretions such as saliva,tears, semen, mucosal secretions <strong>and</strong> neutrophilic granules <strong>of</strong> leucocytes. Membrane separation <strong>and</strong>chromatography are commonly used techniques for isolation <strong>of</strong> high purity lact<strong>of</strong>errin. Comparedwith other chromatographic methods, ion-exchanger is an advantageous technique due to its low cost,reduced number <strong>of</strong> steps <strong>and</strong> easy to scale up. Lact<strong>of</strong>errin is subjected to cation exchanger by takingadvantage <strong>of</strong> its basic nature, as LF has isoelectric point <strong>of</strong> ~ 9, while major whey proteins alphalactalbumin<strong>and</strong> ß-lactoglobulin have pI values <strong>of</strong> 4.2 <strong>and</strong> 5.4, respectively. Therefore, by employingweak cation exchanger at neutral pH, lact<strong>of</strong>errin is allowed to bind to the resin followed by elutionusing a linear gradient <strong>of</strong> NaCl.Materials <strong>and</strong> methodFresh buffalo or cattle colostrum, 7 gms CM-sephadex per liter colostrum, Tris-HCl - 50mM, pH-8.0 equilibration buffer, Tris-HCl (50mM, pH 8.0) + 0.2M NaCl washing buffer, Tris-HCl (50mM, pH8.0) + 0.5M NaCl elution buffer, Tris-HCl (50mM, pH-8.0) +1M NaCl. Glass column <strong>of</strong> ca 1.5-2.5 cmdiameter <strong>and</strong> 50 cm in height can be employed at the first step <strong>of</strong> purification <strong>of</strong> lact<strong>of</strong>errin in a batchmode. High resolution purification requires prepacked cation-exchanger like CM-sepharose or MonoS(GE Biosciences) connected with a medium pressure protein purification system, e.g. AktaPrimer orAkta Explorer (GE Biosciences). The cation exchanger column <strong>and</strong> purification system from othersuppliers may also be used without any effect on purification; however in our lab, the protocol forhigh resolution purification <strong>of</strong> lact<strong>of</strong>errin has been optimized on HiLoad 16/10 SP-Sepharose highperformance cation exchange column from GE Biosciences.ProcedureCM-Sephadex (7g/litre) ion exchanger resin is equilibrated with 2 volume <strong>of</strong> Tris-HCl 50mM,pH 8.0. 2 liters <strong>of</strong> fresh colostrum is defatted by centrifuging at 3-5000 rpm for 15 mins. Fat layer canbe removed from centrifuge bottles by spatula followed by filteration <strong>of</strong> the defatted milk througha double layered cheese cloth. The skimmed milk is then resuspended in 2-3X volume <strong>of</strong> 50 mMTris-HCl pH 8.0. Pre-equilibrated CM-sephadex matrix (50 mM Tris-HCl pH 8.0) is then added <strong>and</strong>lact<strong>of</strong>errin <strong>and</strong> other cationic proteins are allowed to bind to the matrix by continuous manual stirringfor 2-3 hours. Mixture was left overnight on the magnetic stirrer at 4 ºC for effective binding whichwas observed by change in color <strong>of</strong> the gel. Stirring is stopped <strong>and</strong> the matrix gel is allowed to settlein the bottom <strong>of</strong> the vessel. Whey can be decanted carefully without disturbing the gel. The settled gelis then washed with 3-4 volumes <strong>of</strong> Tris-HCl 50mM, pH 8.0 until whey has been completely removed212


Purification <strong>of</strong> Bioactive Proteins from Milkfrom the matrix, which can be packed in the column. Lactoperoxidase <strong>and</strong> immunoglobins are elutedby washing the matrix with Tris-HCl 50mM, pH 8.0 + 0.2M NaCl. Lactoperoxidase is eluted as ablue-greenish layer. This is followed by elution <strong>of</strong> lact<strong>of</strong>errin with 0.5M NaCl with Tris-HCl 50 mM atpH 8.0. Isolated lact<strong>of</strong>errin is then dialyzed in 50mM Tris-HCl pH 8.0 to remove the NaCl, followedby concentration by using 30kDa ultrafiltration devices (4000rpm for 30 mins) like Centricon fromMillipore or equivalent from other manufacturers. Highly purified lact<strong>of</strong>errin can be obtained byloading it into SP-Sephrose column equilibrated with 0.4M NaCl + 50mM Tris-HCl, pH 8.0 <strong>and</strong> elutedthrough a linear gradient <strong>of</strong> 0.4M NaCl -0.7M NaCl with 50 mM Tris-HCl pH 8.0. Level <strong>of</strong> purity <strong>of</strong> thesample can be analyzed by SDS-PAGE.Flow diagram <strong>of</strong> purification <strong>of</strong> lact<strong>of</strong>errin from colostrumFresh colostrumCentrifuged at 4000 rpm (250-500 ml bottle fixed rotor)Remove fat by filtering through cheese clothDilute whey 2-3 times with 50 mM Tris-HCl, pH 8.0Add CM-Sephadex C-50, pre-equilibrated with 0.05M Tris- HCl, pH 8Stir the gel in the colostrums manually for 2-3 hours, leave it O/N with stirringDecant the whey, <strong>and</strong> wash the settled gel with 0.05M Tris HCl pH 8.0Gel washing followed by decantation is repeated at-least thriceProteins like LP <strong>and</strong> Ig are washed from gel with 0.05 M Tris-HCl / 0.2 M NaCl (pH 8.0)The lact<strong>of</strong>errin is eluted as a red solution with 0.05 M Tris-HCl/ 0.5 M NaCl (pH 8.0).Lact<strong>of</strong>errin eluted at 0.5 M NaCl is pooled, ultrafiltered <strong>and</strong> passed through Hiload SP-Sephrosecolumn equilibrated with 0.4 M NaCl/ 50mM Tris-HCl (pH 8.0)Run SDS-PAGE for evaluating the quality <strong>of</strong> purified lact<strong>of</strong>errinThe purified sample can be desalted for biochemical, biophysical or structural analysis work orstorage at -20ºC213


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceIntroductionImmunological Method to DetectBuffalo Milk in Cow MilkArchana Verma<strong>Dairy</strong> Cattle Breeding Division, NDRI, KarnalSince buffalo milk constitutes a major share <strong>of</strong> total milk production in our country, sale <strong>of</strong> watereddown buffalo milk in the name <strong>of</strong> cow milk is commonly practiced. Due to pricing policy in most states,liking for cow milk by a specific group <strong>of</strong> users <strong>and</strong> also for manufacturing some quality productsfrom cow milk it has to be made sure that there is no admixing <strong>of</strong> buffalo milk in the milk /products. Ifbuffalo milk is manipulated in terms <strong>of</strong> fat percentage <strong>and</strong> addition <strong>of</strong> pale yellow coloration, it is verydifficult to distinguish the milk with regards to its species <strong>of</strong> origin by any physico–chemical method.The answer to the problem <strong>of</strong> such manipulations or admixing <strong>of</strong> milk from different species lies witha test known as the ‘Hansa Test’ named after the mythological bird ‘hans’, which detects the admixing<strong>of</strong> buffalo milk in cow milk. This is based on the principle <strong>of</strong> antigen-antibody reaction. The antiserumproduced after immunizing rabbit with buffalo casein, gives visible reaction only with buffalo milk.This is the “Hansa Test Serum” specific to buffalo milk. The test may also be applied to some <strong>of</strong> themilk products after reconstitution.Material required• Rabbits (Adult, healthy <strong>and</strong> preferably male).• Centrifuge- High speed upto 12000 rpm.• Laboratory (upto 5000 rpm).• Autoclave.• Homogenizer.• General laboratory items <strong>and</strong> chemicals (centrifuge tubes, beakers, conical flasks, Scalpel blade,xylene, saline, phenol, slides, pipettes, cotton, tooth-picks, adrenaline 1:50000 I.U etc.).• Syringes (2 ml <strong>and</strong> 5 ml)-needles (21G <strong>and</strong> 23G).• Source <strong>of</strong> pure cow <strong>and</strong> buffalo milk.• Pure cow casein.ProcedureThe test is carried out in following three steps:Preparation <strong>of</strong> antigen• Take 50 ml <strong>of</strong> pure buffalo milk in polypropylene tubes <strong>and</strong> centrifuge at 3000 rpm for 30minutes.• Pierce the top layer <strong>of</strong> fat to pour skimmed milk in a beaker.• Centrifuge the skim milk at 12000 rpm for 30 minutes.• Remove the clear whey <strong>and</strong> scrap out the packed casein in a clean glass beaker containingdistilled water.• Homogenize in a mechanical homogenizer <strong>and</strong> make the final volume equal to the quantity <strong>of</strong>skim milk used.• Filter through several layers <strong>of</strong> muslin cloth <strong>and</strong> store in a refrigerator under clean sterilizedcondition <strong>and</strong> may be used for one week.• Casein, thus prepared, acts as an antigen to produce antibodies against it.214


Immunological Method to Detect Buffalo Milk in Cow MilkImmunization <strong>of</strong> rabbits• Select adult <strong>and</strong> healthy rabbits for immunization. with buffalo casein according to a definiteschedule for a specific period <strong>of</strong> time (Table).• Intra-peritoneal injections are administered taking care that needle(21G) does not pierce theviscera.• Intra-venous injections <strong>and</strong> blood collection are done through marginal vein <strong>of</strong> the ear using23G needle.• The injections should be very slow <strong>and</strong> always use one year for injections <strong>and</strong> other one forblood collection.• A period <strong>of</strong> 3 to 6 weeks <strong>of</strong> immunization is required to get the antisera <strong>of</strong> desired titre.Blood collection <strong>and</strong> testing the titre• After immunizing the rabbits for two consecutive weeks, the blood is collected from each rabbiton the first day <strong>of</strong> 3rd week, before injection <strong>and</strong> the serum is separated.• Dilute cow <strong>and</strong> buffalo milk 1:10 with water.• Place one drop <strong>of</strong> diluted milk on a clean slide. Add one drop <strong>of</strong> serum to be tested <strong>and</strong> mixthoroughly with toothpick.• Observe the agglutination giving swirling movement to the slide (Figure). Those rabbits, whosesera give good titre, further immunization is stopped <strong>and</strong> blood is collected to the maximumextent to get the antiserum. For other rabbits, injections are continued. In case, any rabbit doesnot show titre, suspend immunization after 6 weeks.• Sometimes, due to cross- reacting antibodies in cow <strong>and</strong> buffalo caseins, the titre might be seenin both the species. In such case, cow casein component <strong>of</strong> the antisera is absorbed using driedcow casein, leaving the test valid only for buffalo milk.Preservation <strong>of</strong> serumThe anti-serum is preserved without getting its efficacy affected by adding 5% solution <strong>of</strong> phenol@ 3% <strong>of</strong> the volume <strong>of</strong> the serum.Precautions• For casein (antigen) preparation, utmost care should be taken to use only pure buffalo milk toget anti-serum specific to buffalo milk adulteration.• Intravenous injections should be administered very slowly to avoid shock to the animal. Ifthe animal shows any sign <strong>of</strong> shock, 1 ml <strong>of</strong> adrenaline (1:50000 I.U.) should be given intramuscularly.• Store serum at 4ºC.• Repeated freezing <strong>and</strong> thawing <strong>of</strong> the serum should be avoided.• While testing the titre, use separate pipettes for cow milk, buffalo milk <strong>and</strong> the serum.• Homogenize milk products thoroughly before testing.Benefits <strong>of</strong> the technology• Adulteration <strong>of</strong> buffalo milk in cow milk (or any other milk) can be detected with accuracy.• The test is very fast i.e. less than 30 seconds for one lot <strong>of</strong> milk.• Only one drop <strong>of</strong> antiserum is required to test whole lot <strong>of</strong> milk.• Benefits <strong>of</strong> pricing policy may be obtained by cow breeders.• Test may be performed with equal efficacy with the formalin preserved milk also.• Good <strong>and</strong> acceptable quality products may be manufactured using pure cow milk wheneverrequired.215


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assurance• Test is equally effective for milk products as well.• The technology is applicable to detect admixing <strong>of</strong> milk <strong>of</strong> any species provided the antigen i.e.casein is injected from that species.Table: Immunization ScheduleWeek <strong>of</strong> the *Dose <strong>of</strong> antigen in a week (ml)Immunization**1st Day 2nd Day 3rd DayI 0.5 0.5 1.0II 1.0 1.0 1.5III 1.5 1.5 2.0IV 2.0 2.0 2.5V 2.5 2.5 3.0VI 3.0 3.0 3.5*The three days should be 3 consecutive days <strong>of</strong> theweek <strong>and</strong> the same schedule should be followed for allthe weeks <strong>of</strong> immunization.**All the injections are intravenous except the 1st day<strong>of</strong> week II to week VI, which are intra-peritoneal.Figure: observations using hansa testa) Agglutination reaction means Positive Test i.e. thesample is either buffalo milk or admixed with buffalomilkb) Clear solution means Negative Test i.e. no admixing<strong>of</strong> buffalo milk.216


Conjugated Linoleic Acid <strong>and</strong> Its EstimationIntroductionConjugated Linoleic Acid <strong>and</strong> Its EstimationConjugated linoleic acid:A. K. Tyagi, A. Hossain, A. Tyagi<strong>Dairy</strong> cattle Nutrition, NDRI, KarnalCLA refers to mixture <strong>of</strong> positional <strong>and</strong> geometric isomers <strong>of</strong> LA (cis-9, cis-12 octadecadienoic acid)with a conjugated double bond system, instead <strong>of</strong> the usual methylene-separation. Each double bondcan be <strong>of</strong> cis or trans configuration giving rise to possible CLA isomers (Kelly et al., 1998). Conjugation<strong>of</strong> double bond occurs as part <strong>of</strong> free radical mediated oxidation <strong>of</strong> LA. CLA is a true isomer <strong>of</strong> LA,in that it does not possess additional oxygen (V<strong>and</strong>enberg et al., 1995). The presence <strong>of</strong> fatty acid withconjugated double bond was first demonstrated in food products derived from ruminants by Boothet al. (1935) who observed that fatty acids obtained from summer butter differed from those obtainedfrom winter butter by exhibiting a much stronger spectrophotometric absorption at 230 mm. It wassubsequently concluded that the absorption at this wavelength was due to a conjugated double bondpair (Moore, 1939). Parodi (1977) was the first to identify cis-9, trans-11 octadecadienoic acid as a fattyacid in milk fat that contained the conjugated double bond pair. The discovery <strong>of</strong> “role <strong>of</strong> CLA as afunctional food” occurs decade ago when ground beef contained anti-carcinogen factor that consisted<strong>of</strong> a series <strong>of</strong> conjugated dienoic isomers <strong>of</strong> LA (Pariza et al., 1979 <strong>and</strong> Ha et al., 1989).Isomers <strong>of</strong> CLA:Numerous isomers <strong>of</strong> CLA have been identified <strong>and</strong> these differ by position or geometric orientation<strong>of</strong> the double bond pair (Fig. 2.1). CLA includes more than 28 positional <strong>and</strong> geometrical isomers <strong>of</strong>which only cis-9, trans-11 <strong>and</strong> trans10, cis-12 have thus far been proven to have biological activities(Banny <strong>and</strong> Martin 1994; Park et al., 2003). Of the two physically important isomers, c-9, t-11 is themost prevalent, comprising 80-90% <strong>of</strong> the total CLA in food products from ruminants where as t-10,c-12 is present in small amounts at 3-5% <strong>of</strong> total CLA (Parodi, 2003). The trivial name “Rumenic Acid”(RA) has been proposed for cis-9, trans-11 CLA due to its unique relationship to ruminants (Kramer etal., 1998). Other isomer <strong>of</strong> CLA are present at low concentration, generally representing less than 0.5percent <strong>of</strong> the total CLA in ruminant fat.Sources <strong>of</strong> CLA:CLA is present in a great variety <strong>of</strong> feeds, although usually in residual quantities (Chin et al.,1992). Food products from ruminants (Table 1) are the major dietary sources <strong>of</strong> CLA for humans. Thehighest CLA concentration was found in adipose tissue (38 mg/g fatty acid) <strong>of</strong> kangaroo (Engelke etal., 2004).Potential health benefits <strong>of</strong> CLA:• Anticarcinogenic• Antiatherogenic• Altered nutrient partitioning <strong>and</strong> lipid metabolism• Antidiabetic (type II diabetes)• Immunity enhancement• Improved bone mineralization217


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceTable 1. Total CLA (mg/g fat) content <strong>of</strong> different types <strong>of</strong> selected foodsCategory <strong>of</strong> food<strong>Dairy</strong> productsTotal CLA(mg/g fat)Percent <strong>of</strong> cis-9,trans-11 isomerCategory <strong>of</strong> foodTotal CLA(mg/g fat)Meat (fresh)Percent <strong>of</strong> cis-9,trans- 11 IsomerHomogenized Milk 5.5 92 Fresh Ground Beef 4.3 85Butter 4.7 88 Beef Round 2.9 79Sour Cream 4.6 90 Veal 2.7 84Plain Yogurt 4.8 84 Lamb 5.6 92Non-fat Yogurt 1.7 83 Pork 0.6 82Ice-cream 3.6 86 Poultry (fresh)Cheddar Cheese 3.6 93 Chicken 0.9 84Cottage Cheese 4.5 83 Vegetable oilsMozzarella 4.9 95 Soybean 0.6 25Seafood (fresh) Sunflower 0.4 38Salmon 0.3 — Mustard 0.3 42Shrimp 0.6 — Corn 0.2 39Biosynthesis <strong>of</strong> CLA:Source: Chin et al. (1992)Kepler et al. (1966) had identified CLA as the first intermediate <strong>of</strong> linoleic acid biohydrogenationin the rumen by Butyrivibrio fibrisolvens. Griinari <strong>and</strong> Bauman (1999) concluded that CLA synthesisoccurred in the rumen only. CLA found in milk <strong>and</strong> meat <strong>of</strong> ruminants originates from two sources.One source is CLA formed during ruminal biohydrogenation <strong>of</strong> linoleic acid. The second source isCLA synthesized by animal tissues (mammary gl<strong>and</strong> epithelial tissue) from trans-11 C18:1 or TVA,another intermediate in the biohydrogenation <strong>of</strong> unsaturated fatty acid. Hence, the uniqueness <strong>of</strong> CLAin ruminant edible products relates to incomplete biohydrogenation <strong>of</strong> dietary unsaturated fatty acidsin the rumen.Estimation <strong>of</strong> conjugated linoleic acid in milka) Extraction <strong>of</strong> fatFat is extracted from milk by the method <strong>of</strong> Ha et al. (1989). Fresh milk (3ml) is vortexed with 3 ml<strong>of</strong> methanol <strong>and</strong> 1.5 ml <strong>of</strong> chlor<strong>of</strong>orm. The mixture is vortexed with 1.5 ml chlor<strong>of</strong>orm for an additional2 min. The homogenate is centrifuged at 2200 rpm for 10 min. The upper (methanol-water) layer isremoved through aspiration <strong>and</strong> the bottom layer (chlor<strong>of</strong>orm layer) is passed through anhydroussodium sulphate on Whatman filter paper No.1.The filter paper is rinsed with 3 ml <strong>of</strong> chlor<strong>of</strong>orm <strong>and</strong>the extract is evaporated to dryness under vacuum <strong>and</strong> then under the stream <strong>of</strong> nitrogen.b) Hydrolysis <strong>of</strong> fatExtracted fat is hydrolyzed with 1 ml <strong>of</strong> 1N methanolic sodium hydroxide in a boiling water bathfor 15 minutes <strong>and</strong> then cooled to room temperature for 5 minutes. 1 ml Hydrochloric acid (2N) <strong>and</strong>2 ml chlor<strong>of</strong>orm are added to the tube containing methanolic sodium hydroxide <strong>and</strong> vortexed for 4minutes, followed by centrifugation for 10 minutes at 2200 rpm. The organic layer (lower layer) iscollected <strong>and</strong> evaporated to dryness under vacuum <strong>and</strong> then under the steam <strong>of</strong> nitrogen.c) Preparation <strong>of</strong> st<strong>and</strong>ardA stock solution <strong>of</strong> CLA (1mg/ml) in acetonitrile is prepared. A working st<strong>and</strong>ard solution isprepared by adding (500ml) stock solution to 2000 ml <strong>of</strong> acetonitrile <strong>and</strong> it gives 4mg <strong>of</strong> CLA in 20ml<strong>of</strong> st<strong>and</strong>ard to be injected.218


Conjugated Linoleic Acid <strong>and</strong> Its Estimationd) High performance liquid chromatography (HPLC)HPLC conditions:Column : C 18micro BondapackFlow rate : 1.5 ml per minuteWave length : 234 nmInject volume : 20 µl.Eluent used for the separation <strong>of</strong> CLA consists <strong>of</strong> acetonitrile containing 0.12 per cent glacial aceticacid (v/v) <strong>and</strong> double distilled water in the ratio <strong>of</strong> 70:30.The peak <strong>of</strong> CLA is eluted at 13 to 18 min. The retention time <strong>of</strong> samples are compared with that<strong>of</strong> st<strong>and</strong>ard CLA (Sigma <strong>Chemical</strong> Co., St. Louis, MO, USA).CLA estimation by Gas chromatography (GC)Estimation <strong>of</strong> CLA <strong>and</strong> other fatty acids in feedstuffs, plasma, ruminal liquor, milk <strong>and</strong> muscleare analyzed as per direct transestrification method <strong>of</strong> O’Fallon et al. (2007) with slight modificationusing GC fitted with flame ionization detector. For the methyl ester formation 1 g feedstuff, 1.5 mlplasma, rumen liquor, milk <strong>and</strong> 1.5 g muscle samples are taken.Preparation <strong>of</strong> st<strong>and</strong>ardA stock solution <strong>of</strong> CLA (1mg/ml) in acetonitrile is prepared. A working st<strong>and</strong>ard solution isprepared by adding (500µl) stock solution to 2000 µl <strong>of</strong> acetonitrile <strong>and</strong> it gives 4µg <strong>of</strong> CLA in 20µl <strong>of</strong>st<strong>and</strong>ard to be injected.ConditionsOven temperature : Initial 15°C, Final 24ºCFID : 26ºCInjector : 24ºCFlow rate : 30 ml/min.Attenuation : 1Split ratio : 1:10Inject volume : 0.5 µlHelium can be used as a carrier gas at constant inlet pressure (205 kPa). Conjugated linoleic acidis identified by comparing its retention time with that <strong>of</strong> st<strong>and</strong>ard CLA <strong>and</strong> concentration <strong>of</strong> CLA iscalculated considering the peak area.AfterwordThe evident beneficial potential <strong>of</strong> CLA along with other PUFAs augmented interest in itsenhancement in milk <strong>and</strong> meat products as a consequence. This has caused a great deal <strong>of</strong> effortto be expended toward increasing the concentration <strong>of</strong> CLA in the milk <strong>and</strong> tissues <strong>of</strong> ruminantfoods because these are the predominant source <strong>of</strong> CLA in human diets. Among more than a dozenisomers <strong>of</strong> CLA detected in foods <strong>of</strong> ruminant origin, c-9, t-11, t-10 <strong>and</strong> c-12 are the ones with knownphysiological importance. While c-9, t-11 comprises 80 to 90% <strong>of</strong> total CLA <strong>and</strong> the major source <strong>of</strong>its occurrence is endogenous synthesis via desaturation <strong>of</strong> VA by Δ9-desaturase. , t-10, c-12 comprises3 to 5% <strong>of</strong> the total. As has been shown in many studies reported in the limited review above, thereare several ways to increase CLA levels in milk <strong>and</strong> meat products from ruminants, hence, productswith enhanced CLA content which can effectively discharge their beneficial role in humans can be219


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assurancedesigned, however, To date, statements about health promoting effects <strong>of</strong> CLA are mainly based onanimal trials <strong>and</strong> remain to be proven largely in humans. In human trials synthetic CLA supplementsare usually used <strong>and</strong> these do not reflect natural isomer composition in foodstuffs. Whether naturalCLA sources (meat <strong>and</strong> milk from ruminants) have a similar impact on human health warrants furtherresearch.RefrencesKelly ML, Kolver E S, Bauman DE, Van Amburgh ME, Muller LD (1998) Effect <strong>of</strong> intake <strong>of</strong> pasture on concentrations <strong>of</strong>conjugated linoleic acid in milk <strong>of</strong> lactating cows. J <strong>Dairy</strong> Sci 81:1630–1636Booth RG, Kon SK, Dann WJ & Moore T (1935) A study <strong>of</strong> seasonal variation in butter fat. A seasonal spectroscopicvariation in the fatty acid fraction. Biochem J 29, 133-37.P. Parodi, Conjugated Linoleic Acid: an anticarcinogenic fatty acid present in milk. Australian Journal <strong>of</strong> <strong>Dairy</strong> Technology49 (1977), pp. 49-93.Pariza PW, Ashoor SH, Chu FS & Lund DB (1979) Effects <strong>of</strong> temperature <strong>and</strong> time on mutagen formation in panfriedhamburger. Cancer Lett 7, 63-69.Ha YL, Grimm NK, Pariza MW (1989) Newly recognized anticarcinogenic fatty acids: identification <strong>and</strong> quantificationin natural <strong>and</strong> processed cheese. J Agric Food Chem 37:75-81Parodi, P., 2003. Conjugated linoleic acid in food. In J. Sebedio, W.W. Christie <strong>and</strong> R. Adolf (ed) Advances in ConjugatedLinoleic Acid Research, Vol. 2, pp: 101-121. AOCS Press, Champaign, IL.Banny, S <strong>and</strong> Martin, J.C. 1994. Conjugated Linoleic Acid <strong>and</strong> metabolites in trans fatty acids in human nutrition, Theoily Press, Dundee, Scotl<strong>and</strong> : 261-302.Park, S.J., Park, C.W., Kim, S.J., Kim, J.K., Kim., Y.R. Kim, Y.S <strong>and</strong> Ha, Y.L. 2003. Divergent cytotoxic effects <strong>of</strong> ConjugatedLinoleic Acid isomers on NCI-N87 cells, ACS Symp. Series, 85:1113-118.Chin, S.F., Liu, W., Storkson, J.M., Ha, Y.I. <strong>and</strong> Pariza, M.W. 1992. Dietary sources <strong>of</strong> conjugated dienoic isomers <strong>of</strong>linoleic acid, a newly recognized class <strong>of</strong> anticarcinogens. J. Food Composition <strong>Analysis</strong>, 15: 185-197.Kepler, C.R., Hirons, K.P., McNeil, J.J. <strong>and</strong> Tove, S.B. 1966. Intermediates <strong>and</strong> products <strong>of</strong> the biohydrogenation <strong>of</strong>linoleic acid by Butyrivibrio fibrisolvens . J. Biol. Chem. 241: 1350–1354.Griinari, G.M. <strong>and</strong> Bauman, D.E. 1999. Biosynthesis <strong>of</strong> conjugated linoleic acid <strong>and</strong> its composition, incorporation in tomeat <strong>and</strong> milk in ruminants. Advance in CLA research. AOCS Press, Champaign,II. Pp: 180-200.O’Fallon, J.V., Busboom, J.R., Nelson, M.L. <strong>and</strong> Gaskins, C.T. 2007. A direct method for fatty acid methyl ester synthesis:Application to wet meat tissues, oils <strong>and</strong> feedstuffs. J. Anim. Sci. 85: 1511-1521.V<strong>and</strong>enberg, J.J., Cook N.E. <strong>and</strong> Tribble, D.L. 1995. Reinvestigation <strong>of</strong> the antioxidant properties <strong>of</strong> Conjugated LinoleicAcid. Lipids, 30: 599-605.Moore, T., 1939. Spectroscopic changes in fatty acids. VI. General. Biochem. J. 33: 1635-1638.Kramer, J.K.G., Parodi, P.W., Jensen, R.G., Mossoba, M.M., Yurawecz, M.P., <strong>and</strong> Adl<strong>of</strong>, R.O. 1998. Rumenic acid: Aproposed common name for the major conjugated linoleic acid isomer found in natural products. Lipids. 33: 835.Engelke, C.F., Siebert, B.D., Gregg, K., Wright, A.D.G. <strong>and</strong> Vercoe, P.E. 2004. Kangaroo adipose tissue has higherconcentration <strong>of</strong> cis-9, trans-11 conjugated linoleic acid than lamb adipose tissue. J. Anim. Feed Sci., 13: 689-692.220


Importance <strong>and</strong> Estimation <strong>of</strong> Vitamins A & E In <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong>Importance <strong>and</strong> Estimation <strong>of</strong> Vitamins A & Ein <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong>Harjit Kaur<strong>Dairy</strong> Cattle Nutrition Division, NDRI, KarnalVitamin A, or retinol, is a colorless, alcohol compound. It is essential to the immune system,providing antioxidants that benefit growth, healing, reproduction <strong>and</strong> skin. If this vitamin is deficient,the epithelium becomes keratinized <strong>and</strong> cracks occur, giving easy access to bacteria <strong>and</strong> viruses,resulting in infectious diseases. Vitamin A plays an important role in the chemical processes whichoccur in the eye <strong>and</strong> are essential for vision. This vitamin combines with proteins in the retina <strong>of</strong> the eye<strong>and</strong> forms the pigment called visual purple. These cells, together with the lens pigment, are responsiblefor vision in dim light. During this process, some <strong>of</strong> the vitamin A is excreted <strong>and</strong> has to be replenishedfrom the blood, if normal vision is to be maintained. Vitamin A affects bone development throughits effect on bone metabolism. Essentially, Vitamin A deficiency results in unchecked bone growththat in turn manifests as malformed bones <strong>and</strong> joints. Vitamin A directly affects immunity throughboth production <strong>of</strong> antibodies <strong>and</strong> through maintaining an adequate barrier to infection with healthyepithelial cells. Its deficiency also affects reproduction by interfering with the production <strong>of</strong> spermin males, <strong>and</strong> by causing resorption <strong>of</strong> the foetus in females. The symptoms <strong>of</strong> vitamin A deficiencyare scouring, low resistance to bacterial infection, stiffness <strong>of</strong> joints <strong>and</strong> uncoordinated movements,lesions around the eyes <strong>and</strong> dull watery eyes followed by night blindness at more advanced stages.Excess vitamin A has been demonstrated to have toxic effects in most species.VITAMIN E: Vitamin E has very strong antioxidant properties <strong>and</strong> is involved in the mammalianantioxidant defense system where it stimulates the immune response. For certain purposes, theantioxidant functions <strong>of</strong> vitamin E can be performed by Se, which is present in glutathione peroxidase<strong>and</strong> decomposes peroxides. Most species hydrolyze dietary tocopheryl esters effectively at the mucosalsurface <strong>of</strong> the small intestine. Vitamin E is absorbed as the free alcohol, tocopherol. The vitamin isinsoluble in the aqueous environment <strong>of</strong> the intestinal lumen. Its enteric absorption, like that <strong>of</strong> otherfat-soluble nutrients, therefore is dependent upon its micellar solubilization. Consequently, impairment<strong>of</strong> pancreatic function or bile production results in impaired absorption <strong>of</strong> vitamin E. The efficiency<strong>of</strong> absorption <strong>of</strong> tocopherols is relatively low at 20 to 40 percent. Absorption is increased by mediumchaintriglycerides <strong>and</strong> is decreased by high levels <strong>of</strong> linoleic acid. In mammals, absorbed tocopherol istransported by chylomicrons via the lymphatic circulation to the liver <strong>and</strong> subsequently to the generalcirculation in very low density lipoproteins (VLDL). Most species show normal plasma α-tocopherolconcentrations in the range <strong>of</strong> 1-5 μg/ml. The dietary requirements for vitamin E are estimated in therange <strong>of</strong> 5 to 50 IU/kg <strong>of</strong> diet for most animal species. Vitamin E is generally considered to be one <strong>of</strong>the least toxic <strong>of</strong> the vitamins. Dietary intakes <strong>of</strong> at least 20 times the nutritionally adequate levelsshould be well tolerated by most species.Estimation <strong>of</strong> vitamins A <strong>and</strong> E by HPLCEvaluation <strong>of</strong> vitamin A in dairy products is highly required because <strong>of</strong> its important roles invision, maintenance <strong>of</strong> epithelial lining <strong>and</strong> immunity in man <strong>and</strong> animals. Vitamin E (α-tocopherol),another non enzymatic antioxidant, is involved in maintenance <strong>of</strong> immunity status Due to the criticalrole <strong>of</strong> these vitamins, their quantitative analysis is very important to know their content in the diet aswell as to know the changes in their concentration under different storage <strong>and</strong> processing conditions.High performance liquid chromatography is extensively used for measuring vitamins in milk<strong>and</strong> milk products. Earlier methods <strong>of</strong> vitamin estimation such as, colorimetric lack the ability to221


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assurancedifferentiate between the vitamin congeners with varying activity. In milk, vitamin A occurs mainlyas a mixture <strong>of</strong> fatty acid retinyl esters. β-carotene, the provitamin A, is the predominant form <strong>of</strong>vitamin A in the milk. Evaluation <strong>of</strong> vitamin A <strong>and</strong> β-carotene together enables the evaluation <strong>of</strong> totalvitamin A activity <strong>of</strong> the milk. The major form <strong>of</strong> vitamin E in the milk is α-tocopherol. VitaminsA, β-carotene <strong>and</strong> vitamin E are fat soluble vitamins <strong>and</strong> are found in the fat fraction <strong>of</strong> the milk. Itis therefore necessary to extract the vitamins from the sample. Saponification (alkaline hydrolysis)provides an effective means <strong>of</strong> removing the preponderance <strong>of</strong> neutral lipids (mainly triglycerides)from the sample. Saponification involves refluxing the sample with ethanolic KOH solution <strong>and</strong> addedantioxidant for 30 min. The hydrolysis attacks ester linkages <strong>and</strong> releases the fatty acids from theglycerol moiety <strong>of</strong> glycerides <strong>and</strong> phospholipids <strong>and</strong> from esterified sterols <strong>and</strong> carotenoids. Henceester forms <strong>of</strong> the vitamins are hydrolysed to their respective alcohols which allow the estimation <strong>of</strong>total vitamin content in the sample.1. HPLC method for simultaneous estimation <strong>of</strong> retinol (Vitamin A), β-carotene <strong>and</strong> α-tocopherol(Vitamin E) (Chawla <strong>and</strong> Kaur, 2001)PrincipleThe sample is saponified with ethanolic potassium hydroxide solution <strong>and</strong> vitamins A, β-carotene<strong>and</strong> vitamin E are extracted into petroleum ether. The petroleum ether is removed by evaporation <strong>and</strong>the residue is dissolved in mobile phase. The vitamins A, β-carotene <strong>and</strong> vitamin E concentrations aredetermined simultaneously by reverse-phase liquid chromatography.1. Reagents : Potassium hydroxide solution, 60%, Ethanol, 95 % , Petroleum ether, boilingrange 40º C to 60º C, 0.5 N potassium hydroxide, All-trans-retinol, vitamin A alcohol, α-tocopherol,β-carotene, Water, HPLC grade,Methanol, HPLC grade,Acetonitrile, HPLC grade, Tetrahydr<strong>of</strong>uran,HPLC grade, Ascorbic acid, Whatman phase separator filter paper, Inert gas, nitrogen.Preparation <strong>of</strong> St<strong>and</strong>ards: Prepare stock solutions <strong>of</strong> α-tocopherol (300 µg/ml) <strong>and</strong> retinol (30 µg/ml) in 100 % ethanol. Prepare stock solution <strong>of</strong> β-carotene (30 µg/ml) in chlor<strong>of</strong>orm. Take requisitealiquots <strong>of</strong> individual stock solutions in amber coloured tubes <strong>and</strong> dry under nitrogen at roomtemperature. Reconstitute the dried st<strong>and</strong>ards in mobile phase (mobile phase is prepared by mixingacetonitrile, tetrahydr<strong>of</strong>uran <strong>and</strong> HPLC water in the ratio <strong>of</strong> 47: 42:11). Prepare a working st<strong>and</strong>ardsolution containing 100µg/ml α-tocopherol, 10µg/ml retinol <strong>and</strong> 10 µg/ml β-carotene, at the time <strong>of</strong>use. Store all the vitamin stock st<strong>and</strong>ards at –20ºC.Extraction <strong>of</strong> samples: Take 2-3 ml milk in a 50 ml stoppered test tube. Add 5 ml <strong>of</strong> absoluteethanol containing 0.1% (w/v) ascorbic acid or 1% pyrogallol (w/v) <strong>and</strong> 2ml <strong>of</strong> 50% KOH. The tubesare agitated carefully <strong>and</strong> placed in a water bath at 80ºC for 20 min. After saponification, cool thetubes with running water <strong>and</strong> place in an ice water bath. Add 10 ml petroleum ether (40-60ºC) <strong>and</strong>shake for 15 minutes. Transfer the upper ether layer in another tube. Repeat the extraction thrice <strong>and</strong>collect the ether portion. Transfer the combined ether extract to a separating funnel, wash with 10 ml<strong>of</strong> 0.5 N KOH <strong>and</strong> subsequently with distilled water (2-3 times) to remove excess alkali. Pass the etherextract through phase separator filter paper to remove water, if any. Evaporate the ether extract undernitrogen in a water bath maintained at 37°C. Perform all the extractions under subdued inc<strong>and</strong>escentlight using amber coloured glassware.HPLC system <strong>and</strong> procedure: The HPLC system consists <strong>of</strong> a model 510 pump, UV visibleabsorbance detector 486, rheodyne injector with 20 µl loop, using multiwavelength detector. A reversephase Discovery C-18 (15 cm x 4.6 mm) column is used. The flow rate is 1.5ml/minute. The programmefor the separation <strong>of</strong> retinol, α-tocopherol <strong>and</strong> β-carotene using millennium s<strong>of</strong>tware method is givenin Table 1.222


Importance <strong>and</strong> Estimation <strong>of</strong> Vitamins A & E In <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong>Fig. 1 Chrotomatogram <strong>of</strong> st<strong>and</strong>ard Retinol, α-Tocopherol <strong>and</strong> β-CaroteneTable 1. Program for HPLC analysis <strong>of</strong> Retinol, α-Tocopherol <strong>and</strong> β-CaroteneVitamin Wavelength (nm) Change Time (min) Retention time (min)Retinol 325 0.00 1. 73α-tocopherol 290 2.5 3.37β-carotene 450 4.5 5.67Reconstitute the residue in the mobile phase prior to injection on HPLC. Filter the reconstitutedextract through a 0.45-µm filter <strong>and</strong> inject 20 µl into the HPLC column. The run time is 6 minutesper sample. Measure the area <strong>of</strong> the retinol, α-tocopherol <strong>and</strong> β-carotene peaks. Determine theirconcentrations in the extracted sample with reference to the peak area <strong>of</strong> respective st<strong>and</strong>ards.2. Simultaneous estimation <strong>of</strong> vitamins A <strong>and</strong> E in milk by HPLCFollow the same procedure as mentioned above (for simultaneous estimation <strong>of</strong> α-tocopherol,retinol <strong>and</strong> β-carotene) upto extraction <strong>of</strong> samples. Prepare mobile phase by mixing methanol <strong>and</strong>Fig. 2 Chromatogram <strong>of</strong> st<strong>and</strong>ard retinol <strong>and</strong> α-tocopherolwater in the ratio <strong>of</strong> 95:5 <strong>and</strong> filter through a membrane filter.Separation <strong>of</strong> Vitamins A <strong>and</strong> EReconstitute the dried residue in Table 2: Program for HPLC analysis <strong>of</strong> retinol <strong>and</strong> α-tocopherolthe mobile phase <strong>and</strong> filter through0.45µ membrane filter for injectionon HPLC column. Inject 20 µl <strong>of</strong>Vitamin Wavelength(nm)Change Time(min)Retention time(min)sample extract onto the column <strong>of</strong> the Retinol 325 0.00 1.98liquid chromatograph. A programmefor the separation <strong>of</strong> retinol <strong>and</strong>α-tocopherol at different wavelengthssimultaneously is presented in Table 2.α-tocopherol 290 4.00 7.35The chromatographic separation <strong>of</strong> vitamins A <strong>and</strong> E is shown in Fig. 2.223


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceCalculate the mean peak area from replicate injections <strong>of</strong> the sample extract <strong>and</strong> determine theretinol <strong>and</strong> α-tocopherol concentrations <strong>of</strong> the extract by reference to the mean peak area found fromreplicate injections <strong>of</strong> st<strong>and</strong>ards. Table 3 shows the average values <strong>of</strong> vitamin A <strong>and</strong> E in the milk <strong>of</strong>different species.Table 3. Vitamin A <strong>and</strong> E content <strong>of</strong> milk /serving (244 g)VitaminCow Milk,3.25% fatCow,Skim milkGoat Sheep BuffaloA, ug 68 149 139 108 129E, mg 0.15 0.02 0.17 ND NDReferenceChawla, Rajiv <strong>and</strong> Harjit Kaur (2001). Isocratic HPLC method for simultaneous determination <strong>of</strong> carotene, retinol <strong>and</strong>tocopherol in feeds <strong>and</strong> blood plasma. Indian J. <strong>Dairy</strong> Sci., 54: 84 - 90.224


Use <strong>of</strong> Atomic Absorption Spectrophotometer for the Estimation <strong>of</strong> Minerals in Milk <strong>and</strong> Milk <strong>Products</strong>Use <strong>of</strong> Atomic Absorption Spectrophotometer for theEstimation <strong>of</strong> Minerals in Milk <strong>and</strong> Milk <strong>Products</strong>Veena Mani<strong>Dairy</strong> Cattle Nutrition, NDRI, KarnalBy atomic absorption spectrophotometer, the metals in water /organic sample can be analyzed. Itis the highly sensitive technique highly useful for the determination <strong>of</strong> the presence <strong>and</strong> concentrations(even at very low levels) <strong>of</strong> metals in liquid samples. Thus, prior to the estimation the solid samplesshould be accurately weighed <strong>and</strong> then dissolved <strong>of</strong>ten using strong acids. Metals include Ca, mg,Fe, Cu, Al, Pb, Zn, Cd <strong>and</strong> many more. Typical concentrations range in the low mg/L (ppm) range.As the elements in the sample to be analyzed are not in the free state but are combined with otherelements invariably to make a so-called molecule. For the analysis the combination must be cut <strong>of</strong>f bysome means to free the atoms. This is called atomization. The most popular method <strong>of</strong> atomizationis dissociation by heat. Samples are heated to a high temperature so that molecules are convertedinto free atoms. This method is classified into the flame method, in which a chemical flame is used asthe heat source; <strong>and</strong> an electro thermal atomization method, in which a very small electric furnace isusedThe technique is designed to determine the amount (concentration) <strong>of</strong> an object element in asample, utilizing the phenomenon that the atoms in the ground state absorb the light <strong>of</strong> characteristicwavelength passing through an atomic vapour layer <strong>of</strong> the element <strong>of</strong> interest <strong>and</strong> attain excitedstates. During excitation element being analyzed is dissociated from its chemical bond <strong>and</strong> is placedin an unionized state. This is normally achieved by aspirating the sample into the flame or graphitefurnace. Each metal has a characteristic wavelength that will be absorbed. . The AAS instrumentlooks for a particular metal by focusing a beam <strong>of</strong> UV light at a specific wavelength through a flame<strong>and</strong> into a detector. The instrument measures the change in intensity As a result <strong>of</strong> absorption,the intensity <strong>of</strong> light decreases, which is proportional to the number <strong>of</strong> the examined atoms beingpresent. The more concentrated the solution, the more light energy is absorbed!In atomic absorption, the method is based on the attenuation (weakening) <strong>of</strong> a beam <strong>of</strong> nearlymonochromatic light as a consequence <strong>of</strong> its interaction with <strong>and</strong> partial absorption by the ground stateatoms <strong>of</strong> the element being analyzed. The amount <strong>of</strong> light absorbed at the characteristic wavelengthincreases with the number <strong>of</strong> atoms <strong>of</strong> the selected element in the light path. By comparison withsuitable st<strong>and</strong>ards, the concentration <strong>of</strong> the element in the sample can be inferred from the amount <strong>of</strong>light absorbed. A computer data system converts the change in intensity into an absorbance.Quantitative analysis by Atomic absorption depends on: 1)accurate measurement <strong>of</strong> the intensity<strong>of</strong> the light ,2) the assumption that the radiation absorbed is proportional to atomic concentrationInstrumentationThere are six basic components <strong>of</strong> an atomic absorption spectrometer1. A light source(hollow cathode lamp), which emits a beam <strong>of</strong> radiation <strong>of</strong> a wavelengthcharacteristic <strong>of</strong> the element to be determined.2. An "absorption cell" or atomizer section for atomizinig the sample, in which the sample solutionis reduced to a cloud <strong>of</strong> ground state atoms, for example a flame or graphite furnace.3. A monochromator to select the wavelength that is being absorbed by the element to bemeasured.4. A photomultiplier tube ,which is a detector for converting the light into an electrical signal.Thus, it detects <strong>and</strong> measures the intensity <strong>of</strong> the resultant beam <strong>of</strong> radiation. The PMTdetermines the intensity <strong>of</strong> photons <strong>of</strong> the analytical line exiting the monochromator225


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assurance5.6.226An amplifier <strong>and</strong> associated electronics to amplify <strong>and</strong> process the signal from the photomultipliertube.A display <strong>and</strong>/or a recorder which shows themeasured signal after it has been processed.Hollow cathode lamp To produce the propermonochromatic light necessary for the AAS, so called“hollowcathode lamps” are used which is situated in the centre <strong>of</strong> thelamp <strong>and</strong> is normally composed <strong>of</strong> either the pure form <strong>of</strong>the element or an alloy <strong>of</strong> the element It means that different Schematic Diagram for atomic absorptionspectrophotometer (source :http://www.lamps are used for the determination <strong>of</strong> each elementthebritishmuseum.ac.uk/science/techniques/It is named after the cylindrical shape <strong>of</strong> the cathode sr-techaas.html)that gives direction to emerging beam, <strong>and</strong> helps re-depositsputtered atoms back on cathode. The hollow cathode lamp for the light source consists <strong>of</strong> a hollowcathode <strong>and</strong> an anode(made <strong>of</strong> tungsten) enclosed in a glass (quartz) tube <strong>and</strong> neon or argon gas isfilled at around 10 Torr. in pressure in it. Being made up <strong>of</strong> the element to be measured or its alloy,it emits the light its wavelength is equal to that absorbed by the atoms <strong>of</strong> the sample. These lampsare available for about 70 elements. They are generally reliable <strong>and</strong> most have operating lives well inexcess <strong>of</strong> 5000 mA hours. The life <strong>of</strong> lamps with cathodes constructed <strong>of</strong> alloys <strong>of</strong> volatile elementssuch as arsenic or selenium is shorter. Multi-element lamps are also available <strong>and</strong> can be useful bothfrom the point <strong>of</strong> view <strong>of</strong> economy in lamp numbers <strong>and</strong> also in reduced warm-up time.Absorption Cell/NebulizerIt sucks up liquid sample at a controlled rate. Create a fine aerosol spray for introduction into theflame. It mixes the aerosol <strong>and</strong> fuel <strong>and</strong> oxidant thoroughly for introduction into the flameThe following atomization methods are known:1) Flame atomization 2) Graphite furnace atomizationFlame: The source <strong>of</strong> atoms is usually flame (“flame atomisation”). Metals could be measured atppm concentration (part per million, that is mg kg -1 or mg dm -3 in case <strong>of</strong> dilute solutions). The mostcommonly employed technique in atomic absorption spectrometry is that in which the sample, eitheras a liquid or in solution, is sprayed into a flame as a mist <strong>of</strong> droplets. The liquid or solution is reducedto mist by being drawn through a pneumatic nebulizer which normally employs an impact bead.Once in the flame, the liquid droplets are dried to give solid particles which are then decomposed togive molecules in the gaseous phase. The molecules then dissociate to give free atoms. Only about10% <strong>of</strong> the solution actually reaches the flame. This is one reason for the limited sensitivity <strong>of</strong> flametechniques. The other important reason for the limited sensitivity is the rather short residence time <strong>of</strong>free atoms in the flame (<strong>and</strong> especially in the light path).The sensitivity, however, could be increasedwhen the light travels for longer in the flame. Therefore most <strong>of</strong> the burners are about 5-10 cm long.The air/acetylene flame is the most used type <strong>of</strong> flame which provides a temperature high enoughfor the determination <strong>of</strong> many elements. There is no considerable ionization in the flame (with theexception <strong>of</strong> the alkali elements) <strong>and</strong> almost no absorption at wavelengths above 230 nm. Furthermorelight emission by this flame is rather low. The nitrous oxide/acetylene flame with its high temperatureis recommended for the determination <strong>of</strong> elements which need a high energy for dissociation (thatis, formation <strong>of</strong> free atoms). For those elements, this flame provides suitable chemical, thermal <strong>and</strong>optical conditions. Background emission, however, is rather high at certain wavelengths <strong>and</strong> the hightemperature leads to a considerable risk <strong>of</strong> ionization for certain elements. The air/propane or air/hydrogen flames are mainly recommended for the analysis <strong>of</strong> alkali elements since the temperatureis low enough to prevent larger ionization effects. The hydrogen/argon-diffusion flame is especiallysuitable for the determination <strong>of</strong> arsenic <strong>and</strong> selenium, since its absorption at wavelengths below200 nm is much smaller than absorption <strong>of</strong> other flame types. Due to its low temperature, chemical


Use <strong>of</strong> Atomic Absorption Spectrophotometer for the Estimation <strong>of</strong> Minerals in Milk <strong>and</strong> Milk <strong>Products</strong>interferences must be expected.Fuel gas Oxidant Flame temp. (ºC)Graphite furnace atomisation The graphite Fuel Gas Oxidant Flame Temp. (ºC)furnace AAS (GFAAS), a more recent technique isHydrogen Argon/ air(diffusion) 400 (350-1000)even more sensitive than the traditional, cheaperPropane Air 1930AAS using flame. Measurements could be done atHydrogen Air 2000-2050ppb level (part per billion, ppb = 10-3 ppm, thatis µg kg -1 or µg dm -3 Acetylene Air 2100-2400in case <strong>of</strong> dilute solutions!).Since the presence <strong>of</strong> toxic heavy metal i.e as Acetylene Nitrous oxide 2650-2800contaminants even in very low concentration maybe <strong>of</strong> concern from human health point <strong>of</strong> view, therefore the technique has the importance with thisreference.In graphite furnace AAS, a heatable graphite tube as atomization device is located in the raypath. A droplet <strong>of</strong> the sample is pipetted into the graphite tube, where it dries through electricalheating <strong>and</strong> the residues are ashed. The temperature <strong>of</strong> the tube can be increased in a stepwisefashion such that in the first stage, the tube will be heated to a relatively low temperature in orderto vaporize the solvent. In the second stage, the temperature will be increased by increasing thecurrent such that the solid residue is dry ashed without the loss <strong>of</strong> analyte. Finally, the tube is rapidlyheated to a temperature <strong>of</strong> up to 3000°C in order to atomize the analyte. The heated graphite furnaceprovides the thermal energy to break chemical bonds within the sample held in a graphite tube, <strong>and</strong>produce free ground state atoms. Ground-state atoms then are capable <strong>of</strong> absorbing energy, in theform <strong>of</strong> light, <strong>and</strong> are elevated to an excited state. The amount <strong>of</strong> light energy absorbed increases asthe concentration <strong>of</strong> the selected element increases.The atomic absorption signal is then measured atthis stage. A purge gas <strong>of</strong> argon or nitrogen is passed through the tube during the drying <strong>and</strong> ashingstages but normally the flow <strong>of</strong> inert gas will be stopped during the atomization stage so that thefree atoms will remain in the absorption cell for a longer period. It is important to control the drying<strong>and</strong> ashing stages such that drying comes about without spitting or spreading <strong>of</strong> the sample <strong>and</strong>that ashing occurs in such a way as not to interfere with the final atomization stage.The use <strong>of</strong> automatic background correction is essential when using a graphite furnace, since thelevel <strong>of</strong> non-specific background absorption is much more significant than is the case with the flameatomization. Matrix effects can be compensated for by the method <strong>of</strong> st<strong>and</strong>ard additions <strong>and</strong>/orby the addition <strong>of</strong> matrix or analyte modifiers. The addition <strong>of</strong> analyte modifiers usually decreasesthe volatility <strong>of</strong> the analyte so that it is not lost during the ashing stage or increases the volatility<strong>of</strong> the matrix making it more readily removable Matrix modifiers, on the other h<strong>and</strong>, decrease thevolatility <strong>of</strong> interfering compounds <strong>and</strong> contribute to time resolved analyte/background signals.Monochromator: the main purpose <strong>of</strong> monochromator is to isolate the absorption lines fromthe background lightdue to the interferences. Comparison <strong>of</strong> Flame <strong>and</strong> Electrothermal atomization methodThus, monochrometerFlame Atomization Electrothermal Atomizationis used for selecting theanalysis wavelength <strong>of</strong>Sensitivity ppm level in the solution ppb level in the solutionthe target element, <strong>and</strong> Sample Volume about 1mL for one analysis 5 - 50 µL for one analysisa detector for converting Atomizing effi ciency about 10% More than 90%the light into an electricalMatrix effect Small largesignal. Thus,it Isolate theanalytical line photons Time for analysis 10 - 30 sec. For one sample 2 - 5 min. for one samplepassing through the flame<strong>and</strong> remove scattered light <strong>of</strong> other wavelengths from the flame In doing this, only a narrow spectralline impinges on the PMT.227


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssurancePhotomultiplier tube (PMT)This is the detector. The PMT determines the intensity <strong>of</strong> photons <strong>of</strong> the analytical line exiting themonochromator. The PMT is the most commonly used detector for atomic absorption spectroscopy.They consists <strong>of</strong> a photocathode <strong>and</strong> a series <strong>of</strong> dynodes in an evacuated glass enclosures. However,solid state detectors are now replacing conventional vacuum-type photomultipliers. High techelectronics amplify, filter, <strong>and</strong> process the electrical signal, using a series <strong>of</strong> chips <strong>and</strong> microprocessors,transmitting the result to an internal or external computer which h<strong>and</strong>le all data-h<strong>and</strong>ling <strong>and</strong>display<strong>Analysis</strong> <strong>of</strong> minerals in milk <strong>and</strong> milk products using Atomic absorption spectrophotometerThey can be divided into macro minerals (major elements) <strong>and</strong> micro minerals (trace elements).The macro minerals such as sodium, potassium, magnesium, calcium <strong>and</strong> phosphorus are requiredby the body in amounts greater than 100mg per day whereas the micro minerals such as iron, copper,zinc <strong>and</strong> manganese are required in amounts less than 100mg per day.Sampling <strong>and</strong> processing <strong>of</strong> samplesThe processing <strong>of</strong> milk/ products samples for mineral analysis can be done dry ashing or wetdigestion, since milk is not totally homogenous therefore, it is utmost important that bulk sampleshould be sufficiently homogenized to ensure that the aliquot/sub-sample which is taken for analysisis representative <strong>of</strong> the whole. The size <strong>of</strong> the sample should be proportional to the bulk. Thoroughmixing <strong>of</strong> sub-samples from a large bulk is preferred in representative sampling(a) Dry Ashing Generally, 5 to 25 ml sample (depending upon the concentration <strong>of</strong> the desiredmineral) is taken in a silica crucible <strong>and</strong> weighed. For powdered milk/product, 1-2 gm sample istaken. Then, the sample is placed in the muffle furnace <strong>and</strong> the temperature is brought to 550ºC <strong>and</strong>held for 4 hr. After cooling, the ash obtained is dissolved in dilute HCl (6M) <strong>and</strong> then made uptosuitable volume. The resulting solution is used in mineral element determination.Advantages <strong>and</strong> Disadvantages: Dry ashing is a convenient <strong>and</strong> versatile method using relativelylarge sample size for the sample preparation. It also minimizes the contamination due to reagents.Because ,the ashing is usually done between 400-600ºC, therefore, some elements such as Se, Pb, As<strong>and</strong> Hg, are lost through volatilization or by adsorption on the walls <strong>of</strong> the crucible. Other metals suchas, tin may form un-soluble refractory compounds during ashing(b) Wet digestion: Wet digestion procedure requires the use <strong>of</strong> strong oxidizing acid mixture<strong>of</strong> nitric, sulphuric <strong>and</strong> perchloric acid. A mixture <strong>of</strong> HNO 3<strong>and</strong> HClO 3is useful for many routineapplications. The use <strong>of</strong> mixtures containing H 2SO 4is particularly useful when sample containingfats are to be oxidized. The addition <strong>of</strong> H 2SO 4increases speed <strong>of</strong> wet oxidation process as it raisesthe temperature <strong>of</strong> digestion. Extra care should be taken to avoid charring <strong>of</strong> samples when elementslike As, Se or Hg are to be determined. It is essential that HNO 3should be in excess at all time duringdigestion. Even H 2SO 4<strong>and</strong> HNO 3mixture can be used, but complete digestion <strong>of</strong> fat may take hours.Generally, milk (10-20ml) or 1-2 g milk product is taken in 60 ml test tubes/ kjeldahl flask <strong>and</strong>weighed. To this, 10 ml triacid mixture (HNO 3: HClO 4: H 2SO 4:: 3 : 2 : 1) is added. Tubes are heated tillthe contents become clear <strong>and</strong> perchloric acid fumes cease to come out. The volume is made to 25 mlwith double distilled water.Advantages/ Disadvantages: When compared with dry ashing, this method gives better recoveryfor most <strong>of</strong> the elements as there is less danger <strong>of</strong> loss <strong>of</strong> volatile elements (Pb, Cd, As). But the chances<strong>of</strong> contamination are high as relatively large volumes <strong>of</strong> reagents are required to be added. The otherdrawback with this method is that it is suitable only for small size samples.<strong>Analysis</strong>HCl extract or wet digested samples after suitable dilution are used for the estimation <strong>of</strong> major<strong>and</strong> trace elements by atomic absorption spectrophotometer.228


Use <strong>of</strong> Atomic Absorption Spectrophotometer for the Estimation <strong>of</strong> Minerals in Milk <strong>and</strong> Milk <strong>Products</strong>• Take 1 ml <strong>of</strong> digested sample / HCl extract in a clean test tube.• For Ca estimation, add 1 ml 2% SnCl 2to 1ml <strong>of</strong> digested sample to eliminate interfering elements(such as Al, Be, P, Si, Ti) <strong>and</strong> make the volume to 10 ml with doubled distilled water. Theconcentration <strong>of</strong> 0.2% Sn is required in the test sample as well as in st<strong>and</strong>ards. This sampleis ready for estimation on AAS at 422.7 nm wavelength using acetylene as fuel <strong>and</strong> air as anoxidant.• For Mg estimation, add 1 ml 2% SnCl 2to 1ml <strong>of</strong> digested sample to eliminate interferingTable 1 Conditions for various mineralselements (such as Al, Be, P, Si,Ti) <strong>and</strong> make the volume to 10ml with doubled distilled water.The concentration <strong>of</strong> 0.1% Sn isrequired in the test sample aswell as in st<strong>and</strong>ards. This sampleis ready for estimation on AASat 285.2 nm wavelength usingacetylene as fuel <strong>and</strong> air as anoxidant.MineralWavelength(nm)Lower range(ppm)Upper range(ppm)Calcium 422.7 1.8 18Magnesium 285.2 0.06 0.6Sodium 589 0.26 2.6Potassium 766.5 0.24 2.4Iron 248.3 0.5 8• For other mineral the estimationsare carried out in the <strong>and</strong> suitablydiluted digested sample. Theconditions for the estimation<strong>and</strong> range for preparation <strong>of</strong>CopperZincManganese324.7213.9279.60.080.50.58855.8st<strong>and</strong>ards <strong>of</strong> different minerals are given in Table 1.• Plot the st<strong>and</strong>ard curve for a particular mineral <strong>and</strong> find out the concentration in the unknownsample from the st<strong>and</strong>ard curve considering dilution factor. Express the concentration as percentin case <strong>of</strong> Ca <strong>and</strong> Mg <strong>and</strong> ppm for other minerals.The samples <strong>and</strong> st<strong>and</strong>ards are <strong>of</strong>ten prepared with duplicate acid concentrations to replicate the analyte'schemical matrix as closely as possible. Acid contents <strong>of</strong> 1% to 10% are common. High acid concentrationshelp keep all dissolved ions in solution.Preparation <strong>of</strong> st<strong>and</strong>ards for some trace minerals <strong>of</strong> nutritional significanceZinc st<strong>and</strong>ard stock solution, 1 mg/ml - Take 0.25 g pure zinc metal in 250 ml volumetric flask addabout 50 ml distilled water <strong>and</strong> then add 1 ml sulphuric acid. Heat to dissolve Zn. Dilute to volume <strong>and</strong>store in pyrex bottle. Or dissolve 4.3984 g ZnSO 4.7H 20 in 0.1N HCl <strong>and</strong> dilute to 1 liter. This solutionwill give 1000 ppm concentration. Make working stock solution <strong>of</strong> 100 ppm <strong>and</strong> then prepare workingst<strong>and</strong>ards.Cu St<strong>and</strong>ard stock solution,1 mg/ml - Dissolve 1.9645 g CuSO 4.5H 2O in distilled H 2O <strong>and</strong> diluteto 500 ml. One ml <strong>of</strong> the solution contains 1 mg Cu. Make further dilutions with double glass distilledwater.Fe St<strong>and</strong>ard stock solution, 100 µg/ml - Dissolve 0.7022 g (FeSO 4(NH 3) 2SO 4.6H 2O in 100 ml water.Add 5 ml concentrated H 2SO 4, warm it slightly <strong>and</strong> add potassium permanganate solution (0.1 N)until solution shows slight pink colour. Make volume to 1 liter. It will give 100 µg/ml solution <strong>of</strong> Fe.Make serial dilutions to get st<strong>and</strong>ards in the rangeMn St<strong>and</strong>ard solution ,100 µg/ml - Dissolve 0.5756 g dry KMnO 4in 50 ml water. Add 40 ml conc.H 2SO 4<strong>and</strong> reduce the permanganate by careful addition <strong>of</strong> sodium metabisulphite solution until Mnsolution is colorless. Oxidise excess <strong>of</strong> H 2SO 4in hot solution by addition <strong>of</strong> little HNO 3. Cool, <strong>and</strong>transfer the contents to 2 liter volumetric flask. Make volume upto the mark. This solution contains 0.1mg <strong>of</strong> Mn/ ml. Solution must be protected from light. Make further dilutions.St<strong>and</strong>ard calcium solution – Dissolve 100.1 mg <strong>of</strong> dry calcium carbonate in 30 ml <strong>of</strong> 0.1 N HCl <strong>and</strong>dilute to 200 ml with water. This solution contains 20 mg <strong>of</strong> calcium per 100 ml. Further dilutions aremade to get required working st<strong>and</strong>ards229


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssurancePesticides: <strong>Their</strong> <strong>Analysis</strong> in Milk Using HighPerformance Liquid ChromatographyCh<strong>and</strong>er Datt <strong>and</strong> Monica Puniya<strong>Dairy</strong> Cattle Nutrition Division, NDRI, KarnalPesticides are defined as the substances intended to repel, kill or control any species designatedas pest including weeds, insects, rodents, fungi, bacteria or other organisms. The family <strong>of</strong> pesticidesincludes herbicides, insecticides, rodenticide, bacteriocide, nematocide etc. Pesticides that maycontaminate feeds originate from most <strong>of</strong> the major groups including organochlorine, organophosphate<strong>and</strong> carbamates. Although the residues <strong>of</strong> pesticides are potentially toxic to farm livestock, theprimary focus <strong>of</strong> concern is centered on residues in animal products destined for human consumption.Organochlorine pesticides residues (OCP) are lipophilic in nature <strong>and</strong> relatively stable. Most <strong>of</strong> theOCPR’s <strong>and</strong> their metabolites are readily excreted in milk. Unlike organochlorines, organophophatepesticide (OPP) compounds are readily decomposed by physico-chemical <strong>and</strong> enzymatic processesin plant <strong>and</strong> animal systems, therefore, these are less persistent but could lead to acute toxicity ifconsumed beyond toxic levels. Normally, the milk <strong>and</strong> milk products get contaminated with OPPR ifthe animals are given a feed which is treated with pesticides during storage or the feed is manufacturedfrom the plant material treated during its cultivation. The other sources <strong>of</strong> contamination <strong>of</strong> feeds,milk <strong>and</strong> milk products can be- direct treatment <strong>of</strong> animals against parasites, control <strong>of</strong> flies/insectsin the milk processing area <strong>and</strong> use <strong>of</strong> contaminated water for drinking <strong>of</strong> animals <strong>and</strong> for processing<strong>of</strong> milk. The carry over rate <strong>of</strong> these pesticides from feed to milk varies from 20 to 80% dependingupon the nature <strong>and</strong> stability <strong>of</strong> the pesticide, method <strong>of</strong> its application, duration <strong>of</strong> exposure <strong>and</strong>metabolism within the animalThe OCPR’s damage the peripheral nerves, cause blindness <strong>and</strong> sometimes show tumerogenic effects.In addition, an induction <strong>of</strong> liver enzymes, hydrolases <strong>and</strong> mixed function oxidases also occurs. A negativeinfluence on the reproductive functions is also observed. The toxicity <strong>of</strong> these compounds leads to cardiac<strong>and</strong> respiratory impairment due to disorders <strong>of</strong> autonomous nervous system. Some <strong>of</strong> the OPPR,s inducemyopathy in exposed human beings <strong>and</strong> animals, which is characterized by muscle cell degeneration <strong>and</strong>respiratory muscles are affected. Human erythrocyte cholinesterase activity is inhibited <strong>and</strong> pathologicalalterations are observed in several tissues. Acute poisoning leads to respiratory distress, nervousness,convulsions, paralysis <strong>and</strong> death.During the past few years, there has been a drastic reduction in the level <strong>of</strong> residues <strong>of</strong> organochloropesticides in feeds as well as in milk. For the protection <strong>of</strong> consumers, Codex Committee on PesticideResidues <strong>of</strong> Codex Alimentarius Commission <strong>of</strong> FAO/WHO takes care to establish the MRL fordifferent pesticides for animal feeds <strong>and</strong> foods <strong>of</strong> animal origin. In India, there is an urgent need tomonitor the level <strong>of</strong> pesticide residues in milk with special reference to organophosphates. Thoughmethods for multiresidue analysis <strong>of</strong> pesticide residues have been developed but these have notbeen tried for simultaneous analysis <strong>of</strong> most commonly used OPP <strong>and</strong> OCP compounds in India.Therefore, a technique (Singh <strong>and</strong> Chhabra, 2004) has been evolved in DCN Division for simultaneousdetermination <strong>of</strong> commonly used OCP <strong>and</strong> OPP compounds.MethodologyRequirements1. Pesticide st<strong>and</strong>ards (Sigma-Aldrich): Eighteen OPP including acephate (ACP), chlorpyrifos(CPP), chlorpyrifos-methyl (CPP-me), diazinon (DZN), dichlorvos (DCV), dicrotophos (DCP),dimethoate (DMT), fenitrothion (FTN), malaoxon (MOX), malathion (MTN), monocrotophos(MCP), paraoxon-ethyl (POX), parathion-methyl (PTN), phorate (PRT), phosphamidon (PMD),230


Pesticides: <strong>Their</strong> <strong>Analysis</strong> in Milk Using High Performance Liquid Chromatography2.3.4.5.pr<strong>of</strong>enophos (PFP), quinalphos (QNP), tetrachlorvinphos (TCV) <strong>and</strong> 10 OCP namely aldrin(ADR), dieldrin (DER), endosulfan (ESF), endrin (EDR), heptachlor (HCR), lindane (LDN), 2,4DDE, 2,4 DDT, 4,4 DDD <strong>and</strong> 4,4 DDT.HPLC system: Waters HPLC with binary gradient solvent delivery module, injector, C18µBondaPak column (300 mm x 10 mm i.d.; particle size: 10 µ) with heater to provide columntemperature <strong>of</strong> 39ºC, UV-VIS absorbance detector, Millennium 32 chromatography s<strong>of</strong>tware.Acetonitrile, toluene, methanol, water (all HPLC grade) <strong>and</strong> sodium sulphate (anhyd.)Solvent filtration apparatus with membrane filters (47 mm dia.) viz., aqueous HVLP 04700 <strong>and</strong>organic FHLP 04700 (Millipore India Pvt. Ltd., Bangaluru), Whatman filter paper No. 41, Solidphase extraction (SPE) cartridgeOther equipments: Analytical balance, mixture/blender, vortex mixture, solvent evaporatoryapparatus, vacuum manifold <strong>and</strong> vacuum pumpHPLC conditions for analysisGradient programmeA gradient programme has been developed for separation <strong>of</strong> various pesticides at 200 nm detectionwavelength with column temperature <strong>of</strong> 39ºC. All the pesticides are separated within a run time <strong>of</strong> 60min., however, for proper cleaning the total duration is increased to 86 min, The subsequent samplecan be injected at or after 90 min. <strong>of</strong> run. Acephate is the first pesticide to be eluted while aldrin is thelast one.Limit <strong>of</strong> detection (LOD)LOD is the minimum concentration <strong>of</strong> each pesticide that produces a response which is equal totwice the short term noise at 200 nm. For each pesticide, it was worked out from the average response/area <strong>of</strong> 4 injections <strong>of</strong> st<strong>and</strong>ard pesticide mixture. The LOD was calculated by keeping a min. area <strong>of</strong>1000 units for each pesticide.LinearityLinearity for each pesticide is determined by injecting upto 5 times different concentrations <strong>of</strong>mixed st<strong>and</strong>ard pesticide solution. From the area units <strong>and</strong> concentration for each pesticide, thecorrelation coefficients are calculated. The correlation coefficient for most <strong>of</strong> the residues was about0.99.RepeatabilityFor validation, area units for individual pesticides, 5 samples <strong>of</strong> st<strong>and</strong>ard mixture run during theentire analysis period are r<strong>and</strong>omly selected for the determination <strong>of</strong> coefficient <strong>of</strong> variation (CV). TheCV values for different OPP <strong>and</strong> OCP ranges from 0.86 to 8.13 <strong>and</strong> 1.24 to 19.2%, respectively.Extraction, drying <strong>and</strong> clean up procedures for sample preparation for injection in HPLCExtraction: Milk sample (25 ml) is mixed with 100 ml <strong>of</strong> acetonitrile at high speed for 5 min. It isthen mixed with 10g <strong>and</strong> 20g anhydrous sodium sulphate each time for 2 min. in 2 steps. The sampleis kept undisturbed for 2 min. Supernatant is filtered through Whatman No. 41 <strong>and</strong> kept overnight ina dark place. For determination <strong>of</strong> per cent recoveries, 1 to 5 ppm <strong>of</strong> individual pesticides are addedto 25 ml milk sample <strong>and</strong> after mixing, it is kept overnight in dark before carrying out the extractionwith solvent as explained above.Drying: A 50 ml portion <strong>of</strong> the extract is taken in 500 ml solvent evaporatory apparatus <strong>and</strong> driedunder a stream <strong>of</strong> N2 gas <strong>and</strong> vacuum in 500 ml capacity beaker containing water at 45-50ºC. Then 5ml <strong>of</strong> acetonitrile was added to flask <strong>and</strong> contents were mixed using a vortex mixture. Acetonitrile isevaporated to dryness.231


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceClean up using SPE cartridge: Fresh SPE cartridges were conditioned over vacuum manifoldassembly using 3 ml methanol thrice followed by acetonitrile (3 ml thrice). When acetonitrile phasewas just near to the level <strong>of</strong> sorbent, the individual valves <strong>of</strong> the vacuum manifold assembly wereclosed. The dried sample extract was dissolved in 1.0 ml acetonitrile <strong>and</strong> transferred to preconditionedcartridge. Subsequent rinsing twice with 0.5 ml acetonitrile was also transferred to SPE cartridge. Thena flask was kept below SPE cartridge in vacuum manifold assembly. The contents were collected inthe flask after addition <strong>of</strong> methanol twice. The sample is then evaporated to dryness <strong>and</strong> the residueis dissolved in 1.0 ml acetonitrile. After filtering it through membrane filter, it is injected in HPLCsystem or stored in a refrigerator until used. Likewise, pesticide st<strong>and</strong>ards are run in order to knowthe concentration <strong>of</strong> each pesticide in unknown samples.232


Estimation <strong>of</strong> Microbial GOS by High Performance Liquid ChromatographyIntroductionEstimation <strong>of</strong> Microbial GOS by HighPerformance Liquid ChromatographyVikas Sangwan <strong>and</strong> Sudhir Kumar Tomar<strong>Dairy</strong> Microbiology Division, NDRI, KarnalGalacto-oligosaccharides belong to the group <strong>of</strong> non-digestible oligosaccharides (NDO), whichcan be regarded as soluble dietary fibres because they are completely soluble <strong>and</strong> are fermented byspecific bacteria present in the colon, resulting in the production <strong>of</strong> short-chain fatty acids (propionate,acetate <strong>and</strong> butyrate). <strong>Their</strong> chemical formula is (Galactose)n - Glucose, with n ranging from 1 to 4. Thegalactose-galactose linkage is a β-(1-3), β-(1-4), β-(1-6) linkage, with the β-(1-4) being predominant:the galactose-glucose linkage is mainly β-(1-4). Some disaccharides are also present in GOS (e.g.allolactose <strong>and</strong> galactobiose).GOS have a high solubility <strong>and</strong> a relative sweetness about 35 % that <strong>of</strong> sucrose. They are moreviscous than high-fructose corn syrups, decrease the water activity <strong>and</strong> freezing point, <strong>and</strong> show goodmoisture retention capacities. They also have remarkable stability at high temperatures <strong>and</strong> variable pHlevels. In particular, the stability <strong>of</strong> GOS in acidic <strong>and</strong> high-temperature conditions enables them to beapplied without decomposition in a wider variety <strong>of</strong> foods. GOS remain unchanged after treatment at160ºC for 10 min at pH-2, where about a half or more <strong>of</strong> the sucrose is degraded. Even in acidic conditionsat room temperature, GOS tend to be stable during long-term storage. Galacto-oligosaccharides (GOS)are carbohydrate-based food ingredients that can enhance health- related physiological activities,which can provide protection from infection; decrease the number <strong>of</strong> potentially pathogenic bacteria;facilitate the normal functions <strong>of</strong> the gut; stimulate the absorption <strong>of</strong> some minerals <strong>and</strong> decreaseblood lipids content (Dias <strong>and</strong> others 2009).Production <strong>of</strong> GOSGOS molecules (for example, Gal (β1→4) Gal (β1→4) Glc) are typically synthesised by theenzymatic activity <strong>of</strong> β-galactosidase on lactose in a reaction known as transgalactosylation (Gosling<strong>and</strong> others 2010). β-D-Galactosidases (β-D-galactoside galactohydrolase, EC 3.2.1.23), which are alsoreferred to as lactases, hydrolyze the β(1→4) linkage <strong>of</strong> lactose (galactosyl β(1→4) glucose) to glucose<strong>and</strong> galactose <strong>and</strong> transfer the galactose formed from lactose cleavage onto the galactose moiety <strong>of</strong>another lactose to yield galacto-oligosaccharides (Park <strong>and</strong> others, 2009).The use <strong>of</strong> lactic acid bacteria (LAB) as producers <strong>of</strong> β galactosidase enzymes <strong>of</strong>fers substantialpotential for the production <strong>of</strong> GOS. First, LAB are known to be good producers <strong>of</strong> extracellularβ-galactosidases that enable GOS production from lactose. Second, LAB have a safe tradition in foodFig. 1. Production <strong>of</strong> GOSFig 2. Schematic diagram <strong>of</strong> HPLCfermentations <strong>and</strong> exhibit rapid anaerobic growth on agricultural substrates including waste productssuch as whey. Therefore, GOS may be produced from crude cellular extracts without costly downstreamprocessing. Moreover, GOS may be produced in situ during food fermentations or by using whey toproduce food-grade GOS preparations.233


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceDetection <strong>of</strong> GOS by High Performance Liquid Chromatography (HPLC)High performance liquid chromatography is basically a highly improved form <strong>of</strong> columnchromatography. Instead <strong>of</strong> a solvent being allowed to drip through a column under gravity, it isforced through under high pressure that makes it much faster.Flow Scheme for HPLCLiquid chromatography involves a sample beingdissolved in a mobile phase (liquid, acetonitrile: w1ter, 80:20,in case <strong>of</strong> GOS). The mobile phase is then forced throughan immobile, immiscible stationary phase. The stationaryphases are chosen such that components <strong>of</strong> the sample havedifferent solubility in each phase. A component, which isquite soluble in the stationary phase, will take longer to travelthrough it than a component, which is not very soluble in thestationary phase but very soluble in the mobile phase. As aresult <strong>of</strong> these differences in mobility, sample componentswill become separated from each other as they travel throughthe stationary phase. Figure 3 represents a chromatogramfor GOS obtained in HPLC.Detection limits <strong>of</strong> substances using HPLC in generalare largely dependent on the compound being analyzed as well as the sensitivity <strong>of</strong> detector used.Whereas the RI detector is not the most sensitive, for example being 100 to 1000 less sensitive thanUV detectors, its suitability with detection range <strong>of</strong> micrograms per milliliter (μg/mL) is convenientenough for GOS detection <strong>and</strong> analysis (Otieno, 2010)Materials <strong>of</strong> chromatographic separationDifferent types <strong>of</strong> materials can be used as a solid phase for chromatographic separation. Thestationary phase is the key element in a chromatography system. Separation is enhanced by usingstationary phases that present the shortest possible diffusion pathways to the solutes, have lowresistance to mass transfer, reasonably narrow particle size distribution, <strong>and</strong> are uniformly packed inthe column. The most frequent materials used in sugar separation are:a) Active carbonIn sugar industry, the most used adsorbent is active carbon, because is the cheapest <strong>and</strong> does notrequire a difficult pretreatment. Use <strong>of</strong> active carbon for the separation <strong>of</strong> GOS has shown that the carbonhas higher affinity for oligosaccharides <strong>and</strong> low affinity for monosaccharides (glucose <strong>and</strong> galactose).b) Ion exchange materialsCation exchange resins have been used HPLC program for GOS detectionextensively in the sugar industry for differenttypes <strong>of</strong> separation. The use <strong>of</strong> cation-exchange Mobile phase Acetonitrile: Water (80:20)resins together with water as the mobile phase ColumnAmino (NH2) columnresulted in a better separation <strong>of</strong> saccharides DetectorRefractive Index Detectorthan when anion exchangers were used. Use Run time20 min<strong>of</strong> a method for the separation <strong>of</strong> sugars on theFlow rate0.4 ml/mincation-exchange resin Dowex 50W-X4 (K+),Column temperature800Cusing water as the eluent separate varioussugars including oligosaccharides, hexoses, pentoses, acetals, methyl-α-D-glycosides <strong>and</strong> other sugarderivatives, with recoveries <strong>of</strong> greater than 95%.FractionationFig. 3. HPLC chromatogram <strong>of</strong> GOS sample:Glc: glucose, Gal: galactose, Lac: lactose, a(1–6)galactobiose, DP: degree <strong>of</strong> polymerisation.The separation <strong>of</strong> carbohydrates plays an important role in food production <strong>and</strong> in cosmetic <strong>and</strong>pharmaceutical industries. Also, 90% <strong>of</strong> the cost in food production is related with separation processes.234


Estimation <strong>of</strong> Microbial GOS by High Performance Liquid ChromatographyLiquid chromatography <strong>of</strong>fers high selectivity, efficiency <strong>and</strong> loading capacity <strong>of</strong> the stationary phase<strong>and</strong> speed <strong>of</strong> process. Purification <strong>of</strong> GOS is important because by removing monosaccharide <strong>and</strong>lactose from GOS, there is a decrease in sweetness <strong>and</strong> calorie value. Different techniques are beingused for the fractionation <strong>of</strong> oligosaccharides including• Diafiltration• Yeast treatment,• Activated charcoal treatment• Size exclusion chromatography (SEC) (Hern<strong>and</strong>ez <strong>and</strong> others 2009).Other methods <strong>of</strong> detectionQuemener <strong>and</strong> others (1997) developed a method based on high performance anion-exchangechromatography with pulsed amperometric detection (HPAE-PAD) to measure GOS in food <strong>and</strong>feed products. A few years later, de Slegte (2002) organized collaborative study <strong>of</strong> this method inwhich galactose <strong>and</strong> other sugars were separated on a CarboPacTM PA1 column <strong>and</strong> detected bypulsed amperometric detection (PAD) using a triple potential waveform. Thin layer chromatography(TLC) <strong>and</strong> spectrophotometric (UV spectra) methods are also used for GOS detection. TLC is onlyqualitative <strong>and</strong> less sensitive as compared to HPLC. The UV method together with chemometricmodels <strong>of</strong> calibration is an acceptable analytical method for a fast, simple <strong>and</strong> inexpensive monitoring<strong>of</strong> total GOS production in a predefined fermentation process, allowing to promptly verifying if thefermentation is running as expected, or if some correction action is needed, which is crucial whenan industrial GOS production is envisaged, being a possible alternative to the st<strong>and</strong>ard analyticalmethods usually used (Dias <strong>and</strong> others 2009).ConclusionLiquid chromatography has been largely used depending on the matrix from which GOS is to beextracted <strong>and</strong> analyzed. However, HPAE-PAD has been found to be more superior in the detection<strong>of</strong> GOSs than high-performance liquid chromatography with RI detection. Nevertjeless, in the eventthat HPAE-PAD is not available for use, HPLC-RI can be reliably used instead. Concerning thechemometric methods analyzed, in general, the ANN multiple is robust <strong>and</strong> present the best globalprediction performance. However, further studies are needed in order to obtain better results withthese chemometric models. Although the RI detector has several limitations, namely the dependence<strong>of</strong> sensitivity on changes in solvent composition, temperature, <strong>and</strong> pressure, it however remains themost useful tool so far in the determination <strong>of</strong> sugar concentrations in foods.Referencesde Slegte J. 2002. Determination <strong>of</strong> trans-galactooligosaccharides in selected food products by ion-exchangechromatography. J AOAC Int 85:417–23.Dias LG, Veloso ACA, Correia DM, Rocha O, Torres D, Rocha I, Rodrigues LR, Peres AM. 2009. UV spectrophotometrymethod for the monitoring <strong>of</strong> galacto-oligosaccharides production. Food Chemistry 113:246–252.Gosling A, Stevens GW, Barber AR, Kentish SE, Gras SL. 2010. Recent advances refining galactooligosaccharideproduction from lactose. Food Chemistry 121:307–318.Hern<strong>and</strong>ez O, Matute AIR, Olano A, Moreno FJ, Sanz ML. 2009. Comparison <strong>of</strong> fractionation techniques to obtainprebiotic galactooligosaccharides. International <strong>Dairy</strong> Journal 19:531–536.Morales V, Sanz ML, Olano A, Corzo N. 2006. Rapid separation on activated charcoal <strong>of</strong> high oligosaccharides in honey.Chromatographia 64:233–238.Otieno DO. 2010. Synthesis <strong>of</strong> β-Galactooligosaccharides from Lactose Using Microbial β-Galactosidases. ComprehensiveReviews in Food Science <strong>and</strong> Food Safety 9:471-482.Park AR, Oh DK. 2009. Galacto-oligosaccharide production using microbial β-galactosidase: current state <strong>and</strong>perspectives. Appl Microbiol Biotechnol.235


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceEstimation <strong>of</strong> Trehalose Production by PropionibacteriaIntroduction236Poonam <strong>and</strong> Sudhir Kumar Tomar<strong>Dairy</strong> Microbiology Division, NDRI, KarnalTrehalose also known as mycose, is a non reducing disaccharide in which two glucose moleculesare linked together in a 1,1-glycosidic linkage. Although there are three possible anomers <strong>of</strong> trehalose,that is, α,β-1,1, β,β-1,1, <strong>and</strong> α,α-1,1, only the α,α -trehalose (Figure 1) has been isolated from <strong>and</strong>biosynthesized in living organisms.This naturally occurring disaccharide is widespread throughout the biological world with thefirst tentative report being in ergot <strong>of</strong> rye. Trehalose isfound naturally in insects, plants, fungi, <strong>and</strong> bacteria,the major natural dietary source is mushrooms. It isimplicated in anhydrobiosis—the ability <strong>of</strong> plants <strong>and</strong>animals to withst<strong>and</strong> prolonged periods <strong>of</strong> desiccation.It has high water retention capabilities <strong>and</strong> is usedin food <strong>and</strong> cosmetics. The sugar forms a gel phase Fig. 1. Structure <strong>of</strong> naturally occurring isomer <strong>of</strong>as cells dehydrate, which prevents disruption <strong>of</strong>trehalose, α,α-1,1 trehaloseinternal cell organelles by effectively splinting themin position. Rehydration then allows normal cellularactivity to be resumed without the major, lethal damage that would normally follow a dehydration/rehydration cycle. Trehalose has the added advantage <strong>of</strong> being an antioxidant. Trehalose is a naturallyoccurring reducer <strong>of</strong> cell stress, protecting these organisms from extremes in heat shock <strong>and</strong> osmoticstress (Crowe, 2002). It acts by altering or replacing the water shell that surrounds lipid <strong>and</strong> proteinmacromolecules. It is thought that its flexible glycosidic bond allows trehalose to conform to theirregular polar groups <strong>of</strong> macromolecules. In doing so, it is able to maintain the 3-dimensional structure<strong>of</strong> these biologic molecules under stress, preserving biologic functions. Furthermore, trehalose is verypromising as a sugar substitute in food: it is repeated as being anti-cariogenic <strong>and</strong> can be consideredas a dietetic sugar since it is only partially digested in the human intestine (Neta et al., 2000). Theseproperties place trehalose in the category <strong>of</strong> compounds known as nutraceuticals, defined as foods<strong>and</strong> food components with benefits for human <strong>and</strong> animal health (Hugenholtz et al., 2002).Trehalose production by propionibacteria<strong>Dairy</strong> Propionibacteria are important starter organisms involved in typical flavor <strong>and</strong> eyesformation in Swiss-type <strong>of</strong> cheeses <strong>and</strong> in the production <strong>of</strong> other dairy products. Besides theirtechnological role, these bacteria can also be used as cell factory for the production <strong>of</strong> a variety <strong>of</strong>biomolecules like vitamin B 12, folate, rib<strong>of</strong>lavin <strong>and</strong> propionic acid. They also have been recognizedas potential probiotics in recent years. In cheese manufacturing <strong>and</strong> during other applications,Propionibacteria are subjected to different kind <strong>of</strong> stress conditions <strong>and</strong> a part <strong>of</strong> this defense systeminvolves the intracellular accumulation <strong>of</strong> trehalose.Pathways for trehalose biosynthesisAt least four pathways for the synthesis <strong>of</strong> trehalose in biological system have been reportedthus far: (i) the OtsA–OtsB pathway, the most common route, involves the transfer <strong>of</strong> glucose fromUDPglucose to glucose 6-phosphate to yield trehalose 6- phosphate, which is subsequently convertedto trehalose (ii) the TreS pathway, Trehalose synthase (TS) catalyses an intramolecular arrangement<strong>of</strong> maltose, in order to convert the glycosidic bond α-(1-4) <strong>of</strong> this disaccharide to the α -(1-1) trehalosebond (iii) the TreY–TreZ pathway, a two-step reaction involving maltooligosyl-trehalose synthase(TreY) catalyzing the conversion <strong>of</strong> maltodextrines to maltooligosyl-trehalose <strong>and</strong> subsequently themaltooligosyl-trehalose trehalohydrolase (TreZ) breaks this intermediate to generate trehalose <strong>and</strong>


Estimation <strong>of</strong> Trehalose Production by Propionibacteria(iv) a single-step pathway involving trehalose glycosyltransferringsynthase, that catalyses the reversible conversion <strong>of</strong> glucose <strong>and</strong>NDP-glucose into trehalose.Pathways leading to trehalose accumulation in Propionibacteriafreudenreichii have been studied (Cardoso et al., 2007). P.freudenreichii uses the OtsA–OtsB pathway for trehalose synthesis,whereas trehalose catabolism proceeds via TreS. Maltose derivedfrom TreS activity can be processed by amylomaltase, releasingglucose which is further catabolized via glycolysis (Figure 2).Given the beneficial properties <strong>of</strong> trehalose, there is a needto estimate the level <strong>of</strong> trehalose accumulated by differentPropionibacteria strains so that high trehalose accumulating strainscan be selected which will act as robust cheese starter <strong>and</strong> can beused for enhanced trehalose production at industrial level.Estimation <strong>of</strong> trehalose productionDifferent types <strong>of</strong> methods are available for estimation<strong>of</strong> trehalose production by Propionibacterium strains. All thesemethods include growth <strong>of</strong> culture in YELA medium, extraction <strong>of</strong>intracellular trehalose from the cells <strong>and</strong> then estimating the level <strong>of</strong> trehalose.Growth conditionsFor investigating trehalose biosynthesis, culturing <strong>of</strong> the cells is required in Erlenmeyer flasks(500mL). At the beginning <strong>of</strong> the experiment, a 3% inoculums (v/v) is introduced in 200 mL <strong>of</strong> YELA(Yeast extact lactae agar) medium <strong>and</strong> strieedd at 50 rpm in a water bath at 30 ºC. To establish anaerobicconditions, the medium is aseptically gassed with argon during the 15-min preceding inoculation. Aculture grown until exponential phase is used as inoculum to obtain an initial optical density <strong>of</strong> about0.06.Trehalose extraction from the cellTrehalose extraction using ethanol extraction: Cells are centrifuged (13800 g, 10 min) <strong>and</strong> washed inan isotonic solution. The cell pellets are transferred into a glass tube with 80 % ethanol <strong>and</strong> stirredby vortex for 30 min at ambient temperature. They are evaporated to dryness by means <strong>of</strong> a rotaryevaporator. The residues obtained are then dissolved in the 1.5 ml <strong>of</strong> acetonitrile : water (70:30) <strong>and</strong>directly taken up for HPLC analysis. (Ferreira et al., 1996).Trehalose extraction using TCA: The cell pellet obtained is mixed with 3 volumes <strong>of</strong> TCA 0.5 M for1hr at room temperature. Then the suspension is centrifuged at 20000 g for 10 min. The supernatant isneutralized before trehalose conc. Measurement (Cola et al., 2010).Trehalose extraction using hot water: The cell pellet obtained is washed with 1 ml <strong>of</strong> water. Cells areresuspended in 0.2 ml <strong>of</strong> water <strong>and</strong> transferred to a boiling water bath, followed by incubation for 10min to extract intracellular compounds. After centrifugation <strong>of</strong> the boiled sample, the supernatant isobtained <strong>and</strong> used for measuring the trehalose content (Mahmud et al., 2010).Trehalose extraction using Bead mill: The test tubes are directly taken up from the freezer <strong>and</strong>immersed in boiling water for 10 min. followed by cooling on ice. Glass beads are added to tubes<strong>and</strong> cells are disintegrated in the bead mill for 30 min. Cell debris are removed by centrifugation <strong>and</strong>supernatant is taken for further analysis (Schulze et al., 1995).Estimation <strong>of</strong> trehalose from the cell extractFig.2. Proposed scheme <strong>of</strong> trehalosemetabolism in P. freudenreichii.1, Glucokinase; 2, trehalose-6-phosphate synthase; 3, trehalose-6-phosphate phosphatase; 4, trehalosesynthase; 5, amylomaltose; PolyP,polyphosphate; G, glucose.HPLC method: Trehalose concentration in the supernatant obtained is measured using a HPLCsystem equipped with refractometer detector <strong>and</strong> a silica-amino column (250x4 mm i.d.) coupled to aguard-column (10x4 mm i.d.). Mobile phase used is acetomitrile : water (70:30) at 1mL. min (Deborde237


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assuranceet al., 1996)Enzymatic (Trehalase) method: Trehalose can also be determined by incubating the cell free extractswith a stable trehalase preparation. Extracts (100 µl) plus 25 µl trehalase are incubated overnight (14h) at 40ºC. The resulting glucose is assayed with glucose oxidase by adding to the spectrophotometercell (2.0 ml final volume), the following reagents: 1% odianisidine, prepared by diluting in 0.1 Mphosphate buffer pH 6.0; digested trehalose sample; peroxidase, 200 lg/ml in distilled water (1.5 U/ml <strong>of</strong> the assay mixture); <strong>and</strong> glucose oxidase (1 mg/ml in distilled water, to obtain 21 U/ml in 2 ml<strong>of</strong> the assay mixture). Absorbance changes are measured in the spectrophotometer at 460 nm <strong>and</strong> 25ºC<strong>and</strong> compared to a glucose st<strong>and</strong>ard curve (Gonzalez-Hern<strong>and</strong>ez et al., 2005).Anthrone method: Trehalose extracts are submitted to the reaction with anthrone <strong>and</strong> the colourformed measured at 620 nm, according to the procedure described by Brin (1966). Quantification isachieved using trehalose as external st<strong>and</strong>ard.NMR method: After overnight ethanol extraction, the samples are dried in a desiccator for at least48 h. Dried samples are resuspended in D 2O (Aldrich <strong>Chemical</strong>) <strong>and</strong> analyzed by NMR spectroscopyusing a Bruker AMX300 spectrometer with a 5-mm inverse detection probe head, 32 K data points, a90j flip angle <strong>and</strong> a repetition delay <strong>of</strong> 42.7 s. The water resonance is suppressed with a pre-saturationpulse. The trehalose peak is identified against that <strong>of</strong> the pure substance. (Cardoso et al., 2004).Megazyme kit method: The trehalose content in the supernatant can also be measured using aenzymatic assay kit from Megazyme International Irel<strong>and</strong> Ltd. (Wicklow, Irel<strong>and</strong>). The basic principleincludes hydrolysis <strong>of</strong> trehalose to D-glucose by trehalase <strong>and</strong> then D-Glucose released is measuredby phosphorylating with enzyme hexokinase (HK).Cell protein determination: For expressing the trehalose content in the cell, the total protein in thecell is determined by the method <strong>of</strong> Lowry et al. (1951) after cell lysis with 1 M NaOH (85ºC, 5 min),<strong>and</strong> using bovine serum albumin as a st<strong>and</strong>ard. Trehalose content <strong>of</strong> the cell is expressed in terms <strong>of</strong>protein content <strong>of</strong> the cell (Cardoso et al., 2004).ReferencesBrin, M. (1966). Transketolase: clinical aspects ed. In. S. P. Colowick & N. 0. Kaplan, Methods in Enzymology, 9,Academic Press, pp. 506514.Cardoso, F. S., Castro, R. F., Borges, N., Santos, H. (2007). Biochemical <strong>and</strong> genetic characterization <strong>of</strong> the pathwaysfor trehalose metabolism in Propionibacterium freudenreichii <strong>and</strong> their role in stress response. Microbiology, 153, 270–280.Cardoso, F. S., Gaspar, P., Hugenholtz, J., Ramos, A., Santos, H. (2004). Enhancement <strong>of</strong> trehalose production in dairyPropionibacteria through manipulation <strong>of</strong> environmental conditions. International Journal <strong>of</strong> Food Microbiology, 91,195– 204.Colla, E., Pereira, A. B., Hernalsteens, S., Maugeri F., Rodrigues, M. I. (2010). Optimization <strong>of</strong> trehalose productionby Rhodotorula dairenensis following a sequential strategy <strong>of</strong> experimental Design. Food Bioprocess Technol, 3,265–275.Crowe, L. M. (2002). Lessons from nature: the role <strong>of</strong> sugars in anhydrobiosis. Comp Biochem Physiol AMol Integr Physiol,131, 505–13.Deborde, C., Coree, C., Rolin, D. B., Nadal, L., de certaines, J. D., Boyaval, P. (1996) Trehalose biosynthesis in dairyPropionibacterium. Journal <strong>of</strong> magnetic resonance analysis, 2, 297-304.Ferreira, J. C., Paschoalin, V. M. F., Panek, A. D., Trugo, L. C. ( 1997). Comparison <strong>of</strong> three different methods fortrehalose determination in yeast extracts. Food Chemistry, 60(2), 251-254.Gonzalez-Hern<strong>and</strong>ez, J. C., Jimenez-Estrada, M. (2005). Comparative analysis <strong>of</strong> trehalose production by Debaryomyceshansenii <strong>and</strong> Saccharomyces cerevisiae under saline stress. Extremophiles, 9, 7–16.Hugenholtz, J., Hunik, J., Santos, H., Smid, E. (2002). Nutraceutical production by propionibacteria. Lait, 82, 103– 112.Mahmud, S. A., Hirasawa, T., Shimizu, H. (2010). Differential importance <strong>of</strong> trehalose accumulation in Saccharomycescerevisiae in response to various environmental stresses. Journal <strong>of</strong> Bioscience <strong>and</strong> Bioengineering, 109 (3), 262–266.Neta, T., Takada, K., Hirasawa, M. (2000). Low-cariogenicity <strong>of</strong> trehalose as a substrate. Journal <strong>of</strong> Dentistry, 28, 571–576.Schulze, U., Larsen, M. E., Villadsen, J. (1995). Determination <strong>of</strong> intracellular trehalose <strong>and</strong> glycogen in Saccharomycescerevisiae. Analytical Biochemistry, 228, 143-149.238


Spore Based Biosensor as A <strong>Quality</strong> Control Tool in <strong>Dairy</strong> IndustrySpore Based Biosensor as A <strong>Quality</strong>Control Tool in <strong>Dairy</strong> IndustryNaresh Kumar, Raghu H. V. <strong>and</strong> Avinash<strong>Dairy</strong> Microbiology Division, NDRI, KarnalThe development <strong>of</strong> sensors for detecting foodborne pathogens has been motivated by the needto produce safe foods <strong>and</strong> to provide better healthcare (Irudayaraj, 2009). Improving food <strong>and</strong> watersafety <strong>and</strong> security depends on the ability to detect, identify, <strong>and</strong> trace food <strong>and</strong> water pathogens.As milk is a compulsory part <strong>of</strong> daily diet <strong>and</strong> being nutritious food for human beings, also servesas a good medium for the growth <strong>of</strong> many microorganisms which cause spoilage <strong>of</strong> milk <strong>and</strong> milkproducts. Earlier for detection <strong>of</strong> pathogens conventional methods which rely on specific media toenumerate <strong>and</strong> isolate viable bacterial cells in food were used, <strong>and</strong> are considered as gold-st<strong>and</strong>ardfor their detection. These methods are very sensitive, inexpensive <strong>and</strong> can give both qualitative <strong>and</strong>quantitative information <strong>and</strong> involve the basic steps: pre-enrichment, selective enrichment, selectiveplating, <strong>and</strong> biochemical screening <strong>and</strong> serological confirmation. Hence, a complete series <strong>of</strong> tests are<strong>of</strong>ten required before any identification can be confirmed (M<strong>and</strong>al et al., 2011) Although methods arepowerful, error-pro<strong>of</strong>, <strong>and</strong> dependable but are lengthy, cumbersome <strong>and</strong> are <strong>of</strong>ten ineffective becausethey are not compatible with the speed at which the products are manufactured <strong>and</strong> the short shelflife <strong>of</strong> products. To overcome these challenging criteria <strong>of</strong> time <strong>and</strong> sensitivity rapid methods whichinclude nucleic acid, fluorescent antibody or immuno-based techniques have been developed whichgives instant or real time results but requiring additional expensive devices <strong>and</strong> equipments (Ivnitskiet al., 1999). Biosensor based tools <strong>of</strong>fer the most promising solutions <strong>and</strong> address some <strong>of</strong> the moderndayneeds for fast <strong>and</strong> sensitive detection <strong>of</strong> pathogens in real time.Biosensors are defined as analytical devices integrating biological elements <strong>and</strong> signal transducers.The biological elements interact specifically with an analyte, producing a signal that the transducerrecognizes <strong>and</strong> converts into measurable parameters as shown in fig.1 (Rasooly <strong>and</strong> Herold, 2006).Currently biosensor is defined as a sensor that integrates a biological element with a physiochemicaltransducer to produce an electronic signal proportional to a single analyte which is then conveyed toa detector.Biosensor achievements have revolutionized the detection method <strong>and</strong> provide us with simple touse device, cost-effective, rapid <strong>and</strong> appropriate detection method that give immediate <strong>and</strong> accurateresults comparable to or better than the conventional analytical systems in terms <strong>of</strong> performancei.e. reliability, sensitivity, selectivity,specificity <strong>and</strong> robustness <strong>and</strong> can identifythe contaminants much faster, more efficient<strong>and</strong> can give effective real time monitoring<strong>of</strong> pathogens <strong>and</strong> most importantly ensuringcustomer safety (Scott, 1998).History <strong>of</strong> biosensor: In 1956, Lel<strong>and</strong>C Clark Jr., who is known as the father <strong>of</strong>Biosensors <strong>and</strong> he published his definitivepaper on the oxygen electrode. In 1962, he Fig. 1. Diagrammatic representation <strong>of</strong> Biosensor <strong>and</strong> itsdescribed "how to make electrochemical working principlesensors more intelligent" by adding Source:www.realtimebiosensor.com (Mattias Rudh, 2007)"enzyme transducers as membrane encloseds<strong>and</strong>wiches”. The year wise development in the field <strong>of</strong> biosensor is as follows:1922: First glass pH electrode;1956: Invention <strong>of</strong> the oxygen electrode;1962: First description <strong>of</strong> abiosensor- an amperometric enzyme electrode for glucose; 1969: First potentiometer biosensor- Urease239


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assuranceimmobilized on an ammonia electrode to detect urea; 1972/5: First commercial biosensor-YellowSprings Instruments glucose biosensor;1975: First microbe-based biosensor, First immunosensorovalbuminon a platinum wire, Invention <strong>of</strong> the pO 2/pCO 2optode; 1982: First fibre optic-basedbiosensor for glucose; 1983: First surface plasmon resonance (SPR) immunosensor; 1984: Firstmediated amperometric biosensor: ferrocene used with glucose Oxidase for the detection <strong>of</strong> glucose;1996: Glucocard launched; 1998: Launch <strong>of</strong> LifeScan Fast Take blood glucose biosensor; 2001: LifeScanpurchases Inverness Medicals glucose testing business for $1.3 billion.Types <strong>of</strong> biosensors:1. Optical biosensors: Technique used in this biosensor is based on surface plasma resonance.2. Electrochemical sensing biosensors: Technique used in this biosensor is based on amperometricsensing, Conductometric sensing. In amperometric sensing, increasing potential is applied tothe cell until oxidation <strong>of</strong> the substance to be analysed occurs. This in turn increases the cellcurrent <strong>and</strong> gives a peak current. The height <strong>of</strong> this peak current will be directly proportionalto the concentration <strong>of</strong> electroactive substances or molecules. In conductive sensors substrateconcentration is measured using relationship between conductance <strong>and</strong> concentration <strong>of</strong> ionicspecies.3. Enzymatic biosensors: This type <strong>of</strong> sensors is widely used as they are easy to use. For exampleglucose biosensors. In glucose biosensor enzyme acts as a biorecognition element <strong>and</strong> recognizesonly the glucose molecule. These enzymes are present in the electrode surface. When enzymerecognizes the glucose molecule it act as biocatalyst <strong>and</strong> produces gluconic acid <strong>and</strong> hydrogenperoxide using glucose <strong>and</strong> oxygen from the air. This reaction leads to the flow <strong>of</strong> electronsfrom hydrogen peroxide/oxygen coupling. This flow <strong>of</strong> electron is directly proportional to thenumber <strong>of</strong> glucose, molecules present in the biological fluid such as blood.Classification <strong>of</strong> biosensor:It may be classified according to the biological specificity conferring mechanism or to the mode <strong>of</strong>signal transduction, or alternatively a combination <strong>of</strong> both (Belluzo et al., 2008).Classification based on bioreceptors: A Bioreceptor is a biological molecular species or aliving biological system that utilizes a biochemical mechanism for recognition (Tantilipikara, 2005).Depending upon the mechanism <strong>of</strong> biochemical interaction between the receptor <strong>and</strong> the analyte thebiosensor can categorised into two types:1. Biocatalytic sensors: They are based on the recognition <strong>and</strong> binding <strong>of</strong> an analyte followed bya catalyzed chemical conversion <strong>of</strong> the analyte from a non-detectible form to detectible formwhich are detected <strong>and</strong> recorded by a transducer. This includes:i) Monoenzyme, multienzyme ii) Microorganisms (such as bacteria, fungi, yeast), or sub cellularorganelles <strong>and</strong> particles (mitochondria, cell walls); iii) Animal / plant tissue slice2. Bioaffinity sensors: They are based on the interaction <strong>of</strong> the analyte with biological components,such as antibodies, nucleic acid, lectins, cell membrane receptor or harmone receptor (Rogers,2000).Classification based on transduction system: The transducing element <strong>of</strong> a biosensor is used toconvert the biological recognition step into the measurable signal that can be detected <strong>and</strong> displayed.It is further classified into following types:a) Electrochemical : Electrochemical detectors measure changes in electron transfer caused byan oxidation/reduction reaction involving the analyte at the surface <strong>of</strong> a suitable electrode(Thevenot et al., 2001). It further includesi)Amperometric : It detects the changes in current as a function <strong>of</strong> concentration <strong>of</strong> electroactive species e.g. - Solid electrolyte gas sensors, electronic noses.ii) Potentiometric : It depends on changes in potential <strong>of</strong> a system at constant current (I=0) orit detects the change in distribution <strong>of</strong> charge. e.g. - Ion-selective electrodes (such as pH240


Spore Based Biosensor as A <strong>Quality</strong> Control Tool in <strong>Dairy</strong> Industrymeter), Ion-selective field effect transistors, LAPS.iii) Conductometric : It measures the change in conductance <strong>of</strong> the biological complexsituated between electrodes. or it involves the measurement <strong>of</strong> changes in conductancedue to the migration <strong>of</strong> ions. e. g.-Optical fibers, surface plasmon resonance, absorbance,luminescence.b) Optical : In optical biosensors, the optical fibers allow detection <strong>of</strong> analyte on the basis <strong>of</strong>absorption, fluorescence or light scattering (Chauhan et al., 2004) e.g.-Surface plasmonresonancec) Piezoelectric: The change in frequency is proportional to the mass absorbed material orSensitive to changes in mass, density, viscosity <strong>and</strong> acoustic coupling phenomena e. g.Surface acoustic wave sensorsd) Calorimetric : Many enzyme catalyzed reactions are exothermic, generating heat which maybe used as a basis for measuring the rate <strong>of</strong> reaction <strong>and</strong>, hence, the analyte concentration.Whole-cell bacterial biosensorsBacteria can be used as biosensors to demonstrate the toxicity <strong>of</strong> a variety <strong>of</strong> environmentalmedia including soil, sediment, <strong>and</strong> water by coupling bacteria to transducers that convert a cellularresponse into detectable signals (Biran et al., 2003). These bacterial biosensors are engineered bypairing a reporter gene that generates a signal with a contaminant-sensing component that respondsto chemical or physical change, such as exposure to a specific analyte. When the biosensor is exposedto such a change, the sensing component stimulates the reporter gene through a biochemical pathwayin the cell. The reporter gene then produces a measurable response, such as emitting visible light,which is indicative <strong>of</strong> the degree <strong>of</strong> chemical or physical change (Biran et al., 2003; Tauriainen et al.,2000, Turpeinen et al., 2003; Daunert et al., 2000). Several biosensors have been developed that indicatetoxicity <strong>of</strong> any chemical or physical change; new biosensors are being developed to respond toparticular analytes. Such biosensors have been developed for heavy metals <strong>and</strong> metalloids includingarsenic, cadmium, mercury, <strong>and</strong> lead (NRC, 2003).Biosensors measure the bioavailability concentration for the contaminant they are designed todetect (Tauriainen et al., 2000). To test the measurements made by biosensors, a chelating agent knownto decrease bioavailability <strong>of</strong> lead was added to a lead solution. Measurements <strong>of</strong> the lead solutioncontaining chelating agents were taken <strong>and</strong> compared to measurements <strong>of</strong> the lead-only solution. Adecrease in the biosensors luminescence matched a decrease in bioavailability concentration <strong>of</strong> leadin the solution. This demonstrates that biosensors are sensitive to the bioavailability fraction <strong>of</strong> thecontaminant <strong>and</strong> their luminescence reflects the bioavailability concentration (Tauriainen et al., 2000).Spores based biosensor: Bacterial spores appears to have great potential for their application asbio-sensor as they have the ability to sense environmental changes <strong>and</strong> to respond using explosivemolecular mechanisms that transform dormant spores into rapid growing cells. There are a greatnumber <strong>of</strong> bacterial species which produce spores for example; genus Bacillus (widely dispersed in soil,plant matter, <strong>and</strong> air) may be readily grown in the laboratory to form spores: B. cereus, B. licheniformis,B. megaterium, B. sphaericus, B. stearothermophilus, B. subtilis, <strong>and</strong> B. thuringiensis. They can also survivein a very harsh condition. For the development <strong>of</strong> bacterial spore as a biosensor, it is a prerequisite tohave a complete or descriptive knowledge regarding their germinants (carbohydrates, nucleotides,amino acids etc.) which by their action on the dormant spores convert them into vegetative cells. Thegermination process <strong>of</strong> a whole population <strong>of</strong> spore may be completed in a very short duration <strong>of</strong>time (15-30min) followed by a sequence <strong>of</strong> metabolic reactions <strong>and</strong> synthesis <strong>of</strong> enzymes resulting inoutgrowth <strong>of</strong> vegetative cells. After germination de novo acetyl esterase is released from the core <strong>of</strong>the spore which act upon DAF <strong>and</strong> its hydrolysis results in flouroscence <strong>and</strong> the signal can be capturedusing optical device to quantify the presence <strong>of</strong> target analyte (Rotman, 2001).Characteristic features <strong>of</strong> spores: Bacillus species have inherent characteristics to produce241


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assuranceendospore. These are the dormant form <strong>of</strong> life having no metabolic activity. They are resistant toenvironmental stress like heat, desiccation, irradiation <strong>and</strong> chemical compounds <strong>and</strong> can be storedin a medium for long time even in the absence <strong>of</strong> nutrients. Spores are resistant due to the Calciumdipicolinatepresent in the spores that stabilize <strong>and</strong> protects the DNA from denaturation. DNA-bindingproteins helps in protecting the DNA from heat, drying, chemicals, <strong>and</strong> radiations. While dehydrationprocess that is the loss <strong>of</strong> water provides them resistance toward heat <strong>and</strong> radiation. And finally duringthe germination process damaged DNA they get repaired by DNA repair enzymes (Setlow, 2003).Sporulation: Spore formation, sporogenesis or sporulation, normally commences when growthceases due to lack <strong>of</strong> nutrients. It is a complex process <strong>and</strong> may be divided into seven stages .An axialfilament <strong>of</strong> nuclear material forms (Stage-I), followed by an inward folding <strong>of</strong> the cell membrane toenclose part <strong>of</strong> the DNA <strong>and</strong> produce the forespore septum (Stage-II). The membrane continues togrow <strong>and</strong> engulfs the immature spore in a second membrane (Stage-III). Next, cortex is laid down inthe space between the two membranes, <strong>and</strong> both calcium <strong>and</strong> dipicolinic acid is accumulated (Stage-IV). Protein coats then are formed around the cortex (Stage-V), <strong>and</strong> maturation <strong>of</strong> the spore occurs(Stage-VI). Finally, lytic enzymes destroy the sporangium releasing the spore (Stage-VII). Diagramrepresenting the different stages <strong>of</strong> sporulation (Prescott et al., 2002).Germination: In the presence <strong>of</strong> favorable growth conditions spores get germinated. Thegermination process is essentially a biophysical <strong>and</strong> degradative one – the spore’s inner membraneincreases in fluidity <strong>and</strong> ion fluxes resume; monovalent cations, potassium <strong>and</strong> sodium, move acrossthe spore membrane, <strong>and</strong> calcium ions <strong>and</strong> dipicolinate are excreted. The peptidoglycan <strong>of</strong> thespore cortex is degraded, <strong>and</strong> the coat layers are partially degraded. ATP synthesis <strong>and</strong> oxidativemetabolism resume, DNA damage is repaired <strong>and</strong> the DNA-complexing small acid-soluble proteins(SASPs) are degraded by a specific protease, providing a source <strong>of</strong> amino acids for outgrowth. Asgermination events precede any de novo synthesis <strong>of</strong> macromolecules, the apparatus required forspore germination must be already present in the mature spore (Moir et al., 2002).Application <strong>of</strong> spores as biosensor: Bacterial spores are suitable for use as biosensor because theyhave the ability to sense environmental changes in response to specific “germinant” <strong>and</strong> transforminto rapid growing cells. The spores are heat resistant <strong>and</strong> can remain in non metabolic state for manyyears. This characteristic can effectively be used as a biosensor for tracking these residues in milk <strong>and</strong>milk products <strong>and</strong> the details <strong>of</strong> biosensor developed are as follows:242


Spore Based Biosensor as A <strong>Quality</strong> Control Tool in <strong>Dairy</strong> Industry1.2.3.4.Development <strong>of</strong> analytical process for detection <strong>of</strong> antibiotic residues in milk using bacterialspores as biosensor.(Patent no Reg# IPR /4.9.1/05074/2006)(Kumar et al., 2006)A kit for detection <strong>of</strong> β-lactam antibiotic group in milk using bacterial spore as biosensor (PatentReg # IPR/ 4.14.1/08073/del/2009) (Kumar et al., 2009)Development <strong>of</strong> Spore Inhibition Based -Enzyme Substrate Assay (SIB-ESA) for monitoringAflatoxin M1 in milk (Patent Regd.# IPR /4/14.4/10045)Development <strong>of</strong> Enzyme Substrate Assay (ESA) for Monitoring Enterococci in Milk(Setlow, P, 2003.)Development <strong>of</strong> analytical process for detection <strong>of</strong> antibiotic residues inmilk using bacterial spores as biosensorThe bacterial spores have unique ability to sense environmental changes in response to specific“germinant” <strong>and</strong> transform rapidly into growing vegetative cells. The spores are heat resistant <strong>and</strong> canremain in non metabolic state for many years. This characteristic can effectively be used as a biosensorfor tracking these residues in milk <strong>and</strong> milk products. In the present invention, an analytical process<strong>of</strong> transformation <strong>of</strong> dormant spore <strong>of</strong> Bacillus stearothermophilus into active vegetative cell throughactivation, germination <strong>and</strong> outgrowth has been developed .This analytical process can track majorgroups <strong>of</strong> antibiotic residues in milk within 2.30-3.0 hours at MRL / or above levels recommended bycodex.Brief <strong>of</strong> Invention: An analytical process which involves sporulation & activation <strong>of</strong> dormantspores <strong>of</strong> B.stearothermophilus in newly developed medium & their germination/ outgrowth inpresence <strong>of</strong> selective germinant mixture has been developed (Patent Reg # IPR/ 4.9.1.4/ 05074/ 1479/DEL /2006). The validated process is in line with AOAC approved charm 6602 system & can beused effectively for semi-quantitative detection <strong>of</strong> antibiotic residues in different types <strong>of</strong> milk systemwithin 2.30-3.0 hrs at MRL/ or above levels as recommended by the codex /EU. This cost effectiveprocess can also find applications in targeting spoilage <strong>and</strong> pathogenic organisms in dairy <strong>and</strong> nondairy foods.Market Potential: For monitoring <strong>of</strong> drug residues in milk well defined test / rapid assay techniqueare not available in India. MDR test Kit was <strong>of</strong>fered to various stake holders like m/s Duke ThomsonPvt. Ltd., Indore; Hi-media Pvt. Ltd, Mumbai, NDDB; M/s Neugen diagnostic secunderabad etc. Theproduct was appreciated by all these potential customers <strong>and</strong> finally one non-exclusive license withfee <strong>of</strong> Rs. 2.50 lakhs, royalty 2.0% & validity <strong>of</strong> license for period <strong>of</strong> 7 years was given to M/s Neugendiagnostic Secunderabad who currently is selling our product to different dairy units like Mother<strong>Dairy</strong>, Delhi; Paras <strong>Dairy</strong> (3 units); Bholebaba <strong>Dairy</strong>; Hatsun <strong>Dairy</strong>, TN; Aavin <strong>Dairy</strong>, TN; Kolar <strong>Dairy</strong>,Karnataka; Shipra Lab, Bengaluru; Delhi Milk Scheme etc. Microbial Drug Residues Test Kit (15 settest) developed at dairy microbiology division were sold to different dairy units through M/s NeugenDiagnostic Pvt. Ltd. @ 1200/- + CST @ 10.30% in last six months period. Further steps are required for243


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceAOAC approval <strong>of</strong> this product which will be costing around 10 lakhs <strong>and</strong> may exp<strong>and</strong> its applicationat domestic level by incorporating in our legal st<strong>and</strong>ard (PFA st<strong>and</strong>ard) as well as in export.Novel features <strong>of</strong> process:1. Cost effective2. Better sensitivity3. Semi-quantitative detection4. No false positive /negative results5. Insensitivity towards detergents / sanitizers6. Consistency in color development with in 3.0 hrs7. Validated with AOAC approved charm 6602 system8. Wide spectrum <strong>of</strong> application for different types <strong>of</strong> milk244


Spore Based Biosensor as A <strong>Quality</strong> Control Tool in <strong>Dairy</strong> IndustryA kit for detection <strong>of</strong> β-lactam antibiotic group in milk using bacterial spore as biosensor:This invention relates to application <strong>of</strong> dormant bacterial spores as biosensor. The study isbased on the resistance mechanism <strong>of</strong> some β-lactamase generating Bacillus spp. Some spore formingbacteria such as B. cereus <strong>and</strong> B. licheniformis produce β-lactamase enzyme due to induction by β-lactamantibiotics <strong>and</strong> the enzyme production is proportional to the concentration <strong>of</strong> inducer present in milk.A real time microbial assay based on β-lactamase enzyme using starch iodine as color indicator hasbeen developed. The microbial assay is working on principle <strong>of</strong> non competitive enzyme action oninducer (β-Lactam) resulting in indirect reduction <strong>of</strong> starch iodine mixture through penicilloic acid. Acomparison <strong>of</strong> the intensity <strong>of</strong> the test reaction with that <strong>of</strong> a control was taken as criteria to determineswhether the sample is positive or negative (Kumar et al., 2009) .The assay can detect specifically β-lactam groups in spiked milk with in 15-20 min at regulatory codex limits with negligible sensitivitytowards non β- lactam groups. The presence <strong>of</strong> Inhibitors other than antibiotic residues in milk did notinterfere with the working principle <strong>of</strong> microbial assays. A significant correlation between microbialassay & receptor based assay (charm 6202) was established in survey work with raw, pasteurizedmilk <strong>and</strong> dried products with no false positive/ negative results. Spore suspension was found stableup to 5 months when stored under refrigeration conditions. The microbial assay (Rs 20.54/- test) iscost effective can find immense application in dairy industry as “ON FARM” milk screening test forβ- lactam group (Kumar et al., 2009).The impact <strong>of</strong> innovation on life <strong>of</strong> Rural India: The invention was carried out to test drug residuesat farm level. These drug residues have immense public health <strong>and</strong> processing implications. The fieldlevel testing will be <strong>of</strong> public heath <strong>and</strong> processing value to dairy farmers <strong>and</strong> entrepreneurs who areinvolved in dairy small business.Development <strong>of</strong> spore inhibition based–enzyme substrate assay (sib-esa)for monitoring aflatoxin M1Brief about Innovation: Aflatoxins are toxic, carcinogenic, mutagenic immuno-suppressiveagents produced as secondary metabolites by the fungi Aspergillus flavus & A. parasiticus. Four majorAflatoxins B1, B2, G1, <strong>and</strong> G2 have been isolated from feeds. Aflatoxin M1 is hydroxylated derivativePatent on development <strong>of</strong> spore inhibition based–enzyme substrate assay (SIB-ESA) for monitoring aflatoxinM1 in milk has been filed at NDRI <strong>and</strong> is under processing(Patent Regd.# IPR /4/14.4/10045)245


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> Assurance<strong>of</strong> Aflatoxin B1.The bacterial spores as nano-detector have unique ability to sense environmentalchanges in response to specific “germinant” <strong>and</strong> transform rapidly into growing vegetative cells.This characteristic can be effectively used as biosensor for tracking microbial <strong>and</strong> non–microbialcontaminants (Kumar et al.,2005; Rotman 2001 & 2003).The present hypothesis is based on the specificspore germination inhibition principle in presence <strong>of</strong> specific analyte i.e. aflatoxin M1. In case whereanalyte is absent in milk system, specific indicator enzyme (s) are produced by active bio-sensingmolecules which will act specifically on chromogenic/or fluorogenic substrate resulting in coloredreaction/or fluorescence as end product which is measured semi-quantitatively by either visually/orusing optical system at specific excitation/emission spectra (Kumar et al., 2010).The end product response is significantly different in case <strong>of</strong> buffer/ or milk system containingspecific analyte i. e. aflatoxin M1. The developed test assay was validated by analyzing 25 samples <strong>of</strong>each raw <strong>and</strong> pasteurized milk procured from different organized/or private own dairies <strong>and</strong> otherreputed br<strong>and</strong>s using AOAC approved RIA <strong>and</strong> ELISA based system <strong>and</strong> a significant correlationwith ELISA at Codex MRL Limit (0.5 ppb) <strong>of</strong> Aflatoxin M1 was established.Development <strong>of</strong> Enzyme Substrate Assay (ESA) For Monitoring Enterococci in Milk: AnEnzyme Substrate Assay (ESA) based on β-D-glucosidase activity was attempted for specificdetection <strong>of</strong> Enterococci to meet the emerging dem<strong>and</strong> <strong>of</strong> dairy industry. Four enrichment brothscommercially available in the market were screened for selective recovery <strong>of</strong> Enterococci based onβ-D-glucosidase activity. One <strong>of</strong> these broths namely Chromocult Enterococcus Broth (CEB) showedbetter performance in terms <strong>of</strong> selectivity <strong>and</strong> enzyme activity with partial inhibition <strong>of</strong> contaminantsother than Enterococci. The selected medium was further improved for desired features by increasingthe concentration <strong>of</strong> sodium azide from 0.06 to 0.15 g/100 ml resulting in significant inhibitoryeffect on growth pattern <strong>of</strong> L. lactis, L. casei, Leuconostoc mesenteroides <strong>and</strong> L. monocytogenes. Othermedia components <strong>and</strong> supplements were also optimized for enhanced sensitivity <strong>and</strong> selectivity<strong>of</strong> Enterococcus sp. The optimized selective enrichment medium i. e. Esculin Based Sodium AzideMedium (EBSAM) demonstrated superior features in terms <strong>of</strong> sensitivity, selectivity, fastness, accuracyetc. <strong>and</strong> may be a suitable substitute for existing media used for routine monitoring <strong>of</strong> Enterococci inR&D institutions. Developed assay was screened for Enterococci count with 32 samples <strong>of</strong> raw milk<strong>and</strong> it could detect 2.67, 3.50, 4.25 <strong>and</strong> 4.8 log counts within incubation period <strong>of</strong> 12, 7½, 6½ <strong>and</strong> 5 hrrespectively. ESA could also detect Enterococci log counts <strong>of</strong> 2.84 in pasteurized milk within 12 hrs<strong>of</strong> incubation; however, assay was insensitive at very low level <strong>of</strong> 1.13 <strong>and</strong> 0.915 log counts. As suchESA developed in current investigation may find industrial application as Hygiene Indicator test fordetection <strong>of</strong> Enterococci in raw milk & pasteurized milk with in 5-12 hrs as against 36-48hrs required246


Spore Based Biosensor as A <strong>Quality</strong> Control Tool in <strong>Dairy</strong> Industryin conventional method (Thakur et al., 2010).Concluding remarks: Biosensors are making a great impact on the development <strong>of</strong> rapid, sensitiveassays for the detection <strong>of</strong> microbial <strong>and</strong> non – microbial contaminants in food system. Kits are nowavailable for several organisms such as E. coli O157:H7 <strong>and</strong> Salmonella typhimurium <strong>and</strong> it is hoped thatmore will become available shortly. The most viable openings in the food industry will arise wherea biosensor can rapidly detect total microbial contamination. The largest area <strong>of</strong> application for theenvironment lies in the development <strong>of</strong> biosensors for monitoring bacteria in drinking <strong>and</strong> wastewater, rivers, reservoirs <strong>and</strong> supplies. Spores have a great potential to be used as a biosensor <strong>and</strong>the bioassay are cost effective, rapid, easy to perform <strong>and</strong> require almost negligible infra-structuralfacilities.References:Belluzo, M. S., Ribone, M. E., Lagier, C. M., 2008. Assembling Amperometric Biosensors for Clinical Diagnostics. Sensors8, 1366-1399.Biran, I., Rissin, D., Ron, E. <strong>and</strong> D. Walt. 2003. Optical imaging fiber-based live bacterial cell array biosensor. AnalyticalBiochemistry, 315:1, pp. 106-113.Chauhan, S., Rai, V., Singh, H. B., 2004. Biosensors. Resonance. 33-44.Daunert S., Barrett G., Feliciano J., Shetty R., Shrestha S., <strong>and</strong> W. Smith-Spencer. 2000. Genetically Engineered Whole-Cell Sensing Systems: Coupling Biological Recognition with Reporter Genes. Chem. Rev., 100, pp. 2705-2738.Irudayaraj, J., 2009. Pathogen Sensors. Sensors 9, 8610-8612.Ivnitski, D., Abdel-Hamid, I., Atanasov, P., Wilkins, E., 1999. Biosensors for detection <strong>of</strong> pathogenic bacteria. Biosensors& Bioelectronics 14, 599–624.Kumar, N., Das, S., Manju, G., 2009. A kit for detection <strong>of</strong> β-lactam antibiotic group in milk using bacterial spore asbiosensor (Patent Reg # IPR/115/del/2009).Kumar, N., Sawant, S., Malik, R.K., Patil, G.R., 2005. Development <strong>of</strong> analytical process for detection <strong>of</strong> antibioticresidues in milk using bacterial spores as biosensor (Patent Reg # IPR/4.9.1.4/05074/1479/del/2006).Kumar, N., Singh, N., Singh, V.K., Bh<strong>and</strong>, S., Malik, R.K., 2010. Development <strong>of</strong> spore inhibition based–enzyme substrateassay (SIB-ESA) for monitoring aflatoxin M1 in milk (Patent Regd.# IPR /4/14.4/10045).M<strong>and</strong>al, P. K., Biswas, A. K., Choi, K., Pal, U. K., 2011. Methods for Rapid Detection <strong>of</strong> Foodborne Pathogens: AnOverview. American Journal <strong>of</strong> Food Technology 6(2), 87-102Moir, A., Corfe, B. M., Behravan, J., 2002. Spore germination. Cell Mol Life Sci 59, 403–409.National Research Council (NRC), 2003. Bioavailability <strong>of</strong> Contaminants in Soils <strong>and</strong> Sediments: Processes, Tools, <strong>and</strong>Applications. The National Academies Press.Prescott, L. M., Harley, Klein., 2002. Microbiology. 5th Edition. The McGraw-Hill companies. (Chapter 3)Rasooly <strong>and</strong> Herold, 2006. Biosensors for the <strong>Analysis</strong> <strong>of</strong> Food- <strong>and</strong> Waterborne Pathogens <strong>and</strong> their Toxins. Journal <strong>of</strong>AOAC international 89(3), 873-883.Rogers, K. R., 2000. Principles <strong>of</strong> affinity-based biosensors. Molecular Biotechnology 14(2), 109-129.Rotman, B., 2001. Using living spores for real-time biosensing. Gen. Eng. News 21, 65.Rotman, B., Cote, M. A., 2003. Application <strong>of</strong> a real-time biosensor to detect bacteria in platelet concentrates. Biochem.Biophys. Res. Comm 300, 197-200.Scott, A. O., 1998. Biosensor for food analysis. Published by Royal Society <strong>of</strong> chemistry, Cambridge, UK. (Chapter 1)Setlow, P., 2003. Spore germination. Current Opinion in Microbiology 6, 550–556.Tantilipikara, P., 2005. Optical biosensor for microalbumin determination. A thesis submitted in partial fulfilment <strong>of</strong> therequirement for the degree <strong>of</strong> Master <strong>of</strong> Science. Mahidol University.Tauriainen, S., Virta, M. <strong>and</strong> M. Karp. 2000. Detecting Bioavailable Toxic Metals <strong>and</strong> Metalloids from Natural WaterSamples Using Luminescent Sensor Bacteria. Water Research, 34:10, pp. 2661-2666.Thakur, G., Kumar, N., Raghu, H. V., Malik, R. K., (2010). Development <strong>of</strong> Off-Line Enzyme Substrate Based Assay forMonitoring Enterococci in Milk. NDRI Newsletter Apr – June 2010. Pp 2-3.Thevenot, D. R., Toth, K., Durst, R. A., Wilson, G. S., 2001. Electrochemical biosensors: recommended definitions <strong>and</strong>classification. Biosensors & Bioelectronics 16(1), 121-131.Turpeinen R., Virta M., <strong>and</strong> M. Haggblom. 2003. <strong>Analysis</strong> <strong>of</strong> Arsenic Bioavailability in Contaminated Soils. EnvironmentalToxicology <strong>and</strong> Chemistry, 22:1, pp. 1-6.247


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceDetection <strong>and</strong> Evaluation <strong>of</strong> Antimicrobial Activities <strong>of</strong>Bacteriocins <strong>and</strong> Bioactive Peptides Produced by LABShilpa Vij, Subrota Hati <strong>and</strong> Meenakshi Dahiya<strong>Dairy</strong> Microbiology Division, NDRI, KarnalLactic Acid Bacteria (LAB) have been used for centuries in the fermentation <strong>of</strong> a variety <strong>of</strong> dairyproducts. The preservative ability <strong>of</strong> LAB in foods is attributed to the production <strong>of</strong> anti-microbialmetabolites including organic acids <strong>and</strong> bacteriocins. Bacteriocins generally exert their anti-microbialaction by interfering with the cell wall or the membrane <strong>of</strong> target organisms, either by inhibitingcell wall biosynthesis or causing pore formation, subsequently resulting in death. Bioactive Peptidesare released from milk proteins on enzymatic hydrolysis by the proteolytic enzymes such as trypsin,pepsin , chymotrypsin <strong>and</strong> LAB fermentation <strong>of</strong> milk proteins i.e. whey <strong>and</strong> casein by proteolytic LABsuch as L.helveticus, L.fermentum, L.acidophilus, L casei <strong>and</strong> Lactococci. A large variety <strong>of</strong> techniques haveevolved to assess the ability <strong>of</strong> microorganisms to produce antagonistic substances.Antimicrobial activities <strong>of</strong> bacteriocins/ Bioactive Peptides produced by LABMaterials Required:Sterile Petri-plates, sterile pipettes, Micropipettes, Sterile Micro tips, incubator, MRS agar, TGEagar, TGE s<strong>of</strong>t Agar (0.8 % agar) tubes, indicator strains, the glass tube with a suction bulb, sterile filterpaper discs, forceps, ethyl alcohol (70%).Indicator strainCulture ConditionPediococcus acidilactici LB4230/37ºC MRS / TGE BrothLactobacillus plantarum NCDO 955 37ºC MRS / TGE BrothLactobacillus helveticus37ºC Whey/ Sodium CaseinateImportant:• Only freshly grown (3-4 hours incubation) active indicator strains should be used for determiningantibacterial activity.• Do not use stored (refrigeration temperature) indicator strain for the assay.• Do not use the over night incubated culture for the assay.Procedure:• Grow LAB/ Bacteriocin producing LAB cultures in MRS / M17 broth for 18-24 H as its optimalgrowth temperature (30/37ºC).• Grow proteolytic strains <strong>of</strong> LAB in whey or sodium caseinate (supplemented with 0.5% glucose)for 24 - 48 h as its optimal growth temperature (30/37ºC) for bioactive peptide production.• Remove the cells by centrifugation at 12000 rpm for 20 min at 5ºC.• Sterilize the supernatant from broth by passing through a 0.22 µm membrane or heat treat thesupernatant at 90ºC for 3 min in a dry bath/ water bath.• Alternatively cells are killed by boiling for 3-5 min <strong>and</strong> heat killed cultures can be employed.• Ultrafilterate whey qnd sodium caseinate fermentate from 10K Da membrane for separatingbioactive peptides <strong>of</strong> less than 10 KDa molecular weight.• Prepare agar plates by pouring melted agar (MRS/M17) in sterile Petri plates• After solidification <strong>of</strong> the agar transfer the plates to the incubator at 37ºC overnight for drying<strong>of</strong> the agar surface.248


Detection <strong>and</strong> Evaluation <strong>of</strong> Antimicrobial Activities <strong>of</strong> Bacteriocins <strong>and</strong> Bioactive Peptides Produced by LAB• Overlay 5-7 ml <strong>of</strong> s<strong>of</strong>t agar (0.8% agar) which had been seeded with 50 µl <strong>of</strong> the freshly grown(3-4 h) indicator strain. This will generate a potential mat <strong>of</strong> the indicator bacteria.• Refrigerate the plates at 5ºC for 1-2 h before the wells are punched out <strong>of</strong> the agar.• Punch out the wells with the broad end <strong>of</strong> a sterile Pasteur pipette <strong>and</strong> remove the agarbuttons.• Fill the wells 100 µl <strong>of</strong> the prepared culture supernatant/ heat killed cultures <strong>and</strong> less than 10 KDa bioactive peptides from whey <strong>and</strong> sodium caseinate• Put the plates in the refrigerator (5-7ºC) for 3-4 h to facilitate the diffusion <strong>of</strong> the antimicrobialcompound (Do not invert the plates).• Incubate the plates at optimum temperature <strong>of</strong> the indicator strain for 18-24 h (Do not invert theplates).• Observe the plates for zone <strong>of</strong> clearance (if any) around the edge <strong>of</strong> the wells.• A clear zone <strong>of</strong> 1 mm or greater extending laterally from the edge <strong>of</strong> the wells is consideredpositive inhibition. Use sterile distilled water as a control.Detection <strong>of</strong> bacteriocin (Nisin) produced by LABThis is a faster MTT [3-(4,5-dimethyl thiazol-2-yl)-2,5-diphenyl tetrazolium bromide] colorimetricassay (MCA) for quantitative measurement <strong>of</strong> polypeptide bacteriocins in solutions with nisin as anexample. After an initial incubation <strong>of</strong> nisin <strong>and</strong> indicator bacterium Micrococcus luteus NCIB 8166 intubes, MTT was added for another incubation period. After that, nisin was quantified by estimatingthe number <strong>of</strong> viable bacteria based on measuring the amount <strong>of</strong> purple formazan produced bycleavage <strong>of</strong> yellow tetrazolium salt MTT. Then MCA was compared to a st<strong>and</strong>ard agar diffusionassay (ADA).1. Indicator bacterial strain <strong>and</strong> cultivation: Inoculate a loop <strong>of</strong> Micrococcus luteus on the S1 agar(0.8% tryptone , 0.5% yeast extract 0.5% D-glucose 0.5% NaCl <strong>and</strong> 0.2% Na 2HPO 4. In agarmedium add 1.5% (w/v) Tween 20.) plate <strong>and</strong> incubate at 37°C for 18~24 h. Then, transfer asingle colony <strong>of</strong> bacteria from the S1 agar to S1 broth <strong>and</strong> incubate at 37°C for 12 h.2. Dissolve MTT in phosphate buffered saline (pH 7.2) to a concentration <strong>of</strong> 5 mg/ml, <strong>and</strong> thenfiltere through a 0.2-μm syringe filter.3. Add 100µl <strong>of</strong> MTT solution into each <strong>of</strong> 2 ml fresh S1 broth with indicator bacteria (from 106 to101 CFU/ml) <strong>and</strong> then incubate at 37°C for 1, 2, 3, 4, 5 <strong>and</strong> 6 h, respectively.4. Keep the broth culture in boiling water for 5 min to stop reaction.5. After cooling, centrifuge the cultures at 1 500×g for 20 min to precipitate formazan crystals6. Remove the supernatant. To dissolve the formazan crystals, add 2 ml <strong>of</strong> dimethylsulfoxide(DMSO) <strong>and</strong> then incubate the mixture for 10 min at room temperature.7. Measured the optical density (OD) <strong>of</strong> the formazan solution at the wavelength <strong>of</strong> 510 nm.249


<strong>Chemical</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Value</strong> <strong>Added</strong> <strong>Dairy</strong> <strong>Products</strong> <strong>and</strong> <strong>Their</strong> <strong>Quality</strong> AssuranceList <strong>of</strong> Selected Participants for Winter School1.Sh. Shiv Shanker Chasta7.Dr. S.G. NarwadeAssistant Pr<strong>of</strong>essor,Assist. Pr<strong>of</strong>. (<strong>Dairy</strong> Science)DFT Department, College <strong>of</strong> <strong>Dairy</strong> & FoodDepartment <strong>of</strong> Animal Husb<strong>and</strong>ry & <strong>Dairy</strong>Science Technology, MPUAT, Udaipur-313001Science, College <strong>of</strong> Agriculture M.A.U.(Rajasthan)Parbhani.431 402chasta_ss@rediffmail.com, 09828566021narwades@rediffmail.com, 090285845372.Dr. M. Ilamaran8.Dr. R.A. Patil3.4.5.6.Assistant Pr<strong>of</strong>essor (FSN)Department <strong>of</strong> Food Science <strong>and</strong> Nutrition,Home Science College <strong>and</strong> Research Institute,Tamil Nadu Agricultural University,Madurai - 625 104drilla@rediffmail.com, 09865175206Dr. R. SaravanakumarAssistant Pr<strong>of</strong>essor (FSN) Department <strong>of</strong> FoodScience <strong>and</strong> Nutrition, Home Science College<strong>and</strong> Research Institute,Tamil Nadu Agricultural University,Madurai - 625 104sar<strong>of</strong>sn@yahoo.com, 09942893107Mr. Durga Shankar BunkarAssistant Pr<strong>of</strong>essor,Center <strong>of</strong> Food Science & Technology,Institute <strong>of</strong> Agricultural Sciences,Banaras Hindu University,Varanasi- 221 005dsbunkar.mtech@gmail.com, 09389835175Dr. Raj Kumar DuaryAssistant Pr<strong>of</strong>essor,Department <strong>of</strong> Food Processing Technology,School <strong>of</strong> Engineering, Tejpur University,Napaam, Sonitpur, Assam -784 028rkduary@gmail.com, 09957669564Dr. Ashim Kumar BiswasDepartment <strong>of</strong> Livestock <strong>Products</strong> Technology,COVS, Gadvasu,Ludhiana-141 004 (Punjab)biswaslpt@gmail.com, 09463320622Assistant Pr<strong>of</strong>essor (AHDS)Dept. Animal Husb<strong>and</strong>ry & <strong>Dairy</strong> Science,College <strong>of</strong> Agriculture, Latur-412 513 (M.S.)rapatil1976@gmail.com, 094221890019. Dr. D.D. PatangeAssistant Pr<strong>of</strong>essor, College <strong>of</strong> Agriculture,Kohlapur-416004 (MS)patange1@rediffmail.com, 0942180094110. Dr. K.D. ChavanAssistant Pr<strong>of</strong>essor,Animal Science <strong>and</strong> <strong>Dairy</strong> Science Section,College <strong>of</strong> Agriculture, Pune, Behind MariaiGate , Khadki, Pune 411 003 (MS)chavankrd@rediffmail.com, 0942205869311. Mr. Ramach<strong>and</strong>ra. BAssistant Pr<strong>of</strong>essor, <strong>Dairy</strong> Science College,KVAFSU, Bidar-585 401bangalorerama@yahoo.com, 0948119172812. Mr. Harsh Prakash SharmaAssistant Pr<strong>of</strong>essorDepartment <strong>of</strong> Food EngineeringCollege <strong>of</strong> Food Processing Technology & BioEnergy AAU,An<strong>and</strong>-388110 Gujarat,harshsharma1983@yahoo.co.in, 0940839873713. Dr. Pawas GoswamiAssistant Pr<strong>of</strong>essorDepartment <strong>of</strong> MicrobiologyMaharshi Dayan<strong>and</strong> Saraswati UniversityAjmer – 305009pawasgoswami@gmail.com, 09829273453


List <strong>of</strong> Selected Participants for Winter School14.Dr. Rakesh Kumar20.Mr. Devraja Naika H.SMS (<strong>Dairy</strong> Technology) 303-C, AradhanaVeterinary college, Koravangala Gate,Enclave, Khajpura, Bailey Road, Patna-800 014Arsikere road, Hassan-573201, Karnatakarakesh.dt27@gmail.com, 09934263033devraaz@gmail.com, 990070469515.Sh. Yogesh Khetra21.Dr. S. Shive KumarScientist, <strong>Dairy</strong> Technology Division,Assistant Scientist (DT)NDRI, KarnalCollege <strong>of</strong> <strong>Dairy</strong> Science & Technologyyogeshndri@gmail.com, 09813902989GADVASU, Ludhiana-141 004 (Punjab)16.Dr. P. Narender RajuScientist, <strong>Dairy</strong> Technology Division,22.drshiva2003@yahoo.com, 09646434238Mr. Vilas Mahadeorao ThakreNDRI, KarnalProgramme Coordinator17.pnr.ndri@gmail.com, 09896038983Mr. Awanish Kr. SrivastavaUnipex <strong>Dairy</strong> Product Co. Ltd. UAEPO Box 5646, Sharjah, United Arab Emirate23.KVK, Sindewahi, Distt. Vh<strong>and</strong>rpur(Maharashatra)suraj820@gmail.com, 09881149896Mr. Saraff Sripad18.avi_indian29@yahoo.co.in, 0097150 3637840Er. Tariq AhmadAsstt. Pr<strong>of</strong>essor & Head,Department <strong>of</strong> <strong>Dairy</strong> Chemistry,<strong>Dairy</strong> Technology Programme,Assistant Pr<strong>of</strong>essorSVVU, Kamareddy, Distt. Nizamabad-AP 503Department <strong>of</strong> Food TechnologyIslamic University <strong>of</strong> Science <strong>and</strong> TechnologyAvantipora (J & K)24.111 sripad_saraff@yahoo.co.in, 09848721561Ms. Nikam Pranali Balkishan19.tariqtech@gmail.com, 09906480112Dr. Arun Goel,Assistant Pr<strong>of</strong>essorDFT Department,25.College <strong>of</strong> <strong>Dairy</strong> Technology, Warud,Pusad -445204pranali2801@gmail.com, 09225235250Dr. Vishakha SinghCollege <strong>of</strong> <strong>Dairy</strong> & Food Science Technology,Assistant Pr<strong>of</strong>essorMPUAT, Udaipur-313001 (Rajasthan)Department <strong>of</strong> Foods & Nutrition,arungoel09@gmail.com, 09887182750College <strong>of</strong> Home science, Maharana PratapUniversity <strong>of</strong> Agriculture & Technology,Udaipur 313001(Rajasthan)vishakha.udaipur@gmail.com, 09414029748

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!